PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goossens, H; Ferech, M; Stichele, RV; Elseviers, M				Goossens, H; Ferech, M; Stichele, RV; Elseviers, M		ESAC Project Grp	Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.	LANCET			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL CONSUMPTION; ESCHERICHIA-COLI; TRENDS	Background Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly recognised as the main selective pressure driving this resistance. Our aim was to assess outpatient use of antibiotics and the association with resistance. Methods We, investigated outpatient antibiotic use in 26 countries in Europe that provided. internationally M comparable distribution or reimbursement data, between Jan 1, 1997, and Dec 31, 2002; by calculating the number R of defined daily doses (DDD) per 1000 inhabitants per day, according to WHO anatomic therapeutic chemical M classification and DDD measurement methodology. We assessed the ecological association between antibiotic use and antibiotic resistance rates using Spearman's correlation coefficients. Findings Prescription of antibiotics in primary care in Europe varied greatly; the highest rate was in France (32.2 DDD per 1000 inhabitants daily) and the lowest was in the Netherlands (10.0 DDD per 1000 inhabitants daily). We noted a shift from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. We also recorded striking seasonal fluctuations with heightened winter peaks in countries with high yearly use of antibiotics. We showed higher rates of antibiotic resistance in high consuming countries, probably related, to the higher consumption in southern and eastern Europe than in northern Europe. Interpretation These data might provide a useful method for assessing public-health strategies that aim to reduce antibiotic use and resistance levels.	Univ Antwerp, Dept Microbiol, ESAC Management Team, B-2610 Antwerp, Belgium; Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands	University of Antwerp; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goossens, H (corresponding author), Univ Antwerp, Dept Microbiol, ESAC Management Team, B-2610 Antwerp, Belgium.	Herman.Goossens@uza.be	Stichele, Robert Vander/K-7203-2015	Stichele, Robert Vander/0000-0001-9118-9651; Elseviers, Monique/0000-0001-9415-6900				Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; BRONZWAER S, 2003, THESIS RIJKSUNIVERSI; Bronzwaer SL, 2000, EMERG INFECT DIS, V3, P278; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chow KM, 2003, ARCH INTERN MED, V163, P1617, DOI 10.1001/archinte.163.13.1617-a; *DAN VET LAB, 2001, DANMAP 2000 CONS ANT; De Laat E., 2002, DOES PHARM MARKETING; DESCHEPPER R, 2002, PATIENT EDUC COUNS, V1590, P1; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Garcia-Rey C, 2004, J ANTIMICROB CHEMOTH, V54, P465, DOI 10.1093/jac/dkh375; GARCIAREY C, IMPORTANCE LOCAL VAR; Goossens H, 1998, BRIT MED J, V317, P654, DOI 10.1136/bmj.317.7159.654; GOOSSENS H, 2003, CORRELATION MACROLID, P111; Guillemot D, 1998, J INFECT DIS, V177, P492, DOI 10.1086/517384; Ho PL, 2001, J ANTIMICROB CHEMOTH, V48, P659, DOI 10.1093/jac/48.5.659; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9; Hutchinson JM, 2001, CAN FAM PHYSICIAN, V47, P1217; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P1005, DOI 10.1093/jac/dkg488; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; Monnet DL, 2004, J ANTIMICROB CHEMOTH, V53, P1109, DOI 10.1093/jac/dkh230; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Orero A, 1997, MED CLIN-BARCELONA, V109, P782; Price DB, 2004, RESP MED, V98, P17, DOI 10.1016/j.rmed.2003.08.011; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004; Vander Stichele RH, 2004, BRIT J CLIN PHARMACO, V58, P419, DOI 10.1111/j.1365-2125.2004.02164.x; World Health Organization (WHO), 2004, AN THER CHEM CLASS S; WORLD HEALTH ORGANIZATION (WHO) REGIONAL OFFICE FOR EUROPE, 2003, EUR HLTH ALL DAT	31	2087	2156	11	283	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					579	587		10.1016/S0140-6736(05)17907-0	http://dx.doi.org/10.1016/S0140-6736(05)17907-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708101				2022-12-24	WOS:000226984300030
J	Remuzzi, G; Weening, JJ				Remuzzi, G; Weening, JJ			Albuminuria as early test for vascular disease	LANCET			English	Editorial Material							STAGE RENAL-DISEASE		Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Bergamo, Italy; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Weening, JJ (corresponding author), Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Bergamo, Italy.	j.j.weening@amc.uva.nl	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Brenner Barry M, 2003, Kidney Int Suppl, pS77; Brenner BM, 2003, KIDNEY INT, V64, P370, DOI 10.1046/j.1523-1755.2003.t01-2-00052.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Moeller S, 2002, NEPHROL DIAL TRANSPL, V17, P2071, DOI 10.1093/ndt/17.12.2071; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1997, LANCET, V349, P1857; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Wild SH, 2004, DIABETES CARE, V27, P2569, DOI 10.2337/diacare.27.10.2569-a; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	12	38	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					556	557						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708086				2022-12-24	WOS:000226984300009
J	Sustar, A; Schubiger, G				Sustar, A; Schubiger, G			A transient cell cycle shift in Drosophila imaginal disc cells precedes multipotency	CELL			English	Article							ADULT STEM-CELLS; ECTOPIC EXPRESSION; CLONAL ANALYSIS; WING FORMATION; LEG DISKS; MELANOGASTER; GENE; TRANSDETERMINATION; REGENERATION; GROWTH	When Drosophila imaginal discs regenerate, specific groups of cells can switch disc identity so that, for example, cells determined for leg identity switch to wing. Such switches in cell determination are known as transdetermination. We have developed a system by which individual cells are marked and monitored in vivo as they transdetermine so that their proliferation, cell sizes, and differentiation are accurately traced. Here, we document that when cells transdetermine, they do not convert to a younger cell cycle. Instead, cell cycle changes precede transdetermination and are different from those observed at any time in normal development. We propose that it is not a younger but a unique cell cycle progression and a big cell size that conditions the cells for developmental plasticity.	Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schubiger, G (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	gerold@u.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 1989, DROSOPHILA LAB HDB M; Avots A, 2002, IMMUNOL REV, V187, P9, DOI 10.1034/j.1600-065X.2002.18702.x; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brumby AM, 2002, EMBO J, V21, P3377, DOI 10.1093/emboj/cdf334; BRYANT PJ, 1975, J EXP ZOOL, V193, P49, DOI 10.1002/jez.1401930106; del Alamo D, 2002, DEVELOPMENT, V129, P1975; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Edgar Bruce A., 2004, VVolume 42, P23; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GEHRING W, 1968, J EMBRYOL EXP MORPH, V20, P307; GEHRING W, 1967, DEV BIOL, V16, P438, DOI 10.1016/0012-1606(67)90058-9; GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77; Gehring W., 1972, BIOL IMAGINAL DISKS, P35; GIRTON JR, 1980, DEV BIOL, V77, P1, DOI 10.1016/0012-1606(80)90453-4; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; HADORN E, 1970, P NATL ACAD SCI USA, V65, P633, DOI 10.1073/pnas.65.3.633; HADORN E, 1978, GENET BIOL DROSOPHIL, P555; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JAN YN, 1985, J NEUROSCI, V5, P2453; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Johnston LA, 2003, NAT CELL BIOL, V5, P827, DOI 10.1038/ncb1041; KIEHLE CP, 1985, DEV BIOL, V109, P336, DOI 10.1016/0012-1606(85)90460-9; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; LOOSLI R, 1959, DEV BIOL, V1, P24, DOI 10.1016/0012-1606(59)90040-5; Maves L, 1998, DEVELOPMENT, V125, P115; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MINDEK G, 1968, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V161, P249, DOI 10.1007/BF00573805; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Oldham S, 2002, DEVELOPMENT, V129, P4103; Popperl H, 2000, MOL CELL, V6, P255, DOI 10.1016/S1097-2765(00)00027-7; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCHUBIGE.G, 1973, EXPERIENTIA, V29, P631, DOI 10.1007/BF01926712; Schubiger G., 1968, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V160, P9, DOI 10.1007/BF00573645; SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; Spemann H., 1938, EMBRYONIC DEV INDUCT; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; TOBLER H, 1966, J EMBRYOL EXP MORPH, V16, P609; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Voncken JW, 1999, J CELL SCI, V112, P4627; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; WILDERMU.H, 1968, DEV BIOL, V18, P1, DOI 10.1016/0012-1606(68)90019-5; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0	51	57	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					383	393		10.1016/j.cell.2004.12.008	http://dx.doi.org/10.1016/j.cell.2004.12.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707896	Bronze			2022-12-24	WOS:000227028900013
J	Teuten, EL; Xu, L; Reddy, CM				Teuten, EL; Xu, L; Reddy, CM			Two abundant bioaccumulated halogenated compounds are natural products	SCIENCE			English	Article							POLYBROMINATED DIPHENYL ETHERS; SPONGE DYSIDEA-HERBACEA; MARINE SPONGE; RADIOCARBON; DERIVATIVES; CONGENERS	Methoxylated polybrominated diphenyl ethers (MeO-PBDEs) have been found bioaccumulated in the tissues of a variety of aquatic animals and at concentrations comparable to those of anthropogenic halogenated organic compounds, including polychlorinated biphenyls (PCBs). The origin of the MeO-PBDEs has been uncertain; circumstantial evidence supports a natural and/or an industrial source. By analyzing the natural abundance radiocarbon content of two MeO-PBDEs isolated from a True's beaked whale (Mesoplodon mirus), we show that these compounds were naturally produced.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Reddy, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	creddy@whoi.edu		Reddy, Christopher/0000-0002-7814-2071				Anjaneyulu V, 1996, INDIAN J CHEM B, V35, P89; CAPON R, 1981, J CHEM SOC PERK T 1, P2464, DOI 10.1039/p19810002464; CARTE B, 1981, TETRAHEDRON, V37, P2335, DOI 10.1016/S0040-4020(01)88886-4; Eriksson J, 2004, ENVIRON SCI TECHNOL, V38, P3119, DOI 10.1021/es049830t; FU XO, 1995, J NAT PROD, V58, P1384, DOI 10.1021/np50123a008; Haglund PS, 1997, ENVIRON SCI TECHNOL, V31, P3281, DOI 10.1021/es9702834; Hakk H, 2003, ENVIRON INT, V29, P801, DOI 10.1016/S0160-4120(03)00109-0; Handayani D, 1997, J NAT PROD, V60, P1313, DOI 10.1021/np970271w; HIGA T, 1977, MARINE NATURAL PRODU, P35; Hundt K, 2000, APPL ENVIRON MICROB, V66, P4157, DOI 10.1128/AEM.66.9.4157-4160.2000; Kierkegaard A, 1999, ENVIRON SCI TECHNOL, V33, P1612, DOI 10.1021/es9807082; Kierkegaard A, 2004, ENVIRON POLLUT, V130, P187, DOI 10.1016/j.envpol.2003.12.011; KUNIYOSHI M, 1985, EXPERIENTIA, V41, P523, DOI 10.1007/BF01966182; LETCHER RJ, 2003, ORGANOHALOGEN COMPD, V61, P29; Liu HW, 2004, J NAT PROD, V67, P472, DOI 10.1021/np0304621; Mead J.G., 1989, P349; MEIRONYTE D, 2003, J TOXICOL ENV HLTH, V58, P329; Nydal R, 2000, RADIOCARBON, V42, P81; PEARSON A, 2000, THESIS WOODS HOLE OC; Reddy CM, 2004, ENVIRON SCI TECHNOL, V38, P1992, DOI 10.1021/es030568i; Reddy CM, 2002, ENVIRON POLLUT, V120, P163, DOI 10.1016/S0269-7491(02)00162-8; SCHMIDT S, 1992, APPL ENVIRON MICROB, V58, P2744, DOI 10.1128/AEM.58.9.2744-2750.1992; Stapleton HM, 2004, ENVIRON SCI TECHNOL, V38, P1054, DOI 10.1021/es0348804; Stegeman JJ, 1993, AQUATIC TOXICOLOGY M, P87; Stringer R, 2001, CHLORINE ENV OVERVIE; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Utkina NK, 2002, J NAT PROD, V65, P1213, DOI 10.1021/np0106438; Vetter W, 2002, ENVIRON TOXICOL CHEM, V21, P2014, DOI 10.1897/1551-5028(2002)021<2014:SHNPFA>2.0.CO;2; Vetter W, 2001, ARCH ENVIRON CON TOX, V41, P221; *VIRG MAR SCI MUS, 2003, NECR EX REP	30	278	293	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					917	920		10.1126/science.1106882	http://dx.doi.org/10.1126/science.1106882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705850				2022-12-24	WOS:000226985100051
J	Grice, K; Cao, CQ; Love, GD; Bottcher, ME; Twitchett, RJ; Grosjean, E; Summons, RE; Turgeon, SC; Dunning, W; Jin, YG				Grice, K; Cao, CQ; Love, GD; Bottcher, ME; Twitchett, RJ; Grosjean, E; Summons, RE; Turgeon, SC; Dunning, W; Jin, YG			Photic zone euxinia during the Permian-Triassic superanoxic event	SCIENCE			English	Article							MOLECULAR INDICATORS; MASS EXTINCTION; ORGANIC GEOCHEMISTRY; BOUNDARY; SULFUR; ANOXIA; CARBON; ENRICHMENT; ISOTOPE; SULFATE	Carbon and sulfur isotopic data, together with biomarker and iron speciation analyses of the Hovea-3 core that was drilled in the Perth Basin, Western Australia, indicate that euxinic conditions prevailed in the paleowater column during the Permian-Triassic superanoxic event. Biomarkers diagnostic for anoxygenic photosynthesis, by Chlorobiaceae are particularly abundant at the boundary and into the Early Triassic. Similar conditions prevailed in the contemporaneous seas off South China. Our evidence for widespread photic-zone euxinic conditions suggests that sulfide toxicity was a driver of the extinction and a factor in the protracted recovery.	Curtin Univ Technol, Perth, WA 6001, Australia; MIT, Cambridge, MA 02139 USA; Nanjing Inst Geol & Palaeontol, Nanjing, Peoples R China; Max Planck Inst Marine Microbiol, Bremen, Germany; Univ Plymouth, Plymouth PL4 8AA, Devon, England; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	Curtin University; Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Max Planck Society; University of Plymouth; United States Department of Energy (DOE); Oak Ridge National Laboratory	Grice, K (corresponding author), Curtin Univ Technol, Perth, WA 6001, Australia.	K.Grice@curtin.edu.au	Böttcher, Michael/A-6746-2013; Summons, Roger Everett/AAL-3789-2020	Bottcher, Michael Ernst/0000-0002-8877-0303; Grice, Kliti/0000-0003-2136-3508				Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Foster C.B., 1997, APPEA J, V37, P472; Grice K, 1996, ORG GEOCHEM, V25, P131, DOI 10.1016/S0146-6380(96)00130-1; Grice K, 1996, GEOCHIM COSMOCHIM AC, V60, P3913, DOI 10.1016/0016-7037(96)00199-8; GRICE K, UNPUB; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; KAJIWARA Y, 1994, PALAEOGEOGR PALAEOCL, V111, P367, DOI 10.1016/0031-0182(94)90072-8; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Koopmans MP, 1996, GEOCHIM COSMOCHIM AC, V60, P4467, DOI 10.1016/S0016-7037(96)00238-4; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; KUMP LR, 2003, GSA ANN M GEOL SOC A; LEWAN MD, 1982, GEOCHIM COSMOCHIM AC, V46, P2547, DOI 10.1016/0016-7037(82)90377-5; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Newton RJ, 2004, EARTH PLANET SC LETT, V218, P331, DOI 10.1016/S0012-821X(03)00676-9; Pancost RD, 2004, J GEOL SOC LONDON, V161, P353, DOI 10.1144/0016764903-059; Passier HF, 1999, NATURE, V397, P146, DOI 10.1038/16441; Schouten S, 1998, GEOCHIM COSMOCHIM AC, V62, P1397, DOI 10.1016/S0016-7037(98)00076-3; Schwab V, 2004, APPL GEOCHEM, V19, P55, DOI 10.1016/S0883-2927(03)00127-6; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; Thomas BM, 2004, AUST J EARTH SCI, V51, P423, DOI 10.1111/j.1400-0952.2004.01066.x; TRULL TW, 2001, EOS T AM GEOPHYS UN, V82, P306; WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155	28	591	650	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2005	307	5710					706	709		10.1126/science.1104323	http://dx.doi.org/10.1126/science.1104323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15661975	Green Submitted			2022-12-24	WOS:000226814900038
J	Fan, QR; Hendrickson, WA				Fan, QR; Hendrickson, WA			Structure of human follicle-stimulating hormone in complex with its receptor	NATURE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; LEUCINE-RICH REPEATS; ALPHA-SUBUNIT; LUTEINIZING-HORMONE; HUMAN FOLLITROPIN; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; BINDING DOMAIN; BETA-SUBUNIT; REGION	Follicle-stimulating hormone (FSH) is central to reproduction in mammals. It acts through a G-protein-coupled receptor on the surface of target cells to stimulate testicular and ovarian functions. We present here the 2.9-Angstrom-resolution structure of a partially deglycosylated complex of human FSH bound to the extracellular hormone-binding domain of its receptor (FSHRHB). The hormone is bound in a hand-clasp fashion to an elongated, curved receptor. The buried interface of the complex is large (2,600 Angstrom(2)) and has a high charge density. Our analysis suggests that all glycoprotein hormones bind to their receptors in this mode and that binding specificity is mediated by key interaction sites involving both the common alpha- and hormone-specific beta-subunits. On binding, FSH undergoes a concerted conformational change that affects protruding loops implicated in receptor activation. The FSH-FSHRHB complexes form dimers in the crystal and at high concentrations in solution. Such dimers may participate in transmembrane signal transduction.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			NIGMS NIH HHS [R01 GM068671] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068671] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold CJ, 1998, BIOCHEMISTRY-US, V37, P1762, DOI 10.1021/bi971816o; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN F, 1992, MOL ENDOCRINOL, V6, P914, DOI 10.1210/me.6.6.914; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Dias JA, 2002, VITAM HORM, V64, P249, DOI 10.1016/S0083-6729(02)64008-7; DIAS JA, 1994, J BIOL CHEM, V269, P25289; ERICKSON LD, 1990, ENDOCRINOLOGY, V126, P2555, DOI 10.1210/endo-126-5-2555; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grossmann M, 1997, J BIOL CHEM, V272, P15532, DOI 10.1074/jbc.272.24.15532; Heikoop JC, 1998, EUR J BIOCHEM, V253, P354, DOI 10.1046/j.1432-1327.1998.2530354.x; Hsu SYT, 2003, TRENDS ENDOCRIN MET, V14, P303, DOI 10.1016/S1043-2760(03)00106-1; Ji I, 2004, MOL ENDOCRINOL, V18, P968, DOI 10.1210/me.2003-0443; JI IH, 1993, J BIOL CHEM, V268, P22971; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEUTMANN HT, 1989, MOL ENDOCRINOL, V3, P526, DOI 10.1210/mend-3-3-526; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Laue MT, 1992, ANAL ULTRACENTRIFUGA, P90; LEINUNG MC, 1991, P NATL ACAD SCI USA, V88, P9707, DOI 10.1073/pnas.88.21.9707; Liu C, 1996, ARCH BIOCHEM BIOPHYS, V329, P127, DOI 10.1006/abbi.1996.0200; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; NARAYAN P, 1995, MOL ENDOCRINOL, V9, P1720, DOI 10.1210/me.9.12.1720; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Remy JJ, 1996, MOL CELL ENDOCRINOL, V125, P79, DOI 10.1016/S0303-7207(96)03955-X; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; SUGAHARA T, 1995, P NATL ACAD SCI USA, V92, P2041, DOI 10.1073/pnas.92.6.2041; Szkudlinski MW, 1996, NAT BIOTECHNOL, V14, P1257, DOI 10.1038/nbt1096-1257; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	50	431	455	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					269	277		10.1038/nature03206	http://dx.doi.org/10.1038/nature03206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662415	Green Accepted			2022-12-24	WOS:000226381300045
J	Forman, JP; Rimm, EB; Stampfer, MJ; Curhan, GC				Forman, JP; Rimm, EB; Stampfer, MJ; Curhan, GC			Folate intake and the risk of incident hypertension among US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVES ENDOTHELIAL FUNCTION; CORONARY-ARTERY DISEASE; BLOOD-PRESSURE CHANGE; MIDDLE-AGED MEN; FOLIC-ACID; DEPENDENT VASODILATION; NUTRITIONAL FACTORS; MILD HYPERTENSION; DIETARY FACTORS; CLINICAL-TRIAL	Context Folate has important beneficial effects on endothelial function, but there is limited information about folate intake and risk of incident hypertension. Objective To determine whether higher folate intake is associated with a lower risk of incident hypertension. Design, Setting, and Participants Two prospective cohort studies of 93803 younger women aged 27 to 44 years in the Nurses' Health Study II (1991-1999) and 62260 older women aged 43 to 70 years in the Nurses' Health Study I (1990-1998), who did not have a history of hypertension. Baseline information on dietary folate and supplemental folic acid intake was derived from semiquantitative food frequency questionnaires and was updated every 4 years. Main Outcome Measure Relative risk of incident self-reported hypertension during 8 years of follow-up. Results We identified 7373 incident cases of hypertension in younger women and 12347 cases in older women. After adjusting for multiple potential confounders, younger women who consumed at least 1000 mug/d of total folate (dietary plus supplemental) had a decreased risk of hypertension (relative risk [RR], 0.54; 95% confidence interval [CI], 0.45-0.66; P for trend <.001) compared with those who consumed less than 200 mu g/d. Younger women's absolute risk reduction (ARR) was approximately 8 cases per,1000 person-years (6.7 vs 14.8 cases). The multivariable RR for the same comparison in older women was 0.82 (95% CI, 0.69-0.97; P for trend =.05). Older women's ARR was approximately 6 cases per 1000 person-years (34.7 vs 40.4 cases). When the analysis was restricted to women with low dietary folate intake (<200 mug/d), the multivariable RR for younger women with total folate intake at least 800 mug/d compared with less than 200 mug/d was 0.55 (95% CI, 0.32-0.94; P for trend =.03), and 0.61 (95% CI, 0.34-1.11; P for trend =.05) in the older cohort. Among women who did not take folic acid-containing supplements, dietary folate intake of 400 mug/d or more was not significantly associated with risk of hypertension. Conclusion Higher total folate intake was associated with a decreased risk of incident hypertension, particularly in younger women.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Forman, JP (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	jforman@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL078093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allender PS, 1996, ANN INTERN MED, V124, P825, DOI 10.7326/0003-4819-124-9-199605010-00007; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; Doshi SN, 2002, CIRCULATION, V105, P22, DOI 10.1161/hc0102.101388; Doshi SN, 2001, ARTERIOSCL THROM VAS, V21, P1196, DOI 10.1161/hq0701.092000; ELIASSON K, 1992, J HYPERTENS, V10, P195, DOI 10.1097/00004872-199202000-00014; FIEBACH NH, 1989, AM J EPIDEMIOL, V130, P646; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; He J, 2004, J HYPERTENS, V22, P73, DOI 10.1097/00004872-200401000-00015; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mangoni AA, 2002, J INTERN MED, V252, P497, DOI 10.1046/j.1365-2796.2002.01059.x; MARGETTS BM, 1986, BRIT MED J, V293, P1468, DOI 10.1136/bmj.293.6560.1468; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Stroes ESG, 2000, CIRC RES, V86, P1129; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Sundstrom J, 2003, HYPERTENSION, V42, P1100, DOI 10.1161/01.HYP.0000101690.58391.13; van Dijk RAJM, 2001, ARTERIOSCL THROM VAS, V21, P2072, DOI 10.1161/hq1201.100223; van Etten RW, 2002, DIABETOLOGIA, V45, P1004, DOI 10.1007/s00125-002-0862-1; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Verhaar MC, 1999, CIRCULATION, V100, P335, DOI 10.1161/01.CIR.100.4.335; Verhaar MC, 1998, CIRCULATION, V97, P237, DOI 10.1161/01.CIR.97.3.237; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; WALKER WG, 1993, AM J KIDNEY DIS, V22, P164; WALL RT, 1980, THROMB RES, V18, P113, DOI 10.1016/0049-3848(80)90175-9; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; WHELTON PK, 1989, AM J CARDIOL, V63, pG26, DOI 10.1016/0002-9149(89)90215-4; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.11; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	48	93	100	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					320	329		10.1001/jama.293.3.320	http://dx.doi.org/10.1001/jama.293.3.320			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657325				2022-12-24	WOS:000226358400026
J	Sanchez, PA; Swaminathan, MS				Sanchez, PA; Swaminathan, MS			Hunger in Africa: the link between unhealthy people and unhealthy soils	LANCET			English	Article									Columbia Univ, Earth Inst, Palisades, NY 10964 USA; MS Swaminathan Res Fdn, Madras, Tamil Nadu, India	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, Lamont Doherty Campus,61 Route 9W,POB 1000,Lamont, Palisades, NY 10964 USA.	sanchez@iri.columbia.edu						[Anonymous], 2001, STAT FOOD INS WORLD; [Anonymous], 2003, CROP VARIETY IMPROVE; De Onis M., 2003, WHO GLOBAL DATABASE; KADIYALA S, 2003, 159 INT FOOD POL RES; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; SANCHEZ PA, IN PRESS SCIENCE; *UN, SECR GEN CALLS UN AF; *UN ACC SCN, 2000, 4 UN ACCSCN IFPRI; *UN MILL PROJ TASK, 2005, INV DEV PRACT GUID A; [No title captured]; [No title captured]	12	104	111	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					442	444						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680461				2022-12-24	WOS:000226610900033
J	Luo, WF; Bentley, D				Luo, WF; Bentley, D			Ribonucleolytic rat torpedoes RNA polymerase II	CELL			English	Editorial Material							TRANSCRIPTION TERMINATION; NASCENT RNA; CLEAVAGE; DOMAIN; SITE	Three recent papers reveal a fascinating link between pol II termination and ribonucleolytic decay of the nascent transcript by a 5'-3' exonuclease (yeast Rat1 and human Xrn2). The exonuclease travels with pol II and gains access to the nascent RNA after endonucleolytic cleavage at the poly(A) site or at a second cotranscriptional cleavage site (CoTC). It is then thought to track in a 5'-3' direction like a guided torpedo that ultimately helps dissociate the RNA polymerase elongation complex.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bentley, D (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	david.bentley@uchsc.edu		Bentley, David/0000-0002-8414-4647	NIGMS NIH HHS [R01 GM063873] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063873] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; Liu YM, 2003, RNA, V9, P677, DOI 10.1261/rna.2128903; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; OROZCO IJ, 2002, J BIOL CHEM, V23, P23; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035	20	32	35	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					911	914		10.1016/j.cell.2004.11.041	http://dx.doi.org/10.1016/j.cell.2004.11.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620350	Bronze			2022-12-24	WOS:000226109700004
J	Bettencourt-Dias, M; Giet, R; Sinka, R; Mazumdar, A; Lock, WG; Balloux, F; Zafiropoulos, PJ; Yamaguchi, S; Winter, S; Carthew, RW; Cooper, M; Jones, D; Frenz, L; Glover, DM				Bettencourt-Dias, M; Giet, R; Sinka, R; Mazumdar, A; Lock, WG; Balloux, F; Zafiropoulos, PJ; Yamaguchi, S; Winter, S; Carthew, RW; Cooper, M; Jones, D; Frenz, L; Glover, DM			Genome-wide survey of protein kinases required for cell cycle progression	NATURE			English	Article								Cycles of protein phosphorylation are fundamental in regulating the progression of the eukaryotic cell through its division cycle. Here we test the complement of Drosophila protein kinases (kinome) for cell cycle functions after gene silencing by RNA-mediated interference. We observed cell cycle dysfunction upon downregulation of 80 out of 228 protein kinases, including most kinases that are known to regulate the division cycle. We find new enzymes with cell cycle functions; some of these have family members already known to phosphorylate microtubules, actin or their associated proteins. Additionally, depletion of several signalling kinases leads to specificmitotic aberrations, suggesting novel roles for familiar enzymes. The survey reveals the inter-digitation of systems that monitor cellular physiology, cell size, cellular stress and signalling processes with the basic cell cycle regulatory machinery.	Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Univ Rennes 1, Equipe Labellisee Ligue Natl Contre Canc, Grp Cycle Cellulaire, IFR97,CNRS UMR 6061, F-35043 Rennes, France; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Cyclacel Ltd, Polgen Div, Cambridge CB4 2AT, England	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Northwestern University; Cyclacel Pharmaceuticals Inc.	Bettencourt-Dias, M (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	mbcd2@cam.ac.uk; dmg25@mole.bio.cam.ac.uk	Sinka, Rita/ABA-8767-2021; Balloux, Francois/D-4783-2009; Balloux, Francois/X-7856-2019; Bettencourt-Dias, Monica/B-5176-2015	Balloux, Francois/0000-0003-1978-7715; Balloux, Francois/0000-0003-1978-7715; Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103; Sinka, Rita/0000-0003-4040-4184	NIGMS NIH HHS [R01 GM068743] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	278	291	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					980	987		10.1038/nature03160	http://dx.doi.org/10.1038/nature03160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616552				2022-12-24	WOS:000225887000031
J	Poulsen, M; Boomsma, JJ				Poulsen, M; Boomsma, JJ			Mutualistic fungi control crop diversity in fungus-growing ants	SCIENCE			English	Article							LEAF-CUTTING ANTS; SYMBIOTIC FUNGI; SOMATIC INCOMPATIBILITY; EVOLUTION; SPECIALIZATION; AGRICULTURE; HYMENOPTERA; CONFLICT	Leaf-cutting ants rear clonal fungi for food and transmit the fungi from mother to daughter colonies so that symbiont mixing and conflict, which result from competition between genetically different clones, are avoided. Here we show that despite millions of years of predominantly vertical transmission, the domesticated fungi actively reject mycelial fragments from neighboring colonies, and that the strength of these reactions are in proportion to the overall genetic difference between these symbionts. Fungal incompatibility compounds remain intact during ant digestion, so that fecal droplets, which are used for manuring newly grown fungus, elicit similar hostile reactions when applied to symbionts from other colonies. Symbiont control over new mycelial growth by manurial imprinting prevents the rearing of multiple crops in fungus gardens belonging to the same colony.	Univ Copenhagen, Dept Populat Biol, Inst Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Poulsen, M (corresponding author), Univ Copenhagen, Dept Populat Biol, Inst Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.	Mpoulsen@bi.ku.dk	Boomsma, Jacobus J/M-2785-2014; Poulsen, Michael/C-6276-2012	Boomsma, Jacobus J/0000-0002-3598-1609; Poulsen, Michael/0000-0002-2839-1715				Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Adams RMM, 2000, NATURWISSENSCHAFTEN, V87, P491, DOI 10.1007/s001140050765; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bekkevold D, 1999, BEHAV ECOL SOCIOBIOL, V46, P103, DOI 10.1007/s002650050598; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; CURRIE C, COMMUNICATION; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Diamond J, 1998, SCIENCE, V281, P1974, DOI 10.1126/science.281.5385.1974; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HANSEN EM, 1993, MYCOL RES, V97, P1229, DOI 10.1016/S0953-7562(09)81290-2; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Holldobler B., 1990, pi; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; MARTIN MM, 1970, SCIENCE, V169, P16, DOI 10.1126/science.169.3940.16; Mueller UG, 1996, MOL ECOL, V5, P119, DOI 10.1111/j.1365-294X.1996.tb00297.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Murata M., 1997, Recent Research Developments in Agricultural & Biological Chemistry, V1, P15; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; RISSING SW, 1989, NATURE, V338, P420, DOI 10.1038/338420a0; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schultz TR, 1998, INSECT SOC, V45, P457, DOI 10.1007/s000400050101; SCHULTZ TR, 2004, ECOLOGICAL EVOLUTION, P149; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; Villesen P, 2004, EVOLUTION, V58, P2252; Weber N. A., 1972, GARDENING ANTS ATTIN; Worrall JJ, 1997, MYCOLOGIA, V89, P24, DOI 10.2307/3761169; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	33	127	130	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					741	744		10.1126/science.1106688	http://dx.doi.org/10.1126/science.1106688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692054				2022-12-24	WOS:000226814900048
J	Irwin, DE; Bensch, S; Irwin, JH; Price, TD				Irwin, DE; Bensch, S; Irwin, JH; Price, TD			Speciation by distance in a ring species	SCIENCE			English	Article							WORLD LEAF WARBLERS; PHYLLOSCOPUS; GRADIENTS	Ring species, which consist of two reproductively isolated forms connected by a chain of intergrading populations, have often been described as examples of speciation despite gene flow between populations, but this has never been demonstrated. We used amplified fragment length polymorphism (AFLP) markers to study gene flow in greenish warblers (Phylloscopus trochiloides). These genetic markers show distinct differences between two reproductively isolated forms but gradual change through the ring connecting these forms. These findings provide the strongest evidence yet for "speciation by force of distance" in the face of ongoing gene flow.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of British Columbia; Lund University; University of Chicago	Irwin, DE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	irwin@zoology.ubc.ca	Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841				Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; Coyne J. A., 2004, SPECIATION; Dobzhansky T., 1958, CENTURY DARWIN, P19; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Gavrilets S, 1998, P ROY SOC B-BIOL SCI, V265, P1483, DOI 10.1098/rspb.1998.0461; Irwin DE, 2000, EVOLUTION, V54, P998; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2002, EVOLUTION, V56, P2383; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Marchetti K, 1997, OIKOS, V79, P410, DOI 10.2307/3546026; Mayr E., 1942, SYSTEMATICS ORIGIN S; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Noest AJ, 1997, P ROY SOC B-BIOL SCI, V264, P1389, DOI 10.1098/rspb.1997.0193; RICE WR, 1993, EVOLUTION, V47, P1637, DOI 10.1111/j.1558-5646.1993.tb01257.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Ticehurst CB., 1938, SYSTEMATIC REV GENUS	20	146	169	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					414	416		10.1126/science.1105201	http://dx.doi.org/10.1126/science.1105201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662011				2022-12-24	WOS:000226492300043
J	Falini, B; Mecucci, C; Tiacci, E; Alcalay, M; Rosati, R; Pasqualucci, L; La Starza, R; Diverio, D; Colombo, E; Santucci, A; Bigerna, B; Pacini, R; Pucciarini, A; Liso, A; Vignetti, M; Fazi, P; Meani, N; Pettirossi, V; Saglio, G; Mandelli, F; Lo-Coco, F; Pelicci, P; Martelli, MF				Falini, B; Mecucci, C; Tiacci, E; Alcalay, M; Rosati, R; Pasqualucci, L; La Starza, R; Diverio, D; Colombo, E; Santucci, A; Bigerna, B; Pacini, R; Pucciarini, A; Liso, A; Vignetti, M; Fazi, P; Meani, N; Pettirossi, V; Saglio, G; Mandelli, F; Lo-Coco, F; Pelicci, P; Martelli, MF		GIMEMA Acute Leukemia Working	Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; TUMOR-SUPPRESSOR PROTEIN; MINIMAL-RESIDUAL-DISEASE; NON-HODGKINS-LYMPHOMA; FLT3 MUTATIONS; ADULT PATIENTS; FUSION GENE; RT-PCR; NPM	BACKGROUND: Nucleophosmin (NPM), a nucleocytoplasmic shuttling protein with prominent nucleolar localization, regulates the ARF-p53 tumor-suppressor pathway. Translocations involving the NPM gene cause cytoplasmic dislocation of the NPM protein. METHODS: We used immunohistochemical methods to study the subcellular localization of NPM in bone marrow-biopsy specimens from 591 patients with primary acute myelogenous leukemia (AML). We then correlated the presence of cytoplasmic NPM with clinical and biologic features of the disease. RESULTS: Cytoplasmic NPM was detected in 208 (35.2 percent) of the 591 specimens from patients with primary AML but not in 135 secondary AML specimens or in 980 hematopoietic or extrahematopoietic neoplasms other than AML. It was associated with a wide spectrum of morphologic subtypes of the disease, a normal karyotype, and responsiveness to induction chemotherapy, but not with recurrent genetic abnormalities. There was a high frequency of FLT3 internal tandem duplications and absence of CD34 and CD133 in AML specimens with a normal karyotype and cytoplasmic dislocation of NPM, but not in those in which the protein was restricted to the nucleus. AML specimens with cytoplasmic NPM carried mutations of the NPM gene that were predicted to alter the protein at its C-terminal; this mutant gene caused cytoplasmic localization of NPM in transfected cells. CONCLUSIONS: Cytoplasmic NPM is a characteristic feature of a large subgroup of patients with AML who have a normal karyotype, NPM gene mutations, and responsiveness to induction chemotherapy.	Univ Perugia, Monteluce Policlin, Inst Hematol, I-06122 Perugia, Italy; Univ Perugia, Dept Biochem & Mol Biotechnol, I-06122 Perugia, Italy; European Inst Oncol, Milan, Italy; Columbia Univ, Inst Canc Genet, New York, NY USA; Univ Roma La Sapienza, Inst Hematol, Rome, Italy; Univ Foggia, Inst Hematol, Foggia, Italy; Grp Italiano Malattie Ematol Adulto Data Ctr, Rome, Italy; Osped S Luigi, Div Internal Med & Hematol, Orbassano, Italy; Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy	University of Perugia; University of Perugia; IRCCS European Institute of Oncology (IEO); Columbia University; Sapienza University Rome; University of Foggia; University of Rome Tor Vergata	Falini, B (corresponding author), Univ Perugia, Monteluce Policlin, Inst Hematol, I-06122 Perugia, Italy.	faliniem@unipg.it	Rosati, Roberto/AAF-3708-2020; Vignetti, Marco/HHS-9990-2022; Pelicci, Pier Giuseppe/AAL-6572-2020; Liso, Arcangelo/AAL-2183-2020; Alcalay, Myriam/B-3182-2016; La Starza, Roberta/ABD-0836-2022; Alcalay, Myriam/AAB-4300-2019; Colombo, Emanuela/AAO-8113-2020	Rosati, Roberto/0000-0002-0475-3654; Liso, Arcangelo/0000-0001-5638-227X; Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272; Colombo, Emanuela/0000-0003-2079-7398; FALINI, Brunangelo/0000-0002-7198-5965; Saglio, Giuseppe/0000-0002-1046-3514; Vignetti, Marco/0000-0003-1278-604X				Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Carnicer MJ, 2004, LEUKEMIA RES, V28, P19, DOI 10.1016/S0145-2126(03)00125-5; Chang JH, 1998, BIOCHEM J, V329, P539; Christiansen DH, 2001, LEUKEMIA, V15, P1848, DOI 10.1038/sj.leu.2402246; CIMINO G, 1995, CANCER RES, V55, P1625; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; Crescenzi B, 2000, CANCER GENET CYTOGEN, V120, P25, DOI 10.1016/S0165-4608(99)00245-9; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Falini B, 1999, BLOOD, V93, P2697; Falini B, 2002, BLOOD, V99, P409, DOI 10.1182/blood.V99.2.409; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Jaffe ES, 2001, PATHOLOGY GENETICS T; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Mitelman F, 1995, ISCN INT SYSTEM HUMA; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Noguera N, 2002, LEUKEMIA, V16, P2185, DOI 10.1038/sj.leu.2402723; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; SOEKARMAN D, 1992, BLOOD, V79, P2990; Steudel C, 2003, GENE CHROMOSOME CANC, V37, P237, DOI 10.1002/gcc.10219; Umekawa H, 2001, J BIOCHEM-TOKYO, V130, P199, DOI 10.1093/oxfordjournals.jbchem.a002973; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; YonedaKato N, 1996, ONCOGENE, V12, P265	41	1313	1390	3	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					254	266		10.1056/NEJMoa041974	http://dx.doi.org/10.1056/NEJMoa041974			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659725	Bronze			2022-12-24	WOS:000226370500006
J	Higo, T; Hattori, M; Nakamura, T; Natsume, T; Michikawa, T; Mikoshiba, K				Higo, T; Hattori, M; Nakamura, T; Natsume, T; Michikawa, T; Mikoshiba, K			Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44	CELL			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; CALCIUM; CA2+; TYPE-1; PH; CALRETICULIN; CHROMOGRANIN; RELEASE; ROLES	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) are intracellular channel proteins that mediate Ca2+ release from the endoplasmic reticulum (ER) and are involved in many biological processes and diseases. IP(3)Rs are differentially regulated by a variety of cytosolic proteins, but their regulation by ER lumenal protein(s) remains largely unexplored. In this study, we found that ERp44, an ER lumenal protein of the thioredoxin family, directly interacts with the third lumenal loop of IP3R type 1 (IP(3)R1) and that the interaction is dependent on pH, Call concentration, and redox state: the presence of free cysteine residues in the loop is required. Ca2+-imaging experiments and single-channel recording Of IP3R1 activity with a planar lipid bilayer system demonstrated that IP3R1 is directly inhibited by ERp44. Thus, ERp44 senses the environment in the ER lumen and modulates IP3R1 activity accordingly, which should in turn contribute to regulating both intralumenal conditions and the complex patterns of cytosolic Ca2+ concentrations.	Univ Tokyo, Dept Mol Neurobiol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama 3510198, Japan; JST, ICORP, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; Japan Biol Informat Res Ctr, Prot Network Team, Funct Genome Grp, Koto Ku, Tokyo 1358073, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), Univ Tokyo, Dept Mol Neurobiol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mikosiba@ims.u-tokyo.ac.jp	Hattori, Mitsuharu/F-3859-2010; Mikoshiba, Katsuhiko/N-7943-2015	Hattori, Mitsuharu/0000-0002-0503-4969; 				Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; FOYOUZIYOUSSEFI R, 2000, PO NATL ACAD SCI, V97, P5273; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Kamp F, 1998, BIOPHYS J, V74, P290, DOI 10.1016/S0006-3495(98)77786-0; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paschen W, 2003, CELL CALCIUM, V34, P305, DOI 10.1016/S0143-4160(03)00138-6; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Roderick HL, 1998, CELL CALCIUM, V24, P253, DOI 10.1016/S0143-4160(98)90049-5; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899	35	289	296	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					85	98		10.1016/j.cell.2004.11.048	http://dx.doi.org/10.1016/j.cell.2004.11.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652484	Bronze			2022-12-24	WOS:000226365400013
J	Richly, H; Rape, M; Braun, S; Rumpf, S; Hoege, C; Jentsch, S				Richly, H; Rape, M; Braun, S; Rumpf, S; Hoege, C; Jentsch, S			A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting	CELL			English	Article							AAA-ATPASE CDC48/P97; TRANSCRIPTION FACTOR; DNA-REPAIR; CELL-CYCLE; PROTEIN; ER; RAD23; CHAIN; COMPLEX; DOMAIN	Protein degradation in eukaryotes usually requires multi-ubiquitylation and subsequent delivery of the tagged substrates to the proteasome. Recent studies suggest the involvement of the AAA ATPase CDC48, its cofactors, and other ubiquitin binding factors in protein degradation, but how these proteins work together is unclear. Here we show that these factors cooperate sequentially through protein-protein interactions and thereby escort ubiquitin-protein conjugates to the proteasome. Central to this pathway is the chaperone CDC48/p97, which coordinates substrate recruitment, E4-catalyzed multiubiquitin chain assembly, and proteasomal targeting. Concomitantly, CDC48 prevents the formation of excessive multiubiquitin chain sizes that are surplus to requirements for degradation. In yeast, this escort pathway guides a transcription factor from its activation in the cytosol to its final degradation and also mediates proteolysis at the endoplasmic reticulum by the ERAD pathway.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Rumpf, Sebastian/AHC-9393-2022	Braun, Sigurd/0000-0001-6399-8574; Rape, Michael/0000-0003-4849-6343				Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fu HY, 1999, MOL BIOL REP, V26, P137, DOI 10.1023/A:1006926322501; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HUYTON T, 2003, J STRUCT BIOL, V102, P577; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lambertson D, 1999, GENETICS, V153, P69; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang SR, 1999, GENETICS, V151, P473	48	401	418	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					73	84		10.1016/j.cell.2004.11.013	http://dx.doi.org/10.1016/j.cell.2004.11.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652483	Bronze			2022-12-24	WOS:000226365400012
J	Fletcher, SW; Elmore, JG				Fletcher, SW; Elmore, JG			False-positive mammograms - can the USA learn from Europe?	LANCET			English	Editorial Material							SCREENING MAMMOGRAPHY		Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Boston, MA 02115 USA; Univ Washington, Dept Med, Seattle, WA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Washington; University of Washington Seattle	Fletcher, SW (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	suzanne_fletcher@hms.harvard.edu						Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; BASSETT LW, 1994, AGENCY HLTH CARE POL; BROWN ML, 1995, AM J ROENTGENOL, V165, P1373, DOI 10.2214/ajr.165.6.7484568; de Wolf CJ, 1996, EUROPEAN GUIDELINES; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; JOY JE, 2004, SAVING WOMENS LIVES; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Vainio H, 2002, IARC HDB CANC PREVEN, V7	12	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					7	8		10.1016/S0140-6736(04)17676-9	http://dx.doi.org/10.1016/S0140-6736(04)17676-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639661				2022-12-24	WOS:000226213100005
J	Jeng, MS; Ng, NK; Ng, PKL				Jeng, MS; Ng, NK; Ng, PKL			Feeding behaviour: Hydrothermal vent crabs feast on sea 'snow'	NATURE			English	Editorial Material									Acad Sinica, Inst Zool, Taipei 11529, Taiwan; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Academia Sinica - Taiwan; National University of Singapore	Jeng, MS (corresponding author), Acad Sinica, Inst Zool, Taipei 11529, Taiwan.	jengms@gatz.sinica.edu.tw	Ng, Peter/J-7393-2012					CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Dando P.R., 1995, Geological Society Special Publication, V87, P303, DOI 10.1144/GSL.SP.1995.087.01.23; Jeng MS, 2004, J CRUSTACEAN BIOL, V24, P188, DOI 10.1651/C-2359; KIDO TJ, 1975, TOKYO UNIV FISH, V61, P59; Kuo F.W, 2001, THESIS NATL SUN YAT; Liu C. C., 1995, J GEOL SOC CHINA, V38, P229; Ng N.K., 2000, National Taiwan Museum Special Publication Series, V10, P191; NG NK, UNPUB CRUSTACEANA; Southward AJ, 1997, J MAR BIOL ASSOC UK, V77, P753, DOI 10.1017/S0025315400036171; TAKEDA M, 1993, NATURE ENV SCI RES, V6, P59; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Turkay Michael, 1995, Senckenbergiana Maritima, V26, P25; Van Dover C., 2000, ECOLOGY DEEP SEA HYD	13	70	76	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					969	969		10.1038/432969a	http://dx.doi.org/10.1038/432969a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616550				2022-12-24	WOS:000225887000029
J	Zhou, LQ; Mitra, R; Atkinson, PW; Hickman, AB; Dyda, F; Craig, NL				Zhou, LQ; Mitra, R; Atkinson, PW; Hickman, AB; Dyda, F; Craig, NL			Transposition of hAT elements links transposable elements and V(D)J recombination	NATURE			English	Article							SINGLE ACTIVE-SITE; MUTATIONAL ANALYSIS; MUSCA-DOMESTICA; STRAND TRANSFER; TRANSFER STEPS; RAG PROTEINS; AMINO-ACIDS; DNA; HERMES; RESIDUES	Transposons are DNA sequences that encode functions that promote their movement to new locations in the genome. If unregulated, such movement could potentially insert additional DNA into genes, thereby disrupting gene expression and compromising an organism's viability. Transposable elements are classified by their transposition mechanisms and by the transposases that mediate their movement. The mechanism of movement of the eukaryotic hAT superfamily elements was previously unknown, but the divergent sequence of hAT transposases from other elements suggested that these elements might use a distinct mechanism. Here we have analysed transposition of the insect hAT element Hermes in vitro. Like other transposons, Hermes excises from DNA via double-strand breaks between the donor-site DNA and the transposon ends, and the newly exposed transposon ends join to the target DNA. Interestingly, the ends of the donor double-strand breaks form hairpin intermediates, as observed during V(D)J recombination, the process which underlies the combinatorial formation of antigen receptor genes. Significant similarities exist in the catalytic amino acids of Hermes transposase, the V( D) J recombinase RAG, and retroviral integrase superfamily transposases, thereby linking the movement of transposable elements and V( D) J recombination.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Riverside; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Craig, NL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ncraig@jhmi.edu		Zhou, Li Qin/0000-0001-8900-2835	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036122] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; CRAIG NL, 2002, MOBILE DNA, V2; Davies DR, 1999, J BIOL CHEM, V274, P11904, DOI 10.1074/jbc.274.17.11904; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Kennedy AK, 2000, CELL, V101, P295, DOI 10.1016/S0092-8674(00)80839-9; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kunze R., 2002, MOBILE DNA, P565, DOI DOI 10.1128/9781555817954.CH24; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lewis SM, 1997, CELL, V88, P159, DOI 10.1016/S0092-8674(00)81833-4; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Michel K, 2003, INSECT BIOCHEM MOLEC, V33, P959, DOI 10.1016/S0965-1748(03)00102-4; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; OBrochta DA, 1996, GENETICS, V142, P907; Okuda M, 1998, MOL GEN GENET, V258, P599, DOI 10.1007/s004380050773; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson Hugh M., 2002, P1093; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rubin E, 2001, GENETICS, V158, P949; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Sarkar A, 1997, GENETICA, V99, P15, DOI 10.1023/A:1018349803656; Sarnovsky RJ, 1996, EMBO J, V15, P6348, DOI 10.1002/j.1460-2075.1996.tb01024.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walbot Virginia, 2002, P533; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Yu JH, 2004, MOL CELL BIOL, V24, P1351, DOI 10.1128/MCB.24.3.1351-1364.2004	50	151	159	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					995	1001		10.1038/nature03157	http://dx.doi.org/10.1038/nature03157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616554				2022-12-24	WOS:000225887000033
J	Gallagher, AG; Cates, CU				Gallagher, AG; Cates, CU			Approval of virtual reality training for carotid stenting - What this means for procedural-based medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDARTERECTOMY; ANGIOPLASTY; RISK		Emory Univ, Dept Surg, Atlanta, GA 30322 USA; Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; Emory Heart Ctr, Atlanta, GA USA	Emory University; Emory University	Cates, CU (corresponding author), Emory Univ Hosp, 1364 Clifton Rd NE,Suite C-430, Atlanta, GA 30322 USA.	christopher_cates@emoryhealthcare.org		Gallagher, Anthony G./0000-0003-0887-5613				Cotin S, 2000, Stud Health Technol Inform, V70, P59; GALLAGHER AG, IN PRESS ANN SURG; Gallagher Anthony G, 2003, Semin Laparosc Surg, V10, P127, DOI 10.1177/107155170301000306; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Ouriel K, 2004, J VASC SURG, V39, P916, DOI 10.1016/j.jvs.2004.01.028; Ouriel K, 2004, J AM COLL SURGEONS, V199, P347, DOI 10.1016/j.jamcollsurg.2004.04.012; ROSENFIELD KM, IN PRESS CATHETER CA; Roubin GS, 2002, STROKE, V33, P2520, DOI 10.1161/01.STR.0000033490.22193.1A; SATAVA RM, 1993, SURG ENDOSC-ULTRAS, V7, P203, DOI 10.1007/BF00594110; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; US Food and Drug Administration Center for Devices and Radiological Health Medical Devices Advisory Committee, CIRC SYST DEV PAN M; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; 2004, MEDICARE ANNOUNCES I	13	140	141	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3024	3026		10.1001/jama.292.24.3024	http://dx.doi.org/10.1001/jama.292.24.3024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613672				2022-12-24	WOS:000225841900038
J	Rule, AD; Larson, TS; Bergstralh, EJ; Slezak, JM; Jacobsen, SJ; Cosio, FG				Rule, AD; Larson, TS; Bergstralh, EJ; Slezak, JM; Jacobsen, SJ; Cosio, FG			Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-FUNCTION; PREDICTION EQUATIONS; GFR; ISSUES; ADULTS; DIET	Background: The National Kidney Foundation has advocated the use of the abbreviated Modification of Diet in Renal Disease (MDRD) equation to estimate glomerular filtration rate (GFR) from serum creatinine measurements in clinical laboratories. However, healthy persons were not included in the development of the MDRD equation. Objectives: To assess the accuracy of the MDRD equation in patients with chronic kidney disease compared with healthy persons and to develop a new equation that uses both patients with chronic kidney disease and healthy persons. Design: Cross-sectional study. Setting: The Mayo Clinic, a tertiary-care medical center. Participants: Consecutive patients (n = 320) who had an iothalamate clearance test specifically for chronic kidney disease evaluation and consecutive healthy persons (n = 580) who had an iothalamate clearance test specifically for kidney donor evaluation. Measurements: Serum creatinine levels, GFR, demographic characteristics, and clinical characteristics were abstracted from the medical record. Results: The MDRD equation underestimated GFR by 6.2% in patients with chronic kidney disease and by 29% in healthy persons. Re-estimated coefficients for serum creatinine and sex were similar to the original MDRD equation in the chronic kidney disease series but not in the healthy series. At the same serum creatinine level, age, and sex, GFR was on average 26% higher in healthy persons than in patients with chronic kidney disease (P < 0.001). A quadratic GFR equation was developed to estimate logarithmic GFR from the following covariates: 1/SCr, 1/SCr2, age, and sex (where SCr = serum creatinine). Limitations: The new equation was not developed in a general population sample. Elderly and African-American persons were underrepresented. Conclusion: The MDRD equation systematically underestimates GFR in healthy persons. A new equation developed with patients who have chronic kidney disease and healthy persons may be a step toward accurately estimating GFR when the diagnosis of chronic kidney disease is unknown.	Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Cosio, FG (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	Cosio.Fernando@mayo.edu		Jacobsen, Steven/0000-0002-8174-8533	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07013] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECK GJ, 1991, CONTROL CLIN TRIALS, V12, P566, DOI 10.1016/0197-2456(91)90069-X; Bertolatus JA, 2001, TRANSPLANTATION, V71, P256, DOI 10.1097/00007890-200101270-00016; BUEHRIG CK, 2001, J AM SOC NEPHROL, V12, pA1005; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; HAND DJ, 1998, ENCY BIOSTATISTICS, V5, P3967; Harrell F. E., 2001, REGRESSION MODELING; Hsu CY, 2002, KIDNEY INT, V61, P1567, DOI 10.1046/j.1523-1755.2002.00299.x; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pierrat A, 2003, KIDNEY INT, V64, P1425, DOI 10.1046/j.1523-1755.2003.00208.x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Schuster V.L., 1992, KIDNEY PHYSL PATHOPH, P943; SLACK TK, 1976, MAYO CLIN PROC, V51, P296; Verhave JC, 2004, J AM SOC NEPHROL, V15, P1316; Vervoort G, 2002, NEPHROL DIAL TRANSPL, V17, P1909, DOI 10.1093/ndt/17.11.1909; Wilson DM, 1997, AM J KIDNEY DIS, V30, P646, DOI 10.1016/S0272-6386(97)90488-1	25	862	891	1	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					929	937		10.7326/0003-4819-141-12-200412210-00009	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611490				2022-12-24	WOS:000225923000004
J	Arnett, HA; Fancy, SPJ; Alberta, JA; Zhao, C; Plant, SR; Kaing, S; Raine, CS; Rowitch, DH; Franklin, RJM; Stiles, CD				Arnett, HA; Fancy, SPJ; Alberta, JA; Zhao, C; Plant, SR; Kaing, S; Raine, CS; Rowitch, DH; Franklin, RJM; Stiles, CD			bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS	SCIENCE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; ETHIDIUM-BROMIDE; ADULT CNS; REMYELINATION; EXPRESSION	Olig1 and Olig2 are closely related basic helix-loop-helix (bHLH) transcription factors that are expressed in myelinating oligodendrocytes and their progenitor cells in the developing central nervous system (CNS). Olig2 is necessary for the specification of oligodendrocytes, but the biological functions of Otig1 during oligodendrocyte lineage development are poorly understood. We show here that Olig1 function in mice is required not to develop the brain but to repair it. Specifically, we demonstrate a genetic requirement for Olig1 in repairing the types of lesions that occur in patients with multiple sclerosis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB3 0ES, England; Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Albert Einstein Coll Med, Dept Pathol Neuropathol, Bronx, NY 10461 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Cambridge; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine	Franklin, RJM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	rjf1000@cam.ac.uk; charles-stiles@dfci.harvard.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Rowitch, David/0000-0002-0079-0060; Franklin, Robin/0000-0001-6522-2104	Multiple Sclerosis Society [689] Funding Source: Medline; NINDS NIH HHS [NS4051, NS11920, NS08952] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011920, R01NS008952, P01NS011920] Funding Source: NIH RePORTER	Multiple Sclerosis Society(National Multiple Sclerosis Society); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Penderis J, 2003, EUR J NEUROSCI, V18, P2253, DOI 10.1046/j.1460-9568.2003.02969.x; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raine CS, 1997, J NEUROIMMUNOL, V77, P135, DOI 10.1016/S0165-5728(97)00073-8; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1997, TXB NEUROPATHOLOGY, P245; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	28	334	352	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2111	2115		10.1126/science.1103709	http://dx.doi.org/10.1126/science.1103709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604411				2022-12-24	WOS:000225841000068
J	Saiardi, A; Bhandari, R; Resnick, AC; Snowman, AM; Snyder, SH				Saiardi, A; Bhandari, R; Resnick, AC; Snowman, AM; Snyder, SH			Phosphorylation of proteins by inositol pyrophosphates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; HEXAKISPHOSPHATE KINASE; SUBUNIT; IDENTIFICATION; DICTYOSTELIUM; TRAFFICKING; ADAPTER; CELLS; YEAST	The inositol pyrophosphates IP7 and IP8 contain highly energetic pyrophosphate bonds. Although implicated in various biologic functions, their molecular sites of action have not been clarified. Using radiolabeled IP7, we detected phosphorylation of multiple eukaryotic proteins. We also observed phosphorylation of endogenous proteins by endogenous IP7 in yeast. Phosphorylation by IP7 is nonenzymatic and may represent a novel intracellular signaling mechanism.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu		Bhandari, Rashna/0000-0003-3101-0204	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501, P50MH068830] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00074] Funding Source: Medline; NIMH NIH HHS [MH18501, MH068830-02] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Dixon J, 1996, NAT GENET, V12, P130; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Meier UT, 1996, J BIOL CHEM, V271, P19376; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; Norbis F, 1997, J MEMBRANE BIOL, V156, P19, DOI 10.1007/s002329900183; Paznekas WA, 1997, BIOCHEM BIOPH RES CO, V238, P1, DOI 10.1006/bbrc.1997.7229; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; SAIARDI A, UNPUB; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xue Zhixiong, 1994, Trends in Cell Biology, V4, P414, DOI 10.1016/0962-8924(94)90095-7	25	226	233	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2101	2105		10.1126/science.1103344	http://dx.doi.org/10.1126/science.1103344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	881CM	15604408				2022-12-24	WOS:000225841000065
J	Khazipov, R; Sirota, A; Leinekugel, X; Holmes, GL; Ben-Arf, Y; Buzsaki, G				Khazipov, R; Sirota, A; Leinekugel, X; Holmes, GL; Ben-Arf, Y; Buzsaki, G			Early motor activity drives spindle bursts in the developing somatosensory cortex	NATURE			English	Article							THALAMOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY; DEVELOPING NETWORKS; CORTICAL CIRCUITS; BARREL CORTEX; IN-VIVO; RAT; HIPPOCAMPUS; MECHANISMS; NEOCORTEX	Sensorimotor coordination emerges early in development. The maturation period is characterized by the establishment of somatotopic cortical maps(1,2), the emergence of long-range cortical connections(3), heightened experience-dependent plasticity(4-7) and spontaneous uncoordinated skeletal movement(8,9). How these various processes cooperate to allow the somatosensory system to form a three-dimensional representation of the body is not known. In the visual system, interactions between spontaneous network patterns and afferent activity have been suggested to be vital for normal development(10,11). Although several intrinsic cortical patterns of correlated neuronal activity have been described in developing somatosensory cortex in vitro(12-14), the in vivo patterns in the critical developmental period and the influence of physiological sensory inputs on these patterns remain unknown. We report here that in the intact somatosensory cortex of the newborn rat in vivo, spatially confined spindle bursts represent the first and only organized network pattern. The localized spindles are selectively triggered in a somatotopic manner by spontaneous muscle twitches(8,9), motor patterns analogous to human fetal movements(15,16). We suggest that the interaction between movement-triggered sensory feedback signals and self-organized spindle oscillations shapes the formation of cortical connections required for sensorimotor coordination.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; INMED, INSERM, U29, F-13273 Marseille, France; Dartmouth Coll Sch Med, Ctr Neurosci, Neurol Sect, Lebanon, NH 03756 USA; Univ Paris 06, INSERM, EMI 224, F-75013 Paris, France	Rutgers State University Newark; Rutgers State University New Brunswick; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Dartmouth College; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Leinekugel, Xavier/F-4034-2014; Sirota, Anton/G-1395-2011; Leinekugel, Xavier/ABD-8347-2021; Khazipov, Roustem/M-1834-2016	Leinekugel, Xavier/0000-0003-2878-3791; Khazipov, Roustem/0000-0002-6763-2841; Buzsaki, Gyorgy/0000-0002-3100-4800; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARMSTRONGJAMES MA, 1970, J PHYSIOL-LONDON, V208, pP10; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; CHATRIAN GE, 1959, ELECTROEN CLIN NEURO, V11, P497, DOI 10.1016/0013-4694(59)90048-3; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; Dreyfus-Brisac C, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P95, DOI 10.1016/S0370-4475(71)80022-9; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; Jain N, 2003, J NEUROSCI, V23, P10321; Karlsson KAE, 2003, J NEUROSCI, V23, P1114, DOI 10.1523/JNEUROSCI.23-04-01114.2003; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	30	397	402	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					758	761		10.1038/nature03132	http://dx.doi.org/10.1038/nature03132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592414				2022-12-24	WOS:000225597200049
J	Rose, GJ; Goller, F; Gritton, HJ; Plamondon, SL; Baugh, AT; Cooper, BG				Rose, GJ; Goller, F; Gritton, HJ; Plamondon, SL; Baugh, AT; Cooper, BG			Species-typical songs in white-crowned sparrows tutored with only phrase pairs	NATURE			English	Article							ZEBRA FINCH; ANTERIOR FOREBRAIN; NEURONS; SELECTIVITY; MECHANISMS; BIRDSONG; ORDER; SENSITIVITY; HVC	Modern theories of learned vocal behaviours, such as human speech and singing in songbirds(1), posit that acoustic communication signals are reproduced from memory, using auditory feedback(2). The nature of these memories, however, is unclear. Here we propose and test a model for how complex song structure can emerge from sparse sequence information acquired during tutoring. In this conceptual model, a population of combination-sensitive (phrase-pair) detectors is shaped by early exposure to song and serves as the minimal representation of the template necessary for generating complete song. As predicted by the model, birds that were tutored with only pairs of normally adjacent song phrases were able to assemble full songs in which phrases were placed in the correct order; birds that were tutored with reverse-ordered phrase pairs sang songs with reversed phrase order. Birds that were tutored with all song phrases, but presented singly, failed to produce normal, full songs. These findings provide the first evidence for a minimal requirement of sequence information in the acoustic model that can give rise to correct song structure.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rose, GJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	rose@bioscience.utah.edu	Baugh, Alexander T/E-4777-2010	Baugh, Alexander T/0000-0003-2032-892X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003788] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003788] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aldridge JW, 1998, J NEUROSCI, V18, P2777; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hultsch H, 1996, J COMP PHYSIOL A, V179, P291; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KONISHI M, 1978, PERCEPTION EXPERIENC; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewicki MS, 1996, J NEUROSCI, V16, P6987; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MARLER P, 1962, CONDOR, V64, P363; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; Solis MM, 1997, J NEUROSCI, V17, P6447; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Thorpe WH., 1961, BIRDSONG; VOLMAN SF, 1993, J NEUROSCI, V13, P4737	24	39	39	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					753	758		10.1038/nature02992	http://dx.doi.org/10.1038/nature02992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592413				2022-12-24	WOS:000225597200048
J	Wallis, JW; Aerts, J; Groenen, MAM; Crooijmans, RPMA; Layman, D; Graves, TA; Scheer, DE; Kremitzki, C; Fedele, MJ; Mudd, NK; Cardenas, M; Higginbotham, J; Carter, J; McGrane, R; Gaige, T; Mead, K; Walker, J; Albracht, D; Davito, J; Yang, SP; Leong, S; Chinwalla, A; Sekhon, M; Wylie, K; Dodgson, J; Romanov, MN; Cheng, H; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhang, HB; McPherson, JD; Krzywinski, M; Schein, J; Hillier, L; Mardis, ER; Wilson, RK; Warren, WC				Wallis, JW; Aerts, J; Groenen, MAM; Crooijmans, RPMA; Layman, D; Graves, TA; Scheer, DE; Kremitzki, C; Fedele, MJ; Mudd, NK; Cardenas, M; Higginbotham, J; Carter, J; McGrane, R; Gaige, T; Mead, K; Walker, J; Albracht, D; Davito, J; Yang, SP; Leong, S; Chinwalla, A; Sekhon, M; Wylie, K; Dodgson, J; Romanov, MN; Cheng, H; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhang, HB; McPherson, JD; Krzywinski, M; Schein, J; Hillier, L; Mardis, ER; Wilson, RK; Warren, WC			A physical map of the chicken genome	NATURE			English	Article							MOUSE GENOME; BAC CLONES; INTEGRATION; SEQUENCE; SOFTWARE; LINKAGE	Strategies for assembling large, complex genomes have evolved to include a combination of whole-genome shotgun sequencing and hierarchal map-assisted sequencing(1,2). Whole-genome maps of all types can aid genome assemblies, generally starting with low-resolution cytogenetic maps and ending with the highest resolution of sequence. Fingerprint clone maps are based upon complete restriction enzyme digests of clones representative of the target genome, and ultimately comprise a near-contiguous path of clones across the genome. Such clone-based maps are used to validate sequence assembly order, supply long-range linking information for assembled sequences, anchor sequences to the genetic map and provide templates for closing gaps. Fingerprint maps are also a critical resource for subsequent functional genomic studies, because they provide a redundant and ordered sampling of the genome with clones(3). In an accompanying paper(4) we describe the draft genome sequence of the chicken, Gallus gallus, the first species sequenced that is both a model organism and a global food source. Here we present a clone-based physical map of the chicken genome at 20-fold coverage, containing 260 contigs of overlapping clones. This map represents approximately 91% of the chicken genome and enables identification of chicken clones aligned to positions in other sequenced genomes.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Wageningen & Res Ctr, Anim Breeding & Genet Grp, NL-6709 PG Wageningen, Netherlands; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; USDA ARS, Avian Dis & Oncol Lab, E Lansing, MI 48823 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	Washington University (WUSTL); Wageningen University & Research; Michigan State University; United States Department of Agriculture (USDA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine; British Columbia Cancer Agency	Warren, WC (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	wwarren@watson.wustl.edu	Romanov, Michael N/O-9419-2014; Schein, Jacquie E/G-3674-2015; Crooijmans, Richard PMA/E-2492-2012; Aerts, Jan/AAQ-6949-2020; Sekhon, Mandeep/L-4665-2018; Wilson, Richard K./AAF-4139-2019; Groenen, Martien/D-8408-2012; Aerts, Jan/C-4374-2008; McPherson, John D/D-2633-2017; Mardis, Elaine/W-2202-2019	Romanov, Michael N/0000-0003-3584-4644; Aerts, Jan/0000-0002-6416-2717; Sekhon, Mandeep/0000-0002-9993-6938; Wilson, Richard K./0000-0002-1992-1358; Groenen, Martien/0000-0003-0484-4545; McPherson, John D/0000-0001-8049-9347; Chinwalla, Asif/0000-0001-7831-3996; Cheng, Hans/0000-0003-2071-4644; Kremitzki, Colin/0000-0001-9175-3136				Aerts J, 2003, CYTOGENET GENOME RES, V102, P297, DOI 10.1159/000075766; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Flibotte S, 2004, BIOINFORMATICS, V20, P1264, DOI 10.1093/bioinformatics/bth079; Fuhrmann DR, 2003, GENOME RES, V13, P940, DOI 10.1101/gr.904303; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Groenen M. A. M., 2003, Poultry genetics, breeding and biotechnology, P497, DOI 10.1079/9780851996608.0497; Groenen MAM, 2000, GENOME RES, V10, P137; Kelley JM, 1999, NUCLEIC ACIDS RES, V27, P1539, DOI 10.1093/nar/27.6.1539; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Krzywinski M, 2004, GENOME RES, V14, P766, DOI 10.1101/gr.2336604; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Meyers BC, 2004, NAT REV GENET, V5, P578, DOI 10.1038/nrg1404; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; Romanov MN, 2003, CYTOGENET GENOME RES, V102, P277, DOI 10.1159/000075763; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	19	144	155	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					761	764		10.1038/nature03030	http://dx.doi.org/10.1038/nature03030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592415	Bronze			2022-12-24	WOS:000225597200050
J	Rich, TH; Hopson, JA; Musser, AM; Flannery, TF; Vickers-Rich, P				Rich, TH; Hopson, JA; Musser, AM; Flannery, TF; Vickers-Rich, P			Independent origins of middle ear bones in Monotremes and Therians	SCIENCE			English	Article							OSSIFIED MECKELS CARTILAGE; MAMMALIAN EVOLUTION; MESOZOIC MAMMALS; PLATYPUS	A dentary of the oldest known monotreme, the Early Cretaceous Teinolophos trusleri, has an internal mandibular trough, which in outgroups to mammals houses accessory jaw bones, and probable contact facets for angular, coronoid, and splenial bones. Certain of these accessory bones were detached from the mandible to become middle ear bones in mammals. Evidence that the angular (homologous with the mammalian ectotympanic) and the articular and prearticular (homologous with the mammalian malleus) bones retained attachment to the lower jaw in a basal monotreme indicates that the definitive mammalian middle ear evolved independently in living monotremes and therians (marsupials and placentals).	Museum Victoria, Melbourne, Vic 3001, Australia; Monash Univ, Sch Geosci, Melbourne, Vic 3800, Australia; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Australian Museum, Sydney, NSW 2010, Australia; S Australian Museum, Adelaide, SA 5000, Australia	Museum Victoria; Monash University; University of Chicago; Australian Museum	Rich, TH (corresponding author), Museum Victoria, POB 666E, Melbourne, Vic 3001, Australia.	trich@museum.vic.gov.au						ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; CHOW M, 1982, Australian Mammalogy, V5, P127; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Forasiepi A, 2004, J VERTEBR PALEONTOL, V24, p59A; FOURIE S, 1974, Annals of the South African Museum, V65, P337; HOPSON JA, 1966, AM ZOOL, V6, P437; HOPSON JA, 2000, ENCY PALEONTOLOGY, P691; HOPSON JA, 1994, MAJOR FEATURES VERTE, P190; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; JENKINS FA, 1983, SCIENCE, V222, P1233, DOI 10.1126/science.222.4629.1233; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Ji Q, 1999, NATURE, V398, P326; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KERMACK DM, 1968, J LINN SOC ZOOLOGY, V47, P312; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELANJAWOROWSKA Z, 1987, NATURE, V326, P871, DOI 10.1038/326871a0; Krusat G., 1980, MEMORIAS SERVICOS GE, V27, P1; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Musser AM, 2003, COMP BIOCHEM PHYS A, V136, P927, DOI 10.1016/S1095-6433(03)00275-7; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; NOVACEK MJ, 1993, SKULL, V2, P438; PARRINGTON FR, 1971, PHILOS T R SOC B, V261, P231, DOI 10.1098/rstb.1971.0055; PATTERSON BRUAN, 1956, FIELDIANA GEOL, V13, P1; PATTERSON C, 1980, VICARIANCE BIOGEOGRA, P446; Penny D, 1997, NATURE, V387, P549, DOI 10.1038/42352; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; REICHERT C, 1837, MULLERS ARCH ANAT PH, P120; Rich TH, 2001, ACTA PALAEONTOL POL, V46, P113; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Romer A, 1956, OSTEOLOGY REPTILES; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wible John R., 1995, American Museum Novitates, V3149, P1; WIBLE JR, 1993, MAMMAL PHYLOGENY, V1, P45; Woodburne Michael O., 2003, Journal of Mammalian Evolution, V10, P195, DOI 10.1023/B:JOMM.0000015104.29857.f0; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Zeller U., 1993, MAMMAL PHYLOGENY, P95; [No title captured]; [No title captured]	48	84	88	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					910	914		10.1126/science.1105717	http://dx.doi.org/10.1126/science.1105717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705848				2022-12-24	WOS:000226985100049
J	Dragun, D; Muller, DN; Brasen, JH; Fritsche, L; Nieminen-Kelha, M; Dechend, R; Kintscher, U; Rudolph, B; Hoebeke, J; Eckert, D; Mazak, I; Plehm, R; Schonemann, C; Unger, T; Budde, K; Neumayer, HH; Luft, FC; Wallukat, G				Dragun, D; Muller, DN; Brasen, JH; Fritsche, L; Nieminen-Kelha, M; Dechend, R; Kintscher, U; Rudolph, B; Hoebeke, J; Eckert, D; Mazak, I; Plehm, R; Schonemann, C; Unger, T; Budde, K; Neumayer, HH; Luft, FC; Wallukat, G			Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE FACTOR; DILATED CARDIOMYOPATHY; AGONISTIC ANTIBODIES; VASCULAR REJECTION; ENDOTHELIAL-CELLS; C4D DEPOSITION; AT(1) RECEPTOR; TRANSPLANTATION; CLASSIFICATION; INJURY	BACKGROUND Antibodies against HLA antigens cause refractory allograft rejection with vasculopathy in some, but not all, patients. METHODS We studied 33 kidney-transplant recipients who had refractory vascular rejection. Thirteen had donor-specific anti-HLA antibodies, whereas 20 did not. Malignant hypertension was present in 16 of the patients without anti- HLA antibodies, 4 of whom had seizures. The remaining 17 patients had no malignant hypertension. We hypothesized that activating antibodies targeting the angiotensin II type 1 (AT(1)) receptor might be involved. RESULTS Activating IgG antibodies targeting the AT(1) receptor were detected in serum from all 16 patients with malignant hypertension and without anti- HLA antibodies, but in no other patients. These receptor-activating antibodies are subclass IgG1 and IgG3 antibodies that bind to two different epitopes on the second extracellular loop of the AT(1) receptor. Tissue factor expression was increased in renal-biopsy specimens from patients with these antibodies. In vitro stimulation of vascular cells with an AT(1)-receptor-activating antibody induced phosphorylation of ERK 1/2 kinase and increased the DNA binding activity of the transcription factors activator protein 1 (AP-1) and nuclear factor-kappaB. The AT(1) antagonist losartan blocked agonistic AT(1) - receptor antibody - mediated effects, and passive antibody transfer induced vasculopathy and hypertension in a rat kidney-transplantation model. CONCLUSIONS A non-HLA, AT(1) - receptor - mediated pathway may contribute to refractory vascular rejection, and affected patients might benefit from removal of AT(1) - receptor antibodies or from pharmacologic blockade of AT(1) receptors.	Charite, Dept Nephrol, D-10117 Berlin, Germany; Charite, Dept Pathol, D-10117 Berlin, Germany; Charite, Cardiovasc Res Ctr, D-10117 Berlin, Germany; Franz Volhard Clin, Berlin, Germany; HELIOS Klin, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; HLA Lab, Berlin, Germany; CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Franz-Volhard Clinical Research Center; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dragun, D (corresponding author), Charite, Dept Nephrol & Transplantat, Campus Mitte,Schumannstr 20-21, D-10117 Berlin, Germany.	duska.dragun@charite.de	Budde, Klemens/AAD-2170-2020	Budde, Klemens/0000-0002-7929-5942; Kintscher, Ulrich/0000-0001-7386-0990; Dragun, Duska/0000-0002-0310-9269; Muller, Dominik N/0000-0003-3650-5644; Luft, Friedrich/0000-0002-8635-1199; Nieminen-Kelha, Melina/0000-0002-7577-8058				AHERN AT, 1982, TRANSPLANTATION, V33, P103, DOI 10.1097/00007890-198201000-00023; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dobado-Berrios PM, 2001, ARTHRITIS RHEUM-US, V44, P2467, DOI 10.1002/1529-0131(200111)44:11<2467::AID-ART426>3.0.CO;2-U; Dragun D, 2003, TRANSPLANT P, V35, P2104, DOI 10.1016/S0041-1345(03)00680-8; Dragun D, 2000, KIDNEY INT, V58, P2166, DOI 10.1046/j.1523-1755.2000.00390.x; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Heidenreich S, 1998, J AM SOC NEPHROL, V9, P1309; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Holschermann H, 1999, AM J PATHOL, V154, P211, DOI 10.1016/S0002-9440(10)65267-4; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Le Bas-Bernardet S, 2003, AM J TRANSPLANT, V3, P167, DOI 10.1034/j.1600-6143.2003.00021.x; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Masuda MO, 1998, FASEB J, V12, P1551, DOI 10.1096/fasebj.12.14.1551; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Miller JA, 1999, KIDNEY INT, V56, P2173, DOI 10.1046/j.1523-1755.1999.00770.x; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; PAUL LC, 1985, TRANSPLANTATION, V40, P117, DOI 10.1097/00007890-198508000-00001; Praprotnik S, 2001, ARTHRITIS RHEUM-US, V44, P1484, DOI 10.1002/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rapoport B, 2001, J CLIN INVEST, V108, P1253, DOI 10.1172/JCI14321; Regele H, 2001, NEPHROL DIAL TRANSPL, V16, P2058, DOI 10.1093/ndt/16.10.2058; Remuzzi G, 2002, CURR OPIN NEPHROL HY, V11, P1, DOI 10.1097/00041552-200201000-00001; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; SCHWIMMBECK PL, 1989, J CLIN INVEST, V84, P1174, DOI 10.1172/JCI114282; SHIMADA K, 1978, J BIOCHEM-TOKYO, V84, P1013, DOI 10.1093/oxfordjournals.jbchem.a132183; Thway TM, 2004, CIRCULATION, V110, P1612, DOI 10.1161/01.CIR.0000142855.68398.3A; VANDERWOUDE FJ, 1995, KIDNEY INT, V48, pS11; VANSAASE JLCM, 1995, TRANSPLANTATION, V59, P1280, DOI 10.1097/00007890-199505000-00010; Vos IHC, 2000, FASEB J, V14, P815, DOI 10.1096/fasebj.14.5.815; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P2529; YARD B, 1993, TRANSPLANTATION, V55, P1287, DOI 10.1097/00007890-199306000-00015	39	617	648	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					558	569		10.1056/NEJMoa035717	http://dx.doi.org/10.1056/NEJMoa035717			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895KY	15703421	Green Accepted			2022-12-24	WOS:000226862100006
J	Randau, L; Munch, R; Hohn, MJ; Jahn, D; Soll, D				Randau, L; Munch, R; Hohn, MJ; Jahn, D; Soll, D			Nanoarchaeum equitans creates functional tRNAs from separate genes for their 5 '- and 3 '-halves	NATURE			English	Article							ESCHERICHIA-COLI; ARCHAEAL; RECOGNITION; ENDONUCLEASE; 3'-TERMINUS; SYNTHETASE; SEQUENCES; INVITRO; ORIGIN	Analysis of the genome sequence of the small hyperthermophilic archaeal parasite Nanoarchaeum equitans(1,2) has not revealed genes encoding the glutamate, histidine, tryptophan and initiator methionine transfer RNA species. Here we develop a computational approach to genome analysis that searches for widely separated genes encoding tRNA halves that, on the basis of structural prediction, could form intact tRNA molecules. A search of the N. equitans genome reveals nine genes that encode tRNA halves; together they account for the missing tRNA genes. The tRNA sequences are split after the anticodon-adjacent position 37, the normal location of tRNA introns. The terminal sequences can be accommodated in an intervening sequence that includes a 12 - 14-nucleotide GC-rich RNA duplex between the end of the 50 tRNA half and the beginning of the 30 tRNA half. Reverse transcriptase polymerase chain reaction and amino-acylation experiments of N. equitans tRNA demonstrated maturation to full-size tRNA and acceptor activity of the tRNA His and tRNA(Glu) species predicted in silico. As the joining mechanism possibly involves tRNA trans-splicing, the presence of an intron might have been required for early tRNA synthesis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38023 Braunschweig, Germany; Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; Univ Regensburg, Archaeenzentrum, D-93053 Regensburg, Germany; Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Braunschweig University of Technology; University of Regensburg; University of Regensburg; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu		Jahn, Dieter/0000-0002-4064-9205; Randau, Lennart/0000-0002-2780-2076				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Boucher Y, 2002, NATURE, V417, P27, DOI 10.1038/417027a; Connolly SA, 2004, BIOCHEMISTRY-US, V43, P962, DOI 10.1021/bi035708f; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Di Giulio M, 1999, J THEOR BIOL, V197, P403, DOI 10.1006/jtbi.1998.0882; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Fabbri S, 1998, SCIENCE, V280, P284, DOI 10.1126/science.280.5361.284; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; KONARSKA MM, 1985, CELL, V42, P165, DOI 10.1016/S0092-8674(85)80112-4; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Lohan Amanda J, 2004, Methods Mol Biol, V265, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nagaswamy U, 2003, ORIGINS LIFE EVOL B, V33, P199, DOI 10.1023/A:1024658727570; Salgia SR, 2003, RNA, V9, P319, DOI 10.1261/rna.2118203; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Sekine S, 1996, J MOL BIOL, V256, P685, DOI 10.1006/jmbi.1996.0118; SOLNICK D, 1986, CELL, V44, P211, DOI 10.1016/0092-8674(86)90752-X; Tanaka T., 2001, VIVA ORIGINO, V29, P134; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Williams MA, 2000, NUCLEIC ACIDS RES, V28, P4444, DOI 10.1093/nar/28.22.4444; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4	30	149	160	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					537	541		10.1038/nature03233	http://dx.doi.org/10.1038/nature03233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690044				2022-12-24	WOS:000226727200052
J	Rosen, S; Sanne, I; Collier, A; Simon, JL				Rosen, S; Sanne, I; Collier, A; Simon, JL			Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa	LANCET			English	Editorial Material							HIV; AIDS		Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa	Boston University; University of Witwatersrand	Rosen, S (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	sbrosen@bu.edu	Sanne, Ian/ABH-2231-2020	Simon, Jonathon/0000-0001-6740-549X; Rosen, Sydney/0000-0002-6560-2964				ATTAWELL K, 2003, PROVISION ANTIRETROV; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Fleck F, 2004, BRIT MED J, V328, P1151, DOI 10.1136/bmj.328.7449.1151; *JICC, 2002, KENY NAT PROP ADDR R; KOMBE G, 2004, 29 ABT ASS INC; Loewenson R, 2004, BMJ-BRIT MED J, V328, P241, DOI 10.1136/bmj.328.7434.241; Mitka M, 2002, JAMA-J AM MED ASSOC, V288, P153, DOI 10.1001/jama.288.2.153; SAKYIADDO K, 2004, GHANA GIVES FREE ANT; STIGLITZ JE, 2004, EC PUBLIC SECTOR; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; World Health Organization, 2002, SCAL ANT THER RES LT; 2004, IRINPLUS NEWS   0305; 2004, IRINPLUS NEWS   0506; 2004, THIS DAY        0616; 2004, IRINPLUS NEWS   0128	15	37	38	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					354	356						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664233				2022-12-24	WOS:000226449600041
J	Rhodes, CJ				Rhodes, CJ			Type 2 diabetes - A matter of beta-cell life and death?	SCIENCE			English	Editorial Material							INSULIN-RECEPTOR SUBSTRATE-1; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; FATTY-ACID; RESISTANCE; APOPTOSIS; KINASE; GROWTH; FAILURE; MASS	In type 2 diabetes, the beta cells of the pancreas fail to produce enough insulin to meet the body's demand, in part because of an acquired decrease in beta-cell mass. In adults, pancreatic beta-cell mass is controlled by several mechanisms, including beta-cell replication, neogenesis, hypertrophy, and survival. Here, I discuss evidence supporting the notion that increased beta-cell apoptosis is an important factor contributing to beta-cell loss and the onset of type 2 diabetes. Interestingly, a key signaling molecule that promotes beta-cell growth and survival, insulin receptor substrate 2 (IRS-2), is a member of a family of proteins whose inhibition contributes to the development of insulin resistance in the liver and other insulin-responsive tissues. Thus, the IRS-2 pathway appears to be a crucial participant in the tenuous balance between effective pancreatic beta-cell mass and insulin resistance.	Pacific NW Res Inst, Seattle, WA 98122 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle	Rhodes, CJ (corresponding author), Pacific NW Res Inst, 720 Broadway, Seattle, WA 98122 USA.	cjr@pnri.org	Northe, Hilda/I-1916-2012	Northe, Hilda/0000-0002-8873-5014	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055267] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-55267] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Borge PD, 2003, J BIOL CHEM, V278, P11359, DOI 10.1074/jbc.M209521200; Bouwens L, 1996, VIRCHOWS ARCH, V427, P553; BRIAUD I, 2004, J BIOL CHEM     1109; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MCLEAN N, 1955, DIABETES, V4, P367; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Rajagopal J, 2003, SCIENCE, V299, P363; Rhodes CJ, 2002, EUR J CLIN INVEST, V32, P3, DOI 10.1046/j.1365-2362.32.s3.2.x; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Willaime-Morawek S, 2003, NEUROSCIENCE, V119, P387, DOI 10.1016/S0306-4522(02)00996-X; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2003, J MOL ENDOCRINOL, V30, P271, DOI 10.1677/jme.0.0300271; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	55	684	755	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					380	384		10.1126/science.1104345	http://dx.doi.org/10.1126/science.1104345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662003				2022-12-24	WOS:000226492300033
J	Niess, JH; Brand, S; Gu, XB; Landsman, L; Jung, S; McCormick, BA; Vyas, JM; Boes, M; Ploegh, HL; Fox, JG; Littman, DR; Reinecker, HC				Niess, JH; Brand, S; Gu, XB; Landsman, L; Jung, S; McCormick, BA; Vyas, JM; Boes, M; Ploegh, HL; Fox, JG; Littman, DR; Reinecker, HC			CX(3)CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance	SCIENCE			English	Article							PEYERS PATCH; IMMUNE-RESPONSES; FRACTALKINE; EPITHELIUM; LOCALIZATION; CHEMOKINE; SUBSETS; GUT	Dendritic cells (DCs) and macrophages are critical to innate and adaptive immunity to the intestinal bacterial microbiota. Here, we identify a myeloid-derived mucosal DC in mice, which populates the entire lamina propria of the small intestine. Lamina propria DCs were found to depend on the chemokine receptor CX(3)CR1 to form transepithelial dendrites, which enable the cells to directly sample luminal antigens. CX(3)CR1 was also found to control the clearance of entero-invasive pathogens by DCs. Thus, CX(3)C1-dependent processes, which control host interactions of specialized DCs with commensal and pathogenic bacteria, may regulate immunological tolerance and inflammation.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; MIT, Div Comparat Med, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Reinecker, HC (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St, Boston, MA 02114 USA.	hans-christian-reinecker@hms.harvard.edu	Landsman, Limor/AAT-5982-2020; Vyas, Jatin/Q-1627-2016; Niess, Jan/E-8361-2017; Jung, Steffen/K-1409-2012	Landsman, Limor/0000-0002-8974-1344; Vyas, Jatin/0000-0002-9985-9565; Niess, Jan/0000-0001-6902-5650; Jung, Steffen/0000-0003-4290-5716; Boes, Marianne/0000-0003-2590-1692	NIAID NIH HHS [AI33856] Funding Source: Medline; NIDDK NIH HHS [DK54427, DK33506] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK054427] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelsall BL, 2002, NAT IMMUNOL, V3, P699, DOI 10.1038/ni0802-699; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maric I, 1996, J IMMUNOL, V156, P1408; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Uhlig HH, 2003, J CLIN INVEST, V112, P648, DOI 10.1172/JC1200319545; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	18	1179	1224	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					254	258		10.1126/science.1102901	http://dx.doi.org/10.1126/science.1102901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653504				2022-12-24	WOS:000226361900043
J	Yoshimura, T; Kawano, Y; Arimura, N; Kawabata, S; Kikuchi, A; Kaibuchi, K				Yoshimura, T; Kawano, Y; Arimura, N; Kawabata, S; Kikuchi, A; Kaibuchi, K			GSK-3 beta regulates phosphorylation of CRMP-2 and neuronal polarity	CELL			English	Article							RESPONSE MEDIATOR PROTEIN-2; ADENOMATOUS POLYPOSIS-COLI; SYNTHASE KINASE 3-BETA; HIPPOCAMPAL-NEURONS; LIGHT-CHAIN; MICROTUBULE STABILITY; NEURITE OUTGROWTH; SENSORY NEURONS; RHO-KINASE; GROWTH	Neurons are highly polarized and comprised of two structurally and functionally distinct parts, an axon and dendrites. We previously showed that collapsin response mediator protein-2 (CRMP-2) is critical for specifying axon/dendrite fate, possibly by promoting neurite elongation via microtubule assembly. Here, we showed that glycogen synthase kinase-3beta (GSK-3beta) phosphorylated CRMP-2 at Thr-514 and inactivated it. The expression of the nonphosphorylated form of CRMP-2 or inhibition of GSK-3beta induced the formation of multiple axon-like neurites in hippocampal neurons. The expression of constitutively active GSK-3beta impaired neuronal polarization, whereas the nonphosphorylated form of CRMP-2 counteracted the inhibitory effects of GSK-3beta, indicating that GSK-3beta regulates neuronal polarity through the phosphorylation of CRMP-2. Treatment of hippocampal neurons with neurotrophin-3 (NT-3) induced inactivation of GSK-3beta and dephosphorylation of CRMP-2. Knockdown of CRMP-2 inhibited NT-3-induced axon outgrowth. These results suggest that NT-3 decreases phosphorylated CRMP-2 and increases nonphosphorylated active CRMP-2, thereby promoting axon outgrowth.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; Hiroshima Univ, Dept Biochem, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan	Nagoya University; Hiroshima University	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Yoshimura, Takeshi/F-3817-2012; Kawano, Yoji/C-7484-2011	Kawano, Yoji/0000-0003-0687-2777; Yoshimura, Takeshi/0000-0002-0316-8082				Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; IP NY, 1993, J NEUROSCI, V13, P3394; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MORFINI G, 1994, J NEUROSCI RES, V39, P219, DOI 10.1002/jnr.490390212; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tucker KL, 2002, PANMINERVA MED, V44, P325; UCHIDA Y, IN PRESS GENES CELLS; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	45	723	752	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					137	149		10.1016/j.cell.2004.11.012	http://dx.doi.org/10.1016/j.cell.2004.11.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652488	Bronze			2022-12-24	WOS:000226365400017
J	Kanatsu-Shinohara, M; Inoue, K; Lee, J; Yoshimoto, M; Ogonuki, N; Miki, H; Baba, S; Kato, T; Kazuki, Y; Toyokuni, S; Toyoshima, M; Niwa, O; Oshimura, M; Heike, T; Nakahata, T; Ishino, F; Ogura, A; Shinohara, T				Kanatsu-Shinohara, M; Inoue, K; Lee, J; Yoshimoto, M; Ogonuki, N; Miki, H; Baba, S; Kato, T; Kazuki, Y; Toyokuni, S; Toyoshima, M; Niwa, O; Oshimura, M; Heike, T; Nakahata, T; Ishino, F; Ogura, A; Shinohara, T			Generation of pluripotent stem cells from neonatal mouse testis	CELL			English	Article							PRIMORDIAL GERM-CELLS; H19 METHYLATION IMPRINT; LONG-TERM PROLIFERATION; ES CELLS; PARENTAL ALLELES; DNA METHYLATION; GENE-EXPRESSION; CULTURE; MICE; LINE	Although germline cells can form multipotential embryonic stem (ES)/embryonic germ (EG) cells, these cells can be derived only from embryonic tissues, and such multipotent cells have not been available from neonatal gonads. Here we report the successful establishment of ES-like cells from neonatal mouse testis. These ES-like cells were phenotypically similar to ES/ EG cells except in their genomic imprinting pattern. They differentiated into various types of somatic cells in vitro under conditions used to induce the differentiation of ES cells and produced teratomas after inoculation into mice. Furthermore, these ES-like cells formed germline chimeras when injected into blastocysts. Thus, the capacity to form multipotent cells persists in neonatal testis. The ability to derive multipotential stem cells from the neonatal testis has important implications for germ cell biology and opens the possibility of using these cells for biotechnology and medicine.	Kyoto Univ, Horizontal Med Res Org, Kyoto 6068501, Japan; Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto 6068501, Japan; Kyoto Univ, Ctr Radiat Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; RIKEN, Bioresource Ctr, Inst Phys & Chem Res, Ibaraki 3050074, Japan; Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1010062, Japan; Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet, Tottori 6838503, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; RIKEN; Tokyo Medical & Dental University (TMDU); Tottori University	Shinohara, T (corresponding author), Kyoto Univ, Horizontal Med Res Org, Kyoto 6068501, Japan.	takashi@mfour.med.kyoto-u.ac.jp	Yoshimoto, Momoko/AFP-3523-2022; Toyokuni, Shinya/ABE-7714-2021; Yoshimoto, Momoko/N-4238-2014; Toyokuni, Shinya/C-1358-2010; Ogura, Atsuo/J-3916-2014	Yoshimoto, Momoko/0000-0002-7272-6682; Toyokuni, Shinya/0000-0002-5757-1109; Yoshimoto, Momoko/0000-0002-7272-6682; Toyokuni, Shinya/0000-0002-5757-1109; Ogura, Atsuo/0000-0003-0447-1988				Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; De Rooij DG, 2000, J ANDROL, V21, P776; Dean W, 1998, DEVELOPMENT, V125, P2273; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kanatsu M, 1996, DEVELOPMENT, V122, P823; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kimura C, 2001, DEV BIOL, V235, P12, DOI 10.1006/dbio.2001.0289; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lam MYJ, 2003, APMIS, V111, P184, DOI 10.1034/j.1600-0463.2003.11101221.x; Lee J, 2002, DEVELOPMENT, V129, P1807; Liu X, 1997, DEV DYNAM, V209, P85; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Narasimha M, 1997, CURR BIOL, V7, P881, DOI 10.1016/S0960-9822(06)00377-0; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; ROBERTSON EJ, 1986, EXPT APPROACHES MAMM, P475; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEVENS LC, 1984, CELL DIFFER DEV, V15, P69, DOI 10.1016/0045-6039(84)90054-X; STEVENS LC, 1961, J NATL CANCER I, V27, P443; STEWART CL, 1994, DEV BIOL, V161, P626, DOI 10.1006/dbio.1994.1058; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; TSUKADA T, 1993, ONCOGENE, V8, P3313; Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	56	613	729	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1001	1012		10.1016/j.cell.2004.11.011	http://dx.doi.org/10.1016/j.cell.2004.11.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620358	Bronze			2022-12-24	WOS:000226109700012
J	Bowers, PM; Cokus, SJ; Elsenberg, D; Yeates, TO				Bowers, PM; Cokus, SJ; Elsenberg, D; Yeates, TO			Use of logic relationships to decipher protein network organization	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC PROFILES; FUNCTIONAL LINKAGES; DATABASE; IDENTIFICATION; INTERACTOME; DISCOVERY; COMPLEXES; GENOMES; MAP	A major focus of genome research is to decipher the networks of molecular interactions that underlie cellular function. We describe a computational approach for identifying detailed relationships between proteins on the basis of genomic data. Logic analysis of phylogenetic profiles identifies triplets of proteins whose presence or absence obey certain logic relationships. For example, protein C may be present in a genome only if proteins A and B are both present. The method reveals many previously unidentified higher order relationships. These relationships illustrate the complexities that arise in cellular networks because of branching and alternate pathways, and they also facilitate assignment of cellular functions to uncharacterized proteins.	Univ Calif Los Angeles, Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Inst Genom & Proteom, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839				Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pellegrini M, 2001, J CELL BIOCHEM, V84, P106, DOI 10.1002/jcb.10071; Strong M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r59; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THEIL H, 1972, STUDIES MATH MANAGER, V14, P337; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	24	116	123	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2246	2249		10.1126/science.1103330	http://dx.doi.org/10.1126/science.1103330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618515				2022-12-24	WOS:000225950000043
J	Moran, MA; Buchan, A; Gonzalez, JM; Heidelberg, JF; Whitman, WB; Kiene, RP; Henriksen, JR; King, GM; Belas, R; Fuqua, C; Brinkac, L; Lewis, M; Johri, S; Weaver, B; Pai, G; Eisen, JA; Rahe, E; Sheldon, WM; Ye, WY; Miller, TR; Carlton, J; Rasko, DA; Paulsen, IT; Ren, QH; Daugherty, SC; Deboy, RT; Dodson, RJ; Durkin, AS; Madupu, R; Nelson, WC; Sullivan, SA; Rosovitz, MJ; Haft, DH; Selengut, J; Ward, N				Moran, MA; Buchan, A; Gonzalez, JM; Heidelberg, JF; Whitman, WB; Kiene, RP; Henriksen, JR; King, GM; Belas, R; Fuqua, C; Brinkac, L; Lewis, M; Johri, S; Weaver, B; Pai, G; Eisen, JA; Rahe, E; Sheldon, WM; Ye, WY; Miller, TR; Carlton, J; Rasko, DA; Paulsen, IT; Ren, QH; Daugherty, SC; Deboy, RT; Dodson, RJ; Durkin, AS; Madupu, R; Nelson, WC; Sullivan, SA; Rosovitz, MJ; Haft, DH; Selengut, J; Ward, N			Genome sequence of Silicibacter pomeroyi reveals adaptations to the marine environment	NATURE			English	Article							ORGANIC-MATTER; BACTERIA; DIMETHYLSULFONIOPROPIONATE; SULFUR; BACTERIOPLANKTON; CULTURE; OCEANS; BLOOM; SNOW	Since the recognition of prokaryotes as essential components of the oceanic food web(1), bacterioplankton have been acknowledged as catalysts of most major biogeochemical processes in the sea. Studying heterotrophic bacterioplankton has been challenging, however, as most major clades have never been cultured(2) or have only been grown to low densities in sea water(3,4). Here we describe the genome sequence of Silicibacter pomeroyi, a member of the marine Roseobacter clade ( Fig. 1), the relatives of which comprise similar to10 - 20% of coastal and oceanic mixed-layer bacterioplankton(2,5,6,7). This first genome sequence from any major heterotrophic clade consists of a chromosome ( 4,109,442 base pairs) and megaplasmid ( 491,611 base pairs). Genome analysis indicates that this organism relies upon a lithoheterotrophic strategy that uses inorganic compounds ( carbon monoxide and sulphide) to supplement heterotrophy. Silicibacter pomeroyi also has genes advantageous for associations with plankton and suspended particles, including genes for uptake of algal-derived compounds, use of metabolites from reducing microzones, rapid growth and cell-density-dependent regulation. This bacterium has a physiology distinct from that of marine oligotrophs, adding a new strategy to the recognized repertoire for coping with a nutrient-poor ocean.	Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ La Laguna, Dept Microbiol & Biol Celular, E-38206 Tenerife, Spain; Inst Genom Res, Rockville, MD 20850 USA; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; Univ Maine, Darling Marine Ctr, Dept Biochem Microbiol & Mol Biol, Walpole, ME 04573 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Yale University; Universidad de la Laguna; J. Craig Venter Institute; University of South Alabama; Dauphin Island Sea Lab; University of Maine System; University of Maine Orono; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Buchan, Alison/A-9401-2010; Miller, Todd/Y-3612-2019; Whitman, William/AAC-5896-2020; Gonzalez, Jose M./C-3333-2013; Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016; Paulsen, Ian T/K-3832-2012	Gonzalez, Jose M./0000-0002-9926-3323; Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Paulsen, Ian T/0000-0001-9015-9418; Heidelberg, John/0000-0003-0673-3224; Moran, Mary Ann/0000-0002-0702-8167; Whitman, William/0000-0003-1229-0423; Henriksen, James/0000-0003-2485-0889; David, Rasko/0000-0002-7337-7154; Buchan, Alison/0000-0001-7420-985X; Miller, Todd/0000-0002-2113-1662				Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Chan KL, 2002, APPL ENVIRON MICROB, V68, P2278, DOI 10.1128/AEM.68.5.2278-2284.2002; DELONG E, 2000, MONTEREY BAY MICROBI; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Giovannoni S., 2000, P47; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002; King GA, 2003, APPL ENVIRON MICROB, V69, P7257, DOI 10.1128/AEM.69.12.7257-7265.2003; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043; Sorokin DY, 2003, MICROBIOLOGY+, V72, P641, DOI 10.1023/B:MICI.0000008363.24128.e5; Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Zafiriou OC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001638; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhu J, 2003, APPL ENVIRON MICROB, V69, P6949, DOI 10.1128/AEM.69.11.6949-6953.2003	29	345	754	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					910	913		10.1038/nature03170	http://dx.doi.org/10.1038/nature03170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602564	hybrid, Green Published			2022-12-24	WOS:000225733500055
J	Smith, AJF; Jackson, MW; Neufing, P; McEvoy, RD; Gordon, TP				Smith, AJF; Jackson, MW; Neufing, P; McEvoy, RD; Gordon, TP			A functional autoantibody in narcolepsy	LANCET			English	Article								Narcolepsy is widely believed to have an autoimmune basis, but conventional immunological approaches have failed to detect a serum autoantibody marker. Since cholinergic hyperactivity is a feature of narcolepsy-cataplexy, we transferred IgG from nine patients with narcolepsy and nine healthy controls to mice and assessed the effect on smooth muscle contractile responses to cholinergic stimulation. IgG from all narcolepsy patients significantly enhanced bladder contractile responses to the muscarinic agonist carbachol and to neuronally released acetylcholine compared with control IgG (p<0.0001), whereas contraction of the sympathetically innervated vas deferens was unaltered. Our findings provide direct evidence for the autoimmune hypothesis of narcolepsy.	Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia; Repatriat Gen Hosp, Inst Sleep Hlth, Daw Pk, Australia; Flinders Univ S Australia, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Gordon, TP (corresponding author), Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia.	t.gordon@flinders.edu.au	Smith, Ashley/GZB-0298-2022; McEvoy, Doug/ABB-8052-2020	Neufing, Petra/0000-0001-5740-5250; Gordon, Thomas/0000-0003-3232-8249				Guilleminault C, 1998, NEUROLOGY, V50, pS8, DOI 10.1212/WNL.50.2_Suppl_1.S8; Jackson MW, 2004, GASTROENTEROLOGY, V126, P819, DOI 10.1053/j.gastro.2003.12.015; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7	6	60	62	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2122	2124		10.1016/S0140-6736(04)17553-3	http://dx.doi.org/10.1016/S0140-6736(04)17553-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589310				2022-12-24	WOS:000225742300025
J	Kragelund, C; Gronning, B; Kober, L; Hildebrandt, P; Steffensen, R				Kragelund, C; Gronning, B; Kober, L; Hildebrandt, P; Steffensen, R			N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR SYSTOLIC FUNCTION; ARTERY-DISEASE; CARDIOVASCULAR EVENTS; RISK STRATIFICATION; EXPRESSION; PROGNOSIS; ISCHEMIA; ANGINA; ATRIAL	BACKGROUND: The level of the inactive N-terminal fragment of pro-brain (B-type) natriuretic peptide (BNP) is a strong predictor of mortality among patients with acute coronary syndromes and may be a strong prognostic marker in patients with chronic coronary heart disease as well. We assessed the relationship between N-terminal pro-BNP (NT-pro-BNP) levels and long-term mortality from all causes in a large cohort of patients with stable coronary heart disease. METHODS: NT-pro-BNP was measured in baseline serum samples from 1034 patients referred for angiography because of symptoms or signs of coronary heart disease. The rate of death from all causes was determined after a median follow-up of nine years. RESULTS: At follow-up, 288 patients had died. The median NT-pro-BNP level was significantly lower among patients who survived than among those who died (120 pg per milliliter [interquartile range, 50 to 318] vs. 386 pg per milliliter [interquartile range, 146 to 897], P<0.001). Patients with NT-pro-BNP levels in the highest quartile were older, had a lower left ventricular ejection fraction (LVEF) and a lower creatinine clearance rate, and were more likely to have a history of myocardial infarction, clinically significant coronary artery disease, and diabetes than patients with NT-pro-BNP levels in the lowest quartile. In a multivariable Cox regression model, the hazard ratio for death from any cause for the patients with NT-pro-BNP levels in the fourth quartile as compared with those in the first quartile was 2.4 (95 percent confidence interval, 1.5 to 4.0; P<0.001); the NT-pro-BNP level added prognostic information beyond that provided by conventional risk factors, including the patient's age; sex; family history with respect to ischemic heart disease; the presence or absence of a history of myocardial infarction, angina, hypertension, diabetes, or chronic heart failure; creatinine clearance rate; body-mass index; smoking status; plasma lipid levels; LVEF; and the presence or absence of clinically significant coronary artery disease on angiography. CONCLUSIONS: NT-pro-BNP is a marker of long-term mortality in patients with stable coronary disease and provides prognostic information above and beyond that provided by conventional cardiovascular risk factors and the degree of left ventricular systolic dysfunction.	Univ Copenhagen, Frederiksberg Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark; Hillerod Univ Hosp, Dept Cardiol, Copenhagen, Denmark; Rigshosp, Dept Cardiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kragelund, C (corresponding author), Univ Copenhagen, Frederiksberg Hosp, Dept Cardiol & Endocrinol, Nordre Fasanvej 57, DK-2000 Copenhagen, Denmark.	kragelund@dadlnet.dk		Kober, Lars/0000-0002-6635-1466				Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Cole JH, 2003, J AM COLL CARDIOL, V41, P521, DOI 10.1016/S0735-1097(02)02862-0; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DODGE HT, 1983, J AM COLL CARDIOL, V1, P73, DOI 10.1016/S0735-1097(83)80012-6; Fox KM, 2003, LANCET, V362, P782; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gill D, 2004, CLIN SCI, V106, P135, DOI 10.1042/CS20030131; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Levin ER, 1998, NEW ENGL J MED, V339, P321; MARUMOTO K, 1995, CLIN SCI, V88, P551, DOI 10.1042/cs0880551; McGowan JH, 2003, AM HEART J, V146, P388, DOI 10.1016/S0002-8703(03)00248-5; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1853, DOI 10.1016/S0735-1097(03)00571-0; Nilsson JC, 2002, AM HEART J, V143, P696, DOI 10.1067/mhj.2002.120293; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Talwar S, 2000, HEART, V84, P421, DOI 10.1136/heart.84.4.421; Talwar S, 2000, EUR HEART J, V21, P1514, DOI 10.1053/euhj.1999.2045; Tateishi J, 2000, CLIN CARDIOL, V23, P776, DOI 10.1002/clc.4960231016; Tsutamoto T, 1997, CIRCULATION, V96, P509; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wiviott SD, 2004, CIRCULATION, V109, P580, DOI 10.1161/01.CIR.0000109491.66226.26	30	509	540	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					666	675		10.1056/NEJMoa042330	http://dx.doi.org/10.1056/NEJMoa042330			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716560				2022-12-24	WOS:000227031100005
J	Nieschlag, E; Henke, A				Nieschlag, E; Henke, A			Hopes for male contraception	LANCET			English	Editorial Material							HORMONAL MALE CONTRACEPTION; MONKEYS; IMPACT; EPPIN		Univ Munster, Inst Reprod Med, D-48129 Munster, Germany	University of Munster	Nieschlag, E (corresponding author), Univ Munster, Inst Reprod Med, Steinfurter Str 107, D-48129 Munster, Germany.	eberhard.nieschlag@ukmuenster.de						[Anonymous], 1990, Lancet, V336, P955; DARCANGUES C, 2000, DEP REPROD HLTH RES, P109; Diczfalusy E, 2004, MOL CELL ENDOCRINOL, V216, P1, DOI 10.1016/j.mce.2003.10.067; Kamischke A, 2004, TRENDS PHARMACOL SCI, V25, P49, DOI 10.1016/j.tips.2003.11.009; Martin CW, 2000, HUM REPROD, V15, P637, DOI 10.1093/humrep/15.3.637; Moudgal NR, 1997, HUM REPROD UPDATE, V3, P335, DOI 10.1093/humupd/3.4.335; Nieschlag E, 2001, ANDROLOGY, 2ND EDITION, P399; Nieschlag E, 2004, TESTOSTERONE ACTION, P685; Nieschlag E, 1986, MALE CONTRACEPTION A, p[1986, 395]; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; THAU RB, 1987, AM J REPROD IMMUNOL, V15, P92; Waites GMH, 2003, FERTIL STERIL, V80, P1, DOI 10.1016/S0015-0282(03)00577-6; 2002, INT J ANDROL, V25, P375	14	28	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					554	556						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708085				2022-12-24	WOS:000226984300008
J	Briggman, KL; Abarbanel, HDI; Kristan, WB				Briggman, KL; Abarbanel, HDI; Kristan, WB			Optical imaging of neuronal populations during decision-making	SCIENCE			English	Article							BEHAVIORAL CHOICE; MEDICINAL LEECH; PERCEPTUAL DECISION; PARIETAL CORTEX; NEURAL BASIS; SWIM; PLEUROBRANCHAEA; MECHANISMS; INITIATION; TARGETS	We investigated decision-making in the leech nervous system by stimulating identical sensory inputs that sometimes elicit crawling and other times swimming. Neuronal populations were monitored with voltage-sensitive dyes after each stimulus. By quantifying the discrimination time of each neuron, we found single neurons that discriminate before the two behaviors are evident. We used principal component analysis and linear discriminant analysis to find populations of neurons that discriminated earlier than any single neuron. The analysis highlighted the neuron cell 208. Hyperpolarizing cell 208 during a stimulus biases the leech to swim; depolarizing it biases the leech to crawl or to delay swimming.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Kristan, WB (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wkristan@ucsd.edu	Abarbanel, Henry Don Isaac/AAX-3192-2021		NIMH NIH HHS [MH43396] Funding Source: Medline; NINDS NIH HHS [NS40110] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040110] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; BRODFUEHRER PD, 1995, NEUROBIOL LEARN MEM, V63, P192, DOI 10.1006/nlme.1995.1020; Broomhead D S., 1987, J PHYS A, V20, P563; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Cacciatore TW, 2000, J NEUROSCI, V20, P1643; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; Duda R.O., 2000, PATTERN CLASSIFICATI; Eisenhart FJ, 2000, J COMP PHYSIOL A, V186, P631, DOI 10.1007/s003590000117; Esch T, 2002, INTEGR COMP BIOL, V42, P716, DOI 10.1093/icb/42.4.716; Esch T, 2002, J NEUROSCI, V22, P11045; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gonzalez JE, 1999, DRUG DISCOV TODAY, V4, P431, DOI 10.1016/S1359-6446(99)01383-5; KAPLAN D, 1995, UNDERSTANDING NONLIN; KOVAC MP, 1980, J NEUROPHYSIOL, V43, P469, DOI 10.1152/jn.1980.43.2.469; KOVAC MP, 1977, SCIENCE, V198, P632, DOI 10.1126/science.918659; KRISTAN WB, 1982, J EXP BIOL, V96, P143; Kristan WB, 1997, CURR OPIN NEUROBIOL, V7, P826, DOI 10.1016/S0959-4388(97)80142-0; KRISTAN WB, 1976, J EXP BIOL, V65, P643; KRISTAN WB, 1982, J EXP BIOL, V96, P161; Mardia K.V, 1980, MULTIVARIATE ANAL; MULLER KJ, 1981, NEUROBIOLOGY LEECH; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Schall JD, 2000, CURR BIOL, V10, pR404, DOI 10.1016/S0960-9822(00)00504-2; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shaw BK, 1997, J NEUROSCI, V17, P786; Taylor AL, 2003, J NEUROSCI, V23, P11402; WEEKS JC, 1978, J EXP BIOL, V77, P71; WEEKS JC, 1982, J COMP PHYSIOL, V148, P265, DOI 10.1007/BF00619133; Zochowski M, 2000, J NEUROSCI, V20, P8485, DOI 10.1523/JNEUROSCI.20-22-08485.2000	35	229	232	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					896	901		10.1126/science.1103736	http://dx.doi.org/10.1126/science.1103736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705844				2022-12-24	WOS:000226985100045
J	Hetz, SK; Bradley, TJ				Hetz, SK; Bradley, TJ			Insects breathe discontinuously to avoid oxygen toxicity	NATURE			English	Article							GAS-EXCHANGE CYCLES; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; LIFE-SPAN; RESPIRATION; OVEREXPRESSION; HYPOTHESES; SCARABAEIDAE; VENTILATION; DIFFUSION	The respiratory organs of terrestrial insects consist of tracheal tubes with external spiracular valves that control gas exchange. Despite their relatively high metabolic rate, many insects have highly discontinuous patterns of gas exchange, including long periods when the spiracles are fully closed. Two explanations have previously been put forward to explain this behaviour: first, that this pattern serves to reduce respiratory water loss(1), and second, that the pattern may have initially evolved in underground insects as a way of dealing with hypoxic or hypercapnic conditions(2). Here we propose a third possible explanation based on the idea that oxygen is necessary for oxidative metabolism but also acts as a toxic chemical that can cause oxidative damage of tissues even at relatively low concentrations. At physiologically normal partial pressures of CO2, the rate of CO2 diffusion out of the insect respiratory system is slower than the rate of O-2 entry; this leads to a build-up of intratracheal CO2. The spiracles must therefore be opened at intervals to rid the insect of accumulated CO2, a process that exposes the tissues to dangerously high levels of O-2. We suggest that the cyclical pattern of open and closed spiracles observed in resting insects is a necessary consequence of the need to rid the respiratory system of accumulated CO2, followed by the need to reduce oxygen toxicity.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Humboldt Univ, Dept Anim Physiol, D-10115 Berlin, Germany	University of California System; University of California Irvine; Humboldt University of Berlin	Bradley, TJ (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	tbradley@uci.edu	Hetz, Stefan/E-9094-2010	Hetz, Stefan/0000-0002-4928-8506				Bradley TJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P302, DOI 10.1086/367953; Chown SL, 2000, J EXP BIOL, V203, P397; Davis ALV, 1999, PHYSIOL BIOCHEM ZOOL, V72, P555, DOI 10.1086/316698; Fielden LJ, 1996, PHYSIOL ZOOL, V69, P599, DOI 10.1086/physzool.69.3.30164218; FRIDOVICH I, 1977, BIOSCIENCE, V27, P462, DOI 10.2307/1297527; HADLEY NF, 1994, PHYSIOL ZOOL, V67, P175, DOI 10.1086/physzool.67.1.30163841; HETZ SK, 1994, BIOELECTROCH BIOENER, V33, P165, DOI 10.1016/0302-4598(94)85008-9; JAMIESON D, 1989, FREE RADICAL BIO MED, V7, P87, DOI 10.1016/0891-5849(89)90103-2; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P113, DOI 10.1007/BF01722126; LEVY RI, 1966, J INSECT PHYSIOL, V12, P83, DOI 10.1016/0022-1910(66)90068-0; LIGHTON JRB, 1988, J EXP BIOL, V134, P363; LIGHTON JRB, 1995, J EXP BIOL, V198, P1613; Lighton JRB, 1998, AM ZOOL, V38, P483; Lighton JRB, 1996, ANNU REV ENTOMOL, V41, P309, DOI 10.1146/annurev.en.41.010196.001521; Lighton JRB, 1996, J INSECT PHYSIOL, V42, P347, DOI 10.1016/0022-1910(95)00112-3; Lighton JRB, 2002, PHYSIOL BIOCHEM ZOOL, V75, P345, DOI 10.1086/342252; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671; Sun JT, 2002, GENETICS, V161, P661; Weibel ER, 1996, J EXP BIOL, V199, P1699; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; WIGGLESWORTH VB, 1970, PRINCIPLES INSECT PH; Williams AE, 1998, J EXP BIOL, V201, P2953; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	30	232	246	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					516	519		10.1038/nature03106	http://dx.doi.org/10.1038/nature03106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690040				2022-12-24	WOS:000226727200047
J	Martel, MJ; Rey, E; Beauchesne, MF; Perreault, S; Lefebvre, G; Forget, A; Blais, L				Martel, MJ; Rey, E; Beauchesne, MF; Perreault, S; Lefebvre, G; Forget, A; Blais, L			Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASTHMATIC WOMEN; PERINATAL OUTCOMES; DRUG-USE; INFORMATION; RECALL; MEDICATIONS; POPULATION; SELECTION; ACCURACY; DATABASE	Objective To determine whether the use of inhaled corticosteroids during pregnancy increases the risk of pregnancy induced hypertension and pre-eclampsia among asthmatic women. Design Nested case-control study. Setting Three administrative health databases from Quebec: RAMQ MED-ECHO, and Fichier des evenements demographiques. Participants 3505 women with asthma, totalling 4593 pregnancies, between 1990 and 2000. Main outcome measures Pregnancy induced hypertension and pre-eclampsia. Results 302 cases of pregnancy induced hypertension and 165 cases of pre-eclampsia were identified. Use of inhaled corticosteroids from conception until date of outcome was not associated with an increased risk of pregnancy induced hypertension (adjusted odds ratio 1.02, 95% confidence interval 0.77 to 1.34) or pre-eclampsia (1.06,0.74 to 1.53). No significant dose-response relation was observed between inhaled corticosteroids and pregnancy induced hypertension or pre-eclampsia. Oral corticosteroids were significantly associated with the risk of pregnancy induced hypertension (adjusted odds ratio 1.57, 1.02 to 2.41), and a trend was seen for pre-eclampsia (1.72, 0.98 to 3.02). Conclusion No significant increase of the risk of pregnancy induced hypertension or pre-eclampsia was detected among users of inhaled corticosteroids during pregnancy, while markers of uncontrolled and severe asthma were found to significantly increase the risks of pregnancy induced hypertension and pre-eclampsia.	Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Fac Med, Dept Obstet & Gynecol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Math & Stat, Montreal, PQ H3C 3J7, Canada; Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Blais, L (corresponding author), Univ Montreal, Fac Pharm, CP 6128,Succursale Centreville, Montreal, PQ H3C 3J7, Canada.	lucie.blais@umontreal.ca	Perreault, Sylvie/AAM-8009-2020	Perreault, Sylvie/0000-0002-0066-0127				Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; AVRON J, 1998, JAMA-J AM MED ASSOC, V279, P1458; BAHNA SL, 1972, ACTA ALLERGOL, V27, P397, DOI 10.1111/j.1398-9995.1972.tb01439.x; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Boulet LP, 1999, CAN MED ASSOC J, V161, pS1; Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; Dombrowski MP, 2004, AM J OBSTET GYNECOL, V190, P737, DOI 10.1016/j.ajog.2003.09.071; Duley L, 2003, BRIT MED BULL, V67, P161, DOI 10.1093/bmb/ldg005; Garbe E, 1997, LANCET, V350, P979, DOI 10.1016/S0140-6736(97)03392-8; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; LEHRER S, 1993, AM J OBSTET GYNECOL, V168, P1463, DOI 10.1016/S0002-9378(11)90782-0; LEVY AR, 1995, AM J EPIDEMIOL, V142, P428, DOI 10.1093/oxfordjournals.aje.a117651; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; *NAT ASTHM ED PREV, 2 NIH NAT ASTHM ED P; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2; *QUEB GOV, 1997, REG ASS MAL QUEB STA; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; SCHATZ M, 1995, AM J RESP CRIT CARE, V151, P1170; Schatz M, 1997, J ALLERGY CLIN IMMUN, V100, P301, DOI 10.1016/S0091-6749(97)70241-0; STENIUSAARNIALA B, 1988, THORAX, V43, P12, DOI 10.1136/thx.43.1.12; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Van den Berg LTWDJ, 1999, TERATOLOGY, V60, P33; VANDENBRANDT PA, 1991, PHARM WEEKBLAD, V13, P91, DOI 10.1007/BF01974987; Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563	29	96	101	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2005	330	7485					230	233		10.1136/bmj.38313.624352.8F	http://dx.doi.org/10.1136/bmj.38313.624352.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15659480	Green Published, Bronze			2022-12-24	WOS:000226779400021
J	Bar-Nahum, G; Epshtein, V; Ruckenstein, AE; Rafikov, R; Mustaev, A; Nudler, E				Bar-Nahum, G; Epshtein, V; Ruckenstein, AE; Rafikov, R; Mustaev, A; Nudler, E			A ratchet mechanism of transcription elongation and its control	CELL			English	Article							RNA-POLYMERASE-II; 3.3 ANGSTROM RESOLUTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; ACTIVE-CENTER; NUCLEOSIDE TRIPHOSPHATES; CATALYTIC RESIDUES; ALLOSTERIC BINDING; CRYSTAL-STRUCTURE; BASIC MECHANISMS	RNA chain elongation is a highly processive and accurate process that is finely regulated by numerous intrinsic and extrinsic signals. Here we describe a general mechanism that governs RNA polymerase (RNAP) movement and response to regulatory inputs such as pauses, terminators, and elongation factors. We show that E.coli RNAP moves by a complex Brownian ratchet mechanism, which acts prior to phosphodiester bond formation. The incoming substrate and the flexible F bridge domain of the catalytic center serve as two separate ratchet devices that function in concert to drive forward translocation. The adjacent G loop domain controls F bridge motion, thus keeping the proper balance between productive and inactive states of the elongation complex. This balance is critical for cell viability since it determines the rate, processivity, and fidelity of transcription.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; Publ Hlth Res Inst, Newark, NJ 07103 USA	New York University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu	Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076; Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM064375, R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [P20 GM64375, R01 GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Mustaev A, 2003, METHOD ENZYMOL, V371, P191; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 2003, METHOD ENZYMOL, V371, P369; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Sousa R, 2001, TRENDS BIOCHEM SCI, V26, P695, DOI 10.1016/S0968-0004(01)02000-X; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VOGEL U, 1994, J BIOL CHEM, V269, P16236; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	46	260	268	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					183	193		10.1016/j.cell.2004.11.045	http://dx.doi.org/10.1016/j.cell.2004.11.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680325	Bronze			2022-12-24	WOS:000226740000008
J	Casalino, LP				Casalino, LP			Disease management and the organization of physician practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPROVING PRIMARY-CARE; CHRONIC ILLNESS; QUALITY; PROGRAMS; MODEL		Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago	Casalino, LP (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	lcasalin@uchicago.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; DeBusk RF, 1999, ARCH INTERN MED, V159, P2739, DOI 10.1001/archinte.159.22.2739; ENTHOVEN A, 2004, 21 CENTURY HLTH SYST; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fernandez A, 2001, J GEN INTERN MED, V16, P163, DOI 10.1046/j.1525-1497.2001.91226.x; Fonarow GC, 2004, CIRCULATION, V110, P3506, DOI 10.1161/01.CIR.0000151101.17629.20; FOOTE SM, 2003, HLTH AFF MILLWOOD; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Neil Nancy, 2003, Jt Comm J Qual Saf, V29, P610; Nobel Jeremy J, 2003, Dis Manag, V6, P219, DOI 10.1089/109350703322682531; ROBINSON JC, 2004, HLTH AFF MILLWOOD; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; SUPER N, MEDICARES CHRONIC CA; Villagra V, 2004, MED CARE, V42, P24, DOI 10.1097/01.mlr.0000119395.13327.e9; VILLAGRA V, 2004, HLTH AFF MILLWOOD; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 2004, ANN INTERN MED, V141, P644, DOI 10.7326/0003-4819-141-8-200410190-00015; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Welch WP, 2002, AM J MANAG CARE, V8, P353; Wilson Thomas W, 2004, Jt Comm J Qual Saf, V30, P614	25	91	91	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					485	488		10.1001/jama.293.4.485	http://dx.doi.org/10.1001/jama.293.4.485			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671434				2022-12-24	WOS:000226492900028
J	Ponsonby, AL; van der Mei, I; Dwyer, T; Blizzard, L; Taylor, B; Kemp, A; Simmons, R; Kilpatrick, T				Ponsonby, AL; van der Mei, I; Dwyer, T; Blizzard, L; Taylor, B; Kemp, A; Simmons, R; Kilpatrick, T			Exposure to infant siblings during early life and risk of multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPSTEIN-BARR-VIRUS; BIRTH-ORDER; CELL RESPONSE; T-CELLS; INFECTIONS; ACTIVATION; ANTIBODIES; VARICELLA; CHILDREN; ANTIGEN	Context The "hygiene hypothesis" has implicated sibship as a marker of infection load during early life and suggests that exposure or reexposure to infections can influence the developing immune system. Viral infection has also been implicated in the pathogenesis of multiple sclerosis (MS). Objectives To evaluate whether exposure to infant siblings in early life is associated with the risk of MS, and to explore the possible mechanism for any apparent protective effect, including altered Epstein-Barr virus (EBV) infection patterns. Design, Setting, and Patients Population-based case-control study in Tasmania, Australia, from 1999 to 2001 based on 136 cases of magnetic resonance imaging confirmed MS and 272 community controls, matched on sex and year of birth. Main Outcome Measure Risk of MS by duration of contact with younger siblings aged less than 2 years in the first 6 years of life. Results Increasing duration of contact with a younger sibling aged less than 2 years in the first 6 years of life was associated with reduced MS risk (adjusted odds ratios [AORs]: <1 infant-year, 1.00 [reference); 1 to <3 infant-years, 0.57 (95% confidence interval (0), 0.33-0.98]; 3 to <5 infant-years, 0.40 (95% Cl. 0.19-0.92); >= 5 infant-years, 0.12 [95% Cl, 0.02-0.88); test for trend, P=.002). A history of exposure to infant siblings was associated with a reduced IgG response to EBV among controls. Controls with at least 1 infant-year contact had a reduced risk of infectious mononucleosis and a reduced risk of very high composite EBV IgG titers (AOR, 0.33; 95% Cl, 0.11-0.98) compared with other controls. The inverse association between higher infant contact and MS was independent of EBV IgG titer. Conclusion Higher infant sibling exposure in the first 6 years of life was associated with a reduced risk of MS, possibly by altering childhood infection patterns and related immune responses.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; Royal Hobart Hosp, Hobart, Tas, Australia; Univ Sydney, Discipline Paediat & Child Hlth, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; Canberra Hosp, Canberra, ACT, Australia; Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia	Australian National University; University of Tasmania; Menzies Institute for Medical Research; Royal Hobart Hospital; University of Sydney; Australian National University; Canberra Hospital; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ponsonby, AL (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	anne-louise.ponsonby@anu.edu.au	van der Mei, Ingrid/J-7457-2014; van der Mei, Ingrid/AAI-2566-2020; Ponsonby, Anne-Louise/AAE-4351-2019	van der Mei, Ingrid/0000-0001-9009-7472; van der Mei, Ingrid/0000-0001-9009-7472; Kilpatrick, Trevor/0000-0003-3999-085X; Ponsonby, Anne-Louise/0000-0002-6581-3657				Aalto SM, 1998, J MED VIROL, V56, P186, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;186::AID-JMV2&gt;3.0.CO;2-3; Adams CL, 2003, IMMUNOLOGY, V108, P274, DOI 10.1046/j.1365-2567.2003.01583.x; Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; ARVIN AM, 1983, J INFECT DIS, V148, P200, DOI 10.1093/infdis/148.2.200; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DAGAN R, 1994, EUR J CLIN MICROBIOL, V13, P1029, DOI 10.1007/BF02111822; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; FARR TJ, 1990, EPIDEMIOL INFECT, V105, P603, DOI 10.1017/S095026880004824X; Gartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003; Haahr S, 1995, Mult Scler, V1, P73; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; Hollsberg P, 2003, CLIN EXP IMMUNOL, V132, P137, DOI 10.1046/j.1365-2249.2003.02114.x; HOLT PG, 1994, LANCET, V344, P456, DOI 10.1016/S0140-6736(94)91776-0; HOSMER DW, 2000, WILEY PS TX, P1; HUANG LM, 1993, ARCH DIS CHILD, V68, P408, DOI 10.1136/adc.68.3.408; ISAGER H, 1980, ACTA NEUROL SCAND, V61, P393; Kim BS, 2001, IMMUNOL RES, V24, P121, DOI 10.1385/IR:24:2:121; Knipe D, 2001, FIELDS VIROLOGY, V2; KOCHHENRIKSEN N, 1989, ACTA NEUROL SCAND, V124, pS1; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; MATIASGUIU J, 1994, NEUROEPIDEMIOLOGY, V13, P129, DOI 10.1159/000110371; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Olson JK, 2002, J IMMUNOL, V169, P2719, DOI 10.4049/jimmunol.169.5.2719; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P150; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Savoldo B, 2002, J IMMUNOL, V168, P909, DOI 10.4049/jimmunol.168.2.909; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Ullrich SE, 2002, FRONT BIOSCI-LANDMRK, V7, pD684, DOI 10.2741/ullrich; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Villoslada P, 2003, NEUROLOGY, V60, P1944, DOI 10.1212/01.WNL.0000069461.53733.F7; VISSCHER BR, 1982, ACTA NEUROL SCAND, V66, P209, DOI 10.1111/j.1600-0404.1982.tb04518.x; Wedderburn LR, 2001, IMMUNOLOGY, V102, P301, DOI 10.1046/j.1365-2567.2001.01194.x; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZILBER N, 1988, ACTA NEUROL SCAND, V78, P313, DOI 10.1111/j.1600-0404.1988.tb03662.x	42	117	120	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					463	469		10.1001/jama.293.4.463	http://dx.doi.org/10.1001/jama.293.4.463			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671431	Bronze			2022-12-24	WOS:000226492900025
J	Nadelman, RB; Wormser, GP				Nadelman, RB; Wormser, GP			Poly-ticks: Blue State versus Red State for Lyme disease	LANCET			English	Editorial Material							AMBLYOMMA-AMERICANUM		New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College	Nadelman, RB (corresponding author), New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA.	robert_nadelman@nymc.edu						Masters E, 1998, ARCH DERMATOL, V134, P955, DOI 10.1001/archderm.134.8.955; PIESMAN J, 1988, J MED ENTOMOL, V25, P336, DOI 10.1093/jmedent/25.5.336; SCHULZE TL, 1984, SCIENCE, V224, P601, DOI 10.1126/science.6710158; WORMSER GP, IN PRESS CLIN INFECT; [No title captured]	5	3	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					280	280						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664208				2022-12-24	WOS:000226449600009
J	Sanchez, PA; Swaminathan, MS				Sanchez, PA; Swaminathan, MS			Cutting world hunger in half	SCIENCE			English	Editorial Material									Columbia Univ, Earth Inst, Palisades, NY 10964 USA; MS Swaminathan Res Fdn, Madras 600113, Tamil Nadu, India	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, Palisades, NY 10964 USA.	sanchez@iri.columbia.edu; msswami@mssrf.res.in						Food and Agriculture Organization of the United Nations, 2004, STAT FOOD INS WORLD; KADIYALA S, 2003, 159 INT FOOD POL RES; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; *UN MILL PROJ, 2005, TASK FORC HUNG HALV; UN Millennium Project, 2005, INV DEV PRACT PLAN A	6	125	134	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					357	359		10.1126/science.1109057	http://dx.doi.org/10.1126/science.1109057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15661994				2022-12-24	WOS:000226492300023
J	Lieberman, E; Hauert, C; Nowak, MA				Lieberman, E; Hauert, C; Nowak, MA			Evolutionary dynamics on graphs	NATURE			English	Article							SUBDIVIDED POPULATION; NETWORK FORMATION; FIXATION; PROBABILITY; COOPERATION; MODEL	Evolutionary dynamics have been traditionally studied in the context of homogeneous or spatially extended populations(1-4). Here we generalize population structure by arranging individuals on a graph. Each vertex represents an individual. The weighted edges denote reproductive rates which govern how often individuals place offspring into adjacent vertices. The homogeneous population, described by the Moran process(3), is the special case of a fully connected graph with evenly weighted edges. Spatial structures are described by graphs where vertices are connected with their nearest neighbours. We also explore evolution on random and scale-free networks(5-7). We determine the fixation probability of mutants, and characterize those graphs for which fixation behaviour is identical to that of a homogeneous population(7). Furthermore, some graphs act as suppressors and others as amplifiers of selection. It is even possible to find graphs that guarantee the fixation of any advantageous mutant. We also study frequency-dependent selection and show that the outcome of evolutionary games can depend entirely on the structure of the underlying graph. Evolutionary graph theory has many fascinating applications ranging from ecology to multi-cellular organization and economics.	Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Appl Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); University of British Columbia	Lieberman, E (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	erez@erez.com	Hauert, Christoph/E-5369-2011; Aiden, Erez Lieberman/A-2908-2010; Nowak, Martin A/A-6977-2008	Hauert, Christoph/0000-0002-1239-281X; 				Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; [Anonymous], 1988, LECT NOTES PARTICLE; Asavathiratham C, 2001, IEEE CONTR SYST MAG, V21, P52, DOI 10.1109/37.969135; Bala V, 2000, ECONOMETRICA, V68, P1181, DOI 10.1111/1468-0262.00155; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARTON NH, 1993, GENET RES, V62, P149, DOI 10.1017/S0016672300031748; Boyd S, 2004, SIAM REV, V46, P667, DOI [10.1137/S0036144503423264, 10.1137/s0036144503423264]; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; ERDOS P, 1960, B INT STATIST INST, V38, P343; FISHER RA, 1950, HEREDITY, V4, P117, DOI 10.1038/hdy.1950.8; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Jackson MO, 2002, GAME ECON BEHAV, V41, P265, DOI 10.1016/S0899-8256(02)00504-3; LIGGETT TM, 1999, STOCHASTIC INTERACTI; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Moran P. A. P., 1958, P CAMB PHILOS SOC, V54, P60, DOI DOI 10.1017/S0305004100033193); NAGYLAKI T, 1980, GENETICS, V94, P497; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Neuhauser C, 2001, NOTICES AM MATH SOC, V48, P1304; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; SLATKIN M, 1981, EVOLUTION, V35, P477, DOI 10.1111/j.1558-5646.1981.tb04911.x; Tilman D., 1997, SPATIAL ECOLOGY ROLE; Whitlock MC, 2003, GENETICS, V164, P767; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1932, P INT C GENET, V6, P356	31	804	826	13	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					312	316		10.1038/nature03204	http://dx.doi.org/10.1038/nature03204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662424				2022-12-24	WOS:000226381300055
J	Kinoshita, T; Cano-Delgado, AC; Seto, H; Hiranuma, S; Fujioka, S; Yoshida, S; Chory, J				Kinoshita, T; Cano-Delgado, AC; Seto, H; Hiranuma, S; Fujioka, S; Yoshida, S; Chory, J			Binding of brassinosteroids to the extracellular domain of plant receptor kinase BRI1	NATURE			English	Article							SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CRYSTAL-STRUCTURE; ARABIDOPSIS; PROTEIN; PERCEPTION; MUTANTS; PATHWAY	Both animals and plants use steroids as signalling molecules during growth and development. Animal steroids are principally recognized by members of the nuclear receptor superfamily of transcription factors(1). In plants, BRI1, a leucine-rich repeat (LRR) receptor kinase localized to the plasma membrane, is a critical component of a receptor complex for brassinosteroids(2,3). Here, we present the first evidence for direct binding of active brassinosteroids to BRI1 using a biotin-tagged photoaffinity castasterone (BPCS), a biosynthetic precursor of brassinolide (the most active of the brassinosteroids). Binding studies using BPCS, H-3-labelled brassinolide and recombinant BRI1 fragments show that the minimal binding domain for brassinosteroids consists of a 70-amino acid island domain (ID) located between LRR21 and LRR22 in the extracellular domain of BRI1, together with the carboxy-terminal flanking LRR (ID-LRR22). Our results demonstrate that brassinosteroids bind directly to the 94 amino acids comprising ID-LRR22 in the extracellular domain of BRI1, and define a new binding domain for steroid hormones.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; RIKEN, Plant Funct Lab, Wako, Saitama 3510198, Japan; RIKEN, Plant Sci Ctr, Kanagawa 2300045, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Kyushu University; RIKEN; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Kinoshita, Toshinori/C-2891-2012	Kinoshita, Toshinori/0000-0001-7621-1259				Altmann T, 1999, PLANTA, V208, P1, DOI 10.1007/s004250050528; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1999, BRASSINOSTEROIDS, P163; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GALLAGHER S, 1992, CURRENT PROTOCOLS MO; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Konoki K, 2000, TETRAHEDRON, V56, P9003, DOI 10.1016/S0040-4020(00)00752-3; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Seto H, 2002, TETRAHEDRON, V58, P9741, DOI 10.1016/S0040-4020(02)01247-4; Seto H, 1998, TETRAHEDRON LETT, V39, P7525, DOI 10.1016/S0040-4039(98)01636-0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Ward CW, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-4; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	27	455	482	6	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					167	171		10.1038/nature03227	http://dx.doi.org/10.1038/nature03227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650741				2022-12-24	WOS:000226252200040
J	Xu, M; Arulandu, A; Struck, DK; Swanson, S; Sacchettini, JC; Young, R				Xu, M; Arulandu, A; Struck, DK; Swanson, S; Sacchettini, JC; Young, R			Disulfide isomerization after membrane release of its SAR domain activates P1 lysozyme	SCIENCE			English	Article							ESCHERICHIA-COLI; CELL-LYSIS; SWITCHES; SEQUENCE; HOLINS	The P1 lysozyme Lyz is secreted to the periplasm of Escherichia coli and accumulates in an inactive membra ne-tethered form. Genetic and biochemical experiments show that, when released from the bilayer, Lyz is activated by an intramolecular thiol-disulfide isomerization, which requires a cysteine in its N-terminal SAR (signal-arrest-release) domain. Crystal structures confirm the alternative disulfide linkages in the two forms of Lyz and reveal dramatic conformational differences in the catalytic domain. Thus, the exported P1 endolysin is kept inactive by three levels of control-topological, conformational, and covalent-until its release from the membrane is triggered by the P1 holin.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Young, R (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu; ryland@tamu.edu	Arulandu, Arockiasamy/C-1679-2009	Young, Ry/0000-0001-8001-2914; Arulandu, Arockiasamy/0000-0002-4606-8006	NIGMS NIH HHS [R01 GM027099, GM62410, GM27099] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027099, P50GM062410, R01GM027099] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONOVICH MT, 1991, J BACTERIOL, V173, P2897, DOI 10.1128/JB.173.9.2897-2905.1991; Grundling A, 2001, P NATL ACAD SCI USA, V98, P9348, DOI 10.1073/pnas.151247598; HARDY LW, 1991, BIOCHEMISTRY-US, V30, P9457, DOI 10.1021/bi00103a010; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; High S, 1997, TRENDS CELL BIOL, V7, P206; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Khan AR, 1998, PROTEIN SCI, V7, P815; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Roberts MD, 2004, VIROLOGY, V318, P245, DOI 10.1016/j.virol.2003.09.020; Sao-Jos? C., 2003, RECENT RES DEV BACTE, V1, P103; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Schmidt C, 1996, J BACTERIOL, V178, P1099, DOI 10.1128/jb.178.4.1099-1104.1996; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wu J, 1997, PROTEIN SCI, V6, P391; Xu M, 2004, P NATL ACAD SCI USA, V101, P6415, DOI 10.1073/pnas.0400957101; XU MW, UNPUB; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	21	101	104	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					113	117		10.1126/science.1105143	http://dx.doi.org/10.1126/science.1105143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637279				2022-12-24	WOS:000226214300050
J	Danesh, J				Danesh, J			Antibiotics in the prevention of heart attacks	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; WAVE CORONARY SYNDROMES; CHLAMYDIA-PNEUMONIAE; SECONDARY PREVENTION; DISEASE; AZITHROMYCIN; EVENTS; TWAR; ROXITHROMYCIN		Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England	University of Cambridge	Danesh, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	john.danesh@phpc.cam.ac.uk						CANNON CP, 2004, EUR SOC CARD C AUG 2; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1998, Expert Opin Investig Drugs, V7, P691, DOI 10.1517/13543784.7.5.691; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; GRAYSTON JT, 2004, EUR SOC CARD C AUG 2; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; Leowattana Wattana, 2001, Journal of the Medical Association of Thailand, V84, pS669; Muhlestein JB, 2000, CIRCULATION, V102, P1755; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Sinisalo J, 2002, CIRCULATION, V105, P1555, DOI 10.1161/01.CIR.0000012544.07696.1F; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Zahn R, 2003, CIRCULATION, V107, P1253, DOI 10.1161/01.CIR.0000054613.57105.06	19	28	28	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					365	367						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680439				2022-12-24	WOS:000226610900006
J	Roberts, RJ; Burgess, IF				Roberts, RJ; Burgess, IF			New head-lice treatments: hope or hype?	LANCET			English	Editorial Material							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; PERMETHRIN; KDR; MALATHION		Natl Publ Hlth Serv Wales, Mold, Flintshire, Wales; Insect Res & Dev Ltd, Royston, Herts, England		Roberts, RJ (corresponding author), Natl Publ Hlth Serv Wales, Mold, Flintshire, Wales.	roberts@doctors.org.uk	Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0003-0747-3938				DODD CS, 2001, COCHRANE LIB; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Gao JR, 2003, PESTIC BIOCHEM PHYS, V77, P115, DOI 10.1016/j.pestbp.2003.08.003; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pearlman DL, 2004, PEDIATRICS, V114, pE275, DOI 10.1542/peds.2003-0666-F; Roberts RJ, 2002, NEW ENGL J MED, V346, P1645, DOI 10.1056/NEJMcp012640; Roberts RJ, 2000, LANCET, V356, P540, DOI 10.1016/S0140-6736(00)02578-2; *UPD SOFTW LTD, 2004, NAT RES REG 2004	11	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					8	10		10.1016/S0140-6736(04)17677-0	http://dx.doi.org/10.1016/S0140-6736(04)17677-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639662				2022-12-24	WOS:000226213100006
J	Okie, S				Okie, S			Illness and secrecy on the supreme court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Garrow DJ, 2000, U CHICAGO LAW REV, V67, P995, DOI 10.2307/1600454; GREENHOUSE L, 2004, NY TIMES        1106, P25; HUTCHINSON DJ, 1998, MAN WHO ONCE WHIZZER, P463; Ward Artemus, 2000, J SUPREME COURT HIST, V25, P296; WHITE B, 1975, COMMUNICATION   1020	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2675	2678		10.1056/NEJMp048339	http://dx.doi.org/10.1056/NEJMp048339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	881OR	15616200				2022-12-24	WOS:000225877300001
J	Jonsson, S; Thorsteinsdottir, U; Gudbjartsson, DF; Jonsson, HH; Kristjansson, K; Arnason, S; Gudnason, V; Isaksson, HJ; Hallgrimsson, J; Gulcher, JR; Amundadottir, LT; Kong, A; Stefansson, K				Jonsson, S; Thorsteinsdottir, U; Gudbjartsson, DF; Jonsson, HH; Kristjansson, K; Arnason, S; Gudnason, V; Isaksson, HJ; Hallgrimsson, J; Gulcher, JR; Amundadottir, LT; Kong, A; Stefansson, K			Familial risk of lung carcinoma in the Icelandic population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER SUSCEPTIBILITY; DISEASE; AGGREGATION; SURVIVAL; SMOKING; REPAIR	Context The dominant role of tobacco smoke as a causative factor in lung carcinoma is well established; however, an inherited predisposition may also be an important factor in the susceptibility to lung carcinoma. Objective To investigate the contribution of genetic factors to the risk of developing lung carcinoma in the Icelandic population. Design, Setting, and Participants Risk ratios (RRs) of lung carcinoma for first-, second-, and third-degree relatives of patients with lung carcinoma were estimated by linking records from the Icelandic Cancer Registry (ICR) of all 2756 patients diagnosed with lung carcinoma within the Icelandic population from January 1, 1955, to February 28, 2002, with an extensive genealogical database containing all living Icelanders and most of their ancestors since the settlement of Iceland. The RR for smoking was similarly estimated using a random population-based cohort of 10541 smokers from the Reykjavik Heart Study who had smoked for more than 10 years. Of these smokers, 562 developed lung cancer based on the patients with lung cancer list from the ICR. Main Outcome Measures Estimation of RRs of close and distant relatives of patients with lung carcinoma and comparison with RRs for close and distant relatives of smokers. Results A familial factor for lung carcinoma was shown to extend beyond the nuclear family, as evidenced by significantly increased RR for first-degree relatives (for parents: RR, 2.69; 95% confidence interval [CI], 2.20-3.23; for siblings: RR, 2.02; 95% CI,1.77-2.23; and for children: RR, 1.96; 95% CI,1.53-2.39), second-degree relatives (for uncles/aunts: RR, 1.34; 95% CI, 1.15-1.49; and for nephews/nieces: RR, 1.28; 95% CI, 1.10-1.43), and third-degree relatives (for cousins: RR, 1.14; 95% CI,1.05-1.22) of patients with lung carcinoma. This effect was stronger for relatives of patients with early-onset disease vc (age at onset less than or equal to60 years) (for parents: RR, 3.48; 95% CI,1.83-8.21; for siblings: RR, 3.30; 95% CI, 2.19-4.58; and for children: RR, 2.84; 95% CI, 1.34-7.21). The hypothesis that this increased risk is solely due to the effects of smoking was rejected for all relationships, except cousins and spouses, with a single-sided test of the RRs for lung carcinoma vs RRs for smoking. Conclusions These results underscore the importance of genetic predisposition in the development of lung carcinoma, with its strongest effect in patients with early-onset disease. However, tobacco smoke plays a dominant role in the pathogenesis of this disease, even among those individuals who are genetically predisposed to lung carcinoma.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; Icelandic Heart Assoc, Reykjavik, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Icelandic Heart Association	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kari.stefansson@decode.is	Amundadottir, Laufey T/L-7656-2016; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Stefansson, Kari/AAE-7187-2019	Amundadottir, Laufey T/0000-0003-1859-8971; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Gudbjartsson, Daniel/0000-0002-5222-9857				Amos CI, 1999, RECENT RESULTS CANC, V151, P3; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bosken CH, 2002, JNCI-J NATL CANCER I, V94, P1091; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dong CH, 2001, INT J CANCER, V92, P144; Gauderman WJ, 2000, AM J EPIDEMIOL, V151, P41, DOI 10.1093/oxfordjournals.aje.a010120; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; Hemminki K, 2002, BRIT J CANCER, V86, P1737, DOI 10.1038/sj.bjc.6600302; Hemminki K, 2001, GENET EPIDEMIOL, V20, P107, DOI 10.1002/1098-2272(200101)20:1<107::AID-GEPI9>3.0.CO;2-4; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MACK W, 1990, ENVIRON HEALTH PERSP, V87, P27, DOI 10.2307/3431002; Mannino DM, 1998, INT J EPIDEMIOL, V27, P159, DOI 10.1093/ije/27.2.159; OOI WL, 1986, J NATL CANCER I, V76, P217; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Spitz MR, 1999, CANCER INVEST, V17, P645, DOI 10.3109/07357909909032849; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Thomas A, 1999, COMPUT BIOMED RES, V32, P517, DOI 10.1006/cbmr.1999.1525; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Travis WD, 1999, INT HISTOLOGICAL CLA; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Zatloukal P, 2003, LUNG CANCER-J IASLC, V41, P283, DOI 10.1016/S0169-5002(03)00234-4	32	84	90	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2977	2983		10.1001/jama.292.24.2977	http://dx.doi.org/10.1001/jama.292.24.2977			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613665	Bronze			2022-12-24	WOS:000225841900031
J	Wilson, JF				Wilson, JF			Balancing the risks and benefits of fish consumption	ANNALS OF INTERNAL MEDICINE			English	Editorial Material												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Schantz SL, 2001, ENVIRON HEALTH PERSP, V109, P605, DOI 10.2307/3455035	5	23	24	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					977	980		10.7326/0003-4819-141-12-200412210-00024	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611502				2022-12-24	WOS:000225923000016
J	Herr, AJ; Jensen, MB; Dalmay, T; Baulcombe, DC				Herr, AJ; Jensen, MB; Dalmay, T; Baulcombe, DC			RNA polymerase IV directs silencing of endogenous DNA	SCIENCE			English	Article							METHYLATION; ARABIDOPSIS; ARGONAUTE4	Plants encode subunits for a fourth RNA polymerase (Pot IV) in addition to the well-known DNA-dependent RNA polymerases I, II, and III. By mutation of the two largest subunits (NRPD1a and NRPD2), we show that Pot IV silences certain transposons and repetitive DNA in a short interfering RNA pathway involving RNA-dependent RNA polymerase-2 and Dicer-like 3. The existence of this distinct silencing polymerase may explain the paradoxical involvement of an RNA silencing pathway in maintenance of transcriptional silencing.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@sainsbury-laboratory.ac.uk	Dalmay, Tamas/E-1377-2011	Dalmay, Tamas/0000-0003-1492-5429; Herr, Alan/0000-0002-9498-0972; Baulcombe, David/0000-0003-0780-6878				Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bellaoui M, 2004, PLANTA, V219, P819, DOI 10.1007/s00425-004-1295-5; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Myouga F, 2001, GENES GENET SYST, V76, P169, DOI 10.1266/ggs.76.169; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	14	518	547	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					118	120		10.1126/science.1106910	http://dx.doi.org/10.1126/science.1106910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15692015				2022-12-24	WOS:000228221500046
J	Hessa, T; White, SH; von Heijne, G				Hessa, T; White, SH; von Heijne, G			Membrane insertion of a potassium-channel voltage sensor	SCIENCE			English	Article							DEPENDENT K+ CHANNEL		Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA	Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	White, Stephen/N-1507-2019; von Heijne, Gunnar/AAH-9389-2019; White, Stephen H/B-1053-2009; von Heijne, Gunnar/F-5576-2011	White, Stephen H/0000-0001-8540-7907; von Heijne, Gunnar/0000-0002-4490-8569	NIGMS NIH HHS [GM46823, GM68002] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046823, R01GM068002] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		FREITES JA, UNPUB; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r	7	160	162	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1427	1427		10.1126/science.1109176	http://dx.doi.org/10.1126/science.1109176			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15681341				2022-12-24	WOS:000227503100035
J	Gill, SS; Rochon, PA; Herrmann, N; Lee, PE; Sykora, K; Gunraj, N; Normand, SLT; Gurwitz, JH; Marras, C; Wodchis, WP; Mamdani, M				Gill, SS; Rochon, PA; Herrmann, N; Lee, PE; Sykora, K; Gunraj, N; Normand, SLT; Gurwitz, JH; Marras, C; Wodchis, WP; Mamdani, M			Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CEREBROVASCULAR EVENTS; DEMENTIA; RISPERIDONE; MANAGEMENT; SYMPTOMS; ATTACK; TRIAL	Objective To compare the incidence of admissions to hospital for stroke among older adults with dementia,receiving atypical or typical ancipsychotics. Design Population based retrospective cohort study. Setting Ontario, Canada. Patients 32 7 10 older adults 65 years) with dementia (17 845 dispensed an atypical antipsychotic and 14 865 dispensed a typical antipsychotic). Main outcome measures Admission to hospital with the most responsible diagnosis (single most important condition responsible for the patients admission) of ischaemic stroke. Observation of patients until they were either admitted to hospital with ischaemic stroke, stopped taking antipsychotics, died, or the study ended. Results After adjustment for potential confounders, participants receiving atypical antipsychotics showed no significant increase in risk of ischaemic stroke compared with those receiving typical antipsychotics (adjusted hazard ratio 1.01, 95% confidence interval 0.81 to 1.26). This finding was consistent in a series of subgroup analyses, including ones of individual atypical antipsychotic drugs (risperidone, olanzapine, and quetiapine) and selected subpopulations of the main cohorts. Conclusion Older adults with dementia who take atypical antipsychotics have a similar risk of ischaemic stroke to those taking typical antipsychotics.	Inst Clin Evaluat Sci, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Div Geriatr Psychiat, Toronto, ON, Canada; Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada; Toronto Rehabil Inst, Toronto, ON, Canada; Univ British Columbia, Div Geriatr Med, Vancouver, BC V5Z 1M9, Canada; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gill, SS (corresponding author), St Marys Lake Hosp, Chapel Wing, Room 1-152,340 Union St, Kingston, ON K7L 5A2, Canada.	gills@pccchealth.org	Greiver, Michelle/N-8764-2015; Rochon, Paula A/J-2918-2016	Greiver, Michelle/0000-0001-8957-0285; Rochon, Paula A/0000-0002-5973-4151; Normand, Sharon-Lise/0000-0001-7027-4769; wodchis, walter/0000-0003-2494-7031				Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Brown TM, 2002, BMJ-BRIT MED J, V325, P644, DOI 10.1136/bmj.325.7365.644; *CALM AD, CALM AD TRIAL RAND C; *CEM CMO, CEMCMO20041; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COHEN CA, 1993, GERONTOLOGIST, V33, P714, DOI 10.1093/geront/33.6.714; Cohen-Mansfield J, 1998, J AM GERIATR SOC, V36, P7; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; Harrison-Woolrych M, 2004, BRIT MED J, V328, P1416, DOI 10.1136/bmj.328.7453.1416; Health Canada, IMP DRUG SAF INF RIS; Herrmann N, 2004, AM J PSYCHIAT, V161, P1113, DOI 10.1176/appi.ajp.161.6.1113; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KOZMA CM, 2003 M INT COLL GER; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; LIPEROTI R, 2004 ANN M AM GER SO; LIPEROTI R, 200J ANN M AM GER SO; Mayo N E, 1994, Health Rep, V6, P62; Mowat D, 2004, BRIT MED J, V328, P1262, DOI 10.1136/bmj.328.7450.1262-b; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider LS, 2001, AM J GERIAT PSYCHIAT, V9, P346, DOI 10.1176/appi.ajgp.9.4.346; Smith David A, 2004, J Am Med Dir Assoc, V5, P129, DOI 10.1097/01.JAM.0000113432.52383.E0; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1388, DOI 10.1001/jama.288.11.1388; Tariot PN, 2001, CLIN GERIATR MED, V17, P359, DOI 10.1016/S0749-0690(05)70073-2; Teri L, 2002, MED CLIN N AM, V86, P641, DOI 10.1016/S0025-7125(02)00006-8; *US FDA, 2004, 2003 SAF AL RISPERDA; Wallaschofski H, 2001, J CLIN ENDOCR METAB, V86, P5912, DOI 10.1210/jc.86.12.5912; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539; *WORK GROUP FAC OL, GUID MAN BEH PSYCH S; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7; WUETIAPINE EVALUATED	37	222	227	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2005	330	7489					445	448B		10.1136/bmj.38330.470486.8F	http://dx.doi.org/10.1136/bmj.38330.470486.8F			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15668211	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000227315400016
J	Zhu, GP; Golding, GB; Dean, AM				Zhu, GP; Golding, GB; Dean, AM			The selective cause of an ancient adaptation	SCIENCE			English	Article							ISOCITRATE DEHYDROGENASE; ESCHERICHIA-COLI; 3-ISOPROPYLMALATE DEHYDROGENASE; DECARBOXYLATING DEHYDROGENASE; COFACTOR SPECIFICITY; NUCLEOTIDE-SEQUENCE; ADAPTIVE EVOLUTION; NATURAL-SELECTION; CRYSTAL-STRUCTURE; BRANCH POINT	Phylogenetic analysis reveals that the use of nicotinamide adenine dinucleotide phosphate (NADP) by prokaryotic isocitrate dehydrogenase (IDH) arose around the time eukaryotic mitochondria first appeared, about 3.5 billion years ago. We replaced the wild-type gene that encodes the NADP-dependent IDH of Escherichia coli with an engineered gene that possesses the ancestral NAD-dependent phenotype. The engineered enzyme is disfavored during competition for acetate. The selection intensifies in genetic backgrounds where other sources of reduced NADP have been removed. A survey of sequenced prokaryotic genomes reveals that those genomes that encode isocitrate lyase, which is essential for growth on acetate, always have an NADP-dependent IDH. Those with only an NAD-dependent IDH never have isocitrate lyase. Hence, the NADP dependence of prokaryotic IDH is an ancient adaptation to anabolic demand for reduced NADP during growth on acetate.	Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; McMaster University	Dean, AM (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	adean@biosci.umn.edu		Zhu, Guo-ping/0000-0002-1877-4501	NIGMS NIH HHS [GM060611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; CLARKE B, 1975, GENETICS, V79, P101; CLARKE DM, 1986, EUR J BIOCHEM, V158, P647, DOI 10.1111/j.1432-1033.1986.tb09802.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; DYKHUIZEN DE, 1993, METHOD ENZYMOL, V224, P613, DOI 10.1016/0076-6879(93)24046-W; FELSENSTEIN J, 1994, PHYLIP VER 3 5; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; KIRINO H, 1991, J BIOCHEM-TOKYO, V109, P852, DOI 10.1093/oxfordjournals.jbchem.a123470; Lunzer M, 2002, GENETICS, V162, P485; Madigan M., 2000, BROCK BIOL MICROORGA, V9th; Miller SP, 2000, J BIOL CHEM, V275, P833, DOI 10.1074/jbc.275.2.833; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Sivaraman J, 2003, J BIOL CHEM, V278, P43682, DOI 10.1074/jbc.M306344200; Suiter AM, 2003, P NATL ACAD SCI USA, V100, P12782, DOI 10.1073/pnas.2134994100; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; TIPTON PA, 1994, ARCH BIOCHEM BIOPHYS, V313, P15, DOI 10.1006/abbi.1994.1352; Voet D., 1995, BIOCHEMISTRY; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; Yasutake Y, 2003, J BIOL CHEM, V278, P36897, DOI 10.1074/jbc.M304091200; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; Zhu G., UNPUB	32	109	118	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1279	1282		10.1126/science.1106974	http://dx.doi.org/10.1126/science.1106974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15653464				2022-12-24	WOS:000227313200050
J	Cattadori, IM; Haydon, DT; Hudson, PJ				Cattadori, IM; Haydon, DT; Hudson, PJ			Parasites and climate synchronize red grouse populations	NATURE			English	Article							TRICHOSTRONGYLUS-TENUIS; DYNAMICS; STABILITY; BEHAVIOR; SYSTEM	There is circumstantial evidence that correlated climatic conditions can drive animal populations into synchronous fluctuations in abundance(1-5). However, it is unclear whether climate directly affects the survival and fecundity of individuals, or indirectly, by influencing food and natural enemies. Here we propose that climate affects trophic interactions and could be an important mechanism for synchronizing spatially distributed populations. We show that in specific years the size of red grouse populations in northern England either increases or decreases in synchrony. In these years, widespread and correlated climatic conditions during May and July affect populations regionally and influence the density-dependent transmission of the gastrointestinal nematode Trichostrongylus tenuis, a parasite that reduces grouse fecundity(6). This in turn forces grouse populations into synchrony. We conclude that specific climatic events may lead to outbreaks of infectious diseases or pests that may cause dramatic, synchronized changes in the abundance of their hosts.	Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Glasgow	Cattadori, IM (corresponding author), Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	imc3@psu.edu	Hudson, Peter/AAB-8080-2020	Hudson, Peter/0000-0003-0468-3403; Haydon, Daniel/0000-0002-1240-1886; Cattadori, Isabella/0000-0001-6618-316X				[Anonymous], 2000, NEMATODE PARASITES V; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Cattadori IM, 2000, J ANIM ECOL, V69, P620, DOI 10.1046/j.1365-2656.2000.00421.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P435, DOI 10.1098/rspb.2002.2230; Haydon DT, 2002, P ROY SOC B-BIOL SCI, V269, P1609, DOI 10.1098/rspb.2002.2053; Hudson P.J., 1992, GROUSE SPACE TIME; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; HUDSON PJ, 1986, J ANIM ECOL, V55, P85, DOI 10.2307/4694; Hudson PJ, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P109; Hudson PJ, 2002, PHILOS T R SOC B, V357, P1259, DOI 10.1098/rstb.2002.1126; HUDSON PJ, 1995, INFECT DIS NATURAL P, P144; HUDSON PJ, 1999, SCIENCE, V286, P2425; Lee D.L., 2002, BIOL NEMATODES, DOI 10.1201/b12614; Marquardt W.C., 2000, PARASITOLOGY VECTOR; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mougeot F, 2003, NATURE, V421, P737, DOI 10.1038/nature01395; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Pugesek BH, 2003, STRUCTURAL EQUATION; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Shipley B., 2000, CAUSE CORRELATION BI; SLAGSVOLD T, 1975, Norwegian Journal of Zoology, V23, P269; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; WATSON A, 1984, J ANIM ECOL, V53, P663, DOI 10.2307/4542	29	129	134	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					737	741		10.1038/nature03276	http://dx.doi.org/10.1038/nature03276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716952				2022-12-24	WOS:000227039200038
J	Derry, LA; Kurtz, AC; Ziegler, K; Chadwick, OA				Derry, LA; Kurtz, AC; Ziegler, K; Chadwick, OA			Biological control of terrestrial silica cycling and export fluxes to watersheds	NATURE			English	Article							GERMANIUM; FRACTIONATION; GEOCHEMISTRY; ALUMINUM; FOREST; RIVERS; GE/SI	Silicon has a crucial role in many biogeochemical processes - for example, as a nutrient for marine and terrestrial biota, in buffering soil acidification and in the regulation of atmospheric carbon dioxide. Traditionally, silica fluxes to soil solutions and stream waters are thought to be controlled by the weathering and subsequent dissolution of silicate minerals(1,2). Rates of mineral dissolution can be enhanced by biological processes(3). But plants also take up considerable quantities of silica from soil solution, which is recycled into the soil from falling litter in a separate soil - plant silica cycle that can be significant in comparison with weathering input and hydrologic output(4-8). Here we analyse soil water in basaltic soils across the Hawaiian islands to assess the relative contributions of weathering and biogenic silica cycling by using the distinct signatures of the two processes in germanium/silicon ratios. Our data imply that most of the silica released to Hawaiian stream water has passed through the biogenic silica pool, whereas direct mineral - water reactions account for a smaller fraction of the stream silica flux. We expect that other systems exhibiting strong Si depletion of the mineral soils and/or high Si uptake rates by biomass will also have strong biological control on silica cycling and export.	Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Cornell University; Boston University; University of California System; University of California Santa Barbara	Derry, LA (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	lad9@cornell.edu	Derry, Louis A/H-5637-2016	Derry, Louis A/0000-0001-7062-7333				Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; BARTOLI F, 1980, SOIL SCI SOC AM J, V44, P873, DOI 10.2136/sssaj1980.03615995004400040043x; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; DEARGOLLO R, 1978, GEOCHIM COSMOCHIM AC, V42, P623, DOI 10.1016/0016-7037(78)90007-8; Dove P.M., 1995, CHEM WEATHERING RATE, P235; Drees L.R., 1989, MINERALS SOIL ENV, P914; Drever J.I., 1988, GEOCHEMISTRY NATURAL; Exley C, 2002, COORDIN CHEM REV, V228, P127, DOI 10.1016/S0010-8545(02)00077-2; Fraysse F, 2004, GEOCHIM COSMOCHIM AC, V68, pA216; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; FROELICH PN, 1981, SCIENCE, V213, P205, DOI 10.1126/science.213.4504.205; FROELICH PN, 1985, J GEOPHYS RES-OCEANS, V90, P1133, DOI 10.1029/JC090iC01p01133; Garrels R.M., 1967, RES GEOCHEMISTRY, P405; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Kelly EF, 1998, BIOGEOCHEMISTRY, V42, P21, DOI 10.1023/A:1005919306687; Kurtz A., 2004, P 11 INT S WAT ROCK, P833; Kurtz AC, 2001, GEOCHIM COSMOCHIM AC, V65, P1971, DOI 10.1016/S0016-7037(01)00575-0; Kurtz AC, 2002, GEOCHIM COSMOCHIM AC, V66, P1525, DOI 10.1016/S0016-7037(01)00869-9; Lajtha K, 1999, LT EC RES NETWK SER, V2, P166; LUCAS Y, 1993, SCIENCE, V260, P521, DOI 10.1126/science.260.5107.521; Markewitz D, 1998, BIOGEOCHEMISTRY, V42, P235, DOI 10.1023/A:1005901417165; Meunier JD, 2004, GEOCHIM COSMOCHIM AC, V68, pA411; Meunier JD, 1999, GEOLOGY, V27, P835; MORTLOCK RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2075, DOI 10.1016/0016-7037(87)90257-2; Mortlock RA, 1996, ANAL CHIM ACTA, V332, P277, DOI 10.1016/0003-2670(96)00230-9; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; MURNANE RJ, 1990, NATURE, V344, P749, DOI 10.1038/344749a0; VITOUSEK PM, 1995, J TROP ECOL, V11, P189, DOI 10.1017/S0266467400008634; VITOUSEK PM, 1997, GSA TODAY, V7, P1	30	343	366	7	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					728	731		10.1038/nature03299	http://dx.doi.org/10.1038/nature03299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716949				2022-12-24	WOS:000227039200035
J	Ojikutu, BO; Stone, VE				Ojikutu, BO; Stone, VE			Women, inequality, and the burden of HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ojikutu, BO (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Ojikutu, Bisola/0000-0001-7957-8881				*CDCP, 2004, HIV AIDS SURV REP, V15, P18; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; *UNAIDS, 2004, 2004 REP GLOB AIDS E, P22	4	31	32	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					649	652		10.1056/NEJMp048318	http://dx.doi.org/10.1056/NEJMp048318			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716557				2022-12-24	WOS:000227031100002
J	Larrabee, PB; Johnson, KL; Lai, CQ; Ordovas, J; Cowan, JM; Tantravahi, U; Bianchi, DW				Larrabee, PB; Johnson, KL; Lai, CQ; Ordovas, J; Cowan, JM; Tantravahi, U; Bianchi, DW			Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL PLASMA; CANCER-PATIENTS; MICROSATELLITE ALTERATIONS; FETAL DNA; SERUM; ARRAYS; OLIGONUCLEOTIDE; AQUAPORIN-1	Context No molecular biological tests are available to monitor the ongoing development of human fetuses in vivo. Objective To determine whether cell-free fetal messenger RNA (mRNA) in amniotic fluid can be detected using oligonucleotide microarrays to study large-scale gene expression in living human fetuses, with analysis of sex, gestational age, and fetal pathology as variables. Design, Setting, and Patients Four samples of cell-free amniotic fluid were analyzed from pregnant women between 20 and 32 weeks' gestation and undergoing amnioreduction for polyhydramnios associated with twin-twin transfusion syndrome or hydrops fetalis (cases). The control consisted of 6 pooled amniotic fluid samples from women at 17 weeks' gestation and undergoing genetic amniocentesis. After extraction from the normally discarded fraction of amniotic fluid, RNA was amplified twice, labeled, and analyzed using gene expression microarrays. Main Outcome Measure Relative mRNA expression in cell-free samples of amniotic fluid from fetuses with polyhydramnios at different gestational ages vs cell-free amniotic fluid from a pooled control. Results Thirty-six percent of 22 283 probe sets represented on the arrays were present in the cell-free amniotic fluid, and a median of 20% of all probe sets differed between cases and the pooled control. Only male samples expressed 1 Y chromosome transcript. The expression of some developmental transcripts, such as surfactant proteins, mucins, and keratins, changed with gestational age by up to 64-fold. A water transporter gene transcript was increased up to 18-fold in both twin-twin transfusion samples. Placental gene transcripts were not present in any samples., Conclusions This pilot study demonstrates that cell-free fetal mRNA can be extracted from amniotic fluid and successfully hybridized to gene expression microarrays. Preliminary analysis suggests that gene expression changes can be detected in fetuses of different sexes, gestational age, and disease status. Cell-free mRNA in amniotic fluid appears to originate from the fetus and not the placenta.	Tufts Univ, New England Med Ctr, Div Genet, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA; Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA; Brown Univ, Women & Infants Hosp, Dept Pathol & Lab Med, Providence, RI USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; Brown University; Women & Infants Hospital Rhode Island	Bianchi, DW (corresponding author), Tufts Univ, New England Med Ctr, Div Genet, 750 Washington St,NEMC 394, Boston, MA 02111 USA.	dbianchi@tufts-nemc.org	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680; Lai, Chao-Qiang/0000-0003-1107-8375	NICHD NIH HHS [HD42053] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2001, CLIN CHEM, V47, P1867; Botezatu I, 2000, CLIN CHEM, V46, P1078; Chen XQ, 1996, NAT MED, V2, P1033; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jonker SS, 2003, EXP PHYSIOL, V88, P691, DOI 10.1113/eph8802626; LARSEN WJ, 1993, HUMAN EMBRYOLOGY, P421; LEON SA, 1977, CANCER RES, V37, P646; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mann SE, 2002, AM J OBSTET GYNECOL, V187, P902, DOI 10.1067/mob.2002.127168; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Ng EKO, 2002, CLIN CHEM, V48, P1212; Poon LLM, 2000, CLIN CHEM, V46, P1832; Sekizawa A, 2003, HUM GENET, V113, P307, DOI 10.1007/s00439-003-0987-4; Tsui NBY, 2002, CLIN CHEM, V48, P1647	21	51	53	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					836	842		10.1001/jama.293.7.836	http://dx.doi.org/10.1001/jama.293.7.836			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713773	Bronze			2022-12-24	WOS:000226984600025
J	Li, Y; Di Naro, E; Vitucci, A; Zimmermann, B; Holzgreve, W; Hahn, S				Li, Y; Di Naro, E; Vitucci, A; Zimmermann, B; Holzgreve, W; Hahn, S			Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIME QUANTITATIVE PCR; PRENATAL-DIAGNOSIS; CYSTIC-FIBROSIS; BLOOD; ANEMIA	Context Currently, fetal point mutations cannot be reliably analyzed from circulatory fetal DNA in maternal plasma, due to the predominance of maternal DNA sequences. However, analysis of circulatory fetal DNA sequences in maternal plasma have been shown to selectively enrich for fetal DNA molecules on the basis of a smaller molecular size than maternal DNA. Objective To examine the prenatal analysis of 4 common beta-thalassemia point mutations: IVSI-1, IVSI-6, 1VSI-110, and codon 39. Design, Setting, and Patients A total of 32 maternal blood samples were collected at 10 to 12 weeks of gestation (mean, 10.7 weeks) between February 15, 2003, and February 25, 2004, in Bari, Italy, from women with risk for beta-thalassemia in their newborns immediately prior to chorionic villous sampling. Samples in which the father and mother did not carry the same mutation were examined. Circulatory DNA was size-fractionated by gel electrophoresis and polymerase chain reaction (PCR) amplified with a peptide-nucleic-acid clamp, which suppresses amplification of the normal maternal allele. Presence of the paternal mutant allele was detected by allele-specific real-time PCR. Main Outcome Measure Detection of paternally inherited p-globin gene point mutations. Results Presence or absence of the paternal mutant allele was correctly determined in 6 (86%) of 7 cases with the IVSI-1 mutation, 4 (100%) of 4 with the IVSI-6 mutation, 5 (100%) of 5 with the IVSI-110 mutation, and 13 (81%) of 16 with the codon 39 mutation. One false-positive test result was scored for the IVSI-1 mutation. Two cases with the codon 39 mutation were classified as uncertain and 1 case was excluded due to lack of a diagnostic. test result,at the time of analysis. These results yielded an overall sensitivity of 100% and specificity of 93.8%, with classified cases removed. Conclusion Our recently described technique of the size-fractionation of circulatory DNA in maternal plasma may be potentially useful for the noninvasive prenatal determination of fetal point mutations.	Univ Basel Hosp, Univ Womens Hosp, Dept Res, Lab Prenatal Med, CH-4013 Basel, Switzerland; Univ Bari, Dept Obstet & Gynecol, Bari, Italy; Univ Bari, Div Hematol 2, Bari, Italy	University of Basel; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Hahn, S (corresponding author), Univ Basel Hosp, Univ Womens Hosp, Dept Res, Lab Prenatal Med, Spitalstr 21, CH-4013 Basel, Switzerland.	shahn@uhbs.ch		Zimmermann, Bernhard/0000-0002-5275-4571; di naro, edoardo/0000-0001-7675-7171				Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; Chiu Rossa W K, 2002, Expert Rev Mol Diagn, V2, P32, DOI 10.1586/14737159.2.1.32; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Di Naro E, 2000, MOL HUM REPROD, V6, P571, DOI 10.1093/molehr/6.6.571; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Hahn S, 2000, ANN NY ACAD SCI, V906, P148; Hahn S, 2002, CLIN OBSTET GYNECOL, V45, P649, DOI 10.1097/00003081-200209000-00008; JACKSON LG, 1992, NEW ENGL J MED, V327, P594, DOI 10.1056/NEJM199208273270903; KAZAZIAN HH, 1988, BLOOD, V72, P1107; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Strom CM, 2004, GENET MED, V6, P136, DOI 10.1097/01.GIM.0000127268.65149.69; Swinkels DW, 2003, CLIN CHEM, V49, P525, DOI 10.1373/49.3.525; TABOR A, 1986, LANCET, V1, P1287; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhong XY, 2001, LANCET, V357, P310, DOI 10.1016/S0140-6736(05)71754-2; Zimmermann B, 2002, CLIN CHEM, V48, P362	24	172	242	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					843	849		10.1001/jama.293.7.843	http://dx.doi.org/10.1001/jama.293.7.843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713774	Bronze			2022-12-24	WOS:000226984600026
J	Nettles, RE; Kieffer, TL; Kwon, P; Monie, D; Han, YF; Parsons, T; Cofrancesco, J; Gallant, JE; Quinn, TC; Jackson, B; Flexner, C; Carson, K; Ray, S; Persaud, D; Siliciano, RF				Nettles, RE; Kieffer, TL; Kwon, P; Monie, D; Han, YF; Parsons, T; Cofrancesco, J; Gallant, JE; Quinn, TC; Jackson, B; Flexner, C; Carson, K; Ray, S; Persaud, D; Siliciano, RF			Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; RNA LEVELS; HIV-1-INFECTED PATIENTS; INFLUENZA VACCINATION; VIROLOGICAL FAILURE; GENOTYPIC ANALYSIS; LATENT RESERVOIR; STEADY-STATE	Context Many patients infected with human immunodeficiency virus type 1 (HIV-1) and receiving highly active antiretroviral therapy experience intermittent episodes of detectable viremia ("blips"), which may raise concerns about drug resistance, lead to costly repeat measurements of viral RNA, and sometimes trigger alterations in therapy. Objective To test the hypothesis that blips represent random biological and statistical variation around mean steady-state HIV-1 RNA levels slightly below 50 copies/mL rather than biologically significant elevations in viremia. Design, Setting, and Patients Between June 19, 2003, and February 9, 2004, patients receiving therapy underwent intensive sampling (every 2-3 days) over 3 to 4 months to define the frequency, magnitude, and duration of blips and their association with drug levels and other clinical variables. Blips were defined as HIV-1 RNA measurements greater than or equal to 50 copies/mL preceded and followed by measurements less than 50 copies/mL without a change in treatment. To-determine whether blips result from or lead to drug resistance, an ultrasensitive genotyping assay was used to detect drug resistance mutations before, during, and after blips. Patients were 10 HIV-1-infected asymptomatic adults recruited by clinicians and followed up in the Moore Clinic at the Johns Hopkins Hospital. Patients had suppression of viremia to below 50 copies/mL while receiving a stable antiretroviral regimen for 6 months or longer. Main Outcome Measures At each time point, plasma HIV-1 RNA levels were measured in 2 independent laboratories and drug resistance mutations were analyzed by clonal sequencing. Results With the intensive sampling, blips were detected in 9 of 10 patients. Statistical analysis was consistent with random assay variation around a mean viral load below 50 copies/mL. Blips were not concordant on independent testing and had a short duration (median, <3 days) and low magnitude (median, 79 copies/mL). Blip frequency was not associated with demographic, clinical, or treatment variables. Blips did not occur in relation to illness, vaccination, or directly measured antiretroviral drug concentrations. Blips were marginally associated (P=.08) with reported episodes of nonadherence. Most importantly, in approximately 1000 independent clones sequenced for both protease and reverse transcriptase, no new resistance mutations were seen before, during, or shortly after blips. Conclusion Most blips in this population appear to represent random biological and statistical variation around mean HIV-1 levels below 50 copies/mL rather than clinically significant elevations in viremia.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 879 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	Quinn, Thomas/A-2494-2010; Ray, Stuart C./B-7527-2008	Ray, Stuart C./0000-0002-1051-7260; jackson, brooks/0000-0001-9458-135X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, F32AI056696, Z01AI000361, R01AI051178, K08AI060367, R37AI051178] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00052] Funding Source: Medline; NIAID NIH HHS [K08 AI060367, F32 AI056696, AI43222, AI51178] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aleman S, 2002, AIDS, V16, P1039, DOI 10.1097/00002030-200205030-00010; Armitage P., 1987, STAT METHODS MED RES; BARTLETT JG, 2004, GUIDELINES USE ANTIR; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crommentuyn KML, 2004, ANTIVIR THER, V9, P779; Deeks SG, 1997, J INFECT DIS, V176, P514, DOI 10.1086/517278; Di Mascio M, 2004, MATH BIOSCI, V188, P47, DOI 10.1016/j.mbs.2003.08.003; Di Mascio M, 2004, J VIROL, V78, P10566, DOI 10.1128/JVI.78.19.10566-10573.2004; Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; DOMADULA G, 1999, JAMA-J AM MED ASSOC, V282, P1627; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Gunthard HF, 1999, J VIROL, V73, P9404; Gunthard HF, 1998, J VIROL, V72, P2422; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HAMMOND J, 2004, LOS ALAMOS HIV SEQUE; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; HOLODNIY M, 1994, J ACQ IMMUN DEF SYND, V7, P363; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jackson JB, 2004, J CLIN MICROBIOL, V42, P2774, DOI 10.1128/JCM.42.6.2774-2776.2004; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kolber MA, 2002, AIDS, V16, P537, DOI 10.1097/00002030-200203080-00004; Lamotte C, 1999, J CHROMATOGR B, V735, P159, DOI 10.1016/S0378-4347(99)00419-3; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Miller LG, 2004, J INFECT DIS, V189, P1487, DOI 10.1086/382895; Mira JA, 2002, ANTIVIR THER, V7, P251; Moore AL, 2002, AIDS, V16, P615, DOI 10.1097/00002030-200203080-00013; Parkin NT, 2000, AIDS, V14, P2877, DOI 10.1097/00002030-200012220-00009; Pav JW, 1999, J PHARMACEUT BIOMED, V20, P91, DOI 10.1016/S0731-7085(98)00312-4; Percus JK, 2003, B MATH BIOL, V65, P263, DOI 10.1016/S0092-8240(02)00095-2; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2002, AIDS, V16, P1627, DOI 10.1097/00002030-200208160-00008; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; *ROCH DIAGN CORP, 2002, ROCH AMPL HIV 1 MON; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAFER RW, 2004, GM STANFORD HIV RT P; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Stuart JWTC, 2001, J ACQ IMMUN DEF SYND, V28, P105, DOI 10.1097/00042560-200110010-00001; Swofford D. L., 2000, PAUP PHYLOGENETIC AN; Wain-Hobson S, 2003, J GEN VIROL, V84, P885, DOI 10.1099/vir.0.18894-0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	59	296	300	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					817	829		10.1001/jama.293.7.817	http://dx.doi.org/10.1001/jama.293.7.817			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713771	Bronze			2022-12-24	WOS:000226984600023
J	Kay, B; Nam, VS				Kay, B; Nam, VS			New strategy against Aedes aegypti in Vietnam	LANCET			English	Article							MESOCYCLOPS COPEPODA; FUNNEL TRAP; DENGUE; ALBOPICTUS; CULICIDAE; DIPTERA; MOSQUITOS; LARVAE	The container-breeding mosquito, Aedes aegypti, is the major global vector of dengue viruses, causing around 50 million infections annually. We have developed-a mosquito control strategy, incorporating four elements: (1) a combined vertical and horizontal approach that depends on community understanding; (2) prioritised control according to the larval productivity of major habitat types; (3) use of predacious copepods of the genus Mesocyclops as a biological control agent; delivered by (4) community activities of health volunteers, schools, and the public.. We have previously reported that, from 1998 to 2003, community-based vector control had resulted in A aegypti elimination in six of nine communes, with only small numbers of larvae detected in the others. Here, we report eradication in two further communes and, as a result of local expansion after the project in three northern provinces, elimination from 32 of 37 communes (309 730 people). As a result, no dengue cases have been detected in any commune since 2002. These findings suggest that this strategy is sustainable in Vietnam and applicable where the major sources of A aegypti are large water storage containers.	Queensland Inst Med Res, Australian Ctr Int & Trop Hlth & Nutr, Brisbane, Qld 4006, Australia; Minist Hlth, Gen Dept Prevent Med & HIV AIDS Control, Hanoi, Vietnam	QIMR Berghofer Medical Research Institute	Kay, B (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	brianK@qimr.edu.au						Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3; BRETEAU H, 1954, Bull World Health Organ, V11, P453; Dieng H, 2002, MED VET ENTOMOL, V16, P285, DOI 10.1046/j.1365-2915.2002.00377.x; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1987, ARBOVIRUS RES AUSTR, V4, P30; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; KAY BH, 1992, J AM MOSQUITO CONTR, V8, P372; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Kay BH, 2002, J MED ENTOMOL, V39, P469, DOI 10.1603/0022-2585-39.3.469; KAY BH, 2001, ARBOVIRUS RES AUST, V8, P187; LARDEUX F, 1992, J MED ENTOMOL, V29, P571, DOI 10.1093/jmedent/29.4.571; Lifson AR, 1996, LANCET, V347, P1201, DOI 10.1016/S0140-6736(96)90730-8; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P681; Marten GG, 2000, J VECTOR ECOL, V25, P1; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P689; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nam VS, 2003, J AM MOSQUITO CONTR, V19, P220; Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657; Nam VS, 2000, AM J TROP MED HYG, V62, P5, DOI 10.4269/ajtmh.2000.62.5; Russell BM, 1999, J MED ENTOMOL, V36, P851, DOI 10.1093/jmedent/36.6.851; *SECR 55 WORLD HLT, 2002, DENGUE B, V26, P218; THAN PV, 2004, J PRACTICE MED, V477, P89; TUNLIN W, 1994, J AM MOSQUITO CONTR, V10, P390; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; United Nations, 2003, WAT PEOPL WAT LIF; *WHO, 1972, WKLY EPIDEMIOL REC, V47, P73; ZHEN TM, 1993, J AM MOSQUITO CONTR, V9, P316	30	160	167	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					613	617		10.1016/S0140-6736(05)17913-6	http://dx.doi.org/10.1016/S0140-6736(05)17913-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708107				2022-12-24	WOS:000226984300036
J	Martis, L; Patel, M; Giertych, J; Mongoven, J; Taminne, M; Perrier, MA; Mendoza, O; Goud, N; Costigan, A; Denjoy, N; Verger, C; Owen, WF				Martis, L; Patel, M; Giertych, J; Mongoven, J; Taminne, M; Perrier, MA; Mendoza, O; Goud, N; Costigan, A; Denjoy, N; Verger, C; Owen, WF			Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution	LANCET			English	Article							CHEMICAL PERITONITIS; STERILE PERITONITIS; CYTOKINE RELEASE; ICODEXTRIN; ENDOTOXIN; PYROGENS; ASSAY; CAPD	Background Manufacturers of parenteral solutions adhere to European and US Pharmacopoeia standards to define safety and sterility. In response to excess cases of aseptic peritonitis in peritonea,l dialysis patients using icodextrin-containing dialysate that met all Pharmacopoeia standards, a global recall was issued in May, 2002. We aimed to establish the cause of aseptic peritonitis. Methods We analysed 186 reports of aseptic peritonitis between September, 2001, and January, 2003. Extensive physical, chemical, and microbiological investigations of recalled dialysate were done. We calculated dose-response curves for peptidoglycan-induced interleukin 6 elaboration in peripheral blood mononuclear cells (PBMCs) from healthy donors and for sterile peritonitis in rats. Findings Although its chemical constituents and concentrations of endotoxin were within pharmacopoeia specifications, the dialysis solution elicited an interlukin 6 response in vivo and in vitro. We identified peptidoglycan from thermophilic acidophilic bacteria (Aticyclobacillus acidocaidarius) as the contaminating proinflammatory substance. In the PBMC assay, strong dose-response relations were noted between peptidoglycan concentrations and interleukin 6. in rats injected with peptidoglycan, dose-dependent increases of intraperitoneal neutrophils and pyrogenic cytokines were recorded. We measured a positive relation between peptidoglycan concentrations in recalled dialysate and reports of aseptic peritonitis. After implementation of corrective actions, the rate of peritonitis returned to baseline. Interpretation Excess cases of aseptic peritonitis in peritoneal dialysis patients were due to peptidoglycan contamination of dialysate by Alicyclobacillus. This outbreak serves as an example of how contemporary parenteral products with microbial contaminants can be considered safe under current Pharmacopoeia tests, but provoke adverse clinical effects.	Baxter Healthcare Corp, Mcgaw Pk, IL USA; Hosp Pontoise, Serv Nephrol, Pontoise, France; Duke Univ, Med Ctr, Sch Med, Dept Med, Durham, NC 27710 USA	Baxter International Inc; Duke University	Owen, WF (corresponding author), 1620 Waukegan Rd, Mcgaw Pk, IL 60085 USA.	william_owen@baxter.com	Verger, Christian/T-5139-2019; Verger, Christian/GQA-4459-2022	Verger, Christian/0000-0002-8009-5366; 				BENEVENT D, 1984, PRESSE MED, V13, P1844; Burke RA, 1997, J CHROMATOGR B, V693, P353, DOI 10.1016/S0378-4347(97)00073-X; Fennrich S, 1999, Dev Biol Stand, V101, P131; Garner RE, 1996, INFECT IMMUN, V64, P4561, DOI 10.1128/IAI.64.11.4561-4566.1996; GOKAL R, 1981, CLIN NEPHROL, V15, P328; Gokal R, 2002, PERITON DIALYSIS INT, V22, P445; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; KARANICOLAS S, 1977, NEW ENGL J MED, V296, P1336, DOI 10.1056/NEJM197706092962309; Mangram AJ, 1998, KIDNEY INT, V54, P1367, DOI 10.1046/j.1523-1755.1998.00110.x; Mascoli C C, 1979, J Parenter Drug Assoc, V33, P81; Matsubara H, 2002, INT J SYST EVOL MICR, V52, P1681, DOI [10.1099/ijs.0.02169-0, 10.1099/00207713-52-5-1681]; MISTRY CD, 1987, LANCET, V2, P178; Nakagawa Y, 2002, CLIN DIAGN LAB IMMUN, V9, P588, DOI 10.1128/CDLI.9.3.588-597.2002; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Pool EJ, 1999, J IMMUNOASSAY, V20, P79, DOI 10.1080/01971529909349315; POOLE S, 1988, LANCET, V1, P130; RAY A, 1991, FEMS MICROBIOL LETT, V79, P211, DOI 10.1016/0378-1097(91)90088-R; Royce CL, 1996, J ENDOTOXIN RES, V3, P437, DOI 10.1177/096805199600300601; SCHWAB JH, 1993, INFECT IMMUN, V61, P4535, DOI 10.1128/IAI.61.11.4535-4539.1993; SMITH TA, 1991, DICP ANN PHARMAC, V25, P602, DOI 10.1177/106002809102500607; SRISKANDAN S, 1999, BACTERIAL SEPSIS SEP, P397; TAKTAK YS, 1991, J PHARM PHARMACOL, V43, P578, DOI 10.1111/j.2042-7158.1991.tb03540.x; Tintillier M, 2002, PERITON DIALYSIS INT, V22, P534; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1111/j.1574-695X.1996.tb00063.x; Tuncer H, 2000, NEPHROL DIAL TRANSPL, V15, P2037, DOI 10.1093/ndt/15.12.2037; Vas SI, 1989, PERITONEAL DIALYSIS, V3rd, P261; WEARY M, 1987, DETECTION BACTERIAL, P307; Williams PF, 2002, PERITON DIALYSIS INT, V22, P89; Wolfson M, 2002, AM J KIDNEY DIS, V40, P1055, DOI 10.1053/ajkd.2002.36344; 2002, EUROPEAN PHARMACOPOE, P131	30	66	71	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					588	594						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708102				2022-12-24	WOS:000226984300031
J	Boire, A; Covic, L; Agarwal, A; Jacques, S; Sherifl, S; Kuliopulos, A				Boire, A; Covic, L; Agarwal, A; Jacques, S; Sherifl, S; Kuliopulos, A			PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells	CELL			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; THROMBIN-RECEPTOR; ENDOTHELIAL-CELLS; TISSUE FACTOR; EXPRESSION; INHIBITION; TRANSFORMATION; ANGIOGENESIS; METASTASIS; ANTAGONIST	Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play critical roles in thrombosis, inflammation, and vascular biology. PAR1 is proposed to be involved in the invasive and metastatic processes of various cancers. However, the protease responsible for activating the pro-invasive functions of PAR1 remains to be identified. Here, we show that expression of PAR1 is both required and sufficient to promote growth and invasion of breast carcinoma cells in a xenograft model. Further, we show that the matrix metalloprotease, MMP-1, functions as a protease agonist of PAR1 cleaving the receptor at the proper site to generate PAR1-dependent Ca2+ signals and migration. MMP-1 activity is derived from fibroblasts and is absent from the breast cancer cells. These results demonstrate that MMP-1 in the stromal-tumor microenvironment can alter the behavior of cancer cells through PAR1 to promote cell migration and invasion.	Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Div Hematol Oncol, Tufts New England Med Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Mt Auburn Hosp, Dept Pathol, Cambridge, MA 02138 USA	Tufts University; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Mount Auburn Hospital	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Boire, Adrienne/AAJ-9352-2021; Boire, Adrienne/AAA-3578-2022	Boire, Adrienne/0000-0002-9029-1248; Boire, Adrienne/0000-0002-9029-1248	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64701] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Caunt M, 2003, J THROMB HAEMOST, V1, P2097, DOI 10.1046/j.1538-7836.2003.00426.x; CHEN J, 1994, J BIOL CHEM, V269, P16041; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; FISCHER EG, 1995, CANCER RES, V55, P1629; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Heppner KJ, 1996, AM J PATHOL, V149, P273; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Kamath L, 2001, CANCER RES, V61, P5933; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Ku DD, 1997, J CARDIOVASC PHARM, V30, P649, DOI 10.1097/00005344-199711000-00016; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murray GI, 1998, J PATHOL, V185, P256; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; NIERODZIK MLR, 1992, CANCER RES, V52, P3267; ODAKE S, 1994, BIOCHEM BIOPH RES CO, V199, P1442, DOI 10.1006/bbrc.1994.1392; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Yamamoto A, 2003, INT J CANCER, V103, P822, DOI 10.1002/ijc.10875; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zain J, 2000, BLOOD, V95, P3133; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.3.CO;2-N	43	649	686	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					303	313		10.1016/j.cell.2004.12.018	http://dx.doi.org/10.1016/j.cell.2004.12.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707890	Bronze			2022-12-24	WOS:000227028900007
J	Sanders, GD; Bayoumi, AM; Sundaram, V; Bilir, SP; Neukermans, CP; Rydzak, CE; Douglass, LR; Lazzeroni, LC; Holodniy, M; Owens, DK				Sanders, GD; Bayoumi, AM; Sundaram, V; Bilir, SP; Neukermans, CP; Rydzak, CE; Douglass, LR; Lazzeroni, LC; Holodniy, M; Owens, DK			Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR THERAPY; CD4 CELL COUNT; VIROLOGICAL TREATMENT FAILURE; PLASMA VIRAL LOAD; SEXUALLY-TRANSMITTED-DISEASES; SAQUINAVIR SOFT GELATIN; RNA LEVELS; HETEROSEXUAL TRANSMISSION; COMBINATION THERAPY	BACKGROUND: The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined. METHODS: We developed a Markov model of costs, quality of life, and survival associated with an HIV-screening program as compared with current practice. In both strategies, symptomatic patients were identified through symptom-based case finding. Identified patients started treatment when their CD4 count dropped to 350 cells per cubic millimeter. Disease progression was defined on the basis of CD4 levels and viral load. The likelihood of sexual transmission was based on viral load, knowledge of HIV status, and efficacy of counseling. RESULTS: Given a 1 percent prevalence of unidentified HIV infection, screening increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an estimated cost of $194 per screened patient, for a cost-effectiveness ratio of $15,078 per quality-adjusted life-year. Screening cost less than $50,000 per quality-adjusted life-year if the prevalence of unidentified HIV infection exceeded 0.05 percent. Excluding HIV transmission, the cost-effectiveness of screening was $41,736 per quality-adjusted life-year. Screening every five years, as compared with a one-time screening program, cost $57,138 per quality-adjusted life-year, but was more attractive in settings with a high incidence of infection. Our results were sensitive to the efficacy of behavior modification, the benefit of early identification and therapy, and the prevalence and incidence of HIV infection. CONCLUSIONS: The cost-effectiveness of routine HIV screening in health care settings, even in relatively low-prevalence populations, is similar to that of commonly accepted interventions, and such programs should be expanded.	Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Div Gen Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA USA	Duke University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Sanders, GD (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	gillian.sanders@duke.edu	Lazzeroni, Laura/F-2903-2010; Abrams, William R/A-5782-2008	Lazzeroni, Laura/0000-0002-1846-6920; Holodniy, Mark/0000-0002-6655-7982	NIDA NIH HHS [R01 DA15612-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahdieh-Grant L, 2003, AM J EPIDEMIOL, V157, P738, DOI 10.1093/aje/kwg036; Anastos K, 2002, ARCH INTERN MED, V162, P1973, DOI 10.1001/archinte.162.17.1973; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bayoumi AM, 1998, AIDS, V12, P1503, DOI 10.1097/00002030-199812000-00013; Bellman PC, 1998, AIDS, V12, P1333, DOI 10.1097/00002030-199811000-00015; Bernasconi E, 2000, AIDS, V14, P95, DOI 10.1097/00002030-200001070-00015; Bindman AB, 1998, JAMA-J AM MED ASSOC, V280, P1416, DOI 10.1001/jama.280.16.1416; Bonfanti P, 2000, J ACQ IMMUN DEF SYND, V23, P236; Bonfanti P, 1998, AIDS, V12, P1111; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1; Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954; Butcher D, 2000, ARCH INTERN MED, V160, P394, DOI 10.1001/archinte.160.3.394-a; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Cameron DW, 1999, AIDS, V13, P213, DOI 10.1097/00002030-199902040-00009; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; *CDCP, 2001, HIV COUNS TEST PUBL; *CDCP, 2002, HIV AIDS SURV REP, V14; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; Chene G, 1998, AIDS, V12, P2313, DOI 10.1097/00002030-199817000-00013; Clough LA, 1999, CLIN INFECT DIS, V29, P75, DOI 10.1086/520185; COHEN C, 2000, P 7 C RETR OPP INF S; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Coombs RW, 1996, J INFECT DIS, V174, P704, DOI 10.1093/infdis/174.4.704; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; D'Amato RM, 1998, ANTIVIR THER, V3, P147; De Wit S, 1999, AIDS, V13, P864, DOI 10.1097/00002030-199905070-00020; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; DICLEMENTE RJ, 1995, JAMA-J AM MED ASSOC, V274, P1271, DOI 10.1001/jama.274.16.1271; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P358; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; DURANT J, 1999, LANCET, V354, P118; Erb P, 2000, ARCH INTERN MED, V160, P1134, DOI 10.1001/archinte.160.8.1134; ERICKSON B, 1990, SEX TRANSM DIS, V17, P194, DOI 10.1097/00007435-199010000-00009; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; FERRER E, 2003, P 10 C RETR OPP INF, P910; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gable CB, 1996, J ACQ IMMUN DEF SYND, V12, P413, DOI 10.1097/00042560-199608010-00013; GalettoLacour A, 1996, J INFECT DIS, V173, P1388, DOI 10.1093/infdis/173.6.1388; *GEN ACC OFF, 1998, GAOHEHS992; Guardiola JM, 1999, ARCH INTERN MED, V159, P194, DOI 10.1001/archinte.159.2.194; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hall CS, 1999, AIDS, V13, P1207, DOI 10.1097/00002030-199907090-00009; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HARRIS RL, 1990, INFECT CONT HOSP EP, V11, P628; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hightow LB, 2003, AIDS EDUC PREV, V15, P282, DOI 10.1521/aeap.15.4.282.23826; Hogg RS, 1998, AIDS, V12, P279, DOI 10.1097/00002030-199803000-00005; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; HOLMAN S, 1994, PUBLIC HEALTH REP, V109, P521; HONIDEN S, 2002, MED DECIS MAKING, V22, P560; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Ioannidis JPA, 1996, AIDS, V10, P255, DOI 10.1097/00002030-199603000-00003; Irwin K, 1996, ANN INTERN MED, V125, P471, DOI 10.7326/0003-4819-125-6-199609150-00007; JANSSEN RS, 1992, NEW ENGL J MED, V327, P445, DOI 10.1056/NEJM199208133270701; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Katzenstein DA, 1997, NEW ENGL J MED, V337, P1097; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kaufmann GR, 1998, AIDS, V12, P1625, DOI 10.1097/00002030-199813000-00009; KEET IPM, 1992, AIDS, V6, P223, DOI 10.1097/00002030-199202000-00014; Keet IPM, 1997, J INFECT DIS, V176, P665, DOI 10.1086/514088; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; Keita-Perse O, 1998, AIDS, V12, pF175, DOI 10.1097/00002030-199815000-00002; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Kirk O, 1999, AIDS, V13, pF9, DOI 10.1097/00002030-199901140-00002; KOZAK LJ, 2004, VITAL HLTH STAT, V156, P1; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; LOVEDAY C, 1995, LANCET, V345, P790, DOI 10.1016/S0140-6736(95)90668-1; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; LURIE P, 1994, JAMA-J AM MED ASSOC, V272, P1832, DOI 10.1001/jama.272.23.1832; LURIE P, 1995, JAMA-J AM MED ASSOC, V273, P1000; MACDONALD KL, 1989, ANN INTERN MED, V110, P617, DOI 10.7326/0003-4819-110-8-617; Maher K, 1999, J ACQ IMMUN DEF SYND, V22, P358; Mankiw N.G., 2001, PRINCIPLES EC; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; MCCARTHY BD, 1993, ARCH INTERN MED, V153, P1107, DOI 10.1001/archinte.153.9.1107; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, SCIENCE, V275, P14; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Michael RT, 1998, AM J PUBLIC HEALTH, V88, P749, DOI 10.2105/AJPH.88.5.749; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Mole L, 1999, PHARMACOECONOMICS, V16, P307, DOI 10.2165/00019053-199916030-00007; Monforte AD, 1998, AIDS, V12, P1631, DOI 10.1097/00002030-199813000-00010; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Montaner JSG, 1998, AIDS, V12, pF23, DOI 10.1097/00002030-199805000-00003; Moyle G, 2000, J ACQ IMMUN DEF SYND, V23, P128; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; NEAL JJ, 2002, P 9 C RETR OPP INF S; *NIH, 1998, MMWR-MORBID MORTAL W, V47, P1; Notermans DW, 1998, AIDS, V12, P167, DOI 10.1097/00002030-199802000-00006; O'Brien TR, 1998, J ACQ IMMUN DEF SYND, V18, P155, DOI 10.1097/00042560-199806010-00007; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; OWENS DK, 2003, MED DECIS MAKING, V23, P569; OWENS DK, 2002, MED DECIS MAKING, V22, P534; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; *PAN CLIN PRACT TR, 2004, GUID US ANT AG HIV I; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Paredes R, 1999, J ACQ IMMUN DEF SYND, V22, P132; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Pedersen C, 1997, J ACQ IMMUN DEF SYND, V16, P93, DOI 10.1097/00042560-199710010-00004; Phillips AN, 1996, AIDS, V10, P859, DOI 10.1097/00002030-199607000-00009; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Phillips AN, 1997, AIDS, V11, P169, DOI 10.1097/00002030-199702000-00006; Phillips KA, 2000, AIDS, V14, P2159, DOI 10.1097/00002030-200009290-00013; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 1999, J ACQ IMMUN DEF SYND, V22, P260; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reijers MHE, 2000, AIDS, V14, P59, DOI 10.1097/00002030-200001070-00007; REVICKI DA, 1995, MED CARE, V33, pAS173; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Roca B, 1999, J INFECTION, V39, P141, DOI 10.1016/S0163-4453(99)90006-3; Roca B, 2000, AIDS, V14, P157, DOI 10.1097/00002030-200001280-00011; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Sabin CA, 1998, AIDS, V12, P1347, DOI 10.1097/00002030-199811000-00017; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Salzberger B, 1999, Eur J Med Res, V4, P449; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; SCHWARTZ JS, 1990, JAMA-J AM MED ASSOC, V264, P1704, DOI 10.1001/jama.264.13.1704; Shulman NS, 2000, J ACQ IMMUN DEF SYND, V23, P221; Sinclair M, 2004, INT J STD AIDS, V15, P33, DOI 10.1258/095646204322637236; Spijkerman IJB, 1997, AIDS, V11, P1383, DOI 10.1097/00002030-199711000-00013; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 1998, AIDS, V12, P2360; Stone PW, 2000, AM J PREV MED, V19, P15, DOI 10.1016/S0749-3797(00)00151-3; Stuart JWTC, 1999, AIDS, V13, pF53, DOI 10.1097/00002030-199905070-00001; Sullivan AK, 1998, INT J STD AIDS, V9, P711, DOI 10.1258/0956462981921251; Sullivan PS, 2004, JAIDS-J ACQ IMM DEF, V35, P511, DOI 10.1097/00126334-200404150-00009; Tebas P, 1999, AIDS, V13, pF23, DOI 10.1097/00002030-199902040-00002; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; Tsevat J, 1999, ANN INTERN MED, V131, P194, DOI 10.7326/0003-4819-131-3-199908030-00006; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; *US GOV, 2004, BUDG US GOV; Valdez H, 1999, ARCH INTERN MED, V159, P1771, DOI 10.1001/archinte.159.15.1771; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Welch K, 2000, CLIN INFECT DIS, V30, P407, DOI 10.1086/313670; Welles SL, 1996, J INFECT DIS, V174, P696, DOI 10.1093/infdis/174.4.696; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Yerly S, 1998, ARCH INTERN MED, V158, P247, DOI 10.1001/archinte.158.3.247; Zingmond DS, 2001, AM J PUBLIC HEALTH, V91, P1117, DOI 10.2105/AJPH.91.7.1117; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 2001, MMWR MORB MORTAL WKL, V50, P538; 1988, MMWR MORB MORTAL WKL, V36, P833; 2004, MMWR MORB MORTAL WKL, V53, P523; 2004, COMP 2 WAYS MANAGE A; 1998, MMWR MORB MORTAL WKL, V47, P309; 2000, MED LETT DRUGS THER, V42, P1; 2004, ADV HIV PREVENTION N	182	455	464	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					570	585		10.1056/NEJMsa042657	http://dx.doi.org/10.1056/NEJMsa042657			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	895KY	15703422				2022-12-24	WOS:000226862100007
J	Bartlett, S				Bartlett, S			A hitch-hiker's guide to Titan	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), The Lancet, London NW1 7BY, England.							*MUSIC2TITAN, 2005, SIL MUS	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2005	365	9458					460	460						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705445				2022-12-24	WOS:000226812500009
J	Hessa, T; Kim, H; Bihlmaier, K; Lundin, C; Boekel, J; Andersson, H; Nilsson, I; White, SH; von Heijne, G				Hessa, T; Kim, H; Bihlmaier, K; Lundin, C; Boekel, J; Andersson, H; Nilsson, I; White, SH; von Heijne, G			Recognition of transmembrane helices by the endoplasmic reticulum translocon	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; MEMBRANE-PROTEIN; PEPTIDES; INTEGRATION; PREDICTION; INTERFACES; STABILITY; SEQUENCE; CHANNEL; DOMAIN	Membrane proteins depend on complex translocation machineries for insertion into target membranes. Although it has long been known that an abundance of nonpolar residues in transmembrane helices is the principal criterion for membrane insertion, the specific sequence-coding for transmembrane helices has not been identified. By challenging the endoplasmic reticulum Sec61 translocon with an extensive set of designed polypeptide segments, we have determined the basic features of this code, including a 'biological' hydrophobicity scale. We find that membrane insertion depends strongly on the position of polar residues within transmembrane segments, adding a new dimension to the problem of predicting transmembrane helices from amino acid sequences. Our results indicate that direct protein - lipid interactions are critical during translocon-mediated membrane insertion.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA; Karolinska Inst, NOVUM, Dept Biosci, SE-14157 Huddinge, Sweden	Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine; Karolinska Institutet	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Nilsson, IngMarie/H-2887-2012; von Heijne, Gunnar/AAH-9389-2019; White, Stephen/N-1507-2019; von Heijne, Gunnar/F-5576-2011; White, Stephen H/B-1053-2009	von Heijne, Gunnar/0000-0002-4490-8569; White, Stephen H/0000-0001-8540-7907; Kallgren, Carolina/0000-0002-2372-9721; Boekel, Carolina/0000-0003-2862-6526				Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Bechinger B, 2001, BIOPHYS J, V81, P2251, DOI 10.1016/S0006-3495(01)75872-9; Beuming T, 2004, BIOINFORMATICS, V20, P1822, DOI 10.1093/bioinformatics/bth143; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; DEGLIESPOSTI M, 1990, EUR J BIOCHEM, V190, P207, DOI 10.1111/j.1432-1033.1990.tb15566.x; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; Lewis RNAH, 2001, BIOCHEMISTRY-US, V40, P12103, DOI 10.1021/bi010555m; LILJESTROM P, 1991, J VIROL, V65, P4107; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Saaf A, 1998, EUR J BIOCHEM, V251, P821, DOI 10.1046/j.1432-1327.1998.2510821.x; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Von Heijne G, 2003, ADV PROTEIN CHEM, V63, P1; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; Wallin E, 1997, PROTEIN SCI, V6, P808; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025	36	776	797	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					377	381		10.1038/nature03216	http://dx.doi.org/10.1038/nature03216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674282				2022-12-24	WOS:000226546200033
J	Quinlan, ME; Heuser, JE; Kerkhoff, E; Mullins, RD				Quinlan, ME; Heuser, JE; Kerkhoff, E; Mullins, RD			Drosophila Spire is an actin nucleation factor	NATURE			English	Article							MESSENGER-RNA LOCALIZATION; WISKOTT-ALDRICH-SYNDROME; ARP2/3 COMPLEX; FILAMENT NUCLEATION; WASP/SCAR PROTEINS; STRUCTURAL BASIS; FISSION YEAST; FORMINS; OOCYTE; RAB11	The actin cytoskeleton is essential for many cellular functions including shape determination, intracellular transport and locomotion. Previous work has identified two factors - the Arp2/3 complex and the formin family of proteins - that nucleate new actin filaments via different mechanisms. Here we show that the Drosophila protein Spire represents a third class of actin nucleation factor. In vitro, Spire nucleates new filaments at a rate that is similar to that of the formin family of proteins but slower than in the activated Arp2/3 complex, and it remains associated with the slow-growing pointed end of the new filament. Spire contains a cluster of four WASP homology 2 (WH2) domains, each of which binds an actin monomer. Maximal nucleation activity requires all four WH2 domains along with an additional actin-binding motif, conserved among Spire proteins. Spire itself is conserved among metazoans and, together with the formin Cappuccino, is required for axis specification in oocytes and embryos, suggesting that multiple actin nucleation factors collaborate to construct essential cytoskeletal structures.	Univ Calif San Francisco, Sch Med, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany	University of California System; University of California San Francisco; Washington University (WUSTL); University of Wurzburg	Mullins, RD (corresponding author), Univ Calif San Francisco, Sch Med, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA.	dyche@mullinslab.ucsf.edu	Heuser, John/H-5940-2012					Abo A, 1998, CELL MOL LIFE SCI, V54, P1145, DOI 10.1007/s000180050242; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Dollar G, 2002, DEVELOPMENT, V129, P517; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Fehrenbacher K, 2003, J EXP BIOL, V206, P1977, DOI 10.1242/jeb.00240; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2002, J BIOL CHEM, V277, P14786, DOI 10.1074/jbc.M112064200; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Jankovics F, 2001, GENETICS, V158, P1177; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Manseau L, 1996, DEVELOPMENT, V122, P2109; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wellington A, 1999, DEVELOPMENT, V126, P5267; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	34	253	259	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					382	388		10.1038/nature03241	http://dx.doi.org/10.1038/nature03241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674283				2022-12-24	WOS:000226546200034
J	Kurner, J; Frangakis, AS; Baumeister, W				Kurner, J; Frangakis, AS; Baumeister, W			Cryo-electron tomography reveals the cytoskeletal structure of Spiroplasma melliferum	SCIENCE			English	Article							ELECTRON TOMOGRAPHY; ESCHERICHIA-COLI; CELL-SHAPE; PROTEIN; ORGANIZATION; MOLLICUTES; BACTERIA; SEQUENCE; FIBRILS; MOTOR	Evidence has accumulated recently that not only eukaryotes but also bacteria can have a cytoskeleton. We used cryo-electron tomography to study the three-dimensional structure of Spiroplasma melliferum cells in a close-to-native state at similar to4-nanometer resolution. We showed that these cells possess two types of filaments arranged in three parallel ribbons underneath the cell membrane. These two filamentous structures are built of the fibril protein and possibly the actin-like protein MreB. On the basis of our structural data, we could model the motility modes of these cells and explain how helical Mollicutes can propel themselves by means of coordinated length changes of their cytoskeletal ribbons.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Frangakis, AS (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	frangak@embl.de; baumeist@biochem.mpg.de		Frangakis, Achilleas/0000-0002-8067-6611				Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; KURNER J, UNPUB; NEIMARK H, 1983, YALE J BIOL MED, V56, P419; RUSS JC, 2002, IMAGE PROCESSING HDB, P496; TOWNSEND R, 1985, J GEN MICROBIOL, V131, P983; TOWNSEND R, 1983, J GEN MICROBIOL, V129, P199; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 2003, J BACTERIOL, V185, P1987, DOI 10.1128/JB.185.6.1987-1994.2003; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; Trachtenberg S, 1998, J STRUCT BIOL, V124, P244, DOI 10.1006/jsbi.1998.4063; Tully JG, 1992, ENCY MICROBIOLOGY, P181; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; WILLIAMSON DL, 1974, J BACTERIOL, V117, P904, DOI 10.1128/JB.117.2.904-906.1974; Wolgemuth CW, 2003, BIOPHYS J, V85, P828, DOI 10.1016/S0006-3495(03)74523-8	20	163	167	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					436	438		10.1126/science.1104031	http://dx.doi.org/10.1126/science.1104031			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662018				2022-12-24	WOS:000226492300051
J	Peake, JB				Peake, JB			Beyond the purple heart - Continuity of care for the wounded in Iraq.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											Peake, JB (corresponding author), Project HOPE, Millwood, VA USA.								0	35	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					219	222		10.1056/NEJMp048312	http://dx.doi.org/10.1056/NEJMp048312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659720				2022-12-24	WOS:000226370500001
J	Choudhry, NK; Detsky, AS				Choudhry, NK; Detsky, AS			A perspective on US drug reimportation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEVELOPMENT COSTS; PRICES; MEDICARE; BENEFITS; MARKET; PAY		Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Hlth Network, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	choudhry@fas.harvard.edu						ALEXANDER D, 2004, VANCOUVER SUN   0825, pA1; BAKER C, 2004, WORLD PRESCRIPTION D; Bartlett Donald L., 2004, TIME            0920, P51; COHEN JC, 2003, GLOBE MAIL      0826, pA17; CONNOLLY C, 2004, WASHINGTON POST 0219, pA10; CONNOLLY C, 2004, WASHINGTON POST 0423; Danzon PM, 1998, PHARMACOECONOMICS, V13, P293, DOI 10.2165/00019053-199813030-00004; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Frank RG, 2004, NEW ENGL J MED, V351, P1375, DOI 10.1056/NEJMp048158; Frank RG, 2003, HEALTH AFFAIR, V22, P46, DOI 10.1377/hlthaff.22.3.46; Frank RG, 2003, J HEALTH ECON, V22, P325, DOI 10.1016/S0167-6296(03)00002-X; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; FRIESEN J, 2004, GLOBE MAIL      1111; Gibbons Moira, 2004, Manag Care, V13, P21; *HLTH CAN HLTH PRO, SUMM REP COMPL INSP; HUBBARD WK, 2003, CANADIAN PRESCRIPTIO; Huskamp HA, 2003, HEALTH AFFAIR, V22, P149, DOI 10.1377/hlthaff.22.3.149; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; KAMATH R, 2003, REPORT FEASIBILITY E; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; LESTER W, 3 AM SAY PAYING DRUG; LUECK S, 2004, WALL ST J       0108, pA4; MAJESKI T, 2004, ST PAUL PIONEER 0520, pB8; MARIMOW AE, 2004, CONTRA COSIA TI 0826; Maynard A, 2003, HEALTH AFFAIR, V22, P31, DOI 10.1377/hlthaff.22.3.31; Menon D, 2001, HEALTH AFFAIR, V20, P92, DOI 10.1377/hlthaff.20.3.92; Newhouse JP, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.1.89; *NIH, 2000, NIH CONTR PHARM DEV; NITKIN D, 2004, BALTIMORE SUN   0331, pB1; PEAR R, 2004, NY TIMES        0422, pA23; *PUBL CIT C WATCH, AM OTH DRUG PROBL BN; Rector TS, 2004, HEALTH AFFAIR, V23, P213, DOI 10.1377/hlthaff.23.4.213; RICHER S, 2004, GLOBE MAIL      0517, pA1; Saatsoglou Paul, 2004, Manag Care, V13, P7; SAGER A, 2000, PRESCRIPTION DRUG PE; SAGER A, 2004, DO DRUG MAKERS LOSE; SANDERS B, 2003, INT PRESCRIPTION DRU; Scherer FM, 2004, NEW ENGL J MED, V351, P927, DOI 10.1056/NEJMhpr040117; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Soumerai SB, 2004, HEALTH AFFAIR, V23, P135, DOI 10.1377/hlthaff.23.1.135; STRAHINICH J, 2004, BOSTON HERALD   1118, P46; *US C OFF TECHN AS, 1993, OTAH522; *US DEP HHS, PRESCR DRUG COV SPEN; *US FDA, FDA US CUST IMP BLIT; *US GEN ACC OFF, 2003, NIH PRIV SECT PARTN; *US GEN ACC OFF, 2004, INT PHARM SOM POS SA; Wagner JL, 2004, ANNU REV PUBL HEALTH, V25, P475, DOI 10.1146/annurev.publhealth.25.101802.123042; Ward Christopher, 2004, Manag Care, V13, P17; Wilson JF, 2004, ANN INTERN MED, V140, P677, DOI 10.7326/0003-4819-140-8-200404200-00044; Wolfe W., 2004, MINNEAPOLIS STA 0514, p1B; WALL STREET U; 2004, AARP             JUL	53	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					358	362		10.1001/jama.293.3.358	http://dx.doi.org/10.1001/jama.293.3.358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657329				2022-12-24	WOS:000226358400030
J	Chen, LY; Widom, J				Chen, LY; Widom, J			Mechanism of transcriptional silencing in yeast	CELL			English	Article							RNA-POLYMERASE-II; MATING-TYPE LOCUS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; REGULATORY PROTEIN; DNA-BINDING; CHROMATIN; GENE; ACCESSIBILITY; REPRESSION	Transcriptional silencing is a phenomenon in which the transcription of a gene by RNA polymerase 11 or III is repressed or not, dependent only on the gene's chromosomal location. Two prevailing models exist for silencing: (1) steric hindrance in silenced chromatin inhibits the binding of upstream activator proteins or polymerase or (2) silencing primarily blocks steps downstream of transcription preinitiation complex formation. Here, we test these models quantitatively for the case of SIR2-dependent silencing in budding yeast, using foreign and endogenous reporter proteins, at transgenic and endogenous loci. Our results contradict both models and show instead that transcriptional silencing at several URA3 transgenes, and at the naturally silenced endogenous HMRa and HMLalpha mating type genes, acts downstream of gene activator protein binding to strongly reduce the occupancy of TFIIB, RNA polymerase II, and TFIIE at the silenced promoters.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Widom, J (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-widom@northwestem.edu	Chen, Lingyi/G-6309-2013		NIGMS NIH HHS [GM54692, GM58617] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054692, R01GM058617] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen LY, 2004, BIOCHEM CELL BIOL, V82, P413, DOI 10.1139/O04-035; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LLOUBES R, 1991, J BIOL CHEM, V266, P2303; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LOSSON R, 1985, J MOL BIOL, V185, P65, DOI 10.1016/0022-2836(85)90183-4; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; NASMYTH KA, 1981, NATURE, V289, P244, DOI 10.1038/289244a0; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ptashne M, 2004, GENETIC SWITCH PHAGE; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; SCHLOSSHERR J, 1994, MOL GEN GENET, V243, P453; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SILICIANO PG, 1984, CELL, V37, P969, DOI 10.1016/0092-8674(84)90431-8; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	29	68	71	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					37	48		10.1016/j.cell.2004.11.030	http://dx.doi.org/10.1016/j.cell.2004.11.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652480	Bronze			2022-12-24	WOS:000226365400009
J	Vargas, D; Garcia, L; Gilman, RH; Evans, C; Ticona, E; Navincopa, M; Luo, RF; Caviedes, L; Hong, C; Escombe, R; Moore, DAJ				Vargas, D; Garcia, L; Gilman, RH; Evans, C; Ticona, E; Navincopa, M; Luo, RF; Caviedes, L; Hong, C; Escombe, R; Moore, DAJ			Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru	LANCET			English	Article								Sputum induction, bronchoalveolar lavage, or gastric aspiration are often needed to produce adequate diagnostic respiratory samples from people with HIV in whom tuberculosis is suspected. Since these procedures are rarely appropriate in less-developed countries, we compared the performances of a simple string test and the gold-standard sputum induction. 160 HIV-positive adults under investigation for tuberculosis, and 52 asymptomatic HIV-positive control patients underwent the string test followed by sputum induction. The string test detected tuberculosis in 14 patients in whom this disease was suspected; sputum induction detected only eight of them (McNemar's test, p=0.03). These preliminary data suggest that the string test is safe and effective for retrieval of useful clinical specimens for diagnosis of pulmonary tuberculosis, and is at least as sensitive as sputum induction.	Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, London W12 0NN, England; Asociac Benefica Proyectos Informat Salud Med & A, Lima, Peru; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Hosp Nacl Mayo, Lima, Peru; Univ Peruana Cayetano Heredia, Lima, Peru	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Moore, DAJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, Hammersmith Campus,DuCane Rd, London W12 0NN, England.	daj.moore@imperial.ac.uk	Evans, Carlton/AAI-1653-2020; Vargas-Pacherrez, Daniel/N-9349-2016	Evans, Carlton/0000-0002-6873-5447; Navincopa, Marcos/0000-0002-9951-8234; Ticona, Eduardo/0000-0002-6556-1082; Vargas-Pacherrez, Daniel/0000-0003-0989-1199; Moore, David/0000-0002-3748-0154	PHS HHS [T35A107646] Funding Source: Medline; Wellcome Trust [064672, 057434] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		BEAL CB, 1970, AM J TROP MED HYG, V19, P349, DOI 10.4269/ajtmh.1970.19.349; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; GILMAN RH, 1979, LANCET, V1, P795	4	47	48	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					150	152		10.1016/S0140-6736(05)17705-8	http://dx.doi.org/10.1016/S0140-6736(05)17705-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639297	Green Accepted			2022-12-24	WOS:000226170700030
J	Kusserow, A; Pang, K; Sturm, C; Hrouda, M; Lentfer, J; Schmidt, HA; Technau, U; von Haeseler, A; Hobmayer, B; Martindale, MQ; Holstein, TW				Kusserow, A; Pang, K; Sturm, C; Hrouda, M; Lentfer, J; Schmidt, HA; Technau, U; von Haeseler, A; Hobmayer, B; Martindale, MQ; Holstein, TW			Unexpected complexity of the Wnt gene family in a sea anemone	NATURE			English	Article							NEMATOSTELLA-VECTENSIS; EVOLUTION; ORIGINS; EXPRESSION; BRAIN; MESODERM; CNIDARIA; EMBRYOS; SYSTEM; PHYLUM	The Wnt gene family encodes secreted signalling molecules that control cell fate in animal development and human diseases(1). Despite its significance, the evolution of this metazoan-specific protein family is unclear. In vertebrates, twelve Wnt subfamilies were defined, of which only six have counterparts in Ecdysozoa (for example, Drosophila and Caenorhabditis)(2). Here, we report the isolation of twelve Wnt genes from the sea anemone Nematostella vectensis(3), a species representing the basal group(4) within cnidarians. Cnidarians are diploblastic animals and the sister-group to bilaterian metazoans(5). Phylogenetic analyses of N. vectensis Wnt genes reveal a thus far unpredicted ancestral diversity within the Wnt family(2,6,7). Cnidarians and bilaterians have at least eleven of the twelve known Wnt gene subfamilies in common; five subfamilies appear to be lost in the protostome lineage. Expression patterns of Wnt genes during N. vectensis embryogenesis indicate distinct roles of Wnts in gastrulation, resulting in serial overlapping expression domains along the primary axis of the planula larva. This unexpectedly complex inventory of Wnt family signalling factors evolved in early multicellular animals about 650 million years (Myr) ago, predating the Cambrian explosion by at least 100 Myr (refs 5, 8). It emphasizes the crucial function of Wnt genes in the diversification of eumetazoan body plans(9).	Univ Hawaii, Kewalo Marine Lab PBRC, Honolulu, HI 96813 USA; Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany; Univ Innsbruck, Inst Zool & Limnol, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; Forschungszentrum Julich, John von Neumann Inst Comp, D-52425 Julich, Germany; Univ Dusseldorf, Inst Bioinformat, D-40225 Dusseldorf, Germany; Univ Heidelberg, Dept Mol Evolut & genom, D-69120 Heidelberg, Germany	University of Hawaii System; Technical University of Darmstadt; University of Innsbruck; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg	Martindale, MQ (corresponding author), Univ Hawaii, Kewalo Marine Lab PBRC, 41 Ahui St, Honolulu, HI 96813 USA.	mqmartin@hawaii.edu; holstein@uni-hd.de	Schmidt, Heiko A/AAC-4650-2022; von Haeseler, Arndt/HCI-9958-2022	Schmidt, Heiko A/0000-0002-2311-8592; von Haeseler, Arndt/0000-0002-3366-4458; Technau, Ulrich/0000-0003-4472-8258; Holstein, Thomas/0000-0003-0480-4674				Angerer LM, 2003, CURR TOP DEV BIOL, V53, P159, DOI 10.1016/S0070-2153(03)53005-8; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Christenson JC, 2001, J TRAVEL MED, V8, P1; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Landesman Y, 1997, MECH DEVELOP, V63, P199, DOI 10.1016/S0925-4773(97)00041-5; Le Gouar M, 2004, DEV GENES EVOL, V214, P250, DOI 10.1007/s00427-004-0399-z; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Marsal M, 2003, GENE EXPR PATTERNS, V3, P489, DOI 10.1016/S1567-133X(03)00058-9; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; MCGREW LL, 1992, DEVELOPMENT, V115, P463; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Nusse R, 2001, TRENDS GENET, V17, P443, DOI 10.1016/S0168-9525(01)02349-6; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Primus A, 2004, BIOESSAYS, V26, P474, DOI 10.1002/bies.20031; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; Technau U, 2003, INT J DEV BIOL, V47, P531; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176	30	439	457	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					156	160		10.1038/nature03158	http://dx.doi.org/10.1038/nature03158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650739				2022-12-24	WOS:000226252200037
J	Shahinian, VB; Kuo, Y; Freeman, JL; Goodwin, JS				Shahinian, VB; Kuo, Y; Freeman, JL; Goodwin, JS			Risk of fracture after androgen deprivation for prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENT BONE LOSS; HORMONAL-THERAPY; OSTEOPOROSIS; MEDICARE; MEN; CARCINOMA; CLAIMS; SUPPRESSION; PATTERNS; SURVIVAL	Background: The use of androgen-deprivation therapy for prostate cancer has increased substantially over the past 15 years. This treatment is associated with a loss of bone-mineral density, but the risk of fracture after androgen-deprivation therapy has not been well studied. Methods: We studied the records of 50,613 men who were listed in the linked database of the Surveillance, Epidemiology, and End Results program and Medicare as having received a diagnosis of prostate cancer in the period from 1992 through 1997. The primary outcomes were the occurrence of any fracture and the occurrence of a fracture resulting in hospitalization. Cox proportional-hazards analyses were adjusted for characteristics of the patients and the cancer, other cancer treatment received, and the occurrence of a fracture or the diagnosis of osteoporosis during the 12 months preceding the diagnosis of cancer. Results: Of men surviving at least five years after diagnosis, 19.4 percent of those who received androgen-deprivation therapy had a fracture, as compared with 12.6 percent of those not receiving androgen-deprivation therapy (P<0.001). In the Cox proportional-hazards analyses, adjusted for characteristics of the patient and the tumor, there was a statistically significant relation between the number of doses of gonadotropin-releasing hormone received during the 12 months after diagnosis and the subsequent risk of fracture. Conclusions: Androgen-deprivation therapy for prostate cancer increases the risk of fracture.	Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Shahinian, VB (corresponding author), Univ Texas, Med Branch, Dept Internal Med, John Sealy Annex,Rm 4-200,301 Univ Blvd, Galveston, TX 77555 USA.	vbshahin@utmb.edu			AHRQ HHS [R24HS51161] Funding Source: Medline; NCI NIH HHS [P50CA12385, P50 CA105631-01] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Awodipe A, 2004, J AM GERIATR SOC, V52, pS162; Beahrs OH, 1988, MANUAL STAGING CANC, P177; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; Cooper GS, 2000, MED CARE, V38, P411, DOI 10.1097/00005650-200004000-00008; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Diamond TH, 2004, CANCER-AM CANCER SOC, V100, P892, DOI 10.1002/cncr.20056; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Fleming ID, 1997, AJCC CANC STAGING MA, P219; Fowler FJ, 2002, CANCER-AM CANCER SOC, V95, P287, DOI 10.1002/cncr.10656; GREENE FL, 2002, AJCC CANC STAGING MA, P310; Harlan LC, 2001, J NATL CANCER I, V93, P1864, DOI 10.1093/jnci/93.24.1864; Huggins C, 1941, CANCER RES, V1, P293; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lamont EB, 2002, MED CARE, V40, P201, DOI 10.1097/00005650-200203000-00004; Melton LJ, 2003, J UROLOGY, V169, P1747, DOI 10.1097/01.ju.0000059281.67667.97; Meng MV, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01560-1; Milbank AJ, 2002, UROLOGY, V60, P738, DOI 10.1016/S0090-4295(02)01867-8; Mittan D, 2002, J CLIN ENDOCR METAB, V87, P3656, DOI 10.1210/jc.87.8.3656; Morote J, 2003, EUR UROL, V44, P661, DOI 10.1016/S0302-2838(03)00379-8; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Oefelein MG, 2001, J UROLOGY, V166, P1724, DOI 10.1016/S0022-5347(05)65661-3; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4; Smith MR, 2002, UROLOGY, V60, P79, DOI 10.1016/S0090-4295(02)01579-0; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Soloway MS, 2002, UROLOGY, V60, P735, DOI 10.1016/S0090-4295(02)01964-7; Townsend MF, 1997, CANCER, V79, P545, DOI 10.1002/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3; Virnig BA, 2002, MED CARE, V40, P49; Warren JL, 2002, MED CARE, V40, P3; Wei JT, 1999, UROLOGY, V54, P607, DOI 10.1016/S0090-4295(99)00301-5	35	965	982	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					154	164		10.1056/NEJMoa041943	http://dx.doi.org/10.1056/NEJMoa041943			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647578	Bronze			2022-12-24	WOS:000226251700008
J	Seshadri, R; Adrian, L; Fouts, DE; Eisen, JA; Phillippy, AM; Methe, BA; Ward, NL; Nelson, WC; Deboy, RT; Khouri, HM; Kolonay, JF; Dodson, RJ; Daugherty, SC; Brinkac, LM; Sullivan, SA; Madupu, R; Nelson, KT; Kang, KH; Impraim, M; Tran, K; Robinson, JM; Forberger, HA; Fraser, CM; Zinder, SH; Heidelberg, JF				Seshadri, R; Adrian, L; Fouts, DE; Eisen, JA; Phillippy, AM; Methe, BA; Ward, NL; Nelson, WC; Deboy, RT; Khouri, HM; Kolonay, JF; Dodson, RJ; Daugherty, SC; Brinkac, LM; Sullivan, SA; Madupu, R; Nelson, KT; Kang, KH; Impraim, M; Tran, K; Robinson, JM; Forberger, HA; Fraser, CM; Zinder, SH; Heidelberg, JF			Genome sequence of the PCE-dechlorinating bacterium Dehalococcoides ethenogenes	SCIENCE			English	Article							REDUCTIVE DEHALOGENASE; DEHALOSPIRILLUM-MULTIVORANS; ILLEGITIMATE RECOMBINATION; GENETIC-ANALYSIS; TETRACHLOROETHENE; ETHENE; ENZYME; DEHYDROGENASE; AMPLIFICATION; ACINETOBACTER	Dehalococcoides ethenogenes is the only bacterium known to reductively dechlorinate the groundwater pollutants, tetrachloroethene (PCE) and trichloroethene, to ethene. Its 1,469,720-base pair chromosome contains large dynamic duplicated regions and integrated elements. Genes encoding 17 putative reductive dehalogenases, nearly all of which were adjacent to genes for transcription regulators, and five hydrogenase complexes were identified. These findings, plus a limited repertoire of other metabolic modes, indicate that D. ethenogenes is highly evolved to utilize halogenated organic compounds and H-2. Diversification of reductive dehalogenase functions appears to have been mediated by recent genetic exchange and amplification. Genome analysis provides insights into the organism's complex nutrient requirements and suggests that an ancestor was a nitrogen-fixing autotroph.	Inst Genom Res, Rockville, MD 20850 USA; Tech Univ Berlin, Inst Biotechnol, Fachgebiet Tech Biochem, D-13353 Berlin, Germany; Johns Hopkins Univ, Baltimore, MD 21218 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; George Washington Univ, Sch Med, Dept Pharmacol & Microbiol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Trop Med, Washington, DC 20037 USA; Cornell Univ, Microbiol Sect, Ithaca, NY 14853 USA	J. Craig Venter Institute; Technical University of Berlin; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; George Washington University; George Washington University; Cornell University	Seshadri, R (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	rekha@tigr.org	Nelson, William C/E-9263-2016; Adrian, Lorenz/A-4443-2012; Phillippy, Adam M/U-5731-2018; Eisen, Jonathan A./H-2706-2019	Nelson, William C/0000-0002-1873-3929; Adrian, Lorenz/0000-0001-8205-0842; Phillippy, Adam M/0000-0003-2983-8934; Eisen, Jonathan A./0000-0002-0159-2197; Heidelberg, John/0000-0003-0673-3224; Fraser, Claire/0000-0003-1462-2428				Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Baumer S, 2000, J BIOL CHEM, V275, P17968, DOI 10.1074/jbc.M000650200; DISTEFANO TD, 1992, APPL ENVIRON MICROB, V58, P3622, DOI 10.1128/AEM.58.11.3622-3629.1992; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; EHRLICH SD, 1993, GENE, V135, P161, DOI 10.1016/0378-1119(93)90061-7; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Fennell DE, 2004, ENVIRON SCI TECHNOL, V38, P2075, DOI 10.1021/es034989b; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Magnuson JK, 1998, APPL ENVIRON MICROB, V64, P1270; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; NEUMANN A, 1994, ARCH MICROBIOL, V162, P295, DOI 10.1007/s002030050141; Neumann A, 2002, ARCH MICROBIOL, V177, P420, DOI 10.1007/s00203-002-0409-3; Reams AB, 2004, ANNU REV MICROBIOL, V58, P119, DOI 10.1146/annurev.micro.58.030603.123806; Reams AB, 2004, J MOL BIOL, V338, P643, DOI 10.1016/j.jmb.2004.03.031; Reams AB, 2003, MOL MICROBIOL, V47, P1291, DOI 10.1046/j.1365-2958.2003.03342.x; Sargent F, 2001, TRENDS MICROBIOL, V9, P196, DOI 10.1016/S0966-842X(01)02017-0; Schobert M, 2001, MICROBIOL-SGM, V147, P363, DOI 10.1099/00221287-147-2-363; Schumacher W, 1997, FEBS LETT, V409, P421, DOI 10.1016/S0014-5793(97)00520-6; SIMDT H, 2004, ANNU REV MICROBIOL, V58, P43; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; van de Pas BA, 1999, J BIOL CHEM, V274, P20287, DOI 10.1074/jbc.274.29.20287; van der Meer JR, 2003, CURR OPIN BIOTECH, V14, P248, DOI 10.1016/S0958-1669(03)00058-2; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1016/S0168-6445(01)00063-8; Villemur R, 2002, CAN J MICROBIOL, V48, P697, DOI 10.1139/w02-057; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZINDER SH, 2002, ENCY ENV MICROBIOLOG, P507	35	337	595	11	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					105	108		10.1126/science.1102226	http://dx.doi.org/10.1126/science.1102226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637277	Green Submitted			2022-12-24	WOS:000226214300047
J	Benveniste, M; Dingledine, R				Benveniste, M; Dingledine, R			Limiting stroke-induced damage by targeting an acid channel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SENSING ION CHANNELS; ISCHEMIA; CALCIUM		Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Tel Aviv University; Sackler Faculty of Medicine; Emory University	Benveniste, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520				Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	5	31	40	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2005	352	1					85	86		10.1056/NEJMcibr045010	http://dx.doi.org/10.1056/NEJMcibr045010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884UP	15635119				2022-12-24	WOS:000226112500015
J	Larsson, SC; Bergkvist, L; Wolk, A				Larsson, SC; Bergkvist, L; Wolk, A			Magnesium intake in relation to risk of colorectal cancer in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LARGE-BOWEL CARCINOGENESIS; METHYLAZOXYMETHANOL ACETATE; CELL-PROLIFERATION; C-PEPTIDE; HYDROXIDE; RATS; ASSOCIATION; COLON	Context Animal studies have suggested that dietary magnesium may play a role in the prevention of colorectal cancer, but data in humans are lacking. Objective To evaluate the hypothesis that a high magnesium intake reduces the risk of colorectal cancer in women. Design, Setting, and Participants The Swedish Mammography Cohort, a population-based prospective cohort of 61433 women aged 40 to 75 years without previous diagnosis of cancer at baseline from 1987 to 1990. Main Outcome Measure Incident invasive colorectal cancer. Results During a mean of 14.8 years (911042 person-years) of follow-up, 805 incident colorectal cancer cases were diagnosed. After adjustment for potential confounders, we observed an inverse association of magnesium intake with the risk of colorectal cancer (P for trend=.006). Compared with women in the lowest quintile of magnesium intake, the multivariate rate ratio (RR) was 0.59 (95% confidence interval [CI], 0.40-0.87) for those in the highest quintile. The inverse association was observed for both colon (RR, 0.66; 95% CI, 0.41-1.07) and rectal cancer (RR, 0.45; 95% CI, 0.22-0.89). Conclusion This population-based prospective study suggests that a high magnesium intake may reduce the occurrence of colorectal cancer in women.	Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, SE-17177 Stockholm, Sweden; Cent Hosp Vasteras, Clin Res Ctr, Vasteras, Sweden; Cent Hosp Vasteras, Dept Surg, Vasteras, Sweden	Karolinska Institutet; Vasteras Central Hospital; Vasteras Central Hospital	Larsson, SC (corresponding author), Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, POB 210, SE-17177 Stockholm, Sweden.	susanna.larsson@imm.ki.se	Larsson, Susanna C./F-6065-2015	Larsson, Susanna C./0000-0003-0118-0341				Bergstrom L., 1991, Var Foda, V43, P439; Cox D. R., 1984, ANAL SURVIVAL DATA; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fung TT, 2003, J AM COLL NUTR, V22, P533, DOI 10.1080/07315724.2003.10719332; Gueux E, 1995, BRIT J NUTR, V74, P849, DOI 10.1079/BJN19950011; Hans CP, 2003, MAGNESIUM RES, V16, P13; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; MORI H, 1992, CANCER LETT, V62, P43, DOI 10.1016/0304-3835(92)90196-3; MORI H, 1993, BASIC LIFE SCI, V61, P111; PAOLISSO G, 1989, DIABETES CARE, V12, P265, DOI 10.2337/diacare.12.4.265; PAOLISSO G, 1992, AM J CLIN NUTR, V55, P1161, DOI 10.1093/ajcn/55.6.1161; Rothman K., 1998, MODERN EPIDEMIOLOGY; SJOGREN A, 1988, MAGNESIUM, V7, P117; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; TANAKA T, 1989, CARCINOGENESIS, V10, P613, DOI 10.1093/carcin/10.3.613; WANG A, 1994, CARCINOGENESIS, V15, P2661, DOI 10.1093/carcin/15.11.2661; WANG A, 1993, CANCER LETT, V75, P73, DOI 10.1016/0304-3835(93)90190-K; Willett W., 2012, NUTR EPIDEMIOLOGY; Wolk A, 1998, ARCH INTERN MED, V158, P41, DOI 10.1001/archinte.158.1.41	22	81	81	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2005	293	1					86	89		10.1001/jama.293.1.86	http://dx.doi.org/10.1001/jama.293.1.86			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QY	15632340	Bronze			2022-12-24	WOS:000226102100025
J	Mukamal, KJ; Ascherio, A; Mittleman, MA; Conigrave, KM; Camargo, CA; Kawachi, I; Stampfer, MJ; Willett, WC; Rimm, EB				Mukamal, KJ; Ascherio, A; Mittleman, MA; Conigrave, KM; Camargo, CA; Kawachi, I; Stampfer, MJ; Willett, WC; Rimm, EB			Alcohol and risk for ischemic stroke in men: The role of drinking patterns and usual beverage	ANNALS OF INTERNAL MEDICINE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; CORONARY HEART-DISEASE; CARDIOVASCULAR-HEALTH; LIPID-PEROXIDATION; CONSUMPTION; WINE; WOMEN; MORTALITY; ATHEROSCLEROSIS	Background: The association of light to moderate alcohol consumption with risk for ischemic stroke remains controversial, as do the roles of beverage type and drinking pattern. Objective: To assess the association of drinking patterns and beverage type with risk for ischemic stroke among men. Design: Prospective cohort study. Setting: United States. Participants: 38 156 male health professionals who were free of known cardiovascular disease or cancer at baseline in 1986. Measurements: With a semi-quantitative food-frequency questionnaire, the authors individually ascertained consumption of regular and light beer, red and white wine, and liquor every 4 years. Alcohol consumption was categorized as light (0.1 to 9.9 g/d, or < 1 drink daily), moderate (10.0 to 29.9 g/d, or 1 to 2 drinks daily), and heavier (>= 30.0 g/d, or >= 3 drinks daily). Results: During a follow-up period of 14 years, 412 cases of incident ischemic stroke were documented. Compared with abstainers, light drinkers had a multivariate-adjusted relative risk of 0.99 (95% CI, 0.72 to 1.37), moderate drinkers had a multivariate-adjusted relative risk of 1.26 (CI, 0.90 to 1.76), and heavier drinkers had a multivariate-adjusted relative risk of 1.42 (CI, 0.97 to 2.09; P = 0.01 for trend). Consumption of 10.0 to 29.9 g of alcohol per day on 3 to 4 days per week appeared to be associated with the lowest risk (relative risk, 0.68 [CI, 0.44 to 1.05]). Red wine consumption was inversely associated with risk in a graded manner (P = 0.02 for trend), but other beverages were not. The apparently higher risk for ischemic stroke with heavier alcohol use appeared to be most pronounced for the embolic subtype. Limitations: This study had limited power to examine specific drinking patterns and heavy drinking and could not assess risk for hemorrhagic stroke. Conclusions: In this sample of male health professionals, light and moderate average alcohol use was generally not associated with an increased risk for ischemic stroke, although drinking pattern and beverage type modified this relation. Intake of more than 2 drinks per day may be associated with a higher risk for ischemic stroke.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02115 USA; Univ Sydney, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia	Harvard University; Beth Israel Deaconess Medical Center; University of Sydney; University of Sydney	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,RO-114, Boston, MA 02115 USA.	kmukamal@bidmc.harvard.edu	Camargo, Carlos A./C-2145-2008; Mukamal, Kenneth/GVR-7978-2022	Camargo, Carlos A./0000-0002-5071-7654; Conigrave, Katherine/0000-0002-6428-1441; Mittleman, Murray/0000-0001-9788-7274	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA00299, AA11181] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; Camargo CA, 1996, CLIN CHIM ACTA, V246, P107, DOI 10.1016/0009-8981(96)06231-6; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Djousse L, 2002, STROKE, V33, P907, DOI 10.1161/hs0402.105245; Dulli DA, 2002, STROKE, V33, P890, DOI 10.1161/01.STR.0000013795.19904.73; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldstein LB, 2001, CIRCULATION, V103, P163; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; HILLBLOM M, 1996, ALCOHOL CARDIOVASCUL; Hommel M, 1999, NEW ENGL J MED, V341, P1605, DOI 10.1056/NEJM199911183412109; Iijima K, 2002, CIRCULATION, V105, P2404, DOI 10.1161/01.CIR.0000016349.36385.FB; Jiang R, 2003, AM J EPIDEMIOL, V158, P760, DOI 10.1093/aje/kwg221; Klatsky AL, 1999, ALCOHOL RES HEALTH, V23, P15; Klatsky AL, 2001, AM J CARDIOL, V88, P703, DOI 10.1016/S0002-9149(01)01824-0; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Leppala JM, 1999, CIRCULATION, V100, P1209, DOI 10.1161/01.CIR.100.11.1209; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Malarcher AM, 2001, STROKE, V32, P77, DOI 10.1161/01.STR.32.1.77; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; Nigdikar SV, 1998, AM J CLIN NUTR, V68, P258, DOI 10.1093/ajcn/68.2.258; PALOMAKI H, 1993, STROKE, V24, P1828, DOI 10.1161/01.STR.24.12.1828; Pickle LW, 1997, STROKE, V28, P1639, DOI 10.1161/01.STR.28.8.1639; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; SHAPER AG, 1988, LANCET, V2, P1267; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stocker R, 2004, AM J CLIN NUTR, V79, P123; Tanasescu M, 2001, J AM COLL CARDIOL, V38, P1836, DOI 10.1016/S0735-1097(01)01655-2; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Truelsen T, 1998, STROKE, V29, P2467, DOI 10.1161/01.STR.29.12.2467; *USDA, 1999, NUTR DAT STAND REF; Waddington E, 2004, AM J CLIN NUTR, V79, P54; Weinfeld, 1981, STROKE S1, V12, pI13	45	121	129	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2005	142	1					11	19		10.7326/0003-4819-142-1-200501040-00007	http://dx.doi.org/10.7326/0003-4819-142-1-200501040-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916DS	15630105				2022-12-24	WOS:000228366200002
J	Carpenter, RG; Waite, A; Coombs, RC; Daman-Willems, C; McKenzie, A; Huber, J; Emery, JL				Carpenter, RG; Waite, A; Coombs, RC; Daman-Willems, C; McKenzie, A; Huber, J; Emery, JL			Repeat sudden unexpected and unexplained infant deaths: natural or unnatural?	LANCET			English	Article							INTRAALVEOLAR HEMORRHAGE; RECURRENCE; RISK	Background There have been suggestions that when two or three unexpected unexplained infant deaths occur within a family they are more likely to be unnatural than natural. We aimed to estimate the probability that a second infant death is natural versus unnatural. Methods The Care of Next Infant programme (CONI) supports parents who have previously had an unexpected and apparently unexplained infant death and is currently available in over 90% of health districts in England, Wales, and Northern Ireland. We studied all deaths in 6373 infants who had completed the CONI programme by December, 1999. After a CONI death, we made detailed enquiries into the previous death and the CONI death, including a family interview, a review of autopsies, and case discussion. Findings 57 (8.9 per 1000) CONI infants died. Nine deaths were inevitable, and 48 were unexpected. 44 families lost one child, and two families lost two children. Of the 46 first CONI deaths, 40 were natural; the other six were probable homicides, five committed by one or both parents (two criminally convicted). The ratio of 40 natural to six unnatural deaths is 6.7 (95% CI 2.8-19.4). Enquiries identified 18 families with two SIDS (sudden infant death syndrome) deaths and two families with probable covert double homicides (ratio 9.0 [2.2 to 80.0]). There were no convictions in 13 incomplete cases. Families with three deaths are reported.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London WC1E 7HT, England; Univ Sheffield, Sheffield Childrens Hosp, Acad Unit Child Hlth, Care Next Infant CONI Programme, Sheffield, S Yorkshire, England; Royal Hallamshire Hosp, Neonatal Intens Care Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Hosp, London, England; Univ Hosp Children & Youth, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Sheffield; Wilhelmina Kinderziekenhuis	Carpenter, RG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, Keppel St, London WC1E 7HT, England.	bob.carpenter@lshtm.ac.uk						BARRETT AM, 1954, RECENT ADV PAEDIATRI, P301; BEAL SM, 1988, ARCH DIS CHILD, V63, P924, DOI 10.1136/adc.63.8.924; Berry PJ, 1999, J CLIN PATHOL, V52, P553, DOI 10.1136/jcp.52.8.553; CARPENTER RG, 1977, ARCH DIS CHILD, V52, P606, DOI 10.1136/adc.52.8.606; DiMaio V J M, 1989, FORENSIC PATHOLOGY; EMERY JL, 1985, ARCH DIS CHILD, V60, P505, DOI 10.1136/adc.60.6.505; EMERY JL, 1986, LANCET, V1, P313; EMERY JL, 1993, AM J DIS CHILD, V147, P1097, DOI 10.1001/archpedi.1993.02160340083019; Firstman R, 2001, SUDDEN INFANT DEATH, P291; Fleming P., 2000, SUDDEN UNEXPECTED DE; GUNTHEROTH WG, 1990, J PEDIATR-US, V116, P520, DOI 10.1016/S0022-3476(05)81596-3; GUNTHEROTH WG, 1995, CRIB DEATH SUDDEN IN; KUKULL WA, 1977, AM J EPIDEMIOL, V106, P485, DOI 10.1093/oxfordjournals.aje.a112495; Levene S, 2004, ARCH DIS CHILD, V89, P443, DOI 10.1136/adc.2003.036202; LEVINE M, 1999, LEVINE CORONERS COUR; MCKENZIE A, 1995, HLTH VISITOR, V68, P239; Meadow R, 1999, ARCH DIS CHILD, V80, P7, DOI 10.1136/adc.80.1.7; MEADOW R, 1997, ABC CHILD ABUSE, P27; Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925; PETERSON DR, 1980, J PEDIATR-US, V97, P265, DOI 10.1016/S0022-3476(80)80491-4; *PRES ROYAL STAT S, 2001, RSS NEWS         DEC; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Stanton AN, 2003, ARCH DIS CHILD, V88, P699, DOI 10.1136/adc.88.8.699; TAYLOR EM, 1983, BRIT MED J, V287, P871, DOI 10.1136/bmj.287.6396.871; TAYLOR EM, 1982, ARCH DIS CHILD, V57, P668, DOI 10.1136/adc.57.9.668; VALDESDAPENA MA, 1967, PEDIATRICS, V39, P123; Vege A., 1995, P67; WAITE A, 1998, REPORT 5000 BABIES U; WOLKIND S, 1993, ACTA PAEDIATR, V82, P873, DOI 10.1111/j.1651-2227.1993.tb12583.x; Yukawa N, 1999, J CLIN PATHOL, V52, P581, DOI 10.1136/jcp.52.8.581; [No title captured]	31	42	43	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					29	35		10.1016/S0140-6736(04)17662-9	http://dx.doi.org/10.1016/S0140-6736(04)17662-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639677				2022-12-24	WOS:000226213100025
J	Timonen, M; Laakso, M; Jokelainen, J; Rajala, U; Meyer-Rochow, VB; Keinanen-Kiukaanniemi, S				Timonen, M; Laakso, M; Jokelainen, J; Rajala, U; Meyer-Rochow, VB; Keinanen-Kiukaanniemi, S			Insulin resistance anddepression: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEPRESSION		Oulu Univ Hosp, Unit Gen Practice, Oys 90029, Finland; Int Univ Bremen, Sch Sci & Engn, D-28725 Bremen, Germany; Oulu Hlth Ctr, FIN-90015 Oulu, Finland	University of Oulu; Jacobs University		markku.timonen@oulu.fi	MEYER-ROCHOW, Victor Benno/AAJ-7258-2020	Jokelainen, Jari/0000-0003-4629-0560; MEYER-ROCHOW, V. Benno/0000-0003-1531-9244				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Lawlor DA, 2003, BRIT MED J, V327, P1383, DOI 10.1136/bmj.327.7428.1383; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Rajala U, 2002, J CLIN ENDOCR METAB, V87, P5092, DOI 10.1210/jc.2002-020703; Rasgon NL, 2003, J AFFECT DISORDERS, V74, P299, DOI 10.1016/S0165-0327(02)00117-9	5	95	101	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					17	18		10.1136/bmj.38313.513310.F71	http://dx.doi.org/10.1136/bmj.38313.513310.F71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15604155	Green Published, Bronze			2022-12-24	WOS:000226176700011
J	Chou, S; Huang, L; Liu, HP				Chou, S; Huang, L; Liu, HP			Fus3-regulated Tec1 degradation throulah SCFCdc4 determines MAPK signaling specificity during mating in yeast	CELL			English	Article							TRANSCRIPTION FACTOR; FILAMENTOUS-GROWTH; STRUCTURAL BASIS; GENE-EXPRESSION; INVASIVE GROWTH; KINASE; PHEROMONE; PATHWAY; CASCADE; CYCLIN	Signaling specificity is fundamental for parallel mitogen-activated protein kinase (MAPK) cascades that control growth and differentiation in response to different stimuli. In Saccharomyces cerevisiae, components of the pheromone-responsive MAPK cascade activate Fus3 and Kss1 MAPKs to induce mating and Kss1 to promote filamentation. Active Fus3 is required to prevent the activation of the filamentation program during pheromone response. How Fus3 prevents the crossactivation is not clear. Here we show that Tec1, a cofactor of Ste12 for the expression of filamentation genes, is rapidly degraded during pheromone response. Fus3 but not Kss1 induces Tec1 ubiquination and degradation through the SCFCdc4 ubiquitin ligase. T273 in a predicted high-affinity Cdc4 binding motif is phosphorylated by Fus3 both in vitro and in vivo. Tec1(T273V) blocks Tec1 ubiquitination and degradation and allows the induction of filamentation genes in response to pheromone. Thus, Fus3 inhibits filamentous growth during mating by degrading Tec1.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92687 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92687 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, HP (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	h4liu@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055155] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55155, R01 GM055155] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ELION EA, 1991, COLD SH Q B, V56, P41; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huang L, 2001, J BIOL CHEM, V276, P28327, DOI 10.1074/jbc.M008342200; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Mosch HU, 1997, GENETICS, V145, P671; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oehlen L, 1998, FEBS LETT, V429, P83, DOI 10.1016/S0014-5793(98)00568-7; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Palecek SP, 2000, GENETICS, V156, P1005; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang RB, 1999, MAT SCI ENG C-BIO S, V10, P13, DOI 10.1016/S0928-4931(99)00099-5	43	106	107	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					981	990		10.1016/j.cell.2004.11.053	http://dx.doi.org/10.1016/j.cell.2004.11.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620356	Bronze			2022-12-24	WOS:000226109700010
J	Moore, MJ; Early, GA				Moore, MJ; Early, GA			Cumulative sperm whale bone damage and the bends	SCIENCE			English	Article									Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Moore, MJ (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mmoore@whoi.edu	Moore, Michael/E-1707-2015	Moore, Michael/0000-0003-3074-6631				Flower WH., 1868, T ZOOLOGICAL SOC LON, V6, P309; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Resnick D., 2002, DIAGNOSIS BONE JOINT; ROTHSCHILD B, 1987, SCIENCE, V236, P75, DOI 10.1126/science.236.4797.75; Rothschild BM, 2003, J VERTEBR PALEONTOL, V23, P324, DOI 10.1671/0272-4634(2003)023[0324:DSIPSR]2.0.CO;2; Watkins WA, 2002, MAR MAMMAL SCI, V18, P55, DOI 10.1111/j.1748-7692.2002.tb01018.x	6	56	61	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2215	2215		10.1126/science.1105452	http://dx.doi.org/10.1126/science.1105452			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618509				2022-12-24	WOS:000225950000033
J	Weiss, G; Skurnick, JH; Goldsmith, LT; Santoro, NF; Park, SJ				Weiss, G; Skurnick, JH; Goldsmith, LT; Santoro, NF; Park, SJ			Menopause and hypothalamic-pituitary sensitivity to estrogen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUTEINIZING-HORMONE SECRETION; PREMENOPAUSAL WOMEN; MENSTRUAL-CYCLE; AGE; POPULATION; TRANSITION; INDUCTION; ESTRADIOL; SYMPTOMS; DYNAMICS	Context The onset of human menopause is thought to be caused solely by ovarian failure and oocyte depletion. However, clinical symptoms and certain recent data in perimenopausal women suggest central nervous system involvement. Objective To determine if modifications of hypothalamic-pituitary response to estrogen feedback mechanisms occur in older reproductive-age women as a mechanism of the onset of menopause. Design, Setting, and Participants The Study of Women's Health Across the Nation (SWAN) is a multiethnic observational cohort study of the menopausal transition in 3302 women at 7 US sites. Of the subcohort of 840 women who participated in the Daily Hormone Study between 1997 and 1999, 680 women had evidence of luteal activity. The remaining 160 women (19%) did not have luteal activity and are the subject of this report. Main Outcome Measures Daily urinary hormone levels of estrogen and progesterone metabolites, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Results Three groups of women were studied: those with estrogen increases with an LH surge, those with estrogen increases without an LH surge, and those with neither. There were no differences in age or ethnicity among the 3 groups of women. Women in the third group (no increases) experienced more menopausal symptoms (hot flashes) than did women in the other groups with estrogen increases. In older reproductive-age women, the frequent existence of anovulatory cycles with estrogen peaks, equivalent to those that result in LH surges in younger women, yet in which no LH surges occur, indicates failure of estrogen-positive feedback on LH secretion. In other anovulatory cycles, follicular-phase estrogen levels did not lower LH secretion as occurs in cycles of younger women, indicating decreased estrogen-negative feedback on LH secretion. Conclusion Our findings are compatible with hypothalamic-pituitary insensitivity to estrogen in aging perimenopausal women.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, Newark, NJ 07103 USA; Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University	Goldsmith, LT (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, 185 S Orange Ave, Newark, NJ 07103 USA.	goldsmit@umdnj.edu			NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG012546, U01AG012539, U01AG012505, U01AG012495, U01AG012531, U01AG012535, U01AG012554, U01AG012553] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG012546, U01 AG012535, U01 AG012495, U01 AG012505, U01 AG012531, U01 AG012539, U01 AG012554, U01 AG012553] Funding Source: Medline; NINR NIH HHS [U01 NR04061] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Berkow Robert., 1992, MERCK MANUAL DIAGNOS, V16th; Brown J, 1993, ENDOCR J, V1, P467; BURGER HG, 1995, J CLIN ENDOCR METAB, V80, P3537, DOI 10.1210/jc.80.12.3537; Chakraborty TR, 2003, ENDOCRINOLOGY, V144, P4164, DOI 10.1210/en.2003-0052; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Grumbach M, 1990, CONTROL ONSET PUBERT, P1; HILLIER SG, 1981, J CLIN ENDOCR METAB, V52, P847, DOI 10.1210/jcem-52-5-847; LIU JH, 1983, J CLIN ENDOCR METAB, V57, P797; Matt DW, 1998, AM J OBSTET GYNECOL, V178, P504, DOI 10.1016/S0002-9378(98)70429-6; Reame NE, 1996, J CLIN ENDOCR METAB, V81, P1512, DOI 10.1210/jc.81.4.1512; Santoro N, 1996, J CLIN ENDOCR METAB, V81, P1495, DOI 10.1210/jc.81.4.1495; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; Santoro N, 2003, AM J PHYSIOL-ENDOC M, V284, pE521, DOI 10.1152/ajpendo.00381.2002; Santoro NF, 2004, MENOPAUSE, V11, P11; SOWERS MF, 2000, MENOPAUSE BIOL PATHO; Vande Wiele R L, 1970, Recent Prog Horm Res, V26, P63; WEISS G, 1976, OBSTET GYNECOL, V47, P415; Wise PM, 1996, SCIENCE, V273, P67, DOI 10.1126/science.273.5271.67; World Health Organisation [WHO, 1996, WHO TECHN REP SER, V866; YEN SSC, 1972, J CLIN ENDOCR METAB, V35, P897, DOI 10.1210/jcem-35-6-897; YOUNG JR, 1976, J CLIN ENDOCR METAB, V42, P432, DOI 10.1210/jcem-42-3-432	21	120	127	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2991	2996		10.1001/jama.292.24.2991	http://dx.doi.org/10.1001/jama.292.24.2991			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613667				2022-12-24	WOS:000225841900033
J	Nemoto, S; Fergusson, MM; Finkel, T				Nemoto, S; Fergusson, MM; Finkel, T			Nutrient availability regulates SIRT1 through a forkhead-dependent pathway	SCIENCE			English	Article							LIFE-SPAN; CALORIE RESTRICTION; CELL-SURVIVAL; FHA DOMAIN; P53; DEATH; MDC1; NAD	Nutrient availability regulates life-span in a wide range of organisms. We demonstrate that in mammalian cells, acute nutrient withdrawal simultaneously augments expression of the SIRT1 deacetylase and activates the Forkhead transcription factor Foxo3a. Knockdown of Foxo3a expression inhibited the starvation-induced increase in SIRT1 expression. Stimulation of SIRT1 transcription by Foxo3a was mediated through two p53 binding sites present in the SIRT1 promoter, and a nutrient-sensitive physical interaction was observed between Foxo3a and p53. SIRT1 expression was not induced in starved p53-deficient mice. Thus, in mammalian cells, p53, Foxo3a, and SIRT1, three proteins separately implicated in aging, constitute a nutrient-sensing pathway.	NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, Z01HL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Patterson GI, 2003, CURR BIOL, V13, pR279, DOI 10.1016/S0960-9822(03)00201-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	23	544	568	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2105	2108		10.1126/science.1101731	http://dx.doi.org/10.1126/science.1101731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604409				2022-12-24	WOS:000225841000066
J	van Attikum, H; Fritsch, O; Hohn, B; Gasser, SM				van Attikum, H; Fritsch, O; Hohn, B; Gasser, SM			Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H2A; CHECKPOINT PROTEINS; S-PHASE; DAMAGE; YEAST; ARREST; LIGASE; IDENTIFICATION; INVOLVEMENT	The budding yeast INO80 complex is a conserved ATP-dependent nucleosome remodeler containing actin-related proteins Arp5 and Arp8. Strains lacking INO80, ARP5, or ARP8 have defects in transcription. Here we show that these mutants are hypersensitive to DNA damaging agents and to double-strand breaks (DSBs) induced by the HO endonuclease. The checkpoint response and most transcriptional modulation associated with induction of DNA damage are unaffected by these mutations. Using chromatin immunoprecipitation we show that Ino80, Arp5, and Arp8 are recruited to an HO-induced DSB, where a phosphorylated form of H2A accumulates. Recruitment of Ino80 is compromised in cells lacking the H2A phosphoacceptor S129. Finally, we demonstrate that conversion of the DSB into ssDNA is compromised in arp8 and H2A mutants, which are both deficient for INO80 activity at the site of damage. These results implicate INO80-mediated chromatin remodeling directly at DSBs, where it appears to facilitate processing of the lesion.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; NCCR Frontiers Genet Program, CH-1211 Geneva 4, Switzerland; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Geneva; Friedrich Miescher Institute for Biomedical Research	Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	susan.gasser@fmi.ch	van Attikum, Haico/A-4596-2010; Fritsch, Olivier/L-9829-2019	Van Attikum, Haico/0000-0001-8590-0240; Gasser, Susan/0000-0003-3610-9123; Fritsch, Olivier/0000-0001-6756-9654				Bakshi R, 2004, BIOCHEM BIOPH RES CO, V320, P197, DOI 10.1016/j.bbrc.2004.05.147; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Foss EJ, 2001, GENETICS, V157, P567; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Paciotti V, 2000, GENE DEV, V14, P2046; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Reagan MS, 1997, NUCLEIC ACIDS RES, V25, P4257, DOI 10.1093/nar/25.21.4257; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	469	476	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					777	788		10.1016/j.cell.2004.11.033	http://dx.doi.org/10.1016/j.cell.2004.11.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607975	Bronze			2022-12-24	WOS:000225907200009
J	Redish, AD				Redish, AD			Addiction as a computational process gone awry	SCIENCE			English	Article							REINFORCED BEHAVIOR; RATIONAL ADDICTION; DOPAMINE NEURONS; DRUG-ADDICTION; COCAINE; REWARD; RECEPTORS; NICOTINE; MAINTENANCE; ACQUISITION	Addictive drugs have been hypothesized to access the same neurophysiological mechanisms as natural learning systems. These natural learning systems can be modeled through temporal-difference reinforcement learning (TDRL), which requires a reward-error signal that has been hypothesized to be carried by dopamine. TDRL learns to predict reward by driving that reward-error signal to zero. By adding a noncompensable drug-induced dopamine increase to a TDRL model, a computational model of addiction is constructed that over-selects actions leading to drug receipt. The model provides an explanation for important aspects of the addiction literature and provides a theoretic viewpoint with which to address other aspects.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, 6-145 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	redish@ahc.umn.edu						Ainslie G., 1992, PICOECONOMICS; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bradberry CW, 2002, NEUROSCIENTIST, V8, P315, DOI 10.1177/107385840200800407; CARROLL ME, 1993, DRUG ALCOHOL DEPEN, V33, P201, DOI 10.1016/0376-8716(93)90061-T; CARROLL ME, 1989, PSYCHOPHARMACOLOGY, V97, P23, DOI 10.1007/BF00443407; Daw N., 2003, THESIS CARNEGIE MELL; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; Dickinson A., 1980, CONT ANIMAL LEARNING; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Grossman M, 1998, J HEALTH ECON, V17, P427, DOI 10.1016/S0167-6296(97)00046-5; Higgins ST, 2004, ANNU REV PSYCHOL, V55, P431, DOI 10.1146/annurev.psych.55.090902.142033; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Picciotto MR, 1998, DRUG ALCOHOL DEPEN, V51, P165, DOI 10.1016/S0376-8716(98)00074-X; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Sutton Richard S., 1998, REINFORCEMENT LEARNI; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; WOODWARD M, 1993, ADDICTION, V88, P821, DOI 10.1111/j.1360-0443.1993.tb02096.x; [No title captured]	39	323	328	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1944	1947		10.1126/science.1102384	http://dx.doi.org/10.1126/science.1102384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591205				2022-12-24	WOS:000225695600047
J	Schulz, O; Diebold, SS; Chen, M; Naslund, TI; Nolte, MA; Alexopoulou, L; Azuma, YT; Flavell, RA; Liljestrom, P; Sousa, CRE				Schulz, O; Diebold, SS; Chen, M; Naslund, TI; Nolte, MA; Alexopoulou, L; Azuma, YT; Flavell, RA; Liljestrom, P; Sousa, CRE			Toll-like receptor 3 promotes cross-priming to virus-infected cells	NATURE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; IN-VIVO; VIRAL-INFECTION; CUTTING EDGE; DYING CELLS; ANTIGENS; INTERFERON; IMMUNITY	Cross-presentation of cell-associated antigens plays an important role in regulating CD8(+) T cell responses to proteins that are not expressed by antigen-presenting cells (APCs)(1). Dendritic cells are the principal cross-presenting APCs in vivo and much progress has been made in elucidating the pathways that allow dendritic cells to capture and process cellular material(1). However, little is known about the signals that determine whether such presentation ultimately results in a cytotoxic T cell (CTL) response (cross-priming) or in CD8(+) T cell inactivation (cross-tolerance). Here we describe a mechanism that promotes cross-priming during viral infections. We show that murine CD8alpha(+) dendritic cells are activated by double-stranded (ds)RNA present in virally infected cells but absent from uninfected cells. Dendritic cell activation requires phagocytosis of infected material, followed by signalling through the dsRNA receptor, toll-like receptor 3 (TLR3). Immunization with virus-infected cells or cells containing synthetic dsRNA leads to a striking increase in CTL cross-priming against cell-associated antigens, which is largely dependent on TLR3 expression by antigen-presenting cells. Thus, TLR3 may have evolved to permit cross-priming of CTLs against viruses that do not directly infect dendritic cells.	Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, Dept Vaccine Res, S-17177 Stockholm, Sweden; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Cancer Research UK; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Yale University; Howard Hughes Medical Institute	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Azuma, Yasu-Taka/C-7561-2009; Reis e Sousa, Caetano/ABD-7322-2021; Nolte, Martijn A./AAC-8092-2022; chen, margaret/B-6757-2014; Reis e Sousa, Caetano/O-1657-2014; Alexopoulou, Lena/A-5041-2017	Reis e Sousa, Caetano/0000-0001-7392-2119; Nolte, Martijn A./0000-0002-5447-0839; Reis e Sousa, Caetano/0000-0001-7392-2119; Alexopoulou, Lena/0000-0003-4619-697X; Liljestrom, Peter/0000-0002-2132-0981; Sallberg Chen, Margaret/0000-0002-3793-4064; Azuma, Yasu-Taka/0000-0002-3515-171X; Schulz, Oliver/0000-0002-1493-3341				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HELWIG FC, 1945, SCIENCE, V102, P31, DOI 10.1126/science.102.2637.31; Hoebe K, 2004, J ENDOTOXIN RES, V10, P130, DOI 10.1179/096805104225004031; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898	30	681	718	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					887	892		10.1038/nature03326	http://dx.doi.org/10.1038/nature03326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15711573				2022-12-24	WOS:000227174600048
J	Kwak, SH; Shen, R; Schiefelbein, J				Kwak, SH; Shen, R; Schiefelbein, J			Positional signaling mediated by a receptor-like kinase in Arabidopsis	SCIENCE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; ROOT EPIDERMIS; THALIANA; GENE; REGULATOR; PROTEIN; FATE	The position-dependent specification of root epidermal cells in Arabidopsis provides an elegant paradigm for cell patterning during development. Here, we describe a new gene, SCRAMBLED (SCM), required for cells to appropriately interpret their location within the developing root epidermis. SCM encodes a receptor-like kinase protein with a predicted extracellular domain of six leucine-rich repeats and an intracellular serine-threonine kinase domain. SCM regulates the expression of the GLABRA2, CAPRICE, WEREWOLF, and ENHANCER OF GLABRA3 transcription factor genes that define the cell fates. Further, the SCM gene is expressed throughout the developing root. Therefore, SCM likely enables developing epidermal cells to detect positional cues and establish an appropriate cell-type pattern.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schiefelbein, J (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	schiefel@umich.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Larkin JC, 2003, ANNU REV PLANT BIOL, V54, P403, DOI 10.1146/annurev.arplant.54.031902.134823; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Scheres B, 2002, CURR BIOL, V12, pR804, DOI 10.1016/S0960-9822(02)01313-1; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111	15	167	174	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1111	1113		10.1126/science.1105373	http://dx.doi.org/10.1126/science.1105373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15618487				2022-12-24	WOS:000227197300049
J	Deregnaucourt, S; Mitra, PP; Feher, O; Pytte, C; Tchernichovski, O				Deregnaucourt, S; Mitra, PP; Feher, O; Pytte, C; Tchernichovski, O			How sleep affects the developmental learning of bird song	NATURE			English	Article							ANTERIOR FOREBRAIN; VOCAL IMITATION; AGE; CONSOLIDATION; MEMORIES; DYNAMICS; NEURONS	Sleep affects learning and development in humans and other animals, but the role of sleep in developmental learning has never been examined. Here we show the effects of night-sleep on song development in the zebra finch by recording and analysing the entire song ontogeny. During periods of rapid learning we observed a pronounced deterioration in song structure after night-sleep. The song regained structure after intense morning singing. Daily improvement in similarity to the tutored song occurred during the late phase of this morning recovery; little further improvement occurred thereafter. Furthermore, birds that showed stronger post-sleep deterioration during development achieved a better final imitation. The effect diminished with age. Our experiments showed that these oscillations were not a result of sleep inertia or lack of practice, indicating the possible involvement of an active process, perhaps neural song-replay during sleep. We suggest that these oscillations correspond to competing demands of plasticity and consolidation during learning, creating repeated opportunities to reshape previously learned motor skills.	CUNY City Coll, Dept Biol, New York, NY 10031 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	City University of New York (CUNY) System; City College of New York (CUNY); Cold Spring Harbor Laboratory; Wesleyan University	Deregnaucourt, S (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	sderegna@sci.ccny.cuny.edu	Galantucci, Bruno/E-5770-2010; Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004722] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Brainard MS, 2001, J NEUROSCI, V21, P2501, DOI 10.1523/JNEUROSCI.21-07-02501.2001; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Ho C, 1998, P JOINT S NEUR COMP, V5, P76; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Immelmann K., 1969, P61; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Keasar T, 1996, ANIM BEHAV, V52, P95, DOI 10.1006/anbe.1996.0155; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Loader C., 1999, LOCAL REGRESSION LIK; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; NORDEEN KW, 1988, NATURE, V334, P149, DOI 10.1038/334149a0; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; SCHMIDT MF, 2001, NAT NEUROSCI, V1, P513; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tchernichovski O, 2002, J COMP PHYSIOL A, V188, P867, DOI 10.1007/s00359-002-0352-4; Tchernichovski O, 1998, BIOL CYBERN, V78, P423, DOI 10.1007/s004220050446; Tchernichovski O, 2004, SOUND ANAL PRO USER; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wang NG, 2002, J NEUROSCI, V22, P10864; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; ZUCKERMAN B, 1987, PEDIATRICS, V80, P664	46	224	227	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					710	716		10.1038/nature03275	http://dx.doi.org/10.1038/nature03275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716944				2022-12-24	WOS:000227039200030
J	Doumbo, OK				Doumbo, OK			It takes a village: Medical research and ethics in Mali	SCIENCE			English	Editorial Material									Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Bamako, Mali	University of Bamako	Doumbo, OK (corresponding author), Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, BP 1805, Bamako, Mali.	okd@mrtcbko.org						DOUMBO O, 1999, MULTILATERAL INITIAT; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481	3	32	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					679	681		10.1126/science.1109773	http://dx.doi.org/10.1126/science.1109773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692036				2022-12-24	WOS:000226814900026
J	Knorr, W; Prentice, IC; House, JI; Holland, EA				Knorr, W; Prentice, IC; House, JI; Holland, EA			Long-term sensitivity of soil carbon turnover to warming	NATURE			English	Article							ORGANIC-MATTER; TEMPERATURE-DEPENDENCE; CO2 EMISSIONS; DECOMPOSITION; RESPIRATION; CLIMATE; MINERALIZATION; CONSTRAINTS; RESPONSES; EXCHANGE	The sensitivity of soil carbon to warming is a major uncertainty in projections of carbon dioxide concentration and climate(1). Experimental studies overwhelmingly indicate increased soil organic carbon (SOC) decomposition(2-8) at higher temperatures, resulting in increased carbon dioxide emissions from soils. However, recent findings have been cited as evidence against increased soil carbon emissions in a warmer world(9,10). In soil warming experiments, the initially increased carbon dioxide efflux returns to pre-warming rates within one to three years(10-14), and apparent carbon pool turnover times are insensitive to temperature(15). It has already been suggested that the apparent lack of temperature dependence could be an artefact due to neglecting the extreme heterogeneity of soil carbon(16), but no explicit model has yet been presented that can reconcile all the above findings. Here we present a simple three-pool model that partitions SOC into components with different intrinsic turnover rates. Using this model, we show that the results of all the soil-warming experiments are compatible with long-term temperature sensitivity of SOC turnover: they can be explained by rapid depletion of labile SOC combined with the negligible response of non-labile SOC on experimental timescales. Furthermore, we present evidence that non-labile SOC is more sensitive to temperature than labile SOC, implying that the long-term positive feedback of soil decomposition in a warming world may be even stronger than predicted by global models(1,17-20).	Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Bristol, Dept Earth Sci, QUEST, Bristol BS8 1RJ, Avon, England; Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Max Planck Society; University of Bristol; National Center Atmospheric Research (NCAR) - USA	Knorr, W (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.	wknorr@bgc-jena.mpg.de	House, Joanna I/B-6477-2016	House, Joanna I/0000-0003-4576-3960; Holland, Elisabeth Ann/0000-0002-3570-621X				Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dalias P, 2001, SOIL BIOL BIOCHEM, V33, P1049, DOI 10.1016/S0038-0717(01)00009-8; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Gu LH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002119; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; JENKINSON DS, 1977, SOIL SCI SOC AM J, V41, P912, DOI 10.2136/sssaj1977.03615995004100050020x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jenny H, 1929, SOIL SCI, V27, P169, DOI 10.1097/00010694-192903000-00001; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sanderman J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001833; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393	30	873	972	25	657	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					298	301		10.1038/nature03226	http://dx.doi.org/10.1038/nature03226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662420				2022-12-24	WOS:000226381300051
J	Keegan, BR; Feldman, JL; Begemann, G; Ingham, PW; Yelon, D				Keegan, BR; Feldman, JL; Begemann, G; Ingham, PW; Yelon, D			Retinoic acid signaling restricts the cardiac progenitor pool	SCIENCE			English	Article							ANTEROPOSTERIOR POLARITY; ZEBRAFISH HINDBRAIN; HEART MORPHOGENESIS; DIFFERENTIATION; PROLIFERATION; SPECIFICATION; SEGMENTATION; PATTERN; EMBRYO; RALDH2	Organogenesis begins with specification of a progenitor cell population, the size of which provides a foundation for the organ's final dimensions. Here, we present a new mechanism for regulating the number of progenitor cells by limiting their density within a competent region. We demonstrate that retinoic acid signaling restricts cardiac specification in the zebrafish embryo. Reduction of retinoic acid signaling causes formation of an excess of cardiomyocytes, via fate transformations that increase cardiac progenitor density within a multipotential zone. Thus, retinoic acid signaling creates a balance between cardiac and noncardiac identities, thereby refining the dimensions of the cardiac progenitor pool.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ Konstanz, Lehrstuhl Zool Evolutionary Biol, D-78457 Constance, Germany; Univ Sheffield, Sch Med, Dept Biomed Sci, Ctr Dev Genet, Sheffield S10 2TN, S Yorkshire, England	New York University; New York University; University of Konstanz; University of Sheffield	Yelon, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	yelon@saturn.med.nyu.edu	Ingham, Philip W/E-6710-2010; Ingham, Philip W/G-9903-2011; Begemann, Gerrit/C-6223-2011; Ingham, Philip William/AAH-5884-2020	Ingham, Philip W/0000-0001-8224-9958; Begemann, Gerrit/0000-0001-7822-7617; Ingham, Philip William/0000-0001-8224-9958				Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Drysdale TA, 1997, DEV BIOL, V188, P205, DOI 10.1006/dbio.1997.8623; Goldstein AM, 1998, DEV BIOL, V201, P247, DOI 10.1006/dbio.1998.8976; Grandel H, 2002, DEVELOPMENT, V129, P2851; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Linville A, 2004, DEV BIOL, V270, P186, DOI 10.1016/j.ydbio.2004.02.022; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Rones MS, 2000, DEVELOPMENT, V127, P3865; Schulze GE, 2001, TOXICOL SCI, V59, P297, DOI 10.1093/toxsci/59.2.297; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; YUTZEY KE, 1994, DEVELOPMENT, V120, P871	18	161	170	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					247	249		10.1126/science.1101573	http://dx.doi.org/10.1126/science.1101573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653502				2022-12-24	WOS:000226361900040
J	Green, MA; Fry, SC				Green, MA; Fry, SC			Vitamin C degradation in plant cells via enzymatic hydrolysis of 4-O-oxalyl-L-threonate	NATURE			English	Article							L-ASCORBIC-ACID; PELARGONIUM-CRISPUM; TARTARIC-ACIDS; OXALIC-ACID; ELONGATION; METABOLISM; OXALATE; OXIDASE; OXYGEN; OXIDATION	Increasing the L-ascorbate (vitamin C) content of crops could in principle involve promoting its biosynthesis or inhibiting its degradation. Recent progress has revealed biosynthetic pathways for ascorbate(1-3), but the degradative pathways remain unclear. The elucidation of such pathways could promote an understanding of the roles of ascorbate in plants(4), and especially of the intriguing positive correlation between growth rate and ascorbate oxidase(5,6) (or its products(7)). In some plants (Vitaceae), ascorbate is degraded via L-idonate to L-threarate (L-tartrate), with the latter arising from carbons 1-4 of ascorbate(3,8-11). In most plants, however (including Vitaceae)(11), ascorbate degradation can occur via dehydroascorbate, yielding oxalate(12) plus L-threonate, with the latter from carbons 3-6 of ascorbate(3,10,13). The metabolic steps between ascorbate and oxalate/L-threonate, and their subcellular location, were unknown. Here we show that this pathway operates extracellularly in cultured Rosa cells, proceeds via several novel intermediates including 4-O-oxalyl-L-threonate, and involves at least one new enzyme activity. The pathway can also operate non-enzymatically, potentially accounting for vitamin losses during cooking. Several steps in the pathway may generate peroxide; this may contribute to the role of ascorbate as a pro-oxidant(14,15) that is potentially capable of loosening the plant cell wall and/or triggering an oxidative burst.	Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh Cell Wall Grp, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Fry, SC (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh Cell Wall Grp, Daniel Rutherford Bldg,Kings Bldg, Edinburgh EH9 3JH, Midlothian, Scotland.	S.Fry@Ed.Ac.UK						Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Asard H., 2004, VITAMIN C FUNCTION B; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; DeBolt S, 2004, AUST J GRAPE WINE R, V10, P134, DOI 10.1111/j.1755-0238.2004.tb00016.x; Dekker AO, 1940, J AM CHEM SOC, V62, P2165, DOI 10.1021/ja01865a070; Deutsch JC, 1998, ANAL BIOCHEM, V265, P238, DOI 10.1006/abio.1998.2940; Dumville JC, 2003, PLANTA, V217, P951, DOI 10.1007/s00425-003-1061-0; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; FRY SC, 1980, PLANT PHYSIOL, V65, P472, DOI 10.1104/pp.65.3.472; Fry SC., 2000, GROWING PLANT CELL W; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HELSPER JP, 1982, PLANT PHYSIOL, V69, P1365, DOI 10.1104/pp.69.6.1365; HIDALGO A, 1991, BOT GAZ, V152, P282, DOI 10.1086/337891; Keates SE, 2000, PHYTOCHEMISTRY, V53, P433, DOI 10.1016/S0031-9422(99)00448-3; LANE BG, 1993, J BIOL CHEM, V268, P12239; LIN LS, 1991, PLANT PHYSIOL, V96, P159, DOI 10.1104/pp.96.1.159; OFFORD RE, 1966, NATURE, V211, P591, DOI 10.1038/211591a0; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Plochl M, 2000, PLANTA, V210, P454, DOI 10.1007/PL00008153; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; Rodriguez AA, 2002, PLANT PHYSIOL, V129, P1627, DOI 10.1104/pp.001222; SAITO K, 1992, PHYTOCHEMISTRY, V31, P1219, DOI 10.1016/0031-9422(92)80264-F; SAITO K, 1984, PLANT PHYSIOL, V76, P170, DOI 10.1104/pp.76.1.170; Saito K, 1997, PHYTOCHEMISTRY, V44, P805, DOI 10.1016/S0031-9422(96)00642-5; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; TAKAHAMA U, 1993, PHYSIOL PLANTARUM, V89, P791, DOI 10.1111/j.1399-3054.1993.tb05286.x; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; WILLIAMS M, 1978, PLANT PHYSIOL, V61, P672, DOI 10.1104/pp.61.4.672; YANG JC, 1975, PLANT PHYSIOL, V56, P283, DOI 10.1104/pp.56.2.283	30	202	221	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					83	87		10.1038/nature03172	http://dx.doi.org/10.1038/nature03172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	884WJ	15608627				2022-12-24	WOS:000226117100040
J	Jackson, R; Lawes, CMM; Bennett, DA; Milne, RJ; Rodgers, A				Jackson, R; Lawes, CMM; Bennett, DA; Milne, RJ; Rodgers, A			Treating Individuals 5 - Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk	LANCET			English	Article							CORONARY-HEART-DISEASE; PROSPECTIVELY-DESIGNED OVERVIEWS; SERUM-CHOLESTEROL; PRIMARY PREVENTION; NEW-ZEALAND; OPTIMAL AGE; HEALTH; PREDICTION; MANAGEMENT; EVENTS	In this review, we outline the rationale for targeting blood pressure and blood cholesterol lowering drug treatments to patients at high absolute cardiovascular risk, irrespective of their blood pressure or blood cholesterol levels. Because the specific levels of blood pressure and cholesterol are of little clinical relevance when considered in isolation from other risk factors, terms such as hypertension or hypercholesterolaemia have limited value. Separate management guidelines for raised blood pressure and blood cholesterol need to be replaced by integrated cardiovascular risk management guidelines, and absolute cardiovascular risk prediction scores should be used routinely. Since cardiovascular risk factors interact with each other, moderate reductions in several risk factors can be more effective than major reductions in one. An affordable daily pill combining low doses of various drugs could be useful for the many individuals with slightly abnormal cardiovascular risk factors.	Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Dept Med, Clin Trials Res Unit, Auckland 1, New Zealand	University of Auckland; University of Auckland	Jackson, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Epidemiol & Biostat Sect, POB 92019, Auckland 1, New Zealand.	rt.jackson@auckland.ac.nz	Bennett, Derrick/AAH-1220-2022; Bennett, Derrick/AFL-9254-2022; , Bennett/O-7998-2019	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Jackson, Rod/0000-0001-5914-6934; Rodgers, Anthony/0000-0003-1282-1896				ALDERMAN MH, 1993, ANN INTERN MED, V119, P329, DOI 10.7326/0003-4819-119-4-199308150-00013; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Black N, 2003, BRIT MED J, V326, P2, DOI 10.1136/bmj.326.7379.2; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cruickshank J, 2001, LANCET, V358, P1994, DOI 10.1016/S0140-6736(01)06981-1; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Friedmann PD, 1996, ANN INTERN MED, V124, P414, DOI 10.7326/0003-4819-124-4-199602150-00005; Gold MR, 1996, COST EFFECTIVENESS H; Hall LML, 2003, BRIT MED J, V326, P251, DOI 10.1136/bmj.326.7383.251; Hawthorne V, 2002, HEART, V88, P222; IRWIG L, 1991, JAMA-J AM MED ASSOC, V266, P1678, DOI 10.1001/jama.266.12.1678; Isles CG, 2000, BMJ-BRIT MED J, V320, P690, DOI 10.1136/bmj.320.7236.690; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Jones DW, 2003, JAMA-J AM MED ASSOC, V289, P1027, DOI 10.1001/jama.289.8.1027; Kannel W B, 2000, J Atheroscler Thromb, V6, P60; KANNEL WB, 1976, AM J CARDIOL, V37, P269, DOI 10.1016/0002-9149(76)90323-4; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawes Carlene M M, 2002, Semin Vasc Med, V2, P355, DOI 10.1055/s-2002-36765; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lawes CMM, 2004, STROKE, V35, P776, DOI 10.1161/01.STR.0000116869.64771.5A; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lowensteyn I, 1998, PREV MED, V27, P730, DOI 10.1006/pmed.1998.0351; Lundin J, 2003, BRIT MED J, V326, P29, DOI 10.1136/bmj.326.7379.29; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Marshall T, 2000, BMJ-BRIT MED J, V321, P637; Milne Richard, 2003, N Z Med J, V116, pU662; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Norris RM, 1998, BMJ-BRIT MED J, V316, P1065; *NZ GUID GROUP, MAN MILDL RAIS BLOOD; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; RODGERS A, 1997, NEUROL REV INT, V2, P12; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Shepherd J, 1996, LANCET, V348, P1339; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Trewby PN, 2002, CLIN MED, V2, P527, DOI 10.7861/clinmedicine.2-6-527; Turnbull F, 2003, LANCET, V362, P1527; Ulrich S, 2000, BMJ-BRIT MED J, V320, P1134, DOI 10.1136/bmj.320.7242.1134; Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO, 2002, RED RISKS PROM HLTH; Wood D, 2000, BRIT MED J, V320, P705, DOI 10.1136/bmj.320.7236.705; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	63	378	388	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					434	441						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680460				2022-12-24	WOS:000226610900032
J	Shawcross, D; Jalan, R				Shawcross, D; Jalan, R			Dispelling myths in the treatment of hepatic encephalopathy	LANCET			English	Review							PORTAL-SYSTEMIC ENCEPHALOPATHY; BLIND CLINICAL-TRIAL; CEREBRAL-BLOOD-FLOW; ACUTE LIVER-FAILURE; INDUCED HYPERAMMONEMIA; INTERORGAN AMMONIA; BRAIN EDEMA; CIRRHOSIS; LACTULOSE; METABOLISM	Context Guidelines for the treatment of hepatic encephalopathy suggest ammonia reduction as the main focus, based on strategies to reduce ammonia's generation and absorption in the colon by using lactulose and a reduced protein diet. Starting point Two studies provide compelling and provocative data questioning the relevance of these interventions. Bodils Als-Nielsen and colleagues, in a systematic review of randomised trials, found insufficient evidence about whether non-absorbable disaccharides; are beneficial (BMJ 2004; 328: 1046-50). In a small randomised study, Juan Cordoba and colleagues showed that diets with normal protein content can be administered safely during episodic hepatic encephalopathy due to cirrhosis and that protein restriction does not have any beneficial effect during such episodes (J Hepatol 2004; 41: 38-43). Where next Two approaches to new therapies for hepatic encephalopathy are needed. First, it is important to focus on the interorgan metabolism of ammonia. The small intestine and kidneys might be important producers of ammonia, and muscle is an important organ that can remove ammonia. Novel therapies targeting these organs reduce ammonia. Second, research is needed to explore factors other than ammonia that might be important in hepatic encephalopathy, including the synergistic role of inflammation. The lack of conclusive data about the efficacy of any treatment supports the view that placebo-controlled trials of newer agents are needed and ethical. The emphasis should shift to aggressive management of the precipitating event.	UCL, Inst Hepatol, London WC1E 6HX, England	University of London; University College London	Jalan, R (corresponding author), UCL, Inst Hepatol, London WC1E 6HX, England.	r.jalan@ucLac.uk	Shawcross, Debbie Lindsay/H-9669-2012	Shawcross, Debbie Lindsay/0000-0001-6133-4619				Ahl B, 2004, HEPATOLOGY, V40, P73, DOI 10.1002/hep.20290; Als-Nielsen B, 2004, BMJ-BRIT MED J, V328, P1046, DOI 10.1136/bmj.38048.506134.EE; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Balata S, 2003, HEPATOLOGY, V37, P931, DOI 10.1053/jhep.2003.50156; BIRCHER J, 1966, LANCET, V1, P890; CONN HO, 1977, GASTROENTEROLOGY, V72, P573; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; Cordoba J, 2001, J HEPATOL, V35, P598, DOI 10.1016/S0168-8278(01)00181-7; Damink SWMO, 2003, HEPATOLOGY, V37, P1277, DOI 10.1053/jhep.2003.50221; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; Delcker AM, 2000, HEPATOLOGY, V32, p310A; ELKINGTON SG, 1969, NEW ENGL J MED, V281, P408, DOI 10.1056/NEJM196908212810803; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; GERMAIN L, 1973, ARCH FR MAL APP DIG, V62, P293; Jalan R, 2004, CLIN SCI, V106, P467, DOI 10.1042/CS20030357; Jalan R, 2003, METAB BRAIN DIS, V18, P37, DOI 10.1023/A:1021978618745; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Kircheis G, 1997, HEPATOLOGY, V25, P1351, DOI 10.1002/hep.510250609; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Master S, 1999, HEPATOLOGY, V30, P876, DOI 10.1002/hep.510300428; MULLEN KD, 1991, SEMIN LIVER DIS, V11, P292, DOI 10.1055/s-2008-1040447; NANCE FC, 1974, GASTROENTEROLOGY, V66, P108; RODGERS JB, 1973, AM J GASTROENTEROL, V60, P459; Romero-Gomez M, 2004, J HEPATOL, V41, P49, DOI 10.1016/j.jhep.2004.03.021; Rose C, 1999, HEPATOLOGY, V30, P636, DOI 10.1002/hep.510300311; Sen S, 2004, LIVER TRANSPLANT, V10, P1109, DOI 10.1002/lt.20236; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; SIMMONS F, 1970, GASTROENTEROLOGY, V59, P827; WEBER FL, 1979, GASTROENTEROLOGY, V77, P235; WOLPERT E, 1970, NEW ENGL J MED, V283, P159, DOI 10.1056/NEJM197007232830401	32	75	85	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					431	433						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680459	Green Submitted			2022-12-24	WOS:000226610900031
J	Scott, T; Stanford, N; Thompson, DR				Scott, T; Stanford, N; Thompson, DR			Killing me softly: myth in pharmaceutical advertising	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERTISEMENTS		Univ St Andrews, Sch Management, St Andrews KY16 9AJ, Fife, Scotland; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Chinese Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of St Andrews; University of York - UK; Chinese University of Hong Kong	Scott, T (corresponding author), Univ St Andrews, Sch Management, St Andrews KY16 9AJ, Fife, Scotland.	jts1@st-andrews.ac.uk	Thompson, David R/E-2431-2018; Thompson, David R/C-6320-2009	Thompson, David R/0000-0001-8518-6307; 				Barthes Roland, 1993, MYTHOLOGIES; Baudrillard Jean., 1970, SOC CONSOMMATION; Derrida Jacques., 1981, DISSEMINATION; FARRELL L, 2000, BRIT MED J, V321, P578; GOLDMAN R, 1986, SOC SCI MED, V22, P1047, DOI 10.1016/0277-9536(86)90205-4; HUTCHEON L, 1987, QUEENS QUART, V94, P904; LANDGREN FT, 1988, MED J AUSTRALIA, V149, P595, DOI 10.5694/j.1326-5377.1988.tb120797.x; LEXCHIN J, DRUG PROMOTION DATAB; Mansfield P R, 1991, Int J Risk Saf Med, V2, P171, DOI 10.3233/JRS-1991-2401; Mansfield PR, 2003, MED J AUSTRALIA, V179, P644, DOI 10.5694/j.1326-5377.2003.tb05730.x; MANSFIELD PR, 2003, HLTH SKEPTICISM INT, V1, P10; Morgan S, 2000, HEALTH ECON, V9, P659, DOI 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0; Saussure F. de., 1983, COURSE GEN LINGUISTI; SCOTT DK, 1994, BRIT J CLIN PHARMACO, V37, P217, DOI 10.1111/j.1365-2125.1994.tb04265.x; Sontag S, 2002, ILLNESS METAPHOR AID; STIMSON GV, 1975, J COMMUN, V25, P153, DOI 10.1111/j.1460-2466.1975.tb00618.x; Sutherland Max, 1993, ADVERTISING MIND CON; WADE VA, 1989, LANCET, V2, P1261; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912	19	15	17	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1484	1487		10.1136/bmj.329.7480.1484	http://dx.doi.org/10.1136/bmj.329.7480.1484			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604192	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225965800035
J	Zambon, MC				Zambon, MC			Ethics versus evidence in influenza vaccination	LANCET			English	Editorial Material									Hlth Protect Agcy Ctr Infect, Virus Reference Lab, London NW9 5HT, England	Health Protection Agency	Zambon, MC (corresponding author), Hlth Protect Agcy Ctr Infect, Virus Reference Lab, London NW9 5HT, England.	maria.zambon@hpa.org.uk						*CDCP, 2004, INT EST POP TARG INF; DONALDSON L, 2004, UPDATE INFLUENZA PNE; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Fleming D M, 2000, Commun Dis Public Health, V3, P32; GIBBENS A, 1999, REITH LECT, V2; HARRIS G, 2004, NY TIMES        1028, P18; IRISH C, 1998, HLTH TRENDS, V30, P51; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Harper Scott A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P1670, DOI 10.1001/jama.292.14.1670; PIEDRA PA, 2004, VACCINE         1102; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SAINSBURY J, 2001, PLC ARCH FARE SHARES; Stephenson I, 2002, Commun Dis Public Health, V5, P247; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; WILSON LE, 2004, EUR VIR C MADR SEP; 2001, MMWR MORBID MORTAL W, V50, P582	19	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2161	2163		10.1016/S0140-6736(04)17608-3	http://dx.doi.org/10.1016/S0140-6736(04)17608-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610788				2022-12-24	WOS:000225799700008
J	Li, Z; Okamoto, K; Hayashi, Y; Sheng, M				Li, Z; Okamoto, K; Hayashi, Y; Sheng, M			The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses	CELL			English	Article							FLUORESCENT PROTEIN; MORPHOLOGY; OPA1; ORGANIZATION; INHERITANCE; PARKINSONS; MECHANISMS; MACHINERY; TRANSPORT; DYNAMICS	The proper intracellular distribution of mitochondria is assumed to be critical for normal physiology of neuronal cells, but direct evidence for this idea is lacking. Extension or movement of mitochondria into dendritic protrusions correlates with the development and morphological plasticity of spines. Molecular manipulations of dynamin-like GTPases Drp1 and OPA1 that reduce dendritic mitochondria content lead to loss of synapses and dendritic spines, whereas increasing dendritic mitochondrial content or mitochondrial activity enhances the number and plasticity of spines and synapses. Thus, the dendritic distribution of mitochondria is essential and limiting for the support of synapses. Reciprocally, synaptic activity modulates the motility and fusion/fission balance of mitochondria and controls mitochondrial distribution in dendrites.	MIT, Picower Ctr Learning & Memory, RIKEN, Ctr Res Neurosci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sheng, M (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN, Ctr Res Neurosci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Okamoto, Kenichi/E-4582-2013; Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019; Li, Zheng/I-8016-2014	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Li, Zheng/0000-0002-2978-2531; Okamoto, Kenichi/0000-0001-9527-2444	NINDS NIH HHS [F32-NS046126] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046126] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; CAMERON HA, 1991, SYNAPSE, V8, P107, DOI 10.1002/syn.890080205; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; MORRIS RL, 1993, J CELL SCI, V104, P917; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Overly CC, 1996, J CELL SCI, V109, P971; Perkins GA, 2001, J NEUROSCI RES, V66, P857, DOI 10.1002/jnr.10050; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rintoul GL, 2003, J NEUROSCI, V23, P7881; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rowland KC, 2000, J NEUROSCI, V20, P9135; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Walsh B, 2001, J PHYSIOL-LONDON, V537, P971; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yoon Y, 2001, CURR BIOL, V11, pR67, DOI 10.1016/S0960-9822(01)00011-2	38	1060	1083	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					873	887		10.1016/j.cell.2004.11.003	http://dx.doi.org/10.1016/j.cell.2004.11.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607982	Bronze			2022-12-24	WOS:000225907200016
J	Moura, ACD; Lee, PC				Moura, ACD; Lee, PC			Capuchin stone tool use in Caatinga dry forest	SCIENCE			English	Article							MONKEYS		Univ Cambridge Darwin Coll, Cambridge CB3 9EU, England; Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England	University of Cambridge; University of Cambridge	Moura, ACD (corresponding author), Univ Cambridge Darwin Coll, Silver St, Cambridge CB3 9EU, England.	acdam2@cam.ac.uk	Moura, Antonio/V-6323-2017	Moura, Antonio/0000-0002-7225-2245; Lee, Phyllis/0000-0002-4296-3513				FRAGASZY D, IN PRESS AM J PRIMAT; Langguth Alfredo, 1997, Neotropical Primates, V5, P77; Lanjouw A, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P52, DOI 10.1017/CBO9780511606397.006; Moura ACdeA, 2004, THESIS U CAMBRIDGE; Ottoni EB, 2001, INT J PRIMATOL, V22, P347, DOI 10.1023/A:1010747426841; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Reis AC, 1976, AN ACAD BRAS CIENC, V48, P325; VISALBERGHI E, 1987, FOLIA PRIMATOL, V49, P168, DOI 10.1159/000156320; WESTERGAARD GC, 1995, J ANTHROPOL RES, V51, P1; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	10	157	163	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1909	1909		10.1126/science.1102558	http://dx.doi.org/10.1126/science.1102558			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591195				2022-12-24	WOS:000225695600035
J	Videler, JJ; Stamhuis, EJ; Povel, GDE				Videler, JJ; Stamhuis, EJ; Povel, GDE			Leading-edge vortex lifts swifts	SCIENCE			English	Article							PARTICLE IMAGE VELOCIMETRY; INSECT FLIGHT; WIND-TUNNEL; SPEEDS	The current understanding of how birds fly must be revised, because birds use their hand-wings in an unconventional way to generate lift and drag. Physical models of a common swift wing in gliding posture with a 60degrees sweep of the sharp hand-wing leading edge were tested in a water tunnel. Interactions with the flow were measured quantitatively with digital particle image velocimetry at Reynolds numbers realistic for the gliding flight of a swift between 3750 and 37,500. The results show that gliding swifts can generate stable leading-edge vortices at small (5degrees to 10degrees) angles of attack. We suggest that the flow around the arm-wings of most birds can remain conventionally attached, whereas the swept-back hand-wings generate lift with leading-edge vortices.	Univ Groningen, Dept Marine Biol, Expt Marine Zool Grp, NL-9750 AA Haren, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC	Videler, JJ (corresponding author), Univ Groningen, Dept Marine Biol, Expt Marine Zool Grp, POB 14, NL-9750 AA Haren, Netherlands.	j.j.videler@biol.rug.nl	tay, wee beng/B-1095-2010	Videler, John/0000-0003-1226-9528				Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; LOWSON MV, 1995, J AIRCRAFT, V32, P832, DOI 10.2514/3.46798; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P509; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Stamhuis EJ, 2002, EXP FLUIDS, V33, P801, DOI [10.1007/s00348-002-0520-x, 10.1007/s00348-002-0520-X]; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283	9	106	112	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1960	1962		10.1126/science.1104682	http://dx.doi.org/10.1126/science.1104682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591209				2022-12-24	WOS:000225695600052
J	Krylova, IN; Sablin, EP; Moore, J; Xu, RX; Waitt, GM; MacKay, JA; Juzumiene, D; Bynum, JM; Madauss, K; Montana, V; Lebedeva, L; Suzawa, M; Williams, JD; Williams, SP; Guy, RK; Thornton, JW; Fletterick, RJ; Willson, TM; Ingraham, HA				Krylova, IN; Sablin, EP; Moore, J; Xu, RX; Waitt, GM; MacKay, JA; Juzumiene, D; Bynum, JM; Madauss, K; Montana, V; Lebedeva, L; Suzawa, M; Williams, JD; Williams, SP; Guy, RK; Thornton, JW; Fletterick, RJ; Willson, TM; Ingraham, HA			Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1	CELL			English	Article							STEROIDOGENIC FACTOR-I; NUCLEAR-RECEPTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; TRANSFER PROTEIN; ACTIVATION; TRANSCRIPTION; CHOLESTEROL; INFERENCE; FACTOR-1	Vertebrate members of the nuclear receptor NR5A subfamily, which includes steroidogenic factor 1 (SF-1) and liver receptor homolog 1 (LRH-1), regulate crucial aspects of development, endocrine homeostasis, and metabolism. Mouse LRH-1 is believed to be a ligand-independent transcription factor with a large and empty hydrophobic pocket. Here we present structural and biochemical data for three other NR5A members-mouse and human SF-1 and human LRH-1-which reveal that these receptors bind phosphatidyl inositol second messengers and that ligand binding is required for maximal activity. Evolutionary analysis of structure-function relationships across the SF-1/LRH-1 subfamily indicates that ligand binding is the ancestral state of NR5A receptors and was uniquely diminished or altered in the rodent LRH-1 lineage. We propose that phospholipids regulate gene expression by directly binding to NR5A nuclear receptors.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Bioengn, San Francisco, CA 94143 USA; GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA; Univ Oregon, Ctr Ecol & Evolut Biol, Eugene, OR 97403 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; GlaxoSmithKline; University of Oregon	Ingraham, HA (corresponding author), Univ Calif San Francisco, Dept Physiol, 1550 4th St,Miss Bay Campus, San Francisco, CA 94143 USA.	hollyi@itsa.ucsf.edu	Thornton, Joseph/GSN-4190-2022; feinstein, doug/M-9414-2019; Guy, Rodney/J-7107-2013	Guy, Rodney/0000-0002-9638-2060; Williams, Shawn/0000-0001-8311-2638	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058080, R01DK072246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM070792] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058080-05, R01 DK072246, R01 DK058080] Funding Source: Medline; NIGMS NIH HHS [1R21-GM70792-1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacqueville D, 2001, J BIOL CHEM, V276, P22170, DOI 10.1074/jbc.M011572200; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bland ML, 2000, P NATL ACAD SCI USA, V97, P14488, DOI 10.1073/pnas.97.26.14488; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Christenson LK, 1998, J BIOL CHEM, V273, P30729, DOI 10.1074/jbc.273.46.30729; DARIMONT BD, 1998, GENE DEV, V273, P30729; DEFIGUEIREDO BC, 2004, J CLIN ENDOCR METAB, V10, P2004; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Delerive P, 2004, MOL ENDOCRINOL, V18, P2378, DOI 10.1210/me.2004-0132; Desclozeaux M, 2002, MOL CELL BIOL, V22, P7193, DOI 10.1128/MCB.22.20.7193-7203.2002; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Escriva H, 2000, BIOESSAYS, V22, P717; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Hsuan J, 2001, GENOME BIOL, V2; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; IRVINE RF, 2002, SCI STKE; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Ledeen RW, 2004, J LIPID RES, V45, P1, DOI 10.1194/jlr.R300015-JLR200; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ludbrook LM, 2004, TRENDS ENDOCRIN MET, V15, P116, DOI 10.1016/j.tem.2004.02.002; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Madauss K, 2004, ENDOCR RES, V30, P775, DOI 10.1081/ERC-200044038; Martelli AM, 2003, J CELL BIOCHEM, V88, P455, DOI 10.1002/jcb.10379; Mellon SH, 1998, ENDOCRINOLOGY, V139, P3026, DOI 10.1210/en.139.6.3026; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2000, SYST BIOL, V49, P183, DOI 10.1093/sysbio/49.2.183; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; YANG ZH, 1995, GENETICS, V141, P1641; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	50	319	339	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					343	355		10.1016/j.cell.2005.01.024	http://dx.doi.org/10.1016/j.cell.2005.01.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707893	Bronze			2022-12-24	WOS:000227028900010
J	Hill, WG				Hill, WG			A century of corn selection	SCIENCE			English	Editorial Material							ARTIFICIAL SELECTION; BODY-WEIGHT; TRAITS		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Hill, WG (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	w.g.hill@ed.ac.uk						ANDERSSON L, COMMUNICATION; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HILL WG, 1982, GENET RES, V40, P255, DOI 10.1017/S0016672300019145; Janick J, 2003, PLANT BREEDING REV 1, V24; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; LYNCH M, 1998, INTRO QUANTITATIVE G; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Walsh B., 2004, Plant Breeding Reviews, V24, P177	13	38	45	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					683	684		10.1126/science.1105459	http://dx.doi.org/10.1126/science.1105459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692038				2022-12-24	WOS:000226814900028
J	Kim, C; Xuong, NH; Taylor, SS				Kim, C; Xuong, NH; Taylor, SS			Crystal structure of a complex between the catalytic and regulatory (RI alpha) subunits of PKA	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CAMP-BINDING DOMAINS; AMIDE H/H-2 EXCHANGE; PHOSPHORYLASE-KINASE; MOLECULAR-BASIS; SITES; MONOPHOSPHATE; MECHANISM; CLASSIFICATION; RESOLUTION	The 2.0-angstrom structure of the cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) catalytic subunit bound to a deletion mutant of a regulatory subunit (Rlalpha) defines a previously unidentified extended interface. The complex provides a molecular mechanism for inhibition of PKA and suggests how CAMP binding leads to activation. The interface defines the large lobe of the catalytic subunit as a stable scaffold where Tyr(247) in the G helix and Trp(196) in the phosphorylated activation loop serve as anchor points for binding Rlalpha. These residues compete with CAMP for the phosphate binding cassette in Rlalpha. In contrast to the catalytic subunit, Rlalpha undergoes major conformational changes when the complex is compared with CAMP-bound Rlalpha. The inhibitor sequence docks to the active site, whereas the linker, also disordered in free Rlalpha, folds across the extended interface. The beta barrel of CAMP binding domain A, which is the docking site for CAMP, remains largely intact in the complex, whereas the helical subdomain undergoes major reorganization.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys & Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NIDDK NIH HHS [DK07233] Funding Source: Medline; NIGMS NIH HHS [GM19301, GM34921] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM034921, R01GM019301] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*ACC, 2003, INS 2; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Anand GS, 2003, P NATL ACAD SCI USA, V100, P13264, DOI 10.1073/pnas.2232255100; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; Gibson RM, 1997, J BIOL CHEM, V272, P31998, DOI 10.1074/jbc.272.51.31998; GILL GN, 1971, P NATL ACAD SCI USA, V68, P786, DOI 10.1073/pnas.68.4.786; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hauer JA, 1999, PROTEIN SCI, V8, P545; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IYER G, IN PRESS J BIOL CHEM; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kim C., UNPUB; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAW D, UNPUB; LEON DA, 1991, BIOCHEMISTRY-US, V30, P3035, DOI 10.1021/bi00226a008; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nayal M, 1999, PROTEIN SCI, V8, P676; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OGREID D, 1981, FEBS LETT, V129, P287, DOI 10.1016/0014-5793(81)80185-8; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Stevenson LM, 2002, BIOCHEMISTRY-US, V41, P8528, DOI 10.1021/bi025812h; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Venien-Bryan C, 2002, STRUCTURE, V10, P33, DOI 10.1016/S0969-2126(01)00691-8; Walsh D.A., 2018, PEPT PROT PHOSPH, P43; WALSH DA, 1968, J BIOL CHEM, V243, P3763; YANG SMG, 2004, J MOL BIOL; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	50	274	281	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					690	696		10.1126/science.1104607	http://dx.doi.org/10.1126/science.1104607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692043				2022-12-24	WOS:000226814900033
J	Nakagawa, T; Cheng, YF; Ramm, E; Sheng, M; Walz, T				Nakagawa, T; Cheng, YF; Ramm, E; Sheng, M; Walz, T			Structure and different conformational states of native AMPA receptor complexes	NATURE			English	Article							LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; ION-CHANNEL; KAINATE; DOMAIN; SELECTIVITY; MECHANISMS; TOPOLOGY; SYMMETRY; NEURONS	Ionotropic glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system(1,2). Their modulation is believed to affect learning and memory, and their dysfunction has been implicated in the pathogenesis of neurological and psychiatric diseases(1,2). Despite a wealth of functional data, little is known about the intact, three-dimensional structure of these ligand-gated ion channels. Here, we present the structure of native AMPA receptors (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; AMPA-Rs) purified from rat brain, as determined by single-particle electron microscopy. Unlike the homotetrameric recombinant GluR2 (ref. 3), the native heterotetrameric AMPA-R adopted various conformations, which reflect primarily a variable separation of the two dimeric extracellular amino-terminal domains. Members of the stargazin/ TARP family of transmembrane proteins co-purified with AMPA-Rs and contributed to the density representing the transmembrane region of the complex. Glutamate and cyclothiazide markedly altered the conformational equilibrium of the channel complex, suggesting that desensitization is related to separation of the N-terminal domains. These data provide a glimpse of the conformational changes of an important ligand-gated ion channel of the brain.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu; twalz@hms.harvard.edu		Cheng, Yifan/0000-0001-9535-0369; Walz, Thomas/0000-0003-2606-2835; Sheng, Morgan/0000-0002-8703-5366				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RANK J, 1996, 3 DIMENSIONAL ELECT; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	30	211	217	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					545	549		10.1038/nature03328	http://dx.doi.org/10.1038/nature03328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690046				2022-12-24	WOS:000226727200054
J	Yeo, M; Lee, SK; Lee, B; Ruiz, EC; Pfaff, SL; Gill, GN				Yeo, M; Lee, SK; Lee, B; Ruiz, EC; Pfaff, SL; Gill, GN			Small CTD phosphatases function in silencing neuronal gene expression	SCIENCE			English	Article							TARGET GENES; TRANSCRIPTIONAL REPRESSION; DEACETYLASE COMPLEX; HISTONE H3; LYSINE 9; PROTEIN; DIFFERENTIATION; IDENTIFICATION; DOMAIN	Neuronal gene transcription is repressed in non-neuronal cells by the repressor element 1 (RE-1)-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) complex. To understand how this silencing is achieved, we examined a family of class-C RNA polymerase II (RNAPII) carboxyl-terminal domain (CTD) phosphatases [small CTD phosphatases (SCPs) 1 to 3], whose expression is restricted to non-neuronal tissues. We show that REST/NRSF recruits SCPs to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells. Phosphatase-inactive forms of SCP interfere with REST/NRSF function and promote neuronal. differentiation of P19 stem cells. Likewise, small interfering RNA directed to the single Drosophila SCP unmasks neuronal gene expression in S2 cells. Thus, SCP activity is an evolutionarily conserved transcriptional regulator that acts globally to silence neuronal genes.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Gill, GN (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ggill@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013149, R37DK013149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116, R37NS037116] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK13149] Funding Source: Medline; NINDS NIH HHS [NS37116] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zohn IE, 2001, DEV BIOL, V239, P118, DOI 10.1006/dbio.2001.0420	23	170	184	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					596	600		10.1126/science.1100801	http://dx.doi.org/10.1126/science.1100801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681389				2022-12-24	WOS:000226694000052
J	Xing, HY; Wilkerson, DC; Mayhew, CN; Lubert, EJ; Skaggs, HS; Goodson, ML; Hong, YL; Park-Sarge, OK; Sarge, KD				Xing, HY; Wilkerson, DC; Mayhew, CN; Lubert, EJ; Skaggs, HS; Goodson, ML; Hong, YL; Park-Sarge, OK; Sarge, KD			Mechanism of hsp70i gene bookmarking	SCIENCE			English	Article							CHROMOSOME CONDENSATION; TRANSCRIPTION FACTORS; ACTIVATION; COMPLEXES; PROMOTER; PROTEIN; PHOSPHORYLATION	In contrast to most genomic DNA in mitotic cells, the promoter regions of some genes, such as the stress-inducible hsp70i gene that codes for a heat shock protein, remain uncompacted, a phenomenon called bookmarking. Here we show that hsp70i bookmarking is mediated by a transcription factor called HSF2, which binds this promoter in mitotic cells, recruits protein phosphatase 2A, and interacts with the CAP-G subunit of the condensin enzyme to promote efficient dephosphorylation and inactivation of condensin complexes in the vicinity, thereby preventing compaction at this site. Blocking HSF2-mediated bookmarking by HSF2 RNA interference decreases hsp70i induction and survival of stressed cells in the G, phase, which demonstrates the biological importance of gene bookmarking.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA; Univ Cincinnati, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Battelle Mem Inst, Columbus, OH 43201 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	University of Kentucky; University of Kentucky; University System of Ohio; University of Cincinnati; Battelle Memorial Institute; University of California System; University of California Davis	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	kdsarge@uky.edu	Goodson, Michael L/G-4175-2010; Mayhew, Christopher N/AGB-4929-2022	Goodson, Michael/0000-0002-3464-490X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041609, R01HD036879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36879, HD41609] Funding Source: Medline; NIGMS NIH HHS [GM64606, GM61053] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Deroo BJ, 2001, MOL BIOL CELL, V12, P3365, DOI 10.1091/mbc.12.11.3365; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hirano T, 2004, CELL CYCLE, V3, P26; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hong YL, 1999, J BIOL CHEM, V274, P12967, DOI 10.1074/jbc.274.19.12967; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Li TH, 2000, NUCLEIC ACIDS RES, V28, P3031, DOI 10.1093/nar/28.16.3031; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Morano KA, 1999, GENE EXPRESSION, V7, P271; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; Strunnikov Alexander V, 2003, Prog Cell Cycle Res, V5, P361; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Wang TY, 2002, J IMMUNOL, V169, P795, DOI 10.4049/jimmunol.169.2.795; Yokomori K, 2003, CURR TOP MICROBIOL, V274, P79	25	127	131	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					421	423		10.1126/science.1106478	http://dx.doi.org/10.1126/science.1106478			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662014				2022-12-24	WOS:000226492300046
J	Berwick, DM				Berwick, DM			My right knee	ANNALS OF INTERNAL MEDICINE			English	Article							REGIONAL-VARIATIONS; CARE	Despite some impressive recent gains, improving the glaring deficiencies in health care quality is proving to be very hard. Improvement is local, rather than system-wide, and is sustained with difficulty, rather than becoming an intrinsic feature of care. My right knee will probably need to be replaced soon. This has given me the opportunity to define, in very personal terms, 5 specific dimensions of "total quality" that I will require from the medical institution that does my surgery and that every patient has the right to require of their encounters with the health care system. Don't kill me (no needless deaths). Do help me, and don't hurt me (no needless pain). Don't make me feel helpless. Don't keep me waiting. And don't waste resources, mine or anyone else's. Given my requirements, it is not clear that any health care institution in the United States will want to take me on as a patient. Although at this point individual institutions can meet some of these requirements, no single institution can deliver on all of them. Generating the energy, insight, and courage we need to get to "total quality" may require those of us who work in health care to get much better at seeing images of ourselves in the people we help. As Gandhi said, "You must be the change you wish to see in the world."	Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dberwick@ihi.org						Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; *I HLTH CAR IMPR, PRIM CAR ACC; Institute of Medicine, 2001, CROSSING QUALITY CHA; JULIUSSON R, 1984, ARCH ORTHOP TRAUM SU, V103, P42, DOI 10.1007/BF00451317; McManus ML, 2003, ANESTHESIOLOGY, V98, P1491, DOI 10.1097/00000542-200306000-00029; *PA HLTH CAR COST, 1999, TOT HIP KNEE REPL SU; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; *SWED BOARD HLTH, NAT REG KNEE INJ; Wennberg J. E., 1998, DARTMOUTH ATLAS HLTH; *WI COLL HEALTHC Q, 2003, PERF PROGR REP	12	19	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2005	142	2					121	125		10.7326/0003-4819-142-2-200501180-00011	http://dx.doi.org/10.7326/0003-4819-142-2-200501180-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915LQ	15657160				2022-12-24	WOS:000228306100006
J	Zeman, A				Zeman, A			Tales from the temporal lobe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORIGIN		Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Zeman, A (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.			Zeman, Adam/0000-0003-4875-658X				BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; Blanke O, 2004, BRAIN, V127, P719; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; JACKSON JH, 1880, BRAIN, V3, P206; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	6	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					119	121		10.1056/NEJMp048219	http://dx.doi.org/10.1056/NEJMp048219			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647573				2022-12-24	WOS:000226251700003
J	Indjeian, VB; Stern, BM; Murray, AW				Indjeian, VB; Stern, BM; Murray, AW			The centromeric protein Sgo1 is required to sense lack of tension on mitotic chromosomes	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID COHESION; BUDDING YEAST; AURORA-B; KINETOCHORES; ANAPHASE; MEIOSIS; ACTIVATE; MEI-S332; REVEALS	,Chromosome alignment on the mitotic spindle is monitored by the. spindle checkpoint. We identify Sgo1, a protein involved in meiotic chromosome cohesion, as spindle checkpoint component. Budding yeast cells with mutations in SGO1 respond normally to microtubule depolymerization but not to lack of tension at-the kinetochore, and they have difficulty attaching sister chromatids to opposite boles of the spindle. Sgo1 is thus required for sensing tension between sister chromatids during mitosis, and its degradation when they separate may prevent, cell cycle arrest and chromosome loss in anaphase, a time when sister chromatids are no longer under tension.	Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murray, AW (corresponding author), Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043987, R37GM043987] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM043987, GM043987] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; INDJEIAN VB, UNPUB; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; KERREBROCK AW, 1992, GENETICS, V130, P827; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PALFRAMAN W, UNPUB; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; STERN BM, UNPUB; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Wells WAE, 1996, J CELL BIOL, V133, P75, DOI 10.1083/jcb.133.1.75; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	29	145	152	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					130	133		10.1126/science.1101366	http://dx.doi.org/10.1126/science.1101366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637284				2022-12-24	WOS:000226214300055
J	Rothstein, JD; Patel, S; Regan, MR; Haenggeli, C; Huang, YH; Bergles, DE; Jin, L; Hoberg, MD; Vidensky, S; Chung, DS; Toan, SV; Bruijn, LI; Su, ZZ; Gupta, P; Fisher, PB				Rothstein, JD; Patel, S; Regan, MR; Haenggeli, C; Huang, YH; Bergles, DE; Jin, L; Hoberg, MD; Vidensky, S; Chung, DS; Toan, SV; Bruijn, LI; Su, ZZ; Gupta, P; Fisher, PB			beta-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; PROLONGS SURVIVAL; MOTOR-NEURONS; RAT-BRAIN; MODEL; ALS; GLT-1; EAAT2; MICE	Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS)(3), stroke(4), brain tumours(5) and epilepsy(6). Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene(7). beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways(8). When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity(1,9- 11). Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity(11). When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.	Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA; ALS Assoc, Palm Harbor, FL 34685 USA; Columbia Univ Coll Phys & Surg, Med Ctr, Dept Pathol Neurosurg & Urol, New York, NY 10032 USA	Johns Hopkins University; Johns Hopkins University; Columbia University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA.	jrothste@jhmi.edu	Bergles, Dwight/U-8343-2019; rothstein, jeffrey d/C-9470-2013; Huang, Yanhua/P-1583-2015	Bergles, Dwight/0000-0002-7133-7378; Huang, Yanhua/0000-0003-1770-0196				Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Canton T, 2001, J PHARMACOL EXP THER, V299, P314; CHANDRASEKAR PH, 1984, J ANTIMICROB CHEMOTH, V14, P427, DOI 10.1093/jac/14.4.427; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; KAZRAGIS R, 1996, ANTIMICROB AGENTS CH, V38, P2632; NAU R, 1993, ANTIMICROB AGENTS CH, V37, P1518, DOI 10.1128/AAC.37.7.1518; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Romera C, 2004, J NEUROSCI, V24, P1350, DOI 10.1523/JNEUROSCI.1596-03.2004; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Spalloni A, 2004, NEUROBIOL DIS, V15, P340, DOI 10.1016/j.nbd.2003.11.012; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999	26	1156	1239	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					73	77		10.1038/nature03180	http://dx.doi.org/10.1038/nature03180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635412				2022-12-24	WOS:000226117100038
J	Kittler, R; Putz, G; Pelletier, L; Poser, I; Heninger, AK; Drechsel, D; Fischer, S; Konstantinova, I; Habermann, B; Grabner, H; Yaspo, ML; Himmelbauer, H; Korn, B; Neugebauer, K; Pisabarro, MT; Buchholz, F				Kittler, R; Putz, G; Pelletier, L; Poser, I; Heninger, AK; Drechsel, D; Fischer, S; Konstantinova, I; Habermann, B; Grabner, H; Yaspo, ML; Himmelbauer, H; Korn, B; Neugebauer, K; Pisabarro, MT; Buchholz, F			An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division	NATURE			English	Article							SMALL INTERFERING RNAS; FUNCTIONAL GENOMIC ANALYSIS; CULTURED-MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; SPINDLE FORMATION; EXPRESSION; COMPONENTS; DUPLEXES; CYCLE	RNA interference (RNAi) is an evolutionarily conserved defence mechanism whereby genes are specifically silenced through degradation of messenger RNAs; this process is mediated by homologous double-stranded (ds) RNA molecules(1-4). In invertebrates, long dsRNAs have been used for genome-wide screens and have provided insights into gene functions(5-8). Because long dsRNA triggers a nonspecific interferon response in many vertebrates, short interfering ( si) RNA or short hairpin (sh) RNAs must be used for these organisms to ensure specific gene silencing(9-11). Here we report the generation of a genome-scale library of endoribonuclease-prepared short interfering (esi) RNAs12 from a sequence-verified complementary DNA collection representing 15,497 human genes. We used 5,305 esiRNAs from this library to screen for genes required for cell division in HeLa cells. Using a primary high-throughput cell viability screen followed by a secondary high content videomicroscopy assay, we identified 37 genes required for cell division. These include several splicing factors for which knockdown generates mitotic spindle defects. In addition, a putative nuclear-export terminator was found to speed up cell proliferation and mitotic progression after knockdown. Thus, our study uncovers new aspects of cell division and establishes esiRNA as a versatile approach for genomic RNAi screens in mammalian cells.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Scion Comp Innovat GmbH, D-01307 Dresden, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; RZPD Ressourcenzentrum Genomforsch, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Pisabarro, M. Teresa/D-4270-2012; Buchholz, Frank/B-4700-2017; Kittler, Ralf/I-4662-2013; Habermann, Bianca/N-4886-2016; Kittler, Ralf/AAD-4258-2020; Pelletier, Laurence/F-8858-2013	Buchholz, Frank/0000-0002-4577-3344; Kittler, Ralf/0000-0002-0098-6792; Habermann, Bianca/0000-0002-2457-7504; Kittler, Ralf/0000-0002-0098-6792; Himmelbauer, Heinz/0000-0001-8897-2928; Heninger, Anne-Kristin/0000-0003-3151-826X				Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Biggins S, 2001, GENETICS, V159, P453; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Harborth J, 2001, J CELL SCI, V114, P4557; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Liebel U, 2004, BIOINFORMATICS, V20, P1962, DOI 10.1093/bioinformatics/bth146; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	30	322	343	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1036	1040		10.1038/nature03159	http://dx.doi.org/10.1038/nature03159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616564				2022-12-24	WOS:000225887000044
J	Baxendale, S				Baxendale, S			Memories aren't made of this: amnesia at the movies	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Baxendale, S (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, Box 37, London WC1N 3BG, England.	sallieb@ion.ucl.ac.uk	Baxendale, Sallie/AAN-8312-2020	Baxendale, Sallie/0000-0002-9930-6469					0	33	33	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1480	1483		10.1136/bmj.329.7480.1480	http://dx.doi.org/10.1136/bmj.329.7480.1480			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604191	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225965800034
J	Maruenda, FB				Maruenda, FB			Can the human eye detect an offside position during a football match?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VELOCITY		Ctr Salud Alquerias, Murcia 30580, Spain		Maruenda, FB (corresponding author), Ctr Salud Alquerias, C-R Fernandez Minarro No 1, Murcia 30580, Spain.	fbeldam@meditex.es						ARROYO RO, 1992, TEORIA FUTBOL; BURDE RM, 1988, FISIOLOGIA OJO ADLER, P122; GAVILAN C, 1987, FISIOLOGIA FISIOPATO, P56; GAVILAN J, 1983, ACTA OTO-LARYNGOL, V96, P429, DOI 10.3109/00016488309132729; *INT FOOTB ASS BOA, 2003, LAWS GAM, V24; LEIGH RJ, 1983, NEUROLOGY EYE MOVEME, P39; MOSES RA, 1988, FISIOLOGIA OJO ADLER, P285; PUJOL MM, 1987, FISIOLOGIA FISIOPATO, P43; SCHALEN L, 1984, ACTA OTO-LARYNGOL, P212; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; SHICKMAN GM, 1988, FISIOLOGIA OJO ADLER, P591	11	27	27	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1470	1472		10.1136/bmj.329.7480.1470	http://dx.doi.org/10.1136/bmj.329.7480.1470			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604187	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225965800030
J	Wolfer, DP; Litvin, O; Morf, S; Nitsch, RM; Lipp, HP; Wurbel, H				Wolfer, DP; Litvin, O; Morf, S; Nitsch, RM; Lipp, HP; Wurbel, H			Cage enrichment and-mouse behaviour - Test responses by laboratory mice are unperturbed by more entertaining housing.	NATURE			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; STANDARDIZATION		Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland; Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland; Univ Giessen, Inst Vet Physiol, Anim Welf & Ethol Grp, D-35392 Giessen, Germany	University of Zurich; University of Zurich; Justus Liebig University Giessen	Wolfer, DP (corresponding author), Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland.	hanno.wurbel@vetmed.uni-giessen.de	Würbel, Hanno/D-6281-2012; Wolfer, David P/B-3293-2016	Würbel, Hanno/0000-0002-2934-3010; Wolfer, David P/0000-0002-5957-1401				Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Gartner K., 1999, P INT JOINT M 12 ICL, P207; van der Staay FJ, 2002, GENES BRAIN BEHAV, V1, P9, DOI 10.1046/j.1601-1848.2001.00007.x; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	8	182	186	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					821	822		10.1038/432821a	http://dx.doi.org/10.1038/432821a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602544				2022-12-24	WOS:000225733500035
J	Hiller, NL; Bhattacharjee, S; van Ooij, C; Liolios, K; Harrison, T; Lopez-Estrano, C; Haldar, K				Hiller, NL; Bhattacharjee, S; van Ooij, C; Liolios, K; Harrison, T; Lopez-Estrano, C; Haldar, K			A host-targeting signal in virulence proteins reveals a secretome in malarial infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; TRAFFICKING; CYTOADHERENCE; ANTIGEN; SURFACE	Malaria parasites secrete proteins across the vacuolar membrane into the erythrocyte, inducing modifications linked to disease and parasite survival. We identified an 11-amino acid signal required for the secretion of proteins from the Plasmodium falciparum vacuole to the human erythrocyte, Bioinformatics predicted a secretome of >320 proteins and conservation of the signal across parasite species. Functional studies indicated the predictive value of the signal and its role in targeting virulence proteins to the erythrocyte and implicated its recognition by a receptor/transporter. Erythrocyte modification by the parasite may involve plasmodial heat shock proteins and be vastly more complex than hitherto realized.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Haldar, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	k-haldar@northwestern.edu	Hiller, N. Luisa/A-3739-2016; Estrano, Carlos E./B-3576-2009; Haldar, Kasturi/C-6685-2014	Hiller, N. Luisa/0000-0001-6572-1368; 	NHLBI NIH HHS [HL69630] Funding Source: Medline; NIAID NIH HHS [AI39071] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cheresh P, 2002, J BIOL CHEM, V277, P16265, DOI 10.1074/jbc.M109331200; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kun JFJ, 1997, MOL BIOCHEM PARASIT, V85, P41, DOI 10.1016/S0166-6851(96)02805-8; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; LUSTIGMAN S, 1990, MOL BIOCHEM PARASIT, V38, P261, DOI 10.1016/0166-6851(90)90029-L; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; PERKINS M, 1988, EXP PARASITOL, V65, P61, DOI 10.1016/0014-4894(88)90107-5; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	21	611	637	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1934	1937		10.1126/science.1102737	http://dx.doi.org/10.1126/science.1102737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591203				2022-12-24	WOS:000225695600044
J	Esposito, LW; Colwell, JE; Larsen, K; McClintock, WE; Stewart, AIF; Hallett, JT; Shemansky, DE; Ajello, JM; Hansen, CJ; Hendrix, AR; West, RA; Keller, HU; Korth, A; Pryor, WR; Reulke, R; Yung, YL				Esposito, LW; Colwell, JE; Larsen, K; McClintock, WE; Stewart, AIF; Hallett, JT; Shemansky, DE; Ajello, JM; Hansen, CJ; Hendrix, AR; West, RA; Keller, HU; Korth, A; Pryor, WR; Reulke, R; Yung, YL			Ultraviolet Imaging Spectroscopy shows an active saturnian system	SCIENCE			English	Article							SPACE-TELESCOPE; GAS-DRAG; E-RING; MAGNETOSPHERE; ENCOUNTER; SATELLITE; ACCRETION; EVOLUTION; EMISSION; HYDROGEN	Neutral oxygen in the Saturnian system shows variability, and the total number of oxygen atoms peaks at 4 x 10(34). Saturn's aurora brightens in response to solar-wind forcing, and the auroral spectrum resembles Jupiter's. Phoebe's surface shows variabie water-ice content, and the data indicate it originated in the outer solar system. Saturn's rings also show variable water abundance, with the purest ice in the outermost A ring. This radial variation is consistent with initially pure water ice bombarded by meteors, but smaller radial structures may indicate collisional transport and recent renewal events in the past 10(7) to 10(8) years.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Univ So Calif, Los Angeles, CA 90089 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Cent Arizona Coll, Coolidge, AZ 85228 USA; Univ Stuttgart, Inst Photogrammetry, D-70174 Stuttgart, Germany; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of Colorado System; University of Colorado Boulder; University of Southern California; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Stuttgart; California Institute of Technology	Esposito, LW (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, 234 Innovat Dr, Boulder, CO 80303 USA.	larry.esposito@lasp.colorado.edu	ESPOSITO, LARRY W/AAB-3673-2021; Colwell, Joshua/AAP-2692-2020; Yung, Yuk/AAM-4850-2021	ESPOSITO, LARRY W/0000-0003-3381-2016; Colwell, Joshua/0000-0001-8269-6408; Yung, Yuk/0000-0002-4263-2562				Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; BROADFOOT AL, 1981, SCIENCE, V212, P206, DOI 10.1126/science.212.4491.206; Canup RM, 1996, ICARUS, V119, P427, DOI 10.1006/icar.1996.0028; COLWELL JE, 1993, J GEOPHYS RES-PLANET, V98, P7387, DOI 10.1029/93JE00329; Colwell JE, 2000, J GEOPHYS RES-PLANET, V105, P17589, DOI 10.1029/1999JE001209; Cowley SWH, 2004, ANN GEOPHYS-GERMANY, V22, P1379, DOI 10.5194/angeo-22-1379-2004; Cuk M, 2004, ICARUS, V167, P369, DOI 10.1016/j.icarus.2003.09.026; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; DONES L, 1993, ICARUS, V105, P184, DOI 10.1006/icar.1993.1118; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; ESPOSITO LW, 1986, ICARUS, V67, P345, DOI 10.1016/0019-1035(86)90119-3; ESPOSITO LW, IN PRESS SPACE SCI R; ESPOSITO LW, 2003, M AM GEOPH UN SAN FR; Gerard JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010513; Gurnett DA, 2002, NATURE, V415, P985, DOI 10.1038/415985a; Jonin C, 2000, ASTROPHYS J SUPPL S, V129, P247, DOI 10.1086/313414; Juhasz A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000182; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; McClintock WE, 2000, P SOC PHOTO-OPT INS, V4135, P225, DOI 10.1117/12.494220; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; PRANGE R, IN PRESS NATURE; PRYOR WA, UNPUB; SANDEL BR, 1982, SCIENCE, V215, P548, DOI 10.1126/science.215.4532.548; SHEMANSKY D, 2004, M COMM SPAC RES PAR; SHEMANSKY DE, 1992, J GEOPHYS RES-SPACE, V97, P4143, DOI 10.1029/91JA02805; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; SHEMANSKY DE, UNPUB; SHOWALTER MR, 1991, NATURE, V351, P709, DOI 10.1038/351709a0; Trauger JT, 1998, J GEOPHYS RES-PLANET, V103, P20237, DOI 10.1029/98JE01324; WAGENER R, 1988, ESA SPECIAL PUBLICAT, V1, P85; WAGNER JK, 1987, ICARUS, V69, P14, DOI 10.1016/0019-1035(87)90003-0; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	33	108	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1251	1255		10.1126/science.1105606	http://dx.doi.org/10.1126/science.1105606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15604361				2022-12-24	WOS:000227313200042
J	Kennedy, HJ; Crawford, AC; Fettiplace, R				Kennedy, HJ; Crawford, AC; Fettiplace, R			Force generation by mammalian hair bundles supports a role in cochlear amplification	NATURE			English	Article							GUINEA-PIG COCHLEA; MECHANOELECTRICAL TRANSDUCTION; MECHANICAL AMPLIFICATION; CELL MOTILITY; ADAPTATION; AMPLIFIER; STEREOCILIA; STIFFNESS; RESPONSES; CHANNELS	It is generally accepted that the acute sensitivity and frequency discrimination of mammalian hearing requires active mechanical amplification of the sound stimulus within the cochlea(1). The prevailing hypothesis is that this amplification stems from somatic electromotility of the outer hair cells attributable to the motor protein prestin(2,3). Thus outer hair cells contract and elongate in synchrony with the sound-evoked receptor potential(4,5). But problems arise with this mechanism at high frequencies, where the periodic component of the receptor potential will be attenuated by the membrane time constant. On the basis of work in non-mammalian vertebrates, force generation by the hair bundles has been proposed as an alternative means of boosting the mechanical stimulus(6,7). Here we show that hair bundles of mammalian outer hair cells can also produce force on a submillisecond timescale linked to adaptation of the mechano-transducer channels. Because the bundle motor may ultimately be limited by the deactivation rate of the channels, it could theoretically operate at high frequencies. Our results show the existence of another force generator in outer hair cells that may participate in cochlear amplification.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Bristol, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu						ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1995, SCIENCE, V268, P1420, DOI 10.1126/science.7770765; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Langer MG, 2001, BIOPHYS J, V80, P2608, DOI 10.1016/S0006-3495(01)76231-5; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Preyer S, 1996, AUDIT NEUROSCI, V2, P145; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; STRELIOFF D, 1984, HEARING RES, V15, P19, DOI 10.1016/0378-5955(84)90221-1; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	30	228	239	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					880	883		10.1038/nature03367	http://dx.doi.org/10.1038/nature03367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15696193				2022-12-24	WOS:000227174600046
J	Heikenwalder, M; Zeller, N; Seeger, H; Prinz, M; Klohn, PC; Schwarz, P; Ruddle, NH; Weissmann, C; Aguzzi, A				Heikenwalder, M; Zeller, N; Seeger, H; Prinz, M; Klohn, PC; Schwarz, P; Ruddle, NH; Weissmann, C; Aguzzi, A			Chronic lymphocytic inflammation specifies the organ tropism of prions	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; NONOBESE DIABETIC MICE; LYMPHOID NEOGENESIS; SCRAPIE; LYMPHOTOXIN; PROTEIN; PATHOGENESIS; REPLICATION; EXPRESSION	Prions typically accumulate in nervous and lymphoid tissues. Because proinflammatory cytokines and immune cells are required for lymphoid prion replication, we tested whether inflammatory conditions affect prion pathogenesis. We administered prions to mice with five inflammatory diseases of the kidney, pancreas, or liver. In all cases, chronic lymphocytic inflammation enabled prion accumulation in otherwise prion-free organs. Inflammatory foci consistently correlated with lymphotoxin up-regulation and ectopic induction of FDC-M1(+) cells expressing the normal cellular prion protein PrPc. By contrast, inflamed organs of mice lacking lymphotoxin-alpha or its receptor did not accumulate the abnormal isoform PrPsc, nor did they display infectivity upon prion inoculation. By expanding the tissue distribution of prions, chronic inflammatory conditions may act as modifiers of natural and iatrogenic prion transmission.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of Zurich; University Zurich Hospital; University of London; University College London; Yale University; Yale University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Aguzzi, Adriano/A-3351-2008; Heikenwalder, Mathias/AAA-2269-2020; Kloehn, Peter/AAS-3719-2021	Aguzzi, Adriano/0000-0002-0344-6708	NCI NIH HHS [R01 CA 16885] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016885] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Vernau W, 1997, VET PATHOL, V34, P222, DOI 10.1177/030098589703400307; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103	33	158	161	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1107	1110		10.1126/science.1106460	http://dx.doi.org/10.1126/science.1106460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15661974				2022-12-24	WOS:000227197300048
J	Yanoviak, SP; Dudley, R; Kaspari, M				Yanoviak, SP; Dudley, R; Kaspari, M			Directed aerial descent in canopy ants	NATURE			English	Article							BEHAVIOR; RAIN	Numerous non- flying arboreal vertebrates use controlled descent ( either parachuting or gliding sensu stricto(1,2)) to avoid predation or to locate resources(3 - 7), and directional control during a jump or fall is thought to be an important stage in the evolution of flight(3,8,9). Here we show that workers of the neotropical ant Cephalotes atratus L. ( Hymenoptera: Formicidae) use directed aerial descent to return to their home tree trunk with > 80% success during a fall. Videotaped falls reveal that C. atratus workers descend abdomen- first through steep glide trajectories at relatively high velocities; a field experiment shows that falling ants use visual cues to locate tree trunks before they hit the forest floor. Smaller workers of C. atratus, and smaller species of Cephalotes more generally, regain contact with their associated tree trunk over shorter vertical distances than do larger workers. Surveys of common arboreal ants suggest that directed descent occurs in most species of the tribe Cephalotini and arboreal Pseudomyrmecinae, but not in arboreal ponerimorphs or Dolichoderinae. This is the first study to document the mechanics and ecological relevance of this form of locomotion in the Earth's most diverse lineage, the insects.	Smithsonian Trop Res Inst, Balboa, Panama; Univ Texas, Med Branch, Galveston, TX 77555 USA; Univ Florida, Florida Med Entomol Lab, Vero Beach, FL 32962 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; University of California System; University of California Berkeley; University of Oklahoma System; University of Oklahoma - Norman	Kaspari, M (corresponding author), Smithsonian Trop Res Inst, POB 2072, Balboa, Panama.	mkaspari@ou.edu		Yanoviak, Stephen/0000-0001-6425-1413; Kaspari, Michael/0000-0002-9717-5768				COYLE FA, 1966, INSECT SOC, V13, P93, DOI 10.1007/BF02223565; de Andrade Maria L., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V271, P1; DUDLEY R, 2000, BIOMECHANICS INSECT, P275; ELLINGTON CP, 1991, ADV INSECT PHYSIOL, V23, P171, DOI 10.1016/S0065-2806(08)60094-6; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Haemig PD, 1997, ANIM BEHAV, V54, P89, DOI 10.1006/anbe.1996.0428; HOLLDOBLER B, 1980, SCIENCE, V210, P86, DOI 10.1126/science.210.4465.86; Jackson SM, 2000, MAMMAL REV, V30, P9, DOI 10.1046/j.1365-2907.2000.00056.x; Kempf W. W., 1951, Revista de Entomologia Rio de Janeiro, V22, P1; KINGSOLVER JG, 1994, ANNU REV ENTOMOL, V39, P425, DOI 10.1146/annurev.en.39.010194.002233; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; McCay MG, 2001, J EXP BIOL, V204, P2817; Moffett MW, 2000, BIOTROPICA, V32, P569, DOI 10.1646/0006-3606(2000)032[0569:WSUACL]2.0.CO;2; MORI A, 1994, COPEIA, P124; OLIVER JA, 1951, AM NAT, V85, P171, DOI 10.1086/281666; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; SMITH JM, 1952, EVOLUTION, V6, P127, DOI 10.2307/2405510; Socha JJ, 2002, NATURE, V418, P603, DOI 10.1038/418603a; Stork N.E., 1997, CANOPY ARTHROPODS; Walker JA, 1998, J EXP BIOL, V201, P981; WEBER NEAL A., 1957, PSYCHE, V64, P60, DOI 10.1155/1957/71981; WILSON EDWARD O., 1962, BULL MUS COMP ZOOL HARVARD UNIV, V127, P401; Wohlgemuth S, 2001, NATURE, V411, P795, DOI 10.1038/35081069; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	25	104	104	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					624	626		10.1038/nature03254	http://dx.doi.org/10.1038/nature03254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703745				2022-12-24	WOS:000226862000042
J	Couzin, ID; Krause, J; Franks, NR; Levin, SA				Couzin, ID; Krause, J; Franks, NR; Levin, SA			Effective leadership and decision-making in animal groups on the move	NATURE			English	Article							MIGRATORY BEHAVIOR; FISH	For animals that forage or travel in groups, making movement decisions often depends on social interactions among group members(1,2). However, in many cases, few individuals have pertinent information, such as knowledge about the location of a food source(3,4), or of a migration route(5-9). Using a simple model we show how information can be transferred within groups both without signalling and when group members do not know which individuals, if any, have information. We reveal that the larger the group the smaller the proportion of informed individuals needed to guide the group, and that only a very small proportion of informed individuals is required to achieve great accuracy. We also demonstrate how groups can make consensus decisions, even though informed individuals do not know whether they are in a majority or minority, how the quality of their information compares with that of others, or even whether there are any other informed individuals. Our model provides new insights into the mechanisms of effective leadership and decision-making in biological systems.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England	Princeton University; University of Oxford; University of Leeds; University of Bristol	Couzin, ID (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	iain.couzin@zoo.ox.ac.uk	Franks, Nigel/AAG-8207-2019; Krause, Jens/J-4381-2013; Levin, Simon A/J-1218-2014; Couzin, Iain D./Q-6862-2018; Krause, Jens/C-2750-2011	Franks, Nigel/0000-0001-8139-9604; Krause, Jens/0000-0002-1289-2857; Levin, Simon A/0000-0002-8216-5639; Couzin, Iain D./0000-0001-8556-4558; 	Engineering and Physical Sciences Research Council [GR/T11241/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BATSCHELET E, 1981, CIRCULAR STAT BIOL, P34; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BERTHOLD P, 1981, SCIENCE, V212, P77, DOI 10.1126/science.212.4490.77; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; KRAUSE J, 2002, LIVING GROUPS, P84; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; NEILL WH, 1979, AM ZOOL, V19, P305; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Seeley T. D., 1995, WISDOM HIVE, p[34, 85]; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; SEELEY TD, 1985, HONEYBEE ECOLOGY STU, P71; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; VONFRISCH K, 1967, DANCE LANGUAGE ORIEN, P28	22	1689	1753	19	573	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					513	516		10.1038/nature03236	http://dx.doi.org/10.1038/nature03236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690039	Green Submitted			2022-12-24	WOS:000226727200046
J	Forterre, Y; Skotheim, JM; Dumais, J; Mahadevan, L				Forterre, Y; Skotheim, JM; Dumais, J; Mahadevan, L			How the Venus flytrap snaps	NATURE			English	Article							DIONAEA-MUSCIPULA ELLIS; MECHANISM; MOVEMENT; CLOSURE; GROWTH; PLANTS	The rapid closure of the Venus flytrap (Dionaea muscipula) leaf in about 100 ms is one of the fastest movements in the plant kingdom. This led Darwin to describe the plant as "one of the most wonderful in the world"(1). The trap closure is initiated by the mechanical stimulation of trigger hairs. Previous studies(2-7) have focused on the biochemical response of the trigger hairs to stimuli and quantified the propagation of action potentials in the leaves. Here we complement these studies by considering the post-stimulation mechanical aspects of Venus flytrap closure. Using high-speed video imaging, non-invasive microscopy techniques and a simple theoretical model, we show that the fast closure of the trap results from a snap-buckling instability, the onset of which is controlled actively by the plant. Our study identifies an ingenious solution to scaling up movements in nonletters muscular engines and provides a general framework for understanding nastic motion in plants.	Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Aix Marseille 1, CNRS, IUSTI, F-13453 Marseille 13, France; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Skotheim, Jan/C-3238-2015; Dumais, Jacques/H-7950-2013	Skotheim, Jan/0000-0001-8420-6820; Dumais, Jacques/0000-0003-2344-4766				ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Brown WH, 1916, AM J BOT, V3, P68, DOI 10.2307/2435207; Burdon-Sanderson JS, 1882, PHILOS T R SOC LOND, V173, P1; Darwin C., 1875, INSECTIVOROUS PLANTS; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; FRENSCH J, 1989, PLANT PHYSIOL, V91, P719, DOI 10.1104/pp.91.2.719; GREEN PB, 1991, PLANTA, V185, P502, DOI 10.1007/BF00202959; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; HODICK D, 1988, PLANTA, V174, P8, DOI 10.1007/BF00394867; HODICK D, 1989, PLANTA, V179, P32, DOI 10.1007/BF00395768; Juniper B.E., 1989, CARNIVOROUS PLANTS; Love AEH, 1944, TREATISE MATH THEORY; Mansfield E.H., 1989, BENDING STRETCHING P; Morillon R, 2001, PLANT PHYSIOL, V127, P720, DOI 10.1104/pp.010732; Sibaoka T., 1969, ANNU REV PLANT PHYS, V20, P165; Skotheim JM, 2004, P ROY SOC A-MATH PHY, V460, P1995, DOI 10.1098/rspa.2003.1270; STUHLMAN O, 1950, SCIENCE, V111, P491, DOI 10.1126/science.111.2888.491; STUHLMAN O, 1948, B TORREY BOT CLUB, V7, P22; WILLIAMS SE, 1982, SCIENCE, V218, P1120, DOI 10.1126/science.218.4577.1120	20	667	681	29	489	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					421	425		10.1038/nature03185	http://dx.doi.org/10.1038/nature03185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674293				2022-12-24	WOS:000226546200044
J	Nelson, WA; McCauley, E; Wrona, FJ				Nelson, WA; McCauley, E; Wrona, FJ			Stage-structured cycles promote genetic diversity in a predator-prey system of Daphnia and algae	NATURE			English	Article							LIFE-HISTORY EVOLUTION; CLONAL DIVERSITY; POPULATIONS; PULEX; PLANKTON; ECOLOGY; MODELS	Competition theory predicts that population fluctuations can promote genetic diversity when combined with density-dependent selection(1,2). However, this stabilizing mechanism has rarely been tested, and was recently rejected as an explanation for maintaining diversity in natural populations of the freshwater herbivore Daphnia pulex(3). The primary limitation of competition theory is its failure to account for the alternative types of population cycles that are caused by size- or stage-dependent population vital rates - even though such structure both explains the fluctuating dynamics of many species(4) and may alter the outcome of competition(5). Here we provide the first experimental test of whether alternative types of cycles affect natural selection in predator - prey systems. Using competing Daphnia genotypes, we show that internally generated, stage-structured cycles substantially reduce the magnitude of selection ( thereby contributing to the maintenance of genetic diversity), whereas externally forced cycles show rapid competitive exclusion. The change in selection is ecologically significant, spanning the observed range in natural populations(3). We argue that structured cycles reduce selection through a combination of stalled juvenile development and stage-specific mortality. This potentially general fitness-equalizing mechanism may reduce the need for strong stabilizing mechanisms to explain the maintenance of genetic diversity in natural systems.	Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada; Univ Victoria, Natl Water Res Inst, Water & Climate Impacts Res Ctr, Victoria, BC V8W 3P5, Canada	University of Calgary; Environment & Climate Change Canada; National Water Research Institute; University of Victoria	Nelson, WA (corresponding author), Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada.	wanelson@ucalgary.ca	Wrona, Frederick J/B-8258-2014; Nelson, William A/D-1405-2013	Wrona, Frederick J/0000-0003-1894-351X; 				ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; CARVALHO GR, 1987, J ANIM ECOL, V56, P469, DOI 10.2307/5061; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; DUFRESNE F, 1995, HEREDITY, V75, P45, DOI 10.1038/hdy.1995.102; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HEBERT PDN, 1980, SCIENCE, V207, P1363, DOI 10.1126/science.207.4437.1363; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; HEBERT PDN, 1977, J ANIM ECOL, V46, P399, DOI 10.2307/3819; Hebert PDN, 1993, METHODOLOGIES ALLOZY; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; LOARING JM, 1981, OECOLOGIA, V51, P162, DOI 10.1007/BF00540595; LYNCH M, 1984, EVOLUTION, V38, P465, DOI 10.1111/j.1558-5646.1984.tb00312.x; LYNCH M, 1987, GENETICS, V115, P657; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; Mitchell SE, 1998, ERGEB LIMNOL, V52, P185; MORT MA, 1991, TRENDS ECOL EVOL, V6, P41, DOI 10.1016/0169-5347(91)90120-M; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; NELSON WA, 2004, THESIS U CALGARY; Persson L, 1999, OIKOS, V87, P139, DOI 10.2307/3547005; SPITZE K, 1991, EVOLUTION, V45, P82, DOI [10.2307/2409484, 10.1111/j.1558-5646.1991.tb05268.x]; WATSON S, 1992, CAN J FISH AQUAT SCI, V49, P2605, DOI 10.1139/f92-288; WEIDER LJ, 1985, J PLANKTON RES, V7, P101, DOI 10.1093/plankt/7.1.101; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	28	36	37	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					413	417		10.1038/nature03212	http://dx.doi.org/10.1038/nature03212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674291				2022-12-24	WOS:000226546200042
J	Higuchi, T; Uhlmann, F				Higuchi, T; Uhlmann, F			Stabilization of microtubule dynamics at anaphase onset promotes chromosome segregation	NATURE			English	Article							BUDDING YEAST ANAPHASE; MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; METAPHASE; PROTEIN; COHESIN; KINASE; CDC14; DESTRUCTION	Microtubules of the mitotic spindle form the structural basis for chromosome segregation. In metaphase, microtubules show high dynamic instability, which is thought to aid the 'search and capture' of chromosomes for bipolar alignment on the spindle. Microtubules suddenly become more stable at the onset of anaphase, but how this change in microtubule behaviour is regulated and how important it is for the ensuing chromosome segregation are unknown(1-4). Here we show that in the budding yeast Saccharomyces cerevisiae, activation of the phosphatase Cdc14 at anaphase onset is both necessary and sufficient for silencing microtubule dynamics. Cdc14 is activated by separase, the protease that triggers sister chromatid separation, linking the onset of anaphase to microtubule stabilization(5,6). If sister chromatids separate in the absence of Cdc14 activity, microtubules maintain high dynamic instability; this correlates with defects in both the movement of chromosomes to the spindle poles (anaphase A) and the elongation of the anaphase spindle (anaphase B). Cdc14 promotes localization of microtubule-stabilizing proteins to the anaphase spindle, and dephosphorylation of the kinetochore component Ask1 contributes to both the silencing of microtubule turnover and successful anaphase A.	Canc Res UK London Res Inst, Chromosome Segregat Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619	Cancer Research UK [A3592] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Li YM, 2003, CELL CYCLE, V2, P143, DOI 10.4161/cc.2.2.336; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Murray AW, 1996, P NATL ACAD SCI USA, V93, P12327, DOI 10.1073/pnas.93.22.12327; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yin HW, 2002, MOL BIOL CELL, V13, P1881, DOI 10.1091/mbc.01-09-0458; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	30	146	151	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					171	176		10.1038/nature03240	http://dx.doi.org/10.1038/nature03240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650742	Green Accepted			2022-12-24	WOS:000226252200041
J	Jee, SH; Ohrr, H; Sull, JW; Yun, JE; Ji, M; Samet, JM				Jee, SH; Ohrr, H; Sull, JW; Yun, JE; Ji, M; Samet, JM			Fasting serum glucose level and cancer risk in Korean men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETES-MELLITUS; PANCREATIC-CANCER; PROSTATE-CANCER; BREAST-CANCER; FOLLOW-UP; SMOKING; MORTALITY; DEATH; COHORT; TYPE-2	Context Diabetes is a serious and costly disease that is becoming increasingly common in many countries. The role of diabetes as a cancer risk factor remains unclear. Objective To examine the relationship between fasting serum glucose and diabetes and risk of all cancers and specific cancers in men and women in Korea. Design, Setting, and Participants Ten-year prospective cohort study of 1298 385 Koreans (829770 men and 468615 women) aged 30 to 95 years who received health insurance from the National Health Insurance Corp and had a biennial medical evaluation in 1992-1995 (with follow-up for up to 10 years). Main Outcome Measures Death from cancer and registry-documented incident cancer or hospital admission for cancer. Results During the 10 years of follow-up, there were 20566 cancer deaths in men and 5907 cancer deaths in women. Using Cox proportional hazards models and controlling for smoking and alcohol use, the stratum with the highest fasting serum glucose (greater than or equal to140 mg/dL [greater than or equal to7.8 mmol/L]) had higher death rates from all cancers combined (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.22-1.37 in men and HR, 1.23; 95% Cl, 1.09-1.39 in women) compared with the stratum with the lowest level (<90 mg/dL [<5.0 mmol/L]). By cancer site, the association was strongest for pancreatic cancer, comparing the highest and lowest strata in men (HR, 1.91; 95% Cl, 1.52-2.41) and in women (HR, 2.05; 95% Cl, 1.43-2.93). Significant associations were also found for cancers of the esophagus, liver, and colon/ rectum in men and of the liver and cervix in women, and there were significant trends with glucose level for cancers of the esophagus, colon/rectum, liver, pancreas, and bile duct in men and of the liver and pancreas in women. Of the 26473 total cancer deaths in men and women, 848 were estimated as attributable to having a fasting serum glucose level of less than 90 mg/dL. For cancer incidence, the general patterns reflected those found for mortality. For persons with a diagnosis of diabetes or a fasting serum glucose level greater than 125 mg/dL (6.9 mmol/L), risks for cancer incidence and mortality were generally elevated compared with those without diabetes. Conclusion In Korea, elevated fasting serum glucose levels and a diagnosis of diabetes are independent risk factors for several major cancers, and the risk tends to increase with an increased level of fasting serum glucose.	Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea.	jsunha@yumc.yonsei.ac.kr			NCI NIH HHS [1R03 CA94771-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA094771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Cho N.H, 2001, DIABETES, V25, P1; COX DR, 1972, J R STAT SOC B, V34, P187; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gavin JR, 1997, DIABETES CARE, V20, P1183; GRULICH AE, 1995, INT J CANCER, V63, P164, DOI 10.1002/ijc.2910630203; Hjalgrim H, 1997, J INTERN MED, V241, P471; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; International Agency for Research on Cancer (IARC), 2002, IARC SCI PUBL, V8; Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149; Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; KIM HS, 2000, KOREAN J NURS, V30, P1479; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#; Lee SY, 2002, J HYPERTENS, V20, P617, DOI 10.1097/00004872-200204000-00017; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; National Institute of Diabetes and Digestive and Kidney Disorders, 2004, NAT DIAB INF CLEAR N; Rosenberg DJ, 2002, CANCER INVEST, V20, P157, DOI 10.1081/CNV-120001141; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; SMITH GD, 1992, AM J EPIDEMIOL, V136, P1110, DOI 10.1093/oxfordjournals.aje.a116576; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Szklo M, 2014, EPIDEMIOLOGY BASICS; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Weiderpass E, 1997, INT J CANCER, V71, P360, DOI 10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W; Weiderpass E, 2002, INT J CANCER, V102, P258, DOI 10.1002/ijc.10685; WHO, 2002, DIAB MELL, P138; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Will JC, 1999, EPIDEMIOLOGY, V10, P313, DOI 10.1097/00001648-199905000-00021	30	706	740	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					194	202		10.1001/jama.293.2.194	http://dx.doi.org/10.1001/jama.293.2.194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644546	Bronze			2022-12-24	WOS:000226171000035
J	Di Fonzo, A; Rohe, CF; Ferreira, RJ; Chien, HF; Vacca, L; Stocchi, F; Guedes, L; Fabrizio, E; Manfredi, M; Vanacore, N; Goldwurm, S; Breedveld, G; Sampaio, C; Meco, G; Barbosa, E; Oostra, BA; Bonifati, V				Di Fonzo, A; Rohe, CF; Ferreira, RJ; Chien, HF; Vacca, L; Stocchi, F; Guedes, L; Fabrizio, E; Manfredi, M; Vanacore, N; Goldwurm, S; Breedveld, G; Sampaio, C; Meco, G; Barbosa, E; Oostra, BA; Bonifati, V		Italian Parkinson Genetics Network	A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease	LANCET			English	Article								Mutations in the LRRK2 gene have been identified in families with autosomal dominant parkinsonism. We amplified and sequenced the coding region of LRRK2 from genomic DNA by PCR, and identified a heterozygous mutation (Gly2019Ser) present in four of 61 (6.6%) unrelated families with Parkinson's disease and autosomal dominant inheritance. The families originated from Italy, Portugal, and Brazil, indicating the presence of the mutation in different populations. The associated phenotype was broad, including early and late disease onset. These findings confirm the association of LRRK2 with neurodegeneration, and identify a common mutation associated with dominantly inherited Parkinson's disease.	Erasmus MC Rotterdam, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Milan, IRCCS Osped Maggiore Policlin, Ctr Dino Ferrari, Dept Neurol Sci, Milan, Italy; Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal; Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; Univ Roma La Sapienza, Dept Neurol Sci, Rome, Italy; Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy; Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy	Erasmus University Rotterdam; Erasmus MC; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universidade de Lisboa; Universidade de Sao Paulo; Sapienza University Rome; Istituto Superiore di Sanita (ISS)	Bonifati, V (corresponding author), Erasmus MC Rotterdam, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl	Barbosa, Egberto R/G-7763-2012; stocchi, fabrizio/K-5089-2016; Ferreira, Joaquim/AAA-1837-2020; Vanacore, Nicola/ABC-7196-2021; Goldwurm, Stefano/Q-8978-2016; Di Fonzo, Alessio/A-5702-2013	stocchi, fabrizio/0000-0002-5763-0033; Goldwurm, Stefano/0000-0002-1651-567X; Di Fonzo, Alessio/0000-0001-6478-026X; Vacca, Laura/0000-0002-6634-4119; Ferreira, Joaquim J/0000-0003-3950-5113; Correia Guedes, Leonor/0000-0002-8422-0494; Reis Barbosa, Egberto/0000-0002-6996-9130				Bonifati V, 2004, CELL MOL LIFE SCI, V61, P1729, DOI 10.1007/s00018-004-4104-1; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	5	412	424	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					412	415						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680456				2022-12-24	WOS:000226610900028
J	Gray, PA; Fu, H; Luo, P; Zhao, Q; Yu, J; Ferrari, A; Tenzen, T; Yuk, DI; Tsung, EF; Cai, ZH; Alerta, JA; Cheng, LP; Liu, Y; Stenman, JM; Valerius, MT; Billings, N; Kim, HA; Greenberg, ME; McMahon, AP; Rowitch, DH; Stiles, CD; Ma, QF				Gray, PA; Fu, H; Luo, P; Zhao, Q; Yu, J; Ferrari, A; Tenzen, T; Yuk, DI; Tsung, EF; Cai, ZH; Alerta, JA; Cheng, LP; Liu, Y; Stenman, JM; Valerius, MT; Billings, N; Kim, HA; Greenberg, ME; McMahon, AP; Rowitch, DH; Stiles, CD; Ma, QF			Mouse brain organization revealed through direct genome-scale TF expression analysis	SCIENCE			English	Article							GENE; MUTATIONS; PROFILES; SEQUENCE; DISORDER	In the developing brain, transcription factors (TFs) direct the formation of a diverse array of neurons and glia. We identified 1445 putative TFs in the mouse genome. We used in situ hybridization to map the expression of over 1000 of these TFs and TF-coregulator genes in the brains of developing mice. We found that 349 of these genes showed restricted expression patterns that were adequate to describe the anatomical organization of the brain. We provide a comprehensive inventory of murine TFs and their expression patterns in a searchable brain atlas database.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Childrens Hosp, Informat Program, Boston, MA 02115 USA; Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Stiles, CD (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Charles-Stiles@dfci.harvard.edu; Qiufu_Ma@dfci.harvard.edu	Fu, Hui/O-5811-2019; McMahon, Andrew P/ABE-7520-2020; Fu, Hui/C-2881-2011	Fu, Hui/0000-0003-0252-6009; Fu, Hui/0000-0003-0252-6009; Liu, Yang/0000-0002-0396-3844; Rowitch, David/0000-0002-0079-0060				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Holder JL, 2000, HUM MOL GENET, V9, P101; Kandel ER, 2000, PRINCIPLES NEURAL SC; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073	18	329	334	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2255	2257		10.1126/science.1104935	http://dx.doi.org/10.1126/science.1104935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618518				2022-12-24	WOS:000225950000046
J	Fisher, AE; Barnes, GR; Hillebrand, A; Burrow, C; Furlong, PL; Holliday, IE				Fisher, AE; Barnes, GR; Hillebrand, A; Burrow, C; Furlong, PL; Holliday, IE			Can you tell your clunis from your cubitus? A benchmark for functional imaging	BRITISH MEDICAL JOURNAL			English	Article							SOMATOSENSORY HOMUNCULUS; HUMANS; CORTEX		Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Aston University	Barnes, GR (corresponding author), Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England.	barnesgr@aston.ac.uk	Barnes, Gareth/ABB-7650-2020	Barnes, Gareth/0000-0002-5396-7712; Hillebrand, Arjan/0000-0002-8508-3532; Furlong, Paul/0000-0002-9840-8586				Itomi K, 2001, BRAIN TOPOGR, V14, P15, DOI 10.1023/A:1012511621766; NARICI L, 1991, NEUROSCI LETT, V121, P51, DOI 10.1016/0304-3940(91)90647-C; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; YANG TT, 1993, P NATL ACAD SCI USA, V90, P3098, DOI 10.1073/pnas.90.7.3098; 2003, CAMBRIDGE INT DICT I	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1492	1493		10.1136/bmj.329.7480.1492-a	http://dx.doi.org/10.1136/bmj.329.7480.1492-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604196	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-24	WOS:000225965800040
J	Guogas, LM; Filman, DJ; Hogle, JM; Gehrke, L				Guogas, LM; Filman, DJ; Hogle, JM; Gehrke, L			Cofolding organizes alfalfa mosaic virus RNA and coat protein for replication	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; BINDING-SITES; AMINO-ACIDS; VIRAL RNAS; DETERMINANTS; RECOGNITION; INITIATION; RESOLUTION; INFECTION; CONTAINS	Alfalfa mosaic virus genomic RNAs are infectious only when the viral coat protein binds to the RNA 3' termini. The crystal structure of an alfalfa mosaic virus RNA-peptide complex reveals that conserved AUGC repeats and Pro-Thr-x-Arg-Ser-x-x-Tyr coat protein amino acids cofold upon interacting. Alternating AUGC residues have opposite orientation, and they base pair in different adjacent duplexes. Localized RNA backbone reversals stabilized by arginine-guanine interactions place the adenosines and guanines in reverse order in the duplex. The results suggest that a uniform, organized 3' conformation, similar to that found on viral RNAs with transfer RNA-like ends, may be essential for replication.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Hogle, JM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	James_Hogle@hms.harvard.edu; Lee_Gehrke@hms.harvard.edu	Hogle, James/HIG-9121-2022	filman, david/0000-0002-8714-1644; Hogle, James/0000-0002-3655-1504	NIAID NIH HHS [AI20566, R01 AI020566] Funding Source: Medline; NIGMS NIH HHS [R01 GM042504, GM42504] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020566, R21AI020566, R01AI020566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042504] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansel-McKinney P, 1998, J MOL BIOL, V278, P767, DOI 10.1006/jmbi.1998.1656; AnselMcKinney P, 1996, EMBO J, V15, P5077, DOI 10.1002/j.1460-2075.1996.tb00888.x; BAER ML, 1994, EMBO J, V13, P727, DOI 10.1002/j.1460-2075.1994.tb06312.x; BOL JF, 1971, VIROLOGY, V46, P73, DOI 10.1016/0042-6822(71)90007-9; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chapman MR, 1999, J MOL BIOL, V286, P709, DOI 10.1006/jmbi.1998.2503; DREHER TW, 1984, NATURE, V311, P171, DOI 10.1038/311171a0; FUKUYAMA K, 1983, J MOL BIOL, V167, P873, DOI 10.1016/S0022-2836(83)80116-8; HouserScott F, 1997, J VIROL, V71, P2310, DOI 10.1128/JVI.71.3.2310-2319.1997; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; HOUWING CJ, 1982, BIOCHEMISTRY-US, V21, P3408, DOI 10.1021/bi00257a025; HOUWING CJ, 1978, BIOCHEMISTRY-US, V17, P2927, DOI 10.1021/bi00607a035; JASPARS EMJ, 1985, MOL PLANT VIROLOGY, V1, P155; KOPERZWARTHOFF EC, 1980, NUCLEIC ACIDS RES, V8, P3307, DOI 10.1093/nar/8.15.3307; Kumar A, 1997, J VIROL, V71, P7911, DOI 10.1128/JVI.71.10.7911-7916.1997; Laforest SM, 2004, RNA, V10, P48, DOI 10.1261/rna.5154104; PETRILLO JE, UNPUB; QUIGLEY GJ, 1984, NUCLEIC ACIDS RES, V12, P347, DOI 10.1093/nar/12.1Part1.347; REUSKEN CBEM, 1994, NUCLEIC ACIDS RES, V22, P1346, DOI 10.1093/nar/22.8.1346; Reusken CBEM, 1996, NUCLEIC ACIDS RES, V24, P2660, DOI 10.1093/nar/24.14.2660; Rocheleau G, 2004, J VIROL, V78, P8036, DOI 10.1128/JVI.78.15.8036-8046.2004; Yusibov V, 1998, VIROLOGY, V242, P1, DOI 10.1006/viro.1997.8973; YUSIBOV VM, 1995, VIROLOGY, V208, P405, DOI 10.1006/viro.1995.1168	23	29	31	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2108	2111		10.1126/science.1103399	http://dx.doi.org/10.1126/science.1103399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604410	Green Accepted			2022-12-24	WOS:000225841000067
J	Smeeth, L; Thomas, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P				Smeeth, L; Thomas, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P			Risk of myocardial infarction and stroke after acute infection or vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CASE SERIES; INFLAMMATION; ASSOCIATION; HYPERTENSION; DATABASE; MARKERS; HEALTH	BACKGROUND: There is evidence that chronic inflammation may promote atherosclerotic disease. We tested the hypothesis that acute infection and vaccination increase the short-term risk of vascular events. METHODS: We undertook within-person comparisons, using the case-series method, to study the risks of myocardial infarction and stroke after common vaccinations and naturally occurring infections. The study was based on the United Kingdom General Practice Research Database, which contains computerized medical records of more than 5 million patients. RESULTS: A total of 20,486 persons with a first myocardial infarction and 19,063 persons with a first stroke who received influenza vaccine were included in the analysis. There was no increase in the risk of myocardial infarction or stroke in the period after influenza, tetanus, or pneumococcal vaccination. However, the risks of both events were substantially higher after a diagnosis of systemic respiratory tract infection and were highest during the first three days (incidence ratio for myocardial infarction, 4.95; 95 percent confidence interval, 4.43 to 5.53; incidence ratio for stroke, 3.19; 95 percent confidence interval, 2.81 to 3.62). The risks then gradually fell during the following weeks. The risks were raised significantly but to a lesser degree after a diagnosis of urinary tract infection. The findings for recurrent myocardial infarctions and stroke were similar to those for first events. CONCLUSIONS: Our findings provide support for the concept that acute infections are associated with a transient increase in the risk of vascular events. By contrast, influenza, tetanus, and pneumococcal vaccinations do not produce a detectable increase in the risk of vascular events.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; Open Univ, Div Stat, Milton Keynes MK7 6AA, Bucks, England; UCL, Ctr Clin Pharmacol, British Heart Fdn Labs, Div Med, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; Open University - UK; University of London; University College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	Greiver, Michelle/N-8764-2015; Smeeth, Liam/X-5862-2018	Greiver, Michelle/0000-0001-8957-0285; Smeeth, Liam/0000-0002-9168-6022; Farrington, Conor Patrick/0000-0002-7148-2612	MRC [G108/492] Funding Source: UKRI; Medical Research Council [G108/492] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alber DG, 2000, CIRCULATION, V102, P779, DOI 10.1161/01.CIR.102.7.779; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Farrington CP, 1998, AM J EPIDEMIOL, V147, P93; Gibbs RGJ, 2001, STROKE, V32, P1085, DOI 10.1161/01.STR.32.5.1085; Grau AJ, 2004, STROKE, V35, P1147, DOI 10.1161/01.STR.0000124122.71702.64; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hollowell J, 1997, Popul Trends, P36; Jick H, 1996, PHARMACOTHERAPY, V16, P321; Jick H, 1997, EPIDEMIOLOGY, V8, P446, DOI 10.1097/00001648-199707000-00017; Keaney JF, 2002, NEW ENGL J MED, V347, P55, DOI 10.1056/NEJM200207043470112; KINLAY S, 1997, AM J CARDIOL, V80, P11; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; MATTILA KJ, 1989, J INTERN MED, V225, P293, DOI 10.1111/j.1365-2796.1989.tb00084.x; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; *OFF NAT STAT, 1998, KEY HLTH STAT GE MB6, V1; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SPODICK DH, 1984, AM J CARDIOL, V53, P481, DOI 10.1016/0002-9149(84)90016-X; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; VALTONEN V, 1993, EUR HEART J, V14, P20; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1	30	973	1005	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2611	2618		10.1056/NEJMoa041747	http://dx.doi.org/10.1056/NEJMoa041747			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602021	Green Accepted, Green Published			2022-12-24	WOS:000225726100008
J	Yanik, MF; Cinar, H; Cinar, HN; Chisholm, AD; Jin, YS; Ben-Yakar, A				Yanik, MF; Cinar, H; Cinar, HN; Chisholm, AD; Jin, YS; Ben-Yakar, A			Neurosurgery - Functional regeneration after laser axotomy	NATURE			English	Editorial Material							NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS		Stanford Univ, Ginzton Lab, Dept Appl Phys, Stanford, CA 94305 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Texas, Dept Mech Engn, Austin, TX 78712 USA	Stanford University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin	Yanik, MF (corresponding author), Stanford Univ, Ginzton Lab, Dept Appl Phys, Stanford, CA 94305 USA.	ben-yakar@mail.utexas.edu		Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860; Yanik, Mehmet/0000-0002-8963-2893				Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197; SHEN N, 2003, THESIS HARVARD U; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	10	445	460	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					822	822		10.1038/432822a	http://dx.doi.org/10.1038/432822a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602545				2022-12-24	WOS:000225733500036
J	Horner-Devine, MC; Lage, M; Hughes, JB; Bohannan, BJM				Horner-Devine, MC; Lage, M; Hughes, JB; Bohannan, BJM			A taxa-area relationship for bacteria	NATURE			English	Article							POPULATIONS; DNA	A positive power-law relationship between the number of species in an area and the size of that area has been observed repeatedly in plant and animal communities(1). This species - area relationship, thought to be one of the few laws in ecology(2), is fundamental to our understanding of the distribution of global biodiversity. However, such a relationship has not been reported for bacteria, and little is known regarding the spatial distribution of bacteria, relative to what is known of plants and animals(3). Here we describe a taxa - area relationship for bacteria over a scale of centimetres to hundreds of metres in salt marsh sediments. We found that bacterial communities located close together were more similar in composition than communities located farther apart, and we used the decay of community similarity with distance to show that bacteria can exhibit a taxa - area relationship. This relationship was driven primarily by environmental heterogeneity rather than geographic distance or plant composition.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Stanford University; Brown University	Horner-Devine, MC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	mchd@u.washington.edu	Bohannan, Brendan J. M./R-1582-2017; Martiny, Jennifer/AAB-9323-2019	Bohannan, Brendan J. M./0000-0003-2907-1016; Horner-Devine, Claire/0000-0002-0783-3406; Martiny, Jennifer/0000-0002-2415-1247				Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baas-Becking LGM., 1934, GEOLOGIE INLEIDING M; Bennett JP, 1997, RHODORA, V99, P241; BERTNESS MD, 1999, ECOLOGY ATLANTIC SHO, P313; Burke DJ, 2002, APPL ENVIRON MICROB, V68, P1157, DOI 10.1128/AEM.68.3.1157-1164.2002; Clarke KR., 2001, CHANGE MARINE COMMUN, V2nd; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Harcourt AH, 1999, GLOBAL ECOL BIOGEOGR, V8, P55, DOI 10.1046/j.1365-2699.1999.00125.x; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Legendre P., 1998, NUMERICAL ECOLOGY, P33; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAGURRAN AE, 2004, MEASURING BIOL DIVER, P175; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MCCAIG AE, 1994, FEMS MICROBIOL LETT, V120, P363, DOI 10.1016/0378-1097(94)90497-9; PEITINGER M, 2003, BASIC APPL ECOL, V4, P385; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; SCHLOSS PD, IN PRESS APPL ENV MI; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	29	519	552	14	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					750	753		10.1038/nature03073	http://dx.doi.org/10.1038/nature03073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592412				2022-12-24	WOS:000225597200047
J	Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A				Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A			Depression and anxiety in women with early breast cancer: five year observational cohort study	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; PSYCHIATRIC MORBIDITY; PSYCHOLOGICAL MORBIDITY; MASTECTOMY; CONSERVATION; PREVALENCE; PREDICTORS; DISEASE; IMPACT; TRIAL	Objective To examine the prevalence of, and risk factors for, depression and anxiety in women with early breast cancer in the five years after diagnosis. Design Observational cohort study. Setting NHS breast clinic, London. Participants 222 women with early breast cancer: 170 (77%) provided complete interview data up to either five years after diagnosis or recurrence. Main outcome measures Prevalence of clinically important depression and anxiety (structured psychiatric interview with standardised diagnostic criteria) and clinical and patient risk factors, including stressful life experiences (Bedford College life events and difficulties schedule). Results Nearly 50% of the women with early breast cancer had depression, anxiety, or both in the year after diagnosis, 25% in the second, third, and fourth years, and 15% in the fifth year. Point prevalence was 33% at diagnosis, falling to 15% after one year. 45% of those with recurrence experienced depression, anxiety, or both within three months of the diagnosis. Previous psychological treatment predicted depression, anxiety, or both in the period around diagnosis (one month before diagnosis to four months after diagnosis). Longer term depression and anxiety were associated with previous psychological treatment, lack of an intimate confiding relationship, younger age, and severely stressful non-cancer life experiences. Clinical factors were not associated with depression and anxiety at any time. Lack of intimate confiding support also predicted more protracted episodes of depression and anxiety. Conclusion Increased levels of depression and anxiety in the first year after a diagnosis of early breast cancer highlight the need for dedicated service provision during this time. Psychological interventions for women with breast cancer who remain disease free should take account of the broader social context in which the cancer occurs, with a focus on improving social support.	Kings Coll London, St Thomas Hosp, Inst Psychiat, Canc Res UL London Psychosocial Grp, London SE1 7EH, England; Inst Hlth Sci, Canc Res UK Med Stat Grp, Ctr Stat Med, Oxford OX3 7LF, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; University of Oxford	Burgess, C (corresponding author), Kings Coll London, St Thomas Hosp, Inst Psychiat, Canc Res UL London Psychosocial Grp, London SE1 7EH, England.	caroline.burgess@kcl.ac.uk		Love, Sharon/0000-0002-6695-5390; Cornelius, Victoria/0000-0002-0080-1065				*AM PSYCH ASS COMM, 1987, DIAGN STAT MAN MENT; [Anonymous], [No title captured]; Brown G., 1978, SOCIAL ORIGINS DEPRE; Burgess CC, 2002, EUR J CANCER, V38, P1622, DOI 10.1016/S0959-8049(02)00132-6; CHIA SKL, 2003, P AN M AM SOC CLIN, V22, P6; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; DEAN C, 1987, J PSYCHOSOM RES, V31, P385, DOI 10.1016/0022-3999(87)90059-6; FALLOWFIELD LJ, 1994, BRIT MED J, V309, P448, DOI 10.1136/bmj.309.6952.448; FALLOWFIELD LJ, 1986, BMJ-BRIT MED J, V293, P1331, DOI 10.1136/bmj.293.6558.1331; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Haddad P, 1994, BREAST, V3, P218, DOI DOI 10.1016/0960-9776(94)90049-3; Hall A., 1996, BREAST J, V2, P197; HARRISON J, 1994, BRIT J PSYCHIAT, V165, P593, DOI 10.1192/bjp.165.5.593; HUGHSON AVM, 1986, BMJ-BRIT MED J, V293, P1268, DOI 10.1136/bmj.293.6557.1268; KIEBERT GM, 1991, J CLIN ONCOL, V9, P1059, DOI 10.1200/JCO.1991.9.6.1059; LEE MS, 1992, EUR J CANCER, V28A, P1340, DOI 10.1016/0959-8049(92)90514-3; *NAT I CLIN EXC, 2004, SUPP PALL CAR PEOPL; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; Okamura H, 2000, BREAST CANCER RES TR, V61, P131, DOI 10.1023/A:1006491417791; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; PINDER KL, 1994, PSYCHO-ONCOLOGY, V3, P129; RAMIREZ AJ, 1995, BRIT J CANCER, V72, P1509, DOI 10.1038/bjc.1995.538; Spitzer RL, 1990, STRUCTURED CLIN INTE	24	813	840	4	84	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					702	705		10.1136/bmj.38343.670868.D3	http://dx.doi.org/10.1136/bmj.38343.670868.D3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912IT	15695497	Green Published, Bronze			2022-12-24	WOS:000228071900016
J	Rocks, O; Peyker, A; Kahms, M; Verveer, PJ; Koerner, C; Lumbierres, M; Kuhlmann, J; Waldmann, H; Wittinghofer, A; Bastiaens, PIH				Rocks, O; Peyker, A; Kahms, M; Verveer, PJ; Koerner, C; Lumbierres, M; Kuhlmann, J; Waldmann, H; Wittinghofer, A; Bastiaens, PIH			An acylation cycle regulates localization and activity of palmitoylated Ras isoforms	SCIENCE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEIN PALMITOYLATION; CAAX MOTIF; STRUCTURAL DETERMINANTS; GOLGI-APPARATUS; H-RAS; N-RAS; CELLS; TRAFFICKING	We show that the specific subcellular distribution of H- and Nras guanosine triphosphate-binding proteins is generated by a constitutive de/reacylation cycle that operates on palmitoylated proteins, driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus. Depalmitoylation redistributes farnesylated Ras in all membranes, followed by repalmitoylation and trapping of Ras at the Golgi, from where it is redirected to the PM via the secretory pathway. This continuous cycle prevents Ras from nonspecific residence on endomembranes, thereby maintaining the specific intracellular compartmentalization. The de/reacylation cycle also initiates Ras activation at the Golgi by transport of PM-localized Ras guanosine triphosphate. Different de/repalmitoylation kinetics account for isoform-specific activation responses to growth factors.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society; Max Planck Society	Wittinghofer, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; bastiaen@embl.de	Waldmann, Herbert/B-7406-2017; Rocks, Oliver/AFI-7418-2022; Rocks, Oliver/ABG-3341-2020	Waldmann, Herbert/0000-0002-9606-7247; Rocks, Oliver/0000-0001-6349-9193; Lorentzen, Anna/0000-0002-4405-935X				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; LOWY DR, 1989, NATURE, V341, P384, DOI 10.1038/341384a0; LU JY, 1995, J BIOL CHEM, V270, P7251, DOI 10.1074/jbc.270.13.7251; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; ROCKS O, UNPUB; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Schroeder H, 1997, BIOCHEMISTRY-US, V36, P13102, DOI 10.1021/bi9709497; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Ten Brinke A, 2002, BIOCHEM J, V361, P663, DOI 10.1042/0264-6021:3610663; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	40	605	623	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1746	1752		10.1126/science.1105654	http://dx.doi.org/10.1126/science.1105654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15705808				2022-12-24	WOS:000227883900037
J	Schleinitz, MD; Heidenreich, PA				Schleinitz, MD; Heidenreich, PA			A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel plus aspirin versus aspirin alone	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSIENT ISCHEMIC ATTACK; ACUTE STROKE CARE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERY-DISEASE; RESOURCE USE; BYPASS SURGERY; MEDICAL-CARE	Background: Although clopidogrel plus aspirin is more effective than aspirin alone in preventing subsequent vascular events in patients with unstable angina, the cost-effectiveness of this combination has yet to be examined in this high-risk population. Objective: To determine the cost-effectiveness of clopidogrel plus aspirin compared with aspirin alone. Design: Cost-utility analysis. Data Sources: Published literature. Target Population: Patients with unstable angina and electrocardiographic changes or non-Q-wave myocardial infarction. T ime Horizon: Lifetime. Perspective: Societal. Interventions: Combination therapy with clopidogrel, 75 mg/d, plus aspirin, 325 mg/d, for 1 year, followed by aspirin monotherapy, was compared with lifelong aspirin therapy, 325 mg/d. Outcome Measures: Lifetime costs, life expectancy in quality-adjusted life-years (QALYs), and the incremental cost-effectiveness ratio. Results of Base-Case Analysis: Patients treated with aspirin alone lived 9.51 QALYs after their initial event and incurred expenses of $127 700; the addition of clopidogrel increased life expectancy to 9.61 QALYs and costs to $129 300. The incremental cost-effectiveness ratio for clopidogrel plus aspirin compared with aspirin alone was $15400 per QALY. Results of Sensitivity Analyses: The analysis of 1 year of therapy was robust to all sensitivity analyses. In the probabilistic sensitivity analysis, fewer than 3% of simulations resulted in cost-effectiveness ratios over $50000 per QALY. The cost-effectiveness of longer combination therapy depends critically on the balance of thrombotic event rates, durable efficacy, and the increased bleeding rate in patients taking clopidogrel. Limitations: This analysis may not apply to patients with severe heart failure, those undergoing long-term anticoagulant therapy, those recently managed with revascularization, or those undergoing short-term treatment with glycoprotein IIb/IIIa inhibitors. Conclusions: in patients with high-risk acute coronary syndromes, I year of therapy with clopidogrel plus aspirin results in greater life expectancy than aspirin alone, at a cost within the traditional limits of cost-effectiveness. The durable efficacy of clopidogrel relative to the risk for hemorrhage should be further explored before more protracted therapy can be recommended.	Brown Univ, Div Gen Internal Med, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA; Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; VA Palo Alto Healthcare Syst, Palo Alto, CA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schleinitz, MD (corresponding author), Brown Univ, Div Gen Internal Med, 593 Eddy St,MPB-1, Providence, RI 02903 USA.	Mark-Schleinitz@Brown.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043447] Funding Source: NIH RePORTER; NICHD NIH HHS [HD43447] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alberts MJ, 1996, STROKE, V27, P1825, DOI 10.1161/01.STR.27.10.1825; Ashraf T, 1996, AM J CARDIOL, V78, P409, DOI 10.1016/S0002-9149(96)00328-1; Bennett CL, 2000, NEW ENGL J MED, V343, P1193; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; BERGMAN L, 1995, STROKE, V26, P1830, DOI 10.1161/01.STR.26.10.1830; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Diener HC, 2004, CEREBROVASC DIS, V17, P253, DOI 10.1159/000076962; Diringer MN, 1999, STROKE, V30, P724, DOI 10.1161/01.STR.30.4.724; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Duncan PW, 1997, STROKE, V28, P740, DOI 10.1161/01.STR.28.4.740; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; HLATKY MA, 1990, CIRCULATION, V82, P208; *HLTH CAR INV AN I, 1999, DRG HDB; Holloway RG, 1996, NEUROLOGY, V46, P854; Jiranek GC, 1996, SURG CLIN N AM, V76, P83, DOI 10.1016/S0039-6109(05)70424-2; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Kozak LJ, 2002, VITAL HLTH STAT, V13, P1; Leibson CL, 1996, NEUROLOGY, V46, P861; Lipscomb J, 1996, COST EFFECTIVENESS H, P216; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; MURRAY L, 2002, DRUG TOPICS RED BOOK; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; *NASA, GROSS DOM PROD DEFL; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Porsdal V, 1998, STROKE, V29, P2321, DOI 10.1161/01.STR.29.11.2321; Roberts JA, 2000, J PUBLIC HEALTH MED, V22, P99, DOI 10.1093/pubmed/22.1.99; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Samsa GP, 1998, AM HEART J, V136, P703, DOI 10.1016/S0002-8703(98)70019-5; Sanders GD, 2001, ANN INTERN MED, V135, P870, DOI 10.7326/0003-4819-135-10-200111200-00007; Sarasin FP, 2000, ARCH INTERN MED, V160, P2773, DOI 10.1001/archinte.160.18.2773; Schleinitz MD, 2004, AM J MED, V116, P797, DOI 10.1016/j.amjmed.2004.01.014; Shin AY, 1997, STROKE, V28, P2395, DOI 10.1161/01.STR.28.12.2395; SMURAWSKA LT, 1994, STROKE, V25, P1628, DOI 10.1161/01.STR.25.8.1628; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Torrance GW., 1996, COST EFFECTIVENESS H, P54; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Tung CY, 1999, CIRCULATION, V99, P370, DOI 10.1161/01.CIR.99.3.370; *US DEP LAB BUR LA, 2003, 966 US DEP LAB BUR L; WEINTRAUB WS, 1995, CIRCULATION, V92, P2831, DOI 10.1161/01.CIR.92.10.2831; Weintraub WS, 1998, CIRCULATION, V98, pII23; Yusuf S, 2001, NEW ENGL J MED, V345, P494	53	68	69	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2005	142	4					251	259		10.7326/0003-4819-142-4-200502150-00007	http://dx.doi.org/10.7326/0003-4819-142-4-200502150-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900UJ	15710958				2022-12-24	WOS:000227239500003
J	McGraw, JB; Furedi, MA				McGraw, JB; Furedi, MA			Deer browsing and population viability of a forest understory plant	SCIENCE			English	Article							WHITE-TAILED DEER; AMERICAN GINSENG; PANAX-QUINQUEFOLIUS; ARALIACEAE; ECOSYSTEMS; IMPACTS; GROWTH	American ginseng is the premier medicinal plant harvested from the wild in the United States. In this study, seven populations of ginseng plants were censused every 3 weeks during-the growing season over 5 years to monitor deer browse and harvest and to project population growth and viability. The minimum viable population size was similar to800 plants, a value greater than that of all populations currently being monitored. When simulated deer browsing rates were reduced 50% or more, population viability rose sharply. Without more effective deer population control, ginseng and many other valuable understory herbs are Likely to become extinct, in the coming century.	W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	McGraw, JB (corresponding author), W Virginia Univ, Dept Biol, POB 6057, Morgantown, WV 26506 USA.	jmcgraw@wvu.edu	Liu, Yi-Chun/H-5463-2012					ANDERSON RC, 1993, AM MIDL NAT, V129, P357, DOI 10.2307/2426517; Augustine DJ, 1998, CONSERV BIOL, V12, P995, DOI 10.1046/j.1523-1739.1998.97248.x; CARLSON AW, 1986, ECON BOT, V40, P233, DOI 10.1007/BF02859148; CARPENTER SG, 1982, CAN J BOT, V60, P2692, DOI 10.1139/b82-328; Caswell H., 2001, MATRIX POPULATION MO, V2nd; CHARRON D, 1991, J ECOL, V79, P431, DOI 10.2307/2260724; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Knight TM, 2004, ECOL APPL, V14, P915, DOI 10.1890/03-5048; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; McGraw JB, 2003, J TORREY BOT SOC, V130, P62, DOI 10.2307/3557530; McGraw JB, 2001, BIOL CONSERV, V98, P25, DOI 10.1016/S0006-3207(00)00138-5; Morris W. F., 2002, QUANTITATIVE CONSERV; Nantel P, 1996, CONSERV BIOL, V10, P608, DOI 10.1046/j.1523-1739.1996.10020608.x; Robbins CS, 2000, CONSERV BIOL, V14, P1422, DOI 10.1046/j.1523-1739.2000.99100.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718	18	125	128	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					920	922		10.1126/science.1107036	http://dx.doi.org/10.1126/science.1107036			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705851				2022-12-24	WOS:000226985100052
J	Kao, MH; Doupe, AJ; Brainard, MS				Kao, MH; Doupe, AJ; Brainard, MS			Contributions of an avian basal ganglia-forebrain circuit to real-time modulation of song	NATURE			English	Article							PURSUIT EYE-MOVEMENTS; ZEBRA FINCH; NEURAL ACTIVITY; NUCLEUS; MECHANISMS; LESIONS; STIMULATION; BIRDSONG; NEURONS; PATHWAY	Cortical - basal ganglia circuits have a critical role in motor control and motor learning(1). In songbirds, the anterior forebrain pathway ( AFP) is a basal ganglia - forebrain circuit required for song learning and adult vocal plasticity but not for production of learned song(2 - 5). Here, we investigate functional contributions of this circuit to the control of song, a complex, learned motor skill. We test the hypothesis that neural activity in the AFP of adult birds can direct moment- by- moment changes in the primary motor areas responsible for generating song. We show that song- triggered microstimulation in the output nucleus of the AFP induces acute and specific changes in learned parameters of song(6,7). Moreover, under both natural and experimental conditions, variability in the pattern of AFP activity is associated with variability in song structure. Finally, lesions of the output nucleus of the AFP prevent naturally occurring modulation of song variability. These findings demonstrate a previously unappreciated capacity of the AFP to direct real- time changes in song. More generally, they suggest that frontal cortical and basal ganglia areas may contribute to motor learning by biasing motor output towards desired targets or by introducing stochastic variability required for reinforcement learning.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kao, MH (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	mimi@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907; Kao, Mimi/0000-0001-8884-9022	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006636] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Doya Kenji, 2000, P469; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Perkel DJ, 2004, ANN NY ACAD SCI, V1016, P736, DOI 10.1196/annals.1298.039; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Troyer TW, 2001, CURR OPIN NEUROBIOL, V11, P721, DOI 10.1016/S0959-4388(01)00275-6; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VICARIO DS, 1995, J NEUROPHYSIOL, V73, P2602, DOI 10.1152/jn.1995.73.6.2602; VU ET, 1994, J NEUROSCI, V14, P6924; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; WILLIAMS H, 1989, J COMP PSYCHOL, V103, P366, DOI 10.1037/0735-7036.103.4.366; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	30	365	370	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					638	643		10.1038/nature03127	http://dx.doi.org/10.1038/nature03127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703748				2022-12-24	WOS:000226862000046
J	Chen, XJ; Wang, XW; Kaufman, BA; Butow, RA				Chen, XJ; Wang, XW; Kaufman, BA; Butow, RA			Aconitase couples metabolic regulation to mitochondrial DNA maintenance	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CYTOSOLIC ACONITASE; PROTEIN-COMPONENTS; OXIDATIVE DAMAGE; BINDING-PROTEIN; YEAST; NUCLEOIDS; IDENTIFICATION	Mitochondrial DNA (mtDNA) is essential for cells to maintain respiratory competency and is inherited as a protein-DNA complex called the nucleoid. We have identified 22 mtDNA-associated proteins in yeast, among which is mitochondrial aconitase (Aco1p). We show that this Krebs-cycle enzyme is essential for mtDNA maintenance independent of its catalytic activity. Regulation of ACO1 expression by the HAP and retrograde metabolic signaling pathways directly affects mtDNA maintenance. When constitutively expressed, Aco1p can replace the mtDNA packaging function of the high-mobility-group protein Abf2p. Thus, Aco1p may integrate metabolic signals and mtDNA maintenance.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Butow, RA (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	ronald.butow@utsouthwestern.edu			NIA NIH HHS [R01 AG023731] Funding Source: Medline; NIGMS NIH HHS [GM22525, GM33510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022525, R37GM022525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Jia YK, 1997, MOL MICROBIOL, V24, P53, DOI 10.1046/j.1365-2958.1997.3011669.x; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; LAWRENCE JJ, 1976, BIOCHEMISTRY-US, V15, P3301, DOI 10.1021/bi00660a021; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; MEGRAW TL, 1993, J BIOL CHEM, V268, P12758; MIYAKAWA I, 1987, J CELL SCI, V88, P431; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Sato H, 2002, PROTOPLASMA, V219, P51, DOI 10.1007/s007090200005; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	29	248	260	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					714	717		10.1126/science.1106391	http://dx.doi.org/10.1126/science.1106391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692048				2022-12-24	WOS:000226814900040
J	Kobayashi, KS; Chamaillard, M; Ogura, Y; Henegariu, O; Inohara, N; Nunez, G; Flavell, RA				Kobayashi, KS; Chamaillard, M; Ogura, Y; Henegariu, O; Inohara, N; Nunez, G; Flavell, RA			Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; AVIUM SUBSPECIES PARATUBERCULOSIS; NF-KAPPA-B; CROHNS-DISEASE; ALPHA-DEFENSIN; PANETH CELLS; NOD2 GENE; ACTIVATION; MUTATIONS; MICE	The gene encoding the Nod2 protein is frequently mutated in Crohn's disease (CD) patients, although the physiological function of Nod2 in the intestine remains elusive. Here we show that protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod2-deficient mice. These animals are susceptible to bacterial infection via the oral route but not through intravenous or peritoneal delivery. Nod2 is required for the expression of a subgroup of intestinal anti-microbial peptides, known as cryptdins. The Nod2 protein is thus a critical regulator of bacterial immunity within the intestine, providing a possible mechanism for Nod2 mutations in CD.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA.	richard.flavell@yale.edu	Chamaillard, Mathias/L-6542-2013; Nuñez, Gabriel/A-7160-2014	Chamaillard, Mathias/0000-0002-0243-9717; Kobayashi, Koichi/0000-0003-2930-0114				Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Schmid M, 2004, Z GASTROENTEROL, V42, P333, DOI 10.1055/s-2004-813072; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Selby WS, 2004, LANCET, V364, P1013, DOI 10.1016/S0140-6736(04)17071-2; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Tani K, 2000, INT IMMUNOL, V12, P691, DOI 10.1093/intimm/12.5.691; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9	35	1370	1436	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					731	734		10.1126/science.1104911	http://dx.doi.org/10.1126/science.1104911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692051				2022-12-24	WOS:000226814900045
J	Nguyen, HQ; Jumaan, AO; Seward, JF				Nguyen, HQ; Jumaan, AO; Seward, JF			Decline in mortality due to varicella after implementation of varicella vaccination in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEATHS	BACKGROUND: Varicella disease has been preventable in the United States since 1995. Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella. METHODS: Data on deaths for which varicella was listed as an underlying or contributing cause were obtained from National Center for Health Statistics Multiple Cause-of-Death Mortality Data for 1990 through 2001. We calculated the numbers and rates of death due to varicella according to age, sex, race, ethnic background, and birthplace. RESULTS: The rate of death due to varicella fluctuated from 1990 through 1998 and then declined sharply. For the interval from 1990 through 1994, the average number of varicella-related deaths was 145 per year (varicella was listed as the underlying cause in 105 deaths and as a contributing cause in 40); it then declined to 66 per year during 1999 through 2001. For deaths for which varicella was listed as the underlying cause, age-adjusted mortality rates dropped by 66 percent, from an average of 0.41 death per 1 million population during 1990 through 1994 to 0.14 during 1999 through 2001 (P<0.001). This decline was observed in all age groups under 50 years, with the greatest reduction (92 percent) among children 1 to 4 years of age. In addition, by the period from 1999 through 2001, the average rates of mortality due to varicella among all racial and ethnic groups were below 0.15 per 1 million population, as compared with rates ranging from 0.37 per 1 million for whites to 0.66 per 1 million for other races in the period from 1990 through 1994. CONCLUSIONS: The program of universal childhood vaccination against varicella in the United States has resulted in a sharp decline in the rate of death due to varicella.	CDCP, Viral Vaccine Preventable Dis Branch, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Seward, JF (corresponding author), CDCP, Viral Vaccine Preventable Dis Branch, Natl Immunizat Program, 1600 Clifton Rd,Mailstop E-61, Atlanta, GA 30333 USA.	jseward@cdc.gov						[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Boelle PY, 2002, EPIDEMIOL INFECT, V129, P599, DOI 10.1017/S0950268802007720; Bramley J C, 2000, Commun Dis Public Health, V3, P282; Center for Disease Control and Prevention, NAT IMM SURV NIS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Chant KG, 1998, AUST NZ J PUBL HEAL, V22, P413, DOI 10.1111/j.1467-842X.1998.tb01405.x; Chant KG, 1998, AUST NZ J PUBL HEAL, V22, P630; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; Galil K, 2002, AM J PUBLIC HEALTH, V92, P1248, DOI 10.2105/AJPH.92.8.1248; KILGORE PE, 2003, J MED VIROL S1, V10, pS111; Lam M. S., 1993, Singapore Medical Journal, V34, P213; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; *NAT CTR HLTH STAT, 2004, ICD 0 ACME DEC TA 2C; *NAT CTR HLTH STAT, 2002, BRIDG RAC VINT 2002; *NAT CTR HLTH STAT, 1999, BRIDG RAC INT POP ES; Rawson H, 2001, BRIT MED J, V323, P1091, DOI 10.1136/bmj.323.7321.1091; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; *US BUR CENS, ANN TIM SER STAT POP; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; World Health Organization, 1992, INT STAT CLASS DIS R; 2002, MMWR MORB MORTAL WKL, V51, P664	23	271	301	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					450	458		10.1056/NEJMoa042271	http://dx.doi.org/10.1056/NEJMoa042271			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689583				2022-12-24	WOS:000226725400005
J	Marton, ML; Cordts, S; Broadhvest, J; Dresselhaus, T				Marton, ML; Cordts, S; Broadhvest, J; Dresselhaus, T			Micropylar pollen tube guidance by egg apparatus 1 of maize	SCIENCE			English	Article							FERTILIZATION; POLLINATION; PROTEIN; GROWTH; FEMALE; CELL	Pollen tube guidance precedes the double fertilization of flowering plants. Here, we report the identification of a small maize protein of 94 amino acids involved in short-range signaling required for pollen tube attraction by the female gametophyte. ZmEA1 is exclusively expressed in the egg apparatus, consisting of the egg cell and two synergids. Chimeric ZmEA1 fused to green fluorescent protein (ZmEA1:GFP) was first visible within the filiform apparatus and later was localized to nucellar cell watts below the micropylar opening of the ovule. Transgenic down-regulation of the ZmEA1 gene led to ovule sterility caused by loss of close-range pollen tube guidance to the micropyle.	Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany; Bayer Biosci NV, B-9052 Ghent, Belgium	University of Hamburg; Bayer AG	Dresselhaus, T (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	dresselh@botanik.uni-hamburg.de						Brettschneider R, 1997, THEOR APPL GENET, V94, P737, DOI 10.1007/s001220050473; DIBOLL ALFRED G., 1968, AMER J BOT, V55, P797, DOI 10.2307/2440968; DRESSELHAUS T, 1994, PLANT J, V5, P605, DOI 10.1046/j.1365-313X.1994.5040605.x; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 2003, CURR OPIN PLANT BIOL, V6, P36, DOI 10.1016/S1369-5266(02)00010-9; Ishikawa M, 1918, ANN BOT-LONDON, V32, P279; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton M., UNPUB; Mol R, 2000, PLANTA, V210, P749, DOI 10.1007/s004250050676; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; SHARMA HC, 1995, EUPHYTICA, V82, P43, DOI 10.1007/BF00028709; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Van der Pluijm JE, 1964, POLLEN PHYSL FERTILI, P8; Weterings K, 2004, PLANT CELL, V16, pS107, DOI 10.1105/tpc.016873; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x	16	233	258	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					573	576		10.1126/science.1104954	http://dx.doi.org/10.1126/science.1104954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681383				2022-12-24	WOS:000226694000045
J	Yin, YH; Vafeados, D; Tao, Y; Yoshida, S; Asami, T; Chory, J				Yin, YH; Vafeados, D; Tao, Y; Yoshida, S; Asami, T; Chory, J			A new class of transcription factors mediates brassinosteroid-regulated gene expression in Arabidopsis	CELL			English	Article							PLANT-GROWTH; SIGNAL-TRANSDUCTION; KINASE; RECEPTOR; BRI1; DNA; BIOSYNTHESIS; PERCEPTION; MEMBRANE; THALIANA	Brassinosteroids (BRs) signal through a plasma membrane-localized receptor kinase to regulate plant growth and development. We showed previously that a novel protein, BES1, accumulates in the nucleus in response to BRs, where it plays a role in BR-regulated gene expression; however, the mechanism by which BES1 regulates gene expression is unknown. In this study, we dissect BES1 subdomains and establish that BES1 is a transcription factor that binds to and activates BR target gene promoters both in vitro and in vivo. BES1 interacts with a basic helix-loop-helix protein, BIM1, to synergistically bind to E box (CANNTG) sequences present in many BR-induced promoters. Loss-of-function and gain-of-function mutants of BIM1 and its close family members display BR response phenotypes. Thus, BES1 defines a new class of plant-specific transcription factors that cooperate with transcription factors such as BIM1 to regulate BR-induced genes.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; RIKEN, Plant Funct Lab, Inst Phys & Chem Res, Wako, Saitama 351098, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Tao, Yi/B-7718-2012	Tao, Yi/0000-0002-7460-7927	NIGMS NIH HHS [R01 GM060519, F32 GM020558] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Coll-Garcia D, 2004, FEBS LETT, V563, P82, DOI 10.1016/S0014-5793(04)00255-8; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Friedrichsen DM, 2002, GENETICS, V162, P1445; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Iliev EA, 2002, PLANT PHYSIOL, V130, P770, DOI 10.1104/pp.008680; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; LI J, 1999, J EXP BOT, V50, P332; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Mussig C, 2002, PLANT PHYSIOL, V129, P1241, DOI 10.1104/pp.011003; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; YIN YH, 1995, PLANT J, V7, P969, DOI 10.1046/j.1365-313X.1995.07060969.x; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	48	513	593	11	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					249	259		10.1016/j.cell.2004.11.044	http://dx.doi.org/10.1016/j.cell.2004.11.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680330	Bronze			2022-12-24	WOS:000226740000013
J	Olson, TM; Michels, VV; Ballew, JD; Reyna, SP; Karst, ML; Herron, KJ; Horton, SC; Rodeheffer, RJ; Anderson, JL				Olson, TM; Michels, VV; Ballew, JD; Reyna, SP; Karst, ML; Herron, KJ; Horton, SC; Rodeheffer, RJ; Anderson, JL			Sodium channel mutations and susceptibility to heart failure and atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; LONG-QT SYNDROME; CONDUCTION-SYSTEM DISEASE; LAMIN A/C GENE; VENTRICULAR-FIBRILLATION; CARDIAC-ARRHYTHMIAS; BRUGADA-SYNDROME; SCN5A; FREQUENCY; RELATIVES	Context Dilated cardiomyopathy (DCM), a genetically heterogeneous disorder, causes heart failure and rhythm disturbances. The majority of identified DCM genes encode structural proteins of the contractile apparatus and cytoskeleton. Recently, genetic defects in,calcium and potassium regulation have been discovered in patients with DCM, implicating an alternative disease mechanism. The full spectrum of genetic defects in DCM, however, has not been established. Objectives To identify a novel gene for DCM at a previously mapped locus, define the spectrum of mutations in this gene within a DCM cohort and determine the frequency of DCM among relatives inheriting a mutation in this gene. Design, Setting, and Participants Refined mapping of a DCM locus on chromosome 3p,in a multigenerational family and mutation scanning in 156 unrelated probands with DCM, prospectively identified at the Mayo Clinic between 1987 and 2004. Relatives underwent screening echocardiography and electrocardiography and DNA sample procurement. Main Outcome Measure Correlation of identified mutations with cardiac phenotype. Results Refined locus mapping revealed SCN5A, encoding the cardiac sodium channel, as a candidate gene. Mutation scans identified a missense mutation (D1275N) that cosegregated with an age-dependent, variably expressed phenotype of DCM, atrial fibrillation, impaired automaticity, and conduction delay. In the DCM, cohort, additional missense (T2201, R814W, D1595H) and truncation (2550-2551insTG) SCN5A mutations, segregating with cardiac disease or arising de novo, were discovered in unrelated probands. Among individuals with an SCN5A mutation 27% had early features of DCM (mean age at diagnosis, 20.3 years), 38% had DCM (mean age at diagnosis, 47.9 years), and 43% had atrial fibrillation (mean age at diagnosis, 27.8 years). Conclusions Heritable SCN5A defects are associated with susceptibility to early-onset DCM and atrial fibrillation. Similar or even identical mutations may lead to heart failure, arrhythmia, or both.	Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Med Genet, Rochester, MN 55905 USA; Univ Utah, Latter Day St Hosp, Cardiovasc Dept, Salt Lake City, UT 84143 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Utah System of Higher Education; University of Utah	Olson, TM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	olson.timothy@mayo.edu		Olson, Timothy/0000-0003-2716-9423	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071225] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL71225, R01 HL071225, R01 HL071225-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akai J, 2000, FEBS LETT, V479, P29, DOI 10.1016/S0014-5793(00)01875-5; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen S, 2002, J MED GENET, V39, P913, DOI 10.1136/jmg.39.12.913; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Flesch M, 2001, CARDIOVASC DRUG THER, V15, P379, DOI 10.1023/A:1013329203750; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; GREENLEE PR, 1986, WESTERN J MED, V144, P33; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Michels VV, 2003, AM J CARDIOL, V91, P1389, DOI 10.1016/S0002-9149(03)00341-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Plassart Emmanuelle, 1994, European Journal of Human Genetics, V2, P110; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schonberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; ZIPES DP, 1997, HEART DIS TXB CARDIO, P597	38	391	413	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					447	454		10.1001/jama.293.4.447	http://dx.doi.org/10.1001/jama.293.4.447			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671429	Bronze, Green Accepted			2022-12-24	WOS:000226492900023
J	Wisloff, U; Najjar, SM; Ellingsen, O; Haram, PM; Swoap, S; Al-Share, Q; Fernstrom, M; Rezaei, K; Lee, SJ; Koch, LG; Britton, SL				Wisloff, U; Najjar, SM; Ellingsen, O; Haram, PM; Swoap, S; Al-Share, Q; Fernstrom, M; Rezaei, K; Lee, SJ; Koch, LG; Britton, SL			Cardiovascular risk factors emerge after artificial selection for low aerobic capacity	SCIENCE			English	Article							INSULIN-RESISTANCE; CARDIAC REHABILITATION; YOUNG ADULTHOOD; HEART-FAILURE; MORTALITY; DYSFUNCTION; CHILDHOOD; PARENTS; DISEASE	In humans, the strong statistical association between fitness and survival suggests a link between impaired oxygen metabolism and disease. We hypothesized that artificial selection of rats based on low and high intrinsic exercise capacity would yield models that also contrast for disease risk. After 11 generations, rats with low aerobic capacity scored high on cardiovascular risk factors that constitute the metabolic syndrome. The decrease in aerobic capacity was associated with decreases in the amounts of transcription factors required for mitochondrial biogenesis and in the amounts of oxidative enzymes in skeletal muscle. Impairment of mitochondrial function may link reduced fitness to cardiovascular and metabolic disease.	Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7489 Trondheim, Norway; St Olavs Hosp, Dept Cardiol, N-7006 Trondheim, Norway; Med Coll Ohio, Dept Pharmacol Cardiovasc Biol & Metab Dis, Toledo, OH USA; Williams Coll, Dept Biol, Williamstown, MA 01267 USA; Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Williams College; University of Michigan System; University of Michigan	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Olav Kyrres Gt 3, N-7489 Trondheim, Norway.	ulrik.wisloff@medisin.ntnu.no	Najjar, Sonia M/GXW-2217-2022; Wisloff, Ulrik/K-2899-2012; Koch, Lauren/D-1258-2010	Al-Share, Qusai/0000-0002-2306-6198; Wisloff, Ulrik/0000-0002-7211-3587	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R21DK057497] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 17718] Funding Source: Medline; NHLBI NIH HHS [HL 64270] Funding Source: Medline; NIDDK NIH HHS [DK 57497, DK 54254] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hambrecht R, 2000, JAMA-J AM MED ASSOC, V283, P3095, DOI 10.1001/jama.283.23.3095; Kavanagh T, 2003, J AM COLL CARDIOL, V42, P2139, DOI 10.1016/j.jacc.2003.07.028; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Srinivasan SR, 2003, METABOLISM, V52, P443, DOI 10.1053/meta.2003.50065; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; WISLOFF U, 2001, AM J PHYSIOL, V280, pH1302; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Youssef AA, 2002, ANN EPIDEMIOL, V12, P553, DOI 10.1016/S1047-2797(01)00286-1; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	18	482	492	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					418	420		10.1126/science.1108177	http://dx.doi.org/10.1126/science.1108177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662013				2022-12-24	WOS:000226492300045
J	Wik, L; Kramer-Johansen, J; Myklebust, H; Sorebo, H; Svensson, L; Fellows, B; Steen, PA				Wik, L; Kramer-Johansen, J; Myklebust, H; Sorebo, H; Svensson, L; Fellows, B; Steen, PA			Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATED EXTERNAL DEFIBRILLATOR; CORONARY BLOOD-FLOW; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; CPR PERFORMANCE; COMPRESSION; RETENTION; SKILLS; GUIDELINES; SURVIVAL	Context Cardiopulmonary resuscitation (CPR) guidelines recommend target values for compressions, ventilations, and CPR-free intervals allowed for rhythm analysis and defibrillation. There is little information on adherence to these guidelines during advanced cardiac life support in the field. Objective To measure the quality of out-of-hospital CPR performed by ambulance personnel, as measured by adherence to CPR guidelines. Design and Setting Case series of 176 adult patients with out-of-hospital cardiac arrest treated by paramedics and nurse anesthetists in Stockholm Sweden, London, England, and Akershus, Norway, between March 2002 and October 2003. The defibrillators recorded chest compressions via a sternal pad fitted with an accelerometer and ventilations by changes in thoracic impedance between the defibrillator pads, in addition to standard event and electrocardiographic recordings. Main Outcome Measure Adherence to international guidelines for CPR. Results Chest compressions were not given 48% (95% CI, 45%-51%) of the time without spontaneous circulation; this percentage was 38% (95% CI, 36%-41%) when subtracting the time necessary for electrocardiographic analysis and defibrillation. Combining these data with a mean compression rate of 121/min (95% CI, 118-124/min) when compressions were given resulted in a mean compression rate of 64/min (95% CI, 61-67/min). Mean compression depth was 34 mm (95% CI, 33-35 mm), 28% (95% CI, 24%-32%) of the compressions had a depth of 38 mm to 51 mm (guidelines recommendation), and the compression part of the duty cycle was 42% (95% CI, 41%-42%). A mean of 11 (95% Cl, 11-12) ventilations were given per minute. Sixty-one patients (35%) had return of spontaneous circulation, and 5 of 6 patients discharged alive from the hospital had normal neurological outcomes. Conclusions In this study of CPR during out-of-hospital cardiac arrest, chest compressions were not delivered half of the time, and most compressions were too shallow. Electrocardiographic analysis and defibrillation accounted for only small parts of intervals without chest compressions.	Ullevaal Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Natl Competence Ctr Emergency Med, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Div Prehosp Emergency Med, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Div Surg, N-0407 Oslo, Norway; Norwegian Air Ambulance, Dept Res & Educ Acute Med, Drobak, Norway; Laerdal Med Corp, Stavanger, Norway; Soder Sjukhuset, S-10064 Stockholm, Sweden; London Ambulance Serv NHS Trust, London, England	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Sodersjukhuset Hospital	Wik, L (corresponding author), Ullevaal Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway.		Kramer-Johansen, Jo/P-5132-2018	Kramer-Johansen, Jo/0000-0002-7881-1757				Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; ANDERSEN HS, 2003, THESIS STAVANGER U S; [Anonymous], 2000, GUID 2000 CARD RES E; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BELLAMY RF, 1984, CIRCULATION, V69, P174, DOI 10.1161/01.CIR.69.1.174; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Broomfield R, 1996, J ADV NURS, V23, P1016; Chamberlain DA, 2003, RESUSCITATION, V59, P11, DOI 10.1016/j.resuscitation.2003.08.011; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Donnelly P, 2000, RESUSCITATION, V45, P195, DOI 10.1016/S0300-9572(00)00186-6; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; GEDDES LA, 1989, PRINCIPLES APPL BIO; Handley AJ, 2003, RESUSCITATION, V57, P57, DOI 10.1016/S0300-9572(02)00400-8; KAYE W, 1986, CRIT CARE MED, V14, P620, DOI 10.1097/00003246-198607000-00007; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Liberman M, 1999, RESUSCITATION, V42, P47, DOI 10.1016/S0300-9572(99)00082-9; MAIER GW, 1986, CIRCULATION, V74, P51; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; MOSER DK, 1992, HEART LUNG, V21, P372; ORNATO JP, 1989, ANN EMERG MED, V18, P732, DOI 10.1016/S0196-0644(89)80005-8; Pellis T, 2002, CRIT CARE MED, V30, pS176, DOI 10.1097/00003246-200204001-00012; Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC), 1974, JAMA-J AM MED ASSOC, V227, P864; Sunde K, 1998, RESUSCITATION, V39, P197, DOI 10.1016/S0300-9572(98)00139-7; Sunde K, 1997, RESUSCITATION, V34, P235, DOI 10.1016/S0300-9572(96)01087-8; van Alem AP, 2003, ANN EMERG MED, V42, P449, DOI 10.1067/S0196-0644(03)00383-4; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Wik L, 2001, RESUSCITATION, V50, P167, DOI 10.1016/S0300-9572(01)00331-8; WOLFE JA, 1988, J THORAC CARDIOV SUR, V95, P523; World Medical Association, 1964, DECL HELS; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E; 2000, RESUSCITATION, V46, P1	33	957	1020	1	41	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					299	304		10.1001/jama.293.3.299	http://dx.doi.org/10.1001/jama.293.3.299			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657322	Green Published, Bronze			2022-12-24	WOS:000226358400023
J	Takyar, S; Hickerson, RP; Noller, HF				Takyar, S; Hickerson, RP; Noller, HF			MRNA helicase activity of the ribosome	CELL			English	Article							ELONGATION-FACTOR TU; SECONDARY STRUCTURE; COLI RIBOSOME; TRANSLOCATION; COMPLEXES; SUBUNIT; SITE; MECHANISM; PROTEIN; MODEL	Most mRNAs contain secondary structure, yet their codons must be in single-stranded form to be translated. Until now, no helicase activity has been identified which could account for the ability of ribosomes to translate through downstream mRNA secondary structure. Using an oligonucleotide displacement assay, together with a stepwise in vitro translation system made up of purified components, we show that ribosomes are able to disrupt downstream helices, including a perfect 27 base pair helix of predicted T-m = 70degrees. Using helices of different lengths and registers, the helicase active site can be localized to the middle of the downstream tunnel, between the head and shoulder of the 30S subunit. Mutation of residues in proteins S3 and S4 that line the entry to the tunnel impairs helicase activity. We conclude that the ribosome itself is an mRNA helicase and that proteins S3 and S4 may play a role in its processivity.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu			NIGMS NIH HHS [GM-17129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R37GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; BIRERLEY L, 2001, COLD SPRING HARB SYM, P233; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; FAVRE A, 1975, EUR J BIOCHEM, V57, P147, DOI 10.1111/j.1432-1033.1975.tb02285.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HOLDER JW, 1975, BIOCHEMISTRY-US, V14, P4209, DOI 10.1021/bi00690a009; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LINGELBACH K, 1988, NUCLEIC ACIDS RES, V16, P3405, DOI 10.1093/nar/16.8.3405; Min Jou W, 1972, Nature, V237, P82; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; PESTKA S, 1969, J BIOL CHEM, V244, P1533; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; VANHIMBERGEN J, 1993, NUCLEIC ACIDS RES, V21, P1713, DOI 10.1093/nar/21.8.1713; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	34	362	369	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					49	58		10.1016/j.cell.2004.11.042	http://dx.doi.org/10.1016/j.cell.2004.11.042			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652481	Bronze			2022-12-24	WOS:000226365400010
J	Kenward, B; Weir, AAS; Rutz, C; Kacelnik, A				Kenward, B; Weir, AAS; Rutz, C; Kacelnik, A			Tool manufacture by naive juvenile crows	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Kenward, B (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoology.ox.ac.uk	Kenward, Ben/A-5558-2009; Weir, Alex/B-4664-2008	Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Celli ML, 2004, INT J PRIMATOL, V25, P1267, DOI 10.1023/B:IJOP.0000043962.60837.16; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; SPAULDING B, IN PRESS ANIM BEHAV; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; Tomasello M, 1999, ANNU REV ANTHROPOL, V28, P509, DOI 10.1146/annurev.anthro.28.1.509; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; WESTERGAARD GC, 1987, J COMP PSYCHOL, V101, P159, DOI 10.1037/0735-7036.101.2.159; WESTERGAARD GC, 1989, PERCEPT MOTOR SKILL, V68, P558, DOI 10.2466/pms.1989.68.2.558	11	154	161	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					121	121		10.1038/433121a	http://dx.doi.org/10.1038/433121a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650729	Bronze			2022-12-24	WOS:000226252200025
J	Hartmann, LC				Hartmann, LC			The octogenarian's plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2005	293	1					15	16		10.1001/jama.293.1.15	http://dx.doi.org/10.1001/jama.293.1.15			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QY	15632320				2022-12-24	WOS:000226102100001
J	Hunt, J; Brooks, R; Jennions, MD; Smith, MJ; Bentsen, CL; Bussiere, LF				Hunt, J; Brooks, R; Jennions, MD; Smith, MJ; Bentsen, CL; Bussiere, LF			High-quality male field crickets invest heavily in sexual display but die young	NATURE			English	Article							LEK PARADOX; PHENOTYPIC PLASTICITY; TRADE-OFFS; GOOD GENES; LIFE-SPAN; OLD-AGE; SELECTION; TRAITS; RESTRICTION; HANDICAP	Only high-quality males can bear the costs of an extreme sexual display(1-4). As a consequence, such males are not only more attractive, but they often live longer than average(5). Recent theory predicts, however, that high-quality males should sometimes invest so heavily in sexual displays that they die sooner than lower quality males(2,6-9). We manipulated the phenotypic quality of field crickets, Teleogryllus commodus, by altering the protein content of their diet. Here we show that nymphs and adult females reared on a high-protein diet lived longer than those on a low-protein diet. In contrast, adult males reared on a high-protein diet died sooner than those on low-protein diets because they invested more energy in calling during early adulthood. Our findings uphold the theoretical prediction that the relationship between longevity and sexual advertisement may be dynamic(2,3,6-8) (that is, either positive or negative), depending on local conditions(3,6) such as resource availability. Moreover, they caution the use of longevity as a proxy for fitness in sexual selection studies, and suggest avenues for future research on the relationship between sexual attractiveness and ageing.	Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	University of New South Wales Sydney; Australian National University	Hunt, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia.	john.hunt@unsw.edu.au	Brooks, Robert/A-1251-2008; Hunt, John/F-1279-2014; Jennions, Michael D/C-7560-2009; Bussiere, Luc/T-2134-2018	Brooks, Robert/0000-0001-6926-0781; Jennions, Michael D/0000-0001-9221-2788; Bussiere, Luc/0000-0001-8937-8381; Hunt, John/0000-0002-4962-8750				Candolin U, 2000, P ROY SOC B-BIOL SCI, V267, P2425, DOI 10.1098/rspb.2000.1301; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Eshel I, 2000, EVOL ECOL RES, V2, P509; Gerhardt H.C., 2002, ACOUSTIC COMMUNICATI; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hoglund J, 1998, OIKOS, V83, P478, DOI 10.2307/3546675; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P2109, DOI 10.1098/rspb.1999.0895; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kotiaho J, 1998, J ANIM ECOL, V67, P287, DOI 10.1046/j.1365-2656.1998.00192.x; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Muller HG, 1997, P NATL ACAD SCI USA, V94, P2762, DOI 10.1073/pnas.94.6.2762; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; Roff Derek, 2002, pi; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	30	376	379	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					1024	1027		10.1038/nature03084	http://dx.doi.org/10.1038/nature03084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616562				2022-12-24	WOS:000225887000041
J	Shorr, AF; Scoville, SL; Cersovsky, SB; Shanks, GD; Ockenhouse, CF; Smoak, BL; Carr, WW; Petruccelli, BP				Shorr, AF; Scoville, SL; Cersovsky, SB; Shanks, GD; Ockenhouse, CF; Smoak, BL; Carr, WW; Petruccelli, BP			Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING	Context Acute eosinophilic pneumonia (AEP) is a rare disease of unknown etiology characterized by respiratory failure, radiographic infiltrates, and eosinophilic infiltration of the lung. Objectives To describe a case series of AEP, illustrate the clinical features of this syndrome, and report the results of an epidemiologic investigation. Design, Setting, and Participants Epidemiologic investigation of cases of AEP identified both retrospectively and prospectively from March 2003 through March 2004 among US military personnel deployed in or near Iraq. Survivors were offered a follow-up evaluation. Main Outcome Measure Morbidity and mortality related to AEP. Results There were 18 cases of AEP identified among 183000 military personnel deployed in or near Iraq during the study period, yielding an AEP incidence of 9.1 per 100000 person-years (95% confidence interval, 4.3-13.3). The majority of patients (89%) were men and the median age was 22 (range, 19-47) years. All patients used tobacco, with 78% recently beginning to smoke. All but 1 reported significant exposure to fine airborne sand or dust. Known causes of pulmonary eosinophilia (eg, drug exposures or parasitic disease) were not identified. Epidemiologic investigation revealed no evidence of a common source exposure, temporal or geographic clustering, person-to-person transmission, or an association with recent vaccination. Six patients underwent bronchoalveolar lavage (median eosinophilia of 40.5%). All patients developed peripheral eosinophilia (range, 8%-42%). Mechanical ventilation was required in 67% for a median of 7 (range, 2-16) days. Two Soldiers died; the remainder responded to corticosteroids and/or supportive care. Twelve individuals were reevaluated a median of 3 months after diagnosis. At that point, 3 patients reported mild dyspnea and 1 reported wheezing. All patients had finished treatment and had either normal or nearly normal spirometry results. None had recurrent eosinophilia. Conclusions AEP occurred at an increased rate among this deployed military population and resulted in 2 deaths. Failure to consider AEP in the differential diagnosis of respiratory failure in military personnel can result in missing this syndrome and possibly death. The etiology of AEP remains unclear, but the association with new-onset smoking suggests a possible link.	Walter Reed Army Med Ctr, Pulm Crit Care & Sleep Med Serv, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Allergy & Immunol Serv, Washington, DC 20307 USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; Walter Reed Army Inst Res, Dept Communicable Dis & Immunol, Silver Spring, MD USA; Walter Reed Army Inst Res, Dept Prevent Med, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Shorr, AF (corresponding author), Walter Reed Army Med Ctr, Pulm Crit Care & Sleep Med Serv, 6900 Georgia Ave, Washington, DC 20307 USA.	afshorr@dnamail.com	Shanks, George Dennis/F-4056-2014	Shanks, George Dennis/0000-0001-5763-8660				Allen JN, 2004, CLIN CHEST MED, V25, P77, DOI 10.1016/S0272-5231(03)00141-2; ALLEN JN, 1994, AM J RESP CRIT CARE, V150, P1423, DOI 10.1164/ajrccm.150.5.7952571; ALLEN JN, 1989, NEW ENGL J MED, V321, P569, DOI 10.1056/NEJM198908313210903; BADESCH DB, 1989, AM REV RESPIR DIS, V139, P249, DOI 10.1164/ajrccm/139.1.249; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P857; Degler DA, 1999, MIL MED, V164, P911, DOI 10.1093/milmed/164.12.911; Marchand E, 1998, MEDICINE, V77, P299, DOI 10.1097/00005792-199809000-00001; MIYAZAKI E, 1995, AM J RESP CRIT CARE, V151, P541, DOI 10.1164/ajrccm.151.2.7842218; Nakajima M, 1998, RADIOLOGY, V207, P829, DOI 10.1148/radiology.207.3.829-b; Philit F, 2002, AM J RESP CRIT CARE, V166, P1235, DOI 10.1164/rccm.2112056; PopeHarman AL, 1996, MEDICINE, V75, P334, DOI 10.1097/00005792-199611000-00004; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Shintani H, 2000, CHEST, V117, P277, DOI 10.1378/chest.117.1.277; Shintani H, 2000, INTERNAL MED, V39, P66, DOI 10.2169/internalmedicine.39.66; Tazelaar HD, 1997, AM J RESP CRIT CARE, V155, P296, DOI 10.1164/ajrccm.155.1.9001328; *US DEP DEF, 2003, WORLDW MANP DISTR GE	18	157	166	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2997	3005		10.1001/jama.292.24.2997	http://dx.doi.org/10.1001/jama.292.24.2997			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613668	Bronze			2022-12-24	WOS:000225841900034
J	Jackson, DE; Holcombe, M; Ratnieks, FLW				Jackson, DE; Holcombe, M; Ratnieks, FLW			Trail geometry gives polarity to ant foraging networks	NATURE			English	Article							GENERAL-MODEL; ORIENTATION; HYMENOPTERA	Pheromone trails are used by many ants to guide foragers between nest and food(1-4). But how does a forager that has become displaced from a trail know which way to go on rejoining the trail? A laden forager, for example, should walk towards the nest. Polarized trails would enable ants to choose the appropriate direction, thereby saving time and reducing predation risk. However, previous research has found no evidence that ants can detect polarity from the pheromone trail alone(3,5-7). Pharaoh's ants (Monomorium pharaonis) produce elaborate trail networks throughout their foraging environment(8). Here we show that by using information from the geometry of trail bifurcations within this network, foragers joining a trail can adaptively reorientate themselves if they initially walk in the wrong direction. The frequency of correct reorientations is maximized when the trail bifurcation angle is approximately 60 degrees, as found in natural networks. These are the first data to demonstrate how ant trails can themselves provide polarity information. They also demonstrate previously unsuspected sophistication in the organization and information content of networks in insect societies.	Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield; University of Sheffield	Jackson, DE (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	duncan@dcs.sheffield.ac.uk						ACOSTA FJ, 1993, J THEOR BIOL, V160, P297, DOI 10.1006/jtbi.1993.1020; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; Banks AN, 2003, ETHOLOGY, V109, P835, DOI 10.1046/j.0179-1613.2003.00927.x; BARKER SB, 1973, J THEOR BIOL, V40, P33, DOI 10.1016/0022-5193(73)90163-X; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P217; CARTHY JD, 1951, BEHAVIOUR, V3, P304, DOI 10.1163/156853951X00313; CARTHY JD, 1950, NATURE, V166, P154, DOI 10.1038/166154a0; CARTHY JD, 1951, BEHAVIOUR, V3, P275, DOI 10.1163/156853951X00304; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Feynman RP., 1985, SURELY YOURE JOKING; FOURCASSIE V, 1994, PHYSIOL ENTOMOL, V19, P291, DOI 10.1111/j.1365-3032.1994.tb01055.x; FOWLER HG, 1978, J NEW YORK ENTOMOL S, V86, P132; HOLLDOBLER B, 1974, P NATL ACAD SCI USA, V71, P3274, DOI 10.1073/pnas.71.8.3274; Holldobler B., 1990, pi; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; LEOPOLD LB, 1971, J THEOR BIOL, V31, P339, DOI 10.1016/0022-5193(71)90192-5; QUINET Y, 1991, BELG J ZOOL, V121, P55; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Schu┬ne H., 1984, SPATIAL ORIENTATION; SUDD J. H., 1960, ANIMAL BEHAVIOUR, V8, P67, DOI 10.1016/0003-3472(60)90011-7; SUDD JH, 1967, INTRO BEHAV ANTS, pCH6; TENNANT LE, 1991, J ENTOMOL SCI, V26, P450, DOI 10.18474/0749-8004-26.4.450; Thompson D., 1917, GROWTH FORM; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0	26	130	144	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					907	909		10.1038/nature03105	http://dx.doi.org/10.1038/nature03105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602563				2022-12-24	WOS:000225733500054
J	Akiyama, T; Maeda, S; Yamane, S; Ogino, K; Kasai, M; Kajiura, F; Matsumoto, M; Inoue, J				Akiyama, T; Maeda, S; Yamane, S; Ogino, K; Kasai, M; Kajiura, F; Matsumoto, M; Inoue, J			Dependence of self-tolerance on TRAF6-directed development of thymic stroma	SCIENCE			English	Article							NF-KAPPA-B; PROMISCUOUS GENE-EXPRESSION; NEGATIVE SELECTION; AIRE EXPRESSION; RECEPTOR; CELLS; RELB; MICE; PROTEIN; KINASE	The microenvironments of the thymus are generated by thymic epithelial cells (TECs) and are essential for inducing immune self-toterance or developing T cells. However, the molecular mechanisms that underlie the differentiation of TECs and thymic compartmentalization are not fully understood. Here we show that deficiency in the tumor necrosis factor receptor-associated factor (TRAF) 6 results in disorganized distribution of medullary TECs (mTECs) and the absence of mature mTECs. Engraftment of thymic stroma of TRAF6(-/-)embryos into athymic nude mice induced autoimmunity. Thus, TRAF6 directs the development of thymic stroma and represents a critical point of regulation for self-tolerance and autoimmunity.	Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan; Natl Inst Infect Dis, Div Bacterial & Blood Prod, Musashimurayama, Tokyo 2080011, Japan; Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan	University of Tokyo; National Institute of Infectious Diseases (NIID); Tokushima University	Inoue, J (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan.	jun-i@ims.u-tokyo.ac.jp						Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chiffoleau E, 2003, J IMMUNOL, V171, P5751, DOI 10.4049/jimmunol.171.11.5751; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; KASAI M, 1991, CELL IMMUNOL, V132, P377, DOI 10.1016/0008-8749(91)90035-A; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SCHENINKING J, 1993, MOLT SALT FORUM, V1&2, P13; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	28	225	233	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					248	251		10.1126/science.1105677	http://dx.doi.org/10.1126/science.1105677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15705807				2022-12-24	WOS:000228273700052
J	Loftus, BJ; Fung, E; Roncaglia, P; Rowley, D; Amedeo, P; Bruno, D; Vamathevan, J; Miranda, M; Anderson, IJ; Fraser, JA; Allen, JE; Bosdet, IE; Brent, MR; Chiu, R; Doering, TL; Dontin, MJ; D'Souza, CA; Fox, DS; Grinberg, V; Fu, JM; Fukushima, M; Haas, BJ; Huang, JC; Janbon, G; Jones, SJM; Koo, HL; Krzywinski, MI; Kwon-Chung, JK; Lengeler, KB; Maiti, R; Marra, MA; Marra, RE; Mathewson, CA; Mitchell, TG; Pertea, M; Riggs, FR; Salzberg, SL; Schein, JE; Shvartsbeyn, A; Shin, H; Shumway, M; Specht, CA; Suh, BB; Tenney, A; Utterback, TR; Wickes, BL; Wortman, JR; Wye, NH; Kronstad, JW; Lodge, JK; Heitman, J; Davis, RW; Fraser, CM; Hyman, RW				Loftus, BJ; Fung, E; Roncaglia, P; Rowley, D; Amedeo, P; Bruno, D; Vamathevan, J; Miranda, M; Anderson, IJ; Fraser, JA; Allen, JE; Bosdet, IE; Brent, MR; Chiu, R; Doering, TL; Dontin, MJ; D'Souza, CA; Fox, DS; Grinberg, V; Fu, JM; Fukushima, M; Haas, BJ; Huang, JC; Janbon, G; Jones, SJM; Koo, HL; Krzywinski, MI; Kwon-Chung, JK; Lengeler, KB; Maiti, R; Marra, MA; Marra, RE; Mathewson, CA; Mitchell, TG; Pertea, M; Riggs, FR; Salzberg, SL; Schein, JE; Shvartsbeyn, A; Shin, H; Shumway, M; Specht, CA; Suh, BB; Tenney, A; Utterback, TR; Wickes, BL; Wortman, JR; Wye, NH; Kronstad, JW; Lodge, JK; Heitman, J; Davis, RW; Fraser, CM; Hyman, RW			The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTION; SEQUENCE	Cryptococcus neoformans is a basidionnycetous yeast ubiquitous in the environment, a model for fungal pathogenesis, and an opportunistic human pathogen of global importance. We have sequenced its similar to20-megabase genome, which contains similar to6500 intron-rich gene structures and encodes a transcriptome abundant in alternatively spliced and antisense messages. The genome is rich in transposons, many of which cluster at candidate centromeric regions. The presence of these transposons may drive karyotype instability and phenotypic variation. C. neoformans encodes unique genes that may contribute to its unusual virulence properties, and comparison of two phenotypically distinct strains reveals variation in gene content in addition to sequence polymorphisms between the genomes.	Inst Genom Res, Rockville, MD 20850 USA; Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Scuola Int Super Studi Avanzati, SISSA, I-34014 Trieste, Italy; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Childrens Hosp, Louisiana State Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA; Childrens Hosp, Louisiana State Hlth Sci Ctr, Res Inst Children, New Orleans, LA 70118 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA; Inst Pasteur, Unite Mycol Mol, Paris 15, France; NIAID, Mol Microbiol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Univ Dusseldorf, Inst Mikrobiol, D-4000 Dusseldorf, Germany; Connecticut Agr Expt Stn, New Haven, CT 06511 USA; Boston Univ, Dept Med, Boston, MA 02118 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; J Craig Venter Fdn, Joint Technol Ctr, Rockville, MD 20850 USA	J. Craig Venter Institute; Stanford University; International School for Advanced Studies (SISSA); Duke University; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; University of British Columbia; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Health San Antonio; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Heinrich Heine University Dusseldorf; Connecticut Agricultural Experiment Station; Boston University; University of California System; University of California Santa Cruz; J. Craig Venter Institute	Loftus, BJ (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	bjloftus@tigr.org	Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Jones, Steven J/C-3621-2009; Marra, Robert E/G-4220-2011; Fraser, James A/B-4918-2012; Pertea, Mihaela/AAT-2705-2021; Salzberg, Steven/Q-6514-2019; Janbon, Guilhem/AAL-6607-2021; Salzberg, Steven L/F-6162-2011; Mitchell, Thomas G./A-2356-2008; Heitman, Joseph/ABC-6006-2021; Janbon, Guilhem/AAW-7398-2021; Brent, Michael/AAK-3702-2020	Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Fraser, James A/0000-0001-5724-5285; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Janbon, Guilhem/0000-0002-4788-1154; Brent, Michael/0000-0002-8689-0299; Wickes, Brian/0000-0001-5909-5815; Lodge, Jennifer/0000-0002-2526-1210; Roncaglia, Paola/0000-0002-2825-0621; Allen, Jonathan/0000-0002-4359-8263; Wortman, Jennifer/0000-0002-8713-1227; Fraser, Claire/0000-0003-1462-2428; loftus, brendan/0000-0001-8871-8356; Donlin, Maureen/0000-0001-7312-079X; Vamathevan, Jessica/0000-0003-2016-9754	NHLBI NIH HHS [R01 HL088905-04A2, R01 HL088905] Funding Source: Medline; NIAID NIH HHS [AI48594, R01 AI050184, AI47087, R01 AI050184-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048594, R01AI050184, U01AI047087, Z01AI000057] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bose I, 2003, EUKARYOT CELL, V2, P655, DOI 10.1128/EC.2.4.655-663.2003; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Casadevall A., 1998, CRYPTOCOCCUS NEOFORM, DOI [10.1128/9781555818241, DOI 10.1128/9781555818241]; FRASER JD, UNPUB; Gorlach JM, 2002, MICROBIOL-SGM, V148, P213, DOI 10.1099/00221287-148-1-213; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x	13	542	1296	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1321	1324		10.1126/science.1103773	http://dx.doi.org/10.1126/science.1103773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15653466	Green Submitted, Green Accepted			2022-12-24	WOS:000227313200062
J	Sage, C; Huang, MQ; Karimi, K; Gutierrez, G; Vollrath, MA; Zhang, DS; Garcia-Anoveros, J; Hinds, PW; Corwin, JT; Corey, DP; Chen, ZY				Sage, C; Huang, MQ; Karimi, K; Gutierrez, G; Vollrath, MA; Zhang, DS; Garcia-Anoveros, J; Hinds, PW; Corwin, JT; Corey, DP; Chen, ZY			Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein	SCIENCE			English	Article							INNER-EAR; FATE DETERMINATION; ACOUSTIC TRAUMA; RB; MOUSE; GENE; MUTATION; REGENERATION; SURVIVAL; NEUROGENESIS	In mammals, hair cell loss causes irreversible hearing and balance impairment because hair cells are terminally differentiated and do not regenerate spontaneously. By profiling gene expression in developing mouse vestibular organs, we identified the retinoblastorna protein (pRb) as a candidate regulator of cell cycle exit in hair cells. Differentiated and functional mouse hair cells with a targeted deletion of Rb1 undergo mitosis, divide, and cycle, yet continue to become highly differentiated and functional. Moreover, acute loss of Rb1 in postnatal hair cells caused cell cycle reentry. Manipulation of the pRb pathway may ultimately lead to mammalian hair cell regeneration.	Massachusetts Gen Hosp, MGH HMS Ctr Nervous Syst Repair, Neurol Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Tufts New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Northwestern Univ, Inst Neurosci, Dept Anesthesiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Neurol, Chicago, IL 60611 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Virginia; Tufts Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Northwestern University; Northwestern University; Northwestern University	Chen, ZY (corresponding author), Massachusetts Gen Hosp, MGH HMS Ctr Nervous Syst Repair, Neurol Serv, Boston, MA 02114 USA.	zhengyi@helix.mgh.harvard.edu		Garcia-Anoveros, Jaime/0000-0001-6561-9048; Corey, David/0000-0003-4497-6016; Gutierrez, Gabriel/0000-0001-8487-0414	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004546] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-04546, DC-00200, DC-AG20208] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 2002, DEVELOPMENT, V129, P2495; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Meyers JR, 2003, J NEUROSCI, V23, P4054; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; WOODS AL, 1991, HISTOPATHOLOGY, V19, P21, DOI 10.1111/j.1365-2559.1991.tb00890.x; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	30	193	230	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1114	1118		10.1126/science.1106642	http://dx.doi.org/10.1126/science.1106642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15653467				2022-12-24	WOS:000227197300050
J	Kidwell, SM				Kidwell, SM			Shell composition has no net impact on large-scale evolutionary patterns in mollusks	SCIENCE			English	Article							FOSSIL RECORD; MISSING MOLLUSKS; DISSOLUTION; ARAGONITE; DIVERSITY; CARBONATE; SEAWATER	A major suspected bias in the fossil record of sketetonized groups is variation in preservability owing to differences in shell composition. However, despite extensive changes in shell composition over the 500-million-year history of marine bivalves, genus duration and shell composition show few significant relationships, and of those, virtually all are contrary to bias from preferential loss of highly reactive shell types. Distortion of large-scale temporal patterns in marine bivalves owing to preservability is thus apparently weak or randomly distributed, which increases the likelihood that observed patterns in this and other shelled groups carry a strong biological signal.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Kidwell, SM (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	skidwell@uchicago.edu						BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Cherns L, 2000, GEOLOGY, V28, P791, DOI 10.1130/0091-7613(2000)28<791:MMAEOL>2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; KOCH CF, 1983, PALEOBIOLOGY, V9, P26, DOI 10.1017/S0094837300007351; Kowalewski M, 1996, GEOLOGY, V24, P977, DOI 10.1130/0091-7613(1996)024<0977:IWATFR>2.3.CO;2; KOWALEWSKI M, 2002, 8 PAL SOC; MALIVA RG, 1988, J GEOL, V96, P387, DOI 10.1086/629235; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Paul CRC, 1998, ADEQUACY OF THE FOSSIL RECORD, P111; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; Sanders D, 2003, J AFR EARTH SCI, V36, P99, DOI 10.1016/S0899-5362(03)00027-7; Schubert JK, 1997, GEOLOGY, V25, P1031, DOI 10.1130/0091-7613(1997)025<1031:SRFTTP>2.3.CO;2; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; SMITH AB, 2001, PALAEOBIOLOGY, V2, P504; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Taylor J. D., 1969, B BRIT MUSEUM NATU S, V3, P1; WAINWRIG.SA, 1969, NATURE, V224, P777, DOI 10.1038/224777a0; WALTER LM, 1985, SEPM SPECIAL PUBLICA, V36, P3; Wright P, 2003, GEOLOGY, V31, P211, DOI 10.1130/0091-7613(2003)031<0211:MMFTTL>2.0.CO;2	29	76	77	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					914	917		10.1126/science.1106654	http://dx.doi.org/10.1126/science.1106654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705849				2022-12-24	WOS:000226985100050
J	Sumbre, G; Fiorito, G; Flash, T; Hochner, B				Sumbre, G; Fiorito, G; Flash, T; Hochner, B			Motor control of flexible octopus arms	NATURE			English	Editorial Material							REACHING MOVEMENTS; NERVOUS-SYSTEM; MODEL		Hebrew Univ Jerusalem, Inst Life Sci, Interdisciplinary Ctr Neuronal Computat, IL-91904 Jerusalem, Israel; Staz Zool Anton Dohrn, Neurobiol Lab, I-80121 Naples, Italy; Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Stazione Zoologica Anton Dohrn di Napoli; Weizmann Institute of Science; Hebrew University of Jerusalem	Sumbre, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	bennyh@lobsterls.huji.ac.il	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840				BIZZI E, 1992, BEHAV BRAIN SCI, V15, P603, DOI 10.1017/S0140525X00072538; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P766; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	12	115	117	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					595	596		10.1038/433595a	http://dx.doi.org/10.1038/433595a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703737				2022-12-24	WOS:000226862000031
J	Wittstein, IS; Thiemann, DR; Lima, JAC; Baughman, KL; Schulman, SP; Gerstenblith, G; Wu, KC; Rade, JJ; Bivalacqua, TJ; Champion, HC				Wittstein, IS; Thiemann, DR; Lima, JAC; Baughman, KL; Schulman, SP; Gerstenblith, G; Wu, KC; Rade, JJ; Bivalacqua, TJ; Champion, HC			Neurohumoral features of myocardial stunning due to sudden emotional stress	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; GENDER-DIFFERENCES; SUBARACHNOID HEMORRHAGE; NEUROPEPTIDE-Y; CARDIOMYOPATHY; PLASMA; ABNORMALITIES; LESIONS	BACKGROUND: Reversible left ventricular dysfunction precipitated by emotional stress has been reported, but the mechanism remains unknown. METHODS: We evaluated 19 patients who presented with left ventricular dysfunction after sudden emotional stress. All patients underwent coronary angiography and serial echocardiography; five underwent endomyocardial biopsy. Plasma catecholamine levels in 13 patients with stress-related myocardial dysfunction were compared with those in 7 patients with Killip class III myocardial infarction. RESULTS: The median age of patients with stress-induced cardiomyopathy was 63 years, and 95 percent were women. Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock. Diffuse T-wave inversion and a prolonged QT interval occurred in most patients. Seventeen patients had mildly elevated serum troponin I levels, but only 1 of 19 had angiographic evidence of clinically significant coronary disease. Severe left ventricular dysfunction was present on admission (median ejection fraction, 0.20; interquartile range, 0.15 to 0.30) and rapidly resolved in all patients (ejection fraction at two to four weeks, 0.60; interquartile range, 0.55 to 0.65; P<0.001). Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis. Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction (median epinephrine level, 1264 pg per milliliter [interquartile range, 916 to 1374] vs. 376 pg per milliliter [interquartile range, 275 to 476]; norepinephrine level, 2284 pg per milliliter [interquartile range, 1709 to 2910] vs. 1100 pg per milliliter [interquartile range, 914 to 1320]; and dopamine level, 111 pg per milliliter [interquartile range, 106 to 146] vs. 61 pg per milliliter [interquartile range, 46 to 77]; P<0.005 for all comparisons). CONCLUSIONS: Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary disease. Exaggerated sympathetic stimulation is probably central to the cause of this syndrome.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital	Wittstein, IS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	iwittste@jhmi.edu	Wu, Katherine C/A-9760-2008					Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Brandspiegel HZ, 1998, CIRCULATION, V98, P1349, DOI 10.1161/01.CIR.98.13.1349; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; CEBELIN MS, 1980, HUM PATHOL, V11, P123, DOI 10.1016/S0046-8177(80)80129-8; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; DRISLANE FW, 1987, AM REV RESPIR DIS, V135, P498; FRANKENHAEUSER M, 1976, PSYCHOPHARMACOLOGY, V47, P1, DOI 10.1007/BF00428693; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Grouzmann E, 2001, CLIN CHEM, V47, P1748; Grouzmann E, 2001, CLIN CHEM, V47, P1075; Hernandez-Pampaloni M, 2001, CIRCULATION, V104, P527, DOI 10.1161/hc3001.093503; Hinojosa-Laborde CM, 1999, CLIN EXP PHARMACOL P, V26, P122, DOI 10.1046/j.1440-1681.1999.02995.x; Jonsson BH, 2000, INTEGR PHYS BEH SCI, V35, P256, DOI 10.1007/BF02688788; Kawai S, 2000, JPN CIRC J, V64, P237; Kawai S, 2000, JPN CIRC J, V64, P156, DOI 10.1253/jcj.64.156; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; LACY CR, 1995, AM J CARDIOL, V75, P503, DOI 10.1016/S0002-9149(99)80590-6; Lambert G, 2002, BRAIN RES BULL, V58, P77, DOI 10.1016/S0361-9230(02)00762-1; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; MORI H, 1993, CARDIOVASC RES, V27, P192, DOI 10.1093/cvr/27.2.192; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; Onuoha GN, 2000, EUR J CLIN INVEST, V30, P570; Pavin D, 1997, HEART, V78, P509, DOI 10.1136/hrt.78.5.509; PIERPONT GL, 1984, AM J PHYSIOL, V246, pH824, DOI 10.1152/ajpheart.1984.246.6.H824; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Sadamatsu K, 2000, JPN CIRC J, V64, P789, DOI 10.1253/jcj.64.789; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sharkey SW, 1998, CHEST, V114, P98, DOI 10.1378/chest.114.1.98; SINGAL PK, 1982, CAN J PHYSIOL PHARM, V60, P1390, DOI 10.1139/y82-207; Spreux-Varoquaux O, 2001, LIFE SCI, V69, P647, DOI 10.1016/S0024-3205(01)01158-4; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Villareal RP, 2001, MAYO CLIN PROC, V76, P79, DOI 10.4065/76.1.79; Wang TD, 1997, INT J CARDIOL, V58, P308, DOI 10.1016/S0167-5273(96)02879-3; WILKENFELD C, 1992, J HEART LUNG TRANSPL, V11, P363	39	2067	2172	0	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					539	548		10.1056/NEJMoa043046	http://dx.doi.org/10.1056/NEJMoa043046			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895KY	15703419				2022-12-24	WOS:000226862100004
J	Pedersen, TR; Gerken, EA				Pedersen, TR; Gerken, EA			Creation of visible artificial optical emissions in the aurora by high-power radio waves	NATURE			English	Article								Generation of artificial light in the sky by means of high-power radio waves interacting with the ionospheric plasma has been envisaged since the early days of radio exploration of the upper atmosphere, with proposed applications ranging from regional night-time street lighting to atmospheric measurements(1). Weak optical emissions have been produced for decades in such ionospheric 'heating' experiments, where they serve as key indicators of electron acceleration, thermal heating, and other effects of incompletely understood wave - particle interactions in the plasma under conditions difficult to replicate in the laboratory(2). The extremely low intensities produced previously have, however, required sensitive instrumentation for detection, preventing applications beyond scientific research. Here we report observations of radio-induced optical emissions bright enough to be seen by the naked eye, and produced not in the quiet midlatitude ionosphere, but in the midst of a pulsating natural aurora. This may open the door to visual applications of ionospheric heating technology or provide a way to probe the dynamics of the natural aurora and magnetosphere.	USAF, Space Vehicles Directorate, Res Lab, Hanscom AFB, MA 01731 USA; Cornell Univ, Dept Elect & Comp Engn, Ithaca, NY 14853 USA	United States Department of Defense; United States Air Force; Cornell University	Pedersen, TR (corresponding author), USAF, Space Vehicles Directorate, Res Lab, Hanscom AFB, MA 01731 USA.	todd.pedersen@hanscom.af.mil		Pedersen, Todd/0000-0002-6940-0112				Bailey VA, 1938, PHILOS MAG, V26, P425; BAUER SJ, 1973, PHYS CHEM SPACE, V6, P82; BERNHARDT PA, 1988, SCIENCE, V242, P1022, DOI 10.1126/science.242.4881.1022; Blagoveshchenskaya NF, 2001, J GEOPHYS RES-SPACE, V106, P29071, DOI 10.1029/2001JA900002; CARLSON HC, 1995, INTRO SPACE PHYS, P459; CHAMBERLAIN JW, 1961, INT GEOPHYS SERIES, V2; DAVIS N, 1992, AURORA WATCHERS HDB, V58; Djuth FT, 1999, GEOPHYS RES LETT, V26, P1557, DOI 10.1029/1999GL900296; OMHOLT A, 1971, PHYS CHEM SPACE, V4; Rishbeth H., 1969, INTRO IONOSPHERIC PH, VVolume 14; Sergienko T, 1997, J ATMOS SOL-TERR PHY, V59, P2401, DOI 10.1016/S1364-6826(97)88118-7	11	27	28	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					498	500		10.1038/nature03243	http://dx.doi.org/10.1038/nature03243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690034				2022-12-24	WOS:000226727200041
J	Sawai, S; Thomason, PA; Cox, EC				Sawai, S; Thomason, PA; Cox, EC			An autoregulatory circuit for long-range self-organization in Dictyostelium cell populations	NATURE			English	Article							SPIRAL WAVES; ADENYLYL-CYCLASE; CAMP; AGGREGATION; PROPAGATION; FEEDBACK; KINASE	Nutrient-deprived Dictyostelium amoebae aggregate to form a multicellular structure by chemotaxis, moving towards propagating waves of cyclic AMP that are relayed from cell to cell. Organizing centres are not formed by founder cells, but are dynamic entities consisting of cores of outwardly rotating spiral waves(1-4) that self-organize in a homogeneous cell population. Spiral waves are ubiquitously observed in chemical reactions as well as in biological systems(5-8). Although feedback control of spiral waves in spatially extended chemical reactions has been demonstrated in recent years(9,10), the mechanism by which control is achieved in living systems is unknown. Here we show that mutants of the cyclic AMP/protein kinase A pathway show periodic signalling, but fail to organize coherent long-range wave territories, owing to the appearance of numerous spiral cores. A theoretical model suggests that autoregulation of cell excitability mediated by protein kinase A acts to optimize the number of signalling centres.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Sawai, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ssawai@molbio.princeton.edu; ecox@princeton.edu	Sawai, Satoshi/AAX-8536-2020	Sawai, Satoshi/0000-0003-3764-219X; Thomason, Peter/0000-0003-3104-8392				DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; FEY P, 1995, GENE, V165, P127, DOI 10.1016/0378-1119(95)00430-E; FOERSTER P, 1990, DEVELOPMENT, V109, P11; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GROSS JD, 1976, J CELL SCI, V22, P645; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Kim M, 2001, SCIENCE, V292, P1357, DOI 10.1126/science.1059478; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Lauzeral J, 1997, P NATL ACAD SCI USA, V94, P9153, DOI 10.1073/pnas.94.17.9153; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LEE KJ, 2001, PHYS REV LETT, V87; Levine H, 1996, P NATL ACAD SCI USA, V93, P6382, DOI 10.1073/pnas.93.13.6382; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Palsson E, 1997, P NATL ACAD SCI USA, V94, P13719, DOI 10.1073/pnas.94.25.13719; Patel H, 2000, EMBO J, V19, P2247, DOI 10.1093/emboj/19.10.2247; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; SIEGERT F, 1989, J CELL SCI, V93, P325; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tung CK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248302; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803	28	130	132	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					323	326		10.1038/nature03228	http://dx.doi.org/10.1038/nature03228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662425				2022-12-24	WOS:000226381300057
J	Chao, A; Thun, MJ; Connell, CJ; McCullough, ML; Jacobs, EJ; Flanders, WD; Rodriguez, C; Sinha, R; Calle, EE				Chao, A; Thun, MJ; Connell, CJ; McCullough, ML; Jacobs, EJ; Flanders, WD; Rodriguez, C; Sinha, R; Calle, EE			Meat consumption and risk of colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							II NUTRITION COHORT; COLO-RECTAL CANCER; LARGE-BOWEL-CANCER; HETEROCYCLIC AMINES; UNITED-STATES; RED MEAT; FOOD GROUPS; N-NITROSATION; GASTROINTESTINAL CANCERS; GENETIC SUSCEPTIBILITY	Context Consumption of red and processed meat has been associated with colorectal cancer in many but not all epidemiological studies; few studies have examined risk in relation to long-term meat intake or the association of meat with rectal cancer. Objective To examine the relationship between recent and long-term meat consumption and the risk of incident colon and rectal cancer. Design, Setting, and Participants A cohort of 148610 adults aged 50 to 74 years (median, 63 years), residing in 21 states with population-based cancer registries, who provided information on meat consumption in 1982 and again in 1992/1993 when enrolled in the Cancer Prevention Study II (CPS II) Nutrition Cohort. Follow-up from time of enrollment in 1992/1993 through August 31, 2001, identified 1667 incident colorectal cancers. Participants contributed person-years at risk until death or a diagnosis of colon or rectal cancer. Main Outcome Measure Incidence rate ratio (RR) of colon and rectal cancer. Results High intake of red and processed meat reported in 1992/1993 was associated with higher risk of colon cancer after adjusting for age and energy intake but not after further adjustment for body mass index, cigarette smoking, and other covariates. When long-term consumption was considered, persons in the highest tertile of consumption in both 1982 and 1992/1993 had higher risk of distal colon cancer associated with processed meat (RR, 1.50; 95% confidence interval [CI], 1.04-2.17), and ratio of red meat to poultry and fish (RR, 1.53; 95% Cl, 1.08-2.18) relative to those persons in the lowest tertile at both time points. Long-term consumption of poultry and fish was inversely associated with risk of both proximal and distal colon cancer. High consumption of red meat reported in 1992/1993 was associated with higher risk of rectal cancer (RR, 1.71; 95% Cl, 1.15-2.52; P=.007 for trend), as was high consumption reported in both 1982 and 1992/1993 (RR, 1.43; 95% Cl, 1.00-2.05). Conclusions Our results demonstrate the potential value of examining long-term meat consumption in assessing cancer risk and strengthen the evidence that prolonged high consumption of red and processed meat may increase the risk of cancer in the distal portion of the large intestine.	Amer Canc Soc, Atlanta, GA 30329 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; NCI, Div Canc Epidemiol & Genet, Rockville, MD USA	American Cancer Society; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thun, MJ (corresponding author), Amer Canc Soc, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	mthun@cancer.org	Sinha, Rashmi/G-7446-2015	Sinha, Rashmi/0000-0002-2466-7462; McCullough, Marjorie/0000-0003-3025-6341	NATIONAL CANCER INSTITUTE [ZIACP010127, Z01CP010127, K07CA075062] Funding Source: NIH RePORTER; NCI NIH HHS [K07CA75062] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Taie OH, 2003, NUTR CANCER, V46, P125, DOI 10.1207/S15327914NC4602_04; Augustsson K, 1999, LANCET, V353, P703, DOI 10.1016/S0140-6736(98)06099-1; BENITO E, 1990, INT J CANCER, V45, P69, DOI 10.1002/ijc.2910450114; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; BIDOLI E, 1992, INT J CANCER, V50, P223, DOI 10.1002/ijc.2910500211; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; BLOCK G, 1989, HLTH HABITS HIST QUE; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Boutron-Ruault MC, 1999, EUR J CANCER PREV, V8, P229, DOI 10.1097/00008469-199906000-00011; Butler LM, 2003, AM J EPIDEMIOL, V157, P434, DOI 10.1093/aje/kwf221; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chen J, 1998, CANCER RES, V58, P3307; Cross AJ, 2003, CANCER RES, V63, P2358; DEVERDIER MG, 1991, INT J CANCER, V49, P520, DOI 10.1002/ijc.2910490408; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Fernandez-Banares F, 2002, AM J GASTROENTEROL, V97, P2103, DOI 10.1111/j.1572-0241.2002.05930.x; Flagg EW, 2000, EPIDEMIOLOGY, V11, P462, DOI 10.1097/00001648-200007000-00017; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Gaard M, 1996, EUR J CANCER PREV, V5, P445; GIOVANNUCCI E, 1992, JNCI-J NATL CANCER I, V84, P91, DOI 10.1093/jnci/84.2.91; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, CANCER RES, V54, P718; GRAHAM S, 1978, JNCI-J NATL CANCER I, V61, P709; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; GROSS GA, 1992, J CHROMATOGR, V592, P271, DOI 10.1016/0021-9673(92)85095-B; HAENSZEL W, 1980, JNCI-J NATL CANCER I, V64, P17; HAENSZEL W, 1973, J NATL CANCER I, V51, P1765, DOI 10.1093/jnci/51.6.1765; Hsing AW, 1998, INT J CANCER, V77, P549, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;549::AID-IJC13&gt;3.0.CO;2-1; HU JF, 1991, INT J EPIDEMIOL, V20, P362, DOI 10.1093/ije/20.2.362; Hughes R, 2002, NUTR CANCER, V42, P70, DOI 10.1207/S15327914NC421_10; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Jarvinen R, 2001, BRIT J CANCER, V85, P357, DOI 10.1054/bjoc.2001.1906; Kampman E, 1999, CANCER EPIDEM BIOMAR, V8, P15; KAMPMAN E, 1995, CANCER CAUSE CONTROL, V6, P225, DOI 10.1007/BF00051794; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Kato T, 2002, CANCER LETT, V187, P169, DOI 10.1016/S0304-3835(02)00432-9; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; Kune S, 1987, Nutr Cancer, V9, P21; LAVECCHIA C, 1988, INT J CANCER, V41, P492, DOI 10.1002/ijc.2910410404; LaVecchia C, 1996, INT J CANCER, V66, P60, DOI 10.1002/(SICI)1097-0215(19960328)66:1&lt;60::AID-IJC11&gt;3.0.CO;2-F; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39; LEE HP, 1989, INT J CANCER, V43, P1007, DOI 10.1002/ijc.2910430609; LeMarchand L, 1997, CANCER CAUSE CONTROL, V8, P637, DOI 10.1023/A:1018406716115; Levi F, 1999, BRIT J CANCER, V79, P1283, DOI 10.1038/sj.bjc.6690206; MACQUARTMOULIN G, 1986, INT J CANCER, V38, P183, DOI 10.1002/ijc.2910380207; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P1, DOI 10.1023/A:1022591007673; MILLER AB, 1983, INT J CANCER, V32, P155, DOI 10.1002/ijc.2910320204; Murata M, 1999, JPN J CANCER RES, V90, P711, DOI 10.1111/j.1349-7006.1999.tb00805.x; Murtaugh MA, 2004, J NUTR, V134, P776, DOI 10.1093/jn/134.4.776; Narayanan BA, 2003, CANCER RES, V63, P972; National Cattlemen's Beef Association, 2001, US BEEF IND DEM SPEN; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; PETERS RK, 1992, CANCER CAUSE CONTROL, V3, P457, DOI 10.1007/BF00051359; PHILLIPS RL, 1985, JNCI-J NATL CANCER I, V74, P307; PICKLE LW, 1984, CANCER RES, V44, P363; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; ProbstHensch NM, 1997, CANCER CAUSE CONTROL, V8, P175, DOI 10.1023/A:1018416128894; RobertsThomson IC, 1996, LANCET, V347, P1372, DOI 10.1016/S0140-6736(96)91012-0; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Seow A, 2002, CANCER-AM CANCER SOC, V95, P2390, DOI 10.1002/cncr.10971; Sesink ALA, 1999, CANCER RES, V59, P5704; Shannon J, 1996, CANCER EPIDEM BIOMAR, V5, P495; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Sinha R, 1997, MUTAT RES-FUND MOL M, V376, P195, DOI 10.1016/S0027-5107(97)00043-2; Sinha R, 1999, CANCER RES, V59, P4320; SINHA R, 1995, CANCER RES, V55, P4516; TAJIMA K, 1985, JPN J CANCER RES, V76, P705; *TEX CATTL FEED AS, CAP MEAT CONS POUNDS; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; TUYNS AJ, 1988, NUTR CANCER, V11, P189, DOI 10.1080/01635588809513986; VLAJINAC H, 1987, Archiv fuer Geschwulstforschung, V57, P493; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WOHLLEB JC, 1990, INT J CANCER, V46, P22, DOI 10.1002/ijc.2910460107; World Health Organisation, 1977, INT CLASS DIS 9 REV; World Health Organization, 1992, INT CLASS DIS 10 REV; Yang CX, 2003, EUR J CANCER PREV, V12, P109, DOI 10.1097/00008469-200304000-00004	83	385	407	0	79	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					172	182		10.1001/jama.293.2.172	http://dx.doi.org/10.1001/jama.293.2.172			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644544	Bronze			2022-12-24	WOS:000226171000033
J	Foglia, A				Foglia, A			An unforgivable delay	LANCET			English	Editorial Material									FMH Psichiatria & Psicoterapia, CH-6900 Lugano, Switzerland		Foglia, A (corresponding author), FMH Psichiatria & Psicoterapia, CH-6900 Lugano, Switzerland.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					445	445						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680462				2022-12-24	WOS:000226610900034
J	Paul, C				Paul, C			The relentless therapeutic imperative	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Paul, C (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand.	charlotte.paul@stonebow.otago.ac.nz							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1457	1459		10.1136/bmj.329.7480.1457	http://dx.doi.org/10.1136/bmj.329.7480.1457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604183	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000225965800026
J	Lawlor, DA; Ben-Shlomo, Y; Ebrahim, S; Smith, GD; Stansfeld, SA; Yarnell, JWG; Gallacher, JEJ				Lawlor, DA; Ben-Shlomo, Y; Ebrahim, S; Smith, GD; Stansfeld, SA; Yarnell, JWG; Gallacher, JEJ			Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEART		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Barts & London Queen Mary Univ London, Ctr Psychiat, London WC1E 7HU, England; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; Cardiff Univ, Dept Epidemiol Stat & Publ Hlth, Cardiff CF4 4XN, S Glam, Wales	University of Bristol; University of London; Queen Mary University London; Queens University Belfast; Cardiff University	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.a.lawlor@bristol.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013	Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768				Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; Lawlor DA, 2003, BRIT MED J, V327, P1383, DOI 10.1136/bmj.327.7428.1383; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; STANSFELD SA, 1991, PSYCHOL MED, V21, P157, DOI 10.1017/S0033291700014744; Timonen M, 2005, BMJ-BRIT MED J, V330, P17, DOI 10.1136/bmj.38313.513310.F71	5	41	42	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					705	706		10.1136/bmj.38377.616921.F7	http://dx.doi.org/10.1136/bmj.38377.616921.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912IT	15684022	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000228071900017
J	Qiu, XD; Kumbalasiri, T; Carlson, SM; Wong, KY; Krishna, V; Provencio, I; Berson, DM				Qiu, XD; Kumbalasiri, T; Carlson, SM; Wong, KY; Krishna, V; Provencio, I; Berson, DM			Induction of photosensitivity by heterologous expression of melanopsin	NATURE			English	Article							RETINAL GANGLION-CELLS; TRP CHANNELS; RESPONSES; PHOTOTRANSDUCTION; MELANOPHORES; CURRENTS; OPSIN	Melanopsin(1-8) has been proposed to be the photopigment of the intrinsically photosensitive retinal ganglion cells (ipRGCs)(7-15); these photoreceptors of the mammalian eye drive circadian and pupillary adjustments through direct projections to the brain(5,6,8 - 14,16 - 18). Their action spectrum (lambda(max) approximate to 480 nm) implicates an opsin(10) and melanopsin is the only opsin known to exist in these cells. Melanopsin is required for ipRGC photosensitivity(13) and for behavioural photoresponses that survive disrupted rod and cone function(14,17). Heterologously expressed melanopsin apparently binds retinaldehyde and mediates photic activation of G proteins(19). However, its amino- acid sequence differs from vertebrate photosensory opsins(1,20) and some have suggested that melanopsin may be a photoisomerase, providing retinoid chromophore to an unidentified opsin(3,20). To determine whether melanopsin is a functional sensory photopigment, here we transiently expressed it in HEK293 cells that stably expressed TRPC3 channels. Light triggered a membrane depolarization in these cells and increased intracellular calcium. The light response resembled that of ipRGCs, with almost identical spectral sensitivity (lambda(max) approximate to 479 nm). The phototransduction pathway included Gq or a related G protein, phospholipase C and TRPC3 channels. We conclude that mammalian melanopsin is a functional sensory photopigment, that it is the photopigment of ganglion-cell photoreceptors, and that these photoreceptors may use an invertebrate-like phototransduction cascade.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA	Brown University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.	David_Berson@brown.edu		Provencio, Ignacio/0000-0003-1175-920X; Wong, Kwoon/0000-0001-9279-7827				Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2002, CELL TISSUE RES, V309, P57, DOI 10.1007/s00441-002-0573-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, ANN MED, V34, P401, DOI 10.1080/078538902320772151; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Oh EJ, 2003, J NEUROPHYSIOL, V90, P2069, DOI 10.1152/jn.00026.2003; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	32	321	369	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					745	749		10.1038/nature03345	http://dx.doi.org/10.1038/nature03345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15674243				2022-12-24	WOS:000227039200040
J	Silva-Santos, B; Pennington, DJ; Hayday, AC				Silva-Santos, B; Pennington, DJ; Hayday, AC			Lymphotoxin-mediated regulation of gamma delta cell differentiation by alpha beta T cell progenitors	SCIENCE			English	Article							LYMPHOID ORGAN DEVELOPMENT; THYMOCYTE DEVELOPMENT; ABNORMAL-DEVELOPMENT; MICE LACKING; ROR-GAMMA; RECEPTOR; GENE; EXPRESSION; TISSUES; MICROENVIRONMENTS	The thymus gives rise to two T cell lineages, alphabeta and gammadelta, that are thought to develop independently of one another. Hence, double positive (DP) thymocytes expressing CD4 and CD8 coreceptors are usually viewed simply as progenitors of CD4(+) and CD8(+) alphabeta T cells. Instead we report that DIP cells regulate the differentiation of early thymocyte progenitors and gammadelta cells, by a mechanism dependent on the transcription factor RORgammat, and the lymphotoxin (Lt) beta receptor (LTbetaR). This finding provokes a revised view of the thymus, in which lymphoid-tissue induction-type processes coordinate the developmental and functional integration of the two T cell lineages.	Univ London Kings Coll, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Pennington, DJ (corresponding author), Univ London Kings Coll, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	daniel.pennington@kcl.ac.uk; hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793; Silva-Santos, Bruno/0000-0003-4141-9302; Pennington, Daniel/0000-0001-7889-9923	Wellcome Trust [071534] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bruno L, 1999, CURR BIOL, V9, P559, DOI 10.1016/S0960-9822(99)80259-0; Cuff CA, 1998, J IMMUNOL, V161, P6853; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729	28	123	125	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					925	928		10.1126/science.1103978	http://dx.doi.org/10.1126/science.1103978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15591166				2022-12-24	WOS:000226985100054
J	Kazakova, SV; Hageman, JC; Matava, M; Srinivasan, A; Phelan, L; Garfinkel, B; Boo, T; McAllister, S; Anderson, J; Jensen, B; Dodson, D; Lonsway, D; McDougal, LK; Arduino, M; Fraser, VJ; Killgore, G; Tenover, FC; Cody, S; Jernigan, DB				Kazakova, SV; Hageman, JC; Matava, M; Srinivasan, A; Phelan, L; Garfinkel, B; Boo, T; McAllister, S; Anderson, J; Jensen, B; Dodson, D; Lonsway, D; McDougal, LK; Arduino, M; Fraser, VJ; Killgore, G; Tenover, FC; Cody, S; Jernigan, DB			A clone of methicillin-resistant Staphylococcus aureus among professional football players	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCIBLE CLINDAMYCIN RESISTANCE; PANTON-VALENTINE LEUKOCIDIN; COMMUNITY; INFECTIONS; DISEASES	BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of infections outside of health care settings. We investigated an outbreak of abscesses due to MRSA among members of a professional football team and examined the transmission and microbiologic characteristics of the outbreak strain. METHODS: We conducted a retrospective cohort study and nasal-swab survey of 84 St. Louis Rams football players and staff members. S. aureus recovered from wound, nasal, and environmental cultures was analyzed by means of pulsed-field gel electrophoresis (PFGE) and typing for resistance and toxin genes. MRSA from the team was compared with other community isolates and hospital isolates. RESULTS: During the 2003 football season, eight MRSA infections occurred among 5 of the 58 Rams players (9 percent); all of the infections developed at turf-abrasion sites. MRSA infection was significantly associated with the lineman or linebacker position and a higher body-mass index. No MRSA was found in nasal or environmental samples; however, methicillin-susceptible S. aureus was recovered from whirlpools and taping gel and from 35 of the 84 nasal swabs from players and staff members (42 percent). MRSA from a competing football team and from other community clusters and sporadic cases had PFGE patterns that were indistinguishable from those of the Rams' MRSA; all carried the gene for Panton-Valentine leukocidin and the gene complex for staphylococcal-cassette-chromosome mec type IVa resistance (clone USA300-0114). CONCLUSIONS: We describe a highly conserved, community-associated MRSA clone that caused abscesses among professional football players and that was indistinguishable from isolates from various other regions of the United States.	CDCP, Epidem Intelligence Serv, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; Missouri Dept Hlth & Senior Serv, St Louis, MO USA; BJC Med Grp, St Louis, MO USA; St Louis Rams Profess Football Team, St Louis, MO USA; Santa Clara Cty Hlth Dept, Off Dis Control, San Jose, CA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Washington University (WUSTL); Washington University (WUSTL)	Kazakova, SV (corresponding author), CDCP, Epidem Intelligence Serv, Div Healthcare Qual Promot, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	srk7@cdc.gov	Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X; Fraser, Victoria/0000-0001-6251-0733				Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P919; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Dorman JM, 2000, J AM COLL HEALTH, V49, P105, DOI 10.1080/07448480009596291; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GOODMAN RA, 1994, JAMA-J AM MED ASSOC, V271, P862, DOI 10.1001/jama.271.11.862; HAGEMAN J, 2004, INT C EM INF DIS ATL; Jorgensen JH, 2004, J CLIN MICROBIOL, V42, P1800, DOI 10.1128/JCM.42.4.1800-1802.2004; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Letertre C, 2003, MOL CELL PROBE, V17, P227, DOI 10.1016/S0890-8508(03)00058-6; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Luby S, 2002, AM J TROP MED HYG, V67, P430, DOI 10.4269/ajtmh.2002.67.430; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Maslow Joel N., 1993, P563; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; *NAT COMM CLIN LAB, 2004, M100S14 NAT COMM S14, V24; *NAT CTR HLTH STAT, 2004, 2002 NAT AMB MED CAR; *NAT CTR HLTH STAT, 2004, 2002 NAT HOSP AMB ME; Schreckenberger PC, 2004, J CLIN MICROBIOL, V42, P2777, DOI 10.1128/JCM.42.6.2777-2779.2004; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992	25	552	585	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					468	475		10.1056/NEJMoa042859	http://dx.doi.org/10.1056/NEJMoa042859			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689585				2022-12-24	WOS:000226725400007
J	Fabra, M; Raldua, D; Power, DM; Deen, PMT; Cerda, J				Fabra, M; Raldua, D; Power, DM; Deen, PMT; Cerda, J			Marine fish egg hydration is aquaporin-mediated	SCIENCE			English	Article							WATER CHANNELS; BUOYANCY; OOCYTES		Ctr Aquaculture, Inst Recerca & Tecnol Agroalimentaries, Tarragona, Spain; Reference Ctr Aquaculture, Barcelona, Spain; Univ Algarve, Ctr Marine Sci, Faro, Portugal; Radboud Univ Nijmegen Med Ctr, Dept Physiol, Nijmegen, Netherlands	IRTA; Universidade do Algarve; Radboud University Nijmegen	Cerda, J (corresponding author), Ctr Aquaculture, Inst Recerca & Tecnol Agroalimentaries, Tarragona, Spain.	jcerda@icm.csic.es	Raldúa, Demetrio/K-6661-2014; Raldua, Demetrio/N-9910-2019; Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014; Cerdà, Joan/M-1099-2016; Power, Deborah M/D-3333-2011	Raldúa, Demetrio/0000-0001-5256-1641; Raldua, Demetrio/0000-0001-5256-1641; Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; Cerdà, Joan/0000-0003-2568-6398; Power, Deborah M/0000-0003-1366-0246				Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; MELLINGER J, 1994, ANN BIOL-PARIS, V33, P117; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Selman K, 2001, J EXP ZOOL, V290, P265, DOI 10.1002/jez.1057	5	106	113	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					545	545		10.1126/science.1106305	http://dx.doi.org/10.1126/science.1106305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681377	Green Submitted			2022-12-24	WOS:000226694000037
J	Gerber, LR; Hyrenbach, KD; Zacharias, MA				Gerber, LR; Hyrenbach, KD; Zacharias, MA			Ecology - Do the largest protected areas conserve whales or whalers?	SCIENCE			English	Editorial Material							MANAGEMENT; RESERVES; OCEAN		Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; Duke Univ, Marine Lab, Beaufort, NC 28516 USA; Univ Victoria, Dept Geog, Victoria, BC V8W 3P5, Canada	Arizona State University; Arizona State University-Tempe; Duke University; University of Victoria	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA.	Leah.Gerber@asu.edu; khyrenba@duke.edu; Mark.Zacharias@uvic.ca		Gerber, Leah/0000-0002-6763-6842				Ainley D. G., 2002, Marine Ornithology, V30, P55; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Bannister J.D., 2002, ENCY MARINE MAMMALS, P62; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Clapham PJ, 2003, BIOSCIENCE, V53, P210, DOI 10.1641/0006-3568(2003)053[0210:WAS]2.0.CO;2; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; DAVIS CR, 2004, SC56SOS2 IWC; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; *IWC, 1999, ANN REP INT WHAL COM, P42; Mills CE, 1998, CONSERV BIOL, V12, P244, DOI 10.1046/j.1523-1739.1998.96475.x; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; Reilly S.B., 1984, REP INT WHAL COMM SP, V6, P389; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; YOUNG NM, 2002, UNDERSTANDING REVISE; ZACHARIAS MA, 2004, SC56SOS5 IWC	18	12	15	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					525	526		10.1126/science.1106120	http://dx.doi.org/10.1126/science.1106120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681370				2022-12-24	WOS:000226694000030
J	Park, BJ; Kang, JW; Lee, SW; Choi, SJ; Shin, YK; Ahn, YH; Choi, YH; Choi, DH; Lee, KS; Kim, S				Park, BJ; Kang, JW; Lee, SW; Choi, SJ; Shin, YK; Ahn, YH; Choi, YH; Choi, DH; Lee, KS; Kim, S			The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR	CELL			English	Article							TRANSFER-RNA SYNTHETASE; CELL-CYCLE; DNA-DAMAGE; CHECKPOINT PATHWAY; CANCER CELLS; ATM; GENE; COMPLEX; MICE; PHOSPHORYLATION	p18 was first identified as a factor associated with a macromolecular tRNA synthetase complex. Here we describe the mouse p18 loss-of-function phenotype and a role for p18 in the DNA damage response. Inactivation of both p18 alleles caused embryonic lethality, while heterozygous mice showed high susceptibility to spontaneous tumors. p18 was induced and translocated to the nucleus in response to DNA damage. Expression of p18 resulted in elevated p53 levels, while p18 depletion blocked p53 induction. p18 directly interacted with ATM/ATR in response to DNA damage. The activity of ATM was dependent on the level of p18, suggesting the requirement of p18 for the activation of ATM. Low p18 expression was frequently observed in different human cancer cell lines and tissues. These results suggest that p18 is a haploinsufficient tumor suppressor and a key factor for ATM/ATR-mediated p53 activation.	Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea; Soonchunhyang Univ, Dept Surg, Coll Med, Seoul 140743, South Korea; Hanyang Univ, Dept Surg, Coll Med, Seoul 133791, South Korea; Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon, South Korea	Seoul National University (SNU); Soonchunhyang University; Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, S (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020; Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Ahn, Young Ha/0000-0002-6843-5444				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Baumgartner AK, 2003, LAB INVEST, V83, P1509, DOI 10.1097/01.LAB.0000090157.13040.58; BHATIA K, 1993, FASEB J, V7, P951, DOI 10.1096/fasebj.7.10.8344493; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; French JE, 2001, CARCINOGENESIS, V22, P99, DOI 10.1093/carcin/22.1.99; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Ide F, 2003, AM J PATHOL, V163, P1729, DOI 10.1016/S0002-9440(10)63531-6; ISAACS WB, 1991, CANCER RES, V51, P4716; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lin WC, 2001, GENE DEV, V15, P1833; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Takai H, 2000, GENE DEV, V14, P1439; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang VW, 2001, CANCER RES, V61, P4169; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	38	107	116	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					209	221		10.1016/j.cell.2004.11.054	http://dx.doi.org/10.1016/j.cell.2004.11.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680327	Bronze			2022-12-24	WOS:000226740000010
J	Mendelson, TC; Shaw, KL				Mendelson, TC; Shaw, KL			Sexual behaviour: Rapid speciation in an arthropod	NATURE			English	Editorial Material							SELECTION; DIVERSITY		Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mendelson, TC (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	tamram@lehigh.edu	Mendelson, Tamra/GSN-8151-2022					Carson Hampton L., 1995, P14; Coyne J. A., 2004, SPECIATION; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McCune Amy R., 1997, P585; Mendelson TC, 2004, MOL ECOL, V13, P3787, DOI 10.1111/j.1365-294X.2004.02375.x; Mendelson TC, 2002, GENETICA, V116, P301, DOI 10.1023/A:1021244812270; Otte D., 1994, CRICKETS HAWAII ORIG; Parsons YM, 2001, MOL ECOL, V10, P1765, DOI 10.1046/j.1365-294X.2001.01318.x; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Shaw Kerry L., 1995, P39; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	13	312	317	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					375	376		10.1038/433375a	http://dx.doi.org/10.1038/433375a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674280				2022-12-24	WOS:000226546200031
J	Holt, NE; Zigmantas, D; Valkunas, L; Li, XP; Niyogi, KK; Fleming, GR				Holt, NE; Zigmantas, D; Valkunas, L; Li, XP; Niyogi, KK; Fleming, GR			Carotenoid cation formation and the regulation of photosynthetic light harvesting	SCIENCE			English	Article							PHOTOSYSTEM-II; ARABIDOPSIS MUTANTS; XANTHOPHYLL CYCLE; PURPLE BACTERIA; PSBS PROTEIN; ENERGY; PLANTS; PHOTOPROTECTION; COMPLEXES; STATE	Photosynthetic light harvesting in excess light is regulated by a process known as feedback deexcitation. Femtosecond transient absorption measurements on thylakoid membranes show selective formation of a carotenoid radical cation upon excitation of chlorophyll under conditions of maximum, steady-state feedback deexcitation. Studies on transgenic Arabidopsis thaliana plants confirmed that this carotenoid radical cation formation is correlated with feedback deexcitation and requires the presence of zeaxanthin, the specific carotenoid synthesized during high light exposure. These results indicate that energy transfer from chlorophyll molecules to a chlorophyll-zeaxanthin heterodimer, which then undergoes charge separation, is the mechanism for excess energy dissipation during feedback deexcitation.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Zigmantas, Donatas/E-5541-2014	Zigmantas, Donatas/0000-0003-2007-5256				BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jeevarajan JA, 1996, J PHYS CHEM-US, V100, P5637, DOI 10.1021/jp9530663; Kodis G, 2004, J PHYS CHEM B, V108, P414, DOI 10.1021/jp036139o; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nield J, 2000, PHILOS T R SOC B, V355, P1337, DOI 10.1098/rstb.2000.0695; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pan JX, 2004, J AM CHEM SOC, V126, P3066, DOI 10.1021/ja031775l; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2004, J PHYS CHEM B, V108, P15398, DOI 10.1021/jp0483019; Polivka T, 2002, J PHYS CHEM B, V106, P11016, DOI 10.1021/jp025752p; Tracewell CA, 2003, BIOCHEMISTRY-US, V42, P9127, DOI 10.1021/bi0345844; Zigmantas D, 2002, P NATL ACAD SCI USA, V99, P16760, DOI 10.1073/pnas.262537599	25	620	639	7	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					433	436		10.1126/science.1105833	http://dx.doi.org/10.1126/science.1105833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662017				2022-12-24	WOS:000226492300050
J	Packer, C; Hilborn, R; Mosser, A; Kissui, B; Borner, M; Hopcraft, G; Wilmshurst, J; Mduma, S; Sinclair, ARE				Packer, C; Hilborn, R; Mosser, A; Kissui, B; Borner, M; Hopcraft, G; Wilmshurst, J; Mduma, S; Sinclair, ARE			Ecological change, group territoriality, and population dynamics in Serengeti lions	SCIENCE			English	Article							AFRICAN LIONS; PANTHERA-LEO	Territorial behavior is expected to buffer populations against short-term environmental perturbations, but we have found that group living in African lions causes a complex response to long-term ecological change. Despite numerous gradual changes in prey availability and vegetative cover, regional populations of Serengeti lions remained stable for 10- to 20-year periods and only shifted to new equilibria in sudden leaps. Although gradually improving environmental conditions provided sufficient resources to permit the subdivision of preexisting territories, regional lion populations did not expand until short-term conditions supplied enough prey to generate large cohorts of surviving young. The results of a simulation model show that the observed pattern of "saltatory equilibria" results from the lions' grouping behavior.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98105 USA; Frankfurt Zool Soc, Arusha, Tanzania; Pk Canada, Ecosyst Serv, Winnipeg, MB R3B 0R9, Canada; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC VLT 1Z4, Canada; Tanzanian Wildlife Res Inst, Arusha, Tanzania	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of British Columbia	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	packer@cbs.umn.edu	Hilborn, Ray W/D-6332-2013					Hanby J. P., 1995, SERENGETI, P315; Hanby JP, 1979, SERENGETI DYNAMICS E, P249; HAWKINS D. M., 1998, CUMULATIVE SUM CONTR; Hawkins DM, 2002, STAT MED, V21, P1913, DOI 10.1002/sim.1013; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HOPCRAFT JGC, IN PRESS J ANIM ECOL; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; KREBS CJ, 1972, ECOLOGY EXPT ANAL DI; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Kruuk H., 1985, P521; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Packer C., 1988, P363; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sinclair A. R. E., 1979, SERENGETI DYNAMICS E, P82; VANORSDOL KG, 1985, J ZOOL, V206, P97; Wynne-Edwards V. C., 1962, pUnpaginated	20	178	181	4	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					390	393		10.1126/science.1105122	http://dx.doi.org/10.1126/science.1105122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662005				2022-12-24	WOS:000226492300036
J	Dickinson, M; Farman, G; Frye, M; Bekyarova, T; Gore, D; Maughan, D; Irving, T				Dickinson, M; Farman, G; Frye, M; Bekyarova, T; Gore, D; Maughan, D; Irving, T			Molecular dynamics of cyclically contracting insect flight muscle in vivo	NATURE			English	Article							X-RAY-DIFFRACTION; DROSOPHILA-MELANOGASTER; MYOSIN-FILAMENTS; CROSS-BRIDGES; TARGET ZONES; ACTIN; REFLECTIONS; ACTIVATION; EFFICIENCY; STRETCH	Flight in insects-which constitute the largest group of species in the animal kingdom-is powered by specialized muscles located within the thorax. In most insects each contraction is triggered not by a motor neuron spike but by mechanical stretch imposed by antagonistic muscles(1). Whereas 'stretch activation' and its reciprocal phenomenon 'shortening deactivation' are observed to varying extents in all striated muscles, both are particularly prominent in the indirect flight muscles of insects(1). Here we show changes in thick-filament structure and actin-myosin interactions in living, flying Drosophila with the use of synchrotron small-angle X-ray diffraction. To elicit stable flight behaviour and permit the capture of images at specific phases within the 5-ms wingbeat cycle, we tethered flies within a visual flight simulator(2). We recorded images of 340 mus duration every 625 mus to create an eight-frame diffraction movie, with each frame reflecting the instantaneous structure of the contractile apparatus. These time-resolved measurements of molecular-level structure provide new insight into the unique ability of insect flight muscle to generate elevated power at high frequency.	IIT, Dept BCPS, BioCAT, Chicago, IL 60616 USA; CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; IIT, Dept BCPS, CSRRI, Chicago, IL 60616 USA; Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Illinois Institute of Technology; California Institute of Technology; Illinois Institute of Technology; University of Vermont	Irving, T (corresponding author), IIT, Dept BCPS, BioCAT, Chicago, IL 60616 USA.	irving@iit.edu		Frye, Mark/0000-0003-3277-3094				Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; Chan WP, 1996, J EXP BIOL, V199, P2767; DICKINSON MH, 1995, SCIENCE, V268, P87, DOI 10.1126/science.7701346; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Huxley HE, 1998, ADV EXP MED BIOL, V453, P281; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; Huxley HE, 2003, BIOPHYS J, V84, p139A; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Irving TC, 2000, NUCL INSTRUM METH A, V448, P250, DOI 10.1016/S0168-9002(99)00732-9; Irving TC, 2000, BIOPHYS J, V78, P2511, DOI 10.1016/S0006-3495(00)76796-8; Josephson RK, 2000, J EXP BIOL, V203, P2713; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Littlefield KP, 2003, AM J PHYSIOL-CELL PH, V284, pC1031, DOI 10.1152/ajpcell.00474.2002; MENETRET JF, 1990, J MUSCLE RES CELL M, V11, P1, DOI 10.1007/BF01833321; MILLER A, 1970, NATURE, V226, P1060, DOI 10.1038/2261060a0; Reedy MC, 2000, J CELL SCI, V113, P3551; REEDY MK, 1965, NATURE, V207, P1276, DOI 10.1038/2071276a0; REEDY MK, 1985, J MOL BIOL, V185, P145, DOI 10.1016/0022-2836(85)90188-3; SPARROW J, 1991, J CELL SCI, P73; Squire J, 1981, STRUCTURAL BASIS MUS; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; Tregear RT, 1998, BIOPHYS J, V74, P1439, DOI 10.1016/S0006-3495(98)77856-7; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; WEISFOGH T, 1965, 12TH P INT C ENT, P186	30	64	67	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					330	333		10.1038/nature03230	http://dx.doi.org/10.1038/nature03230			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662427				2022-12-24	WOS:000226381300059
J	Kotera, E; Tasaka, M; Shikanai, T				Kotera, E; Tasaka, M; Shikanai, T			A pentatricopeptide repeat protein is essential for RNA editing in chloroplasts	NATURE			English	Article							NUCLEUS-ENCODED FACTOR; CYCLIC ELECTRON FLOW; MESSENGER-RNA; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; RESTORES FERTILITY; PHOTOSYSTEM-I; SITE; PLANTS	RNA editing is a process of RNA maturation involved in the insertion, deletion or modification of nucleotides(1). In organellar transcripts of higher plants, specific cytidine residues are converted into uridine residues. In many cases, editing results in the restoration of conserved amino acid residues, a process that is essential for protein function in plastids(2,3). Despite the technical breakthrough in establishing systems in vivo(4) and in vitro(5) for analysing RNA editing, its machinery still remains to be identified in higher plants. Here we introduce a genetic approach and report the discovery of a gene responsible for the specific RNA editing event in the chloroplast.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan	Nara Institute of Science & Technology; Kyushu University	Shikanai, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	shikanai@agr.kyushu-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020					Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Chateigner-Boutin AL, 2003, NUCLEIC ACIDS RES, V31, P2586, DOI 10.1093/nar/gkg354; CHAUDHURI S, 1995, EMBO J, V14, P2951, DOI 10.1002/j.1460-2075.1995.tb07295.x; Coffin JW, 1997, CURR GENET, V32, P273, DOI 10.1007/s002940050277; del Campo EM, 2002, J BIOL CHEM, V277, P36457, DOI 10.1074/jbc.M204500200; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; GLEGE P, 1999, P NATL ACAD SCI USA, V96, P15324; Guera A, 2000, PLANT CELL PHYSIOL, V41, P49, DOI 10.1093/pcp/41.1.49; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hirose T, 1997, EMBO J, V16, P6804, DOI 10.1093/emboj/16.22.6804; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Koizuka N, 2003, PLANT J, V34, P407, DOI 10.1046/j.1365-313X.2003.01735.x; LURIN C, PLANT CELL, V16, P2089; Lutz KA, 2001, CURR GENET, V40, P214, DOI 10.1007/s002940100242; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith HC, 1997, RNA, V3, P1105; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	30	419	451	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					326	330		10.1038/nature03229	http://dx.doi.org/10.1038/nature03229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662426				2022-12-24	WOS:000226381300058
J	Xu, XD; Yang, DM; Ding, JH; Wang, W; Chu, PH; Dalton, ND; Wang, HY; Bermingham, JR; Ye, Z; Liu, F; Rosenfeld, MG; Manley, JL; Ross, J; Chen, J; Xiao, RP; Cheng, HP; Fu, XD				Xu, XD; Yang, DM; Ding, JH; Wang, W; Chu, PH; Dalton, ND; Wang, HY; Bermingham, JR; Ye, Z; Liu, F; Rosenfeld, MG; Manley, JL; Ross, J; Chen, J; Xiao, RP; Cheng, HP; Fu, XD			ASF/SF2-Regulated CaMKII delta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle	CELL			English	Article							PROTEIN-KINASE-II; MESSENGER-RNA; DILATED CARDIOMYOPATHY; ISOFORM; ASF/SF2; GENE; SC35; HYPERTROPHY; DISRUPTION; MECHANISMS	The transition from juvenile to adult life is accompanied by programmed remodeling in many tissues and organs, which is key for organisms to adapt to the demand of the environment. Here we report a novel regulated alternative splicing program that is crucial for postnatnal heart remodeling in the mouse. We identify the essential splicing factor ASF/SF2 as a key component of the program, regulating a restricted set of tissue-specific alternative splicing events during heart remodeling. Cardiomyocytes deficient in ASF/SF2 display an unexpected hypercontraction phenotype due to a defect in postnatal splicing switch of the Ca2+/calmodulin-dependent kinase IIdelta (CaMKIIdelta) transcript. This failure results in mistargeting of the kinase to sarcolemmal membranes, causing severe excitation-contraction coupling defects. Our results validate ASF/SF2 as a fundamental splicing regulator in the reprogramming pathway and reveal the central contribution of ASF/SF2-regulated CaMKIIdelta alternative splicing to functional remodeling in developing heart.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University	Fu, XD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	xdfu@ucsd.edu	Chu, Pao-Hsien/P-5249-2019; Chen, Ju/E-5579-2011; Xiao, Rui-Ping/AAE-2629-2019; Chu, Pao-Hsien/G-3685-2010; Yimei, Wang/AAE-4083-2019; wang, wang/GWQ-7272-2022; Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011	Chu, Pao-Hsien/0000-0003-0361-6348; Heping, Cheng/0000-0002-9604-6702; Manley, James/0000-0002-8341-1459; Wang, Wang/0000-0001-9093-412X; Xu, Xiangdong/0000-0003-2220-0890	NHLBI NIH HHS [R01 HL066100, R01 HL66100] Funding Source: Medline; NIGMS NIH HHS [R01 GM49369, R37 GM48259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048259, R01GM049369] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Chen J, 1998, DEVELOPMENT, V125, P1943; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; HAJLHOSSEINI MK, 2001, P NATL ACAD SCI USA, V98, P3855; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; HODGES D, 1994, ADV GENET, V31, P207, DOI 10.1016/S0065-2660(08)60399-5; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Huang XP, 1999, CIRC RES, V84, P1; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kim S, 2003, NUCLEIC ACIDS RES, V31, P1955, DOI 10.1093/nar/gkg286; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; REISER PJ, 1994, AM J PHYSIOL-HEART C, V267, pH1589; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; SIMMERMAN HK, 1998, PHYSIOL REV, V78, P9231; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; XIAO RP, 2001, SCI STKE RE15, DOI DOI 10.1126/STKA.2001.104.RE15; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou YY, 1997, AM J PHYSIOL-HEART C, V273, pH1611, DOI 10.1152/ajpheart.1997.273.3.H1611; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	54	413	433	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					59	72		10.1016/j.cell.2004.11.036	http://dx.doi.org/10.1016/j.cell.2004.11.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652482	Bronze			2022-12-24	WOS:000226365400011
J	Bao, MZ; Schwartz, MA; Cantin, GT; Yates, JR; Madhani, HD				Bao, MZ; Schwartz, MA; Cantin, GT; Yates, JR; Madhani, HD			Pheromone-dependent destruction of the Tec1 transcription factor is required for MAP kinase signaling specificity in yeast	CELL			English	Article							GENE-EXPRESSION; COMBINATORIAL CONTROL; FILAMENTOUS GROWTH; CYCLIN-E; PROTEOLYSIS; COMPLEXES; CASCADE; TRANSDUCTION; SCF	The yeast MAPK pathways required for mating versus filamentous growth share multiple components yet specify distinct programs. The mating-specific MAPK, Fus3, prevents crosstalk between the two pathways by unknown mechanisms. Here we show that pheromone signaling induces Fus3-dependent degradation of Tec1, the transcription factor specific to the filamentation pathway. Degradation requires Fus3 kinase activity and a MAPK phosphorylation site in Tec1 at threonine 273. Fus3 associates with Tec1 in unstimulated cells, and active Fus3 phosphorylates Tec1 on T273 in vitro. Destruction of Tec1 requires the F box protein Dia2 (Digs-into-agar-2), and Cdc53, the Cullin of SCIF (Skp1 Cdc53-F box) ubiquitin ligases. Notably, mutation of the phosphoacceptor site in Tec1, deletion of FUS3, or deletion of DIA2 results in a loss of signaling specificity such that pheromone pathway signaling erroneously activates filamentation pathway gene expression and invasive growth. Signal-induced destruction of a transcription factor for a competing pathway provides a mechanism for signaling specificity.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Scripps Research Institute	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th st, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01-GM63670-01, R01-GM067880] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063670] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gavrias V, 1996, MOL MICROBIOL, V19, P1255, DOI 10.1111/j.1365-2958.1996.tb02470.x; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mosch HU, 1997, GENETICS, V145, P671; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palecek SP, 2000, GENETICS, V156, P1005; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	33	104	107	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					991	1000		10.1016/j.cell.2004.11.052	http://dx.doi.org/10.1016/j.cell.2004.11.052			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620357	Bronze			2022-12-24	WOS:000226109700011
J	Motamedi, MR; Verdel, A; Colmenares, SU; Gerber, SA; Gygi, SP; Moazed, D				Motamedi, MR; Verdel, A; Colmenares, SU; Gerber, SA; Gygi, SP; Moazed, D			Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs	CELL			English	Article							NASCENT MESSENGER-RNA; DOUBLE-STRANDED-RNA; GENE; HETEROCHROMATIN; INTERFERENCE; POLYMERASE; CLEAVAGE; PROTEIN; LINK; ESTABLISHMENT	RNAi-mediated heterochromatin assembly in fission yeast requires the RNA-induced transcriptional silencing (RITS) complex and a putative RNA-directed RNA polymerase (Rdp1). Here we show that Rdp1 is associated with two conserved proteins, Hrr1, an RNA helicase, and Cid12, a member of the polyA polymerase family, in a complex that has RNA-directed RNA polymerase activity (RDRC, RNA-directed RNA polymerase complex). RDRC physically interacts with RITS in a manner that requires the Dicer ribonuclease (Dcr1) and the Clr4 histone methyltransferase. Moreover, both complexes are localized to the nucleus and associate with noncoding centromeric RNAs in a Dcr1-dependent manner. In cells lacking Rdp1, Hrr1, or Cid12, RITS complexes are devoid of siRNAs and fail to localize to centromeric DNA repeats to initiate heterochromatin assembly. These findings reveal a physical and functional link between Rdp1 and RITS and suggest that noncoding RNAs provide a platform for siRNA-dependent localization of RNAi complexes to specific chromosome regions.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Verdel, André/M-5201-2013	VERDEL, Andre/0000-0001-6048-3794; Gerber, Scott/0000-0002-2964-5051				Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Doe CL, 1998, NUCLEIC ACIDS RES, V26, P4222, DOI 10.1093/nar/26.18.4222; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Ekwall K, 2004, MOL CELL, V13, P304, DOI 10.1016/S1097-2765(04)00057-7; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VERDEL A, 2004, IN PRESS METH ENZYMO; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	51	434	463	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					789	802		10.1016/j.cell.2004.11.034	http://dx.doi.org/10.1016/j.cell.2004.11.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607976	Bronze			2022-12-24	WOS:000225907200010
J	Breidenbach, MA; Brunger, AT				Breidenbach, MA; Brunger, AT			Substrate recognition strategy for botulinum neurotoxin serotype A	NATURE			English	Article							BLOCK NEUROTRANSMITTER RELEASE; LIGHT-CHAIN; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; SNARE MOTIF; TETANUS; COMPLEX; CLEAVAGE; SYNAPTOBREVIN; PROTEOLYSIS	Clostridal neurotoxins (CNTs) are the causative agents of the neuroparalytic diseases botulism and tetanus(1,2). CNTs impair neuronal exocytosis through specific proteolysis of essential proteins called SNAREs(3). SNARE assembly into a low-energy ternary complex is believed to catalyse membrane fusion, precipitating neurotransmitter release; this process is attenuated in response to SNARE proteolysis(4-7). Site-specific SNARE hydrolysis is catalysed by the CNT light chains, a unique group of zinc-dependent endopeptidases(3). The means by which a CNT properly identifies and cleaves its target SNARE has been a subject of much speculation; it is thought to use one or more regions of enzyme substrate interaction remote from the active site (exosites)(8-10). Here we report the first structure of a CNT endopeptidase in complex with its target SNARE at a resolution of 2.1 Angstrom: botulinum neurotoxin serotype A (BoNT/A) protease bound to human SNAP-25. The structure, together with enzyme kinetic data, reveals an array of exosites that determine substrate specificity. Substrate orientation is similar to that of the general zinc-dependent metalloprotease thermolysin(11). We observe significant structural changes near the toxin's catalytic pocket upon substrate binding, probably serving to render the protease competent for catalysis. The novel structures of the substrate-recognition exosites could be used for designing inhibitors specific to BoNT/A.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Brunger, AT (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	brunger@stanford.edu	Sandstedt, Sara A/A-3001-2010	Brunger, Axel/0000-0001-5121-2036				Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Debnath AK, 1999, J MED CHEM, V42, P3203, DOI 10.1021/jm990154t; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HOLDEN HM, 1987, BIOCHEMISTRY-US, V26, P8542, DOI 10.1021/bi00400a008; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rupp B, 2001, NAT STRUCT BIOL, V8, P663, DOI 10.1038/90361; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sukonpan C, 2004, J PEPT RES, V63, P181, DOI 10.1111/j.1399-3011.2004.00124.x; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	30	254	272	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					925	929		10.1038/nature03123	http://dx.doi.org/10.1038/nature03123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15592454				2022-12-24	WOS:000225733500059
J	Christopherson, KS; Ullian, EM; Stokes, CCA; Mullowney, CE; Hell, JW; Agah, A; Lawler, J; Mosher, DF; Bornstein, P; Barres, BA				Christopherson, KS; Ullian, EM; Stokes, CCA; Mullowney, CE; Hell, JW; Agah, A; Lawler, J; Mosher, DF; Bornstein, P; Barres, BA			Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis	CELL			English	Article							RETINAL GANGLION-CELLS; INDUCE SYNAPSE FORMATION; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; SILENT SYNAPSES; GLIAL-CELLS; NEURONS; SPECIALIZATIONS; EXPRESSION; CULTURE	The establishment of neural circuitry requires vast numbers of synapses to be generated during a specific window of brain development, but it is not known why the developing mammalian brain has a much greater capacity to generate new synapses than the adult brain. Here we report that immature but not mature astrocytes express thrombospondins (TSPs)-1 and -2 and that these TSPs promote CNS synaptogenesis in vitro and in vivo. TSPs induce ultrastructurally normal synapses that are presynaptically active but postsynaptically silent and work in concert with other, as yet unidentified, astrocyte-derived signals to produce functional synapses. These studies identify TSPs as CNS synaptogenic proteins, provide evidence that astrocytes are important contributors to synaptogenesis within the developing CNS, and suggest that TSP-1 and -2 act as a permissive switch that times CNS synaptogenesis by enabling neuronal molecules to assemble into synapses within a specific window of CNS development.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Wisconsin, Med Sci Ctr, Dept Med, Madison, WI 53706 USA	Stanford University; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison	Christopherson, KS (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ksc@stanford.edu	Lawler, Jack/AAJ-1379-2020; Hell, Johannes W./P-5085-2019; Ritter, Stefanie L/D-9312-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER; NEI NIH HHS [EY07033] Funding Source: Medline; NHLBI NIH HHS [HL68003] Funding Source: Medline; NIAMS NIH HHS [AR45418] Funding Source: Medline; NIDA NIH HHS [DA15043] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adams JC, 2000, DEV DYNAM, V218, P280; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; CHIH B, 2005, IN PRESS SCIENCE; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hayashi K, 1999, J CELL SCI, V112, P1149; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Moller JC, 1996, GLIA, V17, P121; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; ScottDrew S, 1997, J NEUROSCI RES, V50, P202, DOI 10.1002/(SICI)1097-4547(19971015)50:2<202::AID-JNR9>3.0.CO;2-J; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025	37	1125	1173	0	67	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 11	2005	120	3					421	433		10.1016/j.cell.2004.12.020	http://dx.doi.org/10.1016/j.cell.2004.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707899	Bronze			2022-12-24	WOS:000227028900016
J	MacLean, JA; Chen, MGA; Wayne, CM; Bruce, SR; Rao, M; Meistrich, ML; Macleod, C; Wilkinson, MF				MacLean, JA; Chen, MGA; Wayne, CM; Bruce, SR; Rao, M; Meistrich, ML; Macleod, C; Wilkinson, MF			Rhox: A new homeobox gene cluster	CELL			English	Article							RAPID EVOLUTION; CELL-DEATH; EXPRESSION; SEX; HOX; HOMEODOMAIN; TESTIS; TRANSCRIPTION; TESTOSTERONE; HIERARCHY	Homeobox genes encode transcription factors notable for their ability to regulate embryogenesis. Here, we report the discovery of a cluster of 12 related homeobox genes on the X chromosome expressed in male and female reproductive tissues in adult mice. These reproductive homeobox on the X chromosome (Rhox) genes are expressed in a cell type-specific manner; several are hormonally regulated, and their expression pattern during postnatal testis development corresponds to their chromosomal position. Most of the Rhox genes are expressed in Sertoli cells, the nurse cells in direct contact with developing male germ cells, suggesting that they regulate the expression of somatic-cell gene products critical for germ cell development. In support of this, targeted disruption of Rhox5 increased male germ cell apoptosis and reduced sperm production, sperm motility, and fertility. Identification of this family of homeobox genes provides an opportunity to study colinear gene regulation and the transcriptional control of reproduction.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Univ Calif San Diego, Sch Med, Dept Med, Ctr Canc, La Jolla, CA 92093 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Wilkinson, MF (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mwilkins@mdanderson.org						Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Charlesworth B, 2002, NOVART FDN SYMP, V244, P207; Chun JY, 1999, DEV DYNAM, V216, P257, DOI 10.1002/(SICI)1097-0177(199911)216:3<257::AID-DVDY4>3.0.CO;2-0; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; DUBOULE D, 1994, GUIDEBOOK HOMEBOX GE; DYM M, 1971, BIOL REPROD, V4, P195, DOI 10.1093/biolreprod/4.2.195; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Hasegawa M, 1997, RADIAT RES, V147, P457, DOI 10.2307/3579503; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Hurst LD, 2001, NATURE, V411, P149, DOI 10.1038/35075697; Jackson M, 2002, J BIOL CHEM, V277, P38683, DOI 10.1074/jbc.M203459200; Kang YL, 2004, BIOL REPROD, V70, P828, DOI 10.1095/biolreprod.103.021048; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kouprina N, 2004, P NATL ACAD SCI USA, V101, P3077, DOI 10.1073/pnas.0308532100; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIM K, 1994, J ANDROL, V15, P543; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; Maiti S, 1996, GENOMICS, V34, P304, DOI 10.1006/geno.1996.0291; Martinez P, 2002, COMP BIOCHEM PHYS B, V133, P571, DOI 10.1016/S1096-4959(02)00121-5; MEISTRICH ML, 1993, EUR UROL, V23, P136; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Peterson KJ, 2004, MOL PHYLOGENET EVOL, V31, P1208, DOI 10.1016/j.ympev.2003.10.007; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Pollard SL, 2000, CURR BIOL, V10, P1059, DOI 10.1016/S0960-9822(00)00676-X; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Rao MK, 2002, J BIOL CHEM, V277, P48771, DOI 10.1074/jbc.M209417200; Rao MK, 2002, J BIOL CHEM, V277, P26036, DOI 10.1074/jbc.M203374200; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; RUSSELL R, 1993, SERTOLI CELL; Soares MJ, 2001, ENDOCRIN UPDAT, V12, P139; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Sutton KA, 1997, GENOMICS, V45, P447, DOI 10.1006/geno.1997.4946; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Takasaki N, 2000, DEV BIOL, V223, P181, DOI 10.1006/dbio.2000.9741; TREISMAN J, 1989, CELL, V59, P553; Vallender EJ, 2004, BIOESSAYS, V26, P159, DOI 10.1002/bies.10393; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001	55	157	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					369	382		10.1016/j.cell.2004.12.022	http://dx.doi.org/10.1016/j.cell.2004.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707895	Bronze			2022-12-24	WOS:000227028900012
J	Sezen, UU; Chazdon, RL; Holsinger, KE				Sezen, UU; Chazdon, RL; Holsinger, KE			Genetic consequences of tropical second-growth forest regeneration	SCIENCE			English	Article									Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Sezen, UU (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	uzay.sezen@huskymail.uconn.edu	Sezen, Uğur Uzay/V-1186-2019; Holsinger, Kent/A-7435-2009	Sezen, Uğur Uzay/0000-0002-2988-8790; Holsinger, Kent/0000-0003-4312-3804				Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Cespedes M, 2003, MOL ECOL, V12, P3201, DOI 10.1046/j.1365-294X.2003.01986.x; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; *FAO UN, 2001, 140 FAO UN; HENDESON A, 1990, FLORA NEOTROP MONOGR, V53; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607	6	78	83	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					891	891		10.1126/science.1105034	http://dx.doi.org/10.1126/science.1105034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705843	Green Submitted			2022-12-24	WOS:000226985100043
J	Panda, S; Nayak, SK; Campo, B; Walker, JR; Hogenesch, JB; Jegla, T				Panda, S; Nayak, SK; Campo, B; Walker, JR; Hogenesch, JB; Jegla, T			Illumination of the melanopsin signaling pathway	SCIENCE			English	Article							RETINAL GANGLION-CELLS; LIGHT; PHOTOTRANSDUCTION; DROSOPHILA; RESPONSES; MELANOPHORES; EXPRESSION; PROTEIN; SYSTEM; GENE	In mammals, a small population of intrinsically photosensitive retinal ganglion cells (ipRGCs) plays a key role in the regulation of nonvisual photic responses, such as behavioral responses to tight, pineal melatonin synthesis, pupillary light reflex, and steep latency. These ipRGCs also express melanopsin (Opn4), a putative opsin-family photopigment that has been shown to play a rote in mediating these nonvisual photic responses. Melanopsin is required for the function of this inner retinal pathway, but its precise role in generating photic responses has not yet been determined. We found that expression of melanopsin in Xenopus oocytes results in light-dependent activation of membrane currents through the Galpha(q)/Galpha(11) G protein pathway, with an action spectrum closely matching that of melanopsin-expressing ipRGCs and of behavioral responses to light in mice lacking rods and cones. When coexpressed with arrestins, melanopsin could use all-trans-retinaldehyde as a chromophore, which suggests that it may function as a bireactive opsin. We also found that melanopsin could activate the cation channel TRPC3, a mammalian homolog of the Drosophila phototransduction channels TRP and TRPL. Melanopsin therefore signals more like an invertebrate opsin than like a classical vertebrate rod-and-cone opsin.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis	Panda, S (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu; tjegta@gnf.org	Panda, Satchidananda/J-6891-2012	Jegla, Timothy/0000-0001-8616-2390				Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; Knox BE, 2000, METHOD ENZYMOL, V316, P41; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MEYLAN Z, 2005, IN PRESS NATURE 0126, DOI DOI 10.1038/NATURE03344; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QIU X, 2005, NATURE          0126, DOI DOI 10.1038/NATURE03345; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	29	357	409	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					600	604		10.1126/science.1105121	http://dx.doi.org/10.1126/science.1105121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681390				2022-12-24	WOS:000226694000053
J	Waters, AP; Mota, MM; van Dijk, MR; Janse, CJ				Waters, AP; Mota, MM; van Dijk, MR; Janse, CJ			Parasitology - Malaria vaccines: Back to the future?	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM; PROTECTIVE IMMUNITY; IRRADIATED SPOROZOITES; GENOME SEQUENCE		Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Instituto Gulbenkian de Ciencia	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands.	a.p.waters@lumc.nl	Waters, Andy P/C-9377-2009; Mota, Maria/AAF-2048-2019	Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205; Mota, Maria Manuel/0000-0002-2858-1041				Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; LEIRIAO P, IN PRESS CELL MICROB; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; MUELLER AK, 2004, MOL PAR M WOODS HOL; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; VANDIJK MR, UNPUB; ZAVALA F, 1991, RES IMMUNOL, V142, P654, DOI 10.1016/0923-2494(91)90144-8	15	24	35	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					528	530		10.1126/science.1108598	http://dx.doi.org/10.1126/science.1108598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681372				2022-12-24	WOS:000226694000032
J	Petkova, AT; Leapman, RD; Guo, ZH; Yau, WM; Mattson, MP; Tycko, R				Petkova, AT; Leapman, RD; Guo, ZH; Yau, WM; Mattson, MP; Tycko, R			Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STRUCTURAL MODEL; COMMON MECHANISM; PRION PROTEIN; PEPTIDE; STATE; PROTOFIBRILS; CONSTRAINTS; MICROSCOPY; NANOWIRES	Amyloid fibrils commonly exhibit multiple distinct morphologies in electron microscope and atomic force microscope images, often within a single image field. By using electron microscopy and solid-state nuclear magnetic resonance measurements on fibrils formed by the 40-residue beta-amyloid peptide of Alzheimer's disease (Abeta(1-40)), we show that different fibril morphologies have different underlying molecular structures, that the predominant structure can be controlled by subtle variations in fibril growth conditions, and that both morphology and molecular structure are self-propagating when fibrils grow from preformed seeds. Different Abeta(1-40) fibril morphologies also have significantly different toxicities in neuronal cell cultures. These results have implications for the mechanism of amyloid formation, the phenomenon of strains in prion diseases, the role of amyloid fibrils in amyloid diseases, and the development of amyloid-based nanomaterials.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NIH, Div Bioengn & Phys Sci, Off Res Serv, Bethesda, MD 20892 USA; NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tycko, R (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	rt46d@nih.gov	Mattson, Mark P/F-6038-2012	Leapman, Richard/0000-0002-8575-4084	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029029, ZIADK029029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000312, ZIAAG000312] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD011017] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wishart DS, 2001, METHOD ENZYMOL, V338, P3	30	1357	1379	5	353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					262	265		10.1126/science.1105850	http://dx.doi.org/10.1126/science.1105850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653506				2022-12-24	WOS:000226361900045
J	Fang, CM; Smith, P; Moncrieff, JB; Smith, JU				Fang, CM; Smith, P; Moncrieff, JB; Smith, JU			Similar response of labile and resistant soil organic matter pools to changes in temperature	NATURE			English	Article							TRACE GAS FLUXES; MICROBIAL RESPIRATION; CARBON STORAGE; N AVAILABILITY; NET NITROGEN; MINERALIZATION; DECOMPOSITION; DEPENDENCE; BIOMASS	Our understanding of the relationship between the decomposition of soil organic matter (SOM) and soil temperature affects our predictions of the impact of climate change on soil-stored carbon(1). One current opinion is that the decomposition of soil labile carbon is sensitive to temperature variation whereas resistant components are insensitive(2-4). The resistant carbon or organic matter in mineral soil is then assumed to be unresponsive to global warming(2,4). But the global pattern and magnitude of the predicted future soil carbon stock will mainly rely on the temperature sensitivity of these resistant carbon pools. To investigate this sensitivity, we have incubated soils under changing temperature. Here we report that SOM decomposition or soil basal respiration rate was significantly affected by changes in SOM components associated with soil depth, sampling method and incubation time. We find, however, that the temperature sensitivity for SOM decomposition was not affected, suggesting that the temperature sensitivity for resistant organic matter pools does not differ significantly from that of labile pools, and that both types of SOM will therefore respond similarly to global warming.	Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JU, Midlothian, Scotland	University of Aberdeen; University of Edinburgh	Fang, CM (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland.	c.fang@abdn.ac.uk	Smith, Pete/G-1041-2010; Smith, Jo U/F-7763-2012	Smith, Pete/0000-0002-3784-1124; Smith, Jo U/0000-0001-6984-6766				ALLEN SE, 1974, CHEM ANAL ECOLOGICAL, P137; Coleman K, 1996, NATO ASI SERIES 1, V38, P237; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grisi B, 1998, SOIL BIOL BIOCHEM, V30, P1309, DOI 10.1016/S0038-0717(98)00016-9; IPCC, 2000, SPEC REP EM SCEN; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.2307/2641104; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; Liski J, 1999, AMBIO, V28, P171; Lomander A, 1998, SOIL BIOL BIOCHEM, V30, P2017, DOI 10.1016/S0038-0717(98)00076-5; Lovell RD, 1998, SOIL BIOL BIOCHEM, V30, P2077, DOI 10.1016/S0038-0717(98)00084-4; MACDONALD NW, 1995, SOIL SCI SOC AM J, V59, P233, DOI 10.2136/sssaj1995.03615995005900010036x; Martin-Olmedo P, 1999, BIOL FERT SOILS, V29, P386, DOI 10.1007/s003740050569; OHLINGER R, 1995, METHODS SOIL BIOL, P56; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Reichstein M, 2000, SOIL BIOL BIOCHEM, V32, P947, DOI 10.1016/S0038-0717(00)00002-X; ROSS DJ, 1993, SOIL BIOL BIOCHEM, V25, P477, DOI 10.1016/0038-0717(93)90073-K; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sanderman J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001833; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4	26	526	628	24	543	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					57	59		10.1038/nature03138	http://dx.doi.org/10.1038/nature03138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635408				2022-12-24	WOS:000226117100034
J	Stohr, K; Esveld, M				Stohr, K; Esveld, M			Will vaccines be available for the next influenza pandemic?	SCIENCE			English	Editorial Material									WHO, Influenza Programme, CH-1211 Geneva, Switzerland	World Health Organization	Stohr, K (corresponding author), WHO, Influenza Programme, CH-1211 Geneva, Switzerland.							Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MELTZER MI, 2004, WHO CONS PRIOR PUBL; 2004, WHO M INFL PAND VACC; 2004, WHO WKLY EPIDEMIOL R, V79, P366	5	77	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2195	2196		10.1126/science.1108165	http://dx.doi.org/10.1126/science.1108165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618505				2022-12-24	WOS:000225950000025
J	Tian, JD; Gong, H; Sheng, NJ; Zhou, XC; Gulari, E; Gao, XL; Church, G				Tian, JD; Gong, H; Sheng, NJ; Zhou, XC; Gulari, E; Gao, XL; Church, G			Accurate multiplex gene synthesis from programmable DNA microchips	NATURE			English	Article							POLYMERASE CHAIN-REACTION; CHEMICAL SYNTHESIS; AMPLIFICATION; SEQUENCES; PROTEINS; GENOME	Testing the many hypotheses from genomics and systems biology experiments demands accurate and cost-effective gene and genome synthesis. Here we describe a microchip-based technology for multiplex gene synthesis. Pools of thousands of 'construction' oligonucleotides and tagged complementary 'selection' oligonucleotides are synthesized on photo-programmable microfluidic chips(1), released, amplified and selected by hybridization to reduce synthesis errors ninefold. A one-step polymerase assembly multiplexing reaction assembles these into multiple genes. This technology enabled us to synthesize all 21 genes that encode the proteins of the Escherichia coli 30S ribosomal subunit, and to optimize their translation efficiency in vitro through alteration of codon bias. This is a significant step towards the synthesis of ribosomes in vitro and should have utility for synthetic biology in general.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Houston, Dept Chem, Houston, TX 77004 USA; Atact Technol Inc, Houston, TX 77054 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; University of Houston System; University of Houston; University of Michigan System; University of Michigan	Church, G (corresponding author), Harvard Univ, Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	glmlcl@arep.med.harvard.edu	Feng, Miao/B-8220-2012	church, george/0000-0001-6232-9969				BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; CARR PA, IN PRESS NUCL ACIDS; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORSTER AC, UNPUB NATURE; Gao XL, 2001, NUCLEIC ACIDS RES, V29, P4744, DOI 10.1093/nar/29.22.4744; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; IOST I, 1994, NATURE, V372, P193, DOI 10.1038/372193a0; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Smith J, 1997, P NATL ACAD SCI USA, V94, P6847, DOI 10.1073/pnas.94.13.6847; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	21	284	406	6	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1050	1054		10.1038/nature03151	http://dx.doi.org/10.1038/nature03151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616567	Green Published			2022-12-24	WOS:000225887000047
J	Crabbe, L; Verdun, RE; Haggblom, CI; Karlseder, J				Crabbe, L; Verdun, RE; Haggblom, CI; Karlseder, J			Defective telomere lagging strand synthesis in cells lacking WRN helicase activity	SCIENCE			English	Article							WERNER-SYNDROME; PROTEIN; LENGTH; GENE; EXONUCLEASE; SENESCENCE; TRF1; P53; ATM	Cells from Werner syndrome patients are characterized by slow growth rates, premature senescence, accelerated telomere shortening rates, and genome instability. The syndrome is caused by the loss of the RecQ helicase WRN, but the underlying molecular mechanism is unclear. Here we report that cells lacking WRN exhibit deletion of telomeres from single sister chromatids. Only telomeres replicated by lagging strand synthesis were affected, and prevention of loss of individual telomeres was dependent on the helicase activity of WRN. Telomere toss could be counteracted by telomerase activity. We propose that WRN is necessary for efficient replication of G-rich telomeric DNA, preventing telomere dysfunction and consequent genomic instability.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Karlseder@salk.edu	Crabbé, Laure/P-8955-2014	Crabbé, Laure/0000-0001-7764-3600	NIGMS NIH HHS [GM069525] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069525] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baird DM, 2004, HUM MOL GENET, V13, P1515, DOI 10.1093/hmg/ddh159; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Chang CC, 2004, ANAL CHEM, V76, P4490, DOI 10.1021/ac049510s; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; RHODES D, 1995, CURR OPIN STRUC BIOL, V5, P311, DOI 10.1016/0959-440X(95)80092-1; Schulz VP, 1996, HUM GENET, V97, P750; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang L, 2000, GENETICS, V154, P357; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	27	470	479	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1951	1953		10.1126/science.1103619	http://dx.doi.org/10.1126/science.1103619			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591207				2022-12-24	WOS:000225695600049
J	Mehlmann, LM; Saeki, Y; Tanaka, S; Brennan, TJ; Evsikov, AV; Pendola, FL; Knowles, BB; Eppig, JJ; Jaffe, LA				Mehlmann, LM; Saeki, Y; Tanaka, S; Brennan, TJ; Evsikov, AV; Pendola, FL; Knowles, BB; Eppig, JJ; Jaffe, LA			The G(s)-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; MOUSE OOCYTES; G(S) PROTEIN; KINASE; PHOSPHORYLATION; LOCALIZATION; MATURATION; ACTIVATION	Mammalian oocytes are held in prophase arrest by an unknown signal from the surrounding somatic tells. Here we show that the orphan G(s)-linked receptor GPR3, which is localized in the oocyte, maintains this arrest. Oocytes from Gpr3 knockout mice resume meiosis within antral follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed by injection of Gpr3 RNA into the oocytes. Thus, the GPR3 receptor is a link in communication between the somatic cells and oocyte of the ovarian follicle and, is crucial for the regulation of meiosis.	Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA; Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Deltagen Inc, San Carlos, CA 94070 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of Connecticut; Harvard University; Massachusetts General Hospital; Jackson Laboratory	Mehlmann, LM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA.	lmehlmann@neuron.uchc.edu; ljaffe@neuron.uchc.edu	Evsikov, Alexei/E-2577-2012; Tanaka, Shigeru/O-3908-2015	Tanaka, Shigeru/0000-0003-3247-9098; Knowles, Barbara B./0000-0002-2597-5619; Evsikov, Alexei/0000-0003-2138-5440				BORNSLAEGER E A, 1988, Molecular Reproduction and Development, V1, P19, DOI 10.1002/mrd.1080010105; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Bresnick JN, 2003, ASSAY DRUG DEV TECHN, V1, P239, DOI 10.1089/15406580360545053; CHOI T, 1991, DEVELOPMENT, V113, P789; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; ERICKSON GF, 1974, J EXP ZOOL, V190, P123, DOI 10.1002/jez.1401900112; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Kalinowski RR, 2004, DEV BIOL, V267, P1, DOI 10.1016/j.ydbio.2003.11.011; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; LIRI T, 1994, NATURE, V371, P164; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; MEHLMANN LM, UNPUB; NAYUDU PL, 1992, J REPROD FERTIL, V95, P349, DOI 10.1530/jrf.0.0950349; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Tanaka S., UNPUB; TSAFRIRI A, 1993, OVARY, P227; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4	24	237	253	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1947	1950		10.1126/science.1103974	http://dx.doi.org/10.1126/science.1103974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591206				2022-12-24	WOS:000225695600048
J	Papke, RT; Koenig, JE; Rodriguez-Valera, F; Doolittle, WF				Papke, RT; Koenig, JE; Rodriguez-Valera, F; Doolittle, WF			Frequent recombination in a saltern population of Halorubrum	SCIENCE			English	Article							HYPERTHERMOPHILIC ARCHAEON; GENETIC DIVERSITY; SALINITY GRADIENT; SOLAR SALTERN; SYSTEM; TRANSFORMATION; SULFOLOBUS; BACTERIAL	Sex and recombination are driving forces in the evolution of eukaryotes. Homologous recombination is known to be the dominant process in the divergence of many bacterial. species. For Archaea, the only direct evidence bearing on the importance or natural occurrence of homologous recombination is anecdotal reports of mosaicism from comparative genomic studies. Genetic studies, however, reveal that recombination may play a significant role in generating diversity among members of at least one archaeal group, the haloarchaea. We used multi-locus sequence typing to demonstrate that haloarchaea exchange genetic information promiscuously, exhibiting a degree of linkage equilibrium approaching that of a sexual population.	Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; Univ Miguel Hernandez, Div Microbiol, Alacant 03550, Spain	Dalhousie University; Universidad Miguel Hernandez de Elche	Papke, RT (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5859 Univ Ave, Halifax, NS B3H 4H7, Canada.	rpapke@dal.ca	; Rodriguez-Valera, Francisco/M-2782-2013	Papke, Robertson/0000-0003-1371-2341; Doolittle, W. Ford/0000-0002-4675-8832; Rodriguez-Valera, Francisco/0000-0002-9809-2059				Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Cline S. W., 1995, P197; CLINE SW, 1992, J BACTERIOL, V174, P1076, DOI 10.1128/jb.174.3.1076-1080.1992; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; *GENBANK, AJ851932AJ852003 GEN; *GENBANK, AJ851333AJ851368 GEN; *GENBANK, AJ851294AJ851329 GEN; *GENBANK, AJ851895AJ851930 GEN; Jonuscheit M, 2003, MOL MICROBIOL, V48, P1241, DOI 10.1046/j.1365-2958.2003.03509.x; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; MUKOHATA Y, 1988, BIOCHEM BIOPH RES CO, V151, P1339, DOI 10.1016/S0006-291X(88)80509-6; Prangishvili D, 1998, PLASMID, V40, P190, DOI 10.1006/plas.1998.1363; Reilly MS, 2001, J BACTERIOL, V183, P2943, DOI 10.1128/JB.183.9.2943-2946.2001; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004	21	121	127	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1928	1929		10.1126/science.1103289	http://dx.doi.org/10.1126/science.1103289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591201				2022-12-24	WOS:000225695600042
J	Lee, J; Croen, LA; Backstrand, KH; Yoshida, CK; Henning, LH; Lindan, C; Ferriero, DM; Fullerton, HJ; Barkovich, AJ; Wu, YW				Lee, J; Croen, LA; Backstrand, KH; Yoshida, CK; Henning, LH; Lindan, C; Ferriero, DM; Fullerton, HJ; Barkovich, AJ; Wu, YW			Maternal and infant characteristics associated with perinatal arterial stroke in the infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL CEREBRAL INFARCTION; ISCHEMIC-STROKE; TERM INFANTS; CLINICAL PRESENTATION; RISK-FACTORS; CHILDREN; PALSY; NEWBORN; PREECLAMPSIA; WOMEN	Context Perinatal arterial ischemic stroke (PAS) is a common cause of hemiplegic cerebral palsy. Risk factors for this condition have not been clearly defined. Objective To determine maternal and infant characteristics associated with PAS. Design, Setting, and Patients Case-control study nested within the cohort of all 199176 infants born from 1997 through 2002 in the Kaiser Permanente Medical Care Program, a managed care organization providing care for more than 3 million residents of northern California. Case patients were confirmed by review of brain imaging and medical records (n=40). Three controls per case were randomly selected from the study population. Main Outcome Measure Association of maternal and infant complications with risk of PAS. Results The population prevalence of PAS was 20 per 100000 live births. The majority (85%) of infants with PAS were delivered at term. The following prepartum and intrapartum factors were more common among case than control infants: primiparity (73% vs 44%, P=.002), fetal heart rate abnormality (46% vs 14%, P<.001), emergency cesarean delivery (35% vs 13%, P=.002), chorioamnionitis (27% vs 11%, P=.03), prolonged rupture of membranes (26% vs 7%, P=.002), prolonged second stage of labor (25% vs 4%, P<.001), vacuum extraction (24% vs 11%, P=.04), cord abnormality (22% vs 6%, P=.01), preeclampsia (19% vs 5%, P=.01), and oligohydramnios (14% vs 3%, P=.01). Risk factors independently associated with PAS on multivariate analysis were history of infertility (odds ratio [OR], 7.5; 95% confidence interval [CI], 1.3-45.0), preeclampsia (OR, 5.3; 95% Cl, 1.3-22.0), prolonged rupture of membranes (OR, 3.8; 95% Cl, 1.1-12.8), and chorioamnionitis (OR, 3.4; 95% Cl, 1.1-10.5). The rate of PAS increased dramatically when multiple risk factors were present. Conclusions Perinatal arterial ischemic stroke in infants is associated with several independent maternal risk factors. How these complications, along with their potential effects on the placenta and fetus, may play a role in causing perinatal stroke deserves further study.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Kaiser Permanente, Dept Radiol, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Wu, YW (corresponding author), UCSF Dept Child Neurol, Box 0137,350 Parnassus Ave,Suite 609, San Francisco, CA 94117 USA.	wuy@neuropeds.ucsf.edu		Fullerton, Heather/0000-0002-4828-1687; Croen, Lisa/0000-0001-7849-9428	NINDS NIH HHS [NS35902] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIT M, 1980, ARCH NEUROL-CHICAGO, V37, P109, DOI 10.1001/archneur.1980.00500510067013; Andrew M E, 2001, Hematology Am Soc Hematol Educ Program, P358; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Burke CJ, 1997, DEV MED CHILD NEUROL, V39, P726; deVeber GA, 2000, ANN NEUROL, V48, P514; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; deVries LS, 1997, NEUROPEDIATRICS, V28, P88, DOI 10.1055/s-2007-973679; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Estan J, 1997, ARCH DIS CHILD-FETAL, V76, pF88, DOI 10.1136/fn.76.2.F88; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Golomb MR, 2001, ANN NEUROL, V50, P163, DOI 10.1002/ana.1078; Govaert P, 2000, ARCH DIS CHILD-FETAL, V82, pF59, DOI 10.1136/fn.82.1.F59; Hagstrom JN, 1998, J PEDIATR-US, V133, P777, DOI 10.1016/S0022-3476(98)70150-7; HEIER LA, 1991, AM J NEURORADIOL, V12, P951; Hnat MD, 2002, AM J OBSTET GYNECOL, V186, P422, DOI 10.1067/mob.2002.120280; Hogeveen M, 2002, J PEDIATR-US, V141, P429, DOI 10.1067/mpd.2002.126598; Humphreys P, 2000, CAN J NEUROL SCI, V27, P210; Hunt RW, 2001, PEDIATR NEUROL, V25, P242, DOI 10.1016/S0887-8994(01)00291-0; Jan MMS, 1998, EUR J PEDIATR, V157, P846, DOI 10.1007/s004310050950; KOELFEN W, 1995, DEV MED CHILD NEUROL, V37, P204; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kraus FT, 1997, HUM PATHOL, V28, P246, DOI 10.1016/S0046-8177(97)90114-3; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; LIEN JM, 1995, OBSTET GYNECOL, V85, P163, DOI 10.1016/0029-7844(94)00375-N; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; Lynch JK, 2001, NEUROLOGY, V56, pA10; MANNINO FL, 1983, J PEDIATR-US, V102, P605, DOI 10.1016/S0022-3476(83)80200-5; Ment L R, 1986, Pediatr Neurol, V2, P276, DOI 10.1016/0887-8994(86)90019-6; MENT LR, 1984, ANN NEUROL, V16, P559, DOI 10.1002/ana.410160506; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Mercuri E, 2001, PEDIATRICS, V107, P1400, DOI 10.1542/peds.107.6.1400; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Pabinger I, 2001, ARTERIOSCL THROM VAS, V21, P874, DOI 10.1161/01.ATV.21.5.874; PELLICER A, 1992, BRAIN DEV-JPN, V14, P381, DOI 10.1016/S0387-7604(12)80344-5; PERLMAN JM, 1994, PEDIATR NEUROL, V11, P281, DOI 10.1016/0887-8994(94)90002-7; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; Redline RW, 2000, ARCH PATHOL LAB MED, V124, P1785; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Rogolino A, 2003, BLOOD COAGUL FIBRIN, V14, P277, DOI 10.1097/00001721-200304000-00009; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1097, DOI 10.1016/0002-9378(95)91333-5; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Shah D M, 2001, Semin Pediatr Neurol, V8, P108, DOI 10.1053/spen.2001.25812; Sreenan C, 2000, J PEDIATR-US, V137, P351, DOI 10.1067/mpd.2000.107845; *STAT CAL DEP HLTH, 1976, INTR GROWTH NEON RIS; *STAT CORP, 2000, STATA 7 REF MAN; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; UVEBRANT P, 1988, ACTA PAEDIATR SCAND, P1; Wu YW, 2004, PEDIATRICS, V114, P612, DOI 10.1542/peds.2004-0385; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; WULFECK BB, 1991, PEDIATR NEUROL, V7, P266, DOI 10.1016/0887-8994(91)90043-K; Yoshii F, 1999, NEUROLOGY, V53, P225, DOI 10.1212/WNL.53.1.225	54	210	218	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					723	729		10.1001/jama.293.6.723	http://dx.doi.org/10.1001/jama.293.6.723			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701914	Bronze			2022-12-24	WOS:000226842200026
J	Nishimura, EK; Granter, SR; Fisher, DE				Nishimura, EK; Granter, SR; Fisher, DE			Mechanisms of hair graying: Incomplete melanocyte stem cell maintenance in the niche	SCIENCE			English	Article							OUTER ROOT SHEATH; BCL-2-DEFICIENT MICE; FOLLICLE; MITF; TRANSCRIPTION; SENESCENCE; DEFICIENT; APOPTOSIS; NETWORK; CYCLE	Hair graying is the most obvious sign of aging in humans, yet its mechanism is largely unknown. Here, we used melanocyte-tagged transgenic mice and aging human hair follicles to demonstrate that hair graying is caused by defective self-maintenance of melanocyte stem cells. This process is accelerated dramatically with Bcl2 deficiency, which causes selective apoptosis of melanocyte stem cells, but not of differentiated melanocytes, within the niche at their entry into the dormant state. Furthermore, physiologic aging of melanocyte stem cells was associated with ectopic pigmentation or differentiation within the niche, a process accelerated by mutation of the melanocyte master transcriptional regulator Mitf.	Harvard Univ, Sch Med, Boston Childrens Hosp,Dana Farber Canc Inst, Dept Pediat Hematol Oncol,Melanoma Program Med On, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nishimura, EK (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan.	emi_k_nishimura@yahoo.co.jp; David_Fisher@dfci.harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR43369] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Commo S, 2000, PIGM CELL RES, V13, P253, DOI 10.1034/j.1600-0749.2000.130407.x; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Horikawa T, 1996, J INVEST DERMATOL, V106, P28, DOI 10.1111/1523-1747.ep12326989; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; MONTAGNA W, 1956, AM J ANAT, V99, P415, DOI 10.1002/aja.1000990304; Narisawa Y, 1997, ACTA DERM-VENEREOL, V77, P97; NISHIMURA E, UNPUB; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ortonne J. P., 1998, PIGMENTARY SYSTEM PH, P489; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; STARICCO RG, 1963, ANN NY ACAD SCI, V100, P239; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yamamura K, 1996, CANCER RES, V56, P3546	31	504	545	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					720	724		10.1126/science.1099593	http://dx.doi.org/10.1126/science.1099593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15618488				2022-12-24	WOS:000226814900042
J	Gompel, N; Prud'homme, B; Wittkopp, PJ; Kassner, VA; Carroll, SB				Gompel, N; Prud'homme, B; Wittkopp, PJ; Kassner, VA; Carroll, SB			Chance caught on the wing: cis-regulatory evolution and the origin of pigment patterns in Drosophila	NATURE			English	Article							MELANOGASTER SPECIES-GROUP; GROUP DIPTERA; YELLOW LOCUS; PHYLOGENY; EXPRESSION; GENE; DIVERGENCE; MORPHOLOGY; ELEMENTS; LINEAGE	The gain, loss or modification of morphological traits is generally associated with changes in gene regulation during development. However, the molecular bases underlying these evolutionary changes have remained elusive. Here we identify one of the molecular mechanisms that contributes to the evolutionary gain of a male-specific wing pigmentation spot in Drosophila biarmipes, a species closely related to Drosophila melanogaster. We show that the evolution of this spot involved modifications of an ancestral cis-regulatory element of the yellow pigmentation gene. This element has gained multiple binding sites for transcription factors that are deeply conserved components of the regulatory landscape controlling wing development, including the selector protein Engrailed. The evolutionary stability of components of regulatory landscapes, which can be co-opted by chance mutations in cis-regulatory elements, might explain the repeated evolution of similar morphological patterns, such as wing pigmentation patterns in flies.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Gompel, Nicolas/0000-0003-3358-7963				Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; BOCK IR, 1980, SYST ENTOMOL, V5, P341, DOI 10.1111/j.1365-3113.1980.tb00420.x; BOCK IR, 1972, STUDIES GENETICS, P1, DOI DOI 10.1590/S0085-56262014000400004; Carroll S. B., 2004, DNA DIVERSITY MOL GE; CELNIKER SE, 2002, GENOME BIOL, V0003; CHIA W, 1986, EMBO J, V5, P3597, DOI 10.1002/j.1460-2075.1986.tb04688.x; Davidson E. H., 2001, DEV EVOLUTION; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; GONZALEZ P, 1995, MOL BIOL EVOL, V12, P773; HARDY DE, 1965, DIPTERA CYCLORRHAP 1, V2; *HUM GEN SEQ CTR, 2002, DROS GEN PROJ; Kauffman S., 1996, HOME UNIVERSE SEARCH; Kopp A, 2002, EVOL DEV, V4, P278, DOI 10.1046/j.1525-142X.2002.02017.x; Kopp A, 2002, SYST BIOL, V51, P786, DOI 10.1080/10635150290102410; Llopart A, 2002, EVOLUTION, V56, P2262; Majerus MEN, 1998, MELANISM EVOLUTION A; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Miller DFB, 2002, BIOTECHNIQUES, V33, P366, DOI 10.2144/02332rr03; Monod J., 1970, HASARD N CESSIT ESSA; Powell J.R., 1997, PROGR PROSPECTS EVOL; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schawaroch V, 2002, BIOL J LINN SOC, V76, P21, DOI 10.1111/j.1095-8312.2002.tb01711.x; SCHENDEL PF, 1993, CURRENT PROTOCOLS MO; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; SINGH BN, 1987, ETHOLOGY, V75, P81; Solano PJ, 2003, DEVELOPMENT, V130, P1243, DOI 10.1242/dev.00348; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; Wheeler M.R., 1965, DROS INFORM SERV, V40, P98; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Yoon HS, 2004, P NATL ACAD SCI USA, V101, P6524, DOI 10.1073/pnas.0401824101	47	465	484	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					481	487		10.1038/nature03235	http://dx.doi.org/10.1038/nature03235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690032				2022-12-24	WOS:000226727200038
J	McGaha, TL; Sorrentino, B; Ravetch, JV				McGaha, TL; Sorrentino, B; Ravetch, JV			Restoration of tolerance in lupus by targeted inhibitory receptor expression	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; NEGATIVE SELECTION; CLONAL DELETION; DOWN-REGULATION; B-LYMPHOCYTES; MICE; ERYTHEMATOSUS; AUTOIMMUNITY; SUSCEPTIBILITY; REPERTOIRE	Lupus, a multigenic autoimmune condition in which a breakdown of tolerance results in the development of autoantibodies, leads to a variety of pathologic outcomes. Despite the heterogeneity of factors influencing disease susceptibility, we demonstrate that the partial restoration of inhibitory Fc receptor (FcgammaRIIB) levels on B cells in lupus-prone mouse strains is sufficient to restore tolerance and prevent autoimmunity. FcgammaRIIB regulates a common B cell checkpoint in genetically diverse lupus-prone mouse strains, and modest changes in its expression can result in either tolerance or autoimmunity. Therefore, increasing FcgammaRIIB levels on B cells may be an effective way to treat autoimmune diseases.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA	Rockefeller University; St Jude Children's Research Hospital	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; McGaha, Tracy/0000-0003-4721-9301				Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Lange C, 1997, GENE THER, V4, P303, DOI 10.1038/sj.gt.3300395; Lund Anders H., 1996, Journal of Biomedical Science, V3, P365, DOI 10.1007/BF02258042; Marion Tony N, 2003, Curr Dir Autoimmun, V6, P123; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Yan J, 2002, J IMMUNOL, V168, P3188, DOI 10.4049/jimmunol.168.7.3188	24	206	219	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					590	593		10.1126/science.1105160	http://dx.doi.org/10.1126/science.1105160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681388				2022-12-24	WOS:000226694000050
J	Teeling, EC; Springer, MS; Madsen, O; Bates, P; O'Brien, SJ; Murphy, WJ				Teeling, EC; Springer, MS; Madsen, O; Bates, P; O'Brien, SJ; Murphy, WJ			A molecular phylogeny for bats illuminates biogeography and the fossil record	SCIENCE			English	Article							EOCENE BAT; CHIROPTERA; SEQUENCES	Bats make up more than 20% of extant mammals, yet their evolutionary history is largely unknown because of a limited fossil record and conflicting or incomplete phylogenies. Here, we present a highly resolved molecular phylogeny for all extant bat families. Our results support the hypothesis that megabats are nested among four major microbat lineages, which originated in the early Eocene [52 to 50 million years ago (Mya)], coincident with a significant global rise in temperature, increase in plant diversity and abundance, and the zenith of Tertiary insect diversity. Our data suggest that bats originated in Laurasia, possibly in North America, and that three of the major microbat lineages are Laurasian in origin, whereas the fourth is Gondwanan. Combining principles of ghost lineage analysis with molecular divergence dates, we estimate that the bat fossil record underestimates (unrepresented basal branch length, UBBL) first occurrences by, on average, 73% and that the sum of missing fossil history is 61%.	NCI, Lab Genom Divers, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA; Univ Coll Dublin, Dept Zool, Dublin 4, Ireland; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Radboud Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Harrison Inst, Ctr Systemat & Biodivers Res, Sevenoaks TN13 3AQ, Kent, England; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University College Dublin; University of California System; University of California Riverside; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Texas A&M University System; Texas A&M University College Station	Teeling, EC (corresponding author), NCI, Lab Genom Divers, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA.	emma.teeling@ucd.ie; mark.springer@ucr.edu; obrien@mail.ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Raleva, Sofiya/A-3114-2011; Yousfi, Mohamed/A-5754-2012; Madsen, Ole/E-3730-2012; Rossiter, Stephen J/E-2111-2011; Ho, Hilary/F-3029-2011	Yousfi, Mohamed/0000-0003-4831-8635; Madsen, Ole/0000-0001-8082-7881; Teeling, Emma/0000-0002-3309-1346; OBRIEN, STEPHEN/0000-0001-7857-0757	NATIONAL CANCER INSTITUTE [Z01BC005367] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker RJ, 1997, SYST BIOL, V46, P579, DOI 10.2307/2413496; Bates PJJ, 2001, ACTA CHIROPTEROL, V3, P33; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CZAPLEWSKI NJ, EVOLUTION TERTIARY M, V2; Flynn JJ, 1998, TRENDS ECOL EVOL, V13, P449, DOI 10.1016/S0169-5347(98)01457-8; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; HAND S, 1994, J VERTEBR PALEONTOL, V14, P375, DOI 10.1080/02724634.1994.10011565; Hand Suzanne J., 1998, P72; HILL J. E., 1977, B BRIT MUS NAT HIST, V32, P29; Hoofer SR, 2003, J MAMMAL, V84, P809, DOI 10.1644/BWG-034; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; JEPSEN GL, 1966, SCIENCE, V154, P1333, DOI 10.1126/science.154.3754.1333; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; MCKENNA MC, 1997, CLASSIFCATION MAMMAL; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Patterson BD, 2003, BAT ECOLOGY, P536; Simmons Nancy B., 1993, American Museum Novitates, V3077, P1; Simmons NB, 1998, B AM MUS NAT HIST, P1; SIMMONS NB, MAMMALIAN SPECIES WO; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Storch Gerhard, 2002, Palaeontologische Zeitschrift, V76, P189; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2003, MOL PHYLOGENET EVOL, V28, P308, DOI 10.1016/S1055-7903(03)00117-9; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; WING SL, 1992, MESOZOIC EARLY CENOZ, P327; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359	29	766	816	3	384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					580	584		10.1126/science.1105113	http://dx.doi.org/10.1126/science.1105113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681385				2022-12-24	WOS:000226694000047
J	Schwartz, MW; Porte, D				Schwartz, MW; Porte, D			Diabetes, obesity, and the brain	SCIENCE			English	Editorial Material							SEIP CONGENITAL LIPODYSTROPHY; INSULIN-RECEPTOR SUBSTRATE-2; ACTIVATED PROTEIN-KINASE; ACID SYNTHASE INHIBITOR; DIET-INDUCED OBESITY; REDUCES FOOD-INTAKE; GLUCOSE-PRODUCTION; ARCUATE NUCLEUS; BODY-WEIGHT; BETA-CELLS	Recent evidence suggests a key role for the brain in the control of both body fat content and glucose metabolism. Neuronal systems that regulate energy intake, energy expenditure, and endogenous glucose production sense and respond to input from hormonal and nutrient-related signals that convey information regarding both body energy stores and current energy availability. In response to this input, adaptive changes occur that promote energy homeostasis and the maintenance of blood glucose levels in the normal range. Defects in this control system are implicated in the link between obesity and type 2 diabetes.	Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98110 USA; Harborview Med Ctr, Seattle, WA 98110 USA; Univ Calif San Diego, Div Endocrinol Diabet & Metab, San Diego, CA 92161 USA; VA San Diego Hlth Care Syst, Div Endocrinol Diabet & Metab, San Diego, CA 92161 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Schwartz, MW (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98110 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012		NIDDK NIH HHS [DK52989, DK683840] Funding Source: Medline; NINDS NIH HHS [NS32273] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032273, R29NS032273] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adage T, 2001, J NEUROSCI, V21, P3639, DOI 10.1523/JNEUROSCI.21-10-03639.2001; Asilmaz E, 2004, J CLIN INVEST, V113, P414, DOI 10.1172/JCI200419511; Bates SH, 2004, J MOL MED, V82, P12, DOI 10.1007/s00109-003-0494-z; Bernard, 1854, LECONS PHYSL EXPT AP; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Joffe BI, 2001, LANCET, V357, P1379, DOI 10.1016/S0140-6736(00)04616-X; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kotz CM, 1998, AM J PHYSIOL-REG I, V275, pR471, DOI 10.1152/ajpregu.1998.275.2.R471; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Marks JL, 1997, J NEUROENDOCRINOL, V9, P99, DOI 10.1046/j.1365-2826.1997.00554.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; POCAI A, IN PRESS CELL METAB; Porte D, 2001, DIABETES-METAB RES, V17, P181; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Schwartz MW, 2004, J CLIN ENDOCR METAB, V89, P5889, DOI 10.1210/jc.2004-0906; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seaquist ER, 2001, DIABETES, V50, P2203, DOI 10.2337/diabetes.50.10.2203; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	610	635	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					375	379		10.1126/science.1104344	http://dx.doi.org/10.1126/science.1104344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662002				2022-12-24	WOS:000226492300032
J	Hanlon, RT; Naud, MJ; Shaw, PW; Havenhand, JN				Hanlon, RT; Naud, MJ; Shaw, PW; Havenhand, JN			Behavioural ecology - Transient sexual mimicry leads to fertilization	NATURE			English	Editorial Material							ALTERNATIVE REPRODUCTIVE STRATEGIES; SPAWNING AGGREGATION; CUTTLEFISH; SUCCESS; MOLLUSCA		Marine Biol Lab, Marine Resources Ctr, Woods Hole, MA 02543 USA; Univ London, Royal Holloway Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; Univ Gothenburg, Tjarno Marine Biol Lab, S-45296 Stromstad, Sweden	Marine Biological Laboratory - Woods Hole; University of London; Royal Holloway University London; Flinders University South Australia; University of Gothenburg	Hanlon, RT (corresponding author), Marine Biol Lab, Marine Resources Ctr, Woods Hole, MA 02543 USA.	rhanlon@mbl.edu	Hanlon, Roger T/Q-8687-2016; Havenhand, Jon N/F-5435-2013	Hanlon, Roger T/0000-0003-0004-5674; Havenhand, Jon N/0000-0003-0253-3428; Havenhand, Jonathan/0000-0001-6721-7763				Andersson Malte, 1994; Boal JG, 1996, ANIM BEHAV, V52, P529, DOI 10.1006/anbe.1996.0195; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hall KC, 2002, MAR BIOL, V140, P533; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; NAUD MJ, IN PRESS P R SOC L B; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Saetre GP, 1996, AM NAT, V147, P981, DOI 10.1086/285889; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x	11	79	82	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					212	212		10.1038/433212a	http://dx.doi.org/10.1038/433212a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662403				2022-12-24	WOS:000226381300029
J	Wootton, JT				Wootton, JT			Field parameterization and experimental test of the neutral theory of biodiversity	NATURE			English	Article							CAPITA INTERACTION STRENGTH; COMPETITION; MODELS; COMMUNITIES; IMPACT; SPACE; TIME	Ecologists would like to explain general patterns observed across multi-species communities, such as species-area(1) and abundance-frequency relationships(1-4), in terms of the fundamental processes of birth, death and migration underlying the dynamics of all constituent species. The unified neutral theory of biodiversity(5,6) and related theories(7,8) based on these fundamental population processes have successfully recreated general species-abundance patterns without accounting for either the variation among species and individuals or resource-releasing processes such as predation and disturbance, long emphasized in ecological theory(9-14). If ecological communities can be described adequately without estimating variation in species and their interactions(15), our understanding of ecological community organization and the predicted consequences of reduced biodiversity and environmental change would shift markedly. Here, I introduce a strong method to test the neutral theory that combines field parameterization of the underlying population dynamics with a field experiment, and apply it to a rocky intertidal community. Although the observed abundance-frequency distribution of the system follows that predicted by the neutral theory, the neutral theory predicts poorly the field experimental results, indicating an essential role for variation in species interactions.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344				Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Brown JH, 1995, MACROECOLOGY; CASWELL H, 1976, ECOL MONOGR, V46, P327, DOI 10.2307/1942257; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Drossel B, 2004, J THEOR BIOL, V229, P539, DOI 10.1016/j.jtbi.2004.04.033; Elton C., 1927, ANIMAL ECOLOGY; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gause GF, 1934, STRUGGLE EXISTENCE; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kokkoris GD, 1999, ECOL LETT, V2, P70, DOI 10.1046/j.1461-0248.1999.22058.x; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.1890/0012-9658(1998)079[0461:TCAEAT]2.0.CO;2; MacArthur R.H., 1972, pvii; MacArthur R.H., 1969, THEORY ISLAND BIOGEO; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; RAFAELLI DG, 1996, FOOD WEBS INTEGRATIO, P185; Wootton JT, 2004, ECOL LETT, V7, P653, DOI 10.1111/j.1461-0248.2004.00621.x; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	27	110	116	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					309	312		10.1038/nature03211	http://dx.doi.org/10.1038/nature03211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662423				2022-12-24	WOS:000226381300054
J	Flores, G				Flores, G			Preventing hospitalisations for children	LANCET			English	Editorial Material							HOSPITALS; CARE		Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Pediat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Epidemiol, Milwaukee, WI 53226 USA; Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin	Flores, G (corresponding author), Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Pediat, Milwaukee, WI 53226 USA.	gflores@mail.mcw.edu						Billings J, 1989, USE SMALL AREA ANAL; CASANOVA C, 1995, INT J HEALTH SERV, V25, P283, DOI 10.2190/PCF7-ALX9-6CN3-7X9G; Flores G, 2003, PEDIATRICS, V112, P1021, DOI 10.1542/peds.112.5.1021; Johnston Grant, 2004, J Health Serv Res Policy, V9 Suppl 2, P23, DOI 10.1258/1355819042349907; Martinez-Mir I, 1999, BRIT J CLIN PHARMACO, V47, P681, DOI 10.1046/j.1365-2125.1999.00943.x; Miller MR, 2004, PEDIATRICS, V113, P1741, DOI 10.1542/peds.113.6.1741; OWENS P, 2003, AHRQ PUBLICATION; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Rennick JE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00002	9	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					201	202						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652590				2022-12-24	WOS:000226309600008
J	Bradley, J; Dai, ZR; Erni, R; Browning, N; Graham, G; Weber, P; Smith, J; Hutcheon, I; Ishii, H; Bajt, S; Floss, C; Stadermann, F; Sandfords, S				Bradley, J; Dai, ZR; Erni, R; Browning, N; Graham, G; Weber, P; Smith, J; Hutcheon, I; Ishii, H; Bajt, S; Floss, C; Stadermann, F; Sandfords, S			An astronomical 2175 angstrom feature in interplanetary dust particles	SCIENCE			English	Article							ULTRAVIOLET EXTINCTION CURVES; MOLECULAR-CLOUD MATERIAL; IDENTIFICATION; CONSTRAINTS; GRAINS; SHAPES; CARBON	The 2175 angstrom extinction feature is the strongest (visible-ultraviolet) spectral signature of dust in the interstellar medium. Forty years after its discovery, the origin of the feature and the nature of the carrier(s) remain controversial. Using a transmission electron microscope, we detected a 5.7-electron volt (2175 angstrom) feature in interstellar grains embedded within interplanetary dust particles (IDPs). The carriers are organic carbon and amorphous silicates that are abundant in IDPs and in the interstellar medium. These multiple carriers may explain the enigmatic invariant central wavelength and variable bandwidth of the astronomical 2175 angstrom feature.	Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bradley, J (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA.	jbradley@igpp.ucllnl.org	Bajt, Sasa/O-4695-2019; 1.4, ALS Beamline/I-1886-2014; Dai, Zurong/E-6732-2010; Bajt, Sasa/G-2228-2010; Erni, Rolf/P-7435-2014; Weber, Peter Kilian/AAP-9517-2020	Bajt, Sasa/0000-0002-7163-7602; Erni, Rolf/0000-0003-2391-5943; Weber, Peter Kilian/0000-0001-6022-6050; Browning, Nigel/0000-0003-0491-251X; Graham, Gerard/0000-0002-7801-204X; Dai, Zurong/0000-0002-4209-8718; Ishii, Hope/0000-0002-7976-5078				Bernstein MP, 2003, ASTROPHYS J, V582, pL25, DOI 10.1086/345941; Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; BRADLEY JP, 2004, LUNAR PLANET SCI, V35; BRION CE, 1982, AM I PHYS C P, V9, P429; BROWNLEE DE, 2000, LUNAR PLANET SCI, V31, P1921; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; Draine B, 1989, INTERSTELLAR DUST, P313; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; FITZPATRICK EL, 1986, ASTROPHYS J, V307, P286, DOI 10.1086/164415; FITZPATRICK EL, 1990, ASTROPHYS J SUPPL S, V72, P163, DOI 10.1086/191413; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Floss C., 2004, LUNAR PLANET SCI, VXXXV; Flynn GJ, 2004, ADV SPACE RES-SERIES, V33, P57, DOI 10.1016/j.asr.2003.09.036; Henning T, 1998, SCIENCE, V282, P2204, DOI 10.1126/science.282.5397.2204; Henning T., 2004, ASTROPHYS DUST ASP C, V309, P603; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KELLER LP, 1994, AIP C P, V310, P51; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Sandford SA, 1996, METEORIT PLANET SCI, V31, P449, DOI 10.1111/j.1945-5100.1996.tb02088.x; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SANDFORD SA, 1989, ICARUS, V82, P146, DOI 10.1016/0019-1035(89)90028-6; STECHER TP, 1969, ASTROPHYS J, V157, pL125, DOI 10.1086/180400; STEEL TM, 1987, ASTROPHYS J, V315, P337, DOI 10.1086/165138	26	61	61	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					244	247		10.1126/science.1106717	http://dx.doi.org/10.1126/science.1106717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653501				2022-12-24	WOS:000226361900039
J	Azevedo, RBR; Lohaus, R; Braun, V; Gumbel, M; Umamaheshwar, M; Agapow, PM; Houthoofd, W; Platzer, U; Borgonie, G; Meinzer, HP; Leroi, AM				Azevedo, RBR; Lohaus, R; Braun, V; Gumbel, M; Umamaheshwar, M; Agapow, PM; Houthoofd, W; Platzer, U; Borgonie, G; Meinzer, HP; Leroi, AM			The simplicity of metazoan cell lineages	NATURE			English	Article							MORPHOLOGICAL COMPLEXITY; EVOLUTION; NEMATODE; FRAMEWORK	Developmental processes are thought to be highly complex, but there have been few attempts to measure and compare such complexity across different groups of organisms(1-5). Here we introduce a measure of biological complexity based on the similarity between developmental and computer programs(6-9). We define the algorithmic complexity of a cell lineage as the length of the shortest description of the lineage based on its constituent sublineages(9-13). We then use this measure to estimate the complexity of the embryonic lineages of four metazoan species from two different phyla. We find that these cell lineages are significantly simpler than would be expected by chance. Furthermore, evolutionary simulations show that the complexity of the embryonic lineages surveyed is near that of the simplest lineages evolvable, assuming strong developmental constraints on the spatial positions of cells and stabilizing selection on cell number. We propose that selection for decreased complexity has played a major role in moulding metazoan cell lineages.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; German Canc Res Ctr, Div Med & Biol Informat, D-69120 Heidelberg, Germany; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	University of Houston System; University of Houston; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; Ghent University	Azevedo, RBR (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	razevedo@uh.edu	Azevedo, Ricardo/AAV-3963-2021	Azevedo, Ricardo/0000-0001-5402-7071				APTER MJ, 1965, J THEOR BIOL, V8, P244, DOI 10.1016/0022-5193(65)90075-5; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; ATLAN H, 1990, B MATH BIOL, V52, P335, DOI 10.1007/BF02458575; Bennett, 1990, COMPLEXITY ENTROPY P, P137; Bonner JT., 1988, EVOLUTION COMPLEXITY; Borgonie G, 2000, NEMATOLOGY, V2, P65, DOI 10.1163/156854100508908; Braun V, 2003, BIOINFORMATICS, V19, P851, DOI 10.1093/bioinformatics/btg087; Brooks D.R., 1988, EVOLUTION ENTROPY UN; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; GEARD N, IN PRESS ARTIF LIFE; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; GOODWIN BC, 1993, J THEOR BIOL, V163, P135, DOI 10.1006/jtbi.1993.1112; Houthoofd W, 2003, DEV BIOL, V258, P57, DOI 10.1016/S0012-1606(03)00101-5; Kauffman S. A., 1993, ORIGINS ORDER; McShea DW, 1996, EVOLUTION, V50, P477, DOI 10.1111/j.1558-5646.1996.tb03861.x; Minelli A., 2003, DEV ANIMAL FORM ONTO, DOI [10.1017/CBO9780511541476, DOI 10.1017/CBO9780511541476]; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; PAPENTIN F, 1980, J THEOR BIOL, V87, P421, DOI 10.1016/0022-5193(80)90230-1; Raff R.A., 1996, SHAPE LIFE; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; SOMMER RJ, 1994, DEVELOPMENT, P85; Stadler BMR, 2001, J THEOR BIOL, V213, P241, DOI 10.1006/jtbi.2001.2423; STERNBERG PW, 1982, DEV BIOL, V93, P181, DOI 10.1016/0012-1606(82)90251-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; VALENTINE JW, 1994, PALEOBIOLOGY, V20, P131, DOI 10.1017/S0094837300012641; Wagner GP, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P338	30	28	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					152	156		10.1038/nature03178	http://dx.doi.org/10.1038/nature03178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650738				2022-12-24	WOS:000226252200036
J	Hopkinson, CS; Vallino, JJ				Hopkinson, CS; Vallino, JJ			Efficient export of carbon to the deep ocean through dissolved organic matter	NATURE			English	Article							PACIFIC SUBTROPICAL GYRE; EASTERN NORTH PACIFIC; TEMPORAL VARIABILITY; SARGASSO SEA; FLUX; RADIOCARBON; PHOSPHORUS; DYNAMICS; NITROGEN; CYCLE	Oceanic dissolved organic carbon (DOC) constitutes one of the largest pools of reduced carbon in the biosphere. Estimated DOC export from the surface ocean represents 20% of total organic carbon flux to the deep ocean(1-3), which constitutes a primary control on atmospheric carbon dioxide levels(4). DOC is the carbon component of dissolved organic matter (DOM) and an accurate quantification of DOM pools, fluxes and their controls is therefore critical to understanding oceanic carbon cycling. DOC export is directly coupled with dissolved organic nitrogen and phosphorus export. However, the C:N:P stoichiometry (by atoms) of DOM dynamics is poorly understood. Here we study the stoichiometry of the DOM pool and of DOM decomposition in continental shelf, continental slope and central ocean gyre environments. We find that DOM is remineralized and produced with a C:N:P stoichiometry of 199:20:1 that is substantially lower than for bulk pools (typically >775:54:1), but greater than for particulate organic matter (106:16:1-the Redfield ratio). Thus for a given mass of new N and P introduced into surface water, more DOC can be exported than would occur at the Redfield ratio. This may contribute to the excess respiration estimated to occur in the interior ocean(5). Our results place an explicit constraint on global carbon export and elemental balance via advective pathways.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Hopkinson, CS (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.	chopkins@mbl.edu	Vallino, Joseph/J-6177-2015	Vallino, Joseph/0000-0002-4184-4512; hopkinson, charles/0000-0002-7331-8322				Bauer JE, 1998, J GEOPHYS RES-OCEANS, V103, P2867, DOI 10.1029/97JC02545; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Carlson C., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685716, DOI [10.1016/B978-012323841-2/50017-8, DOI 10.1016/B978-012323841-2/50017-8]; Hopkinson CS, 2002, DEEP-SEA RES PT II, V49, P4461, DOI 10.1016/S0967-0645(02)00125-X; Hopkinson CS, 1997, CONT SHELF RES, V17, P473, DOI 10.1016/S0278-4343(96)00046-5; JACKSON GA, 1985, DEEP-SEA RES, V32, P223, DOI 10.1016/0198-0149(85)90030-5; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; LE B, 1995, MAR CHEM, V51, P17; Loh AN, 2000, DEEP-SEA RES PT I, V47, P2287, DOI 10.1016/S0967-0637(00)00027-3; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Peltzer ET, 1996, DEEP-SEA RES PT II, V43, P1155, DOI 10.1016/0967-0645(95)00014-3; Press WH, 1992, COMPUT PHYS, V6, P274, DOI [10.1063/1.4823074, DOI 10.1063/1.4823074]; Qian JG, 1996, ANAL CHEM, V68, P3090, DOI 10.1021/ac960370z; SARMIENTO JL, 1992, ENVIR SCI R, V43, P317; Six KD, 1996, GLOBAL BIOGEOCHEM CY, V10, P559, DOI 10.1029/96GB02561; Sondergaard M, 2000, LIMNOL OCEANOGR, V45, P1097, DOI 10.4319/lo.2000.45.5.1097; TUPAS L, 1997, 977 SOEST U HAW; WALSH T, 1989, MAR CHEM, V26, P151; WILLIAMS PM, 1980, OCEANOL ACTA, V3, P471; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	30	191	206	11	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					142	145		10.1038/nature03191	http://dx.doi.org/10.1038/nature03191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650735				2022-12-24	WOS:000226252200033
J	Marlow, N; Wolke, D; Bracewell, MA; Samara, M				Marlow, N; Wolke, D; Bracewell, MA; Samara, M		EPICure Study Grp	Neurologic and developmental disability at six years of age after extremely preterm birth.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEEKS GESTATION; EXTREMELY PREMATURE; CHILDREN BORN; INFANTS BORN; WEIGHT; OUTCOMES; LESS	BACKGROUND: Birth before 26 weeks of gestation is associated with a high prevalence of neurologic and developmental disabilities in the infant during the first two years of life. METHODS: We studied at the time of early school age children who had been born at 25 or fewer completed weeks of gestation in the United Kingdom and Ireland in 1995. Each child had been evaluated at 30 months of age. The children underwent standardized cognitive and neurologic assessments at six years of age. Disability was defined as severe (indicating dependence on caregivers), moderate, or mild according to predetermined criteria. RESULTS: Of 308 surviving children, 241 (78 percent) were assessed at a median age of six years and four months; 160 classmates delivered at full term served as a comparison group. Although the use of test reference norms showed that cognitive impairment (defined as results more than 2 SD below the mean) was present in 21 percent of the children born extremely preterm (as compared with 1 percent in the standardized data), this value rose to 41 percent when the results were compared with those for their classmates. The rates of severe, moderate, and mild disability were 22 percent, 24 percent, and 34 percent, respectively; disabling cerebral palsy was present in 30 children (12 percent). Among children with severe disability at 30 months of age, 86 percent still had moderate-to-severe disability at 6 years of age. In contrast, other disabilities at the age of 30 months were poorly predictive of developmental problems at 6 years of age. CONCLUSIONS: Among extremely preterm children, cognitive and neurologic impairment is common at school age. A comparison with their classroom peers indicates a level of impairment that is greater than is recognized with the use of standardized norms.	Univ Nottingham, Sch Human Dev, Nottingham NG7 2RD, England; Univ Bristol, Dept Community Based Med, Unit Perinatal & Pediat Epidemiol, Bristol, Avon, England; Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England	University of Nottingham; University of Bristol; University of Hertfordshire	Marlow, N (corresponding author), Queens Med Ctr, Acad Div Child Hlth, Level E E Block, Nottingham NG7 2UH, England.	neil.marlow@nottingham.ac.uk	Fahimifar, Sepideh/M-5303-2019; Wolke, Dieter/C-5372-2008; Samara, Muthanna/B-4101-2009; Marlow, Neil/D-2918-2009	Wolke, Dieter/0000-0003-0304-268X; Marlow, Neil/0000-0001-5890-2953	Medical Research Council [G0401525] Funding Source: Medline; MRC [G0401525] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; BROTHWOOD M, 1986, ARCH DIS CHILD, V61, P559, DOI 10.1136/adc.61.6.559; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; D'Angio CT, 2002, PEDIATRICS, V110, P1094, DOI 10.1542/peds.110.6.1094; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; DRILLIEN CM, 1972, DEV MED CHILD NEUROL, V14, P575, DOI 10.1111/j.1469-8749.1972.tb02639.x; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; EVANS P, 1987, DEV MED CHILD NEUROL, V29, P272; Fanaroff AA, 2003, PEDIATR RES, V53, p398A; Finnstrom O, 2003, J Matern Fetal Neonatal Med, V14, P75, DOI 10.1080/jmf.14.2.75.84; Flynn JR, 1999, AM PSYCHOL, V54, P5, DOI 10.1037/0003-066X.54.1.5; Griffiths R., 1970, ABILITIES YOUNG CHIL; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; Jacobs SE, 2000, ACTA PAEDIATR, V89, P959; JOHNSON A, 1993, BRIT MED J, V306, P1715, DOI 10.1136/bmj.306.6894.1715; Kaufman AS., 2004, KAUFMAN BRIEF INTELL, V2nd; Korkman M, 1998, MANUAL NEPSY DEV NEU; Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609; Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009; Lorenz JM, 2001, PEDIATRICS, V108, P1269, DOI 10.1542/peds.108.6.1269; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; NELSON KB, 1982, PEDIATRICS, V69, P529; *NPEU ORHA, 1995, DIS PER CAR REP 2 WO; Piecuch RE, 1997, OBSTET GYNECOL, V90, P809, DOI 10.1016/S0029-7844(97)00429-8; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Taylor HG, 2000, DEV NEUROPSYCHOL, V17, P289, DOI 10.1207/S15326942DN1703_2; Taylor HG, 2002, CHILD NEUROPSYCHOL, V8, P163, DOI 10.1076/chin.8.3.163.13500; Whitfield MF, 1997, ARCH DIS CHILD-FETAL, V77, pF85, DOI 10.1136/fn.77.2.F85; WOLKE D, 1994, EUR J PEDIATR, V153, P906, DOI 10.1007/s004310050239; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	35	1303	1344	4	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2005	352	1					9	19		10.1056/NEJMoa041367	http://dx.doi.org/10.1056/NEJMoa041367			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884UP	15635108				2022-12-24	WOS:000226112500003
J	Postma, E; van Noordwijk, AJ				Postma, E; van Noordwijk, AJ			Gene flow maintains a large genetic difference in clutch size at a small spatial scale	NATURE			English	Article							TIT PARUS-MAJOR; NATURAL-POPULATIONS; GREAT TIT; ADAPTIVE DIVERGENCE; ISLAND POPULATION; SELECTION; IMMIGRATION; DISPERSAL; LAKE	Understanding the capacity of natural populations to adapt to their local environment is a central topic in evolutionary biology. Phenotypic differences between populations may have a genetic basis, but showing that they reflect different adaptive optima requires the quantification of both gene flow and selection(1-3). Good empirical data are rare(4). Using data on a spatially structured island population of great tits (Parus major), we show here that a persistent difference in mean clutch size between two subpopulations only a few kilometres apart has a major genetic component. We also show that immigrants from outside the island carry genes for large clutches. But gene flow into one subpopulation is low, as a result of a low immigration rate together with strong selection against immigrant genes. This has allowed for adaptation to the island environment and the maintenance of small clutches. In the other area, however, higher gene flow prevents local adaptation and maintains larger clutches. We show that the observed small-scale genetic difference in clutch size is not due to divergent selection on the island, but to different levels of gene flow from outside the island. Our findings illustrate the large effect of immigration on the evolution of local adaptations and on genetic population structure.	Netherlands Inst Ecol, Ctr Terr Ecol, NL-6666 ZG Heteren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Postma, E (corresponding author), Netherlands Inst Ecol, Ctr Terr Ecol, POB 40, NL-6666 ZG Heteren, Netherlands.	e.postma@nioo.knaw.nl	van noordwijk, arie/A-8880-2011; Postma, Erik/B-7258-2008	Postma, Erik/0000-0003-0856-1294				ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; CLOBERT J, 1988, J ANIM ECOL, V57, P287, DOI 10.2307/4779; DHONDT AA, 1990, NATURE, V348, P723, DOI 10.1038/348723a0; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; GARANT D, NATURE; GROENEVELD E, 1992, ARCH TIERZUCHT, V35, P399; Hendry AP, 2002, EVOLUTION, V56, P1199; Hendry AP, 2001, EVOLUTION, V55, P459, DOI 10.1554/0014-3820(2001)055[0459:PMATAD]2.0.CO;2; Institute SAS, 1996, SAS STAT US GUID; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; KING RB, 1995, EVOLUTION, V49, P885, DOI 10.1111/j.1558-5646.1995.tb02324.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Krebs J, 1991, BEHAV ECOLOGY EVOLUT; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LAMBRECHTS MM, 1993, IBIS, V135, P451, DOI 10.1111/j.1474-919X.1993.tb02118.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lynch M., 1998, AM J HUM GENET; Marr AB, 2002, EVOLUTION, V56, P131; MCCLEERY RH, 1990, POPULATION BIOL PASS, P423; Neumaier A, 1998, GENET SEL EVOL, V30, P3, DOI 10.1051/gse:19980101; Quinn GP, 2003, EXPT DESIGN DATA ANA; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Stanton ML, 1997, AM NAT, V150, P143, DOI 10.1086/286061; STEARNS SC, 1980, EVOLUTION, V34, P67; Storfer A, 1998, EVOLUTION, V52, P558, DOI 10.1111/j.1558-5646.1998.tb01654.x; VANNOORDWIJK AJ, 1981, NETH J ZOOL, V31, P342; VANTIENDEREN PH, 1988, J EVOLUTION BIOL, V1, P117, DOI 10.1046/j.1420-9101.1988.1020117.x; Verhulst S, 1996, J EVOLUTION BIOL, V9, P771, DOI 10.1046/j.1420-9101.1996.9060771.x	30	204	209	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2005	433	7021					65	68		10.1038/nature03083	http://dx.doi.org/10.1038/nature03083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635410				2022-12-24	WOS:000226117100036
J	Dietl, GP; Herbert, GS; Vermeij, GJ				Dietl, GP; Herbert, GS; Vermeij, GJ			Reduced competition and altered feeding behavior among marine snails after a mass extinction	SCIENCE			English	Article							CARIBBEAN NEOGENE; DIVERSITY; SEA; GASTROPODS; EVOLUTION; MOLLUSKS; ATLANTIC; FLORIDA; PANAMA; TOOTH	Extinction may alter competitive interactions among surviving species, affecting their subsequent recovery and evolution, but these processes remain poorly understood. Analysis of predation traces produced by shell-drilling muricid snails on bivalve prey reveals that species interactions were substantially different before and after a Plio-Pleistocene mass extinction in the westerm Atlantic. Muricids edge- and wall-drilled their prey in the Pliocene, but Pleistocene and Recent snails attacked prey only through the shell wait. Experiments with living animals suggest that intense competition induces muricid snails to attack shell edges. Pliocene predators, therefore, probably competed for resources more intensely than their post-extinction counterparts.	Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Davis; University of California System; University of California Davis	Dietl, GP (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.							Allmon Warren D., 1996, P271; Allmon WD, 1996, J GEOL, V104, P143, DOI 10.1086/629811; Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; ALLMON WD, 1993, SCIENCE, V260, P1626, DOI 10.1126/science.260.5114.1626; DIETL GP, 2002, AM MAL SOC ABS PROG, V44; Domning DP, 2001, PALAEOGEOGR PALAEOCL, V166, P27, DOI 10.1016/S0031-0182(00)00200-5; Ishida S, 2004, J EXP MAR BIOL ECOL, V305, P233, DOI 10.1016/j.jembe.2003.12.012; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; Morissette S, 2000, ANIM BEHAV, V60, P531, DOI 10.1006/anbe.2000.1500; Nesbitt HW, 1997, J GEOL, V105, P531, DOI 10.1086/515954; PAINE RT, 1963, ECOLOGY, V44, P63, DOI 10.2307/1933181; PETUCH EJ, 1995, SCIENCE, V270, P275, DOI 10.1126/science.270.5234.275; PETUCH EJ, 1982, PALAEOGEOGR PALAEOCL, V37, P277, DOI 10.1016/0031-0182(82)90041-4; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; ROLLER R A, 1984, American Malacological Bulletin, V2, P63; STANLEY S M, 1986, Palaios, V1, P17, DOI 10.2307/3514456; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Vermeij G.J., 1993, NATURAL HIST SHELLS; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT, DOI 10.1017/S0094837300005352; Vermeij GJ, 1998, J PALEONTOL, V72, P465, DOI 10.1017/S0022336000024215; Vermeij GJ, 2001, BIOL J LINN SOC, V72, P461, DOI 10.1006/bijl.2001.0524; WOODRING WP, 1966, P AM PHILOS SOC, V110, P425	23	63	64	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2229	2231		10.1126/science.1106182	http://dx.doi.org/10.1126/science.1106182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618513				2022-12-24	WOS:000225950000038
J	O'Neill, E; Rushworth, L; Baccarini, M; Kolch, W				O'Neill, E; Rushworth, L; Baccarini, M; Kolch, W			Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1	SCIENCE			English	Article							CELL-CYCLE EXIT; PROMOTES APOPTOSIS; PROTEIN INTERACTIONS; C-RAF-1 GENE; ACTIVATION; PROLIFERATION; DROSOPHILA; HIPPO; RAS; SALVADOR	The ablation of the protein kinase Raf-1 renders cells hypersensitive to apoptosis despite normal regulation of extracellular signal-regulated kinases, which suggests that apoptosis protection is mediated by a distinct pathway. We used proteomic analysis of Raf-1 signaling complexes to show that Raf-1 counteracts apoptosis by suppressing the activation of mammalian sterile 20-like kinase (MST2). Raf-1 prevents dimerization and phosphorylation of the activation loop of MST2 independently of its protein kinase activity. Depletion of MST2 from Raf-1(-1-) mouse or human cells abrogated sensitivity to apoptosis, whereas overexpression of MST2 induced apoptosis. Conversely, depletion of Raf-1 from Raf-l(+/+) mouse or human cells led to MST2 activation and apoptosis. The concomitant depletion of both Raf-1 and MST2 prevented apoptosis.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland; Univ Vienna, Max F Perutz Labs, Univ Dept Vienna Bioctr, Dept Genet & Microbiol, A-1030 Vienna, Austria	Beatson Institute; University of Glasgow; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Kolch, W (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	wkolch@beatson.gla.ac.uk	Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Baccarini, Manuela/B-6481-2014	Baccarini, Manuela/0000-0002-3033-391X; Rushworth, Linda/0000-0003-0654-8766; Kolch, Walter/0000-0001-5777-5016				Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Baccarini M, 2002, CELL DEATH DIFFER, V9, P783, DOI 10.1038/sj.cdd.4401070; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; PIAZZOLLA D, UNPUB; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3	25	236	243	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2267	2270		10.1126/science.1103233	http://dx.doi.org/10.1126/science.1103233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618521				2022-12-24	WOS:000225950000050
J	Lang, GA; Iwakuma, T; Suh, YA; Liu, G; Rao, VA; Parant, JM; Valentin-Vega, YA; Terzian, T; Caldwell, LC; Strong, LC; El-Naggar, AK; Lozano, G				Lang, GA; Iwakuma, T; Suh, YA; Liu, G; Rao, VA; Parant, JM; Valentin-Vega, YA; Terzian, T; Caldwell, LC; Strong, LC; El-Naggar, AK; Lozano, G			Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome	CELL			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR; P53-DEFICIENT MICE; EMBRYONIC LETHALITY; BREAST-CANCER; CHEMICAL CARCINOGENESIS; MDM2-DEFICIENT MICE; FAMILIAL SYNDROME; GENE-EXPRESSION; MUTANT	Individuals with Li-Fraumeni syndrome carry inherited mutations in the p53 tumor suppressor gene and are predisposed to tumor development. To examine the mechanistic nature of these p53 missense mutations, we generated mice harboring a G-to-A substitution at nucleotide 515 of p53 (p53(+/515A)) corresponding to the p53R175H hot spot mutation in human cancers. Although p53(+/515A) mice display a similar tumor spectrum and survival curve as p53(+/-) mice, tumors from p53(+/515A) mice metastasized with high frequency. Correspondingly, the embryonic fibroblasts from the p53(515A/515A) mutant mice displayed enhanced cell proliferation, DNA synthesis, and transformation potential. The disruption of p63 and p73 in p53(-/-) cells increased transformation capacity and reinitiated DNA synthesis to levels observed in p53(515A/515A) cells. Additionally, p63 and p73 were functionally inactivated in p53(515A) cells. These results provide in vivo validation for the gain-of-function properties of certain p53 missense mutations and suggest a mechanistic basis for these phenotypes.	Univ Texas, Grad Sch Biomed Sci, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas System; University of Texas System	Lozano, G (corresponding author), Univ Texas, Grad Sch Biomed Sci, Dept Mol Genet, Sect Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gglozano@mdanderson.org	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049	NCI NIH HHS [P01 CA34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; BARTEK J, 1991, ONCOGENE, V6, P1699; Bataille F, 2003, J CLIN PATHOL-MOL PA, V56, P286; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Evans SC, 1997, MOL MED TODAY, V3, P390, DOI 10.1016/S1357-4310(97)01105-2; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; Fillippovich I, 2001, ONCOGENE, V20, P514, DOI 10.1038/sj.onc.1204118; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Ishimoto O, 2002, CANCER RES, V62, P636; Iwakuma T, 2004, ONCOGENE, V23, P7644, DOI 10.1038/sj.onc.1207793; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Lai SL, 2000, J BIOMED SCI, V7, P64, DOI 10.1007/BF02255920; Lane DR, 2003, DRUG DISCOV TODAY, V8, P347, DOI 10.1016/S1359-6446(03)02669-2; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1969, J NATL CANCER I, V43, P1365; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; LUNA RMD, 1995, NATURE, V378, P203; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Powell B, 2000, CLIN CANCER RES, V6, P443; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Sigal A, 2000, CANCER RES, V60, P6788; Skaug V, 2000, CLIN CANCER RES, V6, P1031; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; Soussi T, 2003, CANCER CELL, V3, P303, DOI 10.1016/S1535-6108(03)00081-3; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhivotovsky B, 1999, EXP CELL RES, V248, P10, DOI 10.1006/excr.1999.4452	64	780	797	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					861	872		10.1016/j.cell.2004.11.006	http://dx.doi.org/10.1016/j.cell.2004.11.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607981	Bronze			2022-12-24	WOS:000225907200015
J	Paltiel, AD; Weinstein, MC; Kimmel, AD; Seage, GR; Losina, E; Zhang, H; Freedberg, KA; Walensky, RP				Paltiel, AD; Weinstein, MC; Kimmel, AD; Seage, GR; Losina, E; Zhang, H; Freedberg, KA; Walensky, RP			Expanded screening for HIV in the United States - An analysis of cost-effectiveness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS INDINAVIR; CELL COUNTS; INFECTION; VACCINE; TRIALS; CARE; SEX	BACKGROUND: Although the Centers for Disease Control and Prevention (CDC) recommend routine HIV counseling, testing, and referral (HIVCTR) in settings with at least a 1 percent prevalence of HIV, roughly 280,000 Americans are unaware of their human immunodeficiency virus (HIV) infection. The effect of expanded screening for HIV is unknown in the era of effective antiretroviral therapy. METHODS: We developed a computer simulation model of HIV screening and treatment to compare routine, voluntary HIVCTR with current practice in three target populations: ``high-risk'' (3.0 percent prevalence of undiagnosed HIV infection; 1.2 percent annual incidence); ``CDC threshold'' (1.0 percent and 0.12 percent, respectively); and ``U.S. general'' (0.1 percent and 0.01 percent). Input data were derived from clinical trials and observational cohorts. Outcomes included quality-adjusted survival, cost, and cost-effectiveness. RESULTS: In the high-risk population, the addition of one-time screening for HIV antibodies with an enzyme-linked immunosorbent assay (ELISA) to current practice was associated with earlier diagnosis of HIV (mean CD4 cell count at diagnosis, 210 vs. 154 per cubic millimeter). One-time screening also improved average survival time among HIV-infected patients (quality-adjusted survival, 220.7 months vs. 219.8 months). The incremental cost-effectiveness was $36,000 per quality-adjusted life-year gained. Testing every five years cost $50,000 per quality-adjusted life-year gained, and testing every three years cost $63,000 per quality-adjusted life-year gained. In the CDC threshold population, the cost-effectiveness ratio for one-time screening with ELISA was $38,000 per quality-adjusted life-year gained, whereas testing every five years cost $71,000 per quality-adjusted life-year gained, and testing every three years cost $85,000 per quality-adjusted life-year gained. In the U.S. general population, one-time screening cost $113,000 per quality-adjusted life-year gained. CONCLUSIONS: In all but the lowest-risk populations, routine, voluntary screening for HIV once every three to five years is justified on both clinical and cost-effectiveness grounds. One-time screening in the general population may also be cost-effective.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Risk Anal, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr,Dept Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Paltiel, AD (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	david.paltiel@yale.edu		Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290	NIAID NIH HHS [K23AI01794, K24 AI062476, K24AI062476, K25AI50436, R01AI42006, P30 AI042851, K25 AI050436, P30AI42851, R01 AI042006, K23 AI001794] Funding Source: Medline; NIDA NIH HHS [R01DA015612, R01 DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH065869] Funding Source: Medline; PHS HHS [S1396-20/21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001794, R01AI042006, K24AI062476, K25AI050436, P30AI042851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bos JM, 2002, AIDS, V16, P1185, DOI 10.1097/00002030-200205240-00015; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; CAMPSMITH M, 2001, 2001 NAT HIV PREV C; *CDCP, HIV AIDS UPD GLANC H; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; *DEP HLTH HUM SERV, GUID US ANT AG HIV I; DIGUISEPPI C, 1996, GUIDE CLIN PREVENTIV; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Fleming PL, 2000, AM J PUBLIC HEALTH, V90, P1037, DOI 10.2105/AJPH.90.7.1037; Freedberg KA, 1999, ARCH INTERN MED, V159, P1994, DOI 10.1001/archinte.159.17.1994; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gold MR, 1996, COST EFFECTIVENESS H; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; *HARV CTR RISK AN, COST UT AN PUBL 1976; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; *MACS, 1995, MACS PUBL DAT REL PO; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT TECHN INF SER, 1992, AIDS COST SERV UT SU; *NIH HLTH RES SERV, 2004, MMWR RECOMM REP, V53, P744; *NIH HLTH RES SERV, 2003, MMWR RECOMM REP, V52, P1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Sheon AR, 1998, J ACQ IMMUN DEF SYND, V19, P519, DOI 10.1097/00042560-199812150-00012; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; U.S. Census Bureau, 2002, STAT ABSTR US; Walensky RP, 2005, AM J PUBLIC HEALTH, V95, P71, DOI 10.2105/AJPH.2003.031310; Webster RD, 2003, JAIDS-J ACQ IMM DEF, V33, P223, DOI 10.1097/00126334-200306010-00018; Zaric GS, 2000, J ACQ IMMUN DEF SYND, V25, P403, DOI 10.1097/00126334-200012150-00004; 1998, MMWR MORB MORTAL WKL, V47, P211	36	429	437	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					586	595		10.1056/NEJMsa042088	http://dx.doi.org/10.1056/NEJMsa042088			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	895KY	15703423				2022-12-24	WOS:000226862100008
J	Holland, R; Lenaghan, E; Harvey, I; Smith, R; Shepstone, L; Lipp, A; Christou, M; Evans, D; Hand, C				Holland, R; Lenaghan, E; Harvey, I; Smith, R; Shepstone, L; Lipp, A; Christou, M; Evans, D; Hand, C			Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ELDERLY-PATIENTS; PHARMACIST; EQ-5D	Objective To determine whether home based medication review by pharmacists affects hospital readmission rates among older people. Design Randomised controlled trial. Setting Home based medication review after discharge from acute or community hospitals in Norfolk and Suffolk. Participants 872 patients aged over 80 recruited during an emergency admission (any cause) if returning to own home or warden controlled accommodation and taking two or more drugs daily on discharge. Intervention Two home visits by a pharmacist within two weeks and eight weeks of discharge to educate patients and carers about their drugs, remove out of date drugs, inform general practitioners of drug reactions or interactions, and inform the local pharmacist if a compliance aid is needed. Control arm received usual care. Main outcome measure Total emergency readmissions to hospital at six months. Secondary outcomes included death and quality of life measured with the EQ-5D. Results By six months 178 readmissions had occurred in the control group and 234 in the intervention group (rate ratio = 1.30, 95% confidence interval 1.07 to 1.58; P = 0.009, Poisson model). 49 deaths Occurred in the intervention group compared with 63 in the control group (hazard ratio = 0.75, 0.52 to 1.10; P = 0.14). EQ-5D scores decreased (worsened) by a mean of 0.14 in the control group and 0.13 in the intervention group (difference = 0.01, -0.05 to 0.06; P = 0.84 t test). Conclusions The intervention was associated with a significantly higher rate of hospital admissions and did not significantly improve quality of life or reduce deaths. Further research is needed to explain this counterintuitive finding and to identify more effective methods of medication review.	Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Acad Pharm Practice Unit, Norwich NR4 7TJ, Norfolk, England; Great Yarmouth Teaching Primary Care Trust, Great Yarmouth NR14 8AB, Norfolk, England; Suffolk Publ Hlth Network, Pharmaceut Serv, Ipswich IP3 8LS, Suffolk, England	University of East Anglia; University of East Anglia	Holland, R (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	r.holland@uea.ac.uk		Holland, Richard/0000-0002-4663-6923; Smith, Richard/0000-0003-3837-6559				Al-Eidan FA, 2002, BRIT J CLIN PHARMACO, V53, P163, DOI 10.1046/j.0306-5251.2001.01531.x; Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; Begley S., 1997, INT J PHARM PRACT, V5, P111, DOI [10.1111/j.2042-7174.1997.tb00895.x, DOI 10.1111/J.2042-7174.1997.TB00895.X, DOI 10.1111/j.2042-7174.1997.tb00895.x]; Department of Health, 2001, NAT SERV FRAM OLD PE; GOODYER II, 1995, BR J CLIN PRACT, V19, P173; Holland R, 2004, HEALTH ECON, V13, P793, DOI 10.1002/hec.858; JITAPUNKUL S, 1991, AGE AGEING, V20, P332, DOI 10.1093/ageing/20.5.332; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; LAW R, 1976, BMJ-BRIT MED J, V1, P565, DOI 10.1136/bmj.1.6009.565; Lowe CJ, 2000, BRIT J CLIN PHARMACO, V50, P172, DOI 10.1046/j.1365-2125.2000.00247.x; National Health Service (NHS), GUIDANCE ROLE USE; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; Office for National Statistics, UK CENS 2001; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; *PRESCR SUPP UN, 2001, ASTRO PUS CHAPT STAR; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RAYNOR DK, 1993, BRIT MED J, V306, P1158, DOI 10.1136/bmj.306.6886.1158; Stewart S, 1998, J AM GERIATR SOC, V46, P174, DOI 10.1111/j.1532-5415.1998.tb02535.x; Tidermark J, 2003, QUAL LIFE RES, V12, P1069, DOI 10.1023/A:1026193812514; Varma S, 1999, PHARMACOTHERAPY, V19, P860, DOI 10.1592/phco.19.10.860.31565; WRIGHT EC, 1993, LANCET, V342, P909, DOI 10.1016/0140-6736(93)91951-H; Zermansky AG, 2001, BRIT MED J, V323, P1340, DOI 10.1136/bmj.323.7325.1340	22	210	215	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2005	330	7486					293	295		10.1136/bmj.38338.674583.AE	http://dx.doi.org/10.1136/bmj.38338.674583.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895EM	15665005	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000226843700018
J	Butland, G; Peregrin-Alvarez, JM; Li, J; Yang, WH; Yang, XC; Canadien, V; Starostine, A; Richards, D; Beattie, B; Krogan, N; Davey, M; Parkinson, J; Greenblatt, J; Emili, A				Butland, G; Peregrin-Alvarez, JM; Li, J; Yang, WH; Yang, XC; Canadien, V; Starostine, A; Richards, D; Beattie, B; Krogan, N; Davey, M; Parkinson, J; Greenblatt, J; Emili, A			Interaction network containing conserved and essential protein complexes in Escherichia coli	NATURE			English	Article							PHYLOGENETIC PROFILES; FUNCTIONAL LINKAGES; SIMPLE DEPENDENCE; EVOLUTION RATE; DATABASE; DNA; IDENTIFICATION; DISCOVERY; SYSTEM; NUMBER	Proteins often function as components of multi-subunit complexes. Despite its long history as a model organism(1), no large-scale analysis of protein complexes in Escherichia coli has yet been reported. To this end, we have targeted DNA cassettes into the E. coli chromosome to create carboxy-terminal, affinity-tagged alleles of 1,000 open reading frames (similar to23% of the genome). A total of 857 proteins, including 198 of the most highly conserved, soluble non-ribosomal proteins essential in at least one bacterial species, were tagged successfully, whereas 648 could be purified to homogeneity and their interacting protein partners identified by mass spectrometry. An interaction network of protein complexes involved in diverse biological processes was uncovered and validated by sequential rounds of tagging and purification. This network includes many new interactions as well as interactions predicted based solely on genomic inference or limited phenotypic data(2). This study provides insight into the function of previously uncharacterized bacterial proteins and the overall topology of a microbial interaction network, the core components of which are broadly conserved across Prokaryota.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Hosp Sick Children, Toronto, ON M4K 1X8, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Greenblatt, J (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	jack.greenblatte@utoronto.ca; andrew.emili@utoronto.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189; Davey, Michael/0000-0002-1172-5934; Alvarez, Jose/0000-0002-7184-832X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Haselbeck R, 2002, CURR PHARM DESIGN, V8, P1155, DOI 10.2174/1381612023394818; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SERRES MH, 2001, GENOME BIOL, V2, P7; STUKENBERG PT, 1995, J BIOL CHEM, V270, P13384, DOI 10.1074/jbc.270.22.13384; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; [No title captured]	30	887	922	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					531	537		10.1038/nature03239	http://dx.doi.org/10.1038/nature03239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690043				2022-12-24	WOS:000226727200051
J	Tesfaye, S; Chaturvedi, N; Eaton, SEM; Ward, JD; Manes, C; Ionescu-Tirgoviste, C; Witte, DR; Fuller, JH				Tesfaye, S; Chaturvedi, N; Eaton, SEM; Ward, JD; Manes, C; Ionescu-Tirgoviste, C; Witte, DR; Fuller, JH		EURODIAB Prospective Complications	Vascular risk factors and diabetic neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY; BLOOD-FLOW; CHOLESTEROL; PHOTOGRAPHY; RETINOPATHY; PREVALENCE; MORTALITY; SMOKING	BACKGROUND: Other than glycemic control, there are no treatments for diabetic neuropathy. Thus, identifying potentially modifiable risk factors for neuropathy is crucial. We studied risk factors for the development of distal symmetric neuropathy in 1172 patients with type 1 diabetes mellitus from 31 centers participating in the European Diabetes (EURODIAB) Prospective Complications Study. METHODS: Neuropathy was assessed at baseline (1989 to 1991) and at follow-up (1997 to 1999), with a mean (+/-SD) follow-up of 7.3+/-0.6 years. A standardized protocol included clinical evaluation, quantitative sensory testing, and autonomic-function tests. Serum lipids and lipoproteins, glycosylated hemoglobin, and the urinary albumin excretion rate were measured in a central laboratory. RESULTS: At follow-up, neuropathy had developed in 276 of 1172 patients without neuropathy at baseline (23.5 percent). The cumulative incidence of neuropathy was related to the glycosylated hemoglobin value and the duration of diabetes. After adjustment for these factors, we found that higher levels of total and low-density lipoprotein cholesterol and triglycerides, a higher body-mass index, higher von Willebrand factor levels and urinary albumin excretion rate, hypertension, and smoking were all significantly associated with the cumulative incidence of neuropathy. After adjustment for other risk factors and diabetic complications, we found that duration of diabetes, current glycosylated hemoglobin value, change in glycosylated hemoglobin value during the follow-up period, body-mass index, and smoking remained independently associated with the incidence of neuropathy. Cardiovascular disease at baseline was associated with double the risk of neuropathy, independent of cardiovascular risk factors. CONCLUSIONS: This prospective study indicates that, apart from glycemic control, the incidence of neuropathy is associated with potentially modifiable cardiovascular risk factors, including a raised triglyceride level, body-mass index, smoking, and hypertension.	Royal Hallamshire Hosp, Diabet Res Unit, Sheffield S10 2JF, S Yorkshire, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Fac Med, London, England; Papageorgiou Gen Teaching Hosp, Dept Internal Med, Thessaloniki, Greece; Papageorgiou Gen Teaching Hosp, Ctr Diabet, Thessaloniki, Greece; Inst Diabet Nutr & Metab Dis, Bucharest, Romania; UCL Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, EURODIAB, London, England	University of Sheffield; Imperial College London; Papageorgiou Hospital; Papageorgiou Hospital; University of London; University College London; UCL Medical School	Tesfaye, S (corresponding author), Royal Hallamshire Hosp, Diabet Res Unit, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	solomon.tesfaye@sth.nhs.uk	Witte, Daniel R/C-1722-2008; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Tesfaye, Solomon/0000-0003-1190-1472				ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; [Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; BUCOLO G, 1973, CLIN CHEM, V19, P476; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Chaturvedi N, 2001, KIDNEY INT, V60, P219, DOI 10.1046/j.1523-1755.2001.00789.x; Chaturvedi N, 2001, DIABETES CARE, V24, P284, DOI 10.2337/diacare.24.2.284; Coppini DV, 2000, J CLIN EPIDEMIOL, V53, P519, DOI 10.1016/S0895-4356(99)00170-5; DEFRONZO RA, 1982, DIABETES, V31, P795, DOI 10.2337/diab.31.9.795; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Eaton SEM, 2003, DIABETOLOGIA, V46, P934, DOI 10.1007/s00125-003-1127-3; Erbey JR, 1999, METABOLISM, V48, P1337; Erbey JR, 1999, METABOLISM, V48, P531, DOI 10.1016/S0026-0495(99)90116-6; FORD I, 1992, THROMB HAEMOSTASIS, V68, P628; Forrest KYZ, 1997, DIABETES, V46, P665, DOI 10.2337/diabetes.46.4.665; Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062; FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GADIA MT, 1987, DIABETES CARE, V10, P613, DOI 10.2337/diacare.10.5.613; HARRIS M, 1993, DIABETES CARE, V16, P1446, DOI 10.2337/diacare.16.11.1446; JOHN WG, 1993, CLIN CHEM, V39, P663; KEARNEY EM, 1987, J CLIN PATHOL, V40, P465, DOI 10.1136/jcp.40.4.465; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; MITCHELL BD, 1990, DIABETES CARE, V13, P434, DOI 10.2337/diacare.13.4.434; Rose G, 1982, CARDIOVASCULAR SURVE; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; TESFAYE S, 1993, DIABETOLOGIA, V36, P1266, DOI 10.1007/BF00400804; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; *URODIAB IDDM COMP, 1994, DIABETOLOGIA, V37, P278; Vinik AI, 2000, DIABETOLOGIA, V43, P957, DOI 10.1007/s001250051477; WARNICK GR, 1978, J LIPID RES, V19, P65; WILES PG, 1991, DIABETIC MED, V8, P157, DOI 10.1111/j.1464-5491.1991.tb01563.x; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; WITTE DR, IN PRESS DIABETOLOGI; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; ZENERE BM, 1995, DIABETES CARE, V18, P975, DOI 10.2337/diacare.18.7.975	37	843	907	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					341	350		10.1056/NEJMoa032782	http://dx.doi.org/10.1056/NEJMoa032782			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673800	Green Published			2022-12-24	WOS:000226535900006
J	Hwang, ES; Szabo, SJ; Schwartzberg, PL; Glimcher, LH				Hwang, ES; Szabo, SJ; Schwartzberg, PL; Glimcher, LH			T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3	SCIENCE			English	Article							TEC FAMILY KINASES; TYROSINE PHOSPHORYLATION; LINEAGE COMMITMENT; SIGNALING PATHWAYS; MICE LACKING; DNA-BINDING; ITK; DIFFERENTIATION; ASTHMA	Cell Lineage specification depends on both gene activation and gene silencing, and in the differentiation of T helper progenitors to Th1 or Th2 effector cells, this requires the action of two opposing transcription factors, T-bet and GATA-3. T-bet is essential for the development of Th1 cells, and GATA-3 performs an equivalent role in Th2 development. We report that T-bet represses Th2 lineage commitment through tyrosine kinase-mediated interaction between the two transcription factors that interferes with the binding of GATA-3 to its target DNA. These results provide a novel function for tyrosine phosphorylation of a transcription factor in specifying alternate fates of a common progenitor cell.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NIAID NIH HHS [AI56296, AI48126] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296, R01AI048126] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; HWANG ES, UNPUB; KTISTAKI E, 1995, P NATL ACAD SCI USA, V92, P9876, DOI 10.1073/pnas.92.21.9876; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Novina CD, 1998, J BIOL CHEM, V273, P33443, DOI 10.1074/jbc.273.50.33443; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; REIFELMILLER AE, 1994, J BIOL CHEM, V269, P23861; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takesono A, 2002, J CELL SCI, V115, P3039; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	22	386	433	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					430	433		10.1126/science.1103336	http://dx.doi.org/10.1126/science.1103336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662016				2022-12-24	WOS:000226492300049
J	Anderson, HR; Ayres, JG; Sturdy, PM; Bland, JM; Butland, BK; Peckitt, C; Taylor, JC; Victor, CR				Anderson, HR; Ayres, JG; Sturdy, PM; Bland, JM; Butland, BK; Peckitt, C; Taylor, JC; Victor, CR		Mortality Severe Morbidity Grp Nat	Bronchodilator treatment and deaths from asthma: case-control study	BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; BETA-AGONISTS; MORTALITY; RISK; PREVENTION; DEBATE; UK	Objective To investigate the association between bronchodilator treatment and death from asthma. Design Case-control study. Setting 33 health authorities or health boards in Great Britain. Participants 532 patients under age 65 who died from asthma and 532 controls with a hospital admission for asthma matched for period, age, mid area. Main outcome measures Odds ratios for deaths from asthma associated with prescription of bronchodilators and other treatment, with sensitivity analyses adjusting for age at onset, previous hospital admissions, associated chronic obstructive lung, disease, mid number of other drug categories. Results After full adjustment, there were no significant associations with drugs prescribed in the 4-12 months before the index date. For prescriptions in the 1-5 years before, mortality was positively associated with inhaled short acting beta(2) agonists (odds ratio 2.05, 95% confidence interval 1.26 to 3.33) mid inversely associated with antibiotics (0.59, 0.39 to 0.89). The former association seemed to be confined to those aged 45-64, and the association with antibiotics was more pronounced in those under 45. Significant age interactions across all periods suggested inverse associations with oral steroids confined to the under 45 age group. An inverse association with Ion acting beta(2) agonists and a positive association with methylxanthines in the 1-5 year period were non-significant. Conclusion There was no evidence of adverse effects on mortality with medium to long term use of inhaled long acting beta(2) agonist drugs. The association with short acting beta(2) agonists has several explanations, only one of which may be a direct adverse effect.	St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England; Univ Aberdeen, Liberty Safe Work Res Ctr, Dept Environm & Occupat Med, Aberdeen AB25 2ZP, Scotland	St Georges University London; University of Aberdeen	Anderson, HR (corresponding author), St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England.	r.anderson@sghm.ac.uk	Anderson, Hugh R/A-7417-2016	Victor, Christina/0000-0002-4213-3974; Butland, Barbara/0000-0001-9952-3108				BEASLEY R, 1991, AUST NZ J MED, V21, P753, DOI 10.1111/j.1445-5994.1991.tb01385.x; Blais L, 1996, AM J EPIDEMIOL, V144, P1161; *BRIT THOR SOC, 1984, THORAX, V39, P505; CHUNG KF, 1993, J ROY SOC MED, V86, P96; CRANE J, 1995, THORAX, V50, pS5, DOI 10.1136/thx.50.Suppl_1.S5; Dennis SM, 2000, LANCET, V355, P1675, DOI 10.1016/S0140-6736(00)02238-8; Graham V., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002741; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; Guite HF, 1996, THORAX, V51, P924, DOI 10.1136/thx.51.9.924; Guite HF, 1999, THORAX, V54, P301, DOI 10.1136/thx.54.4.301; INMAN WHW, 1969, LANCET, V2, P279; Lanes SF, 2002, THORAX, V57, P683, DOI 10.1136/thorax.57.8.683; Meier CR, 1997, THORAX, V52, P612, DOI 10.1136/thx.52.7.612; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SEARS MR, 1990, LANCET, V336, P1591; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; Sturdy PM, 2002, THORAX, V57, P1034, DOI 10.1136/thorax.57.12.1034; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; VANSCHAYCK CP, 1981, BRIT MED J, V1, P4256; VATHENEN AS, 1988, LANCET, V1, P554; Williams C, 1998, THORAX, V53, P7, DOI 10.1136/thx.53.1.7	24	90	94	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 15	2005	330	7483					117	120		10.1136/bmj.38316.729907.8F	http://dx.doi.org/10.1136/bmj.38316.729907.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15618231	Green Published, Bronze			2022-12-24	WOS:000226454900015
J	Lohi, H; Young, EJ; Fitzmaurice, SN; Rusbridge, C; Chan, EM; Vervoort, M; Turnbull, J; Zhao, XC; Ianzano, L; Paterson, AD; Sutter, NB; Ostrander, EA; Andre, C; Shelton, GD; Ackerley, CA; Scherer, SW; Minassian, BA				Lohi, H; Young, EJ; Fitzmaurice, SN; Rusbridge, C; Chan, EM; Vervoort, M; Turnbull, J; Zhao, XC; Ianzano, L; Paterson, AD; Sutter, NB; Ostrander, EA; Andre, C; Shelton, GD; Ackerley, CA; Scherer, SW; Minassian, BA			Expanded repeat in canine epilepsy	SCIENCE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LAFORA-DISEASE; EXPANSION		Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Wey Referrals, Surrey GU21 5BP, England; Stone Lion Vet Ctr, London SW19 5AU, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; CNRS Genet & Dev, F-35043 Rennes, France; Univ Calif San Diego, La Jolla, CA 92093 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Fred Hutchinson Cancer Center; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Diego	Minassian, BA (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bminass@sickkids.ca	Paterson, Andrew/AAQ-7511-2020; Rusbridge, Clare/K-6560-2019; Rusbridge, Clare/A-3794-2019; Paterson, Andrew D/A-4088-2011; Scherer, Stephen W./B-3785-2013; Lohi, Hannes/F-4596-2011	Paterson, Andrew/0000-0002-9169-118X; Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Paterson, Andrew D/0000-0002-9169-118X; Scherer, Stephen W./0000-0002-8326-1999; Lohi, Hannes/0000-0003-1087-5532; Ostrander, Elaine/0000-0001-6075-9738; Young, Ted (Edwin)/0000-0003-4882-6752	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200325, ZIAHG200325] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Jacobs L.L., 1998, EVOLUTION TERTIARY M; Minassian BA, 2002, ADV NEUROL, V89, P199; Saha T, 2001, FEBS LETT, V491, P184, DOI 10.1016/S0014-5793(01)02190-1; Schoeman T, 2002, J VET INTERN MED, V16, P201, DOI 10.1892/0891-6640(2002)016&lt;0201:PSDIAD&gt;2.3.CO;2; Weinhaeusel A, 2003, HUM MUTAT, V22, P404, DOI 10.1002/humu.10276	6	122	130	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					81	81		10.1126/science.1102832	http://dx.doi.org/10.1126/science.1102832			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637270				2022-12-24	WOS:000226214300039
J	Andersen, JS; Lam, YW; Leung, AKL; Ong, SE; Lyon, CE; Lamond, AI; Mann, M				Andersen, JS; Lam, YW; Leung, AKL; Ong, SE; Lyon, CE; Lamond, AI; Mann, M			Nucleolar proteome dynamics	NATURE			English	Article							POLYMERASE I TRANSCRIPTION; RNA-SYNTHESIS; GENE; LOCALIZATION; INHIBITION	The nucleolus is a key organelle that coordinates the synthesis and assembly of ribosomal subunits and forms in the nucleus around the repeated ribosomal gene clusters. Because the production of ribosomes is a major metabolic activity, the function of the nucleolus is tightly linked to cell growth and proliferation, and recent data suggest that the nucleolus also plays an important role in cell-cycle regulation, senescence and stress responses(1-4). Here, using mass-spectrometry-based organellar proteomics and stable isotope labelling(5), we perform a quantitative analysis of the proteome of human nucleoli. In vivo fluorescent imaging techniques are directly compared to endogenous protein changes measured by proteomics. We characterize the flux of 489 endogenous nucleolar proteins in response to three different metabolic inhibitors that each affect nucleolar morphology. Proteins that are stably associated, such as RNA polymerase I subunits and small nuclear ribonucleoprotein particle complexes, exit from or accumulate in the nucleolus with similar kinetics, whereas protein components of the large and small ribosomal subunits leave the nucleolus with markedly different kinetics. The data establish a quantitative proteomic approach for the temporal characterization of protein flux through cellular organelles and demonstrate that the nucleolar proteome changes significantly over time in response to changes in cellular growth conditions.	Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 4HN, Scotland; Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Wellcome Trust Bioctr, MSI WTB Complex, Dundee DD1 4HN, Scotland.	a.i.lamond@dundee.ac.uk; mann@bmb.sdu.dk	Andersen, Jens S/L-2100-2015; Mann, Matthias/A-3454-2013	Andersen, Jens S/0000-0002-6091-140X; Mann, Matthias/0000-0003-1292-4799; Lam, Yun Wah/0000-0001-8929-5965; Leung, Anthony/0000-0001-5569-4036; Lamond, Angus/0000-0001-6204-6045	Wellcome Trust [073980] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Guarente L, 1997, GENE DEV, V11, P2449, DOI 10.1101/gad.11.19.2449; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lamond AI, 2003, CURR BIOL, V13, pR825, DOI 10.1016/j.cub.2003.10.012; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Leung AKL, 2002, J CELL BIOL, V157, P615, DOI 10.1083/jcb.200201120; Li DX, 1997, J BIOL CHEM, V272, P3773, DOI 10.1074/jbc.272.6.3773; Masson C, 1996, EXP CELL RES, V226, P114, DOI 10.1006/excr.1996.0209; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; MAURAMATSU M, 1963, CANCER RES, V25, P693; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; TAMM I, 1976, J CELL BIOL, V69, P229, DOI 10.1083/jcb.69.2.229; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x	30	881	934	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					77	83		10.1038/nature03207	http://dx.doi.org/10.1038/nature03207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635413				2022-12-24	WOS:000226117100039
J	Blilou, I; Xu, J; Wildwater, M; Willemsen, V; Paponov, I; Friml, J; Heidstra, R; Aida, M; Palme, K; Scheres, B				Blilou, I; Xu, J; Wildwater, M; Willemsen, V; Paponov, I; Friml, J; Heidstra, R; Aida, M; Palme, K; Scheres, B			The PIN auxin efflux facilitator network controls growth and patterning in Arabidopsis roots	NATURE			English	Article							CELL FATE; TRANSPORT; GENES; GRAVITROPISM; GRADIENTS; LOCALIZATION; THALIANA; MERISTEM; ENCODES; TROPISM	Local accumulation of the plant growth regulator auxin mediates pattern formation in Arabidopsis roots and influences outgrowth and development of lateral root- and shoot-derived primordia. However, it has remained unclear how auxin can simultaneously regulate patterning and organ outgrowth and how its distribution is stabilized in a primordium-specific manner. Here we show that five PIN genes collectively control auxin distribution to regulate cell division and cell expansion in the primary root. Furthermore, the joint action of these genes has an important role in pattern formation by focusing the auxin maximum and restricting the expression domain of PLETHORA (PLT) genes, major determinants for root stem cell specification. In turn, PLT genes are required for PIN gene transcription to stabilize the auxin maximum at the distal root tip. Our data reveal an interaction network of auxin transport facilitators and root fate determinants that control patterning and growth of the root primordium.	Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Utrecht University; University of Freiburg; Eberhard Karls University of Tubingen	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Genet, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Palme, Klaus/A-9524-2013; Aida, Mitsuhiro/AAW-7703-2020; Xu, Jian/I-2921-2012; Paponov, Ivan A./H-9680-2016; Friml, Jiri/D-9511-2012	Palme, Klaus/0000-0002-2728-3835; Aida, Mitsuhiro/0000-0001-9000-7502; Xu, Jian/0000-0001-6194-6316; Paponov, Ivan A./0000-0002-2138-0722; Friml, Jiri/0000-0002-8302-7596; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; DAVIES PJ, 1976, PHYSIOL PLANTARUM, V36, P333, DOI 10.1111/j.1399-3054.1976.tb02252.x; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; KARES C, 1990, PLANT MOL BIOL, V15, P225, DOI 10.1007/BF00036909; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Long JA, 1998, DEVELOPMENT, V125, P3027; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; Srivastava L.M, 2002, PLANT GROWTH DEV HOR, DOI 10.1016/B978-012660570-9/50152-0; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Willemsen V, 1998, DEVELOPMENT, V125, P521	37	1373	1459	40	676	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					39	44		10.1038/nature03184	http://dx.doi.org/10.1038/nature03184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635403	Green Published			2022-12-24	WOS:000226117100029
J	Impey, S; McCorkle, SR; Cha-Molstad, H; Dwyer, JM; Yochum, GS; Boss, JM; McWeeney, S; Dunn, JJ; Mandel, G; Goodman, RH				Impey, S; McCorkle, SR; Cha-Molstad, H; Dwyer, JM; Yochum, GS; Boss, JM; McWeeney, S; Dunn, JJ; Mandel, G; Goodman, RH			Defining the CREB regulon: A genome-wide analysis of transcription factor regulatory regions	CELL			English	Article							CELL LEUKEMIA-VIRUS; BINDING-PROTEIN; CHROMATIN IMMUNOPRECIPITATION; PROMOTER; ACTIVATION; EXPRESSION; REVEALS; ELEMENT; GENES; PHOSPHORYLATION	The CREB transcription factor regulates differentiation, survival, and synaptic plasticity. The complement of CREB targets responsible for these responses has not been identified, however. We developed a novel approach to identify CREB targets, termed serial analysis of chromatin occupancy (SACO), by combining chromatin immunoprecipitation (ChIP) with a modification of SAGE. Using a SACO library derived from rat PC12 cells, we identified similar to41,000 genomic signature tags (GSTs) that mapped to unique genomic loci. CREB binding was confirmed for all loci supported by multiple GSTs. Of the 6302 loci identified by multiple GSTs, 40% were within 2 kb of the transcriptional start of an annotated gene, 49% were within 1 kb of a CpG island, and 72% were within 1 kb of a putative cAMP-response element (CRE). A large fraction of the SACO loci delineated bidirectional promoters and novel antisense transcripts. This study represents the most comprehensive definition of transcription factor binding sites in a metazoan species.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Oregon Health & Science University; United States Department of Energy (DOE); Brookhaven National Laboratory; Oregon Health & Science University; Emory University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	impeys@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607; McCorkle, Sean/0000-0003-1126-4071				Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Cox JM, 1995, CHEM BIOL, V2, P819, DOI 10.1016/1074-5521(95)90088-8; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Dunn JJ, 2002, GENOME RES, V12, P1756, DOI 10.1101/gr.306102; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; FINK JS, 1991, J BIOL CHEM, V266, P3882; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hug BA, 2004, J BIOL CHEM, V279, P825, DOI 10.1074/jbc.M309524200; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Momota R, 1998, FEBS LETT, V424, P11, DOI 10.1016/S0014-5793(98)00128-8; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PACAUCCARALERTKUN S, 1994, MOL CELL BIOL, V14, P456, DOI 10.1128/MCB.14.1.456; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; Schuettengruber B, 2003, J BIOL CHEM, V278, P1784, DOI 10.1074/jbc.M204843200; Shendure J, 2002, GENOME BIOL, V3; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wolfl S, 1999, MOL ENDOCRINOL, V13, P659, DOI 10.1210/me.13.5.659; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	39	584	617	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1041	1054		10.1016/j.cell.2004.10.032	http://dx.doi.org/10.1016/j.cell.2004.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620361	Bronze			2022-12-24	WOS:000226109700015
J	Knight, R				Knight, R			The Poohsticks phenomenon	BRITISH MEDICAL JOURNAL			English	Article											Knight, R (corresponding author), 1 Rutland Gate Mews, London SW7 1PH, England.							Milne A. A., 1992, HOUSE POOH CORNER	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1432	1433		10.1136/bmj.329.7480.1432	http://dx.doi.org/10.1136/bmj.329.7480.1432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604173	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000225965800016
J	Dobson, CM				Dobson, CM			Chemical space and biology	NATURE			English	Article							DRUG DISCOVERY; DIVERSITY; EVOLUTION; DESIGN	Chemical space - which encompasses all possible small organic molecules, including those present in biological systems - is vast. So vast, in fact, that so far only a tiny fraction of it has been explored. Nevertheless, these explorations have greatly enhanced our understanding of biology, and have led to the development of many of today's drugs. The discovery of new bioactive molecules, facilitated by a deeper understanding of the nature of the regions of chemical space that are relevant to biology, will advance our knowledge of biological processes and lead to new strategies to treat disease.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk						Agrafiotis DK, 2002, NAT REV DRUG DISCOV, V1, P337, DOI 10.1038/nrd791; [Anonymous], 2004, SCIENCE, V303, P1798, DOI 10.1126/science.303.5665.1796; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Buckingham S, 2003, NATURE, V425, P209, DOI 10.1038/425209a; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOBSON CM, 2001, FDN CHEM BIOL; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Houghten RA, 2000, ANNU REV PHARMACOL, V40, P273, DOI 10.1146/annurev.pharmtox.40.1.273; KIANO H, 2001, NATURE, V420, P206; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Luria SE, 1981, VIEW LIFE; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mullin R, 2004, CHEM ENG NEWS, V82, P23; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Seeberger PH, 2003, CHEM COMMUN, P1115, DOI 10.1039/b210230g; Sills MA, 2002, J BIOMOL SCREEN, V7, P191, DOI 10.1177/108705710200700304; Skar J, 2003, PHILOS T ROY SOC A, V361, P1047, DOI 10.1098/rsta.2003.1183; Smith A, 2003, NATURE, V426, P883, DOI 10.1038/426883a; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; Townsend JA, 2004, ORG BIOMOL CHEM, V2, P3294, DOI 10.1039/b411033a; TSIEN RY, 2003, NAT REV MOL CELL BIO, V4, pSS16; Voet D., 1995, BIOCHEMISTRY; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Williams R. J. P., 1997, NATURAL SELECTION CH; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987	44	701	756	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					824	828		10.1038/nature03192	http://dx.doi.org/10.1038/nature03192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602547	hybrid			2022-12-24	WOS:000225733500038
J	Matsuura, Y; Stewart, M				Matsuura, Y; Stewart, M			Structural basis for the assembly of a nuclear export complex	NATURE			English	Article							IMPORTIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; LOCALIZATION SIGNAL; DOMAIN; BETA; RAN; TRANSPORT; RECOGNITION; CSE1P	The nuclear import and export of macromolecular cargoes through nuclear pore complexes is mediated primarily by carriers such as importin-beta. Importins carry cargoes into the nucleus, whereas exportins carry cargoes to the cytoplasm. Transport is orchestrated by nuclear RanGTP, which dissociates cargoes from importins, but conversely is required for cargo binding to exportins. Here we present the 2.0 Angstrom crystal structure of the nuclear export complex formed by exportin Cse1p complexed with its cargo ( Kap60p) and RanGTP, thereby providing a structural framework for understanding nuclear protein export and the different functions of RanGTP in export and import. In the complex, Cse1p coils around both RanGTP and Kap60p, stabilizing the RanGTP-state and clamping the Kap60p importin-beta-binding domain, ensuring that only cargo-free Kap60p is exported. Mutagenesis indicated that conformational changes in exportins couple cargo binding to high affinity for RanGTP, generating a spring-loaded molecule to facilitate disassembly of the export complex following GTP hydrolysis in the cytoplasm.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						Askjaer P, 1999, MOL CELL BIOL, V19, P6276; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nilsson J, 2002, J MOL BIOL, V318, P583, DOI 10.1016/S0022-2836(02)00040-2; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Solsbacher J, 1998, MOL CELL BIOL, V18, P6805, DOI 10.1128/MCB.18.11.6805; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691	29	152	160	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					872	877		10.1038/nature03144	http://dx.doi.org/10.1038/nature03144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602554				2022-12-24	WOS:000225733500045
J	Le Gal, G; Testuz, A; Righini, M; Bounameaux, H; Perrier, A				Le Gal, G; Testuz, A; Righini, M; Bounameaux, H; Perrier, A			Reproduction of chest pain by palpation: diagnostic accuracy in suspected pulmonary embolism	BRITISH MEDICAL JOURNAL			English	Article									Brest Univ Hosp, Equipe Accueil GETBO 3878, F-29609 Brest, France; Univ Hosp Geneva, Geneva Fac Med, Dept Internal Med, Div Gen Internal Med, CH-1211 Geneva, Switzerland	CHU Brest; University of Geneva	Le Gal, G (corresponding author), Brest Univ Hosp, Equipe Accueil GETBO 3878, F-29609 Brest, France.	gregoire.legal@chu-brest.fr	Righini, Marc/AAX-8731-2020; LE GAL, Gregoire/K-1077-2012; Perrier, Arnaud/M-2263-2014	LE GAL, Gregoire/0000-0002-9253-248X				DREYFUSS AI, 1984, ARCH INTERN MED, V144, P2057, DOI 10.1001/archinte.144.10.2057; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Stein PD, 1997, CHEST, V112, P974, DOI 10.1378/chest.112.4.974; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	5	17	17	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					452	453		10.1136/bmj.38331.602384.8F	http://dx.doi.org/10.1136/bmj.38331.602384.8F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15684025	Green Published, Bronze			2022-12-24	WOS:000227315400018
J	Fatouros, NE; Huigens, ME; van Loon, JJA; Dicke, M; Hilker, M				Fatouros, NE; Huigens, ME; van Loon, JJA; Dicke, M; Hilker, M			Chemical communication - Butterfly anti-aphrodisiac lures parasitic wasps	NATURE			English	Editorial Material							SCELIONIDAE; HYMENOPTERA		Free Univ Berlin, Inst Biol, D-12163 Berlin, Germany; Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Free University of Berlin; Wageningen University & Research	Fatouros, NE (corresponding author), Free Univ Berlin, Inst Biol, D-12163 Berlin, Germany.	hilker@zedat.fu-berlin.de	Dicke, Marcel/B-2300-2010; van Loon, Joop J.A./B-3744-2009; Fatouros, Nina/AAO-9698-2020	Dicke, Marcel/0000-0001-8565-8896; van Loon, Joop J.A./0000-0002-4260-0501; Fatouros, Nina/0000-0003-0841-3144				Andersson J, 2000, P ROY SOC B-BIOL SCI, V267, P1271, DOI 10.1098/rspb.2000.1138; Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; Arakaki N, 1996, J CHEM ECOL, V22, P1079, DOI 10.1007/BF02027946; Bruni R, 2000, J INSECT BEHAV, V13, P165, DOI 10.1023/A:1007728012482; CLAUSEN CP, 1976, ANNU REV ENTOMOL, V21, P343, DOI 10.1146/annurev.en.21.010176.002015; GILBERT LE, 1976, SCIENCE, V193, P419, DOI 10.1126/science.935877; Hilker M., 2002, CHEMOECOLOGY INSECT; ORR DB, 1986, CAN ENTOMOL, V118, P1063, DOI 10.4039/Ent1181063-10; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Tabata S, 1940, REV APPL ENTOMOL A; Vinson S.B., 1984, Symposia of the Royal Entomological Society of London, V12, P325	11	83	88	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					704	704		10.1038/433704a	http://dx.doi.org/10.1038/433704a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716942				2022-12-24	WOS:000227039200028
J	Tomson, T; Forsgren, L				Tomson, T; Forsgren, L			Life expectancy in epilepsy	LANCET			English	Editorial Material							LONG-TERM; MORTALITY; SEIZURE; COHORT; PEOPLE		Karolinska Inst, Sect Neurol, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol Sect, S-90187 Umea, Sweden	Karolinska Institutet; Umea University	Tomson, T (corresponding author), Karolinska Inst, Sect Neurol, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	torbjorn.tomson@karolinska.se						COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Forsgren L, 1996, EPILEPSIA, V37, P956, DOI 10.1111/j.1528-1157.1996.tb00533.x; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; HAUSER WA, 1967, EPILEPSIA, V16, P1; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x; Loiseau J, 1999, EPILEPSIA, V40, P1388, DOI 10.1111/j.1528-1157.1999.tb02010.x; Olafsson E, 1998, EPILEPSIA, V39, P89, DOI 10.1111/j.1528-1157.1998.tb01279.x; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x	10	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2005	365	9459					557	558						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708087				2022-12-24	WOS:000226984300010
J	Ryu, JS; Kim, JI; Kunkel, T; Kim, BC; Cho, DS; Hong, SH; Kim, SH; Fernandez, AP; Kim, Y; Alonso, JM; Ecker, JR; Nagy, F; Lim, PO; Song, PS; Schafer, E; Nam, HG				Ryu, JS; Kim, JI; Kunkel, T; Kim, BC; Cho, DS; Hong, SH; Kim, SH; Fernandez, AP; Kim, Y; Alonso, JM; Ecker, JR; Nagy, F; Lim, PO; Song, PS; Schafer, E; Nam, HG			Phytochrome-specific type 5 phosphatase controls light signal flux by enhancing phytochrome stability and affinity for a signal transducer	CELL			English	Article							INTERACTING FACTOR-3; HYPOCOTYL ELONGATION; OAT PHYTOCHROME; IN-VITRO; ARABIDOPSIS; PROTEIN; PHOTORECEPTOR; PLANTS; PHOTOMORPHOGENESIS; PHOSPHORYLATION	Environmental light information such as quality, intensity, and duration in red (similar to660 nm) and far-red (similar to730 nm) wavelengths is perceived by phytochrome photoreceptors in plants, critically influencing almost all developmental strategies from germination to flowering. Phytochromes interconvert between red light-absorbing Pr and biologically functional far-red light-absorbing Pfr forms. To ensure optimal photoresponses in plants, the flux of light signal from Pfr-phytochromes should be tightly controlled. Phytochromes are phosphorylated at specific serine residues. We found that a type 5 protein phosphatase (PAPP5) specifically dephosphorylates biologically active Pfr-phytochromes and enhances phytochrome-mediated photoresponses. Depending on the specific serine residues dephosphorylated by PAPP5, phytochrome stability and affinity for a downstream signal transducer, NDPK2, were enhanced. Thus, phytochrome photoreceptors have developed an elaborate biochemical tuning mechanism for modulating the flux of light signal, employing variable phosphorylation states controlled by phosphorylation and PAPP5-mediated dephosphorylation as a mean to control phytochrome stability and affinity for downstream transducers.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Syst Biodynam Res Ctr, Pohang 790784, Kyungbuk, South Korea; Kumho Life & Environm Sci Lab, Kwangju 500712, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea; Univ Freiburg, Inst Bot, D-79104 Freiburg, Germany; Salk Inst Biol Studies, La Jolla, CA 92037 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Gyeongsang National University; University of Freiburg; Salk Institute	Nam, HG (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	nam@postech.ac.kr	Kim, Yumi/AAA-9398-2021; Nagy, Ferenc/D-3532-2015; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014	Kim, Yumi/0000-0001-6369-5055; Nagy, Ferenc/0000-0002-6157-9269; Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571				Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Casal JJ, 2002, PLANT PHYSIOL, V129, P1127, DOI 10.1104/pp.010977; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Jordan ET, 1997, PLANT PHYSIOL, V115, P693, DOI 10.1104/pp.115.2.693; Kim J, 2004, PLANT CELL, V16, P2629, DOI 10.1105/tpc.104.023879; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lagarias DM, 1997, PLANT CELL, V9, P675, DOI 10.1105/tpc.9.5.675; Lapko VN, 1999, PROTEIN SCI, V8, P1032, DOI 10.1110/ps.8.5.1032; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	29	121	137	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					395	406		10.1016/j.cell.2004.12.019	http://dx.doi.org/10.1016/j.cell.2004.12.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707897	Bronze			2022-12-24	WOS:000227028900014
J	Yu, B; Yang, ZY; Li, JJ; Minakhina, S; Yang, MC; Padgett, RW; Steward, R; Chen, XM				Yu, B; Yang, ZY; Li, JJ; Minakhina, S; Yang, MC; Padgett, RW; Steward, R; Chen, XM			Methylation as a crucial step in plant microRNA biogenesis	SCIENCE			English	Article							VIRUS-RESISTANCE; PAZ DOMAIN; RNA; ARABIDOPSIS; GENE; RECOGNITION; METABOLISM; TRANSGENE; GENOMICS; PROTEIN	Methylation on the base or the ribose is prevalent in eukaryotic ribosomal RNAs (rRNAs) and is thought to be crucial for ribosome biogenesis and function. Artificially introduced 2'-O-methyl groups in small interfering RNAs (siRNAs) can stabilize siRNAs in serum without affecting their activities in RNA interference in mammalian cells. Here, we show that plant microRNAs (miRNAs) have a naturally occurring methyl group on the ribose of the last nucleotide. Whereas methylation of rRNAs depends on guide RNAs, the methyltransferase protein HEN1 is sufficient to methylate miRNA/miRNA* duplexes. Our studies uncover a new and crucial step in plant miRNA biogenesis and have profound implications in the function of miRNAs.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, XM (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	xuemei@waksman.rutgers.edu	Yu, Bin/A-7714-2010	Chen, Xuemei/0000-0002-5209-1157	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM61146, R01 GM061146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alefelder S, 1998, NUCLEIC ACIDS RES, V26, P4983, DOI 10.1093/nar/26.21.4983; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG ZB, UNPUB	16	753	822	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					932	935		10.1126/science.1107130	http://dx.doi.org/10.1126/science.1107130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705854	Green Accepted			2022-12-24	WOS:000226985100056
J	Klironomos, JN; Allen, MF; Rillig, MC; Piotrowski, J; Makvandi-Nejad, S; Wolfe, BE; Powell, JR				Klironomos, JN; Allen, MF; Rillig, MC; Piotrowski, J; Makvandi-Nejad, S; Wolfe, BE; Powell, JR			Abrupt rise in atmospheric CO2 overestimates community response in a model plant-soil system	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ELEVATED CO2; COLONIZATION	Attempts to understand the ecological effect of increasing atmospheric CO2 concentration, [CO2], usually involve exposing today's ecosystems to expected future [CO2] levels(1,2). However, a major assumption of these approaches has not been tested that exposing ecosystems to a single- step increase in [ CO2] will yield similar responses to those of a gradual increase over several decades(3). We tested this assumption on a mycorrhizal fungal community over a period of six years. [ CO2] was either increased abruptly, as is typical of most [ CO2] experiments, or more gradually over 21 generations. The two approaches resulted in different structural and functional community responses to increased [ CO2]. Some fungi were sensitive to the carbon pulse of the abrupt [ CO2] treatment. This resulted in an immediate decline in fungal species richness and a significant change in mycorrhizal functioning. The magnitude of changes in fungal diversity and functioning in response to gradually increasing [ CO2] was smaller, and not significantly different to those with ambient [ CO2]. Our results suggest that studies may overestimate some community responses to increasing [ CO2] because biota may be sensitive to ecosystem changes that occur as a result of abrupt increases.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Guelph; University of California System; University of California Riverside; University of Montana System; University of Montana	Klironomos, JN (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jklirono@uoguelph.ca	Powell, Jeff R/A-5076-2010; Rillig, Matthias C./AAE-6980-2019; Rillig, Matthias C./B-3675-2009	Powell, Jeff R/0000-0003-1091-2452; Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853				Allen M. F., 1991, ECOLOGY MYCORRHIZAE; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; Goverde M, 2000, OECOLOGIA, V125, P362, DOI 10.1007/s004420000465; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; *IPCC, 2001, CLIM CHANG 2001 SYNT; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Klironomos J., 2000, MICROB BIOSYS, V1, P845; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Klironomos JN, 1998, NEW PHYTOL, V138, P599, DOI 10.1046/j.1469-8137.1998.00141.x; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Luo Y, 1999, CARBON DIOXIDE ENV S; Luo YQ, 1999, ECOLOGY, V80, P1568, DOI 10.1890/0012-9658(1999)080[1568:VOEFCE]2.0.CO;2; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Piotrowski JS, 2004, NEW PHYTOL, V164, P365, DOI 10.1111/j.1469-8137.2004.01181.x; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, ECOL STU AN, V157, P135; SINEAD C, NATURE, V431, P566; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; Staddon PL, 1998, TRENDS ECOL EVOL, V13, P455, DOI 10.1016/S0169-5347(98)01493-1; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2003, ECOSYSTEMS, V6, P786, DOI 10.1007/s10021-003-0182-4; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x	28	132	151	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					621	624		10.1038/nature03268	http://dx.doi.org/10.1038/nature03268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703744				2022-12-24	WOS:000226862000041
J	McCormick, C; Ganem, D				McCormick, C; Ganem, D			The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs	SCIENCE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; AU-RICH ELEMENTS; MAPKAP KINASE-2; NUCLEAR EXPORT; CELL-LINES; C-FOS; DEGRADATION; PHOSPHORYLATION; IDENTIFICATION; COMPLEX	Cytokine production plays a critical role in diseases caused by Kaposi's sarcoma-associated herpesvirus (KSHV). Here we show that a latent KSHV gene product, kaposin B, increases the expression of cytokines by blocking the degradation of their messenger RNAs (mRNAs). Cytokine transcripts are normally unstable because they contain AU-rich elements (AREs) in their 3' noncoding regions that target them for degradation. Kaposin B reverses this instability by binding to and activating the kinase MK2, a target of the p38 mitogen-activated protein kinase signaling pathway and a known inhibitor of ARE-mRNA decay. These findings define an important mechanism linking latent KSHV infection to cytokine production, and also illustrate a distinctive mode by which viruses can selectively modulate mRNA turnover.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722				Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Drexler HG, 1999, LEUKEMIA, V13, P634, DOI 10.1038/sj.leu.2401371; Drexler HG, 1998, LEUKEMIA, V12, P1507, DOI 10.1038/sj.leu.2401160; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ENSOLI B, 1992, IMMUNOL REV, V127, P147, DOI 10.1111/j.1600-065X.1992.tb01412.x; Ensoli B, 1998, CYTOKINE GROWTH F R, V9, P63, DOI 10.1016/S1359-6101(97)00037-3; ENSOLI B, 1989, SCIENCE, V243, P223, DOI 10.1126/science.2643161; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Komanduri KV, 1996, J ACQ IMMUN DEF SYND, V13, P215, DOI 10.1097/00042560-199611010-00003; Meng WY, 2002, J BIOL CHEM, V277, P37401, DOI 10.1074/jbc.C200418200; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; Nishimoto N, 2000, BLOOD, V95, P56, DOI 10.1182/blood.V95.1.56; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Underwood KW, 2003, STRUCTURE, V11, P627, DOI 10.1016/S0969-2126(03)00092-3; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969	22	169	186	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					739	741		10.1126/science.1105779	http://dx.doi.org/10.1126/science.1105779			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692053				2022-12-24	WOS:000226814900047
J	Liao, SP; Seeman, NC				Liao, SP; Seeman, NC			Translation of DNA signals into polymer assembly instructions	SCIENCE			English	Article							DEVICE	We developed a DNA nanomechanical device that enables the positional synthesis of products whose sequences are determined by the state of the device. This machine emulates the translational capabilities of the ribosome. The device has been prototyped to make specific DNA sequences. The state of the device is established by the addition of DNA set strands. There is no transcriptional relationship between the set strands and the product strands. The device has potential applications that include designer polymer synthesis, encryption of information, and use as a variable-input device for DNA-based computation.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Feng LP, 2003, ANGEW CHEM INT EDIT, V42, P4342, DOI 10.1002/anie.200351818; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Jonoska N, 2004, LECT NOTES COMPUT SC, V2950, P219; LANDWEBER LF, 1997, P 3 DIMACS M DNA BAS, P161; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Simmel FC, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041913; Simmel FC, 2002, APPL PHYS LETT, V80, P883, DOI 10.1063/1.1447008; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; YAN H, 2003, J SUPRAMOL CHEM, V1, P229; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhu L, 2003, J AM CHEM SOC, V125, P10178, DOI 10.1021/ja035186r	13	143	148	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2072	2074		10.1126/science.1104299	http://dx.doi.org/10.1126/science.1104299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604403	Green Accepted			2022-12-24	WOS:000225841000056
J	Boyce, M; Bryant, KF; Jousse, C; Long, K; Harding, HP; Scheuner, D; Kaufman, RJ; Ma, DW; Coen, DM; Ron, D; Yuan, JY				Boyce, M; Bryant, KF; Jousse, C; Long, K; Harding, HP; Scheuner, D; Kaufman, RJ; Ma, DW; Coen, DM; Ron, D; Yuan, JY			A selective inhibitor-of eIF2 alpha dephosphorylation protects cells from ER stress	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; PHOSPHORYLATION; IRE1; INTEGRATION; INFECTION; SURVIVAL; MUTANTS; SHUTOFF; GROWTH	Most protein phosphatases have little intrinsic substrate specificity, making selective pharmacological inhibition of specific dephosphorylation reactions a challenging problem. In a screen for small molecules that protect cells from endoplasmic reticulum (ER) stress, we,identified salubrinal, a selective inhibitor of cellular complexes that dephosphorylate eukaryotic translation initiation factor 2 subunit alpha (eIF2alpha). Salubrinal also blocks eIF2alpha dephosphorylation mediated by a herpes simplex virus protein and inhibits viral replication. These results suggest that selective chemical inhibitors of eIF2a dephosphorylation may be useful in diseases involving ER stress or viral infection. More broadly, salubrinal demonstrates the feasibility of selective pharmacological targeting of cellular dephosphorylation events.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Comm Virol, Boston, MA 02115 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; Shanghai Inst Organ Chem, Shanghai, Peoples R China; Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; New York University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu		Ron, David/0000-0002-3014-5636; Boyce, Michael/0000-0002-2729-4876; Harding, Heather P/0000-0002-7359-7974	NIAID NIH HHS [AI26077, AI19838] Funding Source: Medline; NIA NIH HHS [R37-AG012859] Funding Source: Medline; NIDDK NIH HHS [DK47119, DDK42394] Funding Source: Medline; NIEHS NIH HHS [ES08681] Funding Source: Medline; NIGMS NIH HHS [GM64703] Funding Source: Medline; NINDS NIH HHS [NS35138] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI026077, U01AI026077, R01AI019838, R01AI026077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R29DK047119, R01DK042394, R01DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; BOYCE MC, UNPUB; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1995, P NATL ACAD SCI USA, V92, P10516, DOI 10.1073/pnas.92.23.10516; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sood R, 2000, GENETICS, V154, P787; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	1143	1209	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					935	939		10.1126/science.1101902	http://dx.doi.org/10.1126/science.1101902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705855				2022-12-24	WOS:000226985100057
J	Griffitts, JS; Haslam, SM; Yang, TL; Garczynski, SF; Mulloy, B; Morris, H; Cremer, PS; Dell, A; Adang, MJ; Aroian, RV				Griffitts, JS; Haslam, SM; Yang, TL; Garczynski, SF; Mulloy, B; Morris, H; Cremer, PS; Dell, A; Adang, MJ; Aroian, RV			Glycolipids as receptors for Bacillus thuringiensis crystal toxin	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HELIOTHIS-VIRESCENS; PINK-BOLLWORM; RESISTANCE; BINDING; IDENTIFICATION; GLYCOSYLATION; ENDOTOXIN; PROTEINS	The development of pest resistance threatens the effectiveness of Bacillus thuringiensis (Bt) toxins used in transgenic and organic farming. Here, we demonstrate that (i) the major mechanism for Bt toxin resistance in Caenorhabditis elegans entails a loss of glycolipid carbohydrates; (ii) Bt toxin directly and specifically binds glycotipids; and (iii) this binding is carbohydrate-dependent and relevant for toxin action in vivo. These carbohydrates contain the arthroseries core conserved in insects and nematodes but lacking in vertebrates. We present evidence that insect glycolipids are also receptors for Bt toxin.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Natl Inst Biol Stand & Controls, Mol Struct Lab, Potters Bar EN6 3QG, Herts, England; MSCAN Mass Spectrometry Res & Training Ctr, Ascot SL5 7PZ, Berks, England	University of California System; University of California San Diego; Imperial College London; Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; National Institute for Biological Standards & Control	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu	Yang, Tinglu/N-3569-2013	Yang, Tinglu/0000-0003-0872-8218				Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Dennis R D, 1986, Biomed Chromatogr, V1, P31, DOI 10.1002/bmc.1130010108; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GARCZYNSKI SF, 2000, ENTOMOPATHOGENIC BAC, P181; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Heckel DG, 1997, J ECON ENTOMOL, V90, P75, DOI 10.1093/jee/90.1.75; James C, 2002, ISAAA BRIEFS, V27, P1; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kumaraswami NS, 2001, COMP BIOCHEM PHYS B, V129, P173, DOI 10.1016/S1096-4959(01)00327-X; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; Marroquin LD, 2000, GENETICS, V155, P1693; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Mucha J, 2004, BIOCHEM J, V382, P67, DOI 10.1042/BJ20040535; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f	26	261	309	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					922	925		10.1126/science.1104444	http://dx.doi.org/10.1126/science.1104444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705852				2022-12-24	WOS:000226985100053
J	Nakata, K; Abrams, B; Grill, B; Goncharov, A; Huang, X; Chisholm, AD; Jin, YS				Nakata, K; Abrams, B; Grill, B; Goncharov, A; Huang, X; Chisholm, AD; Jin, YS			Regulation of a DLK-1 and p38 MAP kinase pathway by the ubiquitin ligase RPM-1 is required for presynaptic development	CELL			English	Article							ZIPPER-BEARING KINASE; AMPA RECEPTOR TRAFFICKING; CAENORHABDITIS-ELEGANS; C-ELEGANS; SYNAPTIC GROWTH; PROTEIN-KINASE; ACTIVE ZONES; IN-VIVO; SYNAPSES; LINEAGE	Synapses display a stereotyped ultrastructural organization, commonly containing a single electron-dense presynaptic density surrounded by a cluster of synaptic vesicles. The mechanism controlling subsynaptic proportion is not understood. Loss of function in the C. elegans rpm-1 gene, a putative RING finger/E3 ubiquitin ligase, causes disorganized presynaptic cytoarchitecture. RPM-1 is localized to the presynaptic periactive zone. We report that RPM-1 negatively regulates a p38 MAP kinase pathway composed of the dual leucine zipper-bearing MAPKKK DLK-1, the MAPKK MKK-4, and the p38 MAP kinase PMK-3. Inactivation of this pathway suppresses rpm-1 loss of function phenotypes, whereas overexpression or constitutive activation of this pathway causes synaptic defects resembling rpm-1(lf) mutants. DLK-1, like RPM-1, is localized to the periactive zone. DLK-1 protein levels are elevated in rpm-1 mutants. The RPM-1 RING finger can stimulate ubiquitination of DLK-1. Our data reveal a presynaptic role of a previously unknown p38 MAP kinase cascade.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu		Grill, Brock/0000-0002-0379-3267; Huang, Xun/0000-0002-2653-8293; Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860				Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Guan ZH, 2003, J NEUROSCI, V23, P7317; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Nonet ML, 1997, J NEUROSCI, V17, P8061; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 1997, J NEUROSCI, V17, P5858; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sone M, 2000, DEVELOPMENT, V127, P4157; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	55	249	263	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					407	420		10.1016/j.cell.2004.12.017	http://dx.doi.org/10.1016/j.cell.2004.12.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707898	Bronze			2022-12-24	WOS:000227028900015
J	Yang, HJ; Li, QB; Fan, J; Holloman, WK; Pavletich, NP				Yang, HJ; Li, QB; Fan, J; Holloman, WK; Pavletich, NP			The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction	NATURE			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; PRESYNAPTIC COMPLEX-FORMATION; BREAST-CANCER SUSCEPTIBILITY; RAD51-MEDIATED RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; DIRECTED REPAIR; USTILAGO-MAYDIS; BINDING PROTEIN	The BRCA2 tumour suppressor(1) is essential for the error- free repair of double- strand breaks ( DSBs) in DNA by homologous recombination(2,3). This is mediated by RAD51, which forms a nucleoprotein filament with the 30 overhanging single- stranded DNA ( ssDNA) of the resected DSB, searches for a homologous donor sequence, and catalyses strand exchange with the donor DNA(4). The 3,418- amino- acid BRCA2 contains eight similar to 30- amino-acid BRC repeats that bind RAD51 ( refs 5, 6) and a similar to 700- amino-acid DBD domain that binds ssDNA(7). The isolated BRC and DBD domains have the opposing effects of inhibiting(8,9) and stimulating recombination(7), respectively, and the role of BRCA2 in repair has been unclear. Here we show that a full- length BRCA2 homologue ( Brh2) stimulates Rad51- mediated recombination at substoichiometric concentrations relative to Rad51. Brh2 recruits Rad51 to DNA and facilitates the nucleation of the filament, which is then elongated by the pool of free Rad51. Brh2 acts preferentially at a junction between double- stranded DNA ( dsDNA) and ssDNA, with strict specificity for the 30 overhang polarity of a resected DSB. These results establish a BRCA2 function in RAD51- mediated DSB repair and explain the loss of this repair capacity in BRCA2- associated cancers.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Hearst Microbiol Res Ctr, Dept Microbiol & Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org	fan, jie/A-3922-2012					Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	30	244	249	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					653	657		10.1038/nature03234	http://dx.doi.org/10.1038/nature03234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703751				2022-12-24	WOS:000226862000049
J	Hoebe, K; Georgel, P; Rutschmann, S; Du, X; Mudd, S; Crozat, K; Sovath, S; Shamel, L; Hartung, T; Zahringer, U; Beutler, B				Hoebe, K; Georgel, P; Rutschmann, S; Du, X; Mudd, S; Crozat, K; Sovath, S; Shamel, L; Hartung, T; Zahringer, U; Beutler, B			CD36 is a sensor of diacylglycerides	NATURE			English	Article							TOLL-LIKE RECEPTOR-2; PATTERN-RECOGNITION; LIPOTEICHOIC ACID; IMMUNE-RESPONSE; FATTY-ACID; LIPOPOLYSACCHARIDE; IDENTIFICATION; GENE; LIPOPROTEINS; METABOLISM	Toll-like receptor 2 (TLR2) is required for the recognition of numerous molecular components of bacteria(1-8), fungi(9,10) and protozoa(11). The breadth of the ligand repertoire seems unusual, even if one considers that TLR2 may form heteromers with TLRs 1 and 6 (ref. 12), and it is likely that additional proteins serve as adapters for TLR2 activation. Here we show that an N-ethyl-N-nitrosourea-induced nonsense mutation of Cd36 ( oblivious) causes a recessive immunodeficiency phenotype in which macrophages are insensitive to the R-enantiomer of MALP-2 ( a diacylated bacterial lipopeptide) and to lipoteichoic acid. Homozygous mice are hypersusceptible to Staphylococcus aureus infection. Cd36(obl) macrophages readily detect S-MALP-2, PAM(2)CSK(4), PAM(3)CSK(4) and zymosan, revealing that some - but not all TLR2 ligands are dependent on CD36. Already known as a receptor for endogenous molecules, CD36 is also a selective and nonredundant sensor of microbial diacylglycerides that signal via the TLR2/6 heterodimer.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; EU Joint Res Ctr, ECVAM, I-21020 Ispra, Italy; Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Scripps Research Institute; Forschungszentrum Borstel	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Crozat, Karine/L-7297-2019; georgel, philippe/P-5676-2016; Eckhardt, Erik/G-1567-2010	Crozat, Karine/0000-0003-4761-3675; georgel, philippe/0000-0001-6853-7080; Rutschmann, Sophie/0000-0003-3932-1162; Hoebe, Kasper/0000-0002-3626-8098				Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P3920; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	24	643	666	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					523	527		10.1038/nature03253	http://dx.doi.org/10.1038/nature03253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690042				2022-12-24	WOS:000226727200049
J	Heaton, T; Rowe, J; Turner, S; Aalberse, RC; de Klerk, N; Suriyaarachchi, D; Serralha, M; Holt, BJ; Hollams, E; Yerkovich, S; Holt, K; Sly, PD; Goldblatt, J; Le Souef, P; Holt, PG				Heaton, T; Rowe, J; Turner, S; Aalberse, RC; de Klerk, N; Suriyaarachchi, D; Serralha, M; Holt, BJ; Hollams, E; Yerkovich, S; Holt, K; Sly, PD; Goldblatt, J; Le Souef, P; Holt, PG			An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children	LANCET			English	Article							AIRWAY HYPERRESPONSIVENESS; BRONCHIAL RESPONSIVENESS; RESPIRATORY SYMPTOMS; ATOPIC-DERMATITIS; IMMUNE-RESPONSE; 2 POPULATIONS; ALLERGEN; TH1; INTERLEUKIN-10; EOSINOPHILS	Background Increasing evidence suggests that patterns of T-cell immunity to inhalant allergens in genetically diverse human populations are more heterogeneous than previously assumed, and that covert differences in expression patterns might underlie variations in airway disease phenotypes. We tested this proposition in a community sample of children Methods We analysed data from 172 individuals who had been recruited antenatally to a longitudinal birth cohort study. Of the 194 birth cohort participants, data from the 147 probands (age range 8.6-13.5 years) who consented to blood collection were included along with data from 25 consenting siblings (mean age 11 years [range 7.4-17.4]). We ascertained clinical phenotypes related to asthma and allergy. We measured T-cell responses to allergens and mitogens, together with blood eosinophils and IgE/IgG antibodies, and assessed associations between these indices and clinical phenotypes. Findings Atopy was associated with allergen-specific T-helper (Th)2 responses dominated by interleukin 4, interleukin 5, interleukin 9, interleukin 13, whereas interleukin 10, tumour necrosis factor a, and interferon gamma responses were common to both atopics and non-atopics. The wheal size from skin prick with allergen was positively associated with in-vitro interleukin 5 and interferon gamma responses, and negatively associated with interleukin 10. Asthma, especially in atopics, was strongly associated with eosinophilia/interleukin 5, and bronchial hyperresponsiveness (BHR) was associated with eosinophilia plus polyclonal interferon gamma production. BHR in non-atopics was associated with elevated allergen-specific and polyclonal interleukin 10 production. Interpretation Parallel immunological and clinical profiling of children identified distinctive immune response patterns related to asthma and wheeze compared with BHR, in atopics non-atopics. Immunological hyperresponsiveness, including within the Th1 cytokine compartment, is identified as a hallmark of BHR. Relevance to practice These findings highlight the heterogeneity of immune response patterns in asthmatic children, including those with seemingly homogeneous Th2-driven atopic asthma. Further elucidation of the covert relationships between wheezing phenotypes and underlying immunophenotypes in this age group will potentially lead to more effective treatments for what is an unexpectedly heterogeneous collection of disease subtypes.	Univ Western Australia, Fac Med & Dent, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Fac Med & Dent, Dept Paediat, Perth, WA 6009, Australia; CLB, Sanquin Res Labs, Amsterdam, Netherlands	Telethon Kids Institute; University of Western Australia; University of Western Australia	Holt, PG (corresponding author), Telethon Inst Child Hlth Res, Div Cell Biol, POB 855, Perth, WA 6872, Australia.	patrick@ichr.uwa.edu.au	Le Souef, Peter N/H-5256-2014; Holt, Patrick G/H-1548-2011; Serralha, Michael/CAA-0940-2022; de Klerk, Nicholas H/D-8388-2016; Sly, Peter D/F-1486-2010; Holt, Kathryn E/A-8108-2012	Holt, Patrick G/0000-0003-1193-0935; de Klerk, Nicholas H/0000-0001-9223-0767; Sly, Peter D/0000-0001-6305-2201; Holt, Kathryn E/0000-0003-3949-2471; Serralha, Michael/0000-0002-0121-2879; Hollams, Elysia/0000-0002-3481-6396; Yerkovich, Stephanie/0000-0003-4163-4782				AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Boushey HA, 2000, LANCET, V356, P2114, DOI 10.1016/S0140-6736(00)03486-3; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; BURROWS B, 1995, J ALLERGY CLIN IMMUN, V95, P548, DOI 10.1016/S0091-6749(95)70317-9; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; CALHOUN W J, 1992, American Review of Respiratory Disease, V145, pA638; Castro M, 2000, AM J RESP CELL MOL, V22, P143, DOI 10.1165/ajrcmb.22.2.f174; Colavita AM, 2000, J ALLERGY CLIN IMMUN, V106, P880, DOI 10.1067/mai.2000.110475; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; DEL PG, 1993, J IMMUNOL, V150, P353; Essayan DM, 1996, J ALLERGY CLIN IMMUN, V98, P1035, DOI 10.1016/S0091-6749(96)80188-6; Glass DC, 2001, ANN OCCUP HYG, V45, P275, DOI 10.1016/S0003-4878(01)00022-9; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Grunstein MM, 2001, AM J PHYSIOL-LUNG C, V281, pL1130, DOI 10.1152/ajplung.2001.281.5.L1130; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartmann M, 2004, J CANCER RES CLIN, V130, P93, DOI 10.1007/s00432-003-0513-z; Holgate ST, 1999, J ALLERGY CLIN IMMUN, V104, P1139, DOI 10.1016/S0091-6749(99)70005-9; Holt PG, 2000, J ALLERGY CLIN IMMUN, V105, P1117, DOI 10.1067/mai.2000.105804; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Holt PG, 2000, THORAX, V55, P700, DOI 10.1136/thorax.55.8.700; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Li XM, 1996, J IMMUNOL, V157, P3216; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; O'Sullivan S, 2001, AM J RESP CRIT CARE, V164, P560, DOI 10.1164/ajrccm.164.4.2102018; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Postma DS, 2000, AM J RESP CRIT CARE, V162, pS118, DOI 10.1164/ajrccm.162.supplement_2.ras-13; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; Sharp MJ, 2003, CLIN EXP ALLERGY, V33, P435, DOI 10.1046/j.1365-2222.2003.01627.x; Smart JM, 2002, CLIN EXP ALLERGY, V32, P796, DOI 10.1046/j.1365-2222.2002.01391.x; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; TURNER SW, 2004, IN PRESS AM J RESP C, V169; Umetsu DT, 1999, AM J RESP CELL MOL, V21, P562, DOI 10.1165/ajrcmb.21.5.f171; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; Woolcock AJ, 1995, ALLERGY, V50, P935, DOI 10.1111/j.1398-9995.1995.tb02504.x; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	44	185	205	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					142	149		10.1016/S0140-6736(05)17704-6	http://dx.doi.org/10.1016/S0140-6736(05)17704-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639296				2022-12-24	WOS:000226170700029
J	Zohrabian, A				Zohrabian, A			The long-term effects and economic consequences of treatments for obesity: work in progress	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Div Adult & Community Hlth, Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Zohrabian, A (corresponding author), Ctr Dis Control & Prevent, Div Adult & Community Hlth, Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.	Abz8@cdc.gov						Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; LADDAWALLA D, 2002, 8946 NAT BUR EC RES; PHILIPSON T, 2004, 04004 USDA EFAN EC R; PHILIPSON TJ, 1999, 7423 NAT BUR EC RES; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; STURM R, 2004, RAND REV         SPR, P24; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					104	105		10.1016/S0140-6736(05)17718-6	http://dx.doi.org/10.1016/S0140-6736(05)17718-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639278				2022-12-24	WOS:000226170700007
J	van der Wielen, PWJJ; Bolhuis, H; Borin, S; Daffonchio, D; Corselli, C; Giuliano, L; D'Auria, G; de Lange, GJ; Huebner, A; Varnavas, SP; Thomson, J; Tamburini, C; Marty, D; McGenity, TJ; Timmis, KN				van der Wielen, PWJJ; Bolhuis, H; Borin, S; Daffonchio, D; Corselli, C; Giuliano, L; D'Auria, G; de Lange, GJ; Huebner, A; Varnavas, SP; Thomson, J; Tamburini, C; Marty, D; McGenity, TJ; Timmis, KN		BioDeep Sci Party	The enigma of prokaryotic life in deep hypersaline anoxic basins	SCIENCE			English	Article							EASTERN MEDITERRANEAN-SEA; DEAD-SEA; BANNOCK BASINS; SP-NOV; BRINES; WATER; ENVIRONMENT; ANTARCTICA; DISCOVERY; SEDIMENTS	Deep hypersaline anoxic basins in the Mediterranean Sea are a legacy of dissolution of ancient subterranean salt deposits from the Miocene period. Our study revealed that these hypersaline basins are not biogeochemical dead ends, but support in situ sulfate reduction, methanogenesis, and heterotrophic activity. A wide diversity of prokaryotes was observed, including a new, abundant, deeply branching order within the Euryarchaeota. Furthermore, we demonstrated the presence of a unique,. metabolically active microbial community in the Discovery basin, which is one of the most extreme terrestrial saline environments known, as it is almost saturated with MgCl2 (5 M).	Univ Groningen, Microbial Ecol Lab, NL-9751 NN Haren, Netherlands; Univ Milan, Consorzio Nazl Interuniv Sci Mare, URL DiSTAM, I-20133 Milan, Italy; Univ Milano Bicocca, CoNISMa, URL DGSG, I-20126 Milan, Italy; CNR, Ist Ambiente Marino Costiero, I-98122 Messina, Italy; Univ Utrecht, Fac Geosci, NL-3508 TA Utrecht, Netherlands; Univ Patras, Dept Geol, Patras 26500, Greece; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Mediterranee, LMGEM, CNRS, UMR 6117, F-13288 Marseille 9, France; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; Gesell Biotechnol Forsch mbH, Div Microbiol, D-38124 Braunschweig, Germany	University of Groningen; University of Milan; CoNISMa; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Utrecht University; University of Patras; NERC National Oceanography Centre; University of Southampton; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Essex; Gesellschaft fur Biotechnologische Forschung mbH	van der Wielen, PWJJ (corresponding author), Kiwa Water Res, POB 1072, NL-3430 BB Nieuwegein, Netherlands.	paul.van.der.wielen@kiwa.nl	Bolhuis, Henk/H-8535-2014; Daffonchio, Daniele/AAF-4922-2019; De Lange, Gert J/B-9639-2014; Corselli, Cesare/E-9970-2011; Tamburini, Christian/AAO-8577-2020; Bolhuis, Henk/A-4308-2008; Bolhuis, Henk/S-2986-2019; D'Auria, Giuseppe/E-6583-2010; Bolhuis, Henk/M-6677-2019; Giuliano, Laura/P-2204-2019; Tamburini, Christian/I-7821-2012; McGenity, Terry/B-8661-2011; Hubner, Andreas/G-1751-2016	Bolhuis, Henk/0000-0002-4772-1898; Daffonchio, Daniele/0000-0003-0947-925X; De Lange, Gert J/0000-0002-9420-3022; Tamburini, Christian/0000-0003-3752-7423; Bolhuis, Henk/0000-0002-4772-1898; Tamburini, Christian/0000-0003-3752-7423; Hubner, Andreas/0000-0001-7342-9789; D'Auria, Giuseppe/0000-0003-0672-2541; Borin, Sara/0000-0001-7479-8199; van der Wielen, Paul/0000-0002-4851-5762; McGenity, Terence/0000-0002-1497-8822				Brusa T, 1997, MICROBIOL RES, V152, P45; Brusa T, 2001, MICROBIOL RES, V156, P49, DOI 10.1078/0944-5013-00075; CAMERLENGHI A, 1990, MAR CHEM, V31, P1; DELANGE GJ, 1990, MAR CHEM, V31, P63, DOI 10.1016/S0304-4203(05)80005-2; Dundas I, 1998, EXTREMOPHILES, V2, P375, DOI 10.1007/s007920050081; Eder W, 1999, ARCH MICROBIOL, V172, P213, DOI 10.1007/s002030050762; Gaidos EJ, 2000, NATURE, V405, P637, DOI 10.1038/35015170; HENNEKE E, 1990, MAR CHEM, V31, P113, DOI 10.1016/0304-4203(90)90033-9; HOROWITZ NH, 1972, SCIENCE, V176, P242, DOI 10.1126/science.176.4032.242; JONGSMA D, 1983, NATURE, V305, P795, DOI 10.1038/305795a0; KARGEL JS, 1991, ICARUS, V94, P368, DOI 10.1016/0019-1035(91)90235-L; Karisiddaiah SM, 2000, DEEP-SEA RES PT I, V47, P1999, DOI 10.1016/S0967-0637(00)00010-8; Knauth LP, 1998, NATURE, V395, P554, DOI 10.1038/26879; LAFERLA R, 1991, MAR ECOL PROG SER, V75, P309, DOI 10.3354/meps075309; MATSUBAYA O, 1979, GEOCHIM COSMOCHIM AC, V43, P7, DOI 10.1016/0016-7037(79)90042-5; MEDRIFF Consortium, 1995, EOS T AM GEOPHYS UN, V76, P313, DOI DOI 10.1029/95EO00189; OLLIVIER B, 1994, MICROBIOL REV, V58, P27, DOI 10.1128/MMBR.58.1.27-38.1994; OREN A, 1983, INT J SYST BACTERIOL, V33, P381, DOI 10.1099/00207713-33-2-381; OREN A, 1995, INT J SYST BACTERIOL, V45, P747, DOI 10.1099/00207713-45-4-747; OREN A, 1994, FEMS MICROBIOL REV, V13, P415, DOI 10.1111/j.1574-6976.1994.tb00060.x; Oren A, 1999, HYDROBIOLOGIA, V405, P1, DOI 10.1023/A:1003879932328; Sass AM, 2001, APPL ENVIRON MICROB, V67, P5392, DOI 10.1128/AEM.67.12.5392-5402.2001; SIEGEL BZ, 1979, NATURE, V280, P828, DOI 10.1038/280828a0; VANDERWIELEN PWJ, UNPUB; Vengosh A, 1998, GEOCHIM COSMOCHIM AC, V62, P3221, DOI 10.1016/S0016-7037(98)00236-1; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Wallmann K, 2002, MAR GEOL, V186, P9, DOI 10.1016/S0025-3227(02)00170-6; Wallmann K, 1997, NATURE, V387, P31, DOI 10.1038/387031a0; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Ziebis W., 2000, J C ABSTR, V5, P1134	30	189	196	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					121	123		10.1126/science.1103569	http://dx.doi.org/10.1126/science.1103569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637281				2022-12-24	WOS:000226214300052
J	Neukum, G; Jaumann, R; Hoffmann, H; Hauber, E; Head, JW; Basilevsky, AT; Ivanov, BA; Werner, SC; van Gasselt, S; Murray, JB; McCord, T				Neukum, G; Jaumann, R; Hoffmann, H; Hauber, E; Head, JW; Basilevsky, AT; Ivanov, BA; Werner, SC; van Gasselt, S; Murray, JB; McCord, T		HRSC Co-investigator Team	Recent and episodic volcanic and glacial activity on Mars revealed by the High Resolution Stereo Camera	NATURE			English	Article							WATER ICE; OLYMPUS MONS; EVOLUTION; ORIGIN	The large-area coverage at a resolution of 10 - 20 metres per pixel in colour and three dimensions with the High Resolution Stereo Camera Experiment on the European Space Agency Mars Express Mission has made it possible to study the time-stratigraphic relationships of volcanic and glacial structures in unprecedented detail and give insight into the geological evolution of Mars. Here we show that calderas on five major volcanoes on Mars have undergone repeated activation and resurfacing during the last 20 per cent of martian history, with phases of activity as young as two million years, suggesting that the volcanoes are potentially still active today. Glacial deposits at the base of the Olympus Mons escarpment show evidence for repeated phases of activity as recently as about four million years ago. Morphological evidence is found that snow and ice deposition on the Olympus construct at elevations of more than 7,000 metres led to episodes of glacial activity at this height. Even now, water ice protected by an insulating layer of dust may be present at high altitudes on Olympus Mons.	Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; DLR, Inst Plantenforsch, D-12489 Berlin, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; RAS, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; Inst Dynam Geospheres, Moscow 119334, Russia; Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Brown University; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Open University - UK; University of Hawaii System	Neukum, G (corresponding author), Free Univ Berlin, Inst Geol Wissensch, Malteserstr 74-100,Bldg D, D-12249 Berlin, Germany.	gneukum@zedat.fu-berlin.de	Basilevsky, Alexander T/A-6676-2017; Ivanov, Boris A/E-1413-2016; Hauber, Ernst/U-2521-2018; Jaumann, Ralf/N-1001-2018; van Gasselt, Stephan/L-9762-2013; Werner, Stephanie C/A-6438-2012	Ivanov, Boris A/0000-0002-9938-9428; Hauber, Ernst/0000-0002-1375-304X; Jaumann, Ralf/0000-0002-9759-6597; van Gasselt, Stephan/0000-0003-2130-6343; Werner, Stephanie C/0000-0001-5704-0909				Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BANIN A., 2000, MARS, P594; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Carr, 1996, WATER MARS, P229; Crumpler LS, 1996, GEOL SOC SP, P307, DOI 10.1144/GSL.SP.1996.110.01.24; CRUMPLER LS, 1978, ICARUS, V34, P496, DOI 10.1016/0019-1035(78)90041-6; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; HARRIS SA, 1977, J GEOPHYS RES, V82, P3099, DOI 10.1029/JB082i020p03099; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HAUBER E, 2004, EUR GEOPH UN 1 GEN A; HAUBER E, UNPUB NATURE; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; HEAD JW, IN PRESS NATURE; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Kossacki KJ, 1997, ICARUS, V128, P127, DOI 10.1006/icar.1997.5701; Kossacki KJ, 1999, PLANET SPACE SCI, V47, P1521, DOI 10.1016/S0032-0633(99)00037-9; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LOPES R, 1982, J GEOPHYS RES, V87, P9917, DOI 10.1029/JB087iB12p09917; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MCCORD T, 2004, EUR GEOPH UN 1 GEN A; MILKOVICH SM, 2003, 6 INT MARS C, P3149; MOUGINISMARK PJ, 1982, J GEOPHYS RES, V87, P9890, DOI 10.1029/JB087iB12p09890; MURRAY JB, 2004, UNPUB NATURE; NEUKUM G, 1981, J GEOPHYS RES, V86, P3097, DOI 10.1029/JB086iB04p03097; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Wilson L, 2001, J GEOPHYS RES-PLANET, V106, P1423, DOI 10.1029/2000JE001280	38	308	312	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					971	979		10.1038/nature03231	http://dx.doi.org/10.1038/nature03231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616551				2022-12-24	WOS:000225887000030
J	Breeze, ACG; Lees, CC				Breeze, ACG; Lees, CC			Managing shoulder dystocia	LANCET			English	Editorial Material							EPISIOTOMY; TRIAL		Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lees, CC (corresponding author), Addenbrookes Hosp, Div Maternal Fetal Med, Hills Rd, Cambridge CB2 2QQ, England.	Christoph.lees@addenbrookes.nhs.uk	Breeze, Andrew/A-3801-2009	Breeze, Andrew/0000-0003-4836-1860				BASKETT TF, 1995, OBSTET GYNECOL, V86, P14, DOI 10.1016/0029-7844(95)00099-D; BELIZAN J, 1993, LANCET, V342, P1517; Bodner-Adler B, 2001, J REPROD MED, V46, P752; Gurewitsch ED, 2004, AM J OBSTET GYNECOL, V191, P911, DOI 10.1016/j.ajog.2004.06.041; James DK, 1999, HIGH RISK PREGNANCY; Lurie S, 1994, Asia Oceania J Obstet Gynaecol, V20, P195; *MAT CHILD HLTH RE, 1999, CONF ENQ STILLB DEAT; SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2160	2161		10.1016/S0140-6736(04)17607-1	http://dx.doi.org/10.1016/S0140-6736(04)17607-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610787				2022-12-24	WOS:000225799700007
J	Chworos, A; Severcan, I; Koyfman, AY; Weinkam, P; Oroudjev, E; Hansma, HG; Jaeger, L				Chworos, A; Severcan, I; Koyfman, AY; Weinkam, P; Oroudjev, E; Hansma, HG; Jaeger, L			Building programmable jigsaw puzzles with RNA	SCIENCE			English	Article							RIBOSOMAL-SUBUNIT; DNA; TECTORNA; CONSTRUCTION; DIMERIZATION; COMPLEXES; DESIGN	One challenge in supramolecular chemistry is the design of versatile, self-assembling building blocks to attain total control of arrangement of matter at a molecular level. We have achieved reliable prediction and design of the three-dimensional structure of artificial RNA building blocks to generate molecular jigsaw puzzle units called tectosquares. They can be programmed with control over their geometry, topology, directionatity, and addressability to algorithmically self-assemble into a variety of complex nanoscopic fabrics with predefined periodic and aperiodic patterns and finite dimensions. This work emphasizes the modular and hierarchical characteristics of RNA by showing that small RNA structural motifs can code the precise topology of large molecular architectures. It demonstrates that fully addressable materials based on RNA can be synthesized and provides insights into self-assembly processes involving large populations of RNA molecules.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Diego	Jaeger, L (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	jaeger@chem.ucsb.edu	Chworos, Arkadiusz/AAF-9169-2020	Chworos, Arkadiusz/0000-0001-9924-0503				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Carbone A, 2002, P NATL ACAD SCI USA, V99, P12577, DOI 10.1073/pnas.202418299; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; Hansma HG, 2003, J MICROSC-OXFORD, V212, P273, DOI 10.1111/j.1365-2818.2003.01276.x; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; Ikawa Y, 2002, STRUCTURE, V10, P527, DOI 10.1016/S0969-2126(02)00739-6; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Jaeger L, 2001, NUCLEIC ACIDS RES, V29, P455, DOI 10.1093/nar/29.2.455; Liu B, 2004, J AM CHEM SOC, V126, P4076, DOI 10.1021/ja031552v; Lodmell JS, 2001, J MOL BIOL, V311, P475, DOI 10.1006/jmbi.2001.4879; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Michl J, 2002, P NATL ACAD SCI USA, V99, P4788, DOI 10.1073/pnas.052016299; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Szewczak AA, 1998, BIOCHEMISTRY-US, V37, P11162, DOI 10.1021/bi980633e; Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2000, J BIOMOL STRUCT DYN, P263; Wolfram S., 2002, NEW KIND SCI; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	31	402	425	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2068	2072		10.1126/science.1104686	http://dx.doi.org/10.1126/science.1104686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604402				2022-12-24	WOS:000225841000055
J	Goel, MS; McCarthy, EP; Phillips, RS; Wee, CC				Goel, MS; McCarthy, EP; Phillips, RS; Wee, CC			Obesity among US immigrant subgroups by duration of residence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; HEALTH; MORTALITY; BEHAVIORS; ADULTS	Context The prevalence of obesity has increased substantially since the 1980s. While immigrants are the fastest growing segment of the US population, little is known about obesity or clinician counseling about diet and exercise in this group. Objectives To estimate the prevalence of obesity among immigrant subgroups and quantify the magnitude of the association with duration of US residence, and to describe reported diet and exercise counseling by birthplace, race, and ethnicity. Design, Setting, and Participants Cross-sectional study using data from the 2000 National Health Interview Survey. Main Outcome Measures Body mass index (BMI, measured as weight in kilograms divided by the square of height in meters) based on self-reported height and weight measurements, and self-reported rates of diet and exercise counseling. Results Of 32374 respondents, 14% were immigrants. The prevalence of obesity was 16% among immigrants and 22% among US-born individuals. The age- and sex-adjusted prevalence of obesity was 8% among immigrants living in the United States for less than 1 year, but 19% among those living in the United States for at least 15 years. After adjusting forage, sociodemographic, and lifestyle factors, living in the United States for 10 to 15 and at least 15 years was associated with BMI increases of 0.88 and 1.39, respectively. The association for 15 years or more was significant for all immigrant subgroups except foreign-born blacks. Additionally, immigrants were less likely than US-born individuals to report discussing diet and exercise with clinicians (18% vs 24%, P<.001; 19% vs 23%, P<.001, respectively). These differences were not accounted for by sociodemographic characteristics, illness burden, BMI, or access to care among some subgroups of immigrants. Conclusions Among different immigrant subgroups, number of years of residence in the United States is associated with higher BMI beginning after 10 years. The prevalence of obesity among immigrants living in the United States for at least 15 years approached that of US-born adults. Early intervention with diet and physical activity may represent an opportunity to prevent weight gain, obesity, and obesity-related chronic illnesses.	Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Goel, MS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, 676 N St Clair Ave,Suite 200, Chicago, IL 60611 USA.	mgoel@nmff.org			NCCIH NIH HHS [K24 AT00589-01A1] Funding Source: Medline; NCI NIH HHS [R29 CA79052] Funding Source: Medline; NIDDK NIH HHS [K23DK02962] Funding Source: Medline; BHP HRSA HHS [5T32PE11001] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R29CA079052] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K24AT000589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002962] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Association for Public Opinion Research, 2004, STAND DEF FIN DISP C; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; HARRIS SS, 1989, JAMA-J AM MED ASSOC, V261, P3588, DOI 10.1001/jama.261.24.3588; Johnson T, 1997, WILEY SER PROB STAT, P87; Kaplan MS, 2004, AM J PREV MED, V27, P323, DOI 10.1016/j.amepre.2004.07.005; Ku L, 2001, HEALTH AFFAIR, V20, P247, DOI 10.1377/hlthaff.20.1.247; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; *NAT CTR HLTH STAT, 2002, NAT HLTH INT SURV 20; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SCHMIDLEY AD, 2001, US BUREAU CENSUS CUR; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; *US PREV SERV TASK, 2003, SCREEN OB AD REC RAT; Wee CC, 1999, JAMA-J AM MED ASSOC, V282, P1583, DOI 10.1001/jama.282.16.1583; WHO, 2004, LANCET, V363, P902; World Health Organization, TURN TID MALN RESP C; World Health Organization, OB OV	25	451	454	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2860	2867		10.1001/jama.292.23.2860	http://dx.doi.org/10.1001/jama.292.23.2860			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598917	Bronze			2022-12-24	WOS:000225694500023
J	Begovac, J; Lukas, D				Begovac, J; Lukas, D			Condylomata lata of secondary syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Zagreb, Univ Hosp Infect Dis, Zagreb 10000, Croatia	University of Zagreb	Begovac, J (corresponding author), Univ Zagreb, Univ Hosp Infect Dis, Zagreb 10000, Croatia.		Begovac, Josip/AAI-5672-2021	Begovac, Josip/0000-0003-2641-4327					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					708	708		10.1056/NEJMicm040514	http://dx.doi.org/10.1056/NEJMicm040514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716565				2022-12-24	WOS:000227031100010
J	Miller, WC				Miller, WC			Screening for chlamydial infection: are we doing enough?	LANCET			English	Editorial Material							BARRIERS; WOMEN		Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Miller, WC (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	bill_miller@unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827				Andersen B, 2002, J INFECT DIS, V185, P252, DOI 10.1086/338268; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; *CDCP, 2002, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P983; Cook RL, 2001, J ADOLESCENT HEALTH, V28, P204, DOI 10.1016/S1054-139X(00)00152-X; Idahl A, 2004, HUM REPROD, V19, P1121, DOI 10.1093/humrep/deh155; La Montagne DS, 2004, SEX TRANSM DIS, V31, P283, DOI 10.1097/01.OLQ.0000124613.85111.6B; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Low N, 2002, INT J EPIDEMIOL, V31, P891, DOI 10.1093/ije/31.5.891; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; McNulty CAM, 2004, BRIT J GEN PRACT, V54, P508; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; QUINN K, 2000, THEIR OWN YOUNG ADUL; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Sandman D, 2000, OUT TOUCH AM MEN HLT; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103	16	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					456	458						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705443				2022-12-24	WOS:000226812500007
J	Pease, PJ; Levy, O; Cost, GJ; Gore, J; Ptacin, JL; Sherratt, D; Bustamante, C; Cozzarelli, NR				Pease, PJ; Levy, O; Cost, GJ; Gore, J; Ptacin, JL; Sherratt, D; Bustamante, C; Cozzarelli, NR			Sequence-directed DNA translocation by purified FtsK	SCIENCE			English	Article							ESCHERICHIA-COLI CHROMOSOME; CELL-DIVISION; SINGLE-MOLECULE; RNA-POLYMERASE; RECOMBINATION; REPLICATION; HELICASE; PROTEIN; FORCE; XERC	DNA translocases are molecular motors that move rapidly along DNA using adenosine triphosphate as the source of energy. We directly observed the movement of purified FtsK, an Escherichia coli translocase, on single DNA molecules. The protein moves at 5 kilobases per second and against forces up to 60 piconewtons, and locally reverses direction without dissociation. On three natural substrates, independent of its initial binding position, FtsK efficiently translocates over long distances to the terminal region of the E. coli chromosome, as it does in vivo. Our results imply that FtsK is a bidirectional motor that changes direction in response to short, asymmetric directing DNA sequences.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Oxford	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	carios@alice.berkeley.edu; ncozzare@socrates.berkeley.edu		Cost, Gregory/0000-0002-8509-4653; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031657, R01GM032543, R01GM031657, R37GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08295-15, GM07232-27, GM32543, GM31657] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BLAKELY G, 1991, NEW BIOL, V3, P789; Corre J, 2002, J BACTERIOL, V184, P3801, DOI 10.1128/JB.184.14.3801-3807.2002; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Espeli O, 2003, J BIOL CHEM, V278, P44639, DOI 10.1074/jbc.M308926200; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; LOUARN J, 1994, J BACTERIOL, V176, P7524, DOI 10.1128/JB.176.24.7524-7531.1994; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; Singleton MR, 2003, EMBO J, V22, P4579, DOI 10.1093/emboj/cdg441; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	27	152	155	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					586	590		10.1126/science.1104885	http://dx.doi.org/10.1126/science.1104885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681387				2022-12-24	WOS:000226694000049
J	Miller, TM; Cleveland, DW				Miller, TM; Cleveland, DW			Treating neurodegenerative diseases with antibiotics	SCIENCE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; MECHANISMS; UPDATE; ALS		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med & Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, TM (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS027036] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; ROTHSTEIN JD, 1991, ANN NEUROL, V30, P224, DOI 10.1002/ana.410300223; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	8	45	49	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					361	362		10.1126/science.1109027	http://dx.doi.org/10.1126/science.1109027			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15661995				2022-12-24	WOS:000226492300024
J	Nadel, MR; Shapiro, JA; Klabunde, CN; Seeff, LC; Uhler, R; Smith, RA; Ransohoff, DF				Nadel, MR; Shapiro, JA; Klabunde, CN; Seeff, LC; Uhler, R; Smith, RA; Ransohoff, DF			A national survey of primary care physicians' methods for screening for fecal occult blood	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER-SOCIETY GUIDELINES; COLORECTAL-CANCER; CLINICAL GUIDELINES; SELF-REPORT; FOLLOW-UP; SURVEILLANCE; UPDATE; SIGMOIDOSCOPY; MORTALITY; PROSTATE	Background: Screening with the fecal occult blood test (FOBT) has been shown to reduce colorectal cancer incidence and mortality in randomized, controlled trials. Although the test is simple, implementation requires adherence to specific techniques of testing and follow-up of abnormal results. Objective: To examine how FOBT and follow-up are conducted in community practice across the United States. Design: Cross-sectional national surveys of primary care physicians and the public. Setting: The Survey of Colorectal Cancer Screening Practices in Health Care Organizations and the 2000 National Health Interview Survey. Participants: 1147 primary care physicians who ordered or performed FOBT and 11 365 adults 50 years of age or older who responded to questions about FOBT use. Measurements: Self-reported data on details of FOBT implementation and follow-up of positive results. Results: Although screening guidelines recommend home tests, 32.5% (95% Cl, 29.8% to 35.3%) of physicians used only the less accurate method of single-sample in-office testing; another 41.2% (Cl, 38.3% to 44.0%) used both types of test. Follow-up of positive test results showed considerable nonadherence to guidelines, with 29.7% (Cl, 27.1% to 32.4%) of physicians recommending repeating FOBT. Furthermore, sigmoidoscopy, rather than total colon examination, was commonly recommended to work up abnormal findings. Nearly one third of adults who reported having FOBT said they had only an in-office test, and nearly one third of those who reported abnormal FOBT results reported no follow-up diagnostic procedures. Limitations: The study was based on self-reports. Data from the National Health Interview Survey may underestimate the prevalence of in-office testing and inadequate follow-up. Conclusions: mortality reductions demonstrated with FOBT in clinical trials may not be realized in community practice because of the common use of in-office tests and inappropriate follow-up of positive results. Education of providers and system-level interventions are needed to improve the quality of screening implementation.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Amer Canc Soc, Atlanta, GA 30329 USA; NCI, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Nadel, MR (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway,Mailstop K-55, Atlanta, GA 30341 USA.	mrn1@cdc.gov			DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC085169] Funding Source: NIH RePORTER; NCI NIH HHS [N01-PC-85169] Funding Source: Medline; PHS HHS [99FED06571] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baig N, 2003, AM J GASTROENTEROL, V98, P2078, DOI 10.1016/S0002-9270(03)00424-6; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; *GUID COMM PREV SE, IMPR US BREAST CERV; Hall HI, 2004, PREV MED, V39, P27, DOI 10.1016/j.ypmed.2004.02.024; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 1997, ARCH INTERN MED, V157, P970, DOI 10.1001/archinte.157.9.970; Levin B, 2003, CA-CANCER J CLIN, V53, P44, DOI 10.3322/canjclin.53.1.44; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lurie JD, 1999, J NATL CANCER I, V91, P1641, DOI 10.1093/jnci/91.19.1641; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; MYERS RE, 1993, AM J PUBLIC HEALTH, V83, P1620, DOI 10.2105/AJPH.83.11.1620; Nadel MR, 2002, PREV MED, V35, P199, DOI 10.1006/pmed.2002.1070; NASH C, 2003, GASTROENTEROLOGY S1, V124, pW1053; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Peterson SK., 2000, SEMIN COLON RECTAL S, V11, P58; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; SAS Institute, 2002, SAS PROC GUID VERS 9; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STARFIELD B, 1998, PRIMARY CARE BALANCI, P154; *US PREV SERV TASK, 2002, SCREEN COL CANC; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Yabroff KR, 2003, MED CARE RES REV, V60, P294, DOI 10.1177/1077558703254698; Yamamoto M, 2000, HEPATO-GASTROENTEROL, V47, P396; YOUNG GP, 1996, PREVENTION EARLY DET, P241; 1996, US PREVENTIVE TASK F	39	143	145	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2005	142	2					86	94		10.7326/0003-4819-142-2-200501180-00007	http://dx.doi.org/10.7326/0003-4819-142-2-200501180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915LQ	15657156				2022-12-24	WOS:000228306100002
J	Kearney, PM; Whelton, M; Reynolds, K; Muntner, P; Whelton, PK; He, J				Kearney, PM; Whelton, M; Reynolds, K; Muntner, P; Whelton, PK; He, J			Global burden of hypertension: analysis of worldwide data	LANCET			English	Article							BLOOD-PRESSURE LEVELS; CARDIOVASCULAR-DISEASE; HEALTH SURVEY; RISK-FACTORS; DEVELOPING-COUNTRIES; RURAL-POPULATION; URBAN-POPULATION; PREVALENCE; AWARENESS; EPIDEMIOLOGY	Background Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025. Methods We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently, by two investigators with a standardised protocol and data-collection form. Results Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]). The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries. The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion). Interpretation Hypertension is an important public-health challenge worldwide. Prevention, detection, treatment, and control of this condition should receive high priority.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Med, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England	Tulane University; Tulane University; Tulane University; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	Kearney, Patricia M/AAE-8501-2020; He, Jiang/AAF-5303-2020; Reynolds, Kristi/AAN-1434-2021	He, Jiang/0000-0002-8286-9652; Reynolds, Kristi/0000-0001-7619-1649; Kearney, Patricia/0000-0001-9599-3540	NHLBI NIH HHS [R01 HL68057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068057] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], NATL CARDIOVASCULAR; Arroyo P, 1999, J HUM HYPERTENS, V13, P671, DOI 10.1038/sj.jhh.1000909; BABA S, 1991, J HUM HYPERTENS, V5, P317; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; BENNETT SA, 1994, MED J AUSTRALIA, V161, P519, DOI 10.5694/j.1326-5377.1994.tb127594.x; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Forrester T, 1996, CIBA F SYMP, V201, P17; Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003; Giampaoli S, 2001, Ital Heart J Suppl, V2, P294; Gordis L., 2000, EPIDEMIOLOGY, V2; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2003, EUR J CARDIOV PREV R, V10, P249, DOI 10.1097/01.hjr.0000085254.65733.21; GUPTA R, 1994, J HUM HYPERTENS, V8, P823; GUPTA R, 1995, J HYPERTENS, V13, P1193, DOI 10.1097/00004872-199510000-00014; Gupta R, 1999, J Indian Med Assoc, V97, P74; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Halberstein RA, 1999, HUM BIOL, V71, P659; Hamet P, 2000, CAN J CARDIOL, V16, P1483; He J, 1997, MED CLIN N AM, V81, P1077, DOI 10.1016/S0025-7125(05)70568-X; Hernandez-Hernandez R, 2000, J HUM HYPERTENS, V14, pS2, DOI 10.1038/sj.jhh.1000978; IBRAHIM MM, 1995, HYPERTENSION, V26, P886, DOI 10.1161/01.HYP.26.6.886; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; KIM JS, 1994, AM J PREV MED, V10, P200, DOI 10.1016/S0749-3797(18)30591-9; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Malhotra P, 1999, J HUM HYPERTENS, V13, P467, DOI 10.1038/sj.jhh.1000864; Mbanya JCN, 1998, INT J EPIDEMIOL, V27, P181, DOI 10.1093/ije/27.2.181; Mufunda T, 2000, J HUM HYPERTENS, V14, P65, DOI 10.1038/sj.jhh.1000886; Murray C.J, 1994, GLOBAL COMP ASSESSME; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; POULTER N, 2003, HEART, V89, P2; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; RAMIREZ MOA, 1995, J HUM HYPERTENS, V9, P891; Riecansky I, 1991, Bratisl Lek Listy, V92, P203; Seedat YK, 2000, J HUM HYPERTENS, V14, P739, DOI 10.1038/sj.jhh.1001059; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; Singh RB, 1997, J HUM HYPERTENS, V11, P679, DOI 10.1038/sj.jhh.1000511; Singh RB, 1997, J HUM HYPERTENS, V11, P51, DOI 10.1038/sj.jhh.1000384; Sonmez HM, 1999, J HUM HYPERTENS, V13, P399, DOI 10.1038/sj.jhh.1000824; STATA, 2001, STAT STAT SOFTW REL; Stegmayr B, 1996, CEREBROVASC DIS, V6, P80, DOI 10.1159/000108002; Stergiou GS, 1999, AM J HYPERTENS, V12, P959, DOI 10.1016/S0895-7061(99)00136-3; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Sulbaran T, 2000, J HUM HYPERTENS, V14, pS6, DOI 10.1038/sj.jhh.1000979; THAMM M, 1999, GESUNDHEITSWESEN; THOM TJ, 1989, INT J EPIDEMIOL, V18, pS20; Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054; United Nations Secretariat Department of Economic and Social Affairs Population Division, 2001, WORLD POP PROSP 2000; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; *WHO, WHOMNCCCH02012002; *WHO, 2001, WORLD HLTH REP 2001, P144; *WHO COLL CTR SURV, 2001, GLOB CARD INFOBASE; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wolz M, 2000, AM J HYPERTENS, V13, P103, DOI 10.1016/S0895-7061(99)00241-1; World Bank, 1993, WORLD DEV REP 1993 I; *WORLD BANK GROUP, WORLD DEV IND 2003 C; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	64	5169	5517	15	543	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					217	223		10.1016/S0140-6736(05)17741-1	http://dx.doi.org/10.1016/S0140-6736(05)17741-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652604				2022-12-24	WOS:000226309600027
J	Yuan, ZL; Guan, YJ; Chatterjee, D; Chin, YE				Yuan, ZL; Guan, YJ; Chatterjee, D; Chin, YE			Stat3 dimerization regulated by reversible acetylation of a single lysine residue	SCIENCE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; SH2 DOMAIN; TRANSCRIPTION; DNA; ACTIVATION; CBP/P300; P300/CBP; PEPTIDE; PROTEIN	Upon cytokine treatment, members of the signal transducers and activators of transcription (STAT) family of proteins are phosphorytated on tyrosine and serine sites within the carboxyl-terminal region in cells. We show that in response to cytokine treatment, Stat3 is also acetylated on a single lysine residue, Lys(685). Histone acetyltransferase p300-mediated Stat3 acetylation on Lys(685) was reversible by type I histone deacetylase (HDAC). Use of a prostate cancer cell line (PC3) that lacks Stat3 and PC3 cells expressing wildtype Stat3 or a Stat3 mutant containing a Lys(685)-to-Arg substitution revealed that Lys(685) acetylation was critical for Stat3 to form stable dimers required for cytokine-stimulated DNA binding and transcriptional regulation, to enhance transcription of cell growth-related genes, and to promote cell cycle progression in response to treatment with oncostatin M.	Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chin, YE (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA.	y_eugene_chin@brown.edu						Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; YUAN PZ, UNPUB; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhukovskaya NV, 2004, DEVELOPMENT, V131, P447, DOI 10.1242/dev.00927	27	590	618	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					269	273		10.1126/science.1105166	http://dx.doi.org/10.1126/science.1105166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653507				2022-12-24	WOS:000226361900047
J	Chen, JJ; Zhu, ZL; Gershon, AA; Gershon, MD				Chen, JJ; Zhu, ZL; Gershon, AA; Gershon, MD			Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster	CELL			English	Article							GLYCOPROTEIN-I; HERPES-ZOSTER; CELL; ENVELOPMENT; TRAFFICKING; GROWTH; ENTRY; LOCALIZATION; REPLICATION; LYMPHOCYTES	Varicella zoster virus (VZV) is a highly infectious human pathogen; nevertheless, infectious virions are not released in vitro where infection is cell associated. Four VZV envelope glycoproteins contain mannose 6-phosphate (Man 6-P), and Man 6-P blocks infection of cells by cell-free VZV. Expression of antisense cDNA or siRNA-like transcripts were used to generate five stable human cell lines deficient in cation-independent mannose 6-phosphate receptors (MPRci). All 5 MPRci-deficient lines resisted infection by cell-free, but not cell-associated, VZV, secreted lysosomal enzymes, and released infectious virions when infected by cell-associated VZV. Intracellular MPRci thus appear to divert newly enveloped VZV to late endosomes, and plasmalemmal MPRci are necessary for entry by cellfree VZV. Biopsies from VZV-infected human skin supported the idea that because MPRci expression is naturally lost in maturing superficial epidermal cells, these cells do not divert VZV to endosomes and constitutively secrete infectious VZV.	Columbia Univ, Dept Anat & Cell Biol, P&S, New York, NY 10032 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA	Columbia University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University	Gershon, MD (corresponding author), Columbia Univ, Dept Anat & Cell Biol, P&S, New York, NY 10032 USA.	mdg4@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI024021, R21AI027187, R01AI027187, R01AI024021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012969] Funding Source: NIH RePORTER; NIAID NIH HHS [AI24021, AI27187] Funding Source: Medline; NINDS NIH HHS [NS12969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], VARICELLA ZOSTER VIR; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Arvin AM, 1996, ANNU REV MICROBIOL, V50, P59, DOI 10.1146/annurev.micro.50.1.59; ARVIN AM, 1995, VIROLOGY, P2547; BHAVSAR JH, 1994, ANAL BIOCHEM, V221, P234, DOI 10.1006/abio.1994.1407; BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067; BRUNETTI CR, 1995, J VIROL, V69, P3517, DOI 10.1128/JVI.69.6.3517-3528.1995; Brunetti CR, 1998, J VIROL, V72, P3330, DOI 10.1128/JVI.72.4.3330-3339.1998; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Chen Jason J., 2003, Journal of Medical Virology, V70, pS71, DOI 10.1002/jmv.10325; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; COOK ML, 1970, J ULTRA MOL STRUCT R, V32, P334, DOI 10.1016/S0022-5320(70)80014-4; COOK ML, 1968, J VIROL, V2, P1458, DOI 10.1128/JVI.2.12.1458-1464.1968; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DiRenzo J, 2002, CANCER RES, V62, P89; Duus KM, 1996, J VIROL, V70, P8961, DOI 10.1128/JVI.70.12.8961-8971.1996; GABEL CA, 1989, J VIROL, V63, P4264, DOI 10.1128/JVI.63.10.4264-4276.1989; GERSHON A, 1973, J GEN VIROL, V18, P21, DOI 10.1099/0022-1317-18-1-21; GERSHON AA, 1994, J VIROL, V68, P6372, DOI 10.1128/JVI.68.10.6372-6390.1994; GERSHON AA, 1999, VACCINES, P475; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GROSE C, 1981, PEDIATRICS, V68, P735; HARDY I, 1991, NEW ENGL J MED, V325, P1545, DOI 10.1056/NEJM199111283252204; HARSON R, 1995, J VIROL, V69, P4994, DOI 10.1128/JVI.69.8.4994-5010.1995; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; JONES F, 1988, J VIROL, V62, P2701, DOI 10.1128/JVI.62.8.2701-2711.1988; Kinchington PR, 2000, J VIROL, V74, P2265, DOI 10.1128/JVI.74.5.2265-2277.2000; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KOROPCHAK CM, 1989, J VIROL, V63, P2392, DOI 10.1128/JVI.63.5.2392-2395.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Lungu O, 1998, P NATL ACAD SCI USA, V95, P7080, DOI 10.1073/pnas.95.12.7080; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; SCHMIDT NJ, 1976, INFECT IMMUN, V14, P709, DOI 10.1128/IAI.14.3.709-715.1976; Silverstein S, 2000, VARICELLA ZOSTER VIR, P123; TSOLIA M, 1990, J PEDIATR-US, V116, P184, DOI 10.1016/S0022-3476(05)82872-0; Wang ZH, 2000, J VIROL, V74, P6600, DOI 10.1128/JVI.74.14.6600-6613.2000; Wang ZH, 2001, J VIROL, V75, P323, DOI 10.1128/JVI.75.1.323-340.2001; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; Weller TH, 1996, J INFECT DIS, V174, pS306, DOI 10.1093/infdis/174.Supplement_3.S306; Wertz PW, 2000, ACTA DERM-VENEREOL, P7; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; Zhu Z, 1995, NEUROLOGY, V45, pS15, DOI 10.1212/WNL.45.12_Suppl_8.S15; ZHU ZL, 1995, J VIROL, V69, P7951, DOI 10.1128/JVI.69.12.7951-7959.1995; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	51	103	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					915	926		10.1016/j.cell.2004.11.007	http://dx.doi.org/10.1016/j.cell.2004.11.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620351	Bronze			2022-12-24	WOS:000226109700005
J	Dorus, S; Vallender, EJ; Evans, PD; Anderson, JR; Gilbert, SL; Mahowald, M; Wyckoff, GJ; Malcom, CM; Lahn, BT				Dorus, S; Vallender, EJ; Evans, PD; Anderson, JR; Gilbert, SL; Mahowald, M; Wyckoff, GJ; Malcom, CM; Lahn, BT			Accelerated evolution of nervous system genes in the origin of Homo sapiens	CELL			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; CEREBRAL CORTICAL SIZE; DOPAMINE D2 RECEPTORS; HUMAN BRAIN SIZE; MICE LACKING; ADAPTIVE EVOLUTION; MAJOR DETERMINANT; SONIC HEDGEHOG; MOLECULAR EVOLUTION; MENTAL-RETARDATION	Human evolution is characterized by a dramatic increase in brain size and complexity. To probe its genetic basis, we examined the evolution of genes involved in diverse aspects of nervous system biology. We found that these genes display significantly higher rates of protein evolution in primates than in rodents. Importantly, this trend is most pronounced for the subset of genes implicated in nervous system development. Moreover, within primates, the acceleration of protein evolution is most prominent in the lineage leading from ancestral primates to humans. Thus, the remarkable phenotypic evolution of the human nervous system has a salient molecular correlate, i.e., accelerated evolution of the underlying genes, particularly those linked to nervous system development. In addition to uncovering broad evolutionary trends, our study also identified many candidate genes-most of which are implicated in regulating brain size and behavior-that might have played important roles in the evolution of the human brain.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Anthropol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540; Wyckoff, Gerald/0000-0003-2604-2666				Aiello L, 1990, INTRO HUMAN EVOLUTIO; ARMSTRONG E, 1982, PRIMATE BRAIN EVOLUT; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Byrne R., 1988, MACHIAVELLIAN INTELL; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Darwin C., 1871, P423; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hollander M., 1973, NONPARAMETRIC STAT M; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jerison J. H, 1973, EVOLUTION BRAIN INTE; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li W-H, 1997, MOL EVOLUTION; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Matsuzawa T., 2001, PRIMATE ORIGINS HUMA; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McConkey E, 2002, TRENDS GENET, V18, P446, DOI 10.1016/S0168-9525(02)02748-8; McConkey EH, 2000, MOL PHYLOGENET EVOL, V15, P1, DOI 10.1006/mpev.1999.0735; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; NOBACK CR, 1970, PRIMATE BRAIN; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; PAGEL MD, 1989, SCIENCE, V244, P1589, DOI 10.1126/science.2740904; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shi JX, 2003, P NATL ACAD SCI USA, V100, P8331, DOI 10.1073/pnas.1332748100; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; SPUHLER JN, 1959, EVOLUTION MANS CAPAC; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; SZPIRER C, 1994, P NATL ACAD SCI USA, V91, P11849, DOI 10.1073/pnas.91.25.11849; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WALKER A, 1983, NATURE, V305, P525, DOI 10.1038/305525a0; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Williams MF, 2002, MED HYPOTHESES, V58, P284, DOI 10.1054/mehy.2001.1516; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; YANG ZH, 1995, GENETICS, V141, P1641; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Zhang JZ, 2003, GENETICS, V165, P2063; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	81	330	394	0	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2004	119	7					1027	1040		10.1016/j.cell.2004.11.040	http://dx.doi.org/10.1016/j.cell.2004.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620360	Bronze			2022-12-24	WOS:000226109700014
J	Coburn, PS; Pillar, CM; Jett, BD; Haas, W; Gilmore, MS				Coburn, PS; Pillar, CM; Jett, BD; Haas, W; Gilmore, MS			Enterococcus faecalis senses target cells and in response expresses cytolysin	SCIENCE			English	Article							VIRULENCE; HEMOLYSIN; ENDOPHTHALMITIS; CONTRIBUTES; TOXIN; MODEL	Many virulent strains of Enterococcus faecalis. produce a two-subunit toxin, termed cytolysin. Cytolysin expression is regulated by one of the subunits (CylL(S)") through a quorum-sensing autoinduction mechanism. We found that when target cells are absent, the other subunit (CylL(L)") forms a complex with CylL(S)", blocking it from autoinducing the operon. When target cells are present, however, CylL(L)" binds preferentially to the target, allowing free CylL(S)" to accumulate above the induction threshold. Thus, enterococci use CylL(L)" to actively probe the environment for target cells, and when target cells are detected, allows the organism to express high levels of cytolysin in response.	Univ Oklahoma, Hlth Sci Ctr, Stanton L Young Biomed Res Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Stanton L Young Biomed Res Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gilmore, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	mgilmore@vision.eri.harvard.edu	Coburn, Phillip/V-6698-2019	Coburn, Phillip/0000-0003-3799-5251	NATIONAL EYE INSTITUTE [R01EY008289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041108] Funding Source: NIH RePORTER; NEI NIH HHS [EY08289] Funding Source: Medline; NIAID NIH HHS [AI041108] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GILMORE MS, UNPUB; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; STEVENS SX, 1992, INVEST OPHTH VIS SCI, V33, P1650; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207	13	74	80	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2270	2272		10.1126/science.1103996	http://dx.doi.org/10.1126/science.1103996			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618522				2022-12-24	WOS:000225950000051
J	Thursby-Pelham, F				Thursby-Pelham, F			A remarkable resilience	LANCET			English	Editorial Material									Royal Sussex Cty Hosp, Phys Intens Therapy Unit, Brighton BN2 5BE, E Sussex, England	University of Brighton	Thursby-Pelham, F (corresponding author), Royal Sussex Cty Hosp, Phys Intens Therapy Unit, Brighton BN2 5BE, E Sussex, England.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2229	2229		10.1016/S0140-6736(04)17599-5	http://dx.doi.org/10.1016/S0140-6736(04)17599-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610812				2022-12-24	WOS:000225799700035
J	Winkelmann, A; Guldner, FH				Winkelmann, A; Guldner, FH			Cadavers as teachers: the dissecting room experience in Thailand	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-EDUCATION; TEACHING ANATOMY; STUDENTS; DEAD		Univ Hosp, Inst Cell Biol & Neurobiol, Ctr Anat, Charite, D-10098 Berlin, Germany; Univ W Indies, Sect Anat, Dept Basic Med Sci, Fac Med, Kingston 7, Jamaica	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University West Indies Mona Jamaica	Winkelmann, A (corresponding author), Univ Hosp, Inst Cell Biol & Neurobiol, Ctr Anat, Charite, D-10098 Berlin, Germany.	andreas.winkelmann@charite.de		Winkelmann, Andreas/0000-0003-1047-2477				BERTMAN SL, 1985, MED EDUC, V19, P374, DOI 10.1111/j.1365-2923.1985.tb01340.x; Dyer GSM, 2000, ACAD MED, V75, P969, DOI 10.1097/00001888-200010000-00008; Furness P, 2003, BRIT MED J, V327, P759, DOI 10.1136/bmj.327.7418.759; Good B, 1994, MED RATIONALITY EXPE; Hafferty F.W., 1991, VALLEY DEATH SOCIALI; HAFFERTY FW, 1988, J HEALTH SOC BEHAV, V29, P344, DOI 10.2307/2136868; Hull S K, 1998, Acad Med, V73, P577, DOI 10.1097/00001888-199805000-00038; Lela J. W., 1988, BIOMEDICINE EXAMINED, P125; McLachlan JC, 2004, MED EDUC, V38, P418, DOI 10.1046/j.1365-2923.2004.01795.x; OLSON GA, 1992, ASIAN FOLKLORE STUD, V51, P279, DOI 10.2307/1178335; Ongcharit C, 1998, TRANSPLANT P, V30, P3385, DOI 10.1016/S0041-1345(98)01071-9; Popp Richard L., 1985, MISSIOLOGY, V13, P147; Rosenfield PJ, 2004, MED EDUC, V38, P927, DOI 10.1111/j.1365-2929.2004.01931.x; SCHOTZINGER KA, 1987, OMEGA-J DEATH DYING, V18, P217, DOI 10.2190/UH6B-TYMB-65UU-3PK0; SEGAL DA, 1988, ANTHROPOL QUART, V61, P17, DOI 10.2307/3317868; Shaffer K, 2004, NEW ENGL J MED, V351, P1279, DOI 10.1056/NEJMp048100; SUKOL RB, 1995, HUM PATHOL, V26, P700, DOI 10.1016/0046-8177(95)90216-3; Suwanwela C, 1996, MED EDUC, V30, P401, DOI 10.1111/j.1365-2923.1996.tb00858.x; Tuffs Annette, 2003, BMJ, V327, P1068, DOI 10.1136/bmj.327.7423.1068-c	19	89	90	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1455	1457		10.1136/bmj.329.7480.1455	http://dx.doi.org/10.1136/bmj.329.7480.1455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	882VB	15604182	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000225965800025
J	Broothaerts, W; Mitchell, HJ; Weir, B; Kaines, S; Smith, LMA; Yang, W; Mayer, JE; Roa-Rodriguez, C; Jefferson, RA				Broothaerts, W; Mitchell, HJ; Weir, B; Kaines, S; Smith, LMA; Yang, W; Mayer, JE; Roa-Rodriguez, C; Jefferson, RA			Gene transfer to plants by diverse species of bacteria	NATURE			English	Article							AGROBACTERIUM-TUMEFACIENS C58/; TI-PLASMID; RHIZOBIUM; GENOME; TRANSFORMATION; IDENTIFICATION; ARABIDOPSIS; VIRULENCE; MELILOTI; SEQUENCE	Agrobacterium is widely considered to be the only bacterial genus capable of transferring genes to plants. When suitably modified, Agrobacterium has become the most effective vector for gene transfer in plant biotechnology(1). However, the complexity of the patent landscape(2) has created both real and perceived obstacles to the effective use of this technology for agricultural improvements by many public and private organizations worldwide. Here we show that several species of bacteria outside the Agrobacterium genus can be modified to mediate gene transfer to a number of diverse plants. These plant-associated symbiotic bacteria were made competent for gene transfer by acquisition of both a disarmed Ti plasmid and a suitable binary vector. This alternative to Agrobacterium-mediated technology for crop improvement, in addition to affording a versatile 'open source' platform for plant biotechnology, may lead to new uses of natural bacteria-plant interactions to achieve plant transformation.	Charles Sturt Univ, Affiliated Res Ctr, CAMBIA, Canberra, ACT 2601, Australia	Charles Sturt University	Jefferson, RA (corresponding author), Charles Sturt Univ, Affiliated Res Ctr, CAMBIA, GPO Box 3200, Canberra, ACT 2601, Australia.	r.jefferson@cambia.org	broothaerts, wim/AAF-1287-2020	broothaerts, wim/0000-0003-3420-6368; Jefferson, Richard/0000-0001-5352-4498				Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cottage A, 2001, PLANT MOL BIOL REP, V19, P321, DOI 10.1007/BF02772830; Dennis C, 2004, NATURE, V431, P494, DOI 10.1038/431494a; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Goethals K, 2001, ANNU REV PHYTOPATHOL, V39, P27, DOI 10.1146/annurev.phyto.39.1.27; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; HOOYKAAS PJJ, 1977, J GEN MICROBIOL, V98, P477, DOI 10.1099/00221287-98-2-477; Jefferson R. A., 2003, US Patent, Patent No. [6, 391-547, 6391547]; KLEIN DT, 1953, J BACTERIOL, V66, P220, DOI 10.1128/JB.66.2.220-228.1953; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; LAMBERT B, 1990, APPL ENVIRON MICROB, V56, P1093, DOI 10.1128/AEM.56.4.1093-1102.1990; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Nair GR, 2003, PLANT PHYSIOL, V133, P989, DOI 10.1104/pp.103.030262; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; REIMMANN C, 1993, BACTERIAL CONJUGATIO, P137; ROARODRIGUEZ C, 2003, AGROBACTERIUM MEDIAT; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Suzuki K, 2002, PLANT J, V32, P775, DOI 10.1046/j.1365-313X.2002.01468.x; Svab Zora, 1995, P55; Van Montagu M, 2003, TRENDS PLANT SCI, V8, P353, DOI 10.1016/S1360-1385(03)00160-2; VANVEEN RJM, 1989, ARCH MICROBIOL, V153, P85, DOI 10.1007/BF00277546; Veen R. J. M. van, 1988, Molecular Plant-Microbe Interactions, V1, P231, DOI 10.1094/MPMI-1-231; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young JM, 2003, INT J SYST EVOL MICR, V53, P1689, DOI 10.1099/ijs.0.02762-0	29	201	291	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					629	633		10.1038/nature03309	http://dx.doi.org/10.1038/nature03309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703747				2022-12-24	WOS:000226862000044
J	Ward, PD; Botha, J; Buick, R; De Kock, MO; Erwin, DH; Garrison, GH; Kirschvink, JL; Smith, R				Ward, PD; Botha, J; Buick, R; De Kock, MO; Erwin, DH; Garrison, GH; Kirschvink, JL; Smith, R			Abrupt and gradual extinction among Late Permian land vertebrates in the Karoo Basin, South Africa	SCIENCE			English	Article							TRIASSIC BOUNDARY; STRATIGRAPHIC RANGES; CONFIDENCE-INTERVALS; MASS EXTINCTION; SUPERGROUP; PATTERNS; MARINE	The Karoo basin of South Africa exposes a succession of Upper Permian. to Lower Triassic terrestrial strata containing abundant terrestrial vertebrate fossils. Paleomagnetic/magnetostratigraphic and carbon-isotope data allow sections to be correlated across the basin. With this stratigraphy, the vertebrate fossil data show a gradual extinction in the Upper Permian punctuated by an enhanced extinction pulse at the Permian-Triassic boundary interval, particularly among the dicynodont therapsids, coinciding with negative carbon-isotope anomalies.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; S African Museum, ZA-8000 Cape Town, South Africa; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Rand Afrikaans Univ, Dept Geol, Johannesburg, South Africa; MRC121 Smithsonian Inst, Dept Paleobiol, Washington, DC 20013 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; California Institute of Technology; University of Johannesburg; Smithsonian Institution; Smithsonian National Museum of Natural History	Ward, PD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	argo@u.washington.edu	Botha, Jennifer/N-1893-2013; Erwin, Douglas H/A-9668-2009	Botha, Jennifer/0000-0001-8824-9334; Erwin, Douglas/0000-0003-2518-5614; Buick, Roger/0000-0003-0139-1659; de Kock, Michiel/0000-0002-5036-3438				Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; BOTHA JM, UNPUB; Catuneanu O, 1998, BASIN RES, V10, P417; Cerling TE, 1992, GLOBAL BIOGEOCHEM CY, V6, P307, DOI 10.1029/92GB01102; CONEY L, 2004, LPSC, V35, P1488; De Kock MO, 2004, GONDWANA RES, V7, P175, DOI 10.1016/S1342-937X(05)70316-6; de Wit MJ, 2002, J GEOL, V110, P227, DOI 10.1086/338411; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; FOSTER C, 2002, 1 INT C PAL, P57; GROENWALD GH, 1995, GEOL SURV S AFR BIOS, V1, P35; HOLSER WT, 1992, GEOCHIM COSMOCHIM AC, V56, P3297, DOI 10.1016/0016-7037(92)90306-4; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; KING DA, 1990, CHEM PHYSICS SOLID A, V3, P1; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; MacLeod KG, 2000, GEOLOGY, V28, P227, DOI 10.1130/0091-7613(2000)28<227:TOMREA>2.0.CO;2; MARSHALL CR, 1994, PALEOBIOLOGY, V20, P459, DOI 10.1017/S0094837300012938; Nawrocki J, 2004, TERRA NOVA, V16, P139, DOI 10.1111/j.1365-3121.2004.00543.x; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; RUBIDGE B, 1995, GEOL SURV S AFR BIOS, V1; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; Signor P.W., 1982, GEOL SOC AM SPEC PAP, V190, P291, DOI DOI 10.1130/SPE190-P291; Solow AR, 2003, PALEOBIOLOGY, V29, P181, DOI 10.1666/0094-8373(2003)029<0181:EOSRWF>2.0.CO;2; SPRINGER MS, 1990, PALEOBIOLOGY, V16, P512, DOI 10.1017/S0094837300010228; STEINER M, 1989, J GEOPHYS RES-SOLID, V94, P7343, DOI 10.1029/JB094iB06p07343; Steiner MB, 2003, PALAEOGEOGR PALAEOCL, V194, P405, DOI 10.1016/S0031-0182(03)00230-X; Szurlies M, 2003, EARTH PLANET SC LETT, V212, P263, DOI 10.1016/S0012-821X(03)00288-7; Twitchett RJ, 2001, GEOLOGY, V29, P351, DOI 10.1130/0091-7613(2001)029<0351:RASCOM>2.0.CO;2; Wang SC, 2004, PALEOBIOLOGY, V30, P5, DOI 10.1666/0094-8373(2004)030<0005:ICIFET>2.0.CO;2; Ward PD, 2000, SCIENCE, V289, P1740, DOI 10.1126/science.289.5485.1740	34	257	282	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					709	714		10.1126/science.1107068	http://dx.doi.org/10.1126/science.1107068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15661973	Green Submitted			2022-12-24	WOS:000226814900039
J	Imaizumi-Anraku, H; Takeda, N; Charpentier, M; Perry, J; Miwa, H; Umehara, Y; Kouchi, H; Murakami, Y; Mulder, L; Vickers, K; Pike, J; Downie, JA; Wang, T; Sato, S; Asamizu, E; Tabata, S; Yoshikawa, M; Murooka, Y; Wu, GJ; Kawaguchi, M; Kawasaki, S; Parniske, M; Hayashi, M				Imaizumi-Anraku, H; Takeda, N; Charpentier, M; Perry, J; Miwa, H; Umehara, Y; Kouchi, H; Murakami, Y; Mulder, L; Vickers, K; Pike, J; Downie, JA; Wang, T; Sato, S; Asamizu, E; Tabata, S; Yoshikawa, M; Murooka, Y; Wu, GJ; Kawaguchi, M; Kawasaki, S; Parniske, M; Hayashi, M			Plastid proteins crucial for symbiotic fungal and bacterial entry into plant roots	NATURE			English	Article							LEGUME LOTUS-JAPONICUS; NODULE ORGANOGENESIS; SIGNAL-TRANSDUCTION; CALCIUM SPIKING; LJSYM4 GENE; MUTANTS; NODULATION; RECOGNITION; CHANNEL; GENOME	The roots of most higher plants form arbuscular mycorrhiza, an ancient, phosphate-acquiring symbiosis with fungi, whereas only four related plant orders are able to engage in the evolutionary younger nitrogen-fixing root-nodule symbiosis with bacteria(1). Plant symbioses with bacteria and fungi require a set of common signal transduction components that redirect root cell development(2,3). Here we present two highly homologous genes from Lotus japonicus, CASTOR and POLLUX, that are indispensable for microbial admission into plant cells and act upstream of intracellular calcium spiking(4), one of the earliest plant responses to symbiotic stimulation. Surprisingly, both twin proteins are localized in the plastids of root cells, indicating a previously unrecognized role of this ancient endosymbiont in controlling intracellular symbioses that evolved more recently.	Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Biooriented Technol Res Advancement Inst, Tokyo Off, Minato Ku, Tokyo 1050001, Japan; Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320112, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Agrobiological Sciences - Japan; Osaka University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute; University of Tokyo	Kawasaki, S (corresponding author), Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	kawasa@nias.affrc.go.jp	Sato, Shusei/A-3616-2015; Parniske, Martin/F-2202-2011; Hayashi, Makoto/N-5379-2015; Downie, Allan/I-3487-2012; Parniske, Martin/M-3781-2019	Sato, Shusei/0000-0002-0293-5366; Parniske, Martin/0000-0001-8561-747X; Hayashi, Makoto/0000-0001-6389-4265; Parniske, Martin/0000-0001-8561-747X; Downie, Allan/0000-0003-1011-4960; Kawaguchi, Masayoshi/0000-0002-1032-6261				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Bonfante P, 2000, MOL PLANT MICROBE IN, V13, P1109, DOI 10.1094/MPMI.2000.13.10.1109; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FIRMIN JL, 1993, MOL MICROBIOL, V10, P351, DOI 10.1111/j.1365-2958.1993.tb01961.x; Harris JM, 2003, MOL PLANT MICROBE IN, V16, P335, DOI 10.1094/MPMI.2003.16.4.335; Hayashi M, 2001, DNA RES, V8, P301, DOI 10.1093/dnares/8.6.301; Isono K, 1997, P NATL ACAD SCI USA, V94, P14948, DOI 10.1073/pnas.94.26.14948; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kawaguchi M, 2001, MOL GENET GENOMICS, V266, P157, DOI 10.1007/s004380100540; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Nakamura Y, 2002, DNA RES, V9, P63, DOI 10.1093/dnares/9.2.63; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Novero M, 2002, NEW PHYTOL, V154, P741, DOI 10.1046/j.1469-8137.2002.00424.x; Oldroyd GED, 2001, ANN BOT-LONDON, V87, P709, DOI 10.1006/anbo.2001.1410; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Senoo K, 2000, PLANT CELL PHYSIOL, V41, P726, DOI 10.1093/pcp/41.6.726; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0	30	278	307	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					527	531		10.1038/nature03237	http://dx.doi.org/10.1038/nature03237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15616514				2022-12-24	WOS:000226727200050
J	Berndt, ER				Berndt, ER			To inform or persuade? Direct-to-consumer advetising of prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Berndt, ER (corresponding author), MIT, Cambridge, MA 02139 USA.							AIKIN KJ, 2003, DIR TO CONS PROM PUB; *FOOD DRUG ADM, GUID IND BRIEF SUMM; WEISSMAN JS, 2004, PHYSICIANS REPORT PA; 2004, PINK SHEET      122, P16	4	37	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					325	328		10.1056/NEJMp048357	http://dx.doi.org/10.1056/NEJMp048357			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673797				2022-12-24	WOS:000226535900002
J	Katanaev, VL; Ponzielli, R; Semeriva, M; Tomlinson, A				Katanaev, VL; Ponzielli, R; Semeriva, M; Tomlinson, A			Trimeric G protein-dependent frizzled signaling in Drosophila	CELL			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; NUCLEOTIDE-BINDING; WINGLESS; GENE; EXPRESSION; PATHWAYS; SUBUNIT; LOCALIZATION; TRANSDUCTION	Frizzled (Fz) proteins are serpentine receptors that transduce critical cellular signals during development. Serpentine receptors usually signal to downstream effectors through an associated trimeric G protein complex. However, clear evidence for the role of trimeric G protein complexes for the Fz family of receptors has hitherto been lacking. Here, we show roles for the Go, subunit (Go) in mediating the two distinct pathways transduced by Fz receptors in Drosophila: the Writ and planar polarity pathways. Go is required for transduction of both pathways, and epistasis experiments suggest that it is an immediate transducer of Fz. While overexpression effects of the wild-type form are receptor dependent, the activated form (Go-GTP) can signal when the receptor is removed. Thus, Go is likely part of a trimeric G protein complex that directly tranduces Fz signals from the membrane to downstream components.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Mediterranee, Lab Genet & Physiol Dev, CNRS, UMR 6545,IBDM,INSERM,Case 907, F-13288 Marseille 09, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Tomlinson, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	at4l@columbia.edu	Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; BURTON FH, 1991, NATURE, V350, P74, DOI 10.1038/350074a0; Chen CM, 1999, DEVELOPMENT, V126, P5441; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Ikeda SR, 1999, NEUROSCI LETT, V271, P163, DOI 10.1016/S0304-3940(99)00555-8; INOUE S, 1995, J BIOCHEM-TOKYO, V118, P650, DOI 10.1093/oxfordjournals.jbchem.a124959; Jones KH, 1996, GENETICS, V142, P205; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PFEIFER M, 1994, DEVELOPMENT, V120, P369; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Strapps WR, 2001, DEVELOPMENT, V128, P4829; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Taylor J, 1998, GENETICS, V150, P199; Tomlinson A, 1997, DEVELOPMENT, V124, P4515; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VARMUS H, 1986, TAK S, V17, P31; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wieschaus E., 1986, P199; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	50	211	218	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					111	122		10.1016/j.cell.2004.11.014	http://dx.doi.org/10.1016/j.cell.2004.11.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652486	Bronze			2022-12-24	WOS:000226365400015
J	Sachs, JD				Sachs, JD			Achieving the millennium development goals - The case of malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BURDEN		Columbia Univ, Earth Inst, New York, NY 10027 USA; UN, Millennium Project, New York, NY USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.							Breman JG, 2004, AM J TROP MED HYG, V71, P1; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a	5	31	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					115	117		10.1056/NEJMp048319	http://dx.doi.org/10.1056/NEJMp048319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647571	Green Submitted			2022-12-24	WOS:000226251700001
J	Schanda, H				Schanda, H			Psychiatry reforms and illegal behaviour of the severely mentally ill	LANCET			English	Editorial Material							DISORDERS; DEINSTITUTIONALIZATION; SCHIZOPHRENIA; HOMICIDES; ILLNESS; 25-YEAR; CARE		Justizanstalt Gollersdorf, A-2013 Gollersdorf 17, Austria; Psychiat Univ Clin, Vienna, Austria		Schanda, H (corresponding author), Justizanstalt Gollersdorf, A-2013 Gollersdorf 17, Austria.	hans.schanda@meduniwien.ac.at						Erb Martin, 2001, Crim Behav Ment Health, V11, P6, DOI 10.1002/cbm.366; Eronen M, 1996, ARCH GEN PSYCHIAT, V53, P497; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; GOTTLIEB P, 1987, ACTA PSYCHIAT SCAND, V76, P285, DOI 10.1111/j.1600-0447.1987.tb02897.x; HODGINS S, 1996, ARCH GEN PSYCHIAT, V53, P486; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Munk-Jorgensen P, 1999, EUR ARCH PSY CLIN N, V249, P136, DOI 10.1007/s004060050078; Schanda H, 2000, INT J LAW PSYCHIAT, V23, P481, DOI 10.1016/S0160-2527(00)00045-5; Schanda H, 2004, EUR PSYCHIAT, V19, p30S; Schanda H, 2004, ACTA PSYCHIAT SCAND, V110, P98, DOI 10.1111/j.1600-0047.2004.00305.x; Simpson AIF, 2004, BRIT J PSYCHIAT, V185, P394, DOI 10.1192/bjp.185.5.394; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9; TAYLOR PJ, 1997, CRIMINAL BEHAV MENT, V7, P19; Wallace C, 2004, AM J PSYCHIAT, V161, P716, DOI 10.1176/appi.ajp.161.4.716	14	14	14	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					367	369						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891WE	15680440				2022-12-24	WOS:000226610900007
J	Takato, N; Bus, SJ; Terada, H; Pyo, TS; Kobayashi, N				Takato, N; Bus, SJ; Terada, H; Pyo, TS; Kobayashi, N			Detection of a deep 3-mu m absorption feature in the spectrum of Amalthea (JV)	SCIENCE			English	Article							GALILEAN SATELLITES; SURFACE-COMPOSITION; OPTICAL-PROPERTIES; ICE; SPECTROGRAPH; CONSTANTS	Near-infrared spectra of Jupiter's small inner satellites Amalthea and Thebe are similar to those of D-type asteroids in the 0.8- to 2.5-micrometer wavelength range; A deep absorption feature is detected at 3 micrometers in the spectra of the. trailing side of Amalthea, which is similar to that of the non-ice components of Callisto and can be attributed to hydrous minerals. These surface materials cannot be explained if the satellite formed at its present orbit by accreting from a circumjovian nebula. Amalthea and Thebe may be the remnants of Jupiter's inflowing building blocks that formed in the outer part or outside of the circumjovian nebula.	Natl Astron Observ, Subaru Telescope, Hilo, HI 96720 USA; Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; Univ Tokyo, Grad Sch Sci, Inst Astron, Tokyo 1810015, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Hawaii System; University Hawaii Hilo; University of Tokyo	Takato, N (corresponding author), Natl Astron Observ, Subaru Telescope, 650 N Aohoku Pl, Hilo, HI 96720 USA.	takato@naoj.org						ANDERSON JD, 2002, AM GEOPH UN M SAN FR, P3; Astakhov SA, 2003, NATURE, V423, P264, DOI 10.1038/nature01622; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; DRAINE BT, 1985, ASTROPHYS J SUPPL S, V57, P587, DOI 10.1086/191016; Emery JP, 2003, ICARUS, V164, P104, DOI 10.1016/S0019-1035(03)00143-X; Fuller K. A., 1998, HDB OPTICAL CONSTANT, V3, P899; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GRADIE J, 1980, ICARUS, V44, P373, DOI 10.1016/0019-1035(80)90032-9; Hapke B., 1993, THEORY REFLECTANCE E; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; KHARE BN, 1994, CAN J CHEM, V72, P678, DOI 10.1139/v94-093; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; LEBOFSKY LA, 1989, ORIGIN EVOLUTION PLA, P192; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; Nakano H, 2003, ASTROPHYS J, V592, P1252, DOI 10.1086/375856; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; POLLACK JB, 1982, SATELLITES JUPITER, P872; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Simonelli DP, 2000, ICARUS, V147, P353, DOI 10.1006/icar.2000.6474; STOOKE PJ, 1992, EARTH MOON PLANETS, V56, P123, DOI 10.1007/BF00056353; Thomas PC, 1998, ICARUS, V135, P360, DOI 10.1006/icar.1998.5976; VEVERKA J, 1981, J GEOPHYS RES-SPACE, V86, P8675, DOI 10.1029/JA086iA10p08675; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	28	16	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2224	2227		10.1126/science.1105427	http://dx.doi.org/10.1126/science.1105427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618511				2022-12-24	WOS:000225950000036
J	Dixit, NM; Layden-Almer, JE; Layden, TJ; Perelson, AS				Dixit, NM; Layden-Almer, JE; Layden, TJ; Perelson, AS			Modelling how ribavirin improves interferon response rates in hepatitis C virus infection	NATURE			English	Article							VIRAL DYNAMICS; PLUS RIBAVIRIN; COMBINATION THERAPY; INITIAL TREATMENT; CONTROLLED TRIAL; PLACEBO; ALPHA; REPLICATION; MONOTHERAPY; KINETICS	Nearly 200 million individuals worldwide are currently infected with hepatitis C virus (HCV)(1). Combination therapy with pegylated interferon and ribavirin, the latest treatment for HCV infection, elicits long-term responses in only about 50% of patients treated(2-4). No effective alternative treatments exist for non-responders(5). Consequently, significant efforts are continuing to maximize response to combination therapy(6,7). However, rational therapy optimization is precluded by the poor understanding of the mechanism(s) of ribavirin action against HCV8. Ribavirin alone induces either a transient early decline or no decrease in HCV viral load(9-12), but in combination with interferon it significantly improves long-term response rates(2-4,13-15). Here we present a model of HCV dynamics in which, on the basis of growing evidence(16-21), we assume that ribavirin decreases HCV infectivity in an infected individual in a dose-dependent manner. The model quantitatively predicts long-term response rates to interferon monotherapy and combination therapy, fits observed patterns of HCV RNA decline in patients undergoing therapy, reconciles conflicting observations of the influence of ribavirin on HCV RNA decline, provides key insights into the mechanism of ribavirin action against HCV, and establishes a framework for rational therapy optimization.	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Univ Illinois, Dept Med, Chicago, IL 60612 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Perelson, AS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	asp@lanl.gov	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002				[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Glue P, 1999, SEMIN LIVER DIS, V19, P17; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hong Z, 2003, HEPATOLOGY, V38, P807, DOI 10.1053/jhep.2003.50464; Hoofnagle JH, 2003, HEPATOLOGY, V38, P66, DOI 10.1053/jhep.2003.50258; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Layden-Almer JE, 2003, HEPATOLOGY, V37, P1343, DOI 10.1053/jhep.2003.50217; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2000, GASTROENTEROLOGY, V119, P1317, DOI 10.1053/gast.2000.19289; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Neumann AU, 2000, J INFECT DIS, V182, P28, DOI 10.1086/315661; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Powers KA, 2003, SEMIN LIVER DIS, V23, P13; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Reichard O, 1998, LANCET, V351, P83, DOI 10.1016/S0140-6736(97)06088-1; Shiffman ML, 2001, J INFECT DIS, V184, P405, DOI 10.1086/322778; STEINDLMUNDA P, 2003, 11 INT S VIR HEP LIV, P75; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Tsubota A, 2002, INTERVIROLOGY, V45, P33, DOI 10.1159/000050085; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P18; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Zoulim F, 1998, J VIRAL HEPATITIS, V5, P193, DOI 10.1046/j.1365-2893.1998.00099.x	30	262	277	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					922	924		10.1038/nature03153	http://dx.doi.org/10.1038/nature03153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602565				2022-12-24	WOS:000225733500058
J	Marti, M; Good, RT; Rug, M; Knuepfer, E; Cowman, AF				Marti, M; Good, RT; Rug, M; Knuepfer, E; Cowman, AF			Targeting malaria virulence and remodeling proteins to the host erythrocyte	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; GENOME SEQUENCE; EXPRESSION; TRAFFICKING; SURFACE; GENES	To establish infection in the host, malaria parasites export remodeling and virulence proteins into the erythrocyte. These proteins can traverse a series of membranes, including the parasite membrane, the parasitophorous vacuole membrane, and the erythrocyte membrane. We show that a conserved pentameric sequence plays a central role in protein export into the host cell and predict the exported proteome in Plasmodium falciparum. We identified 400 putative erythrocyte-targeted proteins corresponding to similar to8% of all predicted genes, with 225 virulence proteins and a further 160 proteins likely to be involved in remodeling of the host erythrocyte. The conservation of this signal across Plasmodium species has implications for the development of new antimalarials.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Cowman, Alan F/C-7642-2013; Rug, Melanie/B-5417-2015; Rug, Melanie/A-9504-2011	Cowman, Alan F/0000-0001-5145-9004; Knuepfer, Ellen/0000-0002-6090-1877	PHS HHS [R01-A144008-04A1] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foley M, 1998, INT J PARASITOL, V28, P1671, DOI 10.1016/S0020-7519(98)00132-5; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; KNUEPFER E, UNPUB; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; POLOGE LG, 1987, P NATL ACAD SCI USA, V84, P7139, DOI 10.1073/pnas.84.20.7139; SCHERF A, 1992, EMBO J, V11, P2293, DOI 10.1002/j.1460-2075.1992.tb05288.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	20	667	689	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1930	1933		10.1126/science.1102452	http://dx.doi.org/10.1126/science.1102452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591202				2022-12-24	WOS:000225695600043
J	Gawande, A				Gawande, A			Casualties of war -- Military care for the wounded from Iraq and Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176				[Anonymous], 2004, PRINC WARS WHICH US; *DEP DEF, 2004, US CAS STAT; Harris A. R., 2002, HOMICIDE STUDIES, V6, P128, DOI DOI 10.1177/108876790200600203; Pear R., 2004, NY TIMES, pA22; Whelan T J Jr, 1975, Surg Annu, V7, P1	5	384	404	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2471	2475		10.1056/NEJMp048317	http://dx.doi.org/10.1056/NEJMp048317			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590948				2022-12-24	WOS:000225593100001
J	Mao, JH; Perez-Iosada, J; Wu, D; DelRosario, R; Tsunematsu, R; Nakayama, KI; Brown, K; Bryson, S; Balmain, A				Mao, JH; Perez-Iosada, J; Wu, D; DelRosario, R; Tsunematsu, R; Nakayama, KI; Brown, K; Bryson, S; Balmain, A			Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene	NATURE			English	Article							F-BOX PROTEIN; CYCLIN-E; CENTROSOME AMPLIFICATION; CHROMOSOMAL INSTABILITY; UBIQUITIN LIGASE; P53; CANCER; MICE; NOTCH; EXPRESSION	The FBXW7/hCDC4 gene encodes a ubiquitin ligase implicated in the control of chromosome stability(1). Here we identify the mouse Fbxw7 gene as a p53-dependent tumour suppressor gene by using a mammalian genetic screen for p53-dependent genes involved in tumorigenesis. Radiation-induced lymphomas from p53(+/-) mice, but not those from p53(-/-) mice, show frequent loss of heterozygosity and a 10% mutation rate of the Fbxw7 gene. Fbxw7(+/-) mice have greater susceptibility to radiation-induced tumorigenesis, but most tumours retain and express the wildtype allele, indicating that Fbxw7 is a haploinsufficient tumour suppressor gene. Loss of Fbxw7 alters the spectrum of tumours that develop in p53 deficient mice to include a range of tumours in epithelial tissues such as the lung, liver and ovary. Mouse embryo fibroblasts from Fbxw7-deficient mice, or wild-type mouse cells expressing Fbxw7 small interfering RNA, have higher levels of Aurora-A kinase, c-Jun and Notch4, but not of cyclin E. We propose that p53-dependent loss of Fbxw7 leads to genetic instability by mechanisms that might involve the activation of Aurora-A, providing a rationale for the early occurrence of these mutations in human cancers.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Univ Glasgow, CRC Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland	University of California System; University of California San Francisco; Kyushu University; University of Glasgow	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Browes C, 2001, FEBS LETT, V497, P20, DOI 10.1016/S0014-5793(01)02429-2; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frenkel J, 1999, ONCOGENE, V18, P2901, DOI 10.1038/sj.onc.1202518; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Ye Q, 2004, LEUKEMIA, V18, P777, DOI 10.1038/sj.leu.2403291; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	30	308	320	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					775	779		10.1038/nature03155	http://dx.doi.org/10.1038/nature03155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592418				2022-12-24	WOS:000225597200053
J	Takaoka, A; Yanai, H; Kondo, S; Duncan, G; Negishi, H; Mizutani, T; Kano, S; Honda, K; Ohba, Y; Mak, TW; Taniguchi, T				Takaoka, A; Yanai, H; Kondo, S; Duncan, G; Negishi, H; Mizutani, T; Kano, S; Honda, K; Ohba, Y; Mak, TW; Taniguchi, T			Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; DIFFERENTIAL REGULATION; HOST-DEFENSE; STRANDED-RNA; CPG MOTIFS; KAPPA-B; MYD88; DNA; IMMUNITY; INNATE	The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity(1-3). All TLRs use the adaptor MyD88 for signalling(4), but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully understood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5(-/-) mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-alpha induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5(-/-) mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.	Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan	University of Toronto; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Mak, TW (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, 610 Univ Ave,Room 7-411, Toronto, ON M5G 2M9, Canada.	tmak@uhnres.utroronto.ca; tada@m.u-tokyo.ac.jp	Yanai, Hideyuki/AGK-5933-2022; Honda, Kenya/N-5297-2015; Kano, Shinichi/F-4144-2015; Mizutani, Tatsuaki/AAA-5044-2021; Ohba, Yusuke/E-7944-2011	Yanai, Hideyuki/0000-0002-0115-9000; Kano, Shinichi/0000-0002-5171-3436; Mizutani, Tatsuaki/0000-0002-4323-4347; 				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cowdery JS, 1999, J IMMUNOL, V162, P6770; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; LIN R, IN PRESS J BIOL CHEM; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	30	743	784	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					243	249		10.1038/nature03308	http://dx.doi.org/10.1038/nature03308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15665823				2022-12-24	WOS:000227494500052
J	Kelly, JW				Kelly, JW			Attacking amyloid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; INHIBITORS		Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.							Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a	5	21	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					722	723		10.1056/NEJMcibr044231	http://dx.doi.org/10.1056/NEJMcibr044231			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716569				2022-12-24	WOS:000227031100015
J	McGhee, SM; Ho, SY; Schooling, M; Ho, LM; Thomas, GN; Hedley, AJ; Mak, KH; Peto, R; Lam, TH				McGhee, SM; Ho, SY; Schooling, M; Ho, LM; Thomas, GN; Hedley, AJ; Mak, KH; Peto, R; Lam, TH			Mortality associated with passive smoking in Hong Kong	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE; COHORT; RISK		Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Student Hlth Serv, Kowloon, Hong Kong, Peoples R China; Univ Oxford, Nuffield Dept Clin Med, Oxford OX2 6HE, England	University of Hong Kong; University of Oxford	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Thomas, G. Neil/A-1879-2013; Schooling, Catherine Mary/C-4386-2009; McGhee, Sarah M/A-6460-2013; Hedley, Anthony/C-4305-2009; McGhee, Sarah/C-4367-2009; Hedley, Anthony J/A-9113-2013; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Thomas, G. Neil/0000-0002-2777-1847; McGhee, Sarah M/0000-0003-1025-5915; Lam, Tai Hing/0000-0002-2033-9971; Schooling, Mary/0000-0001-9933-5887; ho, lm/0000-0002-2709-927X; Ho, Daniel Sai Yin/0000-0001-9485-0273				Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; Hill SE, 2004, BMJ-BRIT MED J, V328, P988, DOI 10.1136/bmj.38070.503009.EE; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; KAY R, 1992, NEUROLOGY, V42, P985, DOI 10.1212/WNL.42.5.985; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361	5	50	53	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2005	330	7486					287	288		10.1136/bmj.38342.706748.47	http://dx.doi.org/10.1136/bmj.38342.706748.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895EM	15677632	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000226843700016
J	Reimann, S; Manning, AJ; Simmonds, PG; Cunnold, DM; Wang, RHJ; Li, JL; McCulloch, A; Prinn, RG; Huang, J; Weiss, RF; Fraser, PJ; O'Doherty, S; Greally, BR; Stemmler, K; Hill, M; Folini, D				Reimann, S; Manning, AJ; Simmonds, PG; Cunnold, DM; Wang, RHJ; Li, JL; McCulloch, A; Prinn, RG; Huang, J; Weiss, RF; Fraser, PJ; O'Doherty, S; Greally, BR; Stemmler, K; Hill, M; Folini, D			Low European methyl chloroform emissions inferred from long-term atmospheric measurements	NATURE			English	Article							TROPOSPHERIC OH; TRACE GASES; VARIABILITY; HYDROXYL; HISTORY; TRENDS	Methyl chloroform (CH3CCl3, 1,1,1,-trichloroethane) was used widely as a solvent before it was recognized to be an ozone-depleting substance and its phase-out was introduced under the Montreal Protocol(1). Subsequently, its atmospheric concentration has declined steadily(2-4) and recent European methyl chloroform consumption and emissions were estimated to be less than 0.1 gigagrams per year(1,5). However, data from a short-term tropospheric measurement campaign ( EXPORT) indicated that European methyl chloroform emissions could have been over 20 gigagrams in 2000 (ref. 6), almost doubling previously estimated global emissions(1,4). Such enhanced emissions would significantly affect results from the CH3CCl3 method of deriving global abundances of hydroxyl radicals ( OH) (refs 7 - 12) - the dominant reactive atmospheric chemical for removing trace gases related to air pollution, ozone depletion and the greenhouse effect. Here we use long-term, high-frequency data from MaceHead, Ireland and Jungfraujoch, Switzerland, to infer European methyl chloroform emissions. We find that European emission estimates declined from about 60 gigagrams per year in the mid-1990s to 0.3 - 1.4 and 1.9 - 3.4 gigagrams per year in 2000 - 03, based on Mace Head and Jungfraujoch data, respectively. Our European methyl chloroform emission estimates are therefore higher than calculated from consumption data(1,5), but are considerably lower than those derived from the EXPORT campaign in 2000 ( ref. 6).	Empa, Inst Mat Sci & Technol, CH-8600 Dubendorf, Switzerland; Met Off, Exeter EX1 3PB, Devon, England; Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; CSIRO, PMBI, Aspendale, Vic 3195, Australia	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Met Office - UK; University of Bristol; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Scripps Institution of Oceanography; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reimann, S (corresponding author), Empa, Inst Mat Sci & Technol, Ueberlandstr 129, CH-8600 Dubendorf, Switzerland.	stefan.reimann@empa.ch	Fraser, Paul J. B./D-1755-2012; Reimann, Stefan/A-2327-2009	Reimann, Stefan/0000-0002-9885-7138				Cunnold DM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001226; Forrer J, 2000, J GEOPHYS RES-ATMOS, V105, P12241, DOI 10.1029/1999JD901178; Gros V, 2003, ATMOS CHEM PHYS, V3, P1223, DOI 10.5194/acp-3-1223-2003; Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; Krol M, 1998, J GEOPHYS RES-ATMOS, V103, P10697, DOI 10.1029/98JD00459; Krol MC, 2003, NATURE, V421, P131, DOI 10.1038/nature01311; Manning AJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002312; McCulloch A, 2001, ATMOS ENVIRON, V35, P5311, DOI 10.1016/S1352-2310(01)00306-5; MIDGLEY PM, 1995, ATMOS ENVIRON, V29, P1601, DOI 10.1016/1352-2310(95)00078-D; Montzka SA, 1999, NATURE, V398, P690, DOI 10.1038/19499; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; MONTZKA SA, 2003, 47 WMO GLOB OZ RES M; O'Doherty S, 2001, J GEOPHYS RES-ATMOS, V106, P20429, DOI 10.1029/2000JD900792; Prinn RG, 2001, SCIENCE, V292, P1882, DOI 10.1126/science.1058673; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Reimann S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003923; Ryall DB, 2001, ATMOS ENVIRON, V35, P2507, DOI 10.1016/S1352-2310(00)00433-7; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; UNEP, 2003, 15 M PART MONTR PROT; UNEP ( United Nations Environment Programme), 2002, PROD CONS OZ DEPL SU; VESTRENG V, 2004, 12004 EMEPEEA EMEPMS	22	47	51	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					506	508		10.1038/nature03220	http://dx.doi.org/10.1038/nature03220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690037				2022-12-24	WOS:000226727200044
J	Kern, LM; Powe, NR; Levine, MA; Fitzpatrick, AL; Harris, TB; Robbins, J; Fried, LP				Kern, LM; Powe, NR; Levine, MA; Fitzpatrick, AL; Harris, TB; Robbins, J; Fried, LP			Association between screening for osteoporosis and the incidence of hip fracture	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	25th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 01-05, 2002	ATLANTA, GA	Soc Gen Internal Med			POSTMENOPAUSAL OSTEOPOROSIS; BONE-DENSITY; VITAMIN-D; NONVERTEBRAL FRACTURES; RISK; WOMEN; ALENDRONATE; RISEDRONATE; PREVENTION; OUTCOMES	Background: Because direct evidence for the effectiveness of screening is lacking, guidelines disagree on whether people should be screened for osteoporosis. Objective: To determine whether population-based screening for osteoporosis in older adults is associated with fewer incident hip fractures than usual medical care. Design: Nonconcurrent cohort study. Setting: Population-based cohort enrolled in the Cardiovascular Health Study (CHS) from 4 states (California, Pennsylvania, Maryland, and North Carolina). Patients: 3107 adults 65 years of age and older who attended their CHS study visits in 1994-1995. Measurements: 31 participant characteristics (including demographic characteristics, medical histories, medications, and physical examination findings) and incident hip fractures over 6 years of follow-up. Intervention: Bone density scans (dual-energy x-ray absorptiometry [DEXA] at the hip) for participants in California and Pennsylvania (n = 1422) and usual care for participants in Maryland and North Carolina (n = 1685). Results: The incidence of hip fractures per 1000 person-years was 4.8 in the screened group and 8.2 in the usual care group. Screening was associated with a statistically significant lower hazard of hip fracture than usual care after adjustment for sex and propensity to be screened (Cox proportional hazard ratio, 0.64 [95% CI, 0.41 to 0.99]). Limitations: The mechanism of the association was unclear. A small unmeasured confounder that decreased the hazard of hip fracture could diminish or erase the observed association. Conclusions: Use of hip DEXA scans to screen for osteoporosis in older adults was associated with 36% fewer incident hip fractures over 6 years compared with usual medical care. Further research is needed to explore the mechanism of this association.	Johns Hopkins Bloomberg Sch Publ Hlth, Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Univ Washington, Seattle, WA 98195 USA; Univ Calif Davis, Sacramento, CA 95817 USA; NIA, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kern, LM (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 411 E 69th St,Room KB-311, New York, NY 10021 USA.	lmk2003@med.cornell.edu	Kern, Lisa/AAI-9781-2021	Kern, Lisa/0000-0003-1191-8100; Levine, Michael/0000-0003-0036-7809	NHLBI NIH HHS [N01-HC-85079, N01-HC-85080, N01-HC-35129, N01-HC-85083, N01-HC-85085, N01-HC-85082, N01-HC-85084, N01-HC-85086, 1-Y02-HC-40205, N01-HC-15103, N01-HC-85081] Funding Source: Medline; NIA NIH HHS [Y02-AG-4-0251] Funding Source: Medline; NIDDK NIH HHS [K24DK02643] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082, N01HC015103, N01HC085086, N01HC085083, N01HC085079, N01HC085081, N01HC085084, N01HC085085, N01HC035129, N01HC085080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002643] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Carlin JB, 2003, STATA J, V3, P226, DOI 10.1177/1536867X0300300302; *CTR DRUG EV RES F, 2004, EL OR BOOK APPR DRUG; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gillespie LD, 2002, COCHRANE LIB; Guo ZC, 1998, AM J EPIDEMIOL, V148, P887; Guyatt GH, 2002, ENDOCRIN METAB CLIN, V31, P659, DOI 10.1016/S0889-8529(02)00024-5; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HONAKER J, 2001, AMELIA PROGR MISSING; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; *MED PREV SERV, 2004, OST DIAB PROST CANC; *NAT OS FDN, 2003, PHYS GUID PREV TREAT; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Rodriguez-Martinez MA, 2002, PHARMACOL THERAPEUT, V93, P37, DOI 10.1016/S0163-7258(02)00164-X; Rosenbaum PR, 1998, ENCY BIOSTATISTICS, V5, P3551; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Stevens JA, 2000, MMWR-MORBID MORTAL W, V49, P1; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; *U CAL CHS BON DEN, 1994, CARD HLTH STUD DXA Q; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	42	71	72	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2005	142	3					173	181		10.7326/0003-4819-142-3-200502010-00007	http://dx.doi.org/10.7326/0003-4819-142-3-200502010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	900UH	15684205				2022-12-24	WOS:000227239300003
J	Ellman, T; Culbert, H; Torres-Feced, V				Ellman, T; Culbert, H; Torres-Feced, V			Treatment of AIDS in conflict-affected settings: a failure of imagination	LANCET			English	Editorial Material									Med Sans Frontieres, London WC1R 5DJ, England	Doctors Without Borders	Ellman, T (corresponding author), Med Sans Frontieres, London WC1R 5DJ, England.	tom.ellman@msf.org						CHAIX ML, 2004, ANTIVIR THER, V9, pS176; Hankins CA, 2002, AIDS, V16, P2245, DOI 10.1097/00002030-200211220-00003; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Hehenkamp A, 2003, LANCET, V362, pS30, DOI 10.1016/S0140-6736(03)15066-0; *HUM RIGHTS WATCH, 1995, RAP WEAP WAR TOL P; *INT CRIS GROUP, 2004, HIV AIDS SEC ISS AFR; *INT CRIS GROUP, 2004, ICG CRIS WATCH; International Crisis Group, 2001, HIV AIDS SEC ISS; Tangermann RH, 2000, B WORLD HEALTH ORGAN, V78, P330; *UNAIDS, 1998, AIDS MIL; 2004, INT AIDS C BANGK THA	11	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					278	280						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664207				2022-12-24	WOS:000226449600008
J	Berkley, JA; Lowe, BS; Mwangi, I; Williams, T; Bauni, E; Mwarumba, S; Ngetsa, C; Slack, MPE; Njenga, S; Hart, CA; Maitland, K; English, M; Marsh, K; Scott, JAG				Berkley, JA; Lowe, BS; Mwangi, I; Williams, T; Bauni, E; Mwarumba, S; Ngetsa, C; Slack, MPE; Njenga, S; Hart, CA; Maitland, K; English, M; Marsh, K; Scott, JAG			Bacteremia among children admitted to a rural hospital in Kenya	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMONIA; MENINGITIS; CONJUGATE; INDICATORS; COMMUNITY; DISEASE; TRIAL	BACKGROUND: There are few epidemiologic data on invasive bacterial infections among children in sub-Saharan Africa. We studied every acute pediatric admission to a rural district hospital in Kenya to examine the prevalence, incidence, types, and outcome of community-acquired bacteremia. METHODS: Between August 1998 and July 2002, we cultured blood on admission from 19,339 inpatients and calculated the incidence of bacteremia on the basis of the population served by the hospital. RESULTS: Of a total of 1783 infants who were under 60 days old, 228 had bacteremia (12.8 percent), as did 866 of 14,787 children who were 60 or more days of age (5.9 percent). Among infants who were under 60 days old, Escherichia coli and group B streptococci predominated among a broad range of isolates (14 percent and 11 percent, respectively). Among infants who were 60 or more days of age, Streptococcus pneumoniae, nontyphoidal salmonella species, Haemophilus influenzae, and E. coli accounted for more than 70 percent of isolates. The minimal annual incidence of community-acquired bacteremia was estimated at 1457 cases per 100,000 children among infants under a year old, 1080 among children under 2 years, and 505 among children under 5 years. Of all in-hospital deaths, 26 percent were in children with community-acquired bacteremia. Of 308 deaths in children with bacteremia, 103 (33.4 percent) occurred on the day of admission and 217 (70.5 percent) within two days. CONCLUSIONS: Community-acquired bacteremia is a major cause of death among children at a rural sub-Saharan district hospital, a finding that highlights the need for prevention and for overcoming the political and financial barriers to widespread use of existing vaccines for bacterial diseases.	Ctr Geog Med Res Coast, Kilifi, Kenya; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; Univ Oxford, Dept Paediat, Oxford, England; John Radcliffe Hosp, Hlth Protect Agcy Haemophilus Reference Unit, Oxford OX3 9DU, England; Univ Liverpool, Dept Microbiol, Liverpool L69 3BX, Merseyside, England; Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, London SW7 2AZ, England	University of Oxford; University of Oxford; University of Oxford; University of Liverpool; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Berkley, JA (corresponding author), POB 230, Kilifi, Kenya.	jberkley@kilifi.mimcom.net		Berkley, James/0000-0002-1236-849X; English, Michael/0000-0002-7427-0826; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; BROWN CC, 1981, AM J EPIDEMIOL, V113, P474, DOI 10.1093/oxfordjournals.aje.a113115; COTTON MF, 1992, S AFR MED J, V81, P87; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; GHIORGHIS B, 1992, E AFR MED J, V69, P74; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2000, LANCET, V355, P850; Karstaedt AS, 2000, PEDIATR INFECT DIS J, V19, P454, DOI 10.1097/00006454-200005000-00012; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LEPAGE P, 1987, LANCET, V1, P1458; Luck S, 2003, LANCET, V361, P1953, DOI 10.1016/S0140-6736(03)13553-2; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; *MIN HLTH, 2001, AIDS KEN; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1997, LANCET, V350, P524; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; SAEZLLORENS X, 1995, PEDIATR INFECT DIS J, V14, P557, DOI 10.1097/00006454-199507000-00001; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; *UNICEF, STAT WORLDS CHILDR 2; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2001, PROP MORT 5 WORLDW; WOLF BHM, 1995, EUR J PEDIATR, V154, P299, DOI 10.1007/s004310050293; *WORLD BANK GROUP, SUBS AFR DAT PROF; World Health Organization, 2000, MAN CHILD SER INF SE	29	593	607	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2005	352	1					39	47		10.1056/NEJMoa040275	http://dx.doi.org/10.1056/NEJMoa040275			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884UP	15635111	Green Accepted			2022-12-24	WOS:000226112500006
J	Chen, W; Ren, XR; Nelson, CD; Barak, LS; Chen, JK; Beachy, PA; de Sauvage, F; Lefkowitz, RJ				Chen, W; Ren, XR; Nelson, CD; Barak, LS; Chen, JK; Beachy, PA; de Sauvage, F; Lefkowitz, RJ			Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2	SCIENCE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ACTIVATION; ZEBRAFISH; MUTATIONS; IDENTIFICATION; ASSOCIATION; COSTAL2; KINASES; KINESIN; COMPLEX	Binding of Sonic Hedgehog (Shh) to Patched (Ptc) relieves the latter's tonic inhibition of Smoothened (Smo), a receptor that spans the cell membrane seven times. This initiates signaling which, by unknown mechanisms, regulates vertebrate developmental processes. We find that two molecules interact with mammalian Smo in an activation-dependent manner: G protein-coupled receptor kinase 2 (GRK2) leads to phosphorylation of Smo, and beta-arrestin 2 fused to green fluorescent protein interacts with Smo. These two processes promote endocytosis of Smo in clathrin-coated pits. Ptc inhibits association of beta-arrestin 2 with Smo, and this inhibition is relieved in cells treated with Shh. A Smo agonist stimulated and a Smo antagonist (cyclopamine) inhibited both phosphorylation of Smo by GRK2 and interaction of beta-arrestin 2 with Smo. beta-Arrestin 2 and GRK2 are thus potential mediators of signaling by activated Smo.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Johns Hopkins University; Roche Holding; Genentech	Chen, W (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	w.chen@duke.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436; Chen, Wei/0000-0002-9934-4000				Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WB, 2001, DEVELOPMENT, V128, P2385; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	28	231	246	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2257	2260		10.1126/science.1104135	http://dx.doi.org/10.1126/science.1104135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618519				2022-12-24	WOS:000225950000047
J	Pai, JK; Pischon, T; Ma, J; Manson, JE; Hankinson, SE; Joshipura, K; Curhan, GC; Rifai, N; Cannuscio, CC; Stampfer, MJ; Rimm, EB				Pai, JK; Pischon, T; Ma, J; Manson, JE; Hankinson, SE; Joshipura, K; Curhan, GC; Rifai, N; Cannuscio, CC; Stampfer, MJ; Rimm, EB			Inflammatory markers and the risk of coronary heart disease in men and women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; APPARENTLY HEALTHY-MEN; MIDDLE-AGED MEN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); PREDICTION; ATHEROSCLEROSIS; EVENTS	BACKGROUND: Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial. METHODS: We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in the Nurses' Health Study and men participating in the Health Professionals Follow-up Study in nested case-control analyses. Among participants who provided a blood sample and who were free of cardiovascular disease at baseline, 239 women and 265 men had a nonfatal myocardial infarction or fatal coronary heart disease during eight years and six years of follow-up, respectively. Using risk-set sampling, we selected controls in a 2:1 ratio with matching for age, smoking status, and date of blood sampling. RESULTS: After adjustment for matching factors, high levels of interleukin-6 and C-reactive protein were significantly related to an increased risk of coronary heart disease in both sexes, whereas high levels of soluble TNF-alpha receptors were significant only among women. Further adjustment for lipid and nonlipid factors attenuated all associations; only C-reactive protein levels remained significant. The relative risk among all participants was 1.79 for those with C-reactive protein levels of at least 3.0 mg per liter, as compared with those with levels of less than 1.0 mg per liter (95 percent confidence interval, 1.27 to 2.51; P for trend <0.001). Additional adjustment for the presence or absence of diabetes and hypertension moderately attenuated the relative risk to 1.68 (95 percent confidence interval, 1.18 to 2.38; P for trend = 0.008). CONCLUSIONS: Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; Merck Res Labs, W Point, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Merck & Company	Rimm, EB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	erimm@hsph.harvard.edu	Cannuscio, Carolyn/A-1123-2007; Pischon, Tobias/HGE-8577-2022; Joshipura, Kaumudi J/AAA-3852-2020	Pischon, Tobias/0000-0003-1568-767X; Joshipura, Kaumudi/0000-0003-1964-7579	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464, HL07575, HL34594] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Benjafield AV, 2001, J MOL MED, V79, P109, DOI 10.1007/s001090000168; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pai JK, 2002, CLIN CHEM, V48, P1781; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; Pischon T, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.CIR.0000079224.46084.C2; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Pradhan AD, 2002, EUR HEART J, V23, P831, DOI 10.1053/euhj.2001.3052; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sharrett AR, 2004, ATHEROSCLEROSIS, V172, P143, DOI 10.1016/j.atherosclerosis.2003.09.015; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	41	861	895	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2599	2610		10.1056/NEJMoa040967	http://dx.doi.org/10.1056/NEJMoa040967			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602020				2022-12-24	WOS:000225726100007
J	Sanudo-Wilhelmy, SA; Tovar-Sanchez, A; Fu, FX; Capone, DG; Carpenter, EJ; Hutchins, DA				Sanudo-Wilhelmy, SA; Tovar-Sanchez, A; Fu, FX; Capone, DG; Carpenter, EJ; Hutchins, DA			The impact of surface-adsorbed phosphorus on phytoplankton Redfield stoichiometry	NATURE			English	Article							NORTH-ATLANTIC OCEAN; MARINE-PHYTOPLANKTON; NUTRIENT LIMITATION; NITROGEN-FIXATION; SOUTHERN-OCEAN; IRON; TRICHODESMIUM; PRODUCTIVITY; VARIABILITY; RATIOS	The Redfield ratio of 106 carbon: 16 nitrogen: 1 phosphorus in marine phytoplankton(1) is one of the foundations of ocean biogeochemistry, with applications in algal physiology(2), palaeoclimatology(3) and global climate change(4). However, this ratio varies substantially in response to changes in algal nutrient status(5) and taxonomic affiliation(6,7). Here we report that Redfield ratios are also strongly affected by partitioning into surface-adsorbed and intracellular phosphorus pools. The C: N: surface-adsorbed P (80 - 105 C: 15 - 18 N: 1 P) and total (71 - 80 C: 13 - 14 N: 1 P) ratios in natural populations and cultures of Trichodesmium were close to Redfield values and not significantly different from each other. In contrast, intracellular ratios consistently exceeded the Redfield ratio ( 316 - 434 C: 59 - 83 N: 1 intracellular P). These high intracellular ratios were associated with reduced N-2 fixation rates, suggestive of phosphorus deficiency. Other algal species also have substantial surface-adsorbed phosphorus pools, suggesting that our Trichodesmium results are generally applicable to all phytoplankton. Measurements of the distinct phytoplankton phosphorus pools may be required to assess nutrient limitation accurately from elemental composition. Deviations from Redfield stoichiometry may be attributable to surface adsorption of phosphorus rather than to biological processes, and this scavenging could affect the interpretation of marine nutrient inventories and ecosystem models.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; IMEDEA, CSIC, UIB, Inst Mediterraneo Estudios Avanzados, Mallorca 07190, Islas Baleares, Spain; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Southern California; University of Southern California; California State University System; San Francisco State University	Sanudo-Wilhelmy, SA (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	ssanudo@notes.cc.sunysb.edu	Tovar-Sánchez, Antonio/B-8003-2010; Hutchins, David A/D-3301-2013	Tovar-Sánchez, Antonio/0000-0003-4375-1982; Hutchins, David A/0000-0002-6637-756X				Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Bury SJ, 2001, DEEP-SEA RES PT I, V48, P689, DOI 10.1016/S0967-0637(00)00066-2; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; HUDSON RJM, 1993, DEEP-SEA RES PT I, V40, P129, DOI 10.1016/0967-0637(93)90057-A; Hutchins DA, 1999, AQUAT MICROB ECOL, V19, P129, DOI 10.3354/ame019129; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kuss J, 1999, MAR CHEM, V68, P71, DOI 10.1016/S0304-4203(99)00066-3; LAWS EA, 1983, J THEOR BIOL, V105, P469, DOI 10.1016/0022-5193(83)90188-1; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; MCCARTHY JJ, 1979, J PHYCOL, V15, P75, DOI 10.1111/j.0022-3646.1979.00075.x; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; SIGG L, 1981, COLLOID SURFACE, V2, P101, DOI 10.1016/0166-6622(81)80001-7; Tovar-Sanchez A, 2003, MAR CHEM, V82, P91, DOI 10.1016/S0304-4203(03)00054-9; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; Wang XJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001938	25	159	170	8	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					897	901		10.1038/nature03125	http://dx.doi.org/10.1038/nature03125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602560				2022-12-24	WOS:000225733500051
J	Xia, QY; Zhou, ZY; Lu, C; Cheng, DJ; Dai, FY; Li, B; Zhao, P; Zha, XF; Cheng, TC; Chai, CL; Pan, GQ; Xu, JS; Liu, C; Lin, Y; Qian, JF; Hou, Y; Wu, ZL; Li, GR; Pan, MH; Li, CF; Shen, YH; Lan, XQ; Yuan, LW; Li, T; Xu, HF; Yang, GW; Wan, YJ; Zhu, Y; Yu, MD; Shen, WD; Wu, DY; Xiang, ZH; Yu, J; Wang, J; Li, RQ; Shi, JP; Li, H; Li, GY; Su, JN; Wang, XL; Li, GQ; Zhang, ZJ; Wu, QF; Li, J; Zhang, QP; Wei, N; Xu, JZ; Sun, HB; Dong, L; Liu, DY; Zhao, SL; Zhao, XL; Meng, QS; Lan, FD; Huang, XG; Li, YZ; Fang, L; Li, CF; Li, DW; Sun, YQ; Zhang, ZP; Yang, Z; Huang, YQ; Xi, Y; Qi, QH; He, DD; Huang, HY; Zhang, XW; Wang, ZQ; Li, WJ; Cao, YZ; Yu, YP; Yu, H; Li, JH; Ye, JH; Chen, H; Zhou, Y; Liu, B; Wang, J; Ye, J; Ji, H; Li, ST; Ni, PX; Zhang, JG; Zhang, Y; Zheng, HK; Mao, BY; Wang, W; Ye, C; Li, SG; Wang, J; Wong, GKS; Yang, HM				Xia, QY; Zhou, ZY; Lu, C; Cheng, DJ; Dai, FY; Li, B; Zhao, P; Zha, XF; Cheng, TC; Chai, CL; Pan, GQ; Xu, JS; Liu, C; Lin, Y; Qian, JF; Hou, Y; Wu, ZL; Li, GR; Pan, MH; Li, CF; Shen, YH; Lan, XQ; Yuan, LW; Li, T; Xu, HF; Yang, GW; Wan, YJ; Zhu, Y; Yu, MD; Shen, WD; Wu, DY; Xiang, ZH; Yu, J; Wang, J; Li, RQ; Shi, JP; Li, H; Li, GY; Su, JN; Wang, XL; Li, GQ; Zhang, ZJ; Wu, QF; Li, J; Zhang, QP; Wei, N; Xu, JZ; Sun, HB; Dong, L; Liu, DY; Zhao, SL; Zhao, XL; Meng, QS; Lan, FD; Huang, XG; Li, YZ; Fang, L; Li, CF; Li, DW; Sun, YQ; Zhang, ZP; Yang, Z; Huang, YQ; Xi, Y; Qi, QH; He, DD; Huang, HY; Zhang, XW; Wang, ZQ; Li, WJ; Cao, YZ; Yu, YP; Yu, H; Li, JH; Ye, JH; Chen, H; Zhou, Y; Liu, B; Wang, J; Ye, J; Ji, H; Li, ST; Ni, PX; Zhang, JG; Zhang, Y; Zheng, HK; Mao, BY; Wang, W; Ye, C; Li, SG; Wang, J; Wong, GKS; Yang, HM			A draft sequence for the genome of the domesticated silkworm (Bombyx mori)	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; PATTERN-FORMATION; DISTAL-LESS; PROTEIN; INSECT; GENE; CHROMOSOME; CONSTRUCTION; POSTERIOR	We report a draft sequence for the genome of the domesticated silkworm (Bombyx mori), covering 90.9% of all known silkworm genes. Our estimated gene count is 18,510, which exceeds the 13,379 genes reported for Drosophila melanogaster. Comparative analyses to fruitfly, mosquito, spider, and butterfly reveal both similarities and differences in gene content.	SW Agr Univ, Chongqing Beibei 400716, Peoples R China; Chinese Acad Sci, Beijing Genom Inst, Beijing Proteom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, Hangzhou Genom Inst, Key Lab Genom Bioinformat Zhejiang Prov, James D Watson Inst Genome Sci, Hangzhou 310008, Peoples R China; Univ Washington, Dept Med, Genome Ctr, Seattle, WA 98195 USA	Southwest University - China; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Zhejiang University; University of Washington; University of Washington Seattle	Xia, QY (corresponding author), SW Agr Univ, Chongqing Beibei 400716, Peoples R China.	xiaqy@swau.cq.cn; xzh@swau.cq.cn; junyu@genomics.org.cn; gksw@genomics.org.cn; yanghm@genomics.org.cn	Li, Heng/D-9344-2011; Chen, Huan/CAH-8180-2022; Mao, Bingyu/L-9955-2014; WONG, Gane Ka-Shu/G-5784-2013; 郑, 征/C-8514-2011; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Heng/0000-0003-4874-2874; WONG, Gane Ka-Shu/0000-0001-6108-5560; Zhang, Jianguo/0000-0003-0723-1701; Wang, Jun/0000-0002-2113-5874; Xia, Qingyou/0000-0002-9263-2886; Li, Jun/0000-0001-7218-429X; cheng, tingcai/0000-0002-3862-0817; Zha, Xingfu/0000-0003-2085-5260; Wang, Jun/0000-0002-8540-8931	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002351] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 P50 HG02351] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abe H, 2000, MOL GEN GENET, V263, P916, DOI 10.1007/s004380000270; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DOIRA H, 1992, GENETIC STOCKS MUTAT; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Goldsmith Marian R., 1995, P21, DOI 10.1017/CBO9780511529931.003; GOLDSMITH MR, 2004, ANN REV ENTOMOL; GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Koch PB, 2003, DEV GENES EVOL, V212, P571, DOI 10.1007/s00427-002-0277-5; Li W-H, 1997, MOL EVOLUTION; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; McMillan WO, 2002, TRENDS ECOL EVOL, V17, P125, DOI 10.1016/S0169-5347(01)02427-2; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Mulnix Amy B., 1995, P369, DOI 10.1017/CBO9780511529931.015; Pouchkina NN, 2003, INSECT BIOCHEM MOLEC, V33, P229, DOI 10.1016/S0965-1748(02)00207-2; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schutt C, 2000, DEVELOPMENT, V127, P667; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Suzuki MG, 1998, HEREDITY, V81, P275, DOI 10.1046/j.1365-2540.1998.00356.x; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; WANG J, IN PRESS NUCL ACIDS; Wu C, 1999, MOL GEN GENET, V261, P698, DOI 10.1007/s004380050013; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZHOU Y, 1958, GEN ENTOMOLOGY	33	875	1140	13	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1937	1940		10.1126/science.1102210	http://dx.doi.org/10.1126/science.1102210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591204				2022-12-24	WOS:000225695600045
J	Lim, LP; Lau, NC; Garrett-Engele, P; Grimson, A; Schelter, JM; Castle, J; Bartel, DP; Linsley, PS; Johnson, JM				Lim, LP; Lau, NC; Garrett-Engele, P; Grimson, A; Schelter, JM; Castle, J; Bartel, DP; Linsley, PS; Johnson, JM			Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs	NATURE			English	Article							EXPRESSION; PREDICTION; SIRNAS; PLANT	MicroRNAs ( miRNAs) are a class of noncoding RNAs that post-transcriptionally regulate gene expression in plants and animals(1,2). To investigate the influence of miRNAs on transcript levels, we transfected miRNAs into human cells and used microarrays to examine changes in the messenger RNA profile. Here we show that delivering miR-124 causes the expression profile to shift towards that of brain, the organ in which miR-124 is preferentially expressed, whereas delivering miR-1 shifts the profile towards that of muscle, where miR-1 is preferentially expressed. In each case, about 100 messages were downregulated after 12 h. The 30 untranslated regions of these messages had a significant propensity to pair to the 50 region of the miRNA, as expected if many of these messages are the direct targets of the miRNAs(3). Our results suggest that metazoan miRNAs can reduce the levels of many of their target transcripts, not just the amount of protein deriving from these transcripts. Moreover, miR-1 and miR-124, and presumably other tissue-specific miRNAs, seem to downregulate a far greater number of targets than previously appreciated, thereby helping to define tissue-specific gene expression in humans.	Rosetta Inpharmat, Seattle, WA 98109 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Merck & Company; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lim, LP (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	lee_lim@merck.com	Huang, H/E-9490-2010	Lau, Nelson/0000-0001-9907-1404				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	30	3833	4136	5	348	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					769	773		10.1038/nature03315	http://dx.doi.org/10.1038/nature03315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15685193				2022-12-24	WOS:000227039200045
J	Sword, GA; Lorch, PD; Gwynne, DT				Sword, GA; Lorch, PD; Gwynne, DT			Migratory bands give crickets protection	NATURE			English	Editorial Material									ARS, USDA, No Plains Agr Res Lab, Sidney, MT 59270 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Toronto, Mississauga, ON L5L 1C6, Canada	United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Mississauga	Sword, GA (corresponding author), ARS, USDA, No Plains Agr Res Lab, Sidney, MT 59270 USA.	gsword@sidney.ars.usda.gov		Sword, Gregory/0000-0003-2094-2436				[Anonymous], 2020, ECONOMIST 0326; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; Gwynne DT, 2001, CORNELL S ARTHR BIOL; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Krause J., 2002, LIVING GROUPS; Lorch PD, 2000, NATURWISSENSCHAFTEN, V87, P370, DOI 10.1007/s001140050743; MacVean C.M., 1987, P116; Sword GA, 2005, ANIM BEHAV, V69, P437, DOI 10.1016/j.anbehav.2004.04.016; Uvarov B., 1977, BEHAVIOUR ECOLOGY BI, V2; WILLIAMS KS, 1993, ECOLOGY, V74, P1143, DOI 10.2307/1940484	11	65	69	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					703	703		10.1038/433703a	http://dx.doi.org/10.1038/433703a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716941	Bronze			2022-12-24	WOS:000227039200027
J	Maiorano, D; Cuvier, O; Danis, E; Mechali, M				Maiorano, D; Cuvier, O; Danis, E; Mechali, M			MCM8 is an MCM2-7-related protein that functions as a DNA helicase during replication elongation and not initiation	CELL			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE REGULATION; S-PHASE; POLYMERASE-ALPHA; SCHIZOSACCHAROMYCES-POMBE; ATP HYDROLYSIS; IN-VITRO; CHROMATIN; COMPLEX; FAMILY	MCM2-7 proteins are replication factors required to initiate DNA synthesis and are currently the best candidates for replicative helicases. We show that the MCM2-7-related protein MCM8 is required to efficiently replicate chromosomal DNA in Xenopus egg extracts. MCM8 does not associate with the soluble MCM2-7 complex and binds chromatin upon initiation of DNA synthesis. MCM8 depletion does not affect replication licensing or MCM3 loading but slows down DNA synthesis and reduces chromatin recruitment of RPA34 and DNA polymerase-alpha. Recombinant MCM8 displays both DNA helicase and ATPase activities in vitro. Reconstitution experiments show that ATP binding in MCM8 is required to rescue DNA synthesis in MCM8-depleted extracts. MCM8 colocalizes with replication foci and RPA34 on chromatin. We suggest that MCM8 functions in the elongation step of DNA replication as a helicase that facilitates the recruitment of RPA34 and stimulates the processivity of DNA polymerases at replication foci.	CNRS, Inst Human Genet, F-34396 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 05, France.	mechali@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017; CUVIER, Olivier/AAC-4693-2019; Cuvier, Olivier/ADO-0657-2022	Maiorano, Domenico/0000-0003-4229-5903; CUVIER, Olivier/0000-0003-0644-2734; 				ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; Francon P, 2004, J CELL SCI, V117, P4909, DOI 10.1242/jcs.01361; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Johnson EM, 2003, NUCLEIC ACIDS RES, V31, P2915, DOI 10.1093/nar/gkg395; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Krude T, 1996, J CELL SCI, V109, P309; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Kubota Y, 1997, EMBO J, V16, P3320, DOI 10.1093/emboj/16.11.3320; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; LEIBOVICI M, 1992, J CELL SCI, V102, P63; Liang DT, 1999, J CELL SCI, V112, P559; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Maiorano D, 1996, EMBO J, V15, P861, DOI 10.1002/j.1460-2075.1996.tb00421.x; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MENUT S, 1988, ADV MOL BIOL COMP ME, P196; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; You ZY, 1999, MOL CELL BIOL, V19, P8003	63	96	103	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					315	328		10.1016/j.cell.2004.12.010	http://dx.doi.org/10.1016/j.cell.2004.12.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707891	Bronze			2022-12-24	WOS:000227028900008
J	Borchert, R; Renner, SS; Calle, Z; Navarrete, D; Tye, A; Gautier, L; Spichiger, R; von Hildebrand, P				Borchert, R; Renner, SS; Calle, Z; Navarrete, D; Tye, A; Gautier, L; Spichiger, R; von Hildebrand, P			Photoperiodic induction of synchronous flowering near the Equator	NATURE			English	Article							LENGTH; TREES	In tropical rainforests, 30 - 65% of tree species grow at densities of less than one individual per hectare(1). At these low population densities, successful cross- pollination relies on synchronous flowering. In rainforests with low climatic seasonality, photoperiodic control is the only reliable mechanism for inducing synchronous flowering(2,3). This poses a problem because there is no variation in day length at the Equator. Here we propose a new mechanism of photoperiodic timekeeping based on the perception of variation in sunrise or sunset time, which explains and predicts the annually repeated, staggered, synchronous and bimodal flowering of many tree species in Amazonian rainforests near the Equator.	Univ Kansas, Div Biol, Lawrence, KS 66045 USA; Univ Munich, Dept Biol, D-80638 Munich, Germany; CIPAV, Ctr Res Sustainable Agr, Cali AA 20591, Colombia; Fdn Puerto Rastrojo, Bogota AA 241438, Colombia; Charles Darwin Res Stn, Dept Bot, Quito, Ecuador; Conservatoire & Jardin Bot Ville Geneve, CH-1292 Chambesy, GE, Switzerland	University of Kansas; University of Munich	Borchert, R (corresponding author), Univ Kansas, Div Biol, Lawrence, KS 66045 USA.	borchert@ku.edu						Borchert R, 2004, GLOBAL ECOL BIOGEOGR, V13, P409, DOI 10.1111/j.1466-822X.2004.00111.x; Borchert R, 2001, TREE PHYSIOL, V21, P213, DOI 10.1093/treephys/21.4.213; BORCHERT R, 2004, ENV CONTROL TROPICAL; CALLE Z, 2002, BIOTROPICA, V34, P621; CONDIT R, IN PRESS BIOL SKR DA; DORE J, 1959, NATURE, V183, P413, DOI 10.1038/183413a0; GAUTIER L, 1986, Candollea, V41, P193; GAUTIER L, 1985, THESIS U GENEVE; Holttum R. E., 1940, Gardens' Bulletin, V11, P119; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Justiniano MJ, 2000, BIOTROPICA, V32, P276, DOI 10.1111/j.1744-7429.2000.tb00470.x; *NAT MAR MUS, TIM EQ TIM; Rivera G, 2002, TREES-STRUCT FUNCT, V16, P445, DOI 10.1007/s00468-002-0185-3; Rivera G, 2001, TREE PHYSIOL, V21, P201, DOI 10.1093/treephys/21.4.201; SNOW DW, 1966, OIKOS, V15, P274, DOI 10.2307/3565124; Thomas B., 1997, PHOTOPERIODISM PLANT; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761	17	151	168	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					627	629		10.1038/nature03259	http://dx.doi.org/10.1038/nature03259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703746				2022-12-24	WOS:000226862000043
J	Ohki, K; Chung, S; Ch'ng, YH; Kara, P; Reid, RC				Ohki, K; Chung, S; Ch'ng, YH; Kara, P; Reid, RC			Functional imaging with cellular resolution reveals precise micro-architecture in visual cortex	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; PINWHEEL CENTERS; STRIATE CORTEX; SINGLE NEURONS; CAT AREA-18; CA2+ INFLUX	Neurons in the cerebral cortex are organized into anatomical columns, with ensembles of cells arranged from the surface to the white matter. Within a column, neurons often share functional properties, such as selectivity for stimulus orientation; columns with distinct properties, such as different preferred orientations, tile the cortical surface in orderly patterns. This functional architecture was discovered with the relatively sparse sampling of microelectrode recordings. Optical imaging of membrane voltage or metabolic activity elucidated the overall geometry of functional maps, but is averaged over many cells ( resolution > 100 mum). Consequently, the purity of functional domains and the precision of the borders between them could not be resolved. Here, we labelled thousands of neurons of the visual cortex with a calcium- sensitive indicator in vivo. We then imaged the activity of neuronal populations at single- cell resolution with two- photon microscopy up to a depth of 400 mum. In rat primary visual cortex, neurons had robust orientation selectivity but there was no discernible local structure; neighbouring neurons often responded to different orientations. In area 18 of cat visual cortex, functional maps were organized at a fine scale. Neurons with opposite preferences for stimulus direction were segregated with extraordinary spatial precision in three dimensions, with columnar borders one to two cells wide. These results indicate that cortical maps can be built with single- cell precision.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu						Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; BERMAN NEJ, 1987, J NEUROPHYSIOL, V58, P676, DOI 10.1152/jn.1987.58.4.676; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Braitenberg V, 1991, ANATOMY CORTEX STAT; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kara P, 2003, J NEUROSCI, V23, P8547; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Martinez-Diaz JJ, 2002, TECTONOPHYSICS, V356, P291, DOI 10.1016/S0040-1951(02)00400-6; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1988, PERCEPTUAL NEUROSCIE; Ohki K, 2000, CEREB CORTEX, V10, P593, DOI 10.1093/cercor/10.6.593; PARNAVELAS JG, 1981, NEUROSCI LETT, V27, P291, DOI 10.1016/0304-3940(81)90445-6; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; PETERS A, 1993, CEREB CORTEX, V3, P49, DOI 10.1093/cercor/3.1.49; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROSE D, 1974, EXP BRAIN RES, V20, P1; Shmuel A, 1996, J NEUROSCI, V16, P6945; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; TSIEN RY, 1988, TRENDS NEUROSCI, V11, P419, DOI 10.1016/0166-2236(88)90192-0; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Waters J, 2003, J NEUROSCI, V23, P8558; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; WIESENFELD Z, 1975, BRAIN RES, V94, P401, DOI 10.1016/0006-8993(75)90225-5; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	37	796	811	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					597	603		10.1038/nature03274	http://dx.doi.org/10.1038/nature03274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15660108				2022-12-24	WOS:000226862000035
J	Grossman, DC; Mueller, BA; Riedy, C; Dowd, MD; Villaveces, A; Prodzinski, J; Nakagawara, J; Howard, J; Thiersch, N; Harruff, R				Grossman, DC; Mueller, BA; Riedy, C; Dowd, MD; Villaveces, A; Prodzinski, J; Nakagawara, J; Howard, J; Thiersch, N; Harruff, R			Gun storage practices and risk of youth suicide and unintentional firearm injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADOLESCENT SUICIDE; US HOMES; CHILDREN; PATTERNS; DEATHS; LAWS	Context Household firearms are associated with an elevated risk of firearm death to occupants in the home. Many organizations and health authorities advocate locking firearms and ammunition to prevent access to guns by children and adolescents. The association of these firearm storage practices with the reduction of firearm injury risk is unclear. Objective To measure the association of specific household firearm storage practices (locking guns, locking ammunition, keeping guns unloaded) and the risk of unintentional and self-inflicted firearm injuries. Design and Setting Case-control study of firearms in events identified by medical examiner and coroner offices from 37 counties in Washington, Oregon, and Missouri, and 5 trauma centers in Seattle, Spokane, and Tacoma, Wash, and Kansas City, Mo. Cases and Controls Case firearms were identified by involvement in an incident in which a child or adolescent younger than 20 years gained access to a firearm and shot himself/herself intentionally or unintentionally or shot another individual unintentionally. Firearm assaults and homicides were excluded. We used records from hospitals and medical examiners to ascertain these incidents. Using random-digit dial telephone sampling, control firearms were identified by identification of eligible households with at least 1 firearm and children living or visiting in the home. Controls were frequency matched by age group and county. Main Exposure Measures The key exposures of interest in this study were: (1) whether the subject firearm was stored in a locked location or with an extrinsic lock; (2) whether the firearm was stored unloaded; (3) whether the firearm was stored both unloaded in a locked location; (4) whether the ammunition for the firearm was stored separately; and (5) whether the ammunition was stored in a locked location. Data regarding the storage status of case and control guns were collected by interview with respondents from the households of case and control firearms. Results We interviewed 106 respondents with case firearms and 480 with control firearms. Of the shootings associated with the case firearms, 82 were suicide attempts (95% fatal) and 24 were unintentional injuries (52% fatal). After adjustment for potentially confounding variables, guns from case households were less likely to be stored unloaded than control guns (odds ratio [OR], 0.30; 95% confidence interval [Cl], 0.16-0.56). Similarly, case guns were less likely to be stored locked (OR, 0.27; 95 % Cl, 0.17-0.45), stored separately from ammunition (OR, 0.45; 95% Cl, 0.34-0.93), or to have ammunition that was locked (OR, 0.39; 95% Cl, 0.23-0.66) than were control guns. These findings were consistent for both handguns and long guns and were also similar for both suicide attempts and unintentional injuries. Conclusions The 4 practices of keeping a gun locked, unloaded, storing ammunition locked, and in a separate location are each associated with a protective effect and suggest a feasible strategy to reduce these types of injuries in homes with children and teenagers where guns are stored.	Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; Med Examiner Off King Cty, Washington, DC USA; Med Examiner Off Pierce Cty, Washington, DC USA; Med Examiner Off Snohomish Cty, Washington, DC USA; Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Mercy Hospital	Grossman, DC (corresponding author), Grp Hlth Cooperat Puget Sound, Dept Prevent Care, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	grossman.d@ghc.org		Villaveces, Andres/0000-0002-3725-2741	ODCDC CDC HHS [R49/CCR015592] Funding Source: Medline	ODCDC CDC HHS		Azrael D, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e31; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; BUKSTEIN OG, 1993, ACTA PSYCHIAT SCAND, V88, P403, DOI 10.1111/j.1600-0447.1993.tb03481.x; Centers for Disease Control and Prevention, 2002, BEH RISK FACT SURV S; Coyne-Beasley T, 2001, ARCH PEDIAT ADOL MED, V155, P659, DOI 10.1001/archpedi.155.6.659; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; CUMMINGS P, 1987, AM J PUBLIC HEALTH, V87, P899; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Grossman DC, 2000, PEDIATRICS, V106, P22, DOI 10.1542/peds.106.1.22; HEMENWAY D, 1995, JAMA-J AM MED ASSOC, V273, P46, DOI 10.1001/jama.273.1.46; Horn A, 2003, INJURY PREV, V9, P231, DOI 10.1136/ip.9.3.231; Johnson RM, 2004, AM J PREV MED, V27, P173, DOI 10.1016/j.amepre.2004.04.015; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Schuster MA, 2000, AM J PUBLIC HEALTH, V90, P588, DOI 10.2105/AJPH.90.4.588; Senturia YD, 1996, ARCH PEDIAT ADOL MED, V150, P265, DOI 10.1001/archpedi.1996.02170280035006; Stennies G, 1999, ARCH PEDIAT ADOL MED, V153, P586; Vernick JS, 2003, INJURY PREV, V9, P307, DOI 10.1136/ip.9.4.307; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; WEIL DS, 1992, JAMA-J AM MED ASSOC, V267, P3033, DOI 10.1001/jama.267.22.3033; WINTEMUTE GJ, 1987, JAMA-J AM MED ASSOC, V257, P3107, DOI 10.1001/jama.257.22.3107	23	345	348	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					707	714		10.1001/jama.293.6.707	http://dx.doi.org/10.1001/jama.293.6.707			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701912	Bronze			2022-12-24	WOS:000226842200024
J	de Lichtenberg, U; Jensen, LJ; Brunak, S; Bork, P				de Lichtenberg, U; Jensen, LJ; Brunak, S; Bork, P			Dynamic complex formation during the yeast cell cycle	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; BUDDING YEAST; IDENTIFICATION; DATABASE; BIOLOGY	To analyze the dynamics of protein complexes during the yeast cell cycle, we integrated data on protein interactions and gene expression. The resulting time-dependent interaction network places both periodically and constitutively expressed proteins in a temporal cell cycle context, thereby revealing previously unknown components and modules. We discovered that most complexes consist of both periodically and constitutively expressed subunits, which suggests that the former control complex activity by a mechanism of just-in-time assembly. Consistent with this, we show that additional regulation through targeted degradation and phosphorylation by Cdc28p (Cdk1) specifically affects the periodically expressed proteins.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Technical University of Denmark; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Jensen, Lars Juhl/C-6492-2008; de Lichtenberg, Ulrik/AAY-7279-2020; Brunak, Soren/O-6621-2016	Bork, Peer/0000-0002-2627-833X; Jensen, Lars Juhl/0000-0001-7885-715X; Brunak, Soren/0000-0003-0316-5866; de Lichtenberg, Ulrik/0000-0002-0985-9343				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; DELICHTENBERG U, 2004, BIOINFORMATICS; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; JENSEN LJ, 2004, DRUG DISCOV TODAY, V3, P51; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Measday V, 2000, MOL MICROBIOL, V35, P825, DOI 10.1046/j.1365-2958.2000.01754.x; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034	21	316	321	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					724	727		10.1126/science.1105103	http://dx.doi.org/10.1126/science.1105103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692050				2022-12-24	WOS:000226814900043
J	Lin, JD; Yang, RJ; Tarr, PT; Wu, PH; Handschin, C; Li, SM; Yang, WL; Pei, LM; Uldry, M; Tontonoz, P; Newgard, CB; Spiegelman, BM				Lin, JD; Yang, RJ; Tarr, PT; Wu, PH; Handschin, C; Li, SM; Yang, WL; Pei, LM; Uldry, M; Tontonoz, P; Newgard, CB; Spiegelman, BM			Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 beta cactivation of SREBP	CELL			English	Article							STEROL REGULATORY ELEMENT; LEUCINE ZIPPER PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; TRANSGENIC MICE; CARDIOVASCULAR-DISEASE; DIABETIC DYSLIPIDEMIA; ENERGY-METABOLISM; BINDING PROTEINS	The PGC-1 family of coactivators stimulates the activity of certain transcription factors and nuclear receptors. Transcription factors in the sterol responsive element binding protein (SREBP) family are key regulators of the lipogenic genes in the liver. We show here that high-fat feeding, which induces hyperlipidemia and atherogenesis, stimulates the expression of both PGC-1beta and SREBP1c and 1a in liver. PGC-1beta0 coactivates the SREBP transcription factor family and stimulates lipogenic gene expression. Further, PGC-1beta is required for SREBP-mediated lipogenic gene expression. However, unlike SREBP itself, PGC-1beta reduces fat accumulation in the liver while greatly increasing circulating triglycerides and cholesterol in VLDL particles. The stimulation of lipoprotein transport upon PGC-1beta expression is likely due to the simultaneous coactivation of the liver X receptor, LXRalpha, a nuclear hormone receptor with known roles in hepatic lipid transport. These data suggest a mechanism through which dietary saturated fats can stimulate hyperlipidemia and atherogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Handschin, Christoph/E-6886-2015; Wu, Pei-Hsuan/AAL-1704-2020	Handschin, Christoph/0000-0003-0603-1097; Wu, Pei-Hsuan/0000-0002-6690-0744	NHLBI NIH HHS [R01HL66088] Funding Source: Medline; NIDDK NIH HHS [P01DK58398, R01DK61562, R01DK54477, K01DK065584] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477, P01DK058398, R01DK061562, K01DK065584] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Betteridge DJ, 1999, EUR J CLIN INVEST, V29, P12; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	48	473	499	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					261	273		10.1016/j.cell.2004.11.043	http://dx.doi.org/10.1016/j.cell.2004.11.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680331	Bronze, Green Published			2022-12-24	WOS:000226740000014
J	Paludan, C; Schmid, D; Landthaler, M; Vockerodt, M; Kube, D; Tuschl, T; Munz, C				Paludan, C; Schmid, D; Landthaler, M; Vockerodt, M; Kube, D; Tuschl, T; Munz, C			Endogenous MHC class II processing of a viral nuclear antigen after autophagy	SCIENCE			English	Article							CYTOSOLIC ANTIGEN; RESTRICTED PRESENTATION; PROTEIN-DEGRADATION; T-CELLS; COMPLEX; CD4(+); MOLECULES; PROTEASOMES; INHIBITION; EXPRESSION	CD4(+) T cells classically recognize antigens that are endocytosed and processed in lysosomes for presentation on major histocompatibility complex (MHC) class II molecules. Here, endogenous Epstein-Barr virus nuclear antigen 1 (EBNA1) was found to gain access to this pathway by autophagy. On inhibition of lysosomal acidification, EBNA1, the dominant CD4(+) T cell antigen of latent Epstein-Barr virus infection, slowly accumulated in cytosolic autophagosomes. In addition, inhibition of autophagy decreased recognition by EBNA1-specific CD4(+) T cell clones. Thus, lysosomal processing after autophagy may contribute to MHC class II-restricted surveillance of long-lived endogenous antigens including nuclear proteins relevant to disease.	Rockefeller Univ, Lab Viral Immunobiol, New York, NY 10021 USA; Rockefeller Univ, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Gottingen, Ctr Internal Med Hematol & Oncol, D-37099 Gottingen, Germany	Rockefeller University; Rockefeller University; Rockefeller University; University of Gottingen	Munz, C (corresponding author), Rockefeller Univ, Lab Viral Immunobiol, 1230 York Ave, New York, NY 10021 USA.	munzc@mail.rockefeller.edu	Vockerodt, Martina/L-4465-2014; Münz, Christian/W-4881-2017; Landthaler, Markus/A-1427-2010	Vockerodt, Martina/0000-0001-7761-5829; Landthaler, Markus/0000-0002-1075-8734; Dormann, Dorothee/0000-0002-9260-2775; Munz, Christian/0000-0001-6419-1940				Aichinger G, 1997, J BIOL CHEM, V272, P29127, DOI 10.1074/jbc.272.46.29127; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bonifaz LC, 1999, EUR J IMMUNOL, V29, P119, DOI 10.1002/(SICI)1521-4141(199901)29:01<119::AID-IMMU119>3.0.CO;2-O; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gueguen M, 1996, P NATL ACAD SCI USA, V93, P14692, DOI 10.1073/pnas.93.25.14692; HENDIL KB, 1988, BIOCHEM INT, V17, P471; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lee SP, 2004, J EXP MED, V199, P1409, DOI 10.1084/jem.20040121; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Muller S, 1998, AM J PATHOL, V152, P261; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; PALUDAN C, UNPUB; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219; Voo KS, 2002, CANCER RES, V62, P7195; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T; WU Z, 1994, CLIN EXP IMMUNOL, V98, P470; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yawalkar N, 2001, AM J PATHOL, V158, P803, DOI 10.1016/S0002-9440(10)64027-8; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902	36	668	708	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					593	596		10.1126/science.1104904	http://dx.doi.org/10.1126/science.1104904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15591165				2022-12-24	WOS:000226694000051
J	Arad, M; Maron, BJ; Gorham, JM; Johnson, WH; Saul, JP; Perez-Atayde, AR; Spirito, P; Wright, GB; Kanter, RJ; Seidman, CE; Seidman, JG				Arad, M; Maron, BJ; Gorham, JM; Johnson, WH; Saul, JP; Perez-Atayde, AR; Spirito, P; Wright, GB; Kanter, RJ; Seidman, CE; Seidman, JG			Glycogen storage diseases presenting as hypertrophic cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN-DEATH; MUTATIONS; GENE; IDENTIFICATION; DEFICIENCY	BACKGROUND: Unexplained left ventricular hypertrophy often prompts the diagnosis of hypertrophic cardiomyopathy, a sarcomere-protein gene disorder. Because mutations in the gene for AMP-activated protein kinase gamma(2) (PRKAG2) cause an accumulation of cardiac glycogen and left ventricular hypertrophy that mimics hypertrophic cardiomyopathy, we hypothesized that hypertrophic cardiomyopathy might also be clinically misdiagnosed in patients with other mutations in genes regulating glycogen metabolism. METHODS: Genetic analyses performed in 75 consecutive unrelated patients with hypertrophic cardiomyopathy detected 40 sarcomere-protein mutations. In the remaining 35 patients, PRKAG2, lysosome-associated membrane protein 2 (LAMP2), alpha-galactosidase (GLA), and acid alpha-1,4-glucosidase (GAA) genes were studied. RESULTS: Gene defects causing Fabry's disease (GLA) and Pompe's disease (GAA) were not found, but two LAMP2 and one PRKAG2 mutations were identified in probands with prominent hypertrophy and electrophysiological abnormalities. These results prompted the study of two additional, independent series of patients. Genetic analyses of 20 subjects with massive hypertrophy (left ventricular wall thickness, greater than or equal to 30 mm) but without electrophysiological abnormalities revealed mutations in neither LAMP2 nor PRKAG2. Genetic analyses of 24 subjects with increased left ventricular wall thickness and electrocardiograms suggesting ventricular preexcitation revealed four LAMP2 and seven PRKAG2 mutations. Clinical features associated with defects in LAMP2 included male sex, severe hypertrophy, early onset (at 8 to 17 years of age), ventricular preexcitation, and asymptomatic elevations of two serum proteins. CONCLUSIONS: LAMP2 mutations typically cause multisystem glycogen-storage disease (Danon's disease) but can also present as a primary cardiomyopathy. The glycogen-storage cardiomyopathy produced by LAMP2 or PRKAG2 mutations resembles hypertrophic cardiomyopathy but is distinguished by electrophysiological abnormalities, particularly ventricular preexcitation.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Minneapolis Heart Ind Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA; Univ Alabama Birmingham, Dept Pediat, Div Pediat Cardiol, Birmingham, AL USA; Med Univ S Carolina, Childrens Heart Program S Carolina, Charleston, SC 29425 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Galleria Genova, Dept Cardiol, Genoa, Italy; Childrens Heart Clin, Minneapolis, MN USA; Duke Univ, Med Ctr, Div Pediat Cardiol, Durham, NC USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Harvard University; Boston Children's Hospital; Duke University	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB Rm 256,77 Ave Louis Pasteur, Boston, MA 02115 USA.	seidman@genetics.med.harvard.edu						Amato AA, 2000, NEUROL CLIN, V18, P151, DOI 10.1016/S0733-8619(05)70182-1; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V10; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; CHOU TC, 1996, LEFT VENTRICULAR HYP, P37; DANON MJ, 1981, NEUROLOGY, V31, P51, DOI 10.1212/WNL.31.1.51; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; GOLLOB MH, 2002, NEW ENGL J MED, V346, P300; GOLLOB MH, 2001, NEW ENGL J MED, V345, P552; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; Morita H, 2002, COLD SPRING HARB SYM, V67, P383, DOI 10.1101/sqb.2002.67.383; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Patel VV, 2003, J AM COLL CARDIOL, V42, P942, DOI 10.1016/S0735-1097(03)00850-7; Roberts R, 2001, CIRCULATION, V104, P2249, DOI 10.1161/hc4301.097430; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2	29	396	433	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					362	372		10.1056/NEJMoa033349	http://dx.doi.org/10.1056/NEJMoa033349			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673802				2022-12-24	WOS:000226535900008
J	Basile-Doelsch, I; Meunier, JD; Parron, C				Basile-Doelsch, I; Meunier, JD; Parron, C			Another continental pool in the terrestrial silicon cycle	NATURE			English	Article							ISOTOPIC COMPOSITION; STABLE-ISOTOPES; SILCRETE; FRACTIONATION; DIAGENESIS; CALCRETE; DIATOMS; OCEAN	Silicon is the second most abundant element on Earth. It is an important nutrient for phytoplankton(1) and is readily absorbed by terrestrial vegetation(2); it also assists the removal of carbon dioxide from the atmosphere through the weathering of silicates(3). But the continental cycle of silicon is not well known, and only a few studies have attempted to use silicon stable isotopes (Si-28, Si-29 and Si-30)(4-13) to quantify the continental silicon reservoirs. Dissolved silicon in sea and river waters forms a reservoir of mean isotopic value 11.1parts per thousand (refs 7, 10). It is enriched in Si-30 with respect to the igneous rocks reservoir, which has a mean isotopic value of -0.3parts per thousand (refs 4, 9). This enrichment can only be produced by a major fractionation during weathering, and should result in the formation of a continental Si-30-depleted reservoir. Such a reservoir, however, has not been identified to date. Here we analyse silicon isotopes of in situ quartz from a sandstone series in France, using a new-generation secondary ion mass spectrometry apparatus. We show that quartz that precipitates as siliceous cements forms a strongly Si-30-depleted reservoir with isotopic values down to -5.7parts per thousand, a more negative value than any previously published for terrestrial samples. Our findings suggest that quartz re-precipitation plays an important role in the biogeochemical cycle of silicon.	IRD Reunion, LSTUR, F-97492 St Denis, France; Univ Paul Cezanne, IRD, Europole Arbois, CEREGE UMR CNRS, F-13545 Aix En Provence 4, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Basile-Doelsch, I (corresponding author), IRD Reunion, LSTUR, UR037,BP 172, F-97492 St Denis, France.	basile@cerege.fr	Basile, Isabelle IBD/B-4173-2010; Shrestha, Yesha/N-8890-2014					Abdel-Wahab A, 1998, J AFR EARTH SCI, V27, P277, DOI 10.1016/S0899-5362(98)00061-X; Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; [Anonymous], 1996, SILICON ISOTOPE GEOC; ARAKEL AV, 1989, AUST J EARTH SCI, V36, P73, DOI 10.1080/14400958908527952; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; CHADWICK OA, 1989, SOIL SCI SOC AM J, V53, P158, DOI 10.2136/sssaj1989.03615995005300010030x; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; De La Rocha CL, 2003, GEOLOGY, V31, P423, DOI 10.1130/0091-7613(2003)031<0423:SIFBMS>2.0.CO;2; De la Rocha CL, 2000, GEOCHIM COSMOCHIM AC, V64, P2467, DOI 10.1016/S0016-7037(00)00373-2; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ding T, 2004, GEOCHIM COSMOCHIM AC, V68, P205, DOI 10.1016/S0016-7037(03)00264-3; DOUTHITT CB, 1982, GEOCHIM COSMOCHIM AC, V46, P1449, DOI 10.1016/0016-7037(82)90278-2; DOVE PM, 1996, CHEM WEATHERING RATE, P235; Elsass F, 2000, CLAY MINER, V35, P477, DOI 10.1180/000985500546954; Girard JP, 2000, GEOCHIM COSMOCHIM AC, V64, P409, DOI 10.1016/S0016-7037(99)00299-9; KHALAF FI, 1988, J SEDIMENT PETROL, V58, P1014; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; MOLINIVELSKO C, 1986, GEOCHIM COSMOCHIM AC, V50, P2719, DOI 10.1016/0016-7037(86)90221-8; Nash DJ, 1998, J AFR EARTH SCI, V27, P11, DOI 10.1016/S0899-5362(98)00043-8; PARRON C, 1985, GEOL FR, V2, P137; Parron C., 1976, SCI GEOL B, V29, P273; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; Thiry M, 1996, CATENA, V26, P1, DOI 10.1016/0341-8162(95)00044-5; Thiry M, 1997, SOILS AND SEDIMENTS, P191; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; ZIEGLER K, 2002, GEOCHIM COSMOCHIM AC, V66; ZIEGLER K, 2002, 6 INT S GEOCH EARTHS, P103; ZIEGLER K, 2000, GOLDSCHM C, P1135; ZINNER E, 1989, NEW FRONTIERS STABLE, P145	30	157	173	5	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					399	402		10.1038/nature03217	http://dx.doi.org/10.1038/nature03217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674287				2022-12-24	WOS:000226546200038
J	Taylor, EN; Stampfer, MJ; Curhan, GC				Taylor, EN; Stampfer, MJ; Curhan, GC			Obesity, weight gain, and the risk of kidney stones	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	10th International Symposium on Urolithiasis	MAY 25-28, 2004	Hong Kong, PEOPLES R CHINA				CALCIUM-OXALATE; DIETARY CALCIUM; URIC-ACID; PHOSPHATE-METABOLISM; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; BODY-WEIGHT; FREQUENCY; HYPERINSULINEMIA; REPRODUCIBILITY	Context Larger body size may result in increased urinary excretion of calcium. oxalate, and uric acid, thereby increasing the risk for calcium-containing kidney stones. It is unclear if obesity increases the risk of stone formation, and it is not known if weight gain influences risk. Objective To determine if weight, weight gain, body mass index (BMI), and waist circumference are associated with kidney stone formation. Design, Setting, and Participants A prospective study of 3 large cohorts: the Heath Professionals Follow-up Study (N=45988 men; age range at baseline, 40-75 years). the Nurses' Health Study I (N =93 758 older women; age range at baseline, 34-59 years), and the Nurses' Health Study 11 (N=101 877 younger women; age range at bas-elin-e b 0 0 27-44 years). Main Outcome Measures Incidence of symptomatic kidney stones. Results We documented 4827 incident kidney stones over a combined 46 years of follow-up. After adjusting for age, dietary factors, fluid intake, and thiazide use, the relative risk (RR) for stone formation in men weighing more than 220 lb (100.0 kg) vs men less than 150 lb (68.2 kg) was 1.44 (95% confidence interval [CI], 1.11-1.86; P=.002 for trend). in older and younger women, RRs for these weight categories were 1.89 (95% Cl, 1.52-2.36; P<.001 for trend) and 1.92 (95% Cl, 1.59-2.31; P<.001 for trend), respectively. The RR in men who gained more than 35 lb (15.9 kg) since age 21 years vs men whose weight did not change was 1.39 (95% Cl. 1.14-1.70; P=.001 for trend). Corresponding RRs for the same categories of weight gain since age 18 years in older and younger women were 1.70 (95% Cl, 1.40-2.05; P<.001 for trend) and 1.82 (95% Cl, 1.50-2.21; P<.001 for trend). Body mass index was associated with the risk of kidney stone formation: the RR for men with a BMI of 30 or greater vs those with a BMI of 21 to 22.9 was 1.33 (95% CI, 1.08-1.63; P<.001 for trend). Corresponding RRs for the same categories of BMI in older and younger women were 1.90 (95% Cl, 1.61-2.25; P<.001 for trend) and 2.09 (95% Cl, 1.77-2.48; P<.001 for trend). Waist circumference was also positively associated with risk in men (P=.002 for trend) and in older and younger women (P<.001 for trend for both). Conclusions Obesity and weight gain increase the risk of kidney stone formation. The magnitude of the increased risk may be greater in women than in men.	Harvard Univ, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Taylor, EN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Channing Lab, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	entaylor@partners.org			NCI NIH HHS [CA 55075, CA 50385, CA 87969] Funding Source: Medline; NIDDK NIH HHS [DK 59583, DK 07791] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007791, R01DK059583] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; COE FL, 1980, KIDNEY INT, V17, P662, DOI 10.1038/ki.1980.205; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1974, NEW ENGL J MED, V291, P1344; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645; Elia M, 2001, OBES RES, V9, p244S, DOI 10.1038/oby.2001.126; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Heller HJ, 2002, J UROLOGY, V168, P1923, DOI 10.1016/S0022-5347(05)64264-4; HIATT RA, 1982, AM J EPIDEMIOL, V115, P255, DOI 10.1093/oxfordjournals.aje.a113297; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; KERSTETTER J, 1991, METABOLISM, V40, P707, DOI 10.1016/0026-0495(91)90088-E; Kramer HJM, 2003, J AM SOC NEPHROL, V14, P1272, DOI 10.1097/01.ASN.0000060682.25472.C3; Krivosikova Z, 1998, PHYSIOL RES, V47, P177; Lemann J, 1996, KIDNEY INT, V49, P200, DOI 10.1038/ki.1996.27; LEMANN J, 1969, NEW ENGL J MED, V280, P232, DOI 10.1056/NEJM196901302800502; LEMANN J, 1970, J LAB CLIN MED, V75, P578; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; LINGEMAN JE, 1986, MED CARE, V24, P1151, DOI 10.1097/00005650-198612000-00007; Maalouf NM, 2004, KIDNEY INT, V65, P1422, DOI 10.1111/j.1523-1755.2004.00522.x; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Nowicki M, 1998, NEPHROL DIAL TRANSPL, V13, P2566, DOI 10.1093/ndt/13.10.2566; PAK CYC, 1975, P SOC EXP BIOL MED, V149, P930; Pearle M, 2004, UROLOGIC DIS AM, P34; Powell CR, 2000, UROLOGY, V55, P825, DOI 10.1016/S0090-4295(99)00617-2; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RUMENAPF G, 1990, CALCIFIED TISSUE INT, V46, P73, DOI 10.1007/BF02556090; Shimamoto K, 1995, TOHOKU J EXP MED, V177, P271, DOI 10.1620/tjem.177.271; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett W., 1990, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOOD RJ, 1983, J NUTR, V113, P1561, DOI 10.1093/jn/113.8.1561; YAMASHITA S, 1986, INT J OBESITY, V10, P255	42	729	780	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					455	462		10.1001/jama.293.4.455	http://dx.doi.org/10.1001/jama.293.4.455			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	890DW	15671430	Bronze			2022-12-24	WOS:000226492900024
J	Leimane, V; Riekstina, V; Holtz, TH; Zarovska, E; Skripconoka, V; Thorpe, LE; Laserson, KF; Wells, CD				Leimane, V; Riekstina, V; Holtz, TH; Zarovska, E; Skripconoka, V; Thorpe, LE; Laserson, KF; Wells, CD			Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study	LANCET			English	Article							DOTS-PLUS; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; CHEMOTHERAPY; EXPERIENCE; RIFAMPIN; THERAPY; PERU	Background Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDRTB). Our aim was to assess treatment outcomes for the first full cohort of MDRTB patients treated under Latvia's DOTS-Plus strategy following WHO guidelines. Methods We retrospectively reviewed all civilian patients who began treatment with individualised treatment regimens for pulmonary MDRTB in Latvia between Jan 1, and Dec 31, 2000. We applied treatment outcome definitions for MDRTB, developed by an international. expert consensus group, and assessed treatment effectiveness and risk factors associated with poor outcome. Findings Of the 204 patients assessed, 55 (27%) had been newly diagnosed with MDRTB, and 149 (73%) had earlier been treated with first-line or second-line drugs for this disease. Assessment of treatment outcomes showed that 135 (66%) patients were cured or completed therapy, 14 (7%) died, 26 (13%) defaulted, and treatment failed in 29 (14%). Of the 178 adherent patients, 135 (76%) achieved cure or treatment completion. In a multivariate Cox proportional-hazards model of these patients, independent predictors of poor outcome (death and treatment failure) included having previously received treatment for MDRTB (hazard ratio 5.7, 95% CI 1.9-16.6), the use of five or fewer drugs for 3 months or more (3.2, 1.1-9.6), resistance to ofloxacin (2.6, 1.2-5.4), and body-mass index less than 18.5 at start of treatment (2.3, 1.1-4.9). Interpretation The DOTS-Plus strategy of identifying and treating patients with MDRTB can be effectively implemented on a nationwide scale in a setting of limited resources.	State Ctr TB & Lung Dis, Riga, Latvia; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA	Riga East University Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Leimane, V (corresponding author), Latvia State Ctr TB & Lung Dis, PO Cekule, Stopinup, Riga Region, Latvia.	vaira@tuberculosis.lv						ALLISON P, 1995, SURVIVAL ANAL USIN S; [Anonymous], 1983, Stat Bull Metrop Life Found, V64, P3; [Anonymous], 1995, PHYS STAT US INT ANT; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P661; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Davies GR, 1999, INT J TUBERC LUNG D, V3, P799; Dean AG, 1997, EPI INFO VERSION 6 0; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Hadiarto M, 1996, CHEMOTHERAPY, V42, P24, DOI 10.1159/000239511; Iseman MD, 1998, INT J TUBERC LUNG D, V2, P867; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Kruuner A, 1998, INT J TUBERC LUNG D, V2, P130; LASERSON KF, IN PRESS INT J TB LU; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; Organization WH, 1997, WHOTB97229; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Riekstina V, 2003, INT J TUBERC LUNG D, V7, P903; *SAS I INC, 1999, STAT AN SYST WIND RE; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suo J, 1996, CHEMOTHERAPY, V42, P20, DOI 10.1159/000239510; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; *WHO, 2000, WHOCDSTB2000278; WHO, 2000, WHOCDSTB2000279; World Health Organization, 2003, TREATM TUB GUID NAT; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; Zalesky R, 1997, Monaldi Arch Chest Dis, V52, P142	36	224	241	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2005	365	9456					318	326						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664227				2022-12-24	WOS:000226449600035
J	Abella, BS; Alvarado, JP; Myklebust, H; Edelson, DP; Barry, A; O'Hearn, N; Vanden Hoek, TL; Becker, LB				Abella, BS; Alvarado, JP; Myklebust, H; Edelson, DP; Barry, A; O'Hearn, N; Vanden Hoek, TL; Becker, LB			Quality of cardiopulmonary resuscitation during in-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASIC LIFE-SUPPORT; CHEST COMPRESSIONS; VENTRICULAR-FIBRILLATION; PRECORDIAL COMPRESSION; CPR PERFORMANCE; BYSTANDER CPR; DEFIBRILLATION; SURVIVAL; SYSTEM	Context The survival benefit of well-performed cardiopulmonary resuscitation (CPR) is well-documented, but little objective data exist regarding actual CPR quality during cardiac arrest. Recent studies have challenged the notion that CPR is uniformly performed according to established international guidelines. Objectives To measure multiple parameters of in-hospital CPR quality and to determine compliance with published American Heart Association and international guidelines. Design and Setting A prospective observational study of 67 patients who experienced in-hospital cardiac arrest at the University of Chicago Hospitals, Chicago, III, between December 11, 2002, and April 5, 2004. Using a monitor/defibrillator with novel additional sensing capabilities, the parameters of CPR quality including chest compression rate, compression depth, ventilation rate, and the fraction of arrest time without chest compressions (no-flow fraction) were recorded. Main Outcome Measure Adherence to American Heart Association and international CPR guidelines. Results Analysis of the first 5 minutes of each resuscitation by 30-second segments revealed that chest compression rates were less than 90/min in 28.1% of segments. Compression depth was too shallow (defined as <38 mm) for 37.4% of compressions. Ventilation rates were high, with 60.9% of segments containing a rate of more than 20/min. Additionally, the mean (SD) no-flow fraction was 0.24 (0.18). A 10-second pause each minute of arrest would yield a no-flow fraction of 0.17. A total of 27 patients (40.3%) achieved return of spontaneous circulation and 7 (10.4%) were discharged from the hospital. Conclusions In this study of in-hospital cardiac arrest, the quality of multiple parameters of CPR was inconsistent and often did not meet published guideline recommendations, even when performed by well-trained hospital staff. The importance of high-quality CPR suggests the need for rescuer feedback and monitoring of CPR quality during resuscitation efforts.	Univ Chicago Hosp, Sect Emergency Med, Chicago, IL 60637 USA; Univ Chicago Hosp, Sect Crit Care, Chicago, IL 60637 USA; Laerdal Med Corp, Stavanger, Norway	University of Chicago; University of Illinois System; University of Chicago; University of Illinois System	Becker, LB (corresponding author), Univ Chicago Hosp, Sect Emergency Med, 5841 S Maryland Ave,MC 5068, Chicago, IL 60637 USA.	lbecker@medicine.bsd.uchicago.edu	Abella, Benjamin/G-3579-2010	Abella, Benjamin/0000-0003-2521-0891				Aase SO, 2000, IEEE T BIO-MED ENG, V47, P1440, DOI 10.1109/10.880095; Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; ABELLA BS, IN PRESS CIRCULATION; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker L, 1996, CARDIAC ARREST SCI P, P28; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Donnelly P, 2000, RESUSCITATION, V45, P195, DOI 10.1016/S0300-9572(00)00186-6; Dowie R, 2003, RESUSCITATION, V56, P173, DOI 10.1016/S0300-9572(02)00343-X; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; FENELEY MP, 1988, CIRCULATION, V77, P240, DOI 10.1161/01.CIR.77.1.240; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Handley AJ, 2003, RESUSCITATION, V57, P57, DOI 10.1016/S0300-9572(02)00400-8; HIGHTOWER D, 1995, ANN EMERG MED, V26, P300, DOI 10.1016/S0196-0644(95)70076-5; *INT CONS SCI, 2000, CIRCULATION S1, V102, P1; KAYE W, 1986, CRIT CARE MED, V14, P620, DOI 10.1097/00003246-198607000-00007; Keim SM, 2001, RESUSCITATION, V51, P269, DOI 10.1016/S0300-9572(01)00418-X; Kern KB, 2003, RESUSCITATION, V58, P273, DOI 10.1016/S0300-9572(03)00269-7; Koster RW, 2003, RESUSCITATION, V58, P275, DOI 10.1016/S0300-9572(03)00270-3; Marsch SCU, 2004, RESUSCITATION, V60, P51, DOI 10.1016/j.resuscitation.2003.08.004; MILANDER MM, 1995, ACAD EMERG MED, V2, P708, DOI 10.1111/j.1553-2712.1995.tb03622.x; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Pellis T, 2002, CRIT CARE MED, V30, pS176, DOI 10.1097/00003246-200204001-00012; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Sato Y, 1997, CRIT CARE MED, V25, P733, DOI 10.1097/00003246-199705000-00005; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Sunde K, 1997, RESUSCITATION, V34, P235, DOI 10.1016/S0300-9572(96)01087-8; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; WHITE RD, 1994, ANN EMERG MED, V23, P25, DOI 10.1016/S0196-0644(94)70003-6; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Wik L, 2001, RESUSCITATION, V50, P167, DOI 10.1016/S0300-9572(01)00331-8; Wik L, 2000, RESUSCITATION, V47, P7, DOI 10.1016/S0300-9572(00)00190-8; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E	36	891	958	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					305	310		10.1001/jama.293.3.305	http://dx.doi.org/10.1001/jama.293.3.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657323	Bronze			2022-12-24	WOS:000226358400024
J	Holowiecki, J				Holowiecki, J			NOTCH1 pathway: a molecular target in T-cell cancers?	LANCET			English	Editorial Material							GAMMA-SECRETASE; EXPRESSION; SURVIVAL; LEUKEMIA		Silesian Med Univ, Dept Haematol & BMT, PL-40023 Katowice, Poland	Medical University Silesia	Holowiecki, J (corresponding author), Silesian Med Univ, Dept Haematol & BMT, PL-40023 Katowice, Poland.	holow@slam.katowice.pl	Holowiecki, Jerzy/AAW-7928-2021					Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; HOUDE C, 2004, BLOOD           0803; Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kantarjian HM, 2004, BLOOD, V104, P1979, DOI 10.1182/blood-2004-02-0711; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Lleo A, 2003, J BIOL CHEM, V278, P47370, DOI 10.1074/jbc.M308480200; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	14	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					197	199						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652588				2022-12-24	WOS:000226309600006
J	Jiang, H; Guo, W; Liang, XH; Rao, Y				Jiang, H; Guo, W; Liang, XH; Rao, Y			Both the establishment and the maintenance of neuronal polarity require active mechanisms: Critical roles of GSK-3 beta and its upstream regulators	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HIPPOCAMPAL-NEURONS; PROTEIN-KINASE; TUMOR-SUPPRESSOR; AXON; PHOSPHORYLATION; INHIBITION; GROWTH; TAU; FAMILY	Axon-dendrite polarity is a cardinal feature of neuronal morphology essential for information flow. Here we report a differential distribution of GSK-3beta activity in the axon versus the dendrites. A constitutively active GSK-3beta mutant inhibited axon formation, whereas multiple axons formed from a single neuron when GSK-3beta activity was reduced by pharmacological inhibitors, a peptide inhibitor, or siRNAs. An active mechanism for maintaining neuronal polarity was revealed by the conversion of preexisting dendrites into axons upon GSK-3 inhibition. Biochemical and functional data show that the Akt kinase and the PTEN phosphatase are upstream of GSK-3beta in determining neuronal polarity. Our results demonstrate that there are active mechanisms for maintaining as well as establishing neuronal polarity, indicate that GSK-3beta relays signaling from Akt and PTEN to play critical roles in neuronal polarity, and suggest that application of GSK-3beta inhibitors can be a novel approach to promote generation of new axons after neural injuries.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Grad Sch, Shanghai 200031, Peoples R China; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institute of Biological Sciences, Beijing; Northwestern University; Feinberg School of Medicine	Rao, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	y-rao@northwestem.edu		Jiang, Hui/0000-0002-0277-9711; Rao, Yi/0000-0002-0405-5426; Guo, Wei/0000-0002-9937-7152				AHMAD FJ, 1994, NEURON, V12, P271, DOI 10.1016/0896-6273(94)90270-4; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Esch T, 1999, J NEUROSCI, V19, P6417; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 1999, J CELL SCI, V112, P3373; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; LEIN PJ, 1992, DEV BRAIN RES, V69, P191, DOI 10.1016/0165-3806(92)90159-T; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lucas FR, 1998, J CELL SCI, V111, P1351; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandell JW, 1996, J NEUROSCI, V16, P5727; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Ruthel G, 2000, J NEUROSCI, V20, P2266; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	55	441	461	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					123	135		10.1016/j.cell.2004.12.033	http://dx.doi.org/10.1016/j.cell.2004.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652487	Bronze			2022-12-24	WOS:000226365400016
J	Puig, S; Askeland, E; Thiele, DJ				Puig, S; Askeland, E; Thiele, DJ			Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation	CELL			English	Article							ZINC-FINGER PROTEINS; GENOME-WIDE ANALYSIS; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; TRISTETRAPROLIN BINDS; ESCHERICHIA-COLI; GENE-EXPRESSION; CDNA ARRAYS; YEAST; TRANSCRIPTION	Iron (Fe) is an essential micronutrient for virtually all organisms and serves as a cofactor for a wide variety of vital cellular processes. Although Fe deficiency is the primary nutritional disorder in the world, cellular responses to Fe deprivation are poorly understood. We have discovered a posttranscriptional regulatory process controlled by Fe deficiency, which coordinately drives widespread metabolic reprogramming. We demonstrate that, in response to Fe deficiency, the Saccharomyces cerevisiae Cth2 protein specifically downregulates mRNAs encoding proteins that participate in many Fe-dependent processes. mRNA turnover requires the binding of Cth2, an RNA binding protein conserved in plants and mammals, to specific AU-rich elements in the 3' untranslated region of mRNAs targeted for degradation. These studies elucidate coordinated global metabolic reprogramming in response to Fe deficiency and identify a mechanism for achieving this by targeting specific mRNA molecules for degradation, thereby facilitating the utilization of limited cellular Fe levels.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University	Thiele, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Res Dr LSRC-C351, Durham, NC 27710 USA.	dennis.thiele@duke.edu	Puig, Sergi/E-4788-2010	Puig, Sergi/0000-0002-1856-490X	NIGMS NIH HHS [GM41840] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Khodursky AB, 2003, TRENDS GENET, V19, P113, DOI 10.1016/S0168-9525(02)00047-1; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Nittis T, 2002, SEMIN HEMATOL, V39, P282, DOI 10.1053/shem.2002.35633; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Putz U, 1996, NUCLEIC ACIDS RES, V24, P4838, DOI 10.1093/nar/24.23.4838; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Stoecklin G, 2001, RNA, V7, P1578; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Theil EC, 2000, BIOCHEM PHARMACOL, V59, P87, DOI 10.1016/S0006-2952(99)00300-7; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	38	307	317	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 14	2005	120	1					99	110		10.1016/j.cell.2004.11.032	http://dx.doi.org/10.1016/j.cell.2004.11.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652485	Bronze			2022-12-24	WOS:000226365400014
J	Cosgrove, SE; Fishman, NO; Talbot, TR; Woeltje, KF; Schaffner, W; Fraser, VJ; McMillan, JA; Perl, TM				Cosgrove, SE; Fishman, NO; Talbot, TR; Woeltje, KF; Schaffner, W; Fraser, VJ; McMillan, JA; Perl, TM			Strategies for use of a limited influenza vaccine supply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERUM ANTIBODY-RESPONSES; VIRUS VACCINE; LIVE; TRIVALENT; SAFETY; IMMUNOGENICITY; EFFICACY		Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; University of Pennsylvania; Vanderbilt University; Washington University (WUSTL); Johns Hopkins University	Cosgrove, SE (corresponding author), Johns Hopkins Univ Hosp, Osler 425,600 N Wolfe St, Baltimore, MD 21287 USA.	scosgro1@jhmi.edu		Talbot, Thomas/0000-0002-6139-212X; Fraser, Victoria/0000-0001-6251-0733; Woeltje, Keith/0000-0002-6385-3970				Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Cha TA, 2000, J CLIN MICROBIOL, V38, P839, DOI 10.1128/JCM.38.2.839-845.2000; *DEP HLTH HUM SERV, RESP HYG COUGH ET HE; *DEP HLTH HUM SERV, CDCP ADV COMM IMM PR; Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; Jackson LA, 1999, VACCINE, V17, P1905, DOI 10.1016/S0264-410X(98)00471-X; KEITEL WA, 1993, J INFECT DIS, V167, P305, DOI 10.1093/infdis/167.2.305; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; King JC, 2000, J INFECT DIS, V181, P725, DOI 10.1086/315246; King JC, 2001, PEDIATR INFECT DIS J, V20, P1124, DOI 10.1097/00006454-200112000-00006; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; TALBOT TR, 2004, SOC HEALTHC EP AM 14; Treanor J, 2002, VACCINE, V20, P1099, DOI 10.1016/S0264-410X(01)00440-6; VESIKARI T, 2001, 41 INT C ANT AG CHEM; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	20	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					229	232		10.1001/jama.293.2.229	http://dx.doi.org/10.1001/jama.293.2.229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644550				2022-12-24	WOS:000226171000039
J	Ratnieks, FLW; Wenseleers, T				Ratnieks, FLW; Wenseleers, T			Policing insect societies	SCIENCE			English	Editorial Material							WORKER REPRODUCTION; APIS-MELLIFERA; CONFLICT; HONEYBEE; EGGS		Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Inst Adv Study, D-14193 Berlin, Germany	University of Sheffield	Ratnieks, FLW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.		Wenseleers, Tom/J-3960-2013	Wenseleers, Tom/0000-0002-1434-861X				Bourke A, 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; DETTORRE P, UNPUB; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Grabosky P., 1988, EFFICIENCY EFFECTIVE; HELANTERA H, 2004, THESIS U HELSINKI; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Oldroyd BP, 2000, BEHAV ECOL SOCIOBIOL, V47, P268, DOI 10.1007/s002650050665; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Skogan W., 2004, FAIRNESS EFFECTIVENE; Smith J. M., 1995, MAJOR TRANSITIONS EV; Wenseleers T, 2004, P ROY SOC B-BIOL SCI, V271, pS310, DOI 10.1098/rsbl.2003.0159; Wenseleers T, 2003, J EVOLUTION BIOL, V16, P647, DOI 10.1046/j.1420-9101.2003.00574.x; Wenseleers T, 2004, ETHOLOGY, V110, P725, DOI 10.1111/j.1439-0310.2004.01008.x; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; WENSELEERS T, IN PRESS P R SOC B S	16	82	84	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2005	307	5706					54	56		10.1126/science.1106934	http://dx.doi.org/10.1126/science.1106934			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637260	Green Accepted			2022-12-24	WOS:000226214300029
J	Graf, ER; Zhang, XZ; Jin, SX; Linhoff, MW; Craig, AM				Graf, ER; Zhang, XZ; Jin, SX; Linhoff, MW; Craig, AM			Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins	CELL			English	Article							HIPPOCAMPAL-NEURONS; GABAERGIC SYNAPSES; ADHESION MOLECULE; RECEPTOR; BINDING; DYSTROGLYCAN; LIGAND; HETEROGENEITY; PLASTICITY; EVOLUTION	Formation of synaptic connections requires alignment of neurotransmitter receptors on postsynaptic dendrites opposite matching transmitter release sites on presynaptic axons. beta-neurexins and neuroligins form a trans-synaptic link at glutamate synapses. We show here that neurexin alone is sufficient to induce glutamate postsynaptic differentiation in contacting dendrites. Surprisingly, neurexin also induces GABA postsynaptic differentiation. Conversely, neuroligins induce presynaptic differentiation in both glutamate and GABA axons. Whereas neuroligins-1, -3, and -4 localize to glutamate postsynaptic sites, neuroligin-2 localizes primarily to GABA synapses. Direct aggregation of neuroligins reveals a linkage of neuroligin-2 to GABA and glutamate postsynaptic proteins, but the other neuroligins only to glutamate postsynaptic proteins. Furthermore, mislocalized expression of neuroligin-2 disperses postsynaptic proteins and disrupts synaptic transmission. Our findings indicate that the neurexin-neuroligin link is a core component mediating both GABAergic and glutamatergic synaptogenesis, and differences in isoform localization and binding affinities may contribute to appropriate differentiation and specificity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Craig, AM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	acraig@pcg.wustl.edu	Craig, Ann Marie/M-2054-2014		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184, P01NS034448] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS033184-11, P01 NS034448-070005, R01 NS033184, NS33184, P01 NS034448-080005, R01 NS033184-10, P01 NS034448, NS34448] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Goslin K., 1998, CULTURING NERVE CELL, P339; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	42	696	730	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1013	1026		10.1016/j.cell.2004.11.035	http://dx.doi.org/10.1016/j.cell.2004.11.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620359	Bronze, Green Accepted			2022-12-24	WOS:000226109700013
J	Shi, YJ; Lan, F; Matson, C; Mulligan, P; Whetstine, JR; Cole, PA; Casero, RA; Shi, Y				Shi, YJ; Lan, F; Matson, C; Mulligan, P; Whetstine, JR; Cole, PA; Casero, RA; Shi, Y			Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1	CELL			English	Article							METHYLTRANSFERASE ACTIVITY; LYSINE-9 METHYLATION; H3 METHYLATION; EPSILON-ALKYLLYSINASE; TRANSCRIPTION; ACETYLATION; CHROMATIN; COMPLEX; DOMAIN; PURIFICATION	Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription. While the extent of histone acetylation is determined by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities. Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor. LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription. Lysine demethylation occurs via an oxidation reaction that generates formaldehyde. Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation. The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu		Mulligan, Peter/0000-0003-0737-2328; Casero, Robert/0000-0001-5653-3306	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, F32GM070095, F32GM070690] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071004, GM70095-02, F32GM070690] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Aravind L., 2002, GENOME BIOL, V3, DOI [DOI 10.1186/GB-2002-3-8-RESEARCH0039, 10.1186/gb-2002-3-8-research0039]; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; KIM S, 1964, J BIOL CHEM, V239, P3790; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Landry J, 2003, BIOCHEM BIOPH RES CO, V303, P771, DOI 10.1016/S0006-291X(03)00416-9; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; PAIK WK, 1974, ARCH BIOCHEM BIOPHYS, V165, P369, DOI 10.1016/0003-9861(74)90175-1; PAIK WK, 1973, BIOCHEM BIOPH RES CO, V51, P781, DOI 10.1016/0006-291X(73)91383-1; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rozylo TK, 2000, BIOMED CHROMATOGR, V14, P173, DOI 10.1002/1099-0801(200005)14:3<173::AID-BMC957>3.0.CO;2-O; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	64	2955	3207	12	347	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					941	953		10.1016/j.cell.2004.12.012	http://dx.doi.org/10.1016/j.cell.2004.12.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620353	Bronze			2022-12-24	WOS:000226109700007
J	Jia, JH; Tong, C; Wang, B; Luo, LP; Jiang, J				Jia, JH; Tong, C; Wang, B; Luo, LP; Jiang, J			Hedgehog signalling activity of Smoothened requires phosphorylation by protein kinase A and casein kinase I	NATURE			English	Article							CUBITUS INTERRUPTUS; DROSOPHILA; TRANSDUCTION; TRANSCRIPTION; LOCALIZATION; RECOGNITION; PROTEOLYSIS; EXPRESSION; INHIBITOR; ACTIVATOR	The Hedgehog (Hh) family of secreted proteins governs cell growth and patterning in animal development(1). The Hh signal is transduced by the seven-transmembrane protein Smoothened (Smo); however, the mechanism by which Smo is regulated remains largely unknown. Here we show that protein kinase A (PKA) and casein kinase I (CKI) regulate Smo cell-surface accumulation and activity in response to Hh. Blocking PKA or CKI activity in the Drosophila wing disc prevents Hh-induced Smo accumulation and attenuates pathway activity, whereas increasing PKA activity promotes Smo accumulation and pathway activation. We show that PKA and CKI phosphorylate Smo at several sites, and that phosphorylation-deficient forms of Smo fail to accumulate on the cell surface and are unable to transduce the Hh signal. Conversely, phosphorylation-mimicking Smo variants show constitutive cell-surface expression and signalling activity. Furthermore, we find that the levels of Smo cell-surface expression and activity correlate with its levels of phosphorylation. Our data indicate that Hh induces progressive Smo phosphorylation by PKA and CKI, leading to elevation of Smo cell-surface levels and signalling activity.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, J (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.	jin.jiang@utsouthwestern.edu		Tong, Chao/0000-0001-6521-5465; Jia, Jianhang/0000-0002-9313-3843	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM067045] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061269, R01 GM067045] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Price MA, 1999, DEVELOPMENT, V126, P4331; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Strigini M, 1997, DEVELOPMENT, V124, P4697; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	30	251	263	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1045	1050		10.1038/nature03179	http://dx.doi.org/10.1038/nature03179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616566				2022-12-24	WOS:000225887000046
J	Okajima, T; Xu, AG; Lei, L; Irvine, KD				Okajima, T; Xu, AG; Lei, L; Irvine, KD			Chaperone activity of protein O-fucosyltransferase 1 promotes Notch receptor folding	SCIENCE			English	Article							FUCOSYL-TRANSFERASE; ENDOPLASMIC-RETICULUM; DELTA INTERACTIONS; SIGNALING PATHWAY; C-MANNOSYLATION; QUALITY-CONTROL; IDENTIFICATION; GLYCOSYLATION; DROSOPHILA; ENCODES	Notch proteins are receptors for a conserved signaling pathway that affects numerous cell fate decisions. We found that in, Drosophila, Protein O-fucosyltransferase 1 (OFUT1), an enzyme that glycosylates epidermal growth factor-like domains of Notch, also has a distinct Notch chaperone activity. OFUT1 is an endoplasmic reticulum protein, and its localization was essential for function in vivo. OFUT1 could bind to Notch, was required for the trafficking of wild-type Notch out of the endoplasmic reticulum, and could partially rescue defects in secretion and ligand binding associated with Notch. point mutations. This ability of OFUT1 to facilitate folding of Notch did not require its fucosyltransferase activity. Thus, a glycosyltransferase can bind its substrate in the endoplasmic reticulum to facilitate normal folding.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	NIGMS NIH HHS [R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen DP, 2004, ANN CLIN LAB SCI, V34, P314; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; HALTIWANGER R, COMMUNICATION; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112	32	188	193	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1599	1603		10.1126/science.1108995	http://dx.doi.org/10.1126/science.1108995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15692013				2022-12-24	WOS:000227622400041
J	Lieberman, RL; Rosenzweig, AC				Lieberman, RL; Rosenzweig, AC			Crystal structure of a membrane-bound metalloenzyme that catalyses the biological oxidation of methane	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; CYTOCHROME-C-OXIDASE; MONOOXYGENASE; COPPER; ACTIVATION; HYDROXYLATION; SPECTROSCOPY; BIOCHEMISTRY; PARAMETERS; PROTEINS	Particulate methane monooxygenase ( pMMO) is an integral membrane metalloenzyme that catalyses the conversion of methane to methanol. Knowledge of how pMMO performs this extremely challenging chemistry may have an impact on the use of methane as an alternative energy source by facilitating the development of new synthetic catalysts. We have determined the structure of pMMO from the methanotroph Methylococcus capsulatus ( Bath) to a resolution of 2.8 Angstrom. The enzyme is a trimer with an alpha(3)beta(3)gamma(3) polypeptide arrangement. Two metal centres, modelled as mononuclear copper and dinuclear copper, are located in soluble regions of each pmoB subunit, which resembles cytochrome c oxidase subunit II. A third metal centre, occupied by zinc in the crystal, is located within the membrane. The structure provides new insight into the molecular details of biological methane oxidation.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu						Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; Basu P, 2003, BIOCHEM J, V369, P417, DOI 10.1042/BJ20020823; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan SI, 2004, BIOCHEMISTRY-US, V43, P4421, DOI 10.1021/bi0497603; Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Cook SA, 2002, ARCH BIOCHEM BIOPHYS, V398, P32, DOI 10.1006/abbi.2001.2628; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elliott SJ, 1998, J AM CHEM SOC, V120, P3247, DOI 10.1021/ja972968+; George SD, 2001, J AM CHEM SOC, V123, P5757, DOI 10.1021/ja004109i; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lemos S. S., 2002, CURR TOP BIOPHYS, V26, P43; Lieberman RL, 2004, CRIT REV BIOCHEM MOL, V39, P147, DOI 10.1080/10409230490475507; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Nguyen HHT, 1998, J BIOL CHEM, V273, P7957, DOI 10.1074/jbc.273.14.7957; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Park S, 2002, WASTE MANAGE RES, V20, P434, DOI 10.1177/0734242X0202000507; Periana RA, 2004, J MOL CATAL A-CHEM, V220, P7, DOI 10.1016/j.molcata.2004.05.036; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; SEMRAU JD, 1995, J BACTERIOL, V177, P3071, DOI 10.1128/jb.177.11.3071-3079.1995; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stolyar S, 1999, MICROBIOL-UK, V145, P1235, DOI 10.1099/13500872-145-5-1235; Sullivan JP, 1998, CRIT REV MICROBIOL, V24, P335, DOI 10.1080/10408419891294217; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TSUPRUN VL, 1987, DOKL AKAD NAUK SSSR+, V292, P490; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Yu SSF, 2003, J BACTERIOL, V185, P5915, DOI 10.1128/JB.185.20.5915-5924.2003	48	477	493	7	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					177	182		10.1038/nature03311	http://dx.doi.org/10.1038/nature03311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15674245				2022-12-24	WOS:000227494500036
J	Kishi, M; Pan, YA; Crump, JG; Sanes, JR				Kishi, M; Pan, YA; Crump, JG; Sanes, JR			Mammalian SAD kinases are required for neuronal polarization	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN-KINASE; TAU-PROTEIN; PHOSPHORYLATION; POLARITY; ESTABLISHMENT; PAR-1	Electrical activity in neurons is generally initiated in dendritic processes then propagated along axons to synapses, where it is passed to other neurons. Major structural features of neurons-their dendrites and axons-are thus related to their fundamental functions: the receipt and transmission of information. The acquisition of these distinct properties by dendrites and axons, called polarization, is a critical step in neuronat differentiation. We show here that SAD-A and SAD-B, mammalian orthologs of a kinase needed for presynaptic differentiation in Caenorhabditis elegans, are required for neuronal polarization. These kinases will provide entry points for unraveling signaling mechanisms that polarize neurons.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Washington University (WUSTL); Harvard University; University of California System; University of California San Francisco	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@mcb.harvard.edu	Kishi, Masashi/GLU-0437-2022					Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Goslin K., 1998, CULTURING NERVE CELL, P339; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Mandell JW, 1996, J NEUROSCI, V16, P5727; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Pan Y., UNPUB; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasakura Y, 1998, MECH DEVELOP, V76, P161, DOI 10.1016/S0925-4773(98)00100-2; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; Spicer J, 2004, CURR BIOL, V14, pR383, DOI 10.1016/j.cub.2004.05.012; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	25	255	269	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					929	932		10.1126/science.1107403	http://dx.doi.org/10.1126/science.1107403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705853				2022-12-24	WOS:000226985100055
J	de la Sierra-Gallay, IL; Pellegrini, O; Condon, C				de la Sierra-Gallay, IL; Pellegrini, O; Condon, C			Structural basis for substrate binding, cleavage and allostery in the tRNA maturase RNase Z	NATURE			English	Article							BETA-LACTAMASE; END MATURATION; PRECURSOR; CCA; ENZYME; GENE	Transfer RNAs ( tRNAs) are synthesized as part of longer primary transcripts that require processing of both their 30 and 50 extremities in every living organism known. The 50 side is processed ( matured) by the ubiquitously conserved endonucleolytic ribozyme, RNase P-1, whereas removal of the 30 tails can be either exonucleolytic(2,3) or endonucleolytic(4). The endonucleolytic pathway is catalysed by an enzyme known as RNase Z, or 3' tRNase(5,6). RNase Z cleaves precursor tRNAs immediately after the discriminator base ( the unpaired nucleotide 30 to the last base pair of the acceptor stem, used as an identity determinant by many aminoacyl- tRNA synthetases) in most cases(6 - 8), yielding a tRNA primed for addition of the CCA motif by nucleotidyl transferase. Here we report the crystal structure of Bacillus subtilis RNase Z at 2.1 Angstrom resolution, and propose a mechanism for tRNA recognition and cleavage. The structure explains the allosteric properties of the enzyme, and also sheds light on the mechanisms of inhibition by the CCA motif and long 50 extensions. Finally, it highlights the extraordinary adaptability of the metallo- hydrolase domain of the beta- lactamase family for the hydrolysis of covalent bonds.	Univ Paris 07, CNRS, UPR 9073, F-75221 Paris 05, France; Inst Biol Physicochim, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Condon, C (corresponding author), Univ Paris 07, CNRS, UPR 9073, F-75221 Paris 05, France.	condon@ibpc.fr	Condon, Ciaran/F-6798-2011	Condon, Ciaran/0000-0002-2199-9621; Li de la Sierra-Gallay, Ines/0000-0003-2770-7439				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; GARBER RL, 1979, CELL, V18, P817, DOI 10.1016/0092-8674(79)90134-X; GARBER RL, 1979, CELL, V17, P389, DOI 10.1016/0092-8674(79)90165-X; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Lu GG, 1999, J APPL CRYSTALLOGR, V32, P365, DOI 10.1107/S0021889898015052; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1999, NUCLEIC ACIDS RES, V27, P2770, DOI 10.1093/nar/27.13.2770; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schiffer S, 2001, BIOCHEMISTRY-US, V40, P8264, DOI 10.1021/bi0101953; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200	29	127	131	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					657	661		10.1038/nature03284	http://dx.doi.org/10.1038/nature03284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15654328				2022-12-24	WOS:000226862000050
J	Livesey, A				Livesey, A			A multiagency protocol for responding to sudden unexpected death in infancy: descriptive study	BRITISH MEDICAL JOURNAL			English	Article									Royal Alexandra Hosp Sick Children, S Downs Hlth NHS Trust, Dept Community Child Hlth, Brighton BN1 3JN, E Sussex, England		Livesey, A (corresponding author), Royal Alexandra Hosp Sick Children, S Downs Hlth NHS Trust, Dept Community Child Hlth, Brighton BN1 3JN, E Sussex, England.	anne.livesey@southdowns.nhs.uk						*ROYAL COLL PATH R, 2004, SUDD UN DEATH INF; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689	2	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2005	330	7485					227	228		10.1136/bmj.38323.652523.F7	http://dx.doi.org/10.1136/bmj.38323.652523.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15596417	Green Published, Bronze			2022-12-24	WOS:000226779400019
J	Bano, D; Young, KW; Guerin, CJ; LeFeuvre, R; Rothwell, NJ; Naldini, L; Rizzuto, R; Carafoli, E; Nicotera, P				Bano, D; Young, KW; Guerin, CJ; LeFeuvre, R; Rothwell, NJ; Naldini, L; Rizzuto, R; Carafoli, E; Nicotera, P			Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity	CELL			English	Article							EXCITATORY AMINO-ACIDS; CARDIAC NA+-CA2+ EXCHANGER; CEREBELLAR GRANULE CELLS; ISCHEMIC BRAIN-INJURY; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; CA2+-BINDING DOMAIN; NEURONAL APOPTOSIS; PROTEOLYTIC SYSTEM; NMDA RECEPTOR	In brain ischemia, gating of postsynaptic glutamate receptors and other membrane channels triggers intracellular Ca2+ overload and cell death. In excitotoxic settings, the initial Ca2+ influx through glutamate receptors is followed by a second uncontrolled Ca2+ increase that leads to neuronal demise. Here we report that the major plasma membrane Ca2+ extruding system, the Na+/Ca2+ exchanger (NCX), is cleaved during brain ischemia and in neurons undergoing excitotoxicity. Inhibition of Ca2+-activated proteases (calpains) by overexpressing their endogenous inhibitor protein, calpastatin or the expression of an NCX isoform not cleaved by calpains, prevented Ca2+ overload and rescued neurons from excitotoxic death. Conversely, down-regulation of NCX by siRNA compromised neuronal Ca2+ handling, transforming the Ca2+ transient elicited by non-excitotoxic glutamate concentrations into a lethal Ca2+ overload. Thus, proteolytic in,activation of NCX-driven neuronal Ca2+ extrusion is responsible for the delayed excitotoxic Ca2+ deregulation and neuronal death.	Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Padua, Dept Biochem, I-35121 Padua, Italy; VIMM, I-35129 Padua, Italy	University of Leicester; University of Leicester; University of Manchester; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Padua; Veneto Institute Molecular Medicine	Nicotera, P (corresponding author), Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	pn10@le.ac.uk	Le Feuvre, Rosalind/A-7034-2013; Rizzuto, Rosario/B-6312-2008; Naldini, Luigi/E-9083-2012; Carafoli, Ernesto/K-5192-2016; Bano, Daniele/AAZ-9371-2020; Guerin, Christopher/AAM-3233-2020	Carafoli, Ernesto/0000-0002-7826-0094; Rizzuto, Rosario/0000-0001-7044-5097; NALDINI, Luigi/0000-0002-7835-527X	MRC [G19/24] Funding Source: UKRI; Medical Research Council [G19/24] Funding Source: Medline; Telethon [TGT03D01, TGT06S01] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon)		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BINDOKAS VP, 1995, J NEUROSCI, V15, P6999; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brini M, 2002, J BIOL CHEM, V277, P38693, DOI 10.1074/jbc.M206075200; Budd SL, 1996, J NEUROCHEM, V67, P2282; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Fryer HJL, 1999, J NEUROCHEM, V72, P500, DOI 10.1046/j.1471-4159.1999.0720500.x; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Leist M, 1998, MOL PHARMACOL, V54, P789, DOI 10.1124/mol.54.5.789; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MELLGREN RL, 1989, RBC-CELL BIOL REV, V20, P139; Murachi T, 1987, NEUROPEPTIDES THEIR, P202; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOTERA P, 1986, J BIOL CHEM, V261, P4628; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reynolds IJ, 1999, ANN NY ACAD SCI, V893, P33, DOI 10.1111/j.1749-6632.1999.tb07816.x; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; THUMEYSEN T, 2002, BRAIN RES MOL BRAIN, V107, P145; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; Ward MW, 2000, J NEUROSCI, V20, P7208; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	55	427	444	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					275	285		10.1016/j.cell.2004.11.049	http://dx.doi.org/10.1016/j.cell.2004.11.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680332	Bronze			2022-12-24	WOS:000226740000015
J	Amonlirdviman, K; Khare, NA; Tree, DRP; Chen, WS; Axelrod, JD; Tomlin, CJ				Amonlirdviman, K; Khare, NA; Tree, DRP; Chen, WS; Axelrod, JD; Tomlin, CJ			Mathematical modeling of planar cell polarity to understand domineering nonautonomy	SCIENCE			English	Article							DROSOPHILA EYE; ASYMMETRIC LOCALIZATION; TISSUE POLARITY; VAN-GOGH; PRICKLE; ABDOMEN; GENE; MELANOGASTER; STRABISMUS; AUTONOMY	Planar cell polarity (PCP) signaling generates subcellular asymmetry along an axis orthogonal to the epithelia[ apical-basal axis. Through a poorly understood mechanism, cell clones that have mutations in some PCP signaling components, including some, but not all, alleles of the receptor frizzled, cause polarity disruptions of neighboring wild-type cells, a phenomenon referred to as domineering nonautonomy. Here, a contact-dependent signaling hypothesis, derived from experimental results, is shown by reaction-diffusion, partial differential equation modeling and simulation to fully reproduce PCP phenotypes, including domineering nonautonomy, in the Drosophila wing. The sufficiency of this model and the experimental validation of model predictions reveal how specific protein-protein interactions produce autonomy or domineering nonautonomy.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Aeronaut & Astronaut, Stanford, CA 94305 USA	Stanford University; Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	jaxetrod@stanford.edu; tomlin@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM59823] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER PM, COMMUNICATION; Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; AMONLIRDVIMAN K, UNPUB; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hannus M, 2002, DEVELOPMENT, V129, P3493; Jones KH, 1996, GENETICS, V142, P205; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Struhl G, 1997, DEVELOPMENT, V124, P2155; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	31	216	219	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					423	426		10.1126/science.1105471	http://dx.doi.org/10.1126/science.1105471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662015				2022-12-24	WOS:000226492300047
J	O'Rahilly, S; Barroso, I; Wareham, NJ				O'Rahilly, S; Barroso, I; Wareham, NJ			Genetic factors in type 2 diabetes: The end of the beginning?	SCIENCE			English	Editorial Material							NUCLEAR FACTOR-4-ALPHA GENE; INSULIN-RESISTANCE; ASSOCIATION; POLYMORPHISM; MELLITUS; OBESITY; RISK; SUSCEPTIBILITY; CONTRIBUTE; MUTATIONS	The intensive search for genetic variants that predispose to type 2 diabetes was launched with optimism, but progress has been slower than was hoped. Even so, major advances have been made in the understanding of monogenic forms of the disease which together represent a substantial health burden, and a few common gene variants that influence susceptibility have now been unequivocally identified. Armed with a better understanding of the tools needed to detect such genes, it seems inevitable that the rate of progress will increase and the relevance of genetic information to the diagnosis, treatment, and prevention of diabetes will become increasingly tangible.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; MRC, Epidemiol Unit, Elsie Widdowson Lab, Cambridge CB1 9NL, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England.	so104@medscht.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Barroso, Ines/0000-0001-5800-4520				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Beck-Nielsen H, 2003, BEST PRACT RES CL EN, V17, P445, DOI 10.1016/S1521-690X(03)00041-1; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hegele RA, 1999, DIABETES CARE, V22, P524, DOI 10.2337/diacare.22.3.524b; Horikawa Y, 2000, NAT GENET, V26, P502; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Love-Gregory L, 2003, DIABETOLOGIA, V46, P136, DOI 10.1007/s00125-002-0947-x; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; McCarthy MI, 2002, AM J PHYSIOL-ENDOC M, V283, pE217, DOI 10.1152/ajpendo.00099.2002; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; O'Rahilly S, 2002, EUR J ENDOCRINOL, V147, P435, DOI 10.1530/eje.0.1470435; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Sargeant LA, 2000, INT J OBESITY, V24, P1333, DOI 10.1038/sj.ijo.0801383; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stride A, 2002, ANN MED, V34, P207, DOI 10.1080/713782136; 't Hart LM, 1999, J CLIN ENDOCR METAB, V84, P1002, DOI 10.1210/jc.84.3.1002; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Zhu Q, 2003, DIABETOLOGIA, V46, P567, DOI 10.1007/s00125-003-1067-y	27	199	205	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					370	373		10.1126/science.1104346	http://dx.doi.org/10.1126/science.1104346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662000				2022-12-24	WOS:000226492300030
J	Saez, AG; Lozano, E				Saez, AG; Lozano, E			Body doubles	NATURE			English	Editorial Material									Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid 28006, Spain; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Imperial College London	Saez, AG (corresponding author), Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid 28006, Spain.		Sáez, Alberto García/B-5018-2008; Lozano, Encarnacion/C-5161-2008	Sáez, Alberto García/0000-0003-0209-7179; Lozano, Encarnacion/0000-0003-0254-0935				Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Thierstein HR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P455; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	5	160	164	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					111	111		10.1038/433111a	http://dx.doi.org/10.1038/433111a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650721	Bronze			2022-12-24	WOS:000226252200018
J	van Gils, CH; Peeters, PHT; Bueno-De-Mesquita, HB; Boshuizen, HC; Lahmann, PH; Clavel-Chapelon, F; Thiebaut, A; Kesse, E; Sieri, S; Palli, D; Tumino, R; Panico, S; Vineis, P; Gonzalez, CA; Ardanaz, E; Sanchez, MJ; Amiano, P; Navarro, C; Quiros, JR; Key, TJ; Allen, N; Khaw, KT; Bingham, SA; Psaltopoulou, T; Koliva, M; Trichopoulou, A; Nagel, G; Linseisen, J; Boeing, H; Berglund, G; Wirfalt, E; Hallmans, G; Lenner, P; Overvad, K; Tjonneland, A; Olsen, A; Lund, E; Engeset, D; Alsaker, E; Norat, TA; Kaaks, R; Slimani, N; Riboli, E				van Gils, CH; Peeters, PHT; Bueno-De-Mesquita, HB; Boshuizen, HC; Lahmann, PH; Clavel-Chapelon, F; Thiebaut, A; Kesse, E; Sieri, S; Palli, D; Tumino, R; Panico, S; Vineis, P; Gonzalez, CA; Ardanaz, E; Sanchez, MJ; Amiano, P; Navarro, C; Quiros, JR; Key, TJ; Allen, N; Khaw, KT; Bingham, SA; Psaltopoulou, T; Koliva, M; Trichopoulou, A; Nagel, G; Linseisen, J; Boeing, H; Berglund, G; Wirfalt, E; Hallmans, G; Lenner, P; Overvad, K; Tjonneland, A; Olsen, A; Lund, E; Engeset, D; Alsaker, E; Norat, TA; Kaaks, R; Slimani, N; Riboli, E			Consumption of vegetables and fruits and risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							24-HOUR DIET RECALL; CALIBRATION; FOOD; QUESTIONNAIRES; VALIDITY; NITROGEN	Context The intake of vegetables and fruits has been thought to protect against breast cancer. Most of the evidence comes from case-control studies, but a recent pooled analysis of the relatively few published cohort studies suggests no significantly reduced breast cancer risk is associated with vegetable and fruit consumption. Objective To examine the relation between total and specific vegetable and fruit intake and the incidence of breast cancer. Design, Setting, and Participants Prospective study of 285526 women between the ages of 25 and 70 years, participating in the European Prospective Investigation Into Cancer and Nutrition (EPIC) study, recruited from 8 of the 10 participating European countries. Participants completed a dietary questionnaire in 1992-1998 and were followed up for incidence of cancer until 2002. Main Outcome Measures Relative risks for breast cancer by total and specific vegetable and fruit intake. Analyses were stratified by age at recruitment and study center. Relative risks were adjusted for established breast cancer risk factors. Results During 1486402 person-years (median duration of follow-up, 5.4 years), 3659 invasive incident breast cancer cases were reported. No significant associations between vegetable or fruit intake and breast cancer risk were observed. Relative risks for the highest vs the lowest quintile were 0.98 (95% confidence interval [CI], 0.84-1.14) for total vegetables, 1.09 (95% Cl, 0.94-1.25) for total fruit, and 1.05 (95% Cl, 0.92-1.20) for fruit and vegetable juices. For 6 specific vegetable subgroups no associations with breast cancer risk were observed either. Conclusion Although the period of follow-up is limited for now, the results suggest that total or specific vegetable and fruit intake is not associated with risk for breast cancer.	Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; Natl Inst Publ Hlth & Environm, Ctr Informat Technol & Methodol, NL-3720 BA Bilthoven, Netherlands; German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany; Inst Gustave Roussy, INSERM, Equipe Nutr Hormones & Canc, F-94805 Villejuif, France; Ist Nazl Tumori, Epidemiol Unit, I-20133 Milan, Italy; Sci Inst Tuscany, CSPO, Mol & Nutr Epidemiol Unit, Florence, Italy; Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; Univ Turin, I-10124 Turin, Italy; Univ London Imperial Coll Sci Technol & Med, London, England; Catalan Inst Oncol, Dept Epidemiol, Barcelona, Spain; Inst Publ Hlth, Navarra, Spain; Andalusian Sch Publ Hlth, Granada, Spain; Hlth Dept Basque Country, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; Murcia Hlth Council, Dept Epidemiol, Murcia, Spain; Principal Asturias, Hlth & Hlth Serv Council, Publ Hlth & Planning Directorate, Hlth Informat Unit, Oviedo, Spain; Univ Oxford, Canc Res UK Epidemiol Unit, Oxford OX1 2JD, England; Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; MRC, Dunn Human Nutr Unit, Cambridge, England; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-10679 Athens, Greece; Deutsch Krebsforschungszentrum, Div Clin Epidemiol, D-6900 Heidelberg, Germany; Lund Univ, Malmo Univ Hosp, Dept Med, Malmo, Sweden; Umea Univ, Unit Nutr Res, S-90187 Umea, Sweden; Umea Univ, Unit Oncol, S-90187 Umea, Sweden; Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Univ Tromso, Inst Community Med, Tromso, Norway; WHO, Int Agcy Res Canc, Lyon, France	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; University of Naples Federico II; University of Turin; Imperial College London; Catalan Institute of Oncology; Public Health Institute of Navarra; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; Cancer Research UK; University of Oxford; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Athens Medical School; National & Kapodistrian University of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Skane University Hospital; Umea University; Umea University; Umea University; Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society; UiT The Arctic University of Tromso; World Health Organization; International Agency for Research on Cancer (IARC)	Peeters, PHT (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Room Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	P.H.M.Peeters@umcutrecht.nl	Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Linseisen, Jakob/B-5353-2014; Kesse-Guyot, Emmanuelle/K-4689-2012; Boshuizen, Hendriek/M-3415-2014; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Boshuizen, Hendriek C/B-3718-2014; Thiébaut, Anne C.M./O-1788-2018; Sieri, Sabina/K-4667-2016; Nagel, Gabriele/C-3635-2012; Sánchez, Maria-José/D-1087-2011; Panico, Salvatore/K-6506-2016; Psaltopoulou, Theodora/AAA-6878-2020; Khaw, Kay-Tee/AAZ-3209-2021; Engeset, Dagrun/A-4508-2008	Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Linseisen, Jakob/0000-0002-9386-382X; Boshuizen, Hendriek/0000-0002-3916-9095; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Thiébaut, Anne C.M./0000-0003-2651-2795; Sieri, Sabina/0000-0001-5201-172X; Nagel, Gabriele/0000-0001-6185-8535; Sánchez, Maria-José/0000-0003-4817-0757; Panico, Salvatore/0000-0002-5498-8312; Psaltopoulou, Theodora/0000-0002-1404-9716; LAHMANN, Petra/0000-0002-9563-1635; Olsen, Anja/0000-0003-4788-503X; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Navarro, Carmen/0000-0001-8896-7483; Lund, Eiliv/0000-0002-8071-8711; Riboli, Elio/0000-0001-6795-6080; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X				Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Gandini S, 2000, EUR J CANCER, V36, P636, DOI 10.1016/S0959-8049(00)00022-8; Gaudet MM, 2004, CANCER EPIDEM BIOMAR, V13, P1485; *IARC WORK GROUP E, 2003, IARC WORK GROUP EV C, V8; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; KAAKS R, 1995, AM J EPIDEMIOL, V142, P548, DOI 10.1093/oxfordjournals.aje.a117673; Kipnis V, 2001, AM J EPIDEMIOL, V153, P394, DOI 10.1093/aje/153.4.394; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1; Miller AB, 2004, INT J CANCER, V108, P269, DOI 10.1002/ijc.11559; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2003, CANCER EPIDEM BIOMAR, V12, P784; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; *WHO, 1997, FOOD NUTR PREV CANC; Zhang SM, 1999, JNCI-J NATL CANCER I, V91, P547, DOI 10.1093/jnci/91.6.547	24	188	192	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					183	193		10.1001/jama.293.2.183	http://dx.doi.org/10.1001/jama.293.2.183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644545	Green Published, Bronze			2022-12-24	WOS:000226171000034
J	Yamashita, T; Hige, T; Takahashi, T				Yamashita, T; Hige, T; Takahashi, T			Vesicle endocytosis requires dynamin-dependent GTP hydrolysis at a fast CNS synapse	SCIENCE			English	Article							PRESYNAPTIC CAPACITANCE; SINGLE; EXOCYTOSIS; MEMBRANE; CELLS; GAMMA; TIME; TRANSMISSION; TRANSMITTER; RECRUITMENT	Molecular dependence of vesicular endocytosis was investigated with capacitance measurements at the calyx of Held terminal in brainstem slices. Intraterminal loading of botulinum toxin E revealed that the rapid capacitance transient implicated as "kiss-and-run" was unrelated to transmitter release. The release-related capacitance. change decayed with an endocytotic time constant of 10 to 25 seconds, depending on the magnitude of exocytosis. Presynaptic loading of the nonhydrolyzable guanosine, 5'-triphosphate (GTP) analog GTPgammaS or dynamin-1 proline-rich domain peptide abolished endocytosis. These compounds had no immediate effect on exocytosis, but caused a use-dependent rundown of exocytosis. Thus, the guanosine triphosphatase dynamin-1 is indispensable for vesicle endocytosis at this fast central nervous system (CNS) synapse.	Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan	University of Tokyo	Takahashi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan.	ttakahas-tky@umin.ac.jp	Yamashita, Takayuki/F-7589-2010; Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666; Hige, Toshihide/0000-0002-0007-3192; Yamashita, Takayuki/0000-0002-1849-9837				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; BINZ T, 1994, J BIOL CHEM, V269, P1617; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Kjaerulff O, 2002, NAT CELL BIOL, V4, pE245, DOI 10.1038/ncb1102-e245; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	29	130	134	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					124	127		10.1126/science.1103631	http://dx.doi.org/10.1126/science.1103631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637282				2022-12-24	WOS:000226214300053
J	Iavarone, A; King, ER; Dai, XM; Leone, G; Stanley, ER; Lasorella, A				Iavarone, A; King, ER; Dai, XM; Leone, G; Stanley, ER; Lasorella, A			Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages	NATURE			English	Article							BONE-MARROW; COMPLEX-FORMATION; CHIMERIC MICE; IN-VITRO; MOUSE; RB; CELLS; DIFFERENTIATION; PROTEIN; GENE	tiation(1,2). Targeted disruption of the retinoblastoma (Rb) tumour suppressor gene in the mouse leads to embryonic death caused by failure of erythroblasts to enucleate(3-5). The erythroid defect has been attributed to loss of Rb in cells that support erythropoiesis, but the identity of these cells is unknown(6). Here we show that Rb-deficient embryos carry profound abnormalities of fetal liver macrophages that prevent physical interactions with erythroblasts. In contrast, wild-type macrophages bind Rb-deficient erythroblasts and lead them to terminal differentiation and enucleation. Loss of Id2, a helix - loop - helix protein that mediates the lethality of Rb-deficient embryos(7), rescues the defects of Rb-deficient fetal liver macrophages. Rb promotes differentiation of macrophages by opposing the inhibitory functions of Id2 on the transcription factor PU.1, a master regulator of macrophage differentiation. Thus, Rb has a cell autonomous function in fetal liver macrophages, and restrains Id2 in these cells in order to implement definitive erythropoiesis.In mammals, the fetal liver is the first site of definitive erythropoiesis - the generation of mature, enucleated red cells. The functional unit for definitive erythropoiesis is the erythroblastic island, a multicellular structure composed of a central macrophage surrounded by erythroblasts at various stages of differen	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Columbia University; Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University; Yeshiva University; Albert Einstein College of Medicine	Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065; Iavarone, Antonio/0000-0002-0683-4634; Dai, Xuming/0000-0003-3092-9323				Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Bergh G, 1999, BLOOD, V94, P1971; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MORIOKA Y, 1994, J LEUKOCYTE BIOL, V55, P642, DOI 10.1002/jlb.55.5.642; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Sasaki K, 1997, MICROSC RES TECHNIQ, V39, P398, DOI 10.1002/(SICI)1097-0029(19971201)39:5<398::AID-JEMT2>3.0.CO;2-D; Stanley E R, 1997, Methods Mol Biol, V75, P301; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Toma JG, 2000, J NEUROSCI, V20, P7648; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Vooijs M, 1999, ONCOGENE, V18, P5293, DOI 10.1038/sj.onc.1202999; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	30	112	116	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1040	1045		10.1038/nature03068	http://dx.doi.org/10.1038/nature03068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616565				2022-12-24	WOS:000225887000045
J	Morrison, AJ; Highland, J; Krogan, NJ; Arbel-Eden, A; Greenblatt, JF; Haber, JE; Shen, XT				Morrison, AJ; Highland, J; Krogan, NJ; Arbel-Eden, A; Greenblatt, JF; Haber, JE; Shen, XT			INO80 and gamma-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; HISTONE H2AX; RECRUITMENT; PROTEINS; PHOSPHORYLATION; SUPPRESSOR; PATHWAYS; COMPLEX	While the role of ATP-dependent chromatin remodeling in transcription is well established, a link between chromatin remodeling and DNA repair has remained elusive. We have found that the evolutionarily conserved INO80 chromatin remodeling complex directly participates in the repair of a double-strand break (DSB) in yeast. The INO80 complex is recruited to a HO endonuclease-induced DSB through a specific interaction with the DNA damage-induced phosphorylated histone H2A (gamma-H2AX). This interaction requires Nhp10, an HMG-like subunit of the INO80 complex. The loss of Nhp10 or gamma-H2AX results in reduced INO80 recruitment to the DSB. Finally, components of the INO80 complex show synthetic genetic interactions with the RAD52 DNA repair pathway, the main pathway for DSB repair in yeast. Our findings reveal a new role of ATP-dependent chromatin remodeling in nuclear processes and suggest that an ATP-dependent chromatin remodeling complex can read a DNA repair histone code.	MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	University of Texas System; UTMD Anderson Cancer Center; University of Toronto; Brandeis University; Brandeis University	Shen, XT (corresponding author), MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA.	snowshen@mac.com	Morrison, Ashby/AHE-2820-2022	Haber, James/0000-0002-1878-0610; Shen, Xuetong/0000-0002-4267-5298; Morrison, Ashby/0000-0003-1228-5093	NCI NIH HHS [1K22CA100017] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA100017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Brachmann CB, 1998, YEAST, V14, P115; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fernandez-Capetillo O, 2004, P NATL ACAD SCI USA, V101, P1427, DOI 10.1073/pnas.0307342101; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	33	431	444	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					767	775		10.1016/j.cell.2004.11.037	http://dx.doi.org/10.1016/j.cell.2004.11.037			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607974	Bronze			2022-12-24	WOS:000225907200008
J	Jewitt, DC; Luu, J				Jewitt, DC; Luu, J			Crystalline water ice on the Kuiper belt object (50000) Quaoar	NATURE			English	Article							SURFACE; SPECTROSCOPY; IRRADIATION; SATELLITES; SPECTRUM; CENTAUR	The Kuiper belt is a disk-like structure consisting of solid bodies orbiting the Sun beyond Neptune(1). It is the source of the short-period comets and the likely repository of the Solar System's most primitive materials(2). Surface temperatures in the belt are low (similar to50 K), suggesting that ices trapped at formation should have been preserved over the age of the Solar System. Unfortunately, most Kuiper belt objects are too faint for meaningful compositional study, even with the largest available telescopes. Water ice has been reported in a handful of objects(3-5), but most appear spectrally featureless(5,6). Here we report near-infrared observations of the large Kuiper belt object (50000) Quaoar, which reveal the presence of crystalline water ice and ammonia hydrate. Crystallinity indicates that the ice has been heated to at least 110 K. Both ammonia hydrate and crystalline water ice should be destroyed by energetic particle irradiation on a timescale of about 10(7) yr. We conclude that Quaoar has been recently resurfaced, either by impact exposure of previously buried ( shielded) ices or by cryovolcanic outgassing, or by a combination of these processes.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; MIT, Lincoln Lab, Lexington, MA 02420 USA	University of Hawaii System; Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Jewitt, DC (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	jewitt@hawaii.edu						Bauer JM, 2002, ICARUS, V158, P178, DOI 10.1006/icar.2002.6876; Brown ME, 2000, SCIENCE, V287, P107, DOI 10.1126/science.287.5450.107; Brown ME, 2004, ASTRON J, V127, P2413, DOI 10.1086/382513; Brown RH, 1999, ASTROPHYS J, V519, pL101, DOI 10.1086/312098; Choi YJ, 2002, ICARUS, V160, P300, DOI 10.1006/icar.2002.6976; Churchin J. M, 2001, LUN PLAN I C ABSTR, V32, P1496; Cooper JF, 2003, EARTH MOON PLANETS, V92, P261, DOI 10.1023/B:MOON.0000031944.41883.80; Cruikshank DP, 1998, ICARUS, V135, P389, DOI 10.1006/icar.1998.5997; Czechowski L, 2003, CELEST MECH DYN ASTR, V87, P157, DOI 10.1023/A:1026136025400; DAVIES J, 2004, 1 DECADAL REV EDGEWO; Dumas C, 2001, ASTRON J, V121, P1163, DOI 10.1086/318747; Fornasier S, 2004, ASTRON ASTROPHYS, V422, pL43, DOI 10.1051/0004-6361:20048004; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Hansen GB, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002149; Jenniskens P, 1998, ASTROPHYS SPACE SC L, V227, P139, DOI 10.1007/978-94-011-5252-5_7; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Jewitt DC, 2001, ASTRON J, V122, P2099, DOI 10.1086/323304; Kawakita H, 2002, ASTROPHYS J, V572, pL177, DOI 10.1086/341746; LANZEROTTI LJ, 1984, NATURE, V312, P139, DOI 10.1038/312139a0; Licandro J, 2002, ASTRON ASTROPHYS, V388, pL9, DOI 10.1051/0004-6361:20020533; Marcopulos BA, 2003, CLIN NEUROPSYCHOL, V17, P19, DOI 10.1076/clin.17.1.19.15630; Motohara K, 2002, PUBL ASTRON SOC JPN, V54, P315, DOI 10.1093/pasj/54.2.315; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Schmitt B, 1998, ASTROPHYS SPACE SC L, V227, P199, DOI 10.1007/978-94-011-5252-5_9; STEVENSON DJ, 1982, NATURE, V298, P142, DOI 10.1038/298142a0; STRAZZULLA G, 1991, J GEOPHYS RES-PLANET, V96, P17547, DOI 10.1029/91JE01688	26	186	187	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					731	733		10.1038/nature03111	http://dx.doi.org/10.1038/nature03111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592406				2022-12-24	WOS:000225597200041
J	Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; Moore, C; Pfafferott, KJ; Hilton, L; Zimbwa, P; Moore, S; Allen, T; Brander, C; Addo, MM; Altfeld, M; James, I; Mallal, S; Bunce, M; Barber, LD; Szinger, J; Day, C; Klenerman, P; Mullins, J; Korber, B; Coovadia, HM; Walker, BD; Goulder, PJR				Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; Moore, C; Pfafferott, KJ; Hilton, L; Zimbwa, P; Moore, S; Allen, T; Brander, C; Addo, MM; Altfeld, M; James, I; Mallal, S; Bunce, M; Barber, LD; Szinger, J; Day, C; Klenerman, P; Mullins, J; Korber, B; Coovadia, HM; Walker, BD; Goulder, PJR			Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA	NATURE			English	Article							CLASS-I MOLECULES; IMMUNE-RESPONSES; VIRUS; AIDS; TRANSMISSION; PROGRESSION; INFECTION; ALLELES; ADVANTAGE; EVOLUTION	The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8(+) T cells(1-3). HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8(+) T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8(+) T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8(+) T-cell activity(4,5). In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8(+) T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles(6-8). The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.	Univ KwaZuluNatal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4015 Durban, South Africa; Nuffield Dept Med, Dept Paediat, Oxford OX1 3SY, England; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Royal Perth Hosp, Perth, WA 6000, Australia; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; Dynal Biotech Ltd, Wirral CH62 3QL, Merseyside, England; Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; Santa Fe Inst, Santa Fe, NM 87501 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Kwazulu Natal; University of Oxford; Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Howard Hughes Medical Institute	Goulder, PJR (corresponding author), Univ KwaZuluNatal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, 719 Umbilo Rd, ZA-4015 Durban, South Africa.	philip.goulder@ndm.ox.ac.uk	Mallal, Simon Alexander/HDM-9561-2022; Addo, Marylyn M./GNP-2548-2022; Day, Cheryl L/J-9844-2012; Allen, Todd/F-5473-2011; Day, Cheryl/GQQ-9720-2022; Altfeld, Marcus/AAE-7306-2019	Mallal, Simon Alexander/0000-0002-7036-1309; Day, Cheryl L/0000-0002-6497-4846; Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; leslie, alasdair/0000-0003-2538-6467; Korber, Bette/0000-0002-2026-5757; Thobakgale-Tshabalala, Christina/0000-0001-5619-8894; Szinger, James/0000-0002-6605-9940; Brander, Christian/0000-0002-0548-5778; klenerman, paul/0000-0003-4307-9161; Addo, Marylyn/0000-0003-2836-9224				Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Marsh SG, 2000, HLA FACTS BOOK; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MCADAM SN, 1994, P NATL ACAD SCI USA, V91, P5893, DOI 10.1073/pnas.91.13.5893; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Ramos M, 2002, TISSUE ANTIGENS, V60, P191, DOI 10.1034/j.1399-0039.2002.600301.x; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0	28	618	643	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					769	774		10.1038/nature03113	http://dx.doi.org/10.1038/nature03113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592417				2022-12-24	WOS:000225597200052
J	Schwender, J; Goffman, F; Ohlrogge, JB; Shachar-Hill, Y				Schwender, J; Goffman, F; Ohlrogge, JB; Shachar-Hill, Y			Rubisco without the Calvin cycle improves the carbon efficiency of developing green seeds	NATURE			English	Article							BRASSICA-NAPUS EMBRYOS; METABOLIC NETWORKS; FLUX; OILSEEDS; PATHWAY	Efficient storage of carbon in seeds is crucial to plant fitness and to agricultural productivity. Oil is a major reserve material in most seeds(1), and these oils provide the largest source of renewable reduced carbon chains available from nature. However, the conversion of carbohydrate to oil through glycolysis results in the loss of one-third of the carbon as CO2. Here we show that, in developing embryos of Brassica napus L. (oilseed rape), Rubisco ( ribulose 1,5-bisphosphate carboxylase/oxygenase) acts without the Calvin cycle(2) and in a previously undescribed metabolic context to increase the efficiency of carbon use during the formation of oil. In comparison with glycolysis, the metabolic conversion we describe provides 20% more acetyl-CoA for fatty-acid synthesis and results in 40% less loss of carbon as CO2. Our conclusions are based on measurements of mass balance, enzyme activity and stable isotope labelling, as well as an analysis of elementary flux modes.	Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Schwender, J (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	schwend2@msu.edu	Shachar-Hill, Yair/B-6165-2013; Schwender, Jorg/P-2282-2014	Shachar-Hill, Yair/0000-0001-8793-5084; Schwender, Jorg/0000-0003-1350-4171				BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Goffman FD, 2004, PLANT PHYSIOL BIOCH, V42, P703, DOI 10.1016/j.plaphy.2004.07.003; King SP, 1998, AUST J PLANT PHYSIOL, V25, P377, DOI 10.1071/PP97157; LEVIN DA, 1974, AM NAT, V108, P193, DOI 10.1086/282899; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Schwender J, 2002, PLANT PHYSIOL, V130, P347, DOI 10.1104/pp.004275	11	343	356	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					779	782		10.1038/nature03145	http://dx.doi.org/10.1038/nature03145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592419				2022-12-24	WOS:000225597200054
J	Zhurov, V; Terzin, T; Grbic, M				Zhurov, V; Terzin, T; Grbic, M			Early blastomere determines embryo proliferation and caste fate in a polyembryonic wasp	NATURE			English	Article							SEQUENCE ALIGNMENT; EVOLUTION; SPECIFICATION; INSECTS; EXPRESSION; PATTERN	Polyembryonic development is a unique mode of metazoan development in which a single zygote generates multiple embryos by clonal proliferation(1). The polyembryonic parasitic insect Copidosoma floridanum shows one of the most extreme cases of polyembryony, producing up to 2,000 embryos from a single egg. In addition, this wasp exhibits an unusual polyphenism, producing two morphologically distinct larval castes, termed precocious and reproductive, that develop clonally from the same zygote(2). This form of development seems incompatible with a model of insect development in which maternal prepatterning of the egg specifies embryonic axial polarity(3). Here we show that maternal pre-patterning in the form of germ plasm creates cellular asymmetry at the four-cell stage embryo of Copidosoma that is perpetuated throughout development. Laser ablations of cells show that the cell inheriting the germ plasm regulates both the fate and proliferation of the reproductive caste. Thus, we have uncovered a new mechanism of caste specification, mediated by the regulatory capacity of a single cell. This study shows that the evolution of mammalian-like regulative development of an insect embryo relies on a novel cellular context that might ultimately enhance developmental plasticity.	Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Grbic, M (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	mgrbic@uwo.ca	Grbic, Miodrag/AID-4825-2022; Terzin, Tomislav/C-7592-2015	Terzin, Tomislav/0000-0001-5100-0623; Zhurov, Vladimir/0000-0002-7120-4655				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; Craig SF, 1997, EVOL ECOL, V11, P127, DOI 10.1023/A:1018443714917; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; Dearden PK, 2001, DEVELOPMENT, V128, P3435; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; Gardner RL, 2001, DEVELOPMENT, V128, P839; GEBERDING M, 2002, DEVELOPMENT, V129, P5789; Goldstein B, 1997, BIOESSAYS, V19, P105, DOI 10.1002/bies.950190205; Grbic M, 2000, BIOESSAYS, V22, P920, DOI 10.1002/1521-1878(200010)22:10&lt;920::AID-BIES7&gt;3.0.CO;2-Q; Grbic M, 1997, J INSECT PHYSIOL, V43, P553, DOI 10.1016/S0022-1910(97)00004-8; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; Grbic M, 1996, DEVELOPMENT, V122, P795; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; PEDERSEN RA, 1986, EXPT APPROACHES MAMM, P3; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schwalm F, 1988, INSECT MORPHOGENESIS; Silvestri F., 1906, ANN R SCUOLA SUP AGR, V6, P3; STJOHNSTON D, 1992, CELL, V68, P201; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; WOODRING J, 1994, J INSECT PHYSIOL, V40, P685, DOI 10.1016/0022-1910(94)90095-7	30	39	40	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					764	769		10.1038/nature03171	http://dx.doi.org/10.1038/nature03171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592416				2022-12-24	WOS:000225597200051
J	Melyan, Z; Tarttelin, EE; Bellingham, J; Lucas, RJ; Hankins, MW				Melyan, Z; Tarttelin, EE; Bellingham, J; Lucas, RJ; Hankins, MW			Addition of human melanopsin renders mammalian cells photoresponsive	NATURE			English	Article							RETINAL GANGLION-CELLS; ACTION SPECTRUM; LIGHT; OPSIN; RESPONSES; PIGMENT; SYSTEM; SUPPRESSION; PROTEINS; EXPOSURE	A small number of mammalian retinal ganglion cells act as photoreceptors for regulating certain non-image forming photoresponses(1-10). These intrinsically photosensitive retinal ganglion cells express the putative photopigment melanopsin(11-13). Ablation of the melanopsin gene renders these cells insensitive to light(14); however, the precise role of melanopsin in supporting cellular photosensitivity is unconfirmed. Here we show that heterologous expression of human melanopsin in a mouse paraneuronal cell line (Neuro-2a) is sufficient to render these cells photoreceptive. Under such conditions, melanopsin acts as a sensory photopigment, coupled to a native ion channel via a G-protein signalling cascade, to drive physiological light detection. The melanopsin photoresponse relies on the presence of cis-isoforms of retinaldehyde and is selectively sensitive to short-wavelength light. We also present evidence to show that melanopsin functions as a bistable pigment in this system, having an intrinsic photoisomerase regeneration function that is chromatically shifted to longer wavelengths.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Psychol Med, Dept Visual Neurosci, London W6 8RF, England	University of Manchester; Imperial College London	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	robert.lucas@manchester.ac.uk; m.hankins@imperial.ac.uk	Bellingham, James/GVS-8955-2022; 谭, 德华 德/D-1910-2009	Bellingham, James/0000-0003-3368-5221; Lucas, Robert/0000-0002-1088-8029				ASANO T, 1986, MOL PHARMACOL, V29, P244; Beindl W, 1996, MOL PHARMACOL, V50, P415; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Leszkiewicz DN, 2000, J PHYSIOL-LONDON, V524, P365, DOI 10.1111/j.1469-7793.2000.t01-1-00365.x; LIU RSH, 1986, BIOCHEMISTRY-US, V25, P7026, DOI 10.1021/bi00370a040; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	31	303	351	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					741	745		10.1038/nature03344	http://dx.doi.org/10.1038/nature03344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15674244				2022-12-24	WOS:000227039200039
J	Fonarow, GC; Adams, KF; Abraham, WT; Yancy, CW; Boscardin, WJ				Fonarow, GC; Adams, KF; Abraham, WT; Yancy, CW; Boscardin, WJ		ADHERE Sci Advisory Comm Study Grp	Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; WORSENING RENAL-FUNCTION; NATRIURETIC PEPTIDE; EJECTION FRACTION; OLDER PATIENTS; TRIAL; SCORE; PROGNOSIS; SURVIVAL; PREDICTORS	Context Estimation of mortality risk in patients hospitalized with acute decompensated heart failure (ADHF) may help clinicians guide care. Objective To develop a practical user-friendly bedside tool for risk stratification for patients hospitalized with ADHF. Design, Setting, and Patients The Acute Decompensated Heart Failure National Registry (ADHERE) of patients hospitalized with a primary diagnosis of ADHF in 263 hospitals in the United States was queried with analysis of patient data to develop a risk stratification model. The first 33 046 hospitalizations (derivation cohort; October 2001-February 2003) were analyzed to develop the model and then the validity of the model was prospectively tested using data from 32 229 subsequent hospitalizations (validation cohort; March-July 2003). Patients had a mean age of 72.5 years and 52% were female. Main Outcome Measure Variables predicting mortality in ADHF. Results When the derivation and validation cohorts are combined, 37 772 (58%) of 65 275 patient-records had coronary artery disease. Of a combined cohort consisting of 52 164 patient-records, 23 910 (46%) had preserved left ventricular systolic function. In-hospital mortality was similar in the derivation (4.2%) and validation (4.0%) cohorts. Recursive partitioning of the derivation cohort for 39 variables indicated that the best single predictor for mortality was high admission levels of blood urea nitrogen (greater than or equal to43 mg/dL [15.35 mmol/L]) followed by low admission systolic blood pressure (<115 mm Hg) and then by high levels of serum creatinine (&GE;2.75 mg/dL [243.1 &mu;mol/L]). A simple risk tree identified patient groups with mortality ranging from 2.1% to 21.9%. The odds ratio for mortality between patients identified as high and low risk was 12.9 (95% confidence interval, 10.4-15.9) and similar results were seen when this risk stratification was applied prospectively to the validation cohort. Conclusions These results suggest that ADHF patients at low, intermediate, and high risk for in-hospital mortality can be easily identified using vital sign and laboratory data obtained on hospital admission. The ADHERE risk tree provides clinicians with a validated, practical bedside tool for mortality risk stratification.	Univ Calif Los Angeles, Div Cardiol, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; Ohio State Univ, Med Ctr, Dept Cardiol, Columbus, OH 43210 USA; Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Div Cardiol, Ahmanson UCLA Cardiomyopathy Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; *ACC AHA WRIT COMM, ACC AHA KEY DAT EL D; ADAMS KF, IN PRESS AM HEART J; *AM HEART ASS, 2004, HEART DIS STROK STAT; Ansari M, 2003, AM HEART J, V146, P1, DOI 10.1016/S0002-8703(02)94801-5; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Blackledge HM, 2003, HEART, V89, P615, DOI 10.1136/heart.89.6.615; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Bongartz LG, 2004, HYPERTENSION, V43, pE14, DOI 10.1161/01.HYP.0000118521.06245.b8; Breiman L, 1983, CLASSIFICATION REGRE; Califf RM, 2000, CIRCULATION, V101, P2231, DOI 10.1161/01.CIR.101.19.2231; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; COHN JN, 1993, CIRCULATION, V87, P5; Cowie MR, 2003, EUR HEART J, V24, P1710, DOI 10.1016/S0195-668X(03)00476-7; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Felker GM, 2003, AM HEART J, V145, pS18, DOI 10.1067/mhj.2003.150; Felker GM, 2003, AM J CARDIOL, V92, P625, DOI 10.1016/S0002-9149(03)00740-9; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2484, DOI 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U; Gerald LB, 2002, AM J RESP CRIT CARE, V166, P1122, DOI 10.1164/rccm.200202-124OC; Havranek EP, 2002, AM HEART J, V143, P412, DOI 10.1067/mhj.2002.120773; HUNT SA, GUIDELINES EVALUATIO; Ishii J, 2003, CLIN CHEM, V49, P2020, DOI 10.1373/clinchem.2003.021311; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; Kerzner R, 2003, AM HEART J, V146, P286, DOI 10.1016/S0002-8703(03)00151-0; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krumholz HM, 2001, J AM COLL CARDIOL, V38, P453, DOI 10.1016/S0735-1097(01)01395-X; Kvasnicka HM, 2001, J CLIN ONCOL, V19, P2994, DOI 10.1200/JCO.2001.19.12.2994; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lehmann G, 2003, INT J CARDIOL, V89, P79, DOI 10.1016/S0167-5273(02)00408-4; Lewis RJ., INTRO CLASSIFICATION; Luthi J C, 2000, Eff Clin Pract, V3, P69; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Teo K, 1996, ARCH INTERN MED, V156, P1669, DOI 10.1001/archinte.156.15.1669; Yohannes Y, CLASSIFICATION REGRE; Zugck C, 2001, EUR J HEART FAIL, V3, P577, DOI 10.1016/S1388-9842(01)00167-2	46	1123	1198	1	39	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2005	293	5					572	580		10.1001/jama.293.5.572	http://dx.doi.org/10.1001/jama.293.5.572			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893BL	15687312	Bronze			2022-12-24	WOS:000226694200020
J	Kim, YK; Furic, L; DesGroseillers, L; Maquat, LE				Kim, YK; Furic, L; DesGroseillers, L; Maquat, LE			Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; ROUGH ENDOPLASMIC-RETICULUM; BINDING PROTEIN STAUFEN; HUMAN TELOMERASE RNA; RAT-BRAIN; HIPPOCAMPAL-NEURONS; TERMINATION-CODON; LOCALIZATION; DROSOPHILA	Mammalian Staufen (Stau)1 is an RNA binding protein that is thought to function in mRNA transport and translational control. Nonsense-mediated mRNA decay(NMD) degrades abnormal and natural mRNAs that terminate translation sufficiently upstream of a splicing-generated exon-exon junction. Here we describe an mRNA decay mechanism that involves Stau1, the NMD factor Upf1, and a termination codon. Unlike NMD, this mechanism does not involve pre-mRNA splicing and occurs when Upf2 or Upf3X is downregulated. Stau1 binds directly to Upf1 and elicits mRNA decay when tethered downstream of a termination codon. Stau1 also interacts with the 3'-untranslated region of ADP-ribosylation factor (Arf)1 mRNA. Accordingly, downregulating either Stau1 or Upf1 increases Arf1 mRNA stability. These findings suggest that Arf1 mRNA is a natural target for Stau1-mediated decay, and data indicate that other mRNAs are also natural targets. We discuss this pathway as a means for cells to downregulate the expression of Stau1 binding transcripts.	Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	University of Rochester; Universite de Montreal	Maquat, LE (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu	Furic, Luc/F-4886-2012	Furic, Luc/0000-0002-1893-9812; Maquat, Lynne/0000-0002-2789-2075; Kim, Yoon Ki/0000-0003-1303-072X				Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Grentzmann G, 1998, RNA, V4, P479; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IWAHANA H, 1995, BBA-GENE STRUCT EXPR, V1261, P369, DOI 10.1016/0167-4781(95)00036-G; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kielkopf CL, 2002, BIOCHEMISTRY-US, V41, P11711, DOI 10.1021/bi020393+; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Le SY, 2000, MOL BIOL CELL, V11, P999, DOI 10.1091/mbc.11.3.999; LEE CM, 1992, J BIOL CHEM, V267, P9028; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Macchi P, 2003, J NEUROSCI, V23, P5778; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Maquat LE, 2004, CURR GENOMICS, V5, P175, DOI 10.2174/1389202043349453; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mohr SE, 2001, GENE DEV, V15, P2886; Monshausen M, 2002, J NEUROCHEM, V81, P557, DOI 10.1046/j.1471-4159.2002.00887.x; Monshausen M, 2001, J NEUROCHEM, V76, P155, DOI 10.1046/j.1471-4159.2001.00061.x; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Wilusz CJ, 2001, GENE DEV, V15, P2781; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	74	375	390	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					195	208		10.1016/j.cell.2004.11.050	http://dx.doi.org/10.1016/j.cell.2004.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680326	Bronze			2022-12-24	WOS:000226740000009
J	Moles, AT; Ackerly, DD; Webb, CO; Tweddle, JC; Dickie, JB; Westoby, M				Moles, AT; Ackerly, DD; Webb, CO; Tweddle, JC; Dickie, JB; Westoby, M			A brief history of seed size	SCIENCE			English	Article							DISPERSAL; PLANTS; ANGIOSPERMS; MASS; DIVERSIFICATION; EVOLUTION; PATTERNS; TESTS	Improved phylogenies and the accumulation of broad comparative data sets have opened the way for phylogenetic analyses to trace trait evolution in major groups of organisms. We arrayed seed mass data for 12,987 species on the seed plant phylogeny and show the history of seed size from the emergence of the angiosperms through to the present day. The largest single contributor to the present-day spread of seed mass was the divergence between angiosperms and gymnosperms, whereas the widest divergence was between Celastraceae and Parnassiaceae. Wide divergences in seed size were more often associated with divergences in growth form than with divergences in dispersal syndrome or latitude. Cross-species studies and evolutionary theory are consistent with this evidence that growth form and seed size evolve in a coordinated manner.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Museum Nat Hist, London SW7 5BD, England; Royal Bot Gardens, Ardingly RH17 6TN, W Sussex, England	National Center for Ecological Analysis & Synthesis; Macquarie University; Stanford University; Yale University; Natural History Museum London; Royal Botanic Gardens, Kew	Moles, AT (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	amotes@bio.mq.edu.au	Moles, Angela T/C-3083-2008; Ackerly, David/A-1247-2009; Webb, Campbell/B-1488-2009	Moles, Angela T/0000-0003-2041-7762; Ackerly, David/0000-0002-1847-7398; Webb, Campbell/0000-0003-1031-3249; Westoby, Mark/0000-0001-7690-4530				Aarssen LW, 2001, ECOSCIENCE, V8, P471, DOI 10.1080/11956860.2001.11682677; Ackerly DD, 2004, EVOL ECOL, V18, P249, DOI 10.1023/B:EVEC.0000035031.50566.60; AXELROD DI, 1959, SCIENCE, V130, P203, DOI 10.1126/science.130.3369.203; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Charnov Eric L., 1993, P1; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; FOSTER SA, 1985, ECOLOGY, V66, P773, DOI 10.2307/1940538; HAIG D, 1991, EVOL ECOL, V5, P231, DOI 10.1007/BF02214230; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Judd W.S., 2002, PLANT SYSTEMATICS PH; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; LEISHMAN MR, 1994, AM NAT, V143, P890, DOI 10.1086/285638; LEVIN DA, 1974, AM NAT, V108, P193, DOI 10.1086/282899; Lord J, 1997, J BIOGEOGR, V24, P205, DOI 10.1046/j.1365-2699.1997.00126.x; METCALFE DJ, 1995, CAN J BOT, V73, P817, DOI 10.1139/b95-090; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; MOLES AT, UNPUB; Raven JA, 1999, FUNCT ECOL, V13, P5, DOI 10.1046/j.1365-2435.1999.00293.x; SALISBURY E, 1974, PROC R SOC SER B-BIO, V186, P83, DOI 10.1098/rspb.1974.0039; Schmidt M, 2002, J MOL EVOL, V54, P715, DOI 10.1007/s00239-001-0042-9; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; TIFFNEY BH, 1984, ANN MO BOT GARD, V71, P551, DOI 10.2307/2399037; Tiffney BH, 2004, ANNU REV ECOL EVOL S, V35, P1, DOI 10.1146/annurev.ecolsys.34.011802.132535; Wardle P., 1991, VEGETATION NZ; WEBB CO, IN PRESS MOL ECOL NO; WEBB CO, 2004, PHYLOCOM; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	33	401	460	4	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					576	580		10.1126/science.1104863	http://dx.doi.org/10.1126/science.1104863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681384				2022-12-24	WOS:000226694000046
J	Eustace, K				Eustace, K			Colorectal cancer	LANCET			English	Article																			0	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					166	166		10.1016/S0140-6736(05)17707-1	http://dx.doi.org/10.1016/S0140-6736(05)17707-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639299				2022-12-24	WOS:000226170700032
J	Ikeda, M				Ikeda, M			Family bias by proxy	LANCET			English	Editorial Material									Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan		Ikeda, M (corresponding author), Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					187	187		10.1016/S0140-6736(05)17710-1	http://dx.doi.org/10.1016/S0140-6736(05)17710-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639302				2022-12-24	WOS:000226170700035
J	Quintyne, NJ; Reing, JE; Hoffelder, DR; Gollin, SM; Saunders, WS				Quintyne, NJ; Reing, JE; Hoffelder, DR; Gollin, SM; Saunders, WS			Spindle multipolarity is prevented by centrosomal clustering	SCIENCE			English	Article							MAMMALIAN MITOTIC SPINDLE; ORAL-CANCER CELLS; CHROMOSOMAL INSTABILITY; NUMA; PROGRESSION; DEFECTS; AMPLIFICATION; MICROTUBULES; ORGANIZATION; DUPLICATION	Most tumor cells are characterized by increased genomic instability and chromosome segregational defects, often associated with hyperamplification of the centrosome and the formation of multipolar spindles. However, extra centrosomes do not always lead to multipolarity. Here, we describe a process of centrosomal clustering that prevented the formation of multipolar spindles in noncancer cells. Noncancer cells needed to overcome this clustering mechanism to allow multipolar spindles to form at a high frequency. The microtubule motor cytoplasmic dynein was a critical part of this coalescing machinery, and in some tumor cells overexpression of the spindle protein NuMA interfered with dynein localization, promoting multipolarity.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saunders, WS (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 5th Ave, Pittsburgh, PA 15260 USA.	wsaund@pitt.edu		Gollin, Susanne/0000-0001-5438-6808; Quintyne, Nicholas/0000-0002-8817-2936	NIDCR NIH HHS [DE016086, P60DE13059] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013059] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; COMPTON DA, 1995, J CELL SCI, V108, P621; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; RING D, 1982, J CELL BIOL, V94, pS49; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; SHARP GA, 1982, EUR J CELL BIOL, V29, P97; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; YOSHIDA T, 1985, CELL STRUCT FUNCT, V10, P245, DOI 10.1247/csf.10.245	27	318	326	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					127	129		10.1126/science.1104905	http://dx.doi.org/10.1126/science.1104905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637283				2022-12-24	WOS:000226214300054
J	Carreiras, M; Lopez, J; Rivero, F; Corina, D				Carreiras, M; Lopez, J; Rivero, F; Corina, D			Linguistic perception: Neural processing of a whistled language	NATURE			English	Article							SPEECH-PERCEPTION; CORTEX		Univ La Laguna, Dept Psicol Cognit, Tenerife 38205, Spain; Hosp Univ Canarias, IMETISA, Tenerife 28320, Spain; Univ Washington, Dept Psychol, Seattle, WA 98195 USA	Universidad de la Laguna; Universidad de la Laguna; University of Washington; University of Washington Seattle	Carreiras, M (corresponding author), Univ La Laguna, Dept Psicol Cognit, Tenerife 38205, Spain.	mcarreir@ull.es	Rivero, Francisco/AHI-1281-2022; Carreiras, Manuel/D-5267-2009	Carreiras, Manuel/0000-0001-6726-7613; Rivero, Francisco/0000-0002-6129-8053				Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Joanisse MF, 2003, NEUROIMAGE, V19, P64, DOI 10.1016/S1053-8119(03)00046-6; Kircher TTJ, 2001, NEUROPSYCHOLOGIA, V39, P798, DOI 10.1016/S0028-3932(01)00014-8; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Trujillo Ramon, 1978, SILBO GOMERO ANAL LI; Warren JD, 2003, J NEUROSCI, V23, P5799	13	31	31	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					31	32		10.1038/433031a	http://dx.doi.org/10.1038/433031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635400				2022-12-24	WOS:000226117100024
J	Levine, RJ; Thadhani, R; Qian, C; Lam, C; Lim, KH; Yu, KF; Blink, AL; Sachs, BP; Epstein, FH; Sibai, BM; Sukhatme, VP; Karumanchi, SA				Levine, RJ; Thadhani, R; Qian, C; Lam, C; Lim, KH; Yu, KF; Blink, AL; Sachs, BP; Epstein, FH; Sibai, BM; Sukhatme, VP; Karumanchi, SA			Urinary placental growth factor and risk of preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYROSINE KINASE-1; FACTOR RECEPTOR; HYPERTENSION; CALCIUM; TRIAL; WOMEN	Context Preeclampsia may be caused by an imbalance of angiogenic factors. We previously demonstrated that high serum levels of soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and low levels of placental growth factor (PIGF), a proangiogenic protein, predict subsequent development of preeclampsia. In the absence of glomerular disease leading to proteinuria, sFlt1 is too large a molecule to be filtered into the urine, while PIGF is readily filtered. Objective To test the hypothesis that urinary PIGF is reduced prior to onset of hypertension and proteinuria and that this reduction predicts preeclampsia. Design, Setting, and Patients Nested case-control study within the Calcium for Preeclampsia Prevention trial of healthy nulliparous women enrolled at 5 US university medical centers during 1992-1995. Each woman with preeclampsia was matched to 1 normotensive control by enrollment site, gestational age at collection of the first serum specimen, and sample Storage time at -70degreesC. One hundred twenty pairs of women were randomly chosen for analysis of serum and urine specimens obtained before labor. Main Outcome Measure Cross-sectional urinary PIGF concentrations, before and after normalization for urinary creatinine. Results Among normotensive controls, urinary PIGF increased during the first 2 trimesters, peaked at 29 to 32 weeks, and decreased thereafter. Among cases, before onset of preeclampsia the pattern of urinary PIGF was similar, but levels were significantly reduced beginning at 25 to 28 weeks. There were particularly large differences between controls and cases of preeclampsia with subsequent early onset of the disease or small-for-gestational-age infants. After onset of clinical disease, mean urinary PIGF in women with preeclampsia was 32 pg/mL, compared with 234 pg/mL in controls with fetuses of similar gestational age (P<.001). The adjusted odds ratio for the risk of preeclampsia to begin before 37 weeks of gestation for specimens obtained at 21 to 32 weeks, which were in the lowest quartile of control PIGF concentrations (<118 pg/mL), compared with all other quartiles, was 22.5 (95% confidence interval, 7.4-67.8). Conclusion Decreased urinary PIGF at mid gestation is strongly associated with subsequent early development of preeclampsia.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Renal Div, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Allied Technol Grp, Rockville, MD USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; NICHHD, Div Epidemiol Stat & Prevent Res, US Dept HHS, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Obstet, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Karumanchi, SA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Renal Div, Dana 517,330 Brookline Ave, Boston, MA 02215 USA.	sananth@bidmc.harvard.edu	Sukhatme, Vikas/W-2776-2019; Karumanchi, Subbian Ananth/AAI-1694-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013124, N01HD013121, N01HD013126, N01HD013122, N01HD053246, R01HD039223, N01HD013125, N01HD013123, Z01HD000373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002825] Funding Source: NIH RePORTER; NICHD NIH HHS [R01-HD-3-9223, N01-HD-5-3246, N01-HD-3154, N01-HD-1-3126, N01-HD-1-3125, N01-HD-1-3124, N01-HD-1-3123, N01-HD-1-3122, N01-HD-1-3121] Funding Source: Medline; NIDDK NIH HHS [KO8-DK-002825] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROWN LF, 1992, KIDNEY INT, V42, P1457, DOI 10.1038/ki.1992.441; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roes EM, 2004, INT J BIOL MARKER, V19, P72, DOI 10.1177/172460080401900110; Sibai BM, 2003, SEMIN PERINATOL, V27, P239, DOI 10.1016/S0146-0005(03)00022-3; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	20	245	276	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2005	293	1					77	85		10.1001/jama.293.1.77	http://dx.doi.org/10.1001/jama.293.1.77			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QY	15632339	Bronze			2022-12-24	WOS:000226102100024
J	Melton, DA; Daley, GQ; Jennings, CG				Melton, DA; Daley, GQ; Jennings, CG			Altered nuclear transfer in stem-cell research - A flawed proposal.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Melton, DA (corresponding author), Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; HURLBUT WB, ALTERED NUCL TRANSFE; ZUCKER HA, SESSION 6 SEEKING MO	3	50	51	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2004	351	27					2791	2792		10.1056/NEJMp048348	http://dx.doi.org/10.1056/NEJMp048348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	883IH	15625329				2022-12-24	WOS:000226004300002
J	Gutierrez, MG; Master, SS; Singh, SB; Taylor, GA; Colombo, MI; Deretic, V				Gutierrez, MG; Master, SS; Singh, SB; Taylor, GA; Colombo, MI; Deretic, V			Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages	CELL			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PHAGOSOME MATURATION; CELL-DEATH; YEAST; KINASE; AVIUM; MACROAUTOPHAGY; ACIDIFICATION; BIOGENESIS; LYSOSOMES	Mycobacterium tuberculosis is an intracellular pathogen persisting within phagosomes through interference with phagolysosome biogenesis. Here we show that stimulation of autophagic pathways in macrophages causes mycobacterial phagosomes to mature into phagolysosomes. Physiological induction of autophagy or its pharmacological stimulation by rapamycin resulted in mycobacterial phagosome colocalization with the autophagy effector LC3, an elongation factor in autophagosome formation. Autophagy stimulation increased phagosomal colocalization with Beclin-1, a subunit of the phosphatidylinositol 3-kinase hVPS34, necessary for autophagy and a target for mycobacterial phagosome maturation arrest. Induction of autophagy suppressed intracellular survival of mycobacteria. IFN-gamma induced autophagy in macrophages, and so did transfection with LRG-47, an effector of IFN-gamma required for antimycobacterial action. These findings demonstrate that autophagic pathways can overcome the trafficking block imposed by M. tuberculosis. Autophagy, which is a hormonally, developmentally, and, as shown here, immunologically regulated process, represents an underappreciated innate defense mechanism for control of intracellular pathogens.	Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Inst Histol & Embriol, RA-5500 Mendoza, Argentina; Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Duke Univ, Ctr Med, Dept Med, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Immunol, Durham, NC 27710 USA; Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of New Mexico; Duke University; Duke University; University of New Mexico	Colombo, MI (corresponding author), Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Inst Histol & Embriol, RA-5500 Mendoza, Argentina.	mcolombo@fcm.uncu.edu.ar; vderetic@salud.unm.edu		Gutierrez, Maximiliano/0000-0003-3199-0337; Deretic, Vojo/0000-0002-3624-5208	FOGARTY INTERNATIONAL CENTER [R03TW006982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831, R01AI045148, R01AI042999] Funding Source: NIH RePORTER; FIC NIH HHS [TW06982] Funding Source: Medline; NIAID NIH HHS [AI42999, AI45148, R01 AI057831] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; Dardalhon V, 2002, CELL BIOL INT, V26, P669, DOI 10.1006/cbir.2002.0917; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Saeki K, 2003, J LEUKOCYTE BIOL, V74, P1108, DOI 10.1189/jlb.0503211; Schaible UE, 1998, J IMMUNOL, V160, P1290; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; *SURV MON PROJ, JAMA, V282, P677; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Via LE, 1998, J CELL SCI, V111, P897; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; YAIKO DM, 1995, J CLIN MICROBIOL, V33, P2324; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; J BIOL CHEM, V275, P992	53	1670	1750	5	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					753	766		10.1016/j.cell.2004.11.038	http://dx.doi.org/10.1016/j.cell.2004.11.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607973	Bronze			2022-12-24	WOS:000225907200007
J	Olive, KP; Tuveson, DA; Ruhe, ZC; Yin, B; Willis, NA; Bronson, RT; Crowley, D; Jacks, T				Olive, KP; Tuveson, DA; Ruhe, ZC; Yin, B; Willis, NA; Bronson, RT; Crowley, D; Jacks, T			Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome	CELL			English	Article							WILD-TYPE; TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; FUNCTION MUTATIONS; TRANSFORMED-CELLS; OF-FUNCTION; MICE; GENE; EXPRESSION; P73	The p53 tumor suppressor gene is commonly altered in human tumors, predominantly through missense mutations that result in accumulation of mutant p53 protein. These mutations may confer dominant-negative or gain-of-function properties to p53. To ascertain the physiological effects of p53 point mutation, the structural mutant p53(R172H) and the contact mutant p53(R270H) (codons 175 and 273 in humans) were engineered into the endogenous p53 locus in mice. p53(R270H/+) and p53(R172H/-) mice are models of Li-Fraumeni Syndrome; they developed allele-specific tumor spectra distinct from p53(+/-) mice. In addition, p53(R270H/-) and p53(R172H/-) mice developed novel tumors compared to p53(-/-) mice, including a variety of carcinomas and more frequent endothelial tumors. Dominant effects that varied by allele and function were observed in primary cells derived from p53(R270H/+) and p53(R172H/+), mice. These results demonstrate that point mutant p53 alleles expressed under physiological control have enhanced oncogenic potential beyond the simple loss of p53 function.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Tufts University; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu		Olive, Kenneth/0000-0002-3392-8994				Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; BAKER SJ, 1990, CANCER RES, V50, P7717; Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CORDONCARDO C, 1994, CANCER RES, V54, P794; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eid H, 1999, ANTICANCER RES, V19, P3485; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FORRESTER K, 1995, ONCOGENE, V10, P2103; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSIAO M, 1994, AM J PATHOL, V145, P702; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kleihues P, 1997, AM J PATHOL, V150, P1; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Peller S, 1998, SEMIN CANCER BIOL, V8, P379, DOI 10.1006/scbi.1998.0100; PURDIE CA, 1994, ONCOGENE, V9, P603; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SHAULSKY G, 1991, CANCER RES, V51, P5232; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Webley KM, 2000, J PATHOL, V191, P361; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	56	914	931	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					847	860		10.1016/j.cell.2004.11.004	http://dx.doi.org/10.1016/j.cell.2004.11.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607980	Bronze			2022-12-24	WOS:000225907200014
J	Saper, RB; Kales, SN; Paquin, J; Burns, MJ; Eisenberg, DM; Davis, RB; Phillips, RS				Saper, RB; Kales, SN; Paquin, J; Burns, MJ; Eisenberg, DM; Davis, RB; Phillips, RS			Heavy metal content of Ayurvedic herbal medicine products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD LEAD; EXPOSURE	Context Lead, mercury, and arsenic intoxication have been associated with the use of Ayurvedic herbal medicine product (HMPs). Objectives To determine the prevalence and concentration of heavy metals in Ayurvedic HMPs manufactured in South Asia and sold in Boston-area stores and to compare estimated daily metal ingestion with regulatory standards. Design and Setting Systematic search strategy to identify all stores 20 miles or less from Boston City Hall that sold Ayurvedic HMPs from South Asia by searching online Yellow Pages using the categories markets, supermarkets, and convenience stores, and business names containing the word India, Indian cities, and Indian words. An online national directory of Indian grocery stores, a South Asian community business directory, and a newspaper were also searched. We visited each store and purchased all unique Ayurvedic HMPs between April 25 and October 24, 2003. Main Outcome Measures Concentrations (mug/g) of lead, mercury, and arsenic in each HMP as measured by x-ray fluorescence spectroscopy. Estimates of daily metal ingestion for adults and children estimated using manufacturers' dosage recommendations with comparisons to US Pharmacopeia and US Environmental Protection Agency regulatory standards. Results A total of 14 (20%) of 70 HMPs (95% confidence interval, 11%-31%) contained heavy metals: lead (n=13; median concentration, 40 mug/g; range, 5-37000), mercury (n=6; median concentration, 20225 mug/g; range, 28-104000), and/or arsenic (n=6; median concentration, 430 mug/g; range, 37-8130). If taken as recommended by the manufacturers, each of these 14 could result in heavy metal intakes above published regulatory standards. Conclusions One of 5 Ayurvedic HMPs produced in South Asia and available in Boston South Asian grocery stores contains potentially harmful levels of lead, mercury, and/or arsenic. Users of Ayurvedic medicine may be at risk for heavy metal toxicity, and testing of Ayurvedic HMPs for toxic heavy metals should be mandatory.	Harvard Univ, Sch Med, Osher Inst, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Emergency Med, Div Toxicol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Cambridge Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; US EPA, New England Reg Lab, N Chelmsford, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard T.H. Chan School of Public Health; United States Environmental Protection Agency	Saper, RB (corresponding author), Boston Univ, Sch Med, Dept Family Med, 1 Boston Med Ctr Pl,Dowling 5 S, Boston, MA 02118 USA.	robert.saper@bmc.org	Saper, Robert B/Y-4598-2018	Saper, Robert B/0000-0002-0992-6198	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K24AT000589] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT000051] Funding Source: NIH RePORTER; NCCIH NIH HHS [K24 AT00589, T32 AT00051] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ACHARYA VJT, 1998, RASAMRITAM; AlKhayat S, 1997, ANN TROP PAEDIATR, V17, P39; Ang HH, 2003, HUM EXP TOXICOL, V22, P445, DOI 10.1191/0960327103ht382oa; [Anonymous], 2011, NAT I STAND TECHN ST; ASLAM M, 1979, PUBLIC HEALTH, V93, P274, DOI 10.1016/S0033-3506(79)80078-5; Baer RD, 1998, SOC SCI MED, V47, P1263, DOI 10.1016/S0277-9536(98)00183-X; Barnes PM., 2004, COMPLEMENTARY ALTERN; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P638; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P643; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P582; CHONGHAI T, 1975, MED J AUSTRALIA, V2, P424, DOI 10.5694/j.1326-5377.1975.tb105939.x; Chopra A, 2002, MED CLIN N AM, V86, P75, DOI 10.1016/S0025-7125(03)00073-7; Dwivedi SK, 2002, ARCH ENVIRON HEALTH, V57, P229, DOI 10.1080/00039890209602941; Ernst E, 2002, EUR J CLIN PHARMACOL, V57, P891, DOI 10.1007/s00228-001-0400-y; Gogtay NJ, 2002, DRUG SAFETY, V25, P1005, DOI 10.2165/00002018-200225140-00003; GUNN VL, 2002, H LANE HDB, P722; HONTZ J, 2004, LOS ANGELES TIM 0126, P1; Ibrahim AS, 2002, SAUDI MED J, V23, P591; KLAASSEN CD, 2001, GOODMAN GILMANS PHAR, P1851; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Lecours S, 1989, Can Dis Wkly Rep, V15, P177; Lekouch N, 2001, SCI TOTAL ENVIRON, V280, P39, DOI 10.1016/S0048-9697(01)00801-4; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Marcus DM, 2002, NEW ENGL J MED, V347, P2073, DOI 10.1056/NEJMsb022858; MCELVAINE MD, 1990, JAMA-J AM MED ASSOC, V264, P2212; Moore C, 2000, PEDIATRICS, V106, P600, DOI 10.1542/peds.106.3.600; Nash D, 2003, JAMA-J AM MED ASSOC, V289, P1523, DOI 10.1001/jama.289.12.1523; PrpicMajic D, 1996, J TOXICOL-CLIN TOXIC, V34, P417, DOI 10.3109/15563659609013812; Spriewald BM, 1999, OCCUP ENVIRON MED, V56, P282, DOI 10.1136/oem.56.4.282; Tait PA, 2002, MED J AUSTRALIA, V177, P193, DOI 10.5694/j.1326-5377.2002.tb04731.x; Tertian R., 1982, PRINCIPLES QUANTITAT; Traub SJ, 2002, J TOXICOL-CLIN TOXIC, V40, P781, DOI 10.1081/CLT-120015839; *US EPA, 2004, INT RISK INF SYST; *US PHARM CONV INC, 2003, 2004 USP, V27; Weide R, 2003, DEUT MED WOCHENSCHR, V128, P2418, DOI 10.1055/s-2003-43590; 2003, INDIA NEW ENGLA 0501, P27; INDIAN GROCERIES US	38	405	412	3	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2868	2873		10.1001/jama.292.23.2868	http://dx.doi.org/10.1001/jama.292.23.2868			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598918				2022-12-24	WOS:000225694500024
J	Green, JL; Holmes, AJ; Westoby, M; Oliver, I; Briscoe, D; Dangerfield, M; Gillings, M; Beattie, AJ				Green, JL; Holmes, AJ; Westoby, M; Oliver, I; Briscoe, D; Dangerfield, M; Gillings, M; Beattie, AJ			Spatial scaling of microbial eukaryote diversity	NATURE			English	Article							SPECIES-AREA RELATIONSHIPS; BIODIVERSITY; SOIL; COMMUNITIES; ECOLOGY; SIMILARITY; BACTERIAL; DISTANCE; SYSTEMS; DECAY	Patterns in the spatial distribution of organisms provide important information about mechanisms that regulate the diversity of life and the complexity of ecosystems(1,2). Although microorganisms may comprise much of the Earth's biodiversity(3,4) and have critical roles in biogeochemistry and ecosystem functioning(5-7), little is known about their spatial diversification. Here we present quantitative estimates of microbial community turnover at local and regional scales using the largest spatially explicit microbial diversity data set available (> 10(6) sample pairs). Turnover rates were small across large geographical distances, of similar magnitude when measured within distinct habitats, and did not increase going from one vegetation type to another. The taxa - area relationship of these terrestrial microbial eukaryotes was relatively flat (slope z = 0.074) and consistent with those reported in aquatic habitats(8,9). This suggests that despite high local diversity, microorganisms may have only moderate regional diversity. We show how turnover patterns can be used to project taxa - area relationships up to whole continents. Taxa dissimilarities across continents and between them would strengthen these projections. Such data do not yet exist, but would be feasible to collect.	Macquarie Univ, Dept Biol Sci, Key Ctr Biodivers & Bioresources, N Ryde, NSW 2109, Australia; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ New England, New S Wales Dept Infrastruct Planning & Nat Resou, Armidale, NSW 2351, Australia	Macquarie University; University of Sydney; University of New England	Green, JL (corresponding author), Univ Calif, Sch Nat Sci, POB 2039, Merced, CA 95344 USA.	jgreen@ucmerced.edu	Green, Jessica/C-4828-2009; Carneiro, Fernanda/E-9513-2013; Holmes, Andrew/A-4618-2009; Gillings, Michael R/C-6553-2008; Gillings, Michael/AAF-5772-2020; Holmes, Andrew/AAI-2845-2020	Carneiro, Fernanda/0000-0001-6389-4564; Gillings, Michael R/0000-0002-4043-4351; Gillings, Michael/0000-0002-4043-4351; Westoby, Mark/0000-0001-7690-4530				[Anonymous], 2012, NUMERICAL ECOLOGY; Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Balser TC, 2001, MONOGRAPHS POPULATIO, P265; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Finlay BJ, 1998, PROTIST, V149, P29, DOI 10.1016/S1434-4610(98)70007-0; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Harrison S, 1997, ECOLOGY, V78, P1898, DOI 10.1890/0012-9658(1997)078[1898:HNHPAT]2.0.CO;2; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Manly B. F. J, 1997, RANDOMIZATION BOOTST; Morin PJ, 2004, OIKOS, V104, P458, DOI 10.1111/j.0030-1299.2004.13256.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; ODEN NL, 1992, J CLASSIF, V9, P275, DOI 10.1007/BF02621410; Oliver I, 2004, ECOL APPL, V14, P485, DOI 10.1890/02-5181; Ovreas L, 2000, ECOL LETT, V3, P236, DOI 10.1046/j.1461-0248.2000.00148.x; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Schluter Dolph, 1993, P1; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wardle DA., 2002, COMMUNITIES ECOSYSTE, P7; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Yeates C, 1998, LETT APPL MICROBIOL, V27, P49, DOI 10.1046/j.1472-765X.1998.00383.x	30	427	464	15	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					747	750		10.1038/nature03034	http://dx.doi.org/10.1038/nature03034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592411				2022-12-24	WOS:000225597200046
J	Valadkhan, S				Valadkhan, S			Construction of a minimal, protein-free spliceosome	SCIENCE			English	Editorial Material							TERTIARY INTERACTION; SNRNAS; U6		Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Valadkhan, S (corresponding author), Case Western Reserve Univ, 2109 Adelbert Rd,Wood RT 100-8, Cleveland, OH 44106 USA.	saba.valadkhan@case.edu	Valadkhan, Saba/G-5561-2010; Valadkhan, Saba/G-7271-2012					Collins CA, 2000, NAT STRUCT BIOL, V7, P850; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; Valadkhan S, 2003, RNA, V9, P892, DOI 10.1261/rna.5440303; Valadkhan S, 2002, NAT STRUCT BIOL, V9, P498, DOI 10.1038/nsb0702-498; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H	8	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					863	864		10.1126/science.1110022	http://dx.doi.org/10.1126/science.1110022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705832				2022-12-24	WOS:000226985100034
J	Jordan, IK; Kondrashov, FA; Adzhubei, IA; Wolf, YI; Koonin, EV; Kondrashov, AS; Sunyaev, S				Jordan, IK; Kondrashov, FA; Adzhubei, IA; Wolf, YI; Koonin, EV; Kondrashov, AS; Sunyaev, S			A universal trend of amino acid gain and loss in protein evolution	NATURE			English	Article							FREQUENCIES; SEQUENCES; ALIGNMENT; GENE	Amino acid composition of proteins varies substantially between taxa and, thus, can evolve. For example, proteins from organisms with ( G+C)- rich ( or ( A+T)- rich) genomes contain more ( or fewer) amino acids encoded by ( G+C)- rich codons(1 - 4). However, no universal trends in ongoing changes of amino acid frequencies have been reported. We compared sets of orthologous proteins encoded by triplets of closely related genomes from 15 taxa representing all three domains of life ( Bacteria, Archaea and Eukaryota), and used phylogenies to polarize amino acid substitutions. Cys, Met, His, Ser and Phe accrue in at least 14 taxa, whereas Pro, Ala, Glu and Gly are consistently lost. The same nine amino acids are currently accrued or lost in human proteins, as shown by analysis of non- synonymous single-nucleotide polymorphisms. All amino acids with declining frequencies are thought to be among the first incorporated into the genetic code; conversely, all amino acids with increasing frequencies, except Ser, were probably recruited late(5 - 7). Thus, expansion of initially under- represented amino acids, which began over 3,400 million years ago(8,9), apparently continues to this day.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kondrashov, AS (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	kondrashov@ncbi.nlm.nih.gov; ssunyaev@rics.bwh.harvard.edu	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Wolf, Yuri/0000-0002-0247-8708; Adzhubey, Ivan/0000-0002-1483-9259	NATIONAL LIBRARY OF MEDICINE [Z01LM000095] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Feng DF, 1996, METHOD ENZYMOL, V266, P368; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; Gu X, 1998, GENETICA, V102-3, P383, DOI 10.1023/A:1017028102013; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; HOLM S, 1979, SCAND J STAT, V6, P65; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KNIGHT RD, 2001, GENOME BIOL, V4; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Sorhannus U, 1999, J MOL EVOL, V48, P209, DOI 10.1007/PL00006459; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Wang HC, 2004, MOL BIOL EVOL, V21, P90, DOI [10.1093/molbev/msh003, 10.1093/molbev/msg003]; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	30	196	200	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					633	638		10.1038/nature03306	http://dx.doi.org/10.1038/nature03306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15660107				2022-12-24	WOS:000226862000045
J	Todo, Y; Kitazato, H; Hashimoto, J; Gooday, AJ				Todo, Y; Kitazato, H; Hashimoto, J; Gooday, AJ			Simple foraminifera flourish at the ocean's deepest point	SCIENCE			English	Article							CHALLENGER DEEP; MARIANA TRENCH		Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; Shizuoka Univ, Sch Sci, Dept Life & Earth Sci, Shizuoka, Japan; U Dom Corp, Tokyo, Japan; Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; Southampton Oceanog Ctr, DEEPSEAS Benth Biol Grp, Southampton SO143 ZH, Hants, England	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Shizuoka University; Nagasaki University; NERC National Oceanography Centre	Kitazato, H (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Natsushimacho 2-15, Yokosuka, Kanagawa 2370061, Japan.	kitazatoh@jamstec.go.jp; ang@soton.soc.ac.jp	Gooday, Andrew/ABB-4267-2020; Gooday, Andrew/AAH-8991-2021	Gooday, Andrew/0000-0002-5661-7371; 				Akimoto K, 2001, MAR MICROPALEONTOL, V42, P95, DOI 10.1016/S0377-8398(01)00012-3; Fujioka K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013595; Gooday AJ, 2002, J FORAMIN RES, V32, P384, DOI 10.2113/0320384; HASHIMOTO J, 2002, KR0213 JAMSTEC; Meisterfeld R, 2001, PROTIST, V152, P185, DOI 10.1078/1434-4610-00058; Pawlowski J, 2003, P NATL ACAD SCI USA, V100, P11494, DOI 10.1073/pnas.2035132100; Sabbatini A, 2002, J MICROPALAEONTOL, V21, P131, DOI 10.1144/jm.21.2.131	7	61	66	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					689	689		10.1126/science.1105407	http://dx.doi.org/10.1126/science.1105407			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692042				2022-12-24	WOS:000226814900032
J	Darby, S; Hill, D; Auvinen, A; Barrios-Dios, JM; Baysson, H; Bochicchio, F; Deo, H; Falk, R; Forastiere, F; Hakama, M; Heid, I; Kreienbrock, L; Kreuzer, M; Lagarde, F; Makelainen, I; Muirhead, C; Oberaigner, W; Pershagen, G; Ruano-Ravina, A; Ruosteenoja, E; Rosario, AS; Tirmarche, M; Tomasek, L; Whitley, E; Wichmann, HE; Doll, R				Darby, S; Hill, D; Auvinen, A; Barrios-Dios, JM; Baysson, H; Bochicchio, F; Deo, H; Falk, R; Forastiere, F; Hakama, M; Heid, I; Kreienbrock, L; Kreuzer, M; Lagarde, F; Makelainen, I; Muirhead, C; Oberaigner, W; Pershagen, G; Ruano-Ravina, A; Ruosteenoja, E; Rosario, AS; Tirmarche, M; Tomasek, L; Whitley, E; Wichmann, HE; Doll, R			Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESIDENTIAL RADON; INDOOR RADON; EXPOSURE; MORTALITY	Objective To determine the risk of lung cancer associated with exposure at home to the radioactive disintegration products of naturally Occurring radon gas. Design Collaborative analysis of individual data from 13 case-control studies of residential radon and lung cancer. Setting Nine European countries. Subjects 7148 cases Of lung cancer and 14 208 controls. Main outcome measures Relative risks of lung cancer and radon gas concentrations in homes inhabited during the previous 5-34 years measured in becquerels (radon disintegrations per second) per cubic incite (Bq/m(3)) Of household air. Results The mean measured radon concentration in homes of people in tire control group was 97 Bq/m(3), with 11% measuring > 200 and 4% measuring > 400 Bq/m(3). For cases of lung cancer the mean concentration was 104 Bq/m(3). The risk of lung cancer increased by 8.4% (95% confidence interval 3.0% to 15.8%) per 100 Bq/m(3) increase in measured radon (P = 0.0007). This corresponds to an increase of 16% (5% to 31%) per 100 Bq/m(3) increase in usual radon-that is, after correction for the dilution caused by random uncertainties in measuring radon concentrations. The dose-response relation seemed to be linear with no threshold and remained significant (P=0.04) in analyses limited to individuals from homes with measured radon < 200 Bq/m(3). The proportionate excess risk did not differ significantly with study, age, sex, or smoking. In the absence of other causes of death, the absolute risks of lung cancer by age 75 years at usual radon concentrations of 0, 100, and 400 Bq/m(3) would be about 0.4%, 0.5%, and 0.7%, respectively, for lifelong non-smokers, and about 25 times greater (10%, 12%, and 16%) for cigarette smokers. Conclusions Collectively, though not separately, these studies show appreciable hazards from residential radon, particularly for smokers and recent ex-smokers, and indicate that it is responsible for about 2% of all deaths from cancer in Europe.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; Univ Santiago de Compostela, Area Prevent Med & Publ Hlth, Santiago De Compostela, Spain; Inst Radioprotect & Surete Nucl, Direct Radioprotect Homme, Serv Radiobiol & Epidemiol, Fontenay Aux Roses, France; Italian Natl Inst Hlth, Dept Technol & Hlth, Unit Radioact & Hlth Effects, Rome, Italy; Univ Reading, Dept Appl Stat, Reading RG6 2AL, Berks, England; Swedish Radiat Protect Author, SE-17116 Stockholm, Sweden; Rome E Hlth Author, Dept Epidemiol, Rome, Italy; Finnish Canc Registry, FIN-00170 Helsinki, Finland; GSF, Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; Univ Vet Med, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Neuherberg, Germany; Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; STUK Radiat & Nucl Safety Author, Helsinki, Finland; Natl Radiol Protect Board, Didcot OX11 0RQ, Oxon, England; Tumorregister Tirol, Innsbruck, Austria; Natl Radiat Protect Inst, Epidemiol Unit, Prague, Czech Republic; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Tampere University; Universidade de Santiago de Compostela; Istituto Superiore di Sanita (ISS); University of Reading; Finnish Cancer Registry; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Veterinary Medicine Hannover, Foundation; Karolinska Institutet; Radiation & Nuclear Safety Authority (STUK); National Radiation Protection Institute; State Office for Nuclear Safety - Czech Republic; University of Bristol	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.	sarah.darby@ctsu.ox.ac.uk	Ruano-Ravina, Alberto/M-5705-2018; Wichmann, Heinz Erich/AAA-5695-2022; Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020; BOCHICCHIO, FRANCESCO/E-2134-2015; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Forastiere, Francesco/J-9067-2016	Ruano-Ravina, Alberto/0000-0001-9927-7453; Auvinen, Anssi/0000-0003-1125-4818; Forastiere, Francesco/0000-0002-9162-5684; Muirhead, Colin/0000-0001-5394-1267; BARROS-DIOS, JUAN MIGUEL/0000-0002-8632-6540; Pershagen, Goran/0000-0002-9701-1130; Baysson, Helene/0000-0003-4676-4500				Auvinen A, 1996, J NATL CANCER I, V88, P966, DOI 10.1093/jnci/88.14.966; Auvinen A, 1998, JNCI-J NATL CANCER I, V90, P401; Barros-Dios JM, 2002, AM J EPIDEMIOL, V156, P548, DOI 10.1093/aje/kwf070; Baysson H, 2004, EPIDEMIOLOGY, V15, P709, DOI 10.1097/01.ede.0000142150.60556.b8; BOCHICCHIO F, IN PRESS INT J CANC; Darby S, 1998, BRIT J CANCER, V78, P394, DOI 10.1038/bjc.1998.506; DARBY S, IN PRESS SCAND J WOR; HEID IM, IN PRESS J TOXICOL E; *INT AG RES CANC, 2000, IARC MON EV CARC R 2, V78; International Agency for Research on Cancer, 2001, IARC MON EV CARC R 2, V78; KREWSKI D, IN PRESS EPIDEMIOLOG; Lagarde F, 1997, HEALTH PHYS, V72, P269, DOI 10.1097/00004032-199702000-00010; Lagarde F, 2001, EPIDEMIOLOGY, V12, P396, DOI 10.1097/00001648-200107000-00009; Lubin JH, 2004, INT J CANCER, V109, P132, DOI 10.1002/ijc.11683; Lubin JH, 1997, RADIAT RES, V147, P126, DOI 10.2307/3579412; National Research Council (US), 1999, COMM HLTH RISKS EXP; Oberaigner W., 2002, RADON LUNGENKREBS BE; Pavia M, 2003, B WORLD HEALTH ORGAN, V81, P732; PERSHAGEN G, 1992, HEALTH PHYS, V63, P179, DOI 10.1097/00004032-199208000-00004; PERSHAGEN G, 1994, NEW ENGL J MED, V330, P159, DOI 10.1056/NEJM199401203300302; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Puskin JS, 2003, HEALTH PHYS, V84, P526, DOI 10.1097/00004032-200304000-00012; Ruosteenoja E, 1996, HEALTH PHYS, V71, P185, DOI 10.1097/00004032-199608000-00009; Tomasek L, 2001, Cent Eur J Public Health, V9, P150; *UN SCI COMM EFF A, 2000, SOURC EFF ION RAD UN, V1; Wichmann HE, 2005, HEALTH PHYS, V88, P71, DOI 10.1097/01.HP.0000142497.31627.86; WICHMANN HE, IN PRESS HLTH PHYS	27	1008	1062	6	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2005	330	7485					223	226		10.1136/bmj.38308.477650.63	http://dx.doi.org/10.1136/bmj.38308.477650.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15613366	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000226779400017
J	Pray-Grant, MG; Daniel, JA; Schieltz, D; Yates, JR; Grant, PA				Pray-Grant, MG; Daniel, JA; Schieltz, D; Yates, JR; Grant, PA			Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATION-FACTORS; ACTIVE GENES; CHROMATIN; YEAST; H3; TRANSCRIPTION; COMPLEXES; DOMAIN; ASSOCIATION	The specific post-translational modifications to histones influence many nuclear processes including gene regulation, DNA repair and replication(1). Recent studies have identified effector proteins that recognize patterns of histone modification and transduce their function in downstream processes(2). For example, histone acetyltransferases (HATs) have been shown to participate in many essential cellular processes, particularly those associated with activation of transcription(3). Yeast SAGA (Spt-Ada-Gcn5 acetyltransferase) and SLIK (SAGA-like) are two highly homologous and conserved multi-subunit HAT complexes, which preferentially acetylate histones H3 and H2B and deubiquitinate histone H2B. Here we identify the chromatin remodelling protein Chd1 (chromo-ATPase/helicase-DNAbinding domain 1) as a component of SAGA and SLIK. Our findings indicate that one of the two chromodomains of Chd1 specifically interacts with the methylated lysine 4 mark on histone H3 that is associated with transcriptional activity. Furthermore, the SLIK complex shows enhanced acetylation of a methylated substrate and this activity is dependent upon a functional methyl-binding chromodomain, both in vitro and in vivo. Our study identifies the first chromodomain that recognizes methylated histone H3 (Lys 4) and possibly identifies a larger subfamily of chromodomain proteins with similar recognition properties.	Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Diversa Corp, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Virginia; Scripps Research Institute	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pag9n@virginia.edu	Daniel, Jeremy/S-4729-2016	Daniel, Jeremy/0000-0002-1981-5571				Bernstein NA, 1999, MOTOR CONTROL, V3, P4; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Torok MS, 2004, ADV PROTEIN CHEM, V67, P181; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	30	372	401	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					434	438		10.1038/nature03242	http://dx.doi.org/10.1038/nature03242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15647753				2022-12-24	WOS:000226546200047
J	Lazar, MA				Lazar, MA			How obesity causes diabetes: Not a tall tale	SCIENCE			English	Editorial Material							INDUCED INSULIN-RESISTANCE; FREE FATTY-ACIDS; METABOLIC SYNDROME; STRESS-RESPONSE; ADIPOSE-TISSUE; LINKS OBESITY; PPAR-GAMMA; MELLITUS; INFLAMMATION; LEPTIN	The epidemic of obesity-associated diabetes is a major crisis in modern societies, in which food is plentiful and exercise is optional. The biological basis of this problem has been explored from evolutionary and mechanistic perspectives. Evolutionary theories, focusing on the potential survival advantages of "thrifty" genes that are now maladaptive, are of great interest but are inherently speculative and difficult to prove. Mechanistic studies have revealed numerous fat-derived molecules and a link to inflammation that, together, are hypothesized to underlie the obesity-diabetes connection and thereby represent prospective targets for therapeutic intervention.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mait.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019					Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Damcott CM, 2003, ENDOCRIN METAB CLIN, V32, P761, DOI 10.1016/S0889-8529(03)00076-8; Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GOULD SJ, 1996, NAT HIST, V5, P18; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Haluzik M, 2004, PHYSIOL RES, V53, P123; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ottaviani E, 1998, DOMEST ANIM ENDOCRIN, V15, P291, DOI 10.1016/S0739-7240(98)00021-6; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Petersen M, 2003, DIABETES CARE, V26, P917; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Weyer C, 2001, MOL GENET METAB, V72, P231, DOI 10.1006/mgme.2001.3147; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zimmet P, 2003, J INTERN MED, V254, P114, DOI 10.1046/j.1365-2796.2003.01170.x	51	425	460	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					373	375		10.1126/science.1104342	http://dx.doi.org/10.1126/science.1104342			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662001				2022-12-24	WOS:000226492300031
J	de Garidel-Thoron, T; Rosenthal, Y; Bassinot, F; Beaufort, L				de Garidel-Thoron, T; Rosenthal, Y; Bassinot, F; Beaufort, L			Stable sea surface temperatures in the western Pacific warm pool over the past 1.75 million years	NATURE			English	Article							LAST GLACIAL MAXIMUM; CLIMATE; FORAMINIFERA; MAGNITUDE; PATTERNS; ATLANTIC; RATIOS; SST	About 850,000 years ago, the period of the glacial cycles changed from 41,000 to 100,000 years. This mid-Pleistocene climate transition has been attributed to global cooling, possibly caused by a decrease in atmospheric carbon dioxide concentrations(1,2). However, evidence for such cooling is currently restricted to the cool upwelling regions in the eastern equatorial oceans(3,4), although the tropical warm pools on the western side of the ocean basins are particularly sensitive to changes in radiative forcing(5,6). Here we present high-resolution records of sea surface temperatures spanning the past 1.75 million years, obtained from oxygen isotopes and Mg/Ca ratios in planktonic foraminifera from the western Pacific warm pool. In contrast with the eastern equatorial regions, sea surface temperatures in the western Pacific warm pool are relatively stable throughout the Pleistocene epoch, implying little long-term change in the tropical net radiation budget. Our results challenge the hypothesis of a gradual decrease in atmospheric carbon dioxide concentrations as a dominant trigger of the longer glacial cycles since 850,000 years ago. Instead, we infer that the temperature contrast across the equatorial Pacific Ocean increased, which might have had a significant influence on the mid-Pleistocene climate transition.	Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; CEA, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Aix Marseille 3, CNRS, CEREGE, F-135345 Aix En Provence 4, France	Rutgers State University New Brunswick; Rutgers State University New Brunswick; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	de Garidel-Thoron, T (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	garidel@marine.rutgers.edu	Beaufort, Luc/ABG-2289-2021; Beaufort, Luc/AAH-5305-2021; de Garidel-Thoron, Thibault/B-1204-2008	Beaufort, Luc/0000-0001-6055-9373; de Garidel-Thoron, Thibault/0000-0001-8983-9571				Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Carcaillet JT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017550; CONKRIGHT M, 1998, 16 NODC; Delcroix T, 1998, J GEOPHYS RES-OCEANS, V103, P18611, DOI 10.1029/98JC00814; DELCROIX T, 2002, J GEOPHYS RES-OCEANS, V107, P22135; HALPERT MS, 1992, J CLIMATE, V5, P577, DOI 10.1175/1520-0442(1992)005<0577:STPAWT>2.0.CO;2; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Kawahata H, 2002, DEEP-SEA RES PT II, V49, P2783, DOI 10.1016/S0967-0645(02)00058-9; KIEFER T, IN PRESS QUAT SCI RE; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Marlow JR, 2000, SCIENCE, V290, P2288; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Rosenthal Y, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000749; Rosenthal Y, 1999, ANAL CHEM, V71, P3248, DOI 10.1021/ac981410x; Schefuss E, 2003, NATURE, V422, P418, DOI 10.1038/nature01500; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Sun DZ, 2003, J CLIMATE, V16, P185, DOI 10.1175/1520-0442(2003)016<0185:APEOAI>2.0.CO;2; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627; Visser K, 2003, NATURE, V421, P152, DOI 10.1038/nature01297; Yin JH, 2001, J CLIMATE, V14, P565, DOI 10.1175/1520-0442(2001)014<0565:TIOTSS>2.0.CO;2	30	190	196	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					294	298		10.1038/nature03189	http://dx.doi.org/10.1038/nature03189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662419				2022-12-24	WOS:000226381300050
J	Bloom, S; Rguig, A; Berraho, A; Zniber, L; Bouazzaoui, N; Zaghloul, K; Reef, S; Zidouh, A; Papania, M; Seward, J				Bloom, S; Rguig, A; Berraho, A; Zniber, L; Bouazzaoui, N; Zaghloul, K; Reef, S; Zidouh, A; Papania, M; Seward, J			Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment	LANCET			English	Article							DEVELOPING-COUNTRIES; SYNDROME CRS; CHILDREN; ABNORMALITIES; DISEASE; SCHOOL; DEAF	Background WHO recommends that countries considering introduction of rubella vaccine into their immunisation programme assess their burden of congenital rubella syndrome, to determine whether vaccination is warranted. However, few guidelines exist for such assessments in developing countries. We retrospectively estimated the burden of congenital rubella syndrome in Morocco, and assessed our methods of rapid case finding. Methods We undertook case finding in the two cities with Morocco's main tertiary care referral centres, using medical records from births between Jan 1, 1990, and May 31, 2002, disability records from 1965 to 1997, and retinal examinations from deaf students born between 1985 and 1994, applying the WHO definition for a clinically confirmed case of congenital rubella syndrome. We also reviewed disability data for evidence of epidemic periodicity and estimated yearly incidence of the syndrome from congenital cataract data for births between 1990 and 2001. Findings We identified 62 clinically confirmed cases of congenital rubella syndrome from medical records, 148 from disability records, and 15 in deaf students. We noted no epidemic periodicity in disability data, and estimated a yearly incidence of the syndrome in Morocco of 8.1-12.7 cases per 100 000 livebirths. Interpretation We show evidence of congenital rubella syndrome in Morocco and support the addition of rubella vaccination to the national programme. Various data sources can be explored to rapidly assess burden of the syndrome; ophthalmology departments and outpatient cardiology clinics could offer the most potential for such case finding, dependent on documentation practices.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Minist Hlth, Dept Epidemiol & Dis Prevent, Rabat, Morocco; Ibn Sina Univ Hosp, Dept Ophthalmol, Rabat, Morocco; Ctr Cardiol, Rabat, Morocco; Ibn Sina Univ Hosp, Childrens Hosp, Dept Neonatol, Rabat, Morocco; Ibn Rochd Univ Hosp, Dept Paediat Ophthalmol, Casablanca, Morocco	Centers for Disease Control & Prevention - USA; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca	Bloom, S (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, MS E-61, Atlanta, GA 30333 USA.	SBloom@cdc.gov						[Anonymous], 2003, B WORLD HEAL ORGAN; AZELMAT M, 1999, NATL SURVEY MOTHER C; BLICHTEINWINICK.D, 2002, ANALES FACULTAD MED, V63, P1; BLITCHTEINWINIC.D, 2002, ANALES FACULTAD MED, V63, P93; BOUAZZAOUI NL, 1994, B ACAD NAT MED PARIS, V178, P1013; Cooper L Z, 1969, Dis Mon, P3; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; CUTTS FT, 1999, WHOVB9922; DUDGEON JA, 1972, POSTGRAD MED J, V48, P7; Durkin MS, 2000, AM J EPIDEMIOL, V152, P1024, DOI 10.1093/aje/152.11.1024; Eckstein M, 1996, BRIT J OPHTHALMOL, V80, P628, DOI 10.1136/bjo.80.7.628; ELANGO S, 1994, ANN TROP PAEDIATR, V14, P149, DOI 10.1080/02724936.1994.11747708; GUESSOUSIDRISSI N, 1984, PATHOL BIOL, V32, P761; Hanioglu-Kargi S, 2003, TURKISH J PEDIATR, V45, P39; ISACSOHN M, 1979, ISRAEL J MED SCI, V15, P17; Nejmi S, 1972, Maroc Med, V52, P420; NEJMI S, 2000, P 5 NAT C NEON OCT 2, P77; ORENSTEIN WA, 1985, REV INFECT DIS, V7, pS22; PECKHAM CS, 1972, ARCH DIS CHILD, V47, P571, DOI 10.1136/adc.47.254.571; Preblud S R, 1980, Epidemiol Rev, V2, P171; Rahman M. M., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P811; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928; ROBERTSON SE, 2004, REV PANAM SALUD PUBL, V14, P306; RUDOLPH A J, 1972, International Ophthalmology Clinics, V12, P3, DOI 10.1097/00004397-197201220-00003; SHIFF GM, 1970, PERINATAL INFECT, P31; SIEGEL M, 1968, JAMA-J AM MED ASSOC, V203, P116; Wolf SM, 1973, J PEDIATR OPHTHALMOL, V10, P101; World Health Organization, 2000, WKLY EPIDEMIOL REC, V75, P161	30	22	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					135	141		10.1016/S0140-6736(05)17703-4	http://dx.doi.org/10.1016/S0140-6736(05)17703-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639295				2022-12-24	WOS:000226170700028
J	Hart, DNJ				Hart, DNJ			Dendritic cell biology evolves into clinical application	LANCET			English	Editorial Material							LANGERHANS CELLS; IN-VIVO; RECEPTORS; MATURATION; ANTIGENS; SKIN		Mater Med Res Inst, Dendrit Cell Lab, Brisbane, Qld 4101, Australia	Mater Research	Hart, DNJ (corresponding author), Mater Med Res Inst, Dendrit Cell Lab, Raymond Terrace, Brisbane, Qld 4101, Australia.	dhart@mmri.mater.org.au	Hart, Derek NJ/B-9505-2014					Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; COLLIN M, IN PRESS TRANSPLANTA; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Jocham D, 2004, LANCET, V363, P594, DOI 10.1016/S0140-6736(04)15590-6; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Munster DJ, 2004, INT IMMUNOL, V16, P33, DOI 10.1093/intimm/dxh004; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Soumelis V, 2004, SPRINGER SEMIN IMMUN, V25, P325, DOI 10.1007/s00281-003-0152-0; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Xu MQ, 2004, WORLD J GASTROENTERO, V10, P2361	19	4	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					102	104		10.1016/S0140-6736(05)17717-4	http://dx.doi.org/10.1016/S0140-6736(05)17717-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639277				2022-12-24	WOS:000226170700006
J	Maruyama, K; Kawahara, N; Shin, M; Tago, M; Kishimoto, J; Kurita, H; Kawamoto, S; Morita, A; Kirino, T				Maruyama, K; Kawahara, N; Shin, M; Tago, M; Kishimoto, J; Kurita, H; Kawamoto, S; Morita, A; Kirino, T			The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-KNIFE RADIOSURGERY; LINEAR-ACCELERATOR RADIOSURGERY; FOLLOW-UP DATA; NATURAL-HISTORY; STEREOTACTIC RADIOSURGERY; NIDUS OBLITERATION; BRAIN; SURGERY; EXPERIENCE	Background: Angiography shows that stereotactic radiosurgery obliterates most cerebral arteriovenous malformations after a latency period of a few years. However, the effect of this procedure on the risk of hemorrhage is poorly understood. Methods: We performed a retrospective observational study of 500 patients with malformations who were treated with radiosurgery with use of a gamma knife. The rates of hemorrhage were assessed during three periods: before radiosurgery, between radiosurgery and the angiographic documentation of obliteration of the malformation (latency period), and after angiographic obliteration. Results: Forty-two hemorrhages were documented before radiosurgery (median follow-up, 0.4 year), 23 during the latency period (median follow-up, 2.0 years), and 6 after obliteration (median follow-up, 5.4 years). As compared with the period between diagnosis and radiosurgery, the risk of hemorrhage decreased by 54 percent during the latency period (hazard ratio, 0.46; 95 percent confidence interval, 0.26 to 0.80; P=0.006) and by 88 percent after obliteration (hazard ratio, 0.12; 95 percent confidence interval, 0.05 to 0.29; P<0.001). The risk was significantly reduced during the period after obliteration, as compared with the latency period (hazard ratio, 0.26; 95 percent confidence interval, 0.10 to 0.68; P=0.006). The reduction was greater among patients who presented with hemorrhage than among those without hemorrhage at presentation and similar in analyses that took into account the delay in confirming obliteration by means of angiography and analyses that excluded data obtained during the first year after diagnosis. Conclusions: Radiosurgery significantly decreases the risk of hemorrhage in patients with cerebral arteriovenous malformations, even before there is angiographic evidence of obliteration. The risk of hemorrhage is further reduced, although not eliminated, after obliteration.	Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Clin Bioinformat, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Maruyama, K (corresponding author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kskmaru-tky@umin.ac.jp	Kawamoto, Shunsuke/E-9947-2013	Kawamoto, Shunsuke/0000-0002-1388-1287; Morita, Akio/0000-0002-2497-5772				Chang SD, 1997, CLIN NEUROPATHOL, V16, P111; COLOMBO F, 1994, NEUROSURGERY, V34, P14; COX DR, 1972, J R STAT SOC B, V34, P187; CRAWFORD PM, 1986, J NEUROL NEUROSUR PS, V49, P1, DOI 10.1136/jnnp.49.1.1; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; Duong DH, 1999, NEW ENGL J MED, V340, P1812; Fabrikant J I, 1992, Neurosurg Clin N Am, V3, P99; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Friedman WA, 1996, J NEUROSURG, V84, P912, DOI 10.3171/jns.1996.84.6.0912; FRIEDMAN WA, 1995, J NEUROSURG, V82, P180, DOI 10.3171/jns.1995.82.2.0180; FULTS D, 1984, NEUROSURGERY, V15, P658, DOI 10.1227/00006123-198411000-00003; GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331; ITOYAMA Y, 1989, J NEUROSURG, V71, P805, DOI 10.3171/jns.1989.71.6.0805; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karlsson B, 1997, NEUROSURGERY, V40, P425, DOI 10.1097/00006123-199703000-00001; Karlsson B, 1996, MINIM INVAS NEUROSUR, V39, P21, DOI 10.1055/s-2008-1052210; Karlsson B, 2001, INT J RADIAT ONCOL, V49, P1045, DOI 10.1016/S0360-3016(00)01432-2; LEVY RP, 1989, NEUROSURGERY, V24, P841, DOI 10.1227/00006123-198906000-00009; Lindquist C, 1988, MODERN STEREOTACTIC, P491; Lindqvist M, 2000, NEUROSURGERY, V46, P803, DOI 10.1097/00006123-200004000-00006; LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512; Maruyama K, 2004, J NEUROSURG, V100, P407, DOI 10.3171/jns.2004.100.3.0407; Mast H, 1997, LANCET, V350, P1065, DOI 10.1016/S0140-6736(97)05390-7; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; PHILLIPS TL, 1991, RAD INJURY NERVOUS S, P37; Pollock BE, 1996, NEUROSURGERY, V38, P652, DOI 10.1227/00006123-199604000-00004; Schneider BF, 1997, J NEUROSURG, V87, P352, DOI 10.3171/jns.1997.87.3.0352; Shin M, 2004, J NEUROSURG, V101, P18, DOI 10.3171/jns.2004.101.1.0018; Shin M, 2002, J NEUROSURG, V97, P779, DOI 10.3171/jns.2002.97.4.0779; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; STEINBERG GK, 1990, NEW ENGL J MED, V323, P96, DOI 10.1056/NEJM199007123230205; STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001; Szeifert GT, 2003, NEUROL RES, V25, P718, DOI 10.1179/016164103101202228; YAMAMOTO M, 1992, SURG NEUROL, V37, P219, DOI 10.1016/0090-3019(92)90235-F	35	229	237	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					146	153		10.1056/NEJMoa040907	http://dx.doi.org/10.1056/NEJMoa040907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647577				2022-12-24	WOS:000226251700007
J	Hall, N; Karras, M; Raine, JD; Carlton, JM; Kooij, TWA; Berriman, M; Florens, L; Janssen, CS; Pain, A; Christophides, GK; James, K; Rutherford, K; Harris, B; Harris, D; Churcher, C; Quail, MA; Ormond, D; Doggett, J; Trueman, HE; Mendoza, J; Bidwell, SL; Rajandream, MA; Carucci, DJ; Yates, JR; Kafatos, FC; Janse, CJ; Barrell, B; Turner, CMR; Waters, AP; Sinden, RE				Hall, N; Karras, M; Raine, JD; Carlton, JM; Kooij, TWA; Berriman, M; Florens, L; Janssen, CS; Pain, A; Christophides, GK; James, K; Rutherford, K; Harris, B; Harris, D; Churcher, C; Quail, MA; Ormond, D; Doggett, J; Trueman, HE; Mendoza, J; Bidwell, SL; Rajandream, MA; Carucci, DJ; Yates, JR; Kafatos, FC; Janse, CJ; Barrell, B; Turner, CMR; Waters, AP; Sinden, RE			A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses	SCIENCE			English	Article							PROTEIN FAMILY; GENE FAMILY; MALARIA; FALCIPARUM; EXPRESSION; SEQUENCE; SPOROZOITES; SELECTION; BERGHEI; MOUSE	Plasmodium berghei and Plasmodium chabaudi are widely used model malaria species. Comparison of their genomes, integrated with proteomic and microarray data, with the genomes of Plasmodium falciparum and Plasmodium yoelii revealed a conserved core of 4500 Plasmodium genes in the central regions of the 14 chromosomes and highlighted genes evolving rapidly because of stage-specific selective pressures. Four strategies for gene expression are apparent during the parasites' life cycle: (i) housekeeping; (ii) host-related; (iii) strategy-specific related to invasion, asexual replication, and sexual development; and (iv) stage-specific. We observed posttranscriptional gene silencing through translational repression of messenger RNA during sexual development, and a 47-base 3' untranslated region motif is implicated in this process.	Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Cambridge CB10 1SA, England; Leiden Univ, Med Ctr, Dept Parasitol, Malaria Grp, NL-2300 RA Leiden, Netherlands; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Immunol & Infect Sect, London SW7 2AZ, England; Inst Genom Res, Rockville, MD 20850 USA; Univ Florida, Coll Vet Med, Dept Pathobiol, Gainesville, FL 32608 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; European Mol Biol Lab, D-69117 Heidelberg, Germany; Naval Med Res Ctr, Malaria Program IDD, Silver Spring, MD 20910 USA	Wellcome Trust Sanger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; J. Craig Venter Institute; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Scripps Research Institute; University of Glasgow; European Molecular Biology Laboratory (EMBL); Naval Medical Research Center (NMRC)	Hall, N (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nhall@tigr.org; a.p.waters@tumc.nl; r.sinden@imperial.ac.uk	Hall, Neil/A-8717-2013; Waters, Andy P/C-9377-2009; Pain, Arnab/L-5766-2015; Quail, michael/ABE-6131-2020; Rutherford, Kim/Y-7995-2018; Kooij, Taco W.A./L-5623-2015; Berriman, Matthew/A-7618-2011; Trueman, Holly/C-7883-2012	Hall, Neil/0000-0002-7995-3810; Waters, Andy P/0000-0001-8900-2982; Pain, Arnab/0000-0002-1755-2819; Rutherford, Kim/0000-0001-6277-726X; Kooij, Taco W.A./0000-0002-8547-7523; Berriman, Matthew/0000-0002-9581-0377; Florens, Laurence/0000-0002-9310-6650; Christophides, George/0000-0002-3323-1687; Janse, Chris J/0000-0002-6410-6205; Hall, Neil/0000-0003-2808-0009				Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fischer K, 2003, MOL MICROBIOL, V48, P1209, DOI 10.1046/j.1365-2958.2003.03491.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; PATON MG, 1993, MOL BIOCHEM PARASIT, V59, P263, DOI 10.1016/0166-6851(93)90224-L; Plotkin JB, 2004, NATURE, V428, P942, DOI 10.1038/nature02458; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; VICKERMAN K, 1965, NATURE, V208, P762, DOI 10.1038/208762a0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Waters AP, 2003, SCIENCE, V301, P1487, DOI 10.1126/science.1089799; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	27	637	689	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2005	307	5706					82	86		10.1126/science.1103717	http://dx.doi.org/10.1126/science.1103717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637271				2022-12-24	WOS:000226214300040
J	Norris, DR; Marra, PP; Montgomerie, R; Kyser, TK; Ratcliffe, LM				Norris, DR; Marra, PP; Montgomerie, R; Kyser, TK; Ratcliffe, LM			Reproductive effort molting latitude, and feather color in a migratory songbird	SCIENCE			English	Article							ISOTOPES; GROUNDS; WINTER; BIRD	Toward the end of the breeding season, migratory songbirds face crucial tradeoffs between the timing of reproduction, molt, and migration. Using stable hydrogen isotopes, we show that male American redstarts investing in high levels of reproduction late in the season adopt a unique strategy of combining molt and migration. Tail feathers molted during migration also reflect less orange-red light, indicating reduced carotenoid concentration. Thus, we show how reproduction in a migratory animal can influence both life history strategies (location of molt) and social signals (feather color) during subsequent periods of the annual cycle.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Geol Sci & Engn, Kingston, ON K7L 3N6, Canada; Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; Univ British Columbia, Ctr Appl Conservat Res, Forest Sci Ctr, Vancouver, BC V6T 1Z4, Canada	Queens University - Canada; Queens University - Canada; Smithsonian Institution; Smithsonian Environmental Research Center; University of British Columbia	Norris, DR (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	ryann@biology.queensu.ca	Bond, Alexander L/A-3786-2010; Norris, Ryan/F-4720-2011; Montgomerie, Robert D/C-6516-2008	Norris, Ryan/0000-0003-4874-1425; Montgomerie, Robert D/0000-0003-4701-4525; Kyser, Kurt/0000-0001-9667-4103; Marra, Peter/0000-0002-0508-7577				Graves GR, 2002, P NATL ACAD SCI USA, V99, P8096, DOI 10.1073/pnas.082240899; Hill G. E., 2002, RED BIRD BROWN BAG F; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; HOLMES RT, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P563; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; Sherry Thomas W., 1997, Birds of North America, V277, P1; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; [No title captured]	13	99	102	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2249	2250		10.1126/science.1103542	http://dx.doi.org/10.1126/science.1103542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618516				2022-12-24	WOS:000225950000044
J	Allen, RL; Bittner-Eddy, PD; Grenvitte-Briggs, LJ; Meitz, JC; Rehmany, AP; Rose, LE; Beynon, JL				Allen, RL; Bittner-Eddy, PD; Grenvitte-Briggs, LJ; Meitz, JC; Rehmany, AP; Rose, LE; Beynon, JL			Host-parasite coevolutionary conflict between Arabidopsis and downy mildew	SCIENCE			English	Article							RICE BLAST RESISTANCE; AVIRULENCE GENE; CLADOSPORIUM-FULVUM; DISEASE RESISTANCE; PERONOSPORA-PARASITICA; PROTEIN; THALIANA; ELICITOR; POLYMORPHISM; INFECTION	Plants are constantly exposed to attack by an array of diverse pathogens but lack a somatically adaptive immune system. In spite of this, natural plant populations do not often suffer destructive disease epidemics. Elucidating how allelic diversity within plant genes that function to detect pathogens (resistance genes) counteracts changing structures of pathogen genes required for host invasion (pathogenicity effectors) is critical to our understanding of the dynamics of natural plant populations. The RPP13 resistance gene is the most polymorphic gene analyzed to date in the model plant Arabidopsis thaliana. Here we report the cloning of the avirulence gene, ATR13, that triggers RPP13-mediated resistance, and we show that it too exhibits extreme levels of amino acid polymorphism. Evidence of diversifying selection visible in both components suggests that the host and pathogen may be locked in a coevolutionary conflict at these loci, where attempts to evade host resistance by the pathogen are matched by the development of new detection capabilities by the host.	HRI Univ Warwick, Warwick CV35 9EF, England; Univ Munich, Dept Evolutionary Biol, D-82152 Planegg Martinsried, Germany	University of Warwick; University of Munich	Beynon, JL (corresponding author), HRI Univ Warwick, Warwick CV35 9EF, England.	jim.beynon@warwick.ac.uk	Grenville-Briggs, Laura J/C-3419-2014; Meitz-Hopkins, Julia/M-3938-2016; Grenville-Briggs, Laura/B-3386-2013	Grenville-Briggs, Laura J/0000-0001-5910-3651; Meitz-Hopkins, Julia/0000-0002-8127-6978; 	Biotechnology and Biological Sciences Research Council [P20029] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALLEN R, UNPUB; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bittner-Eddy PD, 2003, MOL PLANT PATHOL, V4, P501, DOI 10.1046/J.1364-3703.2003.00194.X; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hahn M, 2001, CURR OPIN PLANT BIOL, V4, P322, DOI 10.1016/S1369-5266(00)00180-1; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jin QL, 2003, MICROBES INFECT, V5, P301, DOI 10.1016/S1286-4579(03)00032-7; Jones DA, 1997, ADV BOT RES, V24, P90, DOI DOI 10.1016/S0065-2296(08)60072-5; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; KEEN NT, 1990, MOL PLANT MICROBE IN, V3, P112, DOI 10.1094/MPMI-3-112; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; MAY RM, 1983, COEVOLUTION, P189; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Westerink N, 2002, MOL PLANT MICROBE IN, V15, P1219, DOI 10.1094/MPMI.2002.15.12.1219	26	324	343	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1957	1960		10.1126/science.1104022	http://dx.doi.org/10.1126/science.1104022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591208				2022-12-24	WOS:000225695600051
J	Peoples, GE; Jezior, JR; Shriver, CD				Peoples, GE; Jezior, JR; Shriver, CD			Caring for the wounded in Iraq - A photo essay	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Walter Reed Army Med Ctr, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Peoples, GE (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.								0	20	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2476	2480		10.1056/NEJMp048327	http://dx.doi.org/10.1056/NEJMp048327			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15622566				2022-12-24	WOS:000225593100002
J	Gonzalez, E; Kulkarni, H; Bolivar, H; Mangano, A; Sanchez, R; Catano, G; Nibbs, RJ; Freedman, BI; Quinones, MP; Bamshad, MJ; Murthy, KK; Rovin, BH; Bradley, W; Clark, RA; Anderson, SA; O'Connell, RJ; Agan, BK; Ahuja, SS; Bologna, R; Sen, L; Dolan, MJ; Ahuja, SK				Gonzalez, E; Kulkarni, H; Bolivar, H; Mangano, A; Sanchez, R; Catano, G; Nibbs, RJ; Freedman, BI; Quinones, MP; Bamshad, MJ; Murthy, KK; Rovin, BH; Bradley, W; Clark, RA; Anderson, SA; O'Connell, RJ; Agan, BK; Ahuja, SS; Bologna, R; Sen, L; Dolan, MJ; Ahuja, SK			The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; BETA-CHEMOKINES; IN-VITRO; MACROPHAGE; INFECTION; CCR5; LYMPHOCYTES; PROTECTION; EVOLUTION	Segmental duplications in the human genome are selectively enriched for genes involved in immunity, although the phenotypic consequences for host defense are unknown. We show that there are significant interindividual and interpopulation differences in the copy number of a segmental duplication encompassing the gene encoding CCL3L1 (MIP-1alphaP), a potent human immunodeficiency virus-1 (HIV-1)-suppressive chemokine and ligand for the HIV coreceptor CCR5. Possession of a CCL3L1 copy number lower than the population average is associated with markedly enhanced HIV/acquired immunodeficiency syndrome (AIDS) susceptibility. This susceptibility is even greater in individuals who also possess disease-accelerating CCR5 genotypes. This relationship between CCL3L1 dose and altered HIV/AIDS susceptibility points to a central role for CCL3L1 in HIV/AIDS pathogenesis and indicates that differences in the dose of immune response genes may constitute a genetic basis for variable responses to infectious diseases.	Univ Texas, Hlth Sci Ctr, Vet Adm Res Ctr AIDS & HIV1 Infect, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78229 USA; Consejo Nacl Invest Cient & Tecn, Lab Biol Celular & Retrovirus, RA-1245 Buenos Aires, DF, Argentina; Hosp Pediat JP Garrahan, Serv Infectol, RA-1245 Buenos Aires, DF, Argentina; Cancer Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland; Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; SW Fdn Biomed Res, San Antonio, TX 78227 USA; Ohio State Univ, Div Nephrol, Columbus, OH 43210 USA; Wilford Hall USAF Med Ctr, Infect Dis Serv, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Tri Serv AIDS Clin Consortium, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX 78236 USA; Def Inst Med Operat, Brooks AFB, TX 78235 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Beatson Institute; Wake Forest University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Texas Biomedical Research Institute; University System of Ohio; Ohio State University; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force	Ahuja, SK (corresponding author), Univ Texas, Hlth Sci Ctr, Vet Adm Res Ctr AIDS & HIV1 Infect, S Texas Vet Hlth Care Syst, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	matthew.dolan@brooks.af.mil; ahujas@uthscsa.edu	Catano, Gabriel/AAQ-5387-2020; Clark, Robert/Q-6764-2019; Kulkarni, Hemant/AEM-5750-2022	Clark, Robert/0000-0002-4892-3619; Nibbs, Robert/0000-0002-8150-0044; Agan, Brian/0000-0002-5114-1669	NIAID NIH HHS [AI043279, AI046326] Funding Source: Medline; NIMH NIH HHS [MH069270] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046326, R01AI043279, R21AI046326, R37AI046326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmed RKS, 2002, CLIN EXP IMMUNOL, V129, P11, DOI 10.1046/j.1365-2249.2002.01894.x; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Garzino-Demo A, 1999, P NATL ACAD SCI USA, V96, P11986, DOI 10.1073/pnas.96.21.11986; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Heeney JL, 1998, P NATL ACAD SCI USA, V95, P10803, DOI 10.1073/pnas.95.18.10803; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Paxton WA, 2001, J INFECT DIS, V183, P1678, DOI 10.1086/320701; REYNES J, 2003, J ACQ IMMUN DEF SYND, V34, P114; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Ullum H, 1998, J INFECT DIS, V177, P331, DOI 10.1086/514192; Weed DL, 2000, HEMATOL ONCOL CLIN N, V14, P797, DOI 10.1016/S0889-8588(05)70312-9; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3857, DOI 10.1073/pnas.95.7.3857	21	885	989	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1434	1440		10.1126/science.1101160	http://dx.doi.org/10.1126/science.1101160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15637236				2022-12-24	WOS:000227503100037
J	Flasar, FM; Achterberg, RK; Conrath, BJ; Pearl, JC; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Kunde, VG; Nixon, CA; Bezard, B; Orton, GS; Spilker, LJ; Spencer, JR; Irwin, PGJ; Teanby, NA; Owen, TC; Brasunas, J; Segura, ME; Carlson, RC; Mamoutkine, A; Gierasch, PJ; Schinder, PJ; Showaiter, MR; Ferrari, C; Barucci, A; Courtin, R; Coustenis, A; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Abbas, MM; Raulin, F; Ade, P; Edgington, S; Pilorz, S; Wallis, B; Wishnow, EH				Flasar, FM; Achterberg, RK; Conrath, BJ; Pearl, JC; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Kunde, VG; Nixon, CA; Bezard, B; Orton, GS; Spilker, LJ; Spencer, JR; Irwin, PGJ; Teanby, NA; Owen, TC; Brasunas, J; Segura, ME; Carlson, RC; Mamoutkine, A; Gierasch, PJ; Schinder, PJ; Showaiter, MR; Ferrari, C; Barucci, A; Courtin, R; Coustenis, A; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Abbas, MM; Raulin, F; Ade, P; Edgington, S; Pilorz, S; Wallis, B; Wishnow, EH			Temperatures, winds, and composition in the saturnian system	SCIENCE			English	Article							GALILEO PHOTOPOLARIMETER-RADIOMETER; 1990 EQUATORIAL DISTURBANCE; GIANT PLANETS; INFRARED OBSERVATIONS; ZONAL WINDS; RINGS; ABUNDANCES; ATMOSPHERE; ELEMENTS; MODEL	Stratospheric temperatures on Saturn imply a strong decay of the equatorial winds with attitude. If the decrease in winds reported from recent Hubble Space Telescope images is not a temporal change, then the features tracked must have been at least 130 kilometers higher than in earlier studies. Saturn's south polar stratosphere is warmer than predicted from simple radiative models. The C/H ratio on Saturn is seven times solar, twice Jupiter's. Saturn's ring, temperatures have radial variations down to the smallest scale resolved (100 kilometers). Diurnal surface temperature variations on Phoebe suggest a more porous regolith than on the jovian satellites.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Sci Syst & Applicat Inc, Lanham, MD 20706 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Observ Paris, CNRS, UMR 8109, LESIA, F-91925 Meudon, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; QSS Grp Inc, Lanham, MD 20706 USA; NASA, Ames Res Ctr, Stanford Univ, Moffett Field, CA 94035 USA; CEA Saclay, Serv Astrophys, F-91191 Gif Sur Yvette, France; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; NASA, George C Marshall Space Flight Ctr, Natl Space Sci & Technol Ctr SD50, Huntsville, AL 35812 USA; Univ Paris 07, LISA, F-94010 Creteil, France; Univ Paris 12, CNRS, UMR 7583, F-94010 Creteil, France; Univ Cardiff, Dept Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Univ Calif Berkeley, Space Sci Lab, Livermore, CA 94551 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; Cornell University; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Oxford; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Stanford University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Flasar, FM (corresponding author), NASA, Goddard Space Flight Ctr, Code 693, Greenbelt, MD 20771 USA.	f.m.flasar@nasa.gov	Bjoraker, Gordon L/D-5032-2012; brasunas, john/I-2798-2013; Simon, Amy/C-8020-2012; Nixon, Conor A/A-8531-2009; Romani, Paul N/D-2729-2012; Flasar, F Michael/C-8509-2012; Fouchet, Thierry/C-6374-2017; Ferrari, Cécile/P-9735-2016; Jennings, Donald/D-7978-2012; Orton, Glenn/AAD-9862-2020; Strobel, Darrell5/AAO-6643-2021	Simon, Amy/0000-0003-4641-6186; Nixon, Conor A/0000-0001-9540-9121; Fouchet, Thierry/0000-0001-9040-8285; Ferrari, Cécile/0000-0001-5962-7439; Strobel, Darrell5/0000-0002-0944-8675; Achterberg, Richard/0000-0002-7643-7626; Bezard, Bruno/0000-0002-5433-5661; Taylor, Fred/0000-0002-0675-9769; Calcutt, Simon/0000-0002-0102-3170; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Teanby, Nicholas/0000-0003-3108-5775; Ade, Peter/0000-0002-5127-0401				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDREWS DG, 1987, MIDDLE ATMOSPHERE DY, P126; BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BEEBE RF, 1992, ICARUS, V95, P163, DOI 10.1016/0019-1035(92)90035-6; BEZARD B, 1984, ICARUS, V60, P274, DOI 10.1016/0019-1035(84)90189-1; BEZARD B, 1985, ICARUS, V61, P296, DOI 10.1016/0019-1035(85)90110-1; CONRATH BJ, 1983, ICARUS, V53, P286, DOI 10.1016/0019-1035(83)90148-3; CONRATH BJ, 1990, ICARUS, V83, P255, DOI 10.1016/0019-1035(90)90068-K; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FROIDEVAUX L, 1980, J GEOPHYS RES-SPACE, V85, P5929, DOI 10.1029/JA085iA11p05929; HANEL R, 1981, SCIENCE, V212, P192, DOI 10.1126/science.212.4491.192; HANEL R, 1982, SCIENCE, V215, P544, DOI 10.1126/science.215.4532.544; INGERSOLL AP, 1984, SATURN, P195; Kunde V, 1996, P SOC PHOTO-OPT INS, V2803, P162, DOI 10.1117/12.253416; MIZUNO H, 1980, PROG THEOR PHYS, V64, P544, DOI 10.1143/PTP.64.544; Owen T, 2003, SPACE SCI REV, V106, P121, DOI 10.1023/A:1024633603624; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rathbun JA, 2004, ICARUS, V169, P127, DOI 10.1016/j.icarus.2003.10.021; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SanchezLavega A, 1996, SCIENCE, V271, P631, DOI 10.1126/science.271.5249.631; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; Spencer JR, 1999, SCIENCE, V284, P1514, DOI 10.1126/science.284.5419.1514; SPENCER JR, 1987, THESIS U ARIZONA TUS; Spilker L, 2003, PLANET SPACE SCI, V51, P929, DOI 10.1016/j.pss.2003.05.004; Wong MH, 2004, ICARUS, V171, P153, DOI 10.1016/j.icarus.2004.04.010	29	138	138	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1247	1251		10.1126/science.1105806	http://dx.doi.org/10.1126/science.1105806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15618486				2022-12-24	WOS:000227313200041
J	Jenkins, V; Fallowfield, L; Solis-Trapala, I; Langridge, C; Farewell, V				Jenkins, V; Fallowfield, L; Solis-Trapala, I; Langridge, C; Farewell, V			Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research LTK training programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNICATION-SKILLS; KEY	Objective To evaluate a training intervention aimed at improving healthcare professionals' communication with cancer patients about randomised clinical trials. Design Before and after evaluation of training programme. Setting Members of the National Cancer Research Network, Scottish Trials Network, and the Welsh Cancer Trials Network Participants 101 healthcare professionals (33 clinicians and 68 research nurses). Intervention Four modules delivered by a trained facilitator using videotapes and interactive exercises to cover general issues about discussing randomised clinical trials with patients, problems specific to adjuvant trials, trials with palliation as the goal, and trials where patients had a strong preference for one treatment arm. Main outcome measures Before and after the intervention, participants were videotaped discussing a trial with an actor portraying a patient. These consultations were assessed for presence of information required by good clinical practice guidelines. The actor patients gave an assessment after each interview Participants reported their self confidence about key aspects of trial discussion. Results Analysis of the videotaped consultations showed that, after intervention, significantly more participants displayed key communication behaviours such as explaining randomisation (69 v 8 1, odds ratio 2.33, P = 0.033), checking patients' understanding (I I v 3 1, odds ratio 3.22, P = 0.002), and discussing standard treatment (73 v 88, odds ratio 4.75, P = 0.005) and side effects (69 v 85, odds ratio 3.29, P = 0.006). Participants' self confidence increased significantly (P < 0.001) across all areas. Actor patients' ratings of participants' communication showed significant improvements for 12/15 key items. Conclusion This intensive 8 hour intervention significantly improved participants' confidence and competence when communicating about randomised clinical trials.	Univ Sussex, Brighton & Sussex Med Sch, Sussex Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England; Ctr Invest Matemat, Guanajuato, Mexico; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Brighton; University of Sussex; CIMAT - Centro de Investigacion en Matematicas; MRC Biostatistics Unit; University of Cambridge	Jenkins, V (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Sussex Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England.	val@sussex.ac.uk	Solis-Trapala, Ivonne/D-8144-2011; Solis-Trapala, Ivonne/AAZ-2105-2021	Solis-Trapala, Ivonne/0000-0002-1264-1396; Solis-Trapala, Ivonne/0000-0002-1264-1396; Farewell, Vernon/0000-0001-6704-5295; Fallowfield, Lesley/0000-0003-0577-4518				Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324; *DEP HLTH, 2000, 6 DEP HLTH; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Fallowfield L, 2001, CANCER NURS, V24, P185, DOI 10.1097/00002820-200106000-00005; Jenkins V, 2002, BRIT J CANCER, V87, P854, DOI 10.1038/sj.bjc.6600527; Jenkins VA, 1999, EUR J CANCER, V35, P1187, DOI 10.1016/S0959-8049(99)00116-1; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; *MED RES COUNC, 1998, MRC GUID GOOD CLIN P; Pope JE, 2003, J RHEUMATOL, V30, P815; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031	14	67	68	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2005	330	7488					400	403		10.1136/bmj.38366.562685.8F	http://dx.doi.org/10.1136/bmj.38366.562685.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15705666	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000227220400021
J	Zhang, ZX; Roman, GC; Hong, Z; Wu, CB; Qu, QM; Huang, JB; Zhou, B; Geng, ZP; Wu, JX; Wen, HB; Zhao, H; Zahner, GEP				Zhang, ZX; Roman, GC; Hong, Z; Wu, CB; Qu, QM; Huang, JB; Zhou, B; Geng, ZP; Wu, JX; Wen, HB; Zhao, H; Zahner, GEP			Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai	LANCET			English	Article								A cross-sectional prevalence study of Parkinson's disease in China was undertaken in 1997-98. We assessed 29 454 residents aged greater than or equal to55 years from 79 rural and 58 urban communities in Beijing, Xian, and Shanghai, who were selected through stratified, multistage, cluster sampling. With a standardised diagnostic protocol, we identified 277 people with the disease. Prevalence of Parkinson's disease for those aged greater than or equal to65 years was 1.7% (95% CI 1.5-1.9). We estimate that 1.7 million people in China have the disease (aged greater than or equal to55 years). Our findings suggest that prevalence of Parkinson's disease in China is similar to that in developed countries.	Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Epidemiol, Beijing 100037, Peoples R China; Univ Texas, Hlth Sci Ctr, Dept Med & Neurol, San Antonio, TX USA; Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; Xian Transportat Univ, First Hosp, Dept Neurol, Xian, Peoples R China; Tongren Hosp, Dept Neurol, Beijing, Peoples R China; Beijing Sixth Hosp, Dept Neurol, Beijing, Peoples R China; Natl Res Inst Family Planning, Dept Stat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Texas System; University of Texas Health San Antonio; Fudan University; National Research Institute for Family Planning - China	Zhang, ZX (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	zhangzx@pumch.ac.cn						CALNE DB, 1992, ANN NEUROL S, V32, P125; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; SAS Institute, 2000, SAS STAT VERS 8; Tanner C. M., 2004, MOVEMENT DISORDERS N, P177; ZHANG ZX, 1993, NEUROEPIDEMIOLOGY, V12, P195, DOI 10.1159/000110318; Zhang ZX, 2003, MOVEMENT DISORD, V18, P764, DOI 10.1002/mds.10445	6	277	439	4	114	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2005	365	9459					595	597						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708103				2022-12-24	WOS:000226984300032
J	Gital, Z; Dye, NA; Reisenauer, A; Wachi, M; Shapiro, L				Gital, Z; Dye, NA; Reisenauer, A; Wachi, M; Shapiro, L			MreB actin-mediated segregation of a specific region of a bacterial chromosome	CELL			English	Article							CELL-CYCLE PROGRESSION; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; DNA-REPLICATION; POLAR LOCALIZATION; CONTROLLED PROTEOLYSIS; PROTEINS; DIVISION; ORIGIN	Faithful chromosome segregation is an essential component of cell division in all organisms. The eukaryotic mitotic machinery uses the cytoskeleton to move specific chromosomal regions. To investigate the potential role of the actin-like MreB protein in bacterial chromosome segregation, we first demonstrate that MreB is the direct target of the small molecule A22. We then demonstrate that A22 completely blocks the movement of newly replicated loci near the origin of replication but has no qualitative or quantitative effect on the segregation of other loci if added after origin segregation. MreB selectively interacts, directly or indirectly, with origin-proximal regions of the chromosome, arguing that the origin-proximal region segregates via an MreB-dependent mechanism not used by the rest of the chromosome.	Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Stanford University; Stanford University; Princeton University; Tokyo Institute of Technology	Gital, Z (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	zgitai@stanford.edu; shapiro@cmgm.stanford.edu	Dye, Natalie/X-4910-2019; Wachi, Masaaki/D-1220-2015	Dye, Natalie/0000-0002-4859-6670; Wachi, Masaaki/0000-0002-3655-4035	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051426] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM51426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alley MRK, 2001, MOL MICROBIOL, V40, P1335, DOI 10.1046/j.1365-2958.2001.02476.x; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gordon GS, 2002, MOL MICROBIOL, V44, P501, DOI 10.1046/j.1365-2958.2002.02901.x; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jaffe A, 1997, J BACTERIOL, V179, P3494, DOI 10.1128/jb.179.11.3494-3499.1997; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MARCZYNSKI GT, 1990, J MOL BIOL, V212, P709, DOI 10.1016/0022-2836(90)90232-B; MARCZYNSKI GT, 1992, J MOL BIOL, V226, P959, DOI 10.1016/0022-2836(92)91045-Q; Marczynski GT, 2002, ANNU REV MICROBIOL, V56, P625, DOI 10.1146/annurev.micro.56.012302.161103; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Niki H, 2000, GENE DEV, V14, P212; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; WINZELER E, 1995, J MOL BIOL, V251, P346, DOI 10.1006/jmbi.1995.0439; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	51	323	328	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					329	341		10.1016/j.cell.2005.01.007	http://dx.doi.org/10.1016/j.cell.2005.01.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707892	Bronze			2022-12-24	WOS:000227028900009
J	Laugwitz, KL; Moretti, A; Lam, J; Gruber, P; Chen, YH; Woodard, S; Lin, LZ; Cai, CL; Lu, MM; Reth, M; Platoshyn, O; Yuan, JXJ; Evans, S; Chien, KR				Laugwitz, KL; Moretti, A; Lam, J; Gruber, P; Chen, YH; Woodard, S; Lin, LZ; Cai, CL; Lu, MM; Reth, M; Platoshyn, O; Yuan, JXJ; Evans, S; Chien, KR			Postnatal isl1+cardioblasts enter fully differentiated cardiomyocyte lineages	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TAMOXIFEN-INDUCIBLE FORM; CARDIAC MYOCYTES; CRE; EXPRESSION; PATHWAYS; DISEASE; FUSION	The purification, renewal and differentiation of native cardiac progenitors would form a mechanistic underpinning for unravelling steps for cardiac cell lineage formation, and their links to forms of congenital and adult cardiac diseases(1 - 3). Until now there has been little evidence for native cardiac precursor cells in the postnatal heart(4). Herein, we report the identification of isl1(+) cardiac progenitors in postnatal rat, mouse and human myocardium. A cardiac mesenchymal feeder layer allows renewal of the isolated progenitor cells with maintenance of their capability to adopt a fully differentiated cardiomyocyte phenotype. Tamoxifen- inducible Cre/ lox technology enables selective marking of this progenitor cell population including its progeny, at a defined time, and purification to relative homogeneity. Coculture studies with neonatal myocytes indicate that isl1(+) cells represent authentic, endogenous cardiac progenitors ( cardioblasts) that display highly efficient conversion to a mature cardiac phenotype with stable expression of myocytic markers ( 25%) in the absence of cell fusion, intact Ca2+- cycling, and the generation of action potentials. The discovery of native cardioblasts represents a genetically based system to identify steps in cardiac cell lineage formation and maturation in development and disease.	Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Freiburg, Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Max Planck Society; University of Freiburg	Chien, KR (corresponding author), Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA.	syevans@ucsd.edu; kchien@partners.org	Moretti, Alessandra/O-9271-2015; Evans, Sylvia/G-1980-2015	Moretti, Alessandra/0000-0001-5782-7832; 	NHLBI NIH HHS [DP1 HL117649, R01 HL070867] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL117649, R01HL070867] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; D'Amour KA, 2002, NAT MED, V8, P213, DOI 10.1038/nm0302-213; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Epstein J. A., 2001, TRENDS GENET, V17, pS13; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Maltsev VA, 1999, CIRC RES, V84, P136, DOI 10.1161/01.RES.84.2.136; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	25	980	1071	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					647	653		10.1038/nature03215	http://dx.doi.org/10.1038/nature03215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703750	Green Accepted			2022-12-24	WOS:000226862000048
J	Maeda, S; Hsu, LC; Liu, HJ; Bankston, LA; Iimura, M; Kagnoff, MF; Eckmann, L; Karin, M				Maeda, S; Hsu, LC; Liu, HJ; Bankston, LA; Iimura, M; Kagnoff, MF; Eckmann, L; Karin, M			Nod2 mutation in Crohn's disease potentiates NF-kappa B activity and IL-10 processing	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; RECOGNITION; SUSCEPTIBILITY; MACROPHAGES; COLITIS; IKK	Variants of NOD2, an intracellular sensor of bacteria-derived muramyl dipeptide (MDP), increase susceptibility to Crohn's disease (CD). These variants are thought to be defective in activation of nuclear factor kappaB (NF-kappaB) and antibacterial defenses, but CD clinical specimens display elevated NF-kappaB activity. To illuminate the pathophysiological function of NOD2, we introduced such a variant to the mouse Nod2 locus. Mutant mice exhibited elevated NF-kappaB activation in response to MDP and more efficient processing and secretion of the cytokine interleukin-1beta (IL-1beta). These effects are linked to increased susceptibility to bacterial-induced intestinal inflammation and identify NOD2 as a positive regulator of NF-kappaB activation and IL-1beta secretion.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Lab Mucosal Immunol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, Lab Mucosal Immunol, La Jolla, CA 92093 USA; Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Hsu, Li-Chung/0000-0001-7206-5231	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, T32DK007202] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477, AI56075] Funding Source: Medline; NIDDK NIH HHS [DK07202, DK35108] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; MAEDA S, UNPUB; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155	24	626	655	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					734	738		10.1126/science.1103685	http://dx.doi.org/10.1126/science.1103685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692052				2022-12-24	WOS:000226814900046
J	Catania, KC; Remple, FE				Catania, KC; Remple, FE			Asymptotic prey profitability drives star-nosed moles to the foraging speed limit	NATURE			English	Article							FOOD	Foraging theory provides models for predicting predator diet choices assuming natural selection has favoured predators that maximize their rate of energy intake during foraging(1-6). Prey profitability ( energy gained divided by prey handling time) is an essential variable for estimating the optimal diet. Time constraints of capturing and consuming prey generally result in handling times ranging from minutes to seconds, yet profitability increases dramatically as handling time approaches zero, providing the potential for strong directional selection for increasing predator speed at high encounter rates ( tiny increments in speed increase profitability markedly, allowing expanded diets of smaller prey). We provide evidence that the unusual anatomical and behavioural specializations characterizing star-nosed moles resulted from progressively stronger selection for speed, allowing the progressive addition of small prey to their diet. Here we report handling times as short as 120 ms (mean 227 ms) for moles identifying and eating prey. 'Double takes' during prey identification suggest that star-nosed moles have reached the speed limit for processing tactile information. The exceptional speed of star-nosed moles, coupled with unusual specializations for finding and eating tiny prey, provide new support for optimal foraging theory.	Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 351634, Nashville, TN 37235 USA.	ken.catania@Vanderbilt.edu						Anderson JT, 2000, ECOL APPL, V10, P550, DOI 10.1890/1051-0761(2000)010[0550:IRTMSM]2.0.CO;2; Carpenter R.H.S., 1977, MOVEMENTS EYES; Catania KC, 2004, BRAIN BEHAV EVOLUT, V63, P1, DOI 10.1159/000073755; Catania KC, 1997, J COMP NEUROL, V387, P215; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; CUMMINS KW, 1971, INT ASS THEOR APPL L, V18, P2; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; HAMILTON WILLIAM JOHN, 1931, JOUR MAMMAL, V12, P345, DOI 10.2307/1373758; Kamil A. C., 1981, FORAGING BEHAV ECOLO; MAIOROV V I, 1980, Neuroscience and Behavioral Physiology, V10, P374, DOI 10.1007/BF01184053; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P2602, DOI 10.1152/jn.2002.87.5.2602; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Stephens D.W., 1986, pi; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; WITZ BW, 1993, COMP BIOCHEM PHYS A, V105, P151, DOI 10.1016/0300-9629(93)90188-A; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103	20	55	57	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					519	522		10.1038/nature03250	http://dx.doi.org/10.1038/nature03250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690041				2022-12-24	WOS:000226727200048
J	Yamamoto, A; Nagano, T; Takehara, S; Hibi, M; Aizawa, S				Yamamoto, A; Nagano, T; Takehara, S; Hibi, M; Aizawa, S			Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF	CELL			English	Article							ENDOPLASMIC-RETICULUM; MESODERM INDUCTION; QUALITY-CONTROL; HOMEOBOX GENE; XENOPUS; SPECIFICATION; ANTAGONIST; EXPRESSION; ORGANIZER; WINGLESS	Head formation requires simultaneous inhibition of multiple caudalizing signals during early vertebrate embryogenesis. We identified a novel antagonist against Wnt and FGF signaling for head formation, Shisa, which functions cell autonomously in the endoplasmic reticulum (ER). Shisa is specifically expressed in the prospective head ectoderm and the Spemann organizer of Xenopus gastrulae. Overexpression of Shisa inhibited both Wnt and FGF signaling in Xenopus embryos and in a cell line. Loss of Shisa function sensitized the neuroectoderm to Wnt signaling and suppressed head formation during gastrulation. Shisa physically interacted with immature forms of the Wnt receptor Frizzled and the FGF receptor within the ER and inhibited their posttranslational maturation and trafficking to the cell surface. Taken together, these findings indicate that Shisa is a novel molecule that controls head formation by regulating the establishment of the receptors for caudalizing factors.	RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chuou Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuou Ku, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Yamamoto, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chuou Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	akihito@cdb.riken.jp; saizawa@cdb.riken.jp	Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CORNELL RA, 1994, DEVELOPMENT, V120, P453; Cox WG, 1995, DEVELOPMENT, V121, P4349; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hunter T, 1998, Harvey Lect, V94, P81; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kudoh T, 2002, DEVELOPMENT, V129, P4335; LABONNE C, 1994, DEVELOPMENT, V120, P463; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; PANNESE M, 1995, DEVELOPMENT, V121, P707; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pownall ME, 1996, DEVELOPMENT, V122, P3881; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Thisse C, 1999, DEVELOPMENT, V126, P229; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8	48	123	129	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					223	235		10.1016/j.cell.2004.11.051	http://dx.doi.org/10.1016/j.cell.2004.11.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680328	Bronze			2022-12-24	WOS:000226740000011
J	Moore, JP				Moore, JP			Topical microbicides become topical	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEXUAL TRANSMISSION; PREVENTION; INFECTION; HIV		Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.							Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833	5	25	25	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					298	300		10.1056/NEJMcibr043727	http://dx.doi.org/10.1056/NEJMcibr043727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659734				2022-12-24	WOS:000226370500015
J	Sorensen, HT; Pedersen, L; Skriver, MV; Norgaard, M; Norgard, B; Hatch, EE				Sorensen, HT; Pedersen, L; Skriver, MV; Norgaard, M; Norgard, B; Hatch, EE			Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							IN-UTERO; DIETHYLSTILBESTROL	Clomifene is widely used for inducing ovulation.(1) It is structurally related to diethylstilbestrol, which has been linked to vaginal and cervical clear cell adenocarcinoma in women exposed in utero. The adverse effect is less severe in sons, although links to testicular cancer and urogenital anomalies, such as epididymal cysts, have been reported.(2,3) A recent study also found an increased risk of hypospadias in the sons of women exposed to diethylstilbestrol in utero.(4) Clomifene has a half life of about five days, but its metabolites have been found in blood samples on day 22 of the menstrual cycle and in faeces up to six weeks after administration.(5) The occurrence of hypospadias may be increasing. Little is known about the risk of hypospadias in boys born to women who have used clomifene to induce ovulation.	Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Boston University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark.	hts@soci.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Nørgård, Bente M/F-9563-2013	Sorensen, Henrik Toft/0000-0003-4299-7040; Nørgård, Bente M/0000-0002-9514-3033; Skriver, Mette/0000-0002-7017-8221; Norgaard, Mette/0000-0001-6110-5891; Hatch, Elizabeth/0000-0001-7901-3928				FURR BJA, 1988, J ENDOCRINOL INVEST, V11, P535, DOI 10.1007/BF03350179; GEIER A, 1987, FERTIL STERIL, V47, P778; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Strohsnitter WC, 2001, J NATL CANCER I, V93, P545, DOI 10.1093/jnci/93.7.545; WILCOX AJ, 1995, NEW ENGL J MED, V332, P1411, DOI 10.1056/NEJM199505253322104	5	31	31	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 15	2005	330	7483					126	127		10.1136/bmj.38326.606979.79	http://dx.doi.org/10.1136/bmj.38326.606979.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15613365	Bronze, Green Published			2022-12-24	WOS:000226454900018
J	Berjak, P				Berjak, P			Protector of the seeds: Seminal reflections from southern Africa	SCIENCE			English	Article									Univ ZKwaZulu Natal, Dept Life & Environm Sci, Durban, South Africa	University of Kwazulu Natal	Berjak, P (corresponding author), Univ ZKwaZulu Natal, Dept Life & Environm Sci, Durban, South Africa.	berjak@ukzn.ac.za	Berjak, Patricia/E-9362-2010						0	12	14	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					47	49		10.1126/science.1108429	http://dx.doi.org/10.1126/science.1108429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637256				2022-12-24	WOS:000226214300025
J	Mayntz, D; Raubenheimer, D; Salomon, M; Toft, S; Simpson, SJ				Mayntz, D; Raubenheimer, D; Salomon, M; Toft, S; Simpson, SJ			Nutrient-specific foraging in invertebrate predators	SCIENCE			English	Article							MACRONUTRIENT SELF-SELECTION; INSECTS; FOOD	Many herbivores and omnivores adjust their food selection behavior to. regulate the intake of multiple nutrients. Carnivores, however, are generally assumed to optimize the rate of prey capture rather than select prey according to nutrient composition. We showed experimentally that invertebrate predators can forage selectively for protein and lipids to redress specific nutritional imbalances. This selection can take place at different stages of prey handling: The predator may select, among foods of different nutritional composition, eat more of a prey if it is rich in nutrients that the predator is deficient in, or extract specific nutrients from a single prey item.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus C, Denmark; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Auckland, Dept Psychol, Auckland, New Zealand; Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, IL-84105 Beer Sheva, Israel	University of Oxford; Aarhus University; University of Auckland; University of Auckland; Ben Gurion University; Ben Gurion University	Mayntz, D (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	david.mayntz@zoology.oxford.ac.uk		Raubenheimer, David/0000-0001-9050-1447; Simpson, Stephen J./0000-0003-0256-7687				Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Galef BG, 1996, NEUROSCI BIOBEHAV R, V20, P67, DOI 10.1016/0149-7634(95)00041-C; GREENSTONE MH, 1979, NATURE, V282, P501, DOI 10.1038/282501a0; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; RAUBENHEIMER D, 1992, ENTOMOL EXP APPL, V62, P221, DOI 10.1007/BF00353441; REDFORD KH, 1984, J ZOOL, V203, P385, DOI 10.1111/j.1469-7998.1984.tb02339.x; Sanchez-Vazquez FJ, 1999, PHYSIOL BEHAV, V66, P45, DOI 10.1016/S0031-9384(98)00313-8; Seeley, 2000, NEURAL METABOLIC CON; Slansky F. Jr, 1985, P87; Stephens DW, 1986, MONOGRAPHS BEHAV ECO; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Toft S, 1999, J ARACHNOL, V27, P301; Vivas M, 2003, AQUAC RES, V34, P271, DOI 10.1046/j.1365-2109.2003.00799.x	15	347	357	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2005	307	5706					111	113		10.1126/science.1105493	http://dx.doi.org/10.1126/science.1105493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15637278				2022-12-24	WOS:000226214300049
J	Williams, J; Wake, M; Hesketh, K; Maher, E; Waters, E				Williams, J; Wake, M; Hesketh, K; Maher, E; Waters, E			Health-related quality of life of overweight and obese children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED HEALTH; PARENT; QUESTIONNAIRE; FEASIBILITY; RELIABILITY; VALIDITY	Context The negative effects of childhood overweight and obesity on quality of life (QOL) have been shown in clinical samples but not yet in population-based community samples. Objective To determine relationships between weight and health-related QOL reported by parent-proxy and child self-report in a population sample of elementary school children. Design, Setting, and Participants Cross-sectional data collected in 2000 within the Health of Young Victorians Study, a longitudinal cohort study commenced in 1997. individuals were recruited via a random 2-stage sampling design from primary schools in Victoria, Australia. Of the 1943 children in the original cohort, 1569 (80.8%) were, resurveyed 3 years later at a mean age of 10.4 years. Main Outcome Measures Health-related QOL using the PedsQL 4.0 survey completed by both parent-proxy and by child self-report. Summary scores for children's total, physical, and psychosocial health and subscale scores for emotional, social, and school functioning were compared by weight category based on International Obesity Task Force cut points. Results Of 1456 participants, 1099 (75.5%) children were classified as not overweight; 294 (20.2%) overweight; and 63 (4.3%) obese. Parent-proxy and child self-reported PedsQL scores decreased with increasing child weight. The parent-proxy total PedsQL mean (SD) score for children who were not overweight was 83.1 (12.5); overweight, 80.0 (13.6); and obese, 75.0 (14.5); P<.001. The respective child self-reported total PedsQL mean (SD) scores were 80.5 (12.2), 79.3 (12.8), and 74.0 (14.2); P<.001. At the subscale level, child and parent-proxy reported scores were similar, showing decreases in physical and social functioning for obese children compared with children who were not overweight (all P<.001). Decreases in emotional and school functioning scores by weight category were not significant. Conclusion The effects of child overweight and obesity on health-related QOL in this community-based sample were significant but smaller than in a clinical sample using the same measure.	Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Deakin University	Williams, J (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	jo.williams@mcri.edu.au	Wake, Melissa/J-1396-2012; Hesketh, Kylie/B-7031-2013	Wake, Melissa/0000-0001-7501-9257; Hesketh, Kylie/0000-0002-2702-7110; Williams, Joanne/0000-0002-5633-1592; Davis, Elise/0000-0002-5076-2869				ARGLE M, 1996, PURSUIT QUALITY LIFE, P18; *AUSTR BUR STAT CO, 1998, SOC IND AR 1996; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Department of Health, 2019, MAT HLTH 1 2000 DAYS; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; FigueroaColon R, 1996, OBES RES, V4, P419, DOI 10.1002/j.1550-8528.1996.tb00250.x; Friedlander SL, 2003, ARCH PEDIAT ADOL MED, V157, P1206, DOI 10.1001/archpedi.157.12.1206; Hesketh K, 2004, PUBLIC HEALTH NUTR, V7, P303, DOI 10.1079/PHN2003537; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; Kuczmarski RJ, 2000, CDC GROWTH CHARTS US; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Sherman EMS, 2002, EPILEPSIA, V43, P1230, DOI 10.1046/j.1528-1157.2002.03602.x; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Vitale MG, 2001, J PEDIATR ORTHOPED, V21, P622, DOI 10.1097/00004694-200109000-00014; Wake M, 2000, DIABETIC MED, V17, P700, DOI 10.1046/j.1464-5491.2000.00360.x; Wake M, 2002, INT J OBESITY, V26, P717, DOI 10.1038/sj.ijo.0801974; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Waters E, 2000, PEDIATRICS, V106, P1422, DOI 10.1542/peds.106.6.1422; Webber LS, 1995, AM J MED SCI, V310, pS53, DOI 10.1097/00000441-199512000-00010; WHO, 2021, WHO GUID HLTH WORKF; [No title captured]	24	443	452	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2005	293	1					70	76		10.1001/jama.293.1.70	http://dx.doi.org/10.1001/jama.293.1.70			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QY	15632338				2022-12-24	WOS:000226102100023
J	Cohen, JP; Paquette, C; Cairns, CP				Cohen, JP; Paquette, C; Cairns, CP			Switching prescription drugs to over the counter	BRITISH MEDICAL JOURNAL			English	Article									Tufts Univ, Sch Med, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA	Tufts University	Cohen, JP (corresponding author), Tufts Univ, Sch Med, Tufts Ctr Study Drug Dev, 192 South St,Suite 550, Boston, MA 02111 USA.	joshua.cohen@tufts.edu						[Anonymous], 2004, LANCET, V363, P1659; *BRIST MYERS SQUIB, ADV COMM M BRIEF BOO; COHEN J, 2003, AM J THER, P1370; DiMasi J, 2001, J RES PHARMA EC, V11, P43, DOI [10.1300/J063v11n03_04, DOI 10.1300/J063V11N03_04]; *MED HEALTHC PROD, 2003, CONS DOC ARM 18 REQ; *NONPR MED AC, JOINT FDA ADV COMM R; *US FDA, FY 2004 FDA BUDG BRI; *WELLP, ISS PAP FDA PET PRES; *WORLD SELF MED IN, OTC INGR TABL	9	42	42	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 1	2005	330	7481					39	41		10.1136/bmj.330.7481.39	http://dx.doi.org/10.1136/bmj.330.7481.39			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15626806	Green Published			2022-12-24	WOS:000226176700021
J	Jaenisch, R				Jaenisch, R			Human cloning - The science and ethics of nuclear transportation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Cambridge, MA 02139 USA.							Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Jaenisch R, 2004, BIOL NUCL CLONING PO; McHugh PR, 2004, NEW ENGL J MED, V351, P209, DOI 10.1056/NEJMp048147	3	84	91	1	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2004	351	27					2787	2791		10.1056/NEJMp048304	http://dx.doi.org/10.1056/NEJMp048304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	883IH	15625328				2022-12-24	WOS:000226004300001
J	Hayase, A; Takagi, M; Miyazaki, T; Oshiumi, H; Shinohara, M; Shinohara, A				Hayase, A; Takagi, M; Miyazaki, T; Oshiumi, H; Shinohara, M; Shinohara, A			A protein complex containing Mei5 and Sae3 promotes the assembly of the meiosis-specific RecA homolog Dmc1	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; RAD51; DNA; REPAIR; GENES; TRANSITION; PACHYTENE; DISTINCT	Meiotic recombination requires the meiosis-specific RecA homolog Dmc1 as well as the mitotic RecA homolog Rad51. Here, we show that the two meiosisspecific proteins Mei5 and Sae3 are necessary for the assembly of Dmc1, but not for Rad51, on chromosomes including the association of Dmc1 with a recombination hot spot. Mei5, Sae3, and Dmc1 form a ternary and evolutionary conserved complex that requires Rad51 for recruitment to chromosomes. Mei5, Sae3, and Dmc1 are mutually dependent for their chromosome association, and their absence prevents the disassembly of Rad51 filaments. Our results suggest that Mei5 and Sae3 are loading factors for the Dmc1 recombinase and that the Dmc1-Mei5-Sae3 complex is integrated onto Rad51 ensembles and, together with Rad51, plays both catalytic and structural roles in interhomolog recombination during meiosis.	Osaka Univ, Grad Sch Sci, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Shinohara, A (corresponding author), Osaka Univ, Grad Sch Sci, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013; Oshiumi, Hiroyuki/G-1645-2012	Oshiumi, Hiroyuki/0000-0003-1567-8722; Shinohara, Miki/0000-0002-7413-8235				Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dresser ME, 1997, GENETICS, V147, P533; Enyenihi AH, 2003, GENETICS, V163, P47; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; McKee AHZ, 1997, GENETICS, V146, P817; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 2003, GENETICS, V163, P1273; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zierhut C, 2004, CURR BIOL, V14, P752, DOI 10.1016/j.cub.2004.04.030	44	94	102	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					927	940		10.1016/j.cell.2004.10.031	http://dx.doi.org/10.1016/j.cell.2004.10.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620352	Bronze			2022-12-24	WOS:000226109700006
J	Martin, DE; Soulard, A; Hall, MN				Martin, DE; Soulard, A; Hall, MN			TOR regulates ribosomal protein gene expression via PKA and the forkhead transcription factor FHL1	CELL			English	Article							RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; HEAD PROTEIN; FHA DOMAIN; YEAST; RAPAMYCIN; RECRUITMENT; PHOSPHORYLATION; LOCALIZATION	The regulation of ribosome biogenesis in response to environmental conditions is a key aspect of cell growth control. Ribosomal protein (RP) genes are regulated by the nutrient-sensitive, conserved target of rapamycin (TOR) signaling pathway. TOR controls the subcellular localization of protein kinase A (PKA) and the PKA-regulated kinase YAK1. However, the target transcription factor(s) of the TOR-PKA pathway are unknown. We show that regulation of RP gene transcription via TOR and PKA in yeast involves the Forkhead-like transcription factor FHL1 and the two cofactors IFH1 (a coactivator) and CRF1 (a corepressor). TOR, via PKA, negatively regulates YAK1 and maintains CRF1 in the cytoplasm. Upon TOR inactivation, activated YAK1 phosphorylates and activates CRF1. Phosphorylated CRF1 accumulates in the nucleus and competes with IFH1 for binding to FHL1 at RP gene promoters, and thereby inhibits transcription of RP genes. Thus, we describe a signaling mechanism linking an environmental sensor to ribosome biogenesis.	Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Soulard, Alexandre/0000-0003-3556-1994; Hall, Michael N/0000-0002-2998-0757				Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Griffioen G, 2001, MOL CELL BIOL, V21, P511, DOI 10.1128/MCB.21.2.511-523.2001; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; James P, 1996, GENETICS, V144, P1425; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen Paul, 2004, VVolume 42, P329; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SHERMAN F, 1991, METHOD ENZYMOL, V194, P12; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zappacosta F, 2002, ANAL CHEM, V74, P3221, DOI 10.1021/ac025538x; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463	49	350	363	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					969	979		10.1016/j.cell.2004.11.047	http://dx.doi.org/10.1016/j.cell.2004.11.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620355	Bronze			2022-12-24	WOS:000226109700009
J	D'Hondt, S; Jorgensen, BB; Miller, DJ; Batzke, A; Blake, R; Cragg, BA; Cypionka, H; Dickens, GR; Ferdelman, T; Hinrichs, KU; Holm, NG; Mitterer, R; Spivack, A; Wang, GZ; Bekins, B; Engelen, B; Ford, K; Gettemy, G; Rutherford, SD; Sass, H; Skilbeck, CG; Aiello, IW; Guerin, G; House, CH; Inagaki, F; Meister, P; Naehr, T; Niitsuma, S; Parkes, RJ; Schippers, A; Smith, DC; Teske, A; Wiegel, J; Padilla, CN; Acosta, JLS				D'Hondt, S; Jorgensen, BB; Miller, DJ; Batzke, A; Blake, R; Cragg, BA; Cypionka, H; Dickens, GR; Ferdelman, T; Hinrichs, KU; Holm, NG; Mitterer, R; Spivack, A; Wang, GZ; Bekins, B; Engelen, B; Ford, K; Gettemy, G; Rutherford, SD; Sass, H; Skilbeck, CG; Aiello, IW; Guerin, G; House, CH; Inagaki, F; Meister, P; Naehr, T; Niitsuma, S; Parkes, RJ; Schippers, A; Smith, DC; Teske, A; Wiegel, J; Padilla, CN; Acosta, JLS			Distributions of microbial activities in deep subseafloor sediments	SCIENCE			English	Article							PROKARYOTES; OXIDATION; CRUST; LIFE	Diverse microbial communities and numerous energy-yielding activities occur in deeply buried sediments of the eastern Pacific Ocean. Distributions of metabolic activities often deviate from the standard model. Rates of activities, cell concentrations, and populations of cultured bacteria vary consistently from one subseafloor environment to another. Net rates of major activities principally rely on electron acceptors and electron donors from the photosynthetic surface world. At open-ocean sites, nitrate and oxygen are supplied to the deepest sedimentary communities through the underlying basaltic aquifer. In turn, these sedimentary communities may supply dissolved electron donors and nutrients to the underlying crustal biosphere.	Univ Rhode Isl, Grad Sch Oceanog, NASA Astrobiol Inst, Narragansett, RI 02882 USA; Univ Oldenburg, Inst Chem & Biol Meeres, D-26111 Oldenburg, Germany; Univ Oldenburg, Ocean Drilling Program Leg Shipboard Sci Party 20, D-26111 Oldenburg, Germany; Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA	National Aeronautics & Space Administration (NASA); University of Rhode Island; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	D'Hondt, S (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, NASA Astrobiol Inst, S Ferry Rd, Narragansett, RI 02882 USA.	dhondt@gso.uri.edu	Teske, Andreas/AAQ-9577-2021; Skilbeck, Charles/M-6872-2013; chen, qi/C-8585-2011; Holm, Nils/H-3726-2012; Schippers, Axel/AAB-3919-2021; Ferdelman, Timothy G/A-3758-2013; Naehr, Thomas/C-2958-2008; Engelen, Bert/ABB-7315-2021; Jorgensen, Bo B/C-2214-2013; Smith, David/A-8309-2013; Inagaki, Fumio/AAI-1156-2019; Dickens, Gerald R/G-1222-2011; Cragg, Barry/D-2690-2009; Parkes, Ronald/B-1731-2010; Sass, Henrik/B-8817-2009; Hinrichs, Kai-Uwe/C-7675-2009	Holm, Nils/0000-0001-8904-6053; Schippers, Axel/0000-0002-4469-9883; Ferdelman, Timothy G/0000-0002-9701-3793; Engelen, Bert/0000-0002-8117-0460; Jorgensen, Bo B/0000-0001-9398-8027; Smith, David/0000-0003-0627-5788; Inagaki, Fumio/0000-0003-2887-6525; Parkes, Ronald/0000-0001-9402-5943; Sass, Henrik/0000-0001-8740-4224; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Ford, Kathryn H./0000-0002-5515-8521; Dickens, Gerald/0000-0003-2869-4860; Skilbeck, Greg/0000-0003-1634-963X; Wiegel, Juergen/0000-0002-6343-6464; Meister, Patrick/0000-0003-3623-6456; Nicolaus, Anja/0000-0002-2026-3540				Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; BAKER PA, 1991, EARTH PLANET SC LETT, V105, P522, DOI 10.1016/0012-821X(91)90189-O; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; DHONDT S, 2003, P ODP IN REP 201 CD; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; LAUER A, 2004, INT J ASTROBIOL, V3, P63; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Schulz H.D., 2000, MARINE GEOCHEMISTRY, P85; SORENSEN KB, IN PRESS GEOBIOLOGY; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Suess E., 1988, P ODP IN REP, V112; SUSS J, IN PRESS FEMS MICROB; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zink KG, 2003, ORG GEOCHEM, V34, P755, DOI 10.1016/S0146-6380(03)00041-X	19	537	554	3	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2216	2221		10.1126/science.1101155	http://dx.doi.org/10.1126/science.1101155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618510				2022-12-24	WOS:000225950000034
J	Schawalder, SB; Kabani, M; Howald, I; Choudhury, U; Werner, M; Shore, D				Schawalder, SB; Kabani, M; Howald, I; Choudhury, U; Werner, M; Shore, D			Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1	NATURE			English	Article							GENOME-WIDE LOCATION; FORK HEAD PROTEIN; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; EXPRESSION; PATHWAY; RAP1; BINDING; FHL1	Regulation of ribosome biogenesis is central to the control of cell growth(1). In rapidly growing yeast cells, ribosomal protein (RP) genes account for approximately one-half of all polymerase II transcription-initiation events(1), yet these genes are markedly and coordinately downregulated in response to a number of environmental stress conditions(2-4), or during the transition from fermentation to respiration(5). Although several conserved signalling pathways (TOR, RAS/protein kinase A and protein kinase C) impinge upon RP gene transcription(1), little is known about how initiation at these genes is controlled. Rap1 (refs 6, 7) and more recently Fhl1 (ref. 8) were shown to bind upstream of many RP genes. Here we show that the essential protein Ifh1 binds to and activates many RP gene promoters under optimal growth conditions in Saccharomyces cerevisiae. Ifh1 is recruited to RP gene promoters through the forkhead-associated domain of Fhl1. Ifh1 binding decreases when RP genes are downregulated either by TOR inhibition or nutrient depletion, and is restored after release from starvation or upon regulated induction of IFH1 expression. These findings indicate a central role for Ifh1 and Fhl1 in RP gene regulation.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Program Frontiers Genet, CH-1211 Geneva 4, Switzerland; CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France	University of Geneva; University of Geneva; CEA; UDICE-French Research Universities; Universite Paris Saclay	Shore, D (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	David.Shore@molbio.unige.ch	Shore, David/F-6240-2015; Kabani, Mehdi/G-7456-2012; Werner, Michel/B-7316-2009	Shore, David/0000-0002-9859-143X; Kabani, Mehdi/0000-0001-7440-6394; Werner, Michel/0000-0002-2965-5858				Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Jorgensen P, 2000, GENOME BIOL, V1; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Kim M, 2002, J BIOL CHEM, V277, P38781, DOI 10.1074/jbc.M201559200; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	28	171	173	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1058	1061		10.1038/nature03200	http://dx.doi.org/10.1038/nature03200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616569	Green Published			2022-12-24	WOS:000225887000049
J	Wolfrum, C; Asilmaz, E; Luca, E; Friedman, JM; Stoffel, M				Wolfrum, C; Asilmaz, E; Luca, E; Friedman, JM; Stoffel, M			Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes	NATURE			English	Article							INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; COACTIVATOR PGC-1; GENE-EXPRESSION; MICE; SENSITIVITY; ACID; HEPATOCYTES; INHIBITION; MECHANISM	The regulation of fat and glucose metabolism in the liver is controlled primarily by insulin and glucagon. Changes in the circulating concentrations of these hormones signal fed or starvation states and elicit counter-regulatory responses that maintain normoglycaemia. Here we show that in normal mice, plasma insulin inhibits the forkhead transcription factor Foxa2 by nuclear exclusion and that in the fasted ( low insulin) state Foxa2 activates transcriptional programmes of lipid metabolism and ketogenesis. In insulin-resistant or hyperinsulinaemic mice, Foxa2 is inactive and permanently located in the cytoplasm of hepatocytes. In these mice, adenoviral expression of Foxa2T156A, a nuclear, constitutively active Foxa2 that cannot be inhibited by insulin(1), decreases hepatic triglyceride content, increases hepatic insulin sensitivity, reduces glucose production, normalizes plasma glucose and significantly lowers plasma insulin. These changes are associated with increased expression of genes encoding enzymes of fatty acid oxidation, ketogenesis and glycolysis. Chronic hyperinsulinaemia in insulin-resistant syndromes results in the cytoplasmic localization and inactivation of Foxa2, thereby promoting lipid accumulation and insulin resistance in the liver. Pharmacological intervention to inhibit phosphorylation of Foxa2 may be an effective treatment for type 2 diabetes.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@rockefeller.edu	Adiels, Martin/C-9278-2011	Wolfrum, Christian/0000-0002-3862-6805; Stoffel, Markus/0000-0003-1304-5817				Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lang C, 2001, J LIPID RES, V42, P22; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200; MATSUDA T, 1990, J BIOCHEM-TOKYO, V108, P778, DOI 10.1093/oxfordjournals.jbchem.a123280; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Stuempfle KJ, 1996, BIOTECHNIQUES, V21, P48; TOBEY TA, 1982, METABOLISM, V31, P608, DOI 10.1016/0026-0495(82)90100-7; UNTERMAN TG, 1994, BIOCHEM BIOPH RES CO, V203, P1835, DOI 10.1006/bbrc.1994.2401; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	30	298	318	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1027	1032		10.1038/nature03047	http://dx.doi.org/10.1038/nature03047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616563				2022-12-24	WOS:000225887000042
J	Ju, BG; Solum, D; Song, EJ; Lee, KJ; Rose, DW; Glass, CK; Rosenfeld, MG				Ju, BG; Solum, D; Song, EJ; Lee, KJ; Rose, DW; Glass, CK; Rosenfeld, MG			Activating the PARP-1 sensor component of the Groucho/TLE1 corepressor complex mediates a CaMKinase II delta-dependent neurogenic gene activation pathway	CELL			English	Article							POLY(ADP-RIBOSE) POLYMERASE BINDS; NUCLEAR RECEPTOR COREPRESSOR; ALPHA-GLUCOSIDASE GENE; CENTRAL-NERVOUS-SYSTEM; DNA TOPOISOMERASE-II; LOOP-HELIX FACTORS; PROTEIN-KINASE-II; NEURONAL DIFFERENTIATION; STEM-CELLS; TRANSCRIPTIONAL REPRESSION	Switching specific patterns of gene repression and activation in response to precise temporal/spatial signals is critical for normal development. Here we report a pathway in which induction of CaMKIIdelta triggers an unexpected switch in the function of the HES1 transcription factor from a TLE-dependent repressor to an activator required for neuronal differentiation. These events are based on activation of the poly(ADPribose) polymerase1 (PARP-1) sensor component of the groucho/TLE-corepressor complex mediating dismissal of the corepressor complex from HES1-regulated promoters. In parallel, CaMKIIdelta mediates a required phosphorylation of HES1 to permit neurogenic gene activation, revealing the ability of a specific signaling pathway to modulate both the derepression and the subsequent coactivator recruitment events required for transcriptional activation of a neurogenic program. The identification of PARP-1 as a regulated promoter-specific exchange factor required for activation of specific neurogenic gene programs is likely to be prototypic of similar molecular mechanisms.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Ewha Womans Univ, Ctr Cell Signaling Res, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ewha Womans University; Ewha Womans University	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666				ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; ADACHIY, 1991, CELL, V54, P137; Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BROU C, 1993, NUCLEIC ACIDS RES, V21, P4011, DOI 10.1093/nar/21.17.4011; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Carey MB, 1999, DEV BIOL, V215, P298, DOI 10.1006/dbio.1999.9433; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciccolini F, 2003, J NEUROSCI, V23, P103; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Enarsson M, 2002, MOL CANCER RES, V1, P147; FERRO AM, 1982, J BIOL CHEM, V257, P7808; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Gilchrist JSC, 2002, J CELL BIOCHEM, V85, P268, DOI 10.1002/jcb.10121; Glass CK, 2000, GENE DEV, V14, P121; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Plaza S, 1999, ONCOGENE, V18, P1041, DOI 10.1038/sj.onc.1202406; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roger B, 2002, J BIOL CHEM, V277, P10209, DOI 10.1074/jbc.M106412200; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Sewer MB, 2002, ENDOCR RES, V28, P551, DOI 10.1081/ERC-120016840; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; SUGIURA H, 1992, BRAIN RES, V593, P97, DOI 10.1016/0006-8993(92)91269-K; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang HY, 1997, J BIOL CHEM, V272, P1817, DOI 10.1074/jbc.272.3.1817; Yan B, 2002, BIOCHEM BIOPH RES CO, V291, P582, DOI 10.1006/bbrc.2002.6483; Yan B, 2001, J BIOL CHEM, V276, P1789, DOI 10.1074/jbc.M005959200; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	67	240	247	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					815	829		10.1016/j.cell.2004.11.017	http://dx.doi.org/10.1016/j.cell.2004.11.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607978	Bronze			2022-12-24	WOS:000225907200012
J	Charles, D; Ness, AR; Campbell, D; Smith, GD; Hall, MH				Charles, D; Ness, AR; Campbell, D; Smith, GD; Hall, MH			Taking folate in pregnancy and risk of maternal breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID; DEFICIENCY; PREVENTION		Div Child Hlth, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Bristol, Dept Social Med, Bristol B58 2PR, Avon, England	University of Aberdeen; University of Bristol	Ness, AR (corresponding author), Div Child Hlth, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England.	Andy.Ness@bris.ac.uk	Ness, Andy R/M-7612-2013; Davey Smith, George/A-7407-2013; Hall, Mei-Hua/GLR-9172-2022	Ness, Andy R/0000-0003-3548-9523; Davey Smith, George/0000-0002-1407-8314; Hall, Mei-Hua/0000-0002-4558-7023				CHARLES DHM, 2005, IN PRESS PAEDIAT PER, V19; HALL MH, 1972, J OBSTET GYN BR COMM, V79, P159; Kotsopoulos J, 2003, CARCINOGENESIS, V24, P937, DOI 10.1093/carcin/bgg036; Lucock M, 2004, BMJ-BRIT MED J, V328, P211, DOI 10.1136/bmj.328.7433.211; WALD N, 1991, LANCET, V338, P131	5	86	87	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2004	329	7479					1375	1376		10.1136/bmj.329.7479.1375	http://dx.doi.org/10.1136/bmj.329.7479.1375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591563	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000225785000018
J	Tard, C; Liu, XM; Ibrahim, SK; Bruschi, M; De Gioia, L; Davies, SC; Yang, X; Wang, LS; Sawers, G; Pickett, CJ				Tard, C; Liu, XM; Ibrahim, SK; Bruschi, M; De Gioia, L; Davies, SC; Yang, X; Wang, LS; Sawers, G; Pickett, CJ			Synthesis of the H-cluster framework of iron-only hydrogenase	NATURE			English	Article							DENSITY-FUNCTIONAL THEORY; ELECTRONIC-STRUCTURE; DIIRON SUBSITE; ACTIVE-SITE; STRUCTURAL ELEMENTS; MODEL COMPLEXES; APPROXIMATION; MECHANISM; EVOLUTION; LIGANDS	The metal- sulphur active sites of hydrogenases catalyse hydrogen evolution or uptake at rapid rates. Understanding the structure and function of these active sites - through mechanistic studies of hydrogenases(1 - 4), synthetic assemblies(5 - 12) and in silico models(13 - 15) - will help guide the design of new materials for hydrogen production or uptake(16). Here we report the assembly of the iron- sulphur framework of the active site of iron- only hydrogenase ( the H- cluster), and show that it functions as an electrocatalyst for proton reduction. Through linking of a di- iron subsite to a {4Fe4S} cluster, we achieve the first synthesis of a metallosulphur cluster core involved in small- molecule catalysis. In addition to advancing our understanding of the natural biological system, the availability of an active, free- standing analogue of the H- cluster may enable us to develop useful electrocatalytic materials for application in, for example, reversible hydrogen fuel cells. ( Platinum is currently the preferred electrocatalyst for such applications, but is expensive, limited in availability and, in the long term, unsustainable(17).)	John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; Washington State Univ, Dept Phys, Richland, WA USA; Pacific NW Natl Lab, WR Wiley Environm Sci Lab, Richland, WA 99352 USA; Pacific NW Natl Lab, Div Chem Sci, Richland, WA 99352 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Milano-Bicocca; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Pickett, CJ (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	chris.pickett@bbsrc.ac.uk	Liu, Xiaoming/C-4030-2008; Tard, Cédric/A-9318-2008; PICKETT, CHRISTOPHER J/F-3896-2010; De Gioia, Luca/K-6439-2016	Liu, Xiaoming/0000-0003-0038-6292; Tard, Cédric/0000-0002-1515-1915; PICKETT, CHRISTOPHER J/0000-0003-3142-0780; BRUSCHI, MAURIZIO/0000-0002-5709-818X; Yang, Xin/0000-0002-9173-1188				Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bruschi M, 2004, INORG CHEM, V43, P3733, DOI 10.1021/ic035326y; Cao ZX, 2001, J AM CHEM SOC, V123, P3734, DOI 10.1021/ja000116v; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; George SJ, 2002, CHEM-EUR J, V8, P4037, DOI 10.1002/1521-3765(20020902)8:17<4037::AID-CHEM4037>3.0.CO;2-O; Gloaguen F, 2002, INORG CHEM, V41, P6573, DOI 10.1021/ic025838x; Le Cloirec A, 1999, CHEM COMMUN, P2285; Liu ZP, 2002, J AM CHEM SOC, V124, P5175, DOI 10.1021/ja0118690; Lyon EJ, 1999, ANGEW CHEM INT EDIT, V38, P3178, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3178::AID-ANIE3178>3.3.CO;2-W; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Ott S, 2004, ANGEW CHEM INT EDIT, V43, P1006, DOI 10.1002/anie.200353190; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; PICKETT CJ, 1994, J CHEM SOC DALTON, P2181, DOI 10.1039/dt9940002181; Popescu CV, 1999, J AM CHEM SOC, V121, P7877, DOI 10.1021/ja991243y; Razavet M, 2003, DALTON T, P586, DOI 10.1039/b209690k; Razavet M, 2002, CHEM COMMUN, P700, DOI 10.1039/b111613b; Reihlen H, 1929, LIEBIGS ANN CHEM, V472, P268; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schmidt M, 1999, J AM CHEM SOC, V121, P9736, DOI 10.1021/ja9924187; STACK TDP, 1987, J AM CHEM SOC, V109, P2546, DOI 10.1021/ja00242a067; Tard C, 2005, CHEM COMMUN, P133, DOI 10.1039/b411559g; *UK DEP TRANSP, 2003, PLAT HYDR FUEL CELL; *US DEP EN OFF SCI, 2003, BAS EN SCI WORKSH HY; Wang LS, 1999, REV SCI INSTRUM, V70, P1957, DOI 10.1063/1.1149694; Wang XB, 2003, J AM CHEM SOC, V125, P14072, DOI 10.1021/ja036831x; Yang X, 2003, J PHYS CHEM A, V107, P4612, DOI 10.1021/jp034432i; Zhao X, 2002, INORG CHEM, V41, P3917, DOI 10.1021/ic020237r	30	446	449	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					610	613		10.1038/nature03298	http://dx.doi.org/10.1038/nature03298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703741				2022-12-24	WOS:000226862000038
J	Li, ZH; Kosorok, MR; Farrell, PM; Laxova, A; West, SEH; Green, CG; Collins, J; Rock, MJ; Splaingard, ML				Li, ZH; Kosorok, MR; Farrell, PM; Laxova, A; West, SEH; Green, CG; Collins, J; Rock, MJ; Splaingard, ML			Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRONCHOPULMONARY DISEASE; ANTIBIOTIC-TREATMENT; CROSS-INFECTION; YOUNG-CHILDREN; COLONIZATION; TOBRAMYCIN; INHIBITION; RESISTANCE; CONVERSION	Context Although Pseudomonas aeruginosa is the most common virulent respiratory pathogen in cystic fibrosis (CF), the longitudinal development of P aeruginosa infection and its effect on antibody responses and lung disease progression in children with CF remain unclear. Objective To prospectively examine the epidemiology of Paeruginosa infection and its impact on CF pulmonary morbidity. Design, Setting, and Patients We prospectively evaluated 56 CF patients at 2 CF centers in Madison and Milwaukee, Wis, from birth up to age 16 years between April 15, 1985, and April 15, 2004, with diagnoses made through the Wisconsin CF Neonatal Screening Project. Main Outcome Measures Timing of nonmucoid P aeruginosa and mucoid P aeruginosa acquisition was assessed by first positive result. Longitudinal development from no P aeruginosa to nonmucoid P aeruginosa and from nonmucoid Paerugginosa to mucoid Paeruginosa was examined. Outcome measurements included antibody titers, respiratory symptoms, quantitative chest radiography, and pulmonary function tests. Results Sixteen patients (29%) acquired nonmucoid Paeruginosa in the first 6 months of life. The age-specific prevalence of mucoid Paeruginosa increased markedly from age 4 to 16 years. Nonmucoid and mucoid P aeruginosa were acquired at median ages of 1.0 and 13.0 years, respectively. In contrast with the short transition time from no Paeruginosa to nonmucoid P aeruginosa, the transition time from nonmucoid to mucoid P aeruginosa was relatively long (median, 10.9 years) and could be slightly extended by brief/low anti-Paeruginosa antibiotic treatment. Antibody titers increased with both transitions, but the deterioration in cough scores, chest radiograph scores, and pulmonary function correlated best with transition from nonmucoid to mucoid P aeruginosa. Conclusions Early prevention and detection of nonmucoid and mucoid P aeruginosa are critical because of early acquisition and prevalence. There is a Window of opportunity for suppression and possible eradication (by aggressive anti-P aeruginosa treatment) of initial nonmucoid Paeruginosa. Mucoid Paeruginosa plays a much greater role in CF lung disease progression than nonmucoid Paeruginosa. Antibody titers, cough scores, and chest radiographs are early signs of nonmucoid P aeruginosa and especially mucoid P aeruginosa stages.	Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53705 USA; Univ Wisconsin, Dept Biostat Med Informat, Madison, WI 53705 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Radiol, Madison, WI 53705 USA; Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Farrell, PM (corresponding author), Univ Wisconsin, Sch Med, Dept Pediat, Room 4129 HSLC,750 Highland Ave, Madison, WI 53705 USA.	pmfarrel@facstaff.wics.edu	Splaingard, Mark/D-9206-2012; Splaingard, Mark/AAL-7356-2021; Kosorok, Michael/ABB-7427-2021	Splaingard, Mark/0000-0002-1361-4947; 	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034108, R56DK034108] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NIDDK NIH HHS [DK 34108] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Ballmann M, 1998, THORAX, V53, P732, DOI 10.1136/thx.53.9.732; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; CABRAL DA, 1987, PEDIATR RES, V22, P429, DOI 10.1203/00006450-198710000-00013; DORING G, 1988, CHEST, V94, pS109, DOI 10.1378/chest.94.2.109S; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell P M, 2000, Adv Pediatr, V47, P79; Farrell PM, 2003, AM J RESP CRIT CARE, V168, P1100, DOI 10.1164/rccm.200303-434OC; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FEGAN M, 1990, J CLIN MICROBIOL, V28, P1143, DOI 10.1128/JCM.28.6.1143-1146.1990; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Griese M, 2002, EUR J MED RES, V7, P79; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Heinzl B, 2002, PEDIATR PULM, V33, P32, DOI 10.1002/ppul.10019; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; HODGES NA, 1991, ANTIMICROB AGENTS CH, V35, P2450, DOI 10.1128/AAC.35.11.2450; Hoiby N, 2000, Paediatr Drugs, V2, P451; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Li ZH, 2004, PEDIATR PULM, V38, P277, DOI 10.1002/ppul.20092; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; Parad RB, 1999, INFECT IMMUN, V67, P4744, DOI 10.1128/IAI.67.9.4744-4750.1999; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Ratjen F, 2001, LANCET, V358, P983, DOI 10.1016/S0140-6736(01)06124-4; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; SOKOL PA, 1994, J BACTERIOL, V176, P553, DOI 10.1128/jb.176.3.553-562.1994; STIVER HG, 1988, CLIN INVEST MED, V11, P247; Tubbs D, 2001, RESP MED, V95, P147, DOI 10.1053/rmed.2000.1009; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; West SEH, 2002, JAMA-J AM MED ASSOC, V287, P2958, DOI 10.1001/jama.287.22.2958; Yu HW, 2002, FRONT BIOSCI-LANDMRK, V7, pD442	40	395	400	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2005	293	5					581	588		10.1001/jama.293.5.581	http://dx.doi.org/10.1001/jama.293.5.581			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893BL	15687313	Bronze			2022-12-24	WOS:000226694200021
J	Jain, A; Atreja, A; Harris, M; Lehmann, M; Burns, J; Young, J				Jain, A; Atreja, A; Harris, M; Lehmann, M; Burns, J; Young, J			Responding to the rofecoxib withdrawal crisis: A new model for notifying patients at risk and their health care providers	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; SAFETY; MEDICATION; RECALL; INFORMATION; MEDICINES; ARTHRITIS; MERCK; FDA	Background: We decided to inform our patients of the withdrawal of rofecoxib, one of the largest drug withdrawals in United States history, and instruct them to contact their providers for guidance. Objective: To identify and inform patients and providers affected by the rofecoxib withdrawal. Design: Descriptive observational study. Setting: Tertiary care center with an electronic medical record (EMR) system. Patients: Patients with an active rofecoxib prescription within the EMR. Intervention: Existing information technology and traditional communication resources were used to automate the identifying and notifying of patients and providers and to deactivate rofecoxib prescriptions in the EMR. Measurements: characteristics of patients receiving rofecoxib at our institution, details of their prescription and provider, number of EMR alerts, and medication discontinuations. Results: The 11699 patients with a rofecoxib prescription in our practice were sent notifications within 24 hours of the withdrawal. Limitations: we did not directly measure the effect of our notification on patients or providers. Conclusions: information technology enabled our institution to rapidly identify and notify individual patients and their providers about an important drug withdrawal. The methods modeled a feasible way for health care organizations with EMRs to participate in notification processes that may be applicable in a variety of situations.	Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Jain, A (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,A91, Cleveland, OH 44195 USA.			Atreja, Ashish/0000-0002-0628-4417				Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; *CAMH, 2004, OFF HDB CAMH; Delorio NM, 2004, J EMERG MED, V26, P305, DOI 10.1016/j.jemermed.2003.09.009; DICK S, 1997, COMPUTER BASED PATIE; Folz-Murphy N, 1998, J AM MED INFORM ASSN, P260; Foster Erica, 2003, J AHIMA, V74, P34; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Greene H L, 2000, Health News, V6, P4; Harris C Martin, 2003, J Healthc Inf Manag, V17, P37; Houston TK, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e7; JOHNSON LJ, 2001, MED ECON, V78, P118; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kleinke JD, 1998, BRIT MED J, V317, P899; LIMA HA, 1995, AM J HEALTH-SYST PH, V52, P1010, DOI 10.1093/ajhp/52.9.1010; *MERCK CO INC, 2004, NEWS REL, P1; Murphy GF, 1999, ELECT HLTH RECORDS C; Poland GA, 1997, JAMA-J AM MED ASSOC, V278, P1022, DOI 10.1001/jama.278.12.1022; Rich D S, 1995, Hosp Pharm, V30, P165; Schiff GD, 2002, PHARMACOEPIDEM DR S, V11, P643, DOI 10.1002/pds.778; Singh D, 2004, BRIT MED J, V329, P816, DOI 10.1136/bmj.329.7470.816-a; SMITHELLS RW, 1963, LANCET, V1, P1095; SPOONER T, 2003, INTERNET USE REGION, P2; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; *US DEP HLTH HUM S, 2001, STAND PRIV IND ID HL; US Food and Drug Administration, 2004, FDA ISS PUBL HLTH AD; Wolfe SM, 2002, PHARMACOEPIDEM DR S, V11, P641, DOI 10.1002/pds.776; Wood AJJ, 1999, JAMA-J AM MED ASSOC, V281, P1753, DOI 10.1001/jama.281.18.1753; Zaidi STR, 2002, AM J HEALTH-SYST PH, V59, P1569, DOI 10.1093/ajhp/59.16.1569a; *ZIX CORP E PRESCR, 2004, FORB BUS WIRE; 2004, FAMILYMEDS USES NEW, P1	31	17	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2005	142	3					182	186		10.7326/0003-4819-142-3-200502010-00008	http://dx.doi.org/10.7326/0003-4819-142-3-200502010-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900UH	15684206				2022-12-24	WOS:000227239300004
J	Alvarez-Vasquez, F; Sims, KJ; Cowart, LA; Okamoto, Y; Voit, EO; Hannun, YA				Alvarez-Vasquez, F; Sims, KJ; Cowart, LA; Okamoto, Y; Voit, EO; Hannun, YA			Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae	NATURE			English	Article							BINDING-PROTEIN; STRESS; SPHINGOSINE-1-PHOSPHATE; INHIBITION; CERAMIDE; SYSTEMS; GENE	Mathematical models have become a necessary tool for organizing the rapidly increasing amounts of large-scale data on biochemical pathways and for advanced evaluation of their structure and regulation. Most of these models have addressed specific pathways using either stoichiometric(1) or flux-balance analysis(2), or fully kinetic Michaelis - Menten representations(3), metabolic control analysis(4), or biochemical systems theory(5-7). So far, the predictions of kinetic models have rarely been tested using direct experimentation. Here, we validate experimentally a biochemical systems theoretical model of sphingolipid metabolism in yeast(8). Simulations of metabolic fluxes, enzyme deletion and the effects of inositol ( a key regulator of phospholipid metabolism) led to predictions that show significant concordance with experimental results generated post hoc. The model also allowed the simulation of the effects of acute perturbations in fatty-acid precursors of sphingolipids, a situation that is not amenable to direct experimentation. The results demonstrate that modelling now allows testable predictions as well as the design and evaluation of hypothetical 'thought experiments' that may generate new metabolomic approaches.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Med Sch, Atlanta, GA 30332 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Georgia; Georgia Institute of Technology	Voit, EO (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	eberhard.voit@bme.gatech.edu; hannun@musc.edu	OKAMOTO, Yasuo/J-8438-2015	Alvarez-Vasquez, Fernando/0000-0003-4008-9858				Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; BIELAWSKA J, IN PRESS SIMULTANEOU; Fell D., 1997, UNDERSTANDING CONTRO; FERREIRA AEN, 1995, PLAS WINDOWS; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Heinrich R., 1996, REGULATION CELLULAR; JENKINS GM, 1999, APOPTOSIS PRACTICAL; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MANDALA SM, 1994, J ANTIBIOT, V47, P376, DOI 10.7164/antibiotics.47.376; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Mulquiney P. J., 2003, MODELING METABOLISM; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Voit EO, 2004, MATH BIOSCI, V191, P83, DOI 10.1016/j.mbs.2004.04.004; Voit EO, 2000, COMPUTATIONAL ANAL B; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	26	125	126	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					425	430		10.1038/nature03232	http://dx.doi.org/10.1038/nature03232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674294				2022-12-24	WOS:000226546200045
J	Schulz, HN; Schulz, HD				Schulz, HN; Schulz, HD			Large sulfur bacteria and the formation of phosphorite	SCIENCE			English	Article							WASTE-WATER; SEDIMENTS; OXYGEN; PHOSPHOGENESIS; POLYPHOSPHATE; REMOVAL	Phosphorite deposits in marine sediments are a long-term sink for an essential nutrient, phosphorus. Here we show that apatite abundance in sediments on the Namibian shelf correlates with the abundance and activity of the giant sulfur bacterium Thiomargarita namibiensis, which suggests that sulfur bacteria drive phosphogenesis. Sediments populated by Thiomargarita showed sharp peaks of pore water phosphate (less than or equal to300 micromolar) and massive phosphorite accumulations (greater than or equal to50 grams of phosphorus per kilogram). Laboratory experiments revealed that under anoxic conditions, Thiomargarita released enough phosphate to account for the precipitation of hydroxyapatite observed in the environment.	Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; Univ Bremen, Dept Geosci, D-28359 Bremen, Germany	Leibniz University Hannover; University of Bremen	Schulz, HN (corresponding author), Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	schulz@ifmb.uni-hannover.de	Schulz-Vogt, Heide/I-1397-2012	Schulz-Vogt, Heide/0000-0003-1445-0291				Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; KRAJEWSKI KP, 1994, ECLOGAE GEOL HELV, V87, P701; Larkin JM, 1996, MICROSC RES TECHNIQ, V33, P23; MAIER S, 1990, CAN J MICROBIOL, V36, P438, DOI 10.1139/m90-077; Mino T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P341; NATHAN Y, 1993, GEOMICROBIOL J, V11, P69, DOI 10.1080/01490459309377935; Parkhurst D.L, 1999, WATER RESOUR INVESTI; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; REIMERS CE, 1990, PHOSPHATE DEPOSITS W, V3, P300; Schenau S, 2000, MAR GEOL, V169, P1, DOI 10.1016/S0025-3227(00)00083-9; Schmaljohann R, 2001, MAR ECOL PROG SER, V220, P295; SCHULZ HD, 2000, MARINE GEOCHEMISTRY, P417; Schulz HN, 2002, APPL ENVIRON MICROB, V68, P5746, DOI 10.1128/AEM.68.11.5746-5749.2002; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Thiede J., 1983, COASTAL UPWELLING, VB, P11; vanLoosdrecht MCM, 1997, ANTON LEEUW INT J G, V71, P109, DOI 10.1023/A:1000150523030; WILLIAMS LA, 1983, GEOLOGY, V11, P267, DOI 10.1130/0091-7613(1983)11<267:ROBMIO>2.0.CO;2	19	291	301	6	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					416	418		10.1126/science.1103096	http://dx.doi.org/10.1126/science.1103096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662012				2022-12-24	WOS:000226492300044
J	Bilukha, OO; Brennan, M				Bilukha, OO; Brennan, M			Injuries and deaths caused by unexploded ordnance in Afganistan: review of surveillance data, 1997-2002	BMJ-BRITISH MEDICAL JOURNAL			English	Article								In 2000-2, Afghanistan had the highest number of casualties due to landmines and unexploded ordnance in the world.(1) Increasing international awareness of the public health threat posed by landmines is the legacy of the International Campaign to Ban Landmines. More attention must be paid to, the growing and equally deadly threat posed by unexploded ordnance.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Bilukha, OO (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop C-09, Atlanta, GA 30341 USA.	obilukha@cdc.gov	Bilukha, Oleg/ABC-5095-2020					Gall C, 2002, NY TIMES, pA15; *HUM RIGHTS WATCH, 2001, LANDM US AFGH; *INT CAMP BAN LAND, 2002, LANDM MON REP 2003; *INT COMM RED CROS, 2002, SEM REP JAN JUN 2002	4	11	11	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2005	330	7483					127	128		10.1136/bmj.38337.361782.82	http://dx.doi.org/10.1136/bmj.38337.361782.82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15640249	Green Published, Bronze			2022-12-24	WOS:000226454900019
J	Maragakis, LL; Cosgrove, SE; Song, XY; Kim, D; Rosenbaum, P; Ciesla, N; Srinivasan, A; Ross, T; Carroll, K; Perl, TM				Maragakis, LL; Cosgrove, SE; Song, XY; Kim, D; Rosenbaum, P; Ciesla, N; Srinivasan, A; Ross, T; Carroll, K; Perl, TM			An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS; PATTERNS; FEATURES; BROOKLYN; UNIT	Context Pulsatile lavage is a high-pressure irrigation treatment used increasingly in a variety of health care settings to debride wounds. Infection control precautions are not routinely used during the procedure and are not included in pulsatile lavage equipment package labeling. Objectives To investigate an outbreak of multidrug-resistant Acinetobacter baumannii and to test the hypothesis that pulsatile lavage wound treatment was the mode of transmission for the organism. Design Outbreak case-control investigation including case identification, review of medical records, environmental cultures, and pulsed-field gel electrophoresis. Setting A 1000-bed tertiary care hospital in Baltimore, Md, during September and October 2003. Patients The investigation included 11 patients infected or colonized with multidrug-resistant A baumannii. Seven of these patients met the case definition for the case-control study and were compared with 28 controls randomly selected from a list of inpatients without multidrug-resistant A baumannii who had a wound care consultation. Main Outcome Measure Infection or colonization with multidrug-resistant A baumannii. Results Eleven patients had cultures that grew multidrug-resistant A baumannii during the outbreak period. Of the 10 health care-associated cases, 8 had received pulsatile lavage treatment. One strain of multidrug-resistant A baumannii was recovered from all 6 pulsatile lavage patients who had isolates available for pulsed-field gel electrophoresis analysis and from multiple surfaces in the wound care area. Six of 7 cases (86%) were treated with pulsatile lavage vs 4 of 28 controls (14%) (odds ratio, 36; 95% confidence interval, 2.8-1721; P<.001). These results confirm that pulsatile lavage was a significant risk factor for acquisition of multidrug-resistant A baumannii. Conclusions Transmission was apparently caused by dissemination of multidrug-resistant A baumannii during the pulsatile lavage procedure, resulting in environmental contamination. Appropriate infection control precautions should be used during pulsatile lavage therapy and should be included in pulsatile lavage equipment labeling.	Johns Hopkins Univ Hosp, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ Hosp, Dept Phys Med & Rehabil, Baltimore, MD 21287 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Prevent Med, Baltimore, MD USA; Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Maragakis, LL (corresponding author), Johns Hopkins Univ Hosp, Dept Hosp Epidemiol & Infect Control, 600 N Wolfe St,Osler 425, Baltimore, MD 21287 USA.	lmaraga1@jhmi.edu	Maragakis, Lisa/AAW-9806-2020		NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [K01CI000300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER; NIAID NIH HHS [5-T32/AI07291] Funding Source: Medline; ODCDC CDC HHS [UR8/CCU315092] Funding Source: Medline; NCPDCID CDC HHS [1 K01 CI000300-01] Funding Source: Medline	NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ODCDC CDC HHS; NCPDCID CDC HHS		CEFAI C, 1990, J HOSP INFECT, V15, P177, DOI 10.1016/0195-6701(90)90128-B; Das I, 2002, J HOSP INFECT, V50, P110, DOI 10.1053/jhin.2001.1127; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Greene DL, 2004, J ORTHOP TRAUMA, V18, P41, DOI 10.1097/00005131-200401000-00008; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Loeb MB, 2003, AM J EPIDEMIOL, V157, P40, DOI 10.1093/aje/kwf173; LOEHNE HB, 2002, S ADV WOUND CAR MED; LOEHNE HB, 2001, WOUND CARE COLLABORA; Mah MW, 2001, AM J INFECT CONTROL, V29, P284, DOI 10.1067/mic.2001.114232; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tobias AM, 2002, ANN PLAS SURG, V48, P443, DOI 10.1097/00000637-200204000-00019; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Wisplinghoff H, 1999, CLIN INFECT DIS, V28, P59, DOI 10.1086/515067; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040	19	86	95	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3006	3011		10.1001/jama.292.24.3006	http://dx.doi.org/10.1001/jama.292.24.3006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613669				2022-12-24	WOS:000225841900035
J	Kahn-Kirby, AH; Dantzker, JLM; Apicella, AJ; Schafer, WR; Browse, J; Bargmann, CI; Watts, JL				Kahn-Kirby, AH; Dantzker, JLM; Apicella, AJ; Schafer, WR; Browse, J; Bargmann, CI; Watts, JL			Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo	CELL			English	Article							NUCLEOTIDE-GATED CHANNEL; MECHANOSENSORY NEURONS; CAPSAICIN RECEPTOR; CATION CHANNEL; PROTEIN; RESPONSES; ENCODES; MUTANT; TOUCH; CHEMOSENSATION	A variety of lipid and lipid-derived molecules can modulate TRP cation channel activity, but the identity of the lipids that affect TRP channel function in vivo is unknown. Here, we use genetic and behavioral analysis in the nematode C. elegans to implicate a subset of 20-carbon polyunsaturated fatty acids (PUFAs) in TRPV channel-dependent olfactory and nociceptive behaviors. Olfactory and nociceptive TRPV signaling are sustained by overlapping but nonidentical sets of 20-carbon PUFAs including eicosapentaenoic acid (EPA) and arachidonic acid (AA). PUFAs act upstream of TRPV family channels in sensory transduction. Shortterm dietary supplementation with PUFAs can rescue PUFA biosynthetic mutants, and exogenous PUFAs elicit rapid TRPV-dependent calcium transients in sensory neurons, bypassing the normal requirement for PUFA synthesis. These results suggest that a subset of PUFAs with omega-3 and omega-6 acyl groups act as endogenous modulators of TRPV signal transduction.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, HHMI, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Washington State University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego	Watts, JL (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jwatts@mail.wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639; Browse, John/0000-0002-2554-2821; Bargmann, Cornelia/0000-0002-8484-0618; Schafer, William/0000-0002-6676-8034	NIDA NIH HHS [DA016445] Funding Source: Medline; NIDCD NIH HHS [DC04089] Funding Source: Medline; NIGMS NIH HHS [R01 GM62521] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43913; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; Hardie RC, 2001, J EXP BIOL, V204, P3403; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HILGEMANN DW, SCI STKE 2001, pRE19; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; HILLIARD MA, 2004, IN PRESS EMBO J; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kniazeva M, 2003, GENETICS, V163, P159; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lopez PM, 2003, EUR J CLIN NUTR, V57, pS22, DOI 10.1038/sj.ejcn.1601805; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Nonet ML, 1997, J NEUROSCI, V17, P8061; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; von Schacky C, 2004, CURR OPIN CLIN NUTR, V7, P131, DOI 10.1097/00075197-200403000-00005; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	57	125	136	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					889	900		10.1016/j.cell.2004.11.005	http://dx.doi.org/10.1016/j.cell.2004.11.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607983	Bronze			2022-12-24	WOS:000225907200017
J	Wang, ZF; Rolish, ME; Yeo, G; Tung, V; Mawson, M; Burge, CB				Wang, ZF; Rolish, ME; Yeo, G; Tung, V; Mawson, M; Burge, CB			Systematic identification and analysis of exonic splicing silencers	CELL			English	Article							MESSENGER-RNA; HNRNP A1; REGULATORY ELEMENTS; NONSENSE MUTATION; SEQUENCE MOTIFS; A/B PROTEINS; TAT EXON-2; BINDING; SITE; INHIBITION	Exonic splicing silencers (ESSs) are cis-regulatory elements that inhibit the use of adjacent splice sites, often contributing to alternative splicing (AS). To systematically identify ESSs, an in vivo splicing reporter system was developed to screen a library of random decanucleotides. The screen yielded 141 ESS decamers, 133 of which were unique. The silencer activity of over a dozen of these sequences was also confirmed in a heterologous exon/intron context and in a second cell type. Of the unique ESS decamers, most could be clustered into groups to yield seven putative ESS motifs, some resembling known motifs bound by hnRNPs H and A1. Potential roles of ESSs in constitutive splicing were explored using an algorithm, ExonScan, which simulates splicing based on known or putative splicing-related motifs. ExonScan and related bioinformatic analyses suggest that these ESS motifs play important roles in suppression of pseudoexons, in splice site definition, and in AS.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Yeo, Gene/AAE-7676-2019; Burge, Christopher B./AAH-2177-2020	Yeo, Gene/0000-0002-0799-6037; Wang, Zefeng/0000-0002-6605-3637				AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Domsic JK, 2003, MOL CELL BIOL, V23, P8762, DOI 10.1128/MCB.23.23.8762-8772.2003; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Ladd AN, 2002, GENOME BIOL, V3; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Tu M, 2000, MUTAT RES-GENOMICS, V432, P15, DOI 10.1016/S1383-5726(99)00011-4; Valentine CR, 1997, RNA, V3, P660; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	48	506	528	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					831	845		10.1016/j.cell.2004.11.010	http://dx.doi.org/10.1016/j.cell.2004.11.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607979	Bronze			2022-12-24	WOS:000225907200013
J	Brookmeyer, R; Johnson, E; Bollinger, R				Brookmeyer, R; Johnson, E; Bollinger, R			Public health vaccination policies for containing an anthrax outbreak	NATURE			English	Article							POSTEXPOSURE PROPHYLAXIS; EMERGENCY RESPONSE; BIOLOGICAL WEAPON; PREVENTION; ATTACK; RISK	Concern about biological weapons has raised questions about the most effective public health policies to contain an anthrax outbreak(1-3). We developed a probability model to predict the impact of different anthrax antibiotic and vaccination policies. An anthrax outbreak can be significantly contained by minimizing the delay until initiation of antibiotic prophylaxis. However, even if mass distribution of antibiotics is completed within six days of the initial exposure, then at most about 70% of cases can be prevented. Post-exposure vaccination will not significantly increase that prevention rate if adherence to antibiotic regimens is similar or higher than that attained in the 2001 US outbreak(4). However, post-exposure vaccination can be useful either in shortening the duration of a prolonged antibiotic regimen, in the event of an antibiotic-resistant strain, or if antibiotic adherence rates are very low. Here we show that a mass pre-exposure vaccination programme for the general population would require very high population coverage rates to significantly increase prevention rates from that achieved with targeted and rapid post-exposure prophylaxis programmes.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Bollinger, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	rbrook@jhsph.edu		Bollinger, Robert/0000-0002-6798-6834				Bozzette SA, 2003, NEW ENGL J MED, V348, P416, DOI 10.1056/NEJMsa025075; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Brookmeyer R, 2003, P NATL ACAD SCI USA, V100, P10129, DOI 10.1073/pnas.1631983100; Brookmeyer R, 2002, SCIENCE, V295, P1861, DOI 10.1126/science.1068474; Centers for Disease Control and Prevention, 2004, MASS ANT DISP PRIM; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1024; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P1008; CIESLAK TJ, 1999, INFECT DIS, V5, P51; *COMM RES DEV NEED, 1999, CHEM BIOL TERR; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Haas CN, 2002, RISK ANAL, V22, P189, DOI 10.1111/0272-4332.00028; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; HENDERSON D. W., 1956, JOUR HYG, V54, P28; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Joellenbeck LM, 2002, ANTHRAX VACCINE IS I; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; *NAT I ALL INF DIS, 2002, DIS BIOD RES AG CDC; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Shepard CW, 2002, EMERG INFECT DIS, V8, P1124, DOI 10.3201/eid0810.020349; WATSON A, 1994, EPIDEMIOL INFECT, V113, P479, DOI 10.1017/S0950268800068497; Wein LM, 2003, P NATL ACAD SCI USA, V100, P4346, DOI 10.1073/pnas.0636861100	28	47	48	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					901	904		10.1038/nature03087	http://dx.doi.org/10.1038/nature03087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602561				2022-12-24	WOS:000225733500052
J	Nakagawa, T; Sakurai, T; Nishioka, T; Touhara, K				Nakagawa, T; Sakurai, T; Nishioka, T; Touhara, K			Insect sex-pheromone signals mediated by specific combinations of olfactory receptors	SCIENCE			English	Article							MOTH HELIOTHIS-VIRESCENS; BOMBYX-MORI; FLY BRAIN; DROSOPHILA; ACTIVATION; MECHANISMS; RESPONSES; ANTHERAEA; SILKMOTH; NEURONS	We describe two mate-specific olfactory receptors (ORs) in the silk moth, Bombyx mori, that are mutually exclusively expressed in a pair of adjacent pheromone-sensitive neurons of mate antennae: One is specifically tuned to bombykol, the sex pheromone, and the other to bombykal, its oxidized form. Both pheromone ORs are coexpressed with an OR from the highly conserved insect OR subfamily. This coexpression promotes the functional expression of pheromone receptors and confers ligand-stimulated nonselective cation channel activity. The same effects were also observed for general ORs. Both odorant and pheromone signaling pathways are mediated by means of a common mechanism in insects.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan	University of Tokyo; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Nishioka, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan.	nishioka@scl.kyoto-u.ac.jp; touhara@k.u-tokyo.ac.jp						Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mori K, 1998, CHIRALITY, V10, P578, DOI 10.1002/(SICI)1520-636X(1998)10:7<578::AID-CHIR5>3.0.CO;2-Z; NAKAGAWA T, UNPUB; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; TOPAZZINI A, 1990, J INSECT PHYSIOL, V36, P619, DOI 10.1016/0022-1910(90)90065-N; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7	24	392	436	9	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1638	1642		10.1126/science.1106267	http://dx.doi.org/10.1126/science.1106267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15692016				2022-12-24	WOS:000227622400051
J	Morgan, JF; Murphy, H; Lacey, JH; Conway, G				Morgan, JF; Murphy, H; Lacey, JH; Conway, G			Long term psychological outcome for women with congenital adrenal hyperplasia: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							INTERSEX		Univ London St Georges Hosp, Sch Med, Dept Mental Hlth, London SW17 0RE, England; Middlesex Hosp, Dept Endocrinol, London W1T 3AA, England	St Georges University London; University of London; University College London	Morgan, JF (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Mental Hlth, London SW17 0RE, England.	jmorgan@sghms.ac.uk						COOPER P, 1982, BRIT J PSYCHIAT, V141, P68, DOI 10.1192/bjp.141.1.68; Creighton S, 2001, BMJ-BRIT MED J, V323, P1264, DOI 10.1136/bmj.323.7324.1264; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Meyer-Bahlburg HFL, 2001, ENDOCRIN METAB CLIN, V30, P155, DOI 10.1016/S0889-8529(08)70024-0; Slijper FME, 1998, ARCH SEX BEHAV, V27, P125, DOI 10.1023/A:1018670129611	5	27	27	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 12	2005	330	7487					340	341		10.1136/bmj.38334.427361.D3	http://dx.doi.org/10.1136/bmj.38334.427361.D3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897OZ	15677365	Bronze, Green Published			2022-12-24	WOS:000227015800018
J	Bitton, A; Neuman, MD; Barnoya, J; Glantz, SA				Bitton, A; Neuman, MD; Barnoya, J; Glantz, SA			The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest	LANCET			English	Article							TP53 MUTATION SPECTRUM; LUNG-CANCER; MUTAGENIC SIGNATURE; SMOKE; SCIENCE; COMPONENTS; HOTSPOTS; POLICIES; LESSONS	Mutations in the p53 tumour suppressor gene lead to uncontrolled cell division and are found in over 50% of all human tumours, including 60% of lung cancers. Research published in 1996 by Denissenko and colleagues demonstrated patterned in-vitro mutagenic effects on p53 of benzo[a]pyrene, a carcinogen present in tobacco smoke. We investigated the tobacco industry's response to p53 research linking smoking to cancer. We searched online tobacco document archives, including the Legacy Tobacco Documents Library and Tobacco Documents Online, and archives maintained by tobacco companies such as Philip Morris and R J Reynolds. Documents were also obtained from the British American Tobacco Company depository in Guildford, UK. Informal correspondence was carried out with scientists, lawyers, and tobacco control experts in the USA and Europe. We found that executives and scientists at the highest levels of the tobacco industry anticipated and carefully monitored p53 research. The tobacco industry's own scientists conducted research which appeared to cast doubt on the link between smoking and p53 mutations. Researchers and a journal editor with tobacco industry ties participated in the publication of this research in a peer-reviewed journal without clear disclosure of their tobacco industry links. Tobacco industry responses to research linking smoking to carcinogenic p53 mutations mirror prior industry efforts to challenge the science linking smoking and lung cancer. The extent of tobacco industry involvement in p53 research and the potential conflict of interest discussed here demonstrate the need for consistent standards for the disclosure and evaluation of such potential conflicts in biomedical research.	Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu		Barnoya, Joaquin/0000-0002-1731-479X	NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER; NCI NIH HHS [CA-87472] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM ASS CANC RES, 2000, AM ASS CANC RES 91 A; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BARNOYA J, IN PRESS EUR J PUB H; BINNS RM, 1988, COMMUNICATION   0506; BORELLI T, 1993, WALL STREET J   0728; BOULLIN J, 2004, COMMUNICATION; BOULLIN JM, 2003, COMMUNICATION; BOULLIN JM, 2001, COMMUNICATION   0404; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006; COGGINS C, 2000, VERBANDT PAPER KEIN; DEMPSEY R, 1996, COMMUNICATION   1219; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIETHELM PA, WHOLE TRUTH NOTHING; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; *ED BOARD, 2003, MUTAGENESIS; Francey N, 2000, BRIT MED J, V321, P371, DOI 10.1136/bmj.321.7257.371; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; GERNTENBACH R, 1988, 135R1 COUNC TOB RES; GERTENBACH R, 1988, 135R2 COUNC TOB RES; Glantz S.A., 1996, CIGARETTE PAPERS; GORI G, 1993, INVOICE CONSULTING; GORI G, 1992, INVOICE CONSULTATION; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2001, MUTAGENESIS, V16, P551, DOI 10.1093/mutage/16.6.551; HAINAUT P, 2001, COMMUNICATION   0112; HELLER WD, 1999, AD HOC ARBEITSGRUPPE; Hernandez-Boussard TM, 1998, ENVIRON HEALTH PERSP, V106, P385, DOI 10.2307/3434065; Hirschhorn N, 2000, TOB CONTROL, V9, P242, DOI 10.1136/tc.9.2.242; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hong MK, 2002, BRIT MED J, V325, P1413, DOI 10.1136/bmj.325.7377.1413; Horton R, 2003, BRIT MED J, V327, P503, DOI 10.1136/bmj.327.7413.503-a; *INBIFO, 1997, P53 ADD; *INT COMM MED J ED, 2001, UN REQ MAN SUBM BIOM; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; Krawczak M, 1998, MUTAGENESIS, V13, P319, DOI 10.1093/mutage/13.4.319; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; LAEK R, 2000, ANAL MISSENSE POINT; MASSEY ED, 1998, COMMUNICATION   0427; MASSEY ED, 1988, COMMUNICATION   0603; ME R, 1998, P53 MUTATIONS LUNG C; MUELLER T, 1996, TECHNICAL REV SCI PA; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; *NAT PUBL GROUP, ONC; Ong E, 2000, B WORLD HEALTH ORGAN, V78, P938; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; PARRY JM, 2001, COMMUNICATION   0212; Paschke T, 2001, MUTAGENESIS, V16, P555, DOI 10.1093/mutage/16.6.555; Paschke T, 2000, MUTAGENESIS, V15, P457, DOI 10.1093/mutage/15.6.457; *PHIL MORR US, 2003, HLTH ISS; Rampton S, 2002, PUBLIC HEALTH REP, V117, P331, DOI 10.1016/S0033-3549(04)50169-3; RENNIE D, 1993, JAMA-J AM MED ASSOC, V270, P1742, DOI 10.1001/jama.270.14.1742; ROE F, 1993, FUTURE DIRECTIONS HL; Samet JM, 2001, AM J PUBLIC HEALTH, V91, P1742, DOI 10.2105/AJPH.91.11.1742; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; SOLANA R, 1996, PM US SAYS NEW STUDY; THORNTON R, 1993, SMOKE CLUE CANC MUTA; THORNTON R, 1991, VISIT M CURIE RES I; THORNTON RE, 1991, VISIT US CANADA; THORNTON RE, 1993, SRG CONSULTANTS; THORNTON RE, 1993, NOTE TOBACCO STRATEG; TRICKER A, 1998, LIST ACCOUNTABILITIE; TRICKER A, 1998, TRIP REPORT; WYNDER EL, 1994, CANCER RES, V54, P5284; Yach D, 2001, AM J PUBLIC HEALTH, V91, P1745, DOI 10.2105/AJPH.91.11.1745; 1995, SCI RES REV COMMITTE; 2000, SCI RES REV COMMITTE; 1993, SMOKING HLTH REGULAT; 1999, POTENTIAL AREAS CONS; 1996, REV PREFERENTIAL FOR; 1996, BENZO ALPHA PYRENE P	77	19	19	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					531	540						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705463				2022-12-24	WOS:000226812500031
J	Frankino, WA; Zwaan, BJ; Stern, DL; Brakefield, PM				Frankino, WA; Zwaan, BJ; Stern, DL; Brakefield, PM			Natural selection and developmental constraints in the evolution of allometries	SCIENCE			English	Article							QUANTITATIVE VARIATION; SEXUAL SELECTION; BODY-SIZE; FLIGHT; BUTTERFLIES; SURVIVAL; CANALIZATION; DIOPSIDAE; INSECTS; DIPTERA	In animals, scaling relationships between appendages and body size exhibit high interspecific variation but low intraspecific variation. This pattern could result from natural selection for specific allometries or from developmental constraints on patterns of differential growth. We performed artificial selection on the allometry between forewing area and body size in a butterfly to test for developmental constraints, and then used the resultant increased range of phenotypic variation to quantify natural selection on the scaling relationship. Our results show that the short-term evolution of allometries is not limited by developmental constraints. Instead, scaling relationships are shaped by strong natural selection.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Leiden Univ, Inst Biol, Sect Evolutionary Biol, NL-2300 RA Leiden, Netherlands	Princeton University; Leiden University; Leiden University - Excl LUMC	Frankino, WA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	frankino@alumni.indiana.edu	Zwaan, Bas J/D-8721-2015	Zwaan, Bas J/0000-0002-8221-4998; Stern, David/0000-0002-1847-6483	NIGMS NIH HHS [R01 GM063622, R01 GM063622-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURKHARDT D, 1987, ENTOMOL GEN, V12, P221; Dudley R., 2000, BIOMECHANICS INSECT; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Falconer D.S., 1997, INTRO QUANTITATIVE G, VFourth; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Huxley J.S., 1932, PROBLEMS RELATIVE GR; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Kingsolver JG, 1999, EVOLUTION, V53, P1479, DOI [10.2307/2640894, 10.1111/j.1558-5646.1999.tb05412.x]; Kingsolver JG, 2000, EVOL ECOL RES, V2, P593; Kooi RE, 1996, ENTOMOL EXP APPL, V80, P149, DOI 10.1007/BF00194745; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Srygley RB, 2000, BIOL J LINN SOC, V70, P707, DOI 10.1111/j.1095-8312.2000.tb00225.x; Stern DL, 1999, DEVELOPMENT, V126, P1091; STRAUSS RE, 1990, EVOLUTION, V44, P86, DOI [10.2307/2409526, 10.1111/j.1558-5646.1990.tb04281.x]; Strauss Richard E., 1992, P157; Thompson D., 1917, GROWTH FORM; Van Dyck H, 1999, TRENDS ECOL EVOL, V14, P172, DOI 10.1016/S0169-5347(99)01610-9; VOGEL S, 2003, COMP BIOMECHANICS; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wagner GP, 1996, AM ZOOL, V36, P36; WEBER KE, 1990, GENETICS, V126, P975; WICKMAN PO, 1992, EVOLUTION, V46, P1525, DOI 10.1111/j.1558-5646.1992.tb01142.x; WILKINSON GS, 1993, GENET RES, V62, P213, DOI 10.1017/S001667230003192X; Wolf JB, 2001, EVOLUTION, V55, P232	29	173	177	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					718	720		10.1126/science.1105409	http://dx.doi.org/10.1126/science.1105409			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692049	Green Accepted			2022-12-24	WOS:000226814900041
J	Otomo, T; Tomchick, DR; Otomo, C; Panchal, SC; Machius, M; Rosen, MK				Otomo, T; Tomchick, DR; Otomo, C; Panchal, SC; Machius, M; Rosen, MK			Structural basis of actin filament nucleation and processive capping by a formin homology 2 domain	NATURE			English	Article							DIAPHANOUS-RELATED FORMINS; DIFFRACTION DATA; FISSION YEAST; CELL-DIVISION; MOUSE FORMIN; PROFILIN; PROTEIN; POLYMERIZATION; CYTOKINESIS; MECHANISM	The conserved formin homology 2 (FH2) domain nucleates actin filaments and remains bound to the barbed end of the growing filament. Here we report the crystal structure of the yeast Bni1p FH2 domain in complex with tetramethylrhodamine - actin. Each of the two structural units in the FH2 dimer binds two actins in an orientation similar to that in an actin filament, suggesting that this structure could function as a filament nucleus. Biochemical properties of heterodimeric FH2 mutants suggest that the wild-type protein equilibrates between two bound states at the barbed end: one permitting monomer binding and the other permitting monomer dissociation. Interconversion between these states allows processive barbed-end polymerization and depolymerization in the presence of bound FH2 domain. Kinetic and/or thermodynamic differences in the conformational and binding equilibria can explain the variable activity of different FH2 domains as well as the effects of the actin-binding protein profilin on FH2 function.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rosen, MK (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mrosen@biochem.swmed.edu	Tomchick, Diana/HGV-2018-2022	Otomo, Takanori/0000-0003-3589-238X; Tomchick, Diana/0000-0002-7529-4643				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang F, 1999, CURR BIOL, V9, P849, DOI 10.1016/S0960-9822(99)80372-8; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DeLano WL, 2002, PYMOL USERS MANUAL; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	36	272	277	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					488	494		10.1038/nature03251	http://dx.doi.org/10.1038/nature03251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15635372				2022-12-24	WOS:000226727200039
J	Grassly, NC; Fraser, C; Garnett, GP				Grassly, NC; Fraser, C; Garnett, GP			Host immunity and synchronized epidemics of syphilis across the United States	NATURE			English	Article							TRANSMISSION DYNAMICS; MODELS; GONORRHEA; MORTALITY; REGIONS; AIDS; MEN; SEX	A central question in population ecology is the role of 'exogenous' environmental factors versus density-dependent 'endogenous' biological factors in driving changes in population numbers(1). This question is also central to infectious disease epidemiology, where changes in disease incidence due to behavioural or environmental change must be distinguished from the nonlinear dynamics of the parasite population(2). Repeated epidemics of primary and secondary syphilis infection in the United States over the past 50 yr have previously been attributed to social and behavioural changes(3). Here, we show that these epidemics represent a rare example of unforced, endogenous oscillations in disease incidence, with an 8-11-yr period that is predicted by the natural dynamics of syphilis infection, to which there is partially protective immunity(4). This conclusion is supported by the absence of oscillations in gonorrhoea cases, where a protective immune response is absent(5,6). We further demonstrate increased synchrony of syphilis oscillations across cities over time, providing empirical evidence for an increasingly connected sexual network in the United States.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	n.grassly@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008; Garnett, Geoffrey P/A-9312-2008; Fraser, Christophe/A-8109-2008	Grassly, Nicholas C/0000-0001-6067-4507; Fraser, Christophe/0000-0003-2399-9657				Aral SO, 1996, SEX TRANSM DIS, V23, P9, DOI 10.1097/00007435-199601000-00005; Bailey N. T. J., 1975, MATH THEORY INFECT D; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; Chesson HW, 2003, SEX TRANSM DIS, V30, P419, DOI 10.1097/00007435-200305000-00008; Cliff A, 1998, DECIPHERING GLOBAL E; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Gibson Campbell, 1998, 27 US CENS BUR POP D; Greenberg Judith B, 2002, J Public Health Manag Pract, V8, P59; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAMERS FF, 1995, AM J PUBLIC HEALTH, V85, P1104, DOI 10.2105/AJPH.85.8_Pt_1.1104; Hethcote H.W., 1984, LECT NOTES BIOMATH, V56; Hook EW, 1997, SEX TRANSM DIS, V24, P443, DOI 10.1097/00007435-199709000-00001; Kahn RH, 2002, SEX TRANSM DIS, V29, P285, DOI 10.1097/00007435-200205000-00006; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Morgan CA, 2003, INFECT IMMUN, V71, P5605, DOI 10.1128/IAI.71.10.5605-5612.2003; Nakashima AK, 1996, SEX TRANSM DIS, V23, P16, DOI 10.1097/00007435-199601000-00006; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Schmidt KA, 2001, SEX TRANSM DIS, V28, P555, DOI 10.1097/00007435-200110000-00001; *US DEP TRANSP BUR, 2003, NAT TRANSP STAT 2003; Wallace R, 1997, SOC SCI MED, V44, P935, DOI 10.1016/S0277-9536(96)00197-9; Wasserheit J.N., 1996, J INFECT DIS S2, V174, P201; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883	30	155	160	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2005	433	7024					417	421		10.1038/nature03072	http://dx.doi.org/10.1038/nature03072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674292				2022-12-24	WOS:000226546200043
J	Lowell, BB; Shulmanz, GI				Lowell, BB; Shulmanz, GI			Mitochondrial dysfunction and type 2 diabetes	SCIENCE			English	Editorial Material							BETA-CELL LIPOTOXICITY; FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; UNCOUPLING PROTEIN-2; RESISTANCE; OBESITY; FAILURE; MUSCLE; PATHOGENESIS; MECHANISMS	Maintenance of normal blood glucose levels depends on a complex interplay between the insulin responsiveness of skeletal muscle and liver and glucose-stimutated insulin secretion by pancreatic beta cells. Defects in the former are responsible for insulin resistance, and defects in the latter are responsible for progression to hyperglycemia. Emerging evidence supports the potentially unifying hypothesis that both of these prominent features of type 2 diabetes are caused by mitochondrial dysfunction.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Yale Univ, Sch Med, Dept Internal Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University	Lowell, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 99 Brookline Ave, Boston, MA 02215 USA.	blowell@bidmc.harvard.edu; gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019; Northe, Hilda/I-1916-2012	Shulman, Gerald I./0000-0003-1529-5668; Northe, Hilda/0000-0002-8873-5014	NIDDK NIH HHS [R01 DK040936] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azen SP, 1998, CONTROL CLIN TRIALS, V19, P217, DOI 10.1016/S0197-2456(97)00151-7; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dufour E, 2004, BBA-BIOENERGETICS, V1658, P122, DOI 10.1016/j.bbabio.2004.04.020; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gerich JE, 2003, MAYO CLIN PROC, V78, P447, DOI 10.4065/78.4.447; Hui HX, 2004, J CELL PHYSIOL, V200, P177, DOI 10.1002/jcp.20021; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331; Langin D, 2001, NEW ENGL J MED, V345, P1772, DOI 10.1056/NEJM200112133452412; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI200215001, 10.1172/JCI0215001]; Petersen M, 2003, DIABETES CARE, V26, P917; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 2004, ENDOCRINOLOGY, V145, P3563, DOI 10.1210/en.2004-0479; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; RANDLE PJ, 1963, LANCET, V1, P785; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; VONDRA K, 1977, DIABETOLOGIA, V13, P527, DOI 10.1007/BF01234508; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Winzell MS, 2003, DIABETES, V52, P2057; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamashita T, 2004, ENDOCRINOLOGY, V145, P3566, DOI 10.1210/en.2003-1602; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	58	1502	1594	5	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					384	387		10.1126/science.1104343	http://dx.doi.org/10.1126/science.1104343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662004				2022-12-24	WOS:000226492300034
J	Kublin, JG; Patnaik, P; Jere, CS; Miller, WC; Hoffman, IF; Chimbiya, N; Pendame, R; Taylor, TE; Molyneux, ME				Kublin, JG; Patnaik, P; Jere, CS; Miller, WC; Hoffman, IF; Chimbiya, N; Pendame, R; Taylor, TE; Molyneux, ME			Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; VIRAL LOAD; IMMUNE ACTIVATION; HIV-INFECTION; TRANSMISSION; TUBERCULOSIS; REPLICATION; PARASITEMIA; INDUCTION	Background Raised HIV viral load in blood has been associated with accelerated disease progression and increased transmission of infection. To assess the effect of Plasmodium falciparum malaria on concentrations of HIV in blood, we did a prospective cohort study in Malawi. Methods We recruited 367 HIV-1-infected adults. Among 334 people aparasitaemic at baseline, 148 had at least one malaria episode during follow-up and received antimalarial treatment. Of these, 77 had HIV-1-RNA measurements at baseline, during malaria, and post-malaria. We used linear regression with generalised estimating equations to assess effect of four definitions of malaria (any parasitaemia, parasite density greater than or equal to2000/muL, febrile parasitaemia, and febrile parasitaemia with parasite density greater than or equal to2000/mul) on changes in log HIV-1 RNA, overall and by baseline CD4 count. Findings With malaria defined as any parasitaemia, HIV-1-RNA concentration almost doubled between baseline (median 96 215 copies per mL) and malaria (168 901 copies per mL), a 0.25 (95% CI 0.11-0.39) log increase in mean RNA concentration. HIV-1-RNA concentration fell to median 82 058 copies per mL by about 8-9 weeks postmalaria. Increases in HIV-1-RNA were greatest for people with fever, parasite density 2000/muL or greater, and CD4 count more than 300 cells per p,L, in whom concentrations rose from median 38 483 copies per mL at baseline to 196 098 copies per mL during malaria, a mean log increase of 0.82 (95% CI 0.55-1.10, p<0.0001), and fell to median 75 331 copies per mL post-malaria. People who remained aparasitaemic showed no changes in HIV-1-RNA concentration. Interpretation HIV-infected individuals with malaria have a significantly increased viral load, which might enhance HIV transmission and accelerate disease progression.	Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Minist Hlth & Populat, Llongwe, Malawi; Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of Malawi; University of Malawi; University of Malawi; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Malawi	Kublin, JG (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,EL-500, Seattle, WA 98109 USA.	jkublin@fhcrc.com	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Kublin, James/0000-0003-1279-3741	FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TWO1039-05 S1] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Artzrouni M, 2002, AIDS, V16, pW1; BATE CAW, 1988, IMMUNOLOGY, V64, P227; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; Delley V, 2000, TROP MED INT HEALTH, V5, P404, DOI 10.1046/j.1365-3156.2000.00566.x; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Lawn SD, 1999, AIDS, V13, P2231, DOI 10.1097/00002030-199911120-00005; Lyles CM, 1999, EUR J EPIDEMIOL, V15, P99, DOI 10.1023/A:1007556327269; Lyles RH, 1999, AIDS, V13, P341, DOI 10.1097/00002030-199902250-00006; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morgan D, 2001, NAT MED, V7, P143, DOI 10.1038/84564; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rowland-Jones SL, 2002, MICROBES INFECT, V4, P1265, DOI 10.1016/S1286-4579(02)01655-6; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Whitty CJM, 2002, LANCET, V359, P80, DOI 10.1016/S0140-6736(02)07300-2; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	29	179	191	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					233	240		10.1016/S0140-6736(05)17743-5	http://dx.doi.org/10.1016/S0140-6736(05)17743-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652606				2022-12-24	WOS:000226309600029
J	Hijri, M; Sanders, IR				Hijri, M; Sanders, IR			Low gene copy number shows that arbuscular mycorrhizal fungi inherit genetically different nuclei	NATURE			English	Article							GLOMUS-INTRARADICES; DNA CONTENT; DIVERSITY; GLOMALES	Arbuscular mycorrhizal fungi (AMF) are ancient asexually reproducing organisms that form symbioses with the majority of plant species, improving plant nutrition and promoting plant diversity(1,2). Little is known about the evolution or organization of the genomes of any eukaryotic symbiont or ancient asexual organism. Direct evidence shows that one AMF species is heterokaryotic; that is, containing populations of genetically different nuclei(3). It has been suggested, however, that the genetic variation passed from generation to generation in AMF is simply due to multiple chromosome sets (that is, high ploidy)(4). Here we show that previously documented genetic variation in Pol-like sequences, which are passed from generation to generation, cannot be due to either high ploidy or repeated gene duplications. Our results provide the clearest evidence so far for substantial genetic differences among nuclei in AMF. We also show that even AMF with a very large nuclear DNA content are haploid. An underlying principle of evolutionary theory is that an individual passes on one or half of its genome to each of its progeny. The coexistence of a population of many genomes in AMF and their transfer to subsequent generations, therefore, has far-reaching consequences for understanding genome evolution.	Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	ian.sanders@unil.ch	Hijri, Mohamed/ABC-5969-2021; Hijri, Mohamed/AAL-5737-2021; Sanders, Ian R/T-9988-2017	Hijri, Mohamed/0000-0001-6112-8372; Sanders, Ian R/0000-0002-9591-8214				BIANCIOTTO V, 1992, MYCOL RES, V96, P1071, DOI 10.1016/S0953-7562(09)80118-4; Corradi N, 2004, FUNGAL GENET BIOL, V41, P262, DOI 10.1016/j.fgb.2003.11.001; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; GRAUT D, 2000, FUNDAMENTALS MOL EVO; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hijri M, 2004, FUNGAL GENET BIOL, V41, P253, DOI 10.1016/j.fgb.2003.10.011; Hosny M, 1998, GENOME, V41, P422, DOI 10.1139/gen-41-3-422; HOSNY M, 1997, GENOME SIZE GLOMALES; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Rosendahl S, 1997, MOL ECOL, V6, P821, DOI 10.1046/j.1365-294X.1997.d01-213.x; Schussler A, 1999, NEW PHYTOL, V144, P205, DOI 10.1046/j.1469-8137.1999.00526.x; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	14	130	144	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					160	163		10.1038/nature03069	http://dx.doi.org/10.1038/nature03069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650740				2022-12-24	WOS:000226252200038
J	Lindorff-Larsen, K; Best, RB; DePristo, MA; Dobson, CM; Vendruscolo, M				Lindorff-Larsen, K; Best, RB; DePristo, MA; Dobson, CM; Vendruscolo, M			Simultaneous determination of protein structure and dynamics	NATURE			English	Article							X-RAY; COUPLING-CONSTANTS; ORDER PARAMETERS; BACKBONE MOTION; NATIVE PROTEINS; NMR RELAXATION; UBIQUITIN; TRANSITION; SIMULATIONS; STATE	We present a protocol for the experimental determination of ensembles of protein conformations that represent simultaneously the native structure and its associated dynamics. The procedure combines the strengths of nuclear magnetic resonance spectroscopy-for obtaining experimental information at the atomic level about the structural and dynamical features of proteins-with the ability of molecular dynamics simulations to explore a wide range of protein conformations. We illustrate the method for human ubiquitin in solution and find that there is considerable conformational heterogeneity throughout the protein structure. The interior atoms of the protein are tightly packed in each individual conformation that contributes to the ensemble but their overall behaviour can be described as having a significant degree of liquid-like character. The protocol is completely general and should lead to significant advances in our ability to understand and utilize the structures of native proteins.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Vendruscolo, M (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; mv245@cam.ac.uk	Vendruscolo, Michele/F-5901-2012; Best, Robert/H-7588-2016; Lindorff-Larsen, Kresten/K-6469-2014	Vendruscolo, Michele/0000-0002-3616-1610; Best, Robert/0000-0002-7893-3543; Lindorff-Larsen, Kresten/0000-0002-4750-6039				Benitez-Cardoza CG, 2004, BIOCHEMISTRY-US, V43, P5195, DOI 10.1021/bi0361620; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Best RB, 2004, J AM CHEM SOC, V126, P8090, DOI 10.1021/ja0396955; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; BONVIN AMJJ, 1993, PROTEINS, V15, P385, DOI 10.1002/prot.340150406; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 1999, J AM CHEM SOC, V121, P9645, DOI 10.1021/ja991309p; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750; Clore GM, 2004, J AM CHEM SOC, V126, P2923, DOI 10.1021/ja0386804; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Fox T, 1996, PROTEINS, V25, P315, DOI 10.1002/(SICI)1097-0134(199607)25:3<315::AID-PROT4>3.0.CO;2-E; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HOCH JC, 1985, BIOCHEMISTRY-US, V24, P3831, DOI 10.1021/bi00336a003; Johnson EC, 1999, STRUCTURE, V7, P967, DOI 10.1016/S0969-2126(99)80123-3; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kitao A, 2000, P NATL ACAD SCI USA, V97, P2064, DOI 10.1073/pnas.030540397; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Lee AL, 1999, J AM CHEM SOC, V121, P2891, DOI 10.1021/ja983758f; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MIERKE DF, 1994, BIOPOLYMERS, V34, P559, DOI 10.1002/bip.360340411; Ottiger M, 1999, J AM CHEM SOC, V121, P4690, DOI 10.1021/ja984484z; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Peti W, 2002, J AM CHEM SOC, V124, P5822, DOI 10.1021/ja011883c; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; SCHEEK RM, 1991, NATO ADV SCI I A-LIF, V225, P209; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; STILLINGER FH, 1990, J CHEM PHYS, V93, P6013, DOI 10.1063/1.459488; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Vendruscolo M, 2003, J AM CHEM SOC, V125, P15686, DOI 10.1021/ja036523z; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wong CF, 2003, ANNU REV PHARMACOL, V43, P31, DOI 10.1146/annurev.pharmtox.43.100901.140216; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	46	548	557	6	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					128	132		10.1038/nature03199	http://dx.doi.org/10.1038/nature03199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650731				2022-12-24	WOS:000226252200029
J	Gilks, WP; Abou-Sleiman, PM; Gandhi, S; Jain, S; Singleton, A; Lees, AJ; Shaw, K; Bhatia, KP; Bonifati, V; Quinn, NP; Lynch, J; Healy, DG; Holton, JL; Revesz, T; Wood, NW				Gilks, WP; Abou-Sleiman, PM; Gandhi, S; Jain, S; Singleton, A; Lees, AJ; Shaw, K; Bhatia, KP; Bonifati, V; Quinn, NP; Lynch, J; Healy, DG; Holton, JL; Revesz, T; Wood, NW			Common LRRK2 mutation in idiopathic Parkinson's disease	LANCET			English	Article								Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant Parkinson's disease. Few mutations in this gene have been identified. We investigated the frequency of a common heterozygous mutation, 2877510G-->A, which produces a glycine to serine aminoacid substitution at codon 2019 (Gly2019Ser), in idiopathic Parkinson's disease. We assessed 482 patients with the disorder, of whom 263 had pathologically confirmed disease, by direct sequencing for mutations in exon 41 of LRRK2. The mutation was present in eight (1.6%) patients. We have shown that a common single Mendelian mutation is implicated in sporadic Parkinson's disease. We suggest that testing for this mutation will be important in the management and genetic counselling of patients with Parkinson's disease.	Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Inst Neurol, Dept Motor Neurosci, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Reta Lila Weston Inst Neurol Studies, London, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; University of London; University College London	Wood, NW (corresponding author), Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucLac.uk	Holton, Janice L/F-6831-2011; Gilks, William/P-9137-2015; Revesz, Tamas/A-8732-2010; Wood, Nicholas W/C-2505-2009; Singleton, Andrew B/C-3010-2009; Lees, Andrew J/A-6605-2009	Holton, Janice L/0000-0002-3882-5249; Gilks, William/0000-0001-7814-3173; Revesz, Tamas/0000-0003-2501-0259; Wood, Nicholas W/0000-0002-9500-3348; Lees, Andrew J/0000-0002-2476-4385	Parkinson&apos;s UK [G-4062, G-4029] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000957, Z01AG000958, ZIAAG000958, ZIAAG000957] Funding Source: NIH RePORTER	Parkinson&apos;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Healy DG, 2004, LANCET NEUROL, V3, P652, DOI 10.1016/S1474-4422(04)00905-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	5	581	610	1	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					415	416		10.1016/S0140-6736(05)17830-1	http://dx.doi.org/10.1016/S0140-6736(05)17830-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680457				2022-12-24	WOS:000226610900029
J	Olesen, C; Sorensen, TLM; Nielsen, RC; Moller, JV; Nissen, P				Olesen, C; Sorensen, TLM; Nielsen, RC; Moller, JV; Nissen, P			Dephosphorylation of the calcium pump coupled to counterion occlusion	SCIENCE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; RECONSTITUTED PROTEOLIPOSOMES; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; DOMAIN-A; TRANSPORT; COUNTERTRANSPORT; CA-2+-ATPASE; TRANSDUCTION	P-type ATPases extract energy by hydrolysis of adenosine triphosphate (ATP) in two steps, formation and breakdown of a covalent phosphoenzyme intermediate. This process drives active. transport and countertransport of the cation pumps. We have determined the crystal structure of rabbit sarcoplasmic reticulum Ca2+ adenosine triphosphatase in complex with aluminum fluoride, which mimics the transition state of hydrolysis of the counterion-bound (protonated) phosphoenzyme. On the basis of structural analysis and biochemical data, we find this form to represent an occluded state of the proton counterions. Hydrolysis is catalyzed by the conserved Thr-Gly-Glu-Ser motif, and it exploits an associative nucleophilic reaction mechanism of the same type as phosphoryl transfer from ATP. On this basis, we propose a general mechanism of occluded transition states of Ca2+ transport and H+ countertransport coupled to phosphorylation and dephosphorylation, respectively.	Aarhus Univ, Dept Mol Biol, Ctr Struct Biol, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, Dept Biophys, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moller, JV (corresponding author), Aarhus Univ, Dept Mol Biol, Ctr Struct Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; pn@mb.au.dk	Sørensen, Thomas Lykke-Møller/AAA-7052-2020; Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Olesen, Claus/0000-0002-0462-1686				Barth A, 1997, J BIOL CHEM, V272, P25507, DOI 10.1074/jbc.272.41.25507; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FORBUSH B, 1991, SOC GEN PHY, V46, P211; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; Lancaster CRD, 2004, NATURE, V432, P286, DOI 10.1038/432286a; LEVY D, 1990, J BIOL CHEM, V265, P19524; Moller JV, 2003, ANN NY ACAD SCI, V986, P82, DOI 10.1111/j.1749-6632.2003.tb07142.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	27	229	232	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2251	2255		10.1126/science.1106289	http://dx.doi.org/10.1126/science.1106289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618517				2022-12-24	WOS:000225950000045
J	Revankar, CM; Cimino, DF; Sklar, LA; Arterburn, JB; Prossnitz, ER				Revankar, CM; Cimino, DF; Sklar, LA; Arterburn, JB; Prossnitz, ER			A transmembrane intracellular estrogen receptor mediates rapid cell signaling	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PLASMA-MEMBRANE; ACTIVATION; TRANSACTIVATION; MECHANISMS; GPR30	The steroid hormone estrogen regulates many functionally unrelated processes in numerous tissues. Although it is traditionally thought to control transcriptional activation through the classical nuclear estrogen receptors, it also initiates many rapid nongenomic signaling events. W. found that of all G protein-coupled receptors characterized to date, GPR30 is uniquely localized to the endoplasmic reticulum, where it specifically bind.,. estrogen and fluorescent estrogen derivatives. Activating GPR30 by estrogen resulted in intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus. Thus, GPR30 represents an intracellular transmembrane estrogen receptor that may contribute to normal estrogen physiology as well as pathophysiology.	Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; New Mexico State University	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.	eprossnitz@salud.unm.edu	Prossnitz, Eric R./B-4543-2008; Prossnitz, Eric/I-4599-2019	Prossnitz, Eric/0000-0001-9190-8302	NATIONAL CANCER INSTITUTE [R24CA088339] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011830, S10RR014668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036357, R29AI036357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R24EB000264] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA88339] Funding Source: Medline; NCRR NIH HHS [1 S10 RR14668, P20 RR11830] Funding Source: Medline; NIAID NIH HHS [AI36357] Funding Source: Medline; NIBIB NIH HHS [EB00264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Arterburn JB, 2000, TETRAHEDRON LETT, V41, P839, DOI 10.1016/S0040-4039(99)02205-4; Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Govind AP, 2003, MOL CELL BIOCHEM, V253, P233, DOI 10.1023/A:1026068017309; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Shao WL, 2004, BREAST CANCER RES, V6, P39, DOI 10.1186/bcr742; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tsai EM, 2001, CANCER RES, V61, P8390; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	22	1733	1848	6	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1625	1630		10.1126/science.1106943	http://dx.doi.org/10.1126/science.1106943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15705806				2022-12-24	WOS:000227622400048
J	Schumacher, B; Hanazawa, M; Lee, MH; Nayak, S; Volkmann, K; Hofmann, R; Hengartner, M; Schedl, T; Gartner, A				Schumacher, B; Hanazawa, M; Lee, MH; Nayak, S; Volkmann, K; Hofmann, R; Hengartner, M; Schedl, T; Gartner, A			Translational repression of C-elegans p53 by GLD-1 regulates DNA damage-induced apoptosis	CELL			English	Article							MESSENGER-RNA TARGETS; PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR GENE; CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; BINDING PROTEIN; T-REGION; CHECKPOINT; GERMLINE; ENCODES	p53 is a tumor suppressor gene whose regulation is crucial to maintaining genome stability and for the apoptotic elimination of abnormal, potentially cancer-predisposing cells. C. elegans contains a primordial p53 gene, cep-1, that acts as a transcription factor necessary for DNA damage-induced apoptosis. In a genetic screen for negative regulators of CEP-1, we identified a mutation in GLD-1, a translational repressor implicated in multiple C. elegans germ cell fate decisions and related to mammalian Quaking proteins. CEP-1-dependent transcription of proapoptotic genes is upregulated in the gld-1(op236) mutant and an elevation of p53-mediated germ cell apoptosis in response to DNA damage is observed. Further, we demonstrate that GLD-1 mediates its repressive effect by directly binding to the 3'UTR of cep-1/p53 mRNA and repressing its translation. This study reveals that the regulation of cep-1/p53 translation influences DNA damage-induced apoptosis and demonstrates the physiological importance of this mechanism.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	Max Planck Society; Washington University (WUSTL); University of Zurich	Gartner, A (corresponding author), Univ Dundee, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	a.gartner@dundee.ac.uk	Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008; Schumacher, Björn/I-4829-2013	Schumacher, Björn/0000-0001-6097-5238; Gartner, Anton/0000-0003-4639-9902; Hengartner, Michael/0000-0002-7584-596X	NIGMS NIH HHS [R01 GM63310, R01 GM063310] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BODE VC, 1984, GENETICS, V108, P457; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2004, Methods Mol Biol, V280, P257; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hofmann ER, 2000, COLD SPRING HARB SYM, V65, P467, DOI 10.1101/sqb.2000.65.467; Hubbard EJA, 2000, DEV DYNAM, V218, P2, DOI 10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Kelly WG, 1997, GENETICS, V146, P227; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mootz D, 2004, DEVELOPMENT, V131, P3263, DOI 10.1242/dev.01196; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; PIEROTTI M A, 1992, Current Opinion in Oncology, V4, P127, DOI 10.1097/00001622-199202000-00017; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roemer K, 1999, BIOL CHEM, V380, P879, DOI 10.1515/BC.1999.108; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SAMORAJS.T, 1970, J NEUROPATH EXP NEUR, V29, P507, DOI 10.1097/00005072-197010000-00001; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Seydoux G, 2001, INT REV CYTOL, V203, P139; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Sjoblom T, 1996, ONCOGENE, V12, P2499; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WOOD WB, 1996, NEMATODE CAENORHABDI; Xu L, 2001, GENETICS, V159, P1007; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	63	168	177	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					357	368		10.1016/j.cell.2004.12.009	http://dx.doi.org/10.1016/j.cell.2004.12.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707894	Bronze			2022-12-24	WOS:000227028900011
J	de Duve, C				de Duve, C			The onset of selection	NATURE			English	Editorial Material							UNIVERSAL ANCESTOR		ICP, B-1200 Brussels, Belgium; Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	de Duve, C (corresponding author), ICP, B-1200 Brussels, Belgium.							DEDUVE C, 2002, SINGULARITIES; DEDUVE C, 2002, LIFE EVOLVING; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P282, DOI 10.1007/BF01047470; Freeland SJ, 2003, ORIGINS LIFE EVOL B, V33, P457, DOI 10.1023/A:1025771327614; Morris Simon Conway, 2003, LIFES SOLUTION; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854	8	40	41	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2005	433	7026					581	582		10.1038/433581a	http://dx.doi.org/10.1038/433581a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703726				2022-12-24	WOS:000226862000022
J	Blom, JW; Doggen, CJM; Osanto, S; Rosendaal, FR				Blom, JW; Doggen, CJM; Osanto, S; Rosendaal, FR			Malignancies, prothrombotic mutations, and the risk of venous thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; THROMBOEMBOLIC DISEASE; CANCER; GENE; THROMBOPHILIA; LEIDEN; BLOOD	Context Venous thrombosis is a common complication inpatients with cancer, leading to additional morbidity and compromising quality of life. Objective To identify individuals with cancer with an increased thrombotic risk, evaluating different tumor sites, the presence of distant metastases, and carrier status of prothrombotic mutations. Design, Setting, and Patients A large population-based, case-control (Multiple Environmental and Genetic Assessment [MEGA] of risk factors for venous thrombosis) study of 3220 consecutive patients aged 18 to 70 years, with a first deep venous thrombosis of the leg or pulmonary embolism, between March 1, 1999, and May 31, 2002, at 6 anticoagulation clinics in the Netherlands, and separate 2131 control participants (partners of the patients) reported via a questionnaire on acquired risk factors forvenous thrombosis. Three months after discontinuation of the anticoagulant therapy, all patients and controls were interviewed, a blood sample was taken, and DNA was isolated to ascertain the factor V Leiden and prothrombin 20210A mutations. Main Outcome Measure Risk of venous thrombosis. Results The overall risk of venous thrombosis was increased 7-fold in patients with a malignancy (odds ratio [OR], 6.7; 95% confidence interval [Cl], 5.2-8.6) vs persons without malignancy. Patients with hematological malignancies had the highest risk of venous thrombosis, adjusted for age and sex (adjusted OR, 28.0; 95% Cl, 4.0-199.7), followed by lung cancer and gastrointestinal cancer. The risk of venous thrombosis was highest in the first few months after the diagnosis of malignancy (adjusted OR, 53.5; 95% Cl, 8.6-334.3). Patients with cancer with distant metastases had a higher risk vs patients without distant metastases (adjusted OR, 19.8; 95% Cl, 2.6-149.1). Carriers of the factor V Leiden mutation who also had cancer had a 12-fold increased risk vs individuals without cancer and factor V Leiden (adjusted OR, 12.1; 95% Cl, 1.6-88.1). Similar results were indirectly calculated for the prothrombin 20210A mutation in patients with cancer. Conclusions Patients with cancer have a highly increased risk of venous thrombosis especially in the first few months after diagnosis and in the presence of distant metastases. Carriers of the factor V Leiden and prothrombin 20210A mutations appear to have an even higher risk.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Oncol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Buller H R, 2000, Ned Tijdschr Geneeskd, V144, P1531; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Falanga A, 1999, SEMIN THROMB HEMOST, V25, P173, DOI 10.1055/s-2007-994919; Falanga A, 1998, HAEMOSTASIS, V28, P50; Francis JL, 1998, SEMIN THROMB HEMOST, V24, P93, DOI 10.1055/s-2007-995829; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159/000046586; Gomez E, 1998, BLOOD, V91, P2208, DOI 10.1182/blood.V91.6.2208.2208_2208_2209; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monreal M, 1997, THROMB HAEMOSTASIS, V78, P1316; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Otterson GA, 1996, AM J MED, V101, P406, DOI 10.1016/S0002-9343(96)00235-5; Palareti G, 2000, THROMB HAEMOSTASIS, V84, P805; Pihusch R, 2002, CANCER, V94, P3120, DOI 10.1002/cncr.10590; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Thodiyil PA, 2001, ACTA HAEMATOL-BASEL, V106, P73, DOI 10.1159/000046592; TROUSSEAU A, 1868, PHLEGMASIA ALBA DOLE, V5, P281; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	27	1316	1438	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					715	722		10.1001/jama.293.6.715	http://dx.doi.org/10.1001/jama.293.6.715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701913	Bronze, Green Published			2022-12-24	WOS:000226842200025
J	Sanz, EJ; De-las-Cuevas, C; Kiuru, A; Bate, A; Edwards, R				Sanz, EJ; De-las-Cuevas, C; Kiuru, A; Bate, A; Edwards, R			Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis	LANCET			English	Article							ANTIDEPRESSANT WITHDRAWAL; DISCONTINUATION; SIGNALS	Background Selective serotonin reuptake inhibitors (SSRIs) have been associated with withdrawal symptoms. We investigated whether use of these drugs in pregnant women might cause neonatal withdrawal syndrome. Methods An association between paroxetine and neonatal convulsions was identified in December, 2001, by the data mining method routinely used to screen the WHO database of adverse drug reactions. An information component (IC) measure was used to screen for unexpected adverse reactions relative to the information in the database. We then assessed cases of neonatal convulsions and neonatal withdrawal syndrome associated with drugs included in the anatomical therapeutic chemical groups N06AB and N06AX. Findings By November, 2003, a total of 93 suspected cases of SSRI-induced neonatal withdrawal syndrome had been reported, and were regarded as enough information to confirm a possible causal relation. 64 of the cases were associated with paroxetine, 14 with fluoxetine, nine with sertraline, and seven with citalopram. The IC-2 SD for the group became greater than 0 in the first quarter of 1991, and the IC increased to 2.68 (IC-2 SD 0-32) by the second quarter of 2003. For each individual compound, the IC-2 SD was greater than 0. Interpretation SSRIs, especially paroxetine, should be cautiously managed in the treatment of pregnant women with a psychiatric disorder.	Univ La Laguna, Sch Med, Tenerife 38071, Spain; WHO, Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden	Universidad de la Laguna; World Health Organization	Sanz, EJ (corresponding author), Univ La Laguna, Sch Med, Tenerife 38071, Spain.	esanz@ull.es	De las Cuevas, Carlos/F-6423-2011; Sanz, Emilio J/C-9793-2009; Sanz Alvarez, Emilio J/M-3535-2019; Bate, Andrew/J-3799-2019	De las Cuevas, Carlos/0000-0001-5742-905X; Sanz, Emilio J/0000-0001-6788-4435; Sanz Alvarez, Emilio J/0000-0001-6788-4435; 				Bate A, 2002, EUR J CLIN PHARMACOL, V58, P483, DOI 10.1007/s00228-002-0484-x; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; BAUMAN HE, 1995, ADV MEAT RES, V10, P1; Benazzi F, 1996, CAN J PSYCHIAT, V41, P487, DOI 10.1177/070674379604100722; *BRIT MED ASS ROYA, 1990, BRIT NAT FORM; BROSEN K, 1993, CLIN INVESTIGATOR, V71, P1002; BRYOIS C, 1998, SCHWEIZERISCHE RUNDS, V87, P345; CECCHERININELLI A, 1993, AM J PSYCHIAT, V150, P165; *COMM SAF MED, 2003, SER MUST NOT BE US T; Dahl ML, 1997, BRIT J PSYCHIAT, V171, P391, DOI 10.1192/bjp.171.4.391c; DILSAVER SC, 1984, BIOL PSYCHIAT, V19, P237; Edwards I, 2002, PHARMACOVIGILANCE, P169; EDWARDS IR, 1994, DRUG SAFETY, V10, P93, DOI 10.2165/00002018-199410020-00001; Haddad P, 1998, BMJ-BRIT MED J, V316, P1105, DOI 10.1136/bmj.316.7138.1105; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Lejoyeux M, 1997, J CLIN PSYCHIAT, V58, P11; Lindquist M, 2000, DRUG SAFETY, V23, P533, DOI 10.2165/00002018-200023060-00004; Mareth TR, 1996, J CLIN PSYCHIAT, V57, P310; Mavissakalian MR, 1999, ARCH GEN PSYCHIAT, V56, P821, DOI 10.1001/archpsyc.56.9.821; Nijhuis IJM, 2001, ARCH DIS CHILD-FETAL, V84, pF77; Orre R, 2000, COMPUT STAT DATA AN, V34, P473, DOI 10.1016/S0167-9473(99)00114-0; Rosenbaum JF, 1998, BIOL PSYCHIAT, V44, P77, DOI 10.1016/S0006-3223(98)00126-7; SPENCER MJ, 1993, PEDIATRICS, V92, P721; Stahl MMS, 1997, EUR J CLIN PHARMACOL, V53, P163, DOI 10.1007/s002280050357; Stiskal JA, 2001, ARCH DIS CHILD-FETAL, V84, pF134, DOI 10.1136/fn.84.2.F134; VALDESSARINI RJ, 2001, PHARMACOL BASIS THER, P431; Young AH, 1997, BRIT J PSYCHIAT, V170, P288, DOI 10.1192/bjp.170.3.288a	27	257	260	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					482	487		10.1016/S0140-6736(05)17865-9	http://dx.doi.org/10.1016/S0140-6736(05)17865-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705457				2022-12-24	WOS:000226812500025
J	Jeong, PY; Jung, M; Yim, YH; Kim, H; Park, M; Hong, EM; Lee, W; Kim, YH; Kim, K; Paik, YK				Jeong, PY; Jung, M; Yim, YH; Kim, H; Park, M; Hong, EM; Lee, W; Kim, YH; Kim, K; Paik, YK			Chemical structure and biological activity of the Caenorhabditis elegans dauer-inducing pheromone	NATURE			English	Article							MULTIPLE-QUANTUM NMR; CHEMOSENSORY NEURONS; LARVAL DEVELOPMENT; SPECTROSCOPY; PARALLEL; FOOD	Pheromones are cell type-specific signals used for communication between individuals of the same species. When faced with overcrowding or starvation, Caenorhabditis elegans secrete the pheromone daumone, which facilitates communication between individuals for adaptation to adverse environmental stimuli(1-4). Daumone signals C. elegans to enter the dauer stage, an enduring and non-ageing stage of the nematode life cycle with distinctive adaptive features and extended life. Because daumone is a key regulator of chemosensory processes in development and ageing(5,6), the chemical identification of daumone is important for elucidating features of the daumone-mediated signalling pathway. Here we report the isolation of natural daumone from C. elegans by large-scale purification, as well as the total chemical synthesis of daumone. We present the stereospecific chemical structure of purified daumone, a fatty acid derivative. We demonstrate that both natural and chemically synthesized daumones equally induce dauer larva formation in C. elegans (N2 strain) and certain dauer mutants, and also result in competition between food and daumone. These results should help to elucidate the daumone-mediated signalling pathway, which might in turn influence ageing and obesity research and the development of antinematodal drugs.	Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; Yonsei Univ, Dept Chem, Seoul 120749, South Korea; Yonsei Univ, Bioprod Res Ctr, Seoul 120749, South Korea; Korea Res Inst Stand & Sci, Taejon 305600, South Korea; Korea Basic Sci Inst, Taejon 305333, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Korea Research Institute of Standards & Science (KRISS); Korea Basic Science Institute (KBSI)	Paik, YK (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Kim, Young Hwan/AAA-5484-2022	Kim, Young Hwan/0000-0003-3478-8839; Lee, Weontae/0000-0003-2347-1262				Antebi A, 1998, DEVELOPMENT, V125, P1191; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bird DM, 1998, J NEMATOL, V30, P299; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Koga M, 1999, DEVELOPMENT, V126, P5387; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REGNIER FE, 1968, J LIPID RES, V9, P541; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; THOMAS JH, 1993, GENETICS, V134, P1105; Viney ME, 2004, NATURWISSENSCHAFTEN, V91, P123, DOI 10.1007/s00114-004-0503-2; VOWELS JJ, 1994, GENETICS, V138, P303	25	271	287	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					541	545		10.1038/nature03201	http://dx.doi.org/10.1038/nature03201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	893NT	15690045				2022-12-24	WOS:000226727200053
J	Lum, JJ; Bauer, DE; Kong, M; Harris, MH; Li, C; Lindsten, T; Thompson, CB				Lum, JJ; Bauer, DE; Kong, M; Harris, MH; Li, C; Lindsten, T; Thompson, CB			Growth factor regulation of autophagy and cell survival in the absence of apoptosis	CELL			English	Article							MALIGNANT GLIOMA-CELLS; DROSOPHILA FAT-BODY; SACCHAROMYCES-CEREVISIAE; DEATH; MUTANTS; MACROAUTOPHAGY; PATHWAY; YEAST; GENE; SIZE	In animals, cells are dependent on extracellular signals to prevent apoptosis. However, using growth factor-dependent cells from Bax/Bak-deficient mice, we demonstrate that apoptosis is not essential to limit cell autonomous survival. Following growth factor withdrawal, Bax(-/-)Bak(-/-) cells activate autophagy, undergo progressive atrophy, and ultimately succumb to death. These effects result from loss of the ability to take up sufficient nutrients to maintain cellular bioenergetics. Despite abundant extracellular nutrients, growth factor-deprived cells maintain ATP production from catabolism of intracellular substrates through autophagy. Autophagy is essential for maintaining cell survival following growth factor withdrawal and can sustain viability for several weeks. During this time, cells respond to growth factor readdition by rapid restoration of the ability to take up and metabolize glucose and by subsequent recovery of their original size and proliferative potential. Thus, growth factor signal transduction is required to direct the utilization of sufficient exogenous nutrients to maintain cell viability.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	craig@mail.upenn.edu		Lum, Julian/0000-0002-5624-3541				Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Aubert S, 1996, J CELL BIOL, V133, P1251, DOI 10.1083/jcb.133.6.1251; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAN O, 1994, J EXP MED, V180, P917, DOI 10.1084/jem.180.3.917; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KUMA A, 2004, NATURE, V433, P1; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Paglin S, 2001, CANCER RES, V61, P439; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 1997, ONCOGENE, V15, P971, DOI 10.1038/sj.onc.1201266	48	1209	1269	4	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					237	248		10.1016/j.cell.2004.11.046	http://dx.doi.org/10.1016/j.cell.2004.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680329	Bronze			2022-12-24	WOS:000226740000012
J	Cote, IM; Cheney, KL				Cote, IM; Cheney, KL			Animal mimicry: Choosing when to be a cleaner-fish mimic - A dangerous fish can discard a seemingly harmless disguise to suit its circumstances	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Cote, IM (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	i.cote@uea.ac.uk	Cheney, Karen L/A-6827-2013; Cote, Isabelle/ABD-5898-2021; Cheney, Karen/L-3427-2018	Cheney, Karen L/0000-0001-5622-9494; Cheney, Karen/0000-0001-5622-9494				Cote IM, 2004, P ROY SOC B-BIOL SCI, V271, P2627, DOI 10.1098/rspb.2004.2904; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Kuwamura T., 1981, Nanki Seibutu, V23, P61; Randall J.E., 1997, FISHES GREAT BARRIER; RUSSELL BC, 1976, J ZOOL, V180, P407; SMITHVANIZ WF, 1976, ACAD NAT SCI PHILADE, V19, P1	6	31	33	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2005	433	7023					211	212		10.1038/433211a	http://dx.doi.org/10.1038/433211a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662402				2022-12-24	WOS:000226381300028
J	Ahn, SH; Cheung, WL; Hsu, JY; Diaz, RL; Smith, MM; Allis, CD				Ahn, SH; Cheung, WL; Hsu, JY; Diaz, RL; Smith, MM; Allis, CD			Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae	CELL			English	Article							PROGRAMMED CELL-DEATH; PROTEIN-KINASE; YEAST; DNA; PCR; PROLIFERATION; MODULES; STE20P; GROWTH; HIPPO	Apoptosis is a highly coordinated cell suicide mechanism in vertebrates. Phosphorylation of serine 14 of histone H2B, catalyzed by Mst1 kinase, has been linked to chromatin compaction during apoptosis. We extend these results to unicellular eukaryotes by demonstrating that H2B is specifically phosphorylated at serine 10 (S10) in a hydrogen peroxide-induced cell death pathway in S. cerevisiae. H2B S10A mutants are resistant to cell death elicited by H2O2 while H2B S10E phospho-site mimics promote cell death and induce the "constitutive" formation of condensed chromatin. Ste20 kinase, a yeast homolog of mammalian Mst1 kinase, translocates into the nucleus in a caspase-independent fashion and directly phosphorylates H2B at S10. Conservation of targeted H2B phosphorylation and the enzyme system responsible for the process point to an ancient mechanism of chromatin remodeling that likely plays an important role in governing cellular homeostasis in a wide range of organisms.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Biochem, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Mol Genet, Charlottesville, VA 22908 USA	Rockefeller University; University of Virginia; University of Virginia; University of Virginia	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, Box 78, New York, NY 10021 USA.	alliscd@rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40922] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rose MD., 1990, METHODS YEAST GENETI; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; SIKORSKI RS, 1989, GENETICS, V122, P19; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang Z, 2003, BIOCHEM PHARMACOL, V65, P1767, DOI 10.1016/S0006-2952(03)00117-5; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200	37	198	212	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					25	36		10.1016/j.cell.2004.11.016	http://dx.doi.org/10.1016/j.cell.2004.11.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652479	Bronze			2022-12-24	WOS:000226365400008
J	Balmford, A; Bennun, L; ten Brink, B; Cooper, D; Cote, IM; Crane, P; Dobson, A; Dudley, N; Dutton, I; Green, RE; Gregory, RD; Harrison, J; Kennedy, ET; Kremen, C; Leader-Williams, N; Lovejoy, TE; Mace, G; May, R; Mayaux, P; Morling, P; Phillips, J; Redford, K; Ricketts, TH; Rodriguez, JP; Sanjayan, M; Schei, PJ; van Jaarsveld, AS; Walther, BA				Balmford, A; Bennun, L; ten Brink, B; Cooper, D; Cote, IM; Crane, P; Dobson, A; Dudley, N; Dutton, I; Green, RE; Gregory, RD; Harrison, J; Kennedy, ET; Kremen, C; Leader-Williams, N; Lovejoy, TE; Mace, G; May, R; Mayaux, P; Morling, P; Phillips, J; Redford, K; Ricketts, TH; Rodriguez, JP; Sanjayan, M; Schei, PJ; van Jaarsveld, AS; Walther, BA			The convention on biological diversity's 2010 target	SCIENCE			English	Article									Royal Bot Gardens, Richmond, England; Univ Cambridge, Cambridge CB2 1TN, England; Univ Cape Town, ZA-7700 Rondebosch, South Africa; BirdLife Int, Cambridge, England; RIVM, Bilthoven, Netherlands; Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; Princeton Univ, Princeton, NJ 08544 USA; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; UN, Environm Program, World Conservat Monitoring Ctr, New York, NY USA; Conservat Int, Washington, DC USA; Univ Kent, Canterbury CT2 7NZ, Kent, England; Zool Soc London, London, England; Univ Oxford, Oxford OX1 2JD, England; Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; Wildlife Conservat Soc, Bronx, NY USA; World Wildlife Fund, Washington, DC 20037 USA; Inst Venezolano Invest Cient, Caracas, Venezuela; Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa	Royal Botanic Gardens, Kew; University of Cambridge; University of Cape Town; BirdLife International; Netherlands National Institute for Public Health & the Environment; University of East Anglia; Princeton University; Royal Society for Protection of Birds; United Nations Environment Programme; Conservation International; University of Kent; Zoological Society of London; University of Oxford; European Commission Joint Research Centre; EC JRC ISPRA Site; Wildlife Conservation Society; World Wildlife Fund; Venezuelan Institute Science Research; Stellenbosch University	Dobson, A (corresponding author), Royal Bot Gardens, Richmond, England.	dobber@prince-ton.edu	Rodriguez, Jon P/A-1491-2009; Mace, Georgina M/I-3072-2016; Rodriguez, Jon P/G-7224-2012; Cote, Isabelle/ABD-5898-2021; van Jaarsveld, Albert/H-5368-2013	Rodriguez, Jon P/0000-0001-5019-2870; Mace, Georgina M/0000-0001-8965-5211; Cooper, David/0000-0003-4538-205X; Gregory, Richard/0000-0002-7419-5053; Crane, Peter/0000-0003-4331-6948; Balmford, Andrew/0000-0002-0144-3589				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 1997, NATURES SERVICES; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BUTCHART SHM, IN PRESS NATURE; CDB, 2002, CONTRIBUTION 6 NATL; COTE IM, IN PRESS PHILOS T B; Department of Environment Food and Rural Affairs (DEFRA), 2002, ACH BETT QUAL LIF RE; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; *EUR COUNC, 2001, SN200101 EC, P8; GREGORY RD, IN PRESS T R SOC L B; Heinz Center, 2002, STAT NAT EC MEAS LAN; Homewood KM, 2004, ENVIRON SCI POLICY, V7, P125, DOI 10.1016/j.envsci.2003.12.006; HUTCHINGS JA, IN PRESS PHILOS T B; LOH J, IN PRESS PHILOS T B; MAYAUX P, IN PRESS PHILOS T B; Millennium Ecosystem Assessment, 2003, EC HUM WELL BEING FR; PAULY D, IN PRESS PHILOS T B; Ten Brink B J E, 2000, 402001014 RIVM NAT I; *UNEP, 2003, UNEPCCBDSBSTTA9INF26; *UNEP, 2004, C PART CONV BIOL DIV	20	299	319	7	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					212	213		10.1126/science.1106281	http://dx.doi.org/10.1126/science.1106281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653489				2022-12-24	WOS:000226361900026
J	Evason, K; Huang, C; Yamben, I; Covey, DF; Kornfeld, K				Evason, K; Huang, C; Yamben, I; Covey, DF; Kornfeld, K			Anticonvulsant medications extend worm life-span	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; MUTANTS; ETHOSUXIMIDE; LONG	Genetic studies have elucidated mechanisms that regulate aging, but there has been little progress in identifying drugs that delay aging. Here, we report that ethosuximide, trimethadione, and 3,3-diethyl-2-pyrrolidinone increase mean and maximum life-span of Caenorhabditis elegans and delay age-related declines of physiological processes, indicating that these compounds retard the aging process. These compounds, two of which are approved for human use, are anticonvulsants that modulate neural activity. These compounds also regulated neuromuscular activity in nematodes. These findings suggest that the life-span-extending activity of these compounds is related to the anticonvulsant activity and implicate neural activity in the regulation of aging.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Kornfeld, K (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	kornfeid@molecool.wustl.edu	Evason, Kimberley/AAC-2506-2020		NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Gems D, 2000, GENETICS, V154, P1597; Gomora JC, 2001, MOL PHARMACOL, V60, P1121, DOI 10.1124/mol.60.5.1121; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; KATZUNG BG, 1998, BASIC CLIN PHARM; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Leresche N, 1998, J NEUROSCI, V18, P4842; Levy R.H., 2002, ANTIEPILEPTIC DRUGS, V5th ed.; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Reddy PA, 1996, J MED CHEM, V39, P1898, DOI 10.1021/jm9600196; Riddle D. L, 1997, COLD SPRING HARBOR M, V33; TRENT C, 1983, GENETICS, V104, P619	20	149	171	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					258	262		10.1126/science.1105299	http://dx.doi.org/10.1126/science.1105299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653505				2022-12-24	WOS:000226361900044
J	Kotwal, RS; Wenzel, RB; Sterling, RA; Porter, WD; Jordan, NN; Petruccelli, BP				Kotwal, RS; Wenzel, RB; Sterling, RA; Porter, WD; Jordan, NN; Petruccelli, BP			An outbreak of malaria in US Army Ranges returning from Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PLASMODIUM-VIVAX MALARIA; UNITED-STATES; PRIMAQUINE; WAR; CHEMOPROPHYLAXIS; RESISTANCE; SOLDIERS; VIETNAM; SOMALIA	Context With numerous US military personnel currently deployed throughout the world, military and civilian health care professionals may encounter imported malaria from this population. Objective To identify malaria in US Army personnel deployed to a combat zone. Design, Setting, and Patients Case series in the US Army health care system. A total of 38 cases of malaria were identified in a 725-man Ranger Task Force that deployed to eastern Afghanistan between June and September 2002. Main Outcome Measures Identification of malaria cases and soldiers' self-report of compliance with antimalarial measures. Results A total of 38 patients were infected with Plasmodium vivax, yielding an attack rate of 52.4 cases per 1000 soldiers. Diagnosis was confirmed a median of 233 days (range, 1-339 days) after return from the malaria endemic region, with additional laboratory findings noting anemia and thrombocytopenia. One case was complicated with acute respiratory distress syndrome during the patient's primary attack and a spontaneous pneumothorax during relapse. This case accounted for 1 of 2 relapse cases in the study population. From an anonymous postdeployment survey of 72% (521/725) of the task force, the self-reported compliance rate was 52% for weekly chemoprophylaxis, 41% for terminal (postdeployment) chemoprophylaxis, 31% for both weekly and terminal chemoprophylaxis, 82% for treating uniforms with permethrin, and 29% for application of insect repellent. Conclusions Delayed clinical presentation can occur with P vivax. Symptoms are often vague, but malaria should be included in the differential diagnosis for soldiers returning from an endemic region. Suboptimal compliance with preventive measures can result in a malaria outbreak.	Naval Operat Med Inst, Army Navy Aerosp Med Residency, Pensacola, FL 32508 USA; Univ Texas, Med Branch, Dept Prevent Med, Galveston, TX 77550 USA; Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; 75th Ranger Regiment, Ft Benning, GA USA; 1st Cavalry Div, Div Prevent Med, Ft Hood, TX USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Uniformed Services University of the Health Sciences - USA	Kotwal, RS (corresponding author), Naval Operat Med Inst, Army Navy Aerosp Med Residency, Pensacola, FL 32508 USA.	russ.kotwal@us.army.mil						Addington W, 2003, ANN INTERN MED, V139, P305, DOI 10.7326/0003-4819-139-4-200308190-00024; *AFMIC, 2002, 05202 AFMIC; *AFMIC, 2002, 04002 AFMIC; *ARM MED SURV ACT, 2004, DEF MED EP DAT VERS; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; BARRETT O, 1969, AM J TROP MED HYG, V18, P495, DOI 10.4269/ajtmh.1969.18.495; BEADLE C, 1993, CLIN INFECT DIS, V16, P320, DOI 10.1093/clind/16.2.320; Carlini ME, 1999, CLIN INFECT DIS, V28, P1182, DOI 10.1086/517779; *CDCP, 2001, MAL SURV US 2001; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P22; *CDCP, 2003, HLTH INF INT TRAV 20; Chin J, 2001, CONTROL COMMUNICABLE, P310; COATES JB, 1963, PREVENTIVE MED WORLD; Collins WE, 1996, AM J TROP MED HYG, V55, P243, DOI 10.4269/ajtmh.1996.55.243; Curlin ME, 1999, CLIN INFECT DIS, V28, P1166, DOI 10.1086/517767; Gambel JM, 1998, J TRAVEL MED, V5, P217, DOI 10.1111/j.1708-8305.1998.tb00511.x; ISLAM N, 1995, TROP GEOGR MED, V47, P141; Joy RJT, 1999, MED HIST, V43, P192, DOI 10.1017/S002572730006508X; NEWTON JA, 1994, JAMA-J AM MED ASSOC, V272, P397, DOI 10.1001/jama.272.5.397; PUKRITTAYAKAMEE S, 1994, J INFECT DIS, V169, P932, DOI 10.1093/infdis/169.4.932; Robert L L, 2001, Med Trop (Mars), V61, P67; SHANKS GD, 1991, MIL MED, V156, P684, DOI 10.1093/milmed/156.12.684; Shanks GD, 2001, CLIN INFECT DIS, V33, P381, DOI 10.1086/321866; SHANKS GD, 1995, MED J AUSTRALIA, V162, P306, DOI 10.5694/j.1326-5377.1995.tb139906.x; Smoak BL, 1997, AM J TROP MED HYG, V56, P231, DOI 10.4269/ajtmh.1997.56.231; Tanios MA, 2001, CRIT CARE MED, V29, P665, DOI 10.1097/00003246-200103000-00037; *US DEP ARM, 2000, FIELD MAN 4 02 17 PR; *WHO EXP COMM MAL, 1998, WHO TECHN REP SER, V892	28	83	86	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					212	216		10.1001/jama.293.2.212	http://dx.doi.org/10.1001/jama.293.2.212			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644548	Bronze			2022-12-24	WOS:000226171000037
J	Garant, D; Kruuk, LEB; Wilkin, TA; McCleery, RH; Sheldon, BC				Garant, D; Kruuk, LEB; Wilkin, TA; McCleery, RH; Sheldon, BC			Evolution driven by differential dispersal within a wild bird population	NATURE			English	Article							GREAT TITS; GENE FLOW; SELECTION; BLUE; HERITABILITY; COMPETITION; TRAITS; SIZE	Evolutionary theory predicts that local population divergence will depend on the balance between the diversifying effect of selection and the homogenizing effect of gene flow(1-3). However, spatial variation in the expression of genetic variation will also generate differential evolutionary responses. Furthermore, if dispersal is non-random it may actually reinforce, rather than counteract, evolutionary differentiation. Here we document the evolution of differences in body mass within a population of great tits, Parus major, inhabiting a single continuous woodland, over a 36-year period. We show that genetic variance for nestling body mass is spatially variable, that this generates different potential responses to selection, and that this diversifying effect is reinforced by non-random dispersal. Matching the patterns of variation, selection and evolution with population ecological data, we argue that the small-scale differentiation is driven by density-related differences in habitat quality affecting settlement decisions. Our data show that when gene flow is not homogeneous, evolutionary differentiation can be rapid and can occur over surprisingly small spatial scales. Our findings have important implications for questions of the scale of adaptation and speciation, and challenge the usual treatment of dispersal as a force opposing evolutionary differentiation.	Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Oxford; University of Edinburgh	Garant, D (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	dany.garant@zoology.oxford.ac.uk	Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012; Sheldon, Ben C/A-8056-2010; Garant, Dany/D-7406-2013; Wilkin, Teddy/B-9979-2008	Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123; Sheldon, Ben C/0000-0002-5240-7828; Garant, Dany/0000-0002-8091-1044; 				Barton Nick H., 2001, P329; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; Braillet C, 2002, J AVIAN BIOL, V33, P446, DOI 10.1034/j.1600-048X.2002.02956.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1986, Monographs in Population Biology, pviii; Fairbairn DJ, 1996, EVOLUTION, V50, P1549, DOI 10.1111/j.1558-5646.1996.tb03927.x; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; GROENEVELD E, 1992, ARCH TIERZUCHT, V35, P399; HARVEY PH, 1979, J ANIM ECOL, V48, P305, DOI 10.2307/4115; Hendry AP, 2001, EVOLUTION, V55, P459, DOI 10.1554/0014-3820(2001)055[0459:PMATAD]2.0.CO;2; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Lynch M., 1998, AM J HUM GENET; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; MINOT EO, 1981, J ANIM ECOL, V50, P375, DOI 10.2307/4061; MINOT EO, 1986, J ANIM ECOL, V55, P331, DOI 10.2307/4712; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Neumaier A, 1998, GENET SEL EVOL, V30, P3, DOI 10.1051/gse:19980101; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; RHYNSBURGER D, 1973, GEOGR ANAL, V5, P133; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; SPITZE K, 1993, GENETICS, V135, P367; van der Jeugd HP, 2002, J EVOLUTION BIOL, V15, P380, DOI 10.1046/j.1420-9101.2002.00411.x; Verhulst S, 1997, ECOLOGY, V78, P864, DOI 10.1890/0012-9658(1997)078[0864:NDOGTI]2.0.CO;2; *VSN INT, 2003, GENSTAT VERS 7 1	30	227	236	1	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					60	65		10.1038/nature03051	http://dx.doi.org/10.1038/nature03051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884WJ	15635409				2022-12-24	WOS:000226117100035
J	Raine, TR; Harper, CC; Rocca, CH; Fischer, R; Padian, N; Klausner, JD; Darney, PD				Raine, TR; Harper, CC; Rocca, CH; Fischer, R; Padian, N; Klausner, JD; Darney, PD			Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY PHARMACIES; ADVANCE PROVISION; NATIONAL-SURVEY; USERS; PILLS; FDA	Context It is estimated that half of unintended pregnancies could be averted if emergency contraception (EC) were easily accessible and used. Objective To evaluate the effect of direct access to EC through pharmacies and advance provision on reproductive health outcomes. Design, Setting, and Participants A randomized, single-blind, controlled trial (July 2001-June 2003) of 2117 women, ages 15 to 24 years, attending 4 California clinics providing family planning services, who were not desiring pregnancy, using long-term hormonal contraception or requesting EC. Intervention Participants were assigned to 1 of the following groups: (1) pharmacy access to EC; (2) advance provision of 3 packs of levonorgestrel EC; or (3) clinic access (control). Main Outcome Measures Primary outcomes were use of EC, pregnancies, and sexually transmitted infections (STIs) assessed at 6 months; secondary outcomes were changes in contraceptive and condom use and sexual behavior. Results Women in the pharmacy access group were no more likely to use EC (24.2%) than controls (21.0%) (P=.25). Women in the advance provision group (37.4%) were almost twice as likely to use EC than controls (21.0%) (P<.001) even though the frequency of unprotected intercourse was similar (39.8% vs 41.0%, respectively, P=.46). Only half (46.7%) of study participants who had unprotected intercourse used EC over the study period. Eight percent of participants became pregnant and 12% acquired an STI; compared with controls, women in the pharmacy access and advance provision groups did not experience a significant reduction in pregnancy rate (pharmacy access group: adjusted odds ratio [OR], 0.98; 95% confidence interval [CI], 0.58-1.64; P=.93; advance provision group: OR, 1.10; 95% CI, 0.66-1.84, P=.71) or increase in STIs (pharmacy access group: adjusted OR, 1.08, 95% CI, 0.71-1.63, P=.73; advance provision group: OR, 0.94, 95% CI, 0.62-1.44, P=.79). There were no differences in patterns of contraceptive or condom use or sexual behaviors by study group. Conclusions While removing the requirement to go through pharmacists or clinics to obtain EC increases use, the public health impact may be negligible because of high rates of unprotected intercourse and relative underutilization of the method. Given that there is clear evidence that neither pharmacy access nor advance provision compromises contraceptive or sexual behavior, it seems unreasonable to restrict access to EC to clinics.	Univ Calif San Francisco, Ctr Reprod Hlth Res & Policy, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Planned Parenthood Mar Monte, San Jose, CA USA; San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health	Raine, TR (corresponding author), San Francisco Gen Hosp, Dept Obstet Gynecol & Reprod Sci, 1001 Potrero Ave, San Francisco, CA 94110 USA.	rainet@obgyn.ucsf.edu						Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; Ellertson C, 2001, OBSTET GYNECOL, V98, P570, DOI 10.1016/S0029-7844(01)01506-X; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Gardner JS, 2001, FAM PLANN PERSPECT, V33, P172, DOI 10.2307/2673721; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Glasier A, 2004, CONTRACEPTION, V69, P361, DOI 10.1016/j.contraception.2004.01.002; Gold MA, 1997, FAM PLANN PERSPECT, V29, P15, DOI 10.2307/2953348; Gold Melanie A, 2004, J Pediatr Adolesc Gynecol, V17, P87, DOI 10.1016/j.jpag.2003.11.018; Grimes D, 1998, LANCET, V352, P428; Harvey SM, 1999, FAM PLANN PERSPECT, V31, P237, DOI 10.2307/2991571; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Lovvorn A, 2000, CONTRACEPTION, V61, P287, DOI 10.1016/S0010-7824(00)00107-4; Mosher WD, 1998, FAM PLANN PERSPECT, V30, P43, DOI 10.2307/2991525; Paukku M, 2003, OBSTET GYNECOL, V101, P534, DOI 10.1016/S0029-7844(02)02717-5; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; Raine T, 2002, OBSTET GYNECOL, V99, P241, DOI 10.1016/S0029-7844(01)01714-8; Roye CF, 2001, J ADOLESCENT HEALTH, V28, P165, DOI 10.1016/S1054-139X(01)00203-8; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P2805, DOI 10.1001/jama.291.23.2805	22	237	243	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2005	293	1					54	62		10.1001/jama.293.1.54	http://dx.doi.org/10.1001/jama.293.1.54			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QY	15632336	Bronze			2022-12-24	WOS:000226102100021
J	Pereira, MA; Kartashov, AI; Ebbeling, CB; Van Horn, L; Slattery, M; Jacobs, DR; Ludwig, DS				Pereira, MA; Kartashov, AI; Ebbeling, CB; Van Horn, L; Slattery, M; Jacobs, DR; Ludwig, DS			Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; GLYCEMIC INDEX; DIABETES-MELLITUS; DIETARY FIBER; OBESITY; CHILDREN; WOMEN; RISK; PREVALENCE	Background Fast-food consumption has increased greatly in the USA during the past three decades. However, the effect of fast food on risk of obesity and type 2 diabetes has received little attention. We aimed to investigate the association between reported fast-food habits and changes in bodyweight and insulin resistance over a 15-year period in the USA. Methods Participants for the CARDIA study included 3031 young (age 18-30 years in 1985-86) black and white adults who were followed up with repeated dietary assessment. We used multiple linear regression models to investigate the association of frequency of fast-food restaurant visits (fast-food frequency) at baseline and follow-up with 15-year changes in bodyweight and the homoeostasis model (HOMA) for insulin resistance. Findings Fast-food frequency was lowest for white women (about 1.3 times per week) compared with the other ethnic-sex groups (about twice a week). After adjustment for lifestyle factors, baseline fast-food frequency was directly associated with changes in bodyweight in both black (p=0.0050) and white people (p=0.0013). Change in fast-food frequency over 15 years was directly associated with changes in bodyweight in white individuals (p<0.0001), with a weaker association recorded in black people (p=0.1004). Changes were also directly associated with insulin resistance in both ethnic groups (p=0.0015 in black people, p<0.0001 in white people). By comparison with the average 15-year weight gain in participants with infrequent (less than once a week) fast-food restaurant use at baseline and follow-up (n=203), those with frequent (more than twice a week) visits to fast-food restaurants at baseline and follow-up (n=87) gained an extra 4.5 kg of bodyweight (p=0.0054) and had a two-fold greater increase in insulin resistance (p=0.0083). Interpretation Fast-food consumption has strong positive associations with weight gain and insulin resistance, suggesting that fast food increases the risk of obesity and type 2 diabetes.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Univ Oslo, Dept Nutr, Oslo, Norway	Harvard University; Boston Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Northwestern University; Utah System of Higher Education; University of Utah; University of Oslo	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Jacobs, David/0000-0002-7232-0543; Pereira, Mark/0000-0002-6704-5276; Ludwig, David/0000-0003-3307-8544	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048050, N01HC048048, N01HC048047, N01HC048049] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR02172] Funding Source: Medline; NHLBI NIH HHS [N01-HC-48049, N01-HC-95095, N01-HC-48048, N01-HC-48047, N01-HC-48050] Funding Source: Medline; NIDDK NIH HHS [1R01DK59240] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; American Diabetes Association, 2002, DIABETES CARE, V25, pS50, DOI DOI 10.2337/DIACARE.25.2007.S50; BIINGHWAN L, 1997, FOOD REV, P33; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; FRENCH SA, 1994, INT J OBESITY, V18, P145; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jarvi AE, 1999, DIABETES CARE, V22, P10, DOI 10.2337/diacare.22.1.10; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; *TECN INF SERV, 2002, US FOODS IND FOR; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; *USDA, 1997, CONT SURV FOOD INT I	33	853	873	3	143	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					36	42		10.1016/S0140-6736(04)17663-0	http://dx.doi.org/10.1016/S0140-6736(04)17663-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639678				2022-12-24	WOS:000226213100026
J	Wilbanks, AM; Fralish, GB; Kirby, ML; Barak, LS; Li, YX; Caron, MG				Wilbanks, AM; Fralish, GB; Kirby, ML; Barak, LS; Li, YX; Caron, MG			beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway	SCIENCE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; NEGATIVE REGULATOR; BETA-ARRESTIN; EXPRESSION; RECEPTOR; MUTATIONS; TRANSDUCTION; SUPPRESSOR; HOMOLOG	beta-arrestins are multifunctional proteins that act as scaffolds and transducers of intracellular signals from heptahelical transmembrane-spanning receptors (7TMR). Hedgehog (Hh) signaling, which uses the putative 7TMR, Smoothened, is established as a fundamental pathway in development, and unregulated Hh signaling is associated with certain malignancies. Here, we show that the functional knockdown of beta-arrestin 2 in zebrafish embryos recapitulates the many phenotypes of Hh pathway mutants. Expression of wild-type beta-arrestin 2, or constitutive activation of the Hh pathway downstream of Smoothened, rescues the phenotypes caused by beta-arrestin 2 deficiency. These results suggest that a functional interaction between beta-arrestin 2 and Smoothened may be critical to regulate Hh signaling in zebrafish development.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Li, YX (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	lyx@duke.edu; caron002@mc.duke.edu		Li, Yinxiong/0000-0002-8802-7720	NHLBI NIH HHS [HL36059, HL61365] Funding Source: Medline; NIGMS NIH HHS [GM069086-01] Funding Source: Medline; NINDS NIH HHS [NS19576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036059, R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM069086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen WB, 2001, DEVELOPMENT, V128, P2385; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Concordet JP, 1996, DEVELOPMENT, V122, P2835; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; EKKER M, 1992, DEVELOPMENT, V116, P1001; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; HATTA K, 1991, DEVELOPMENT, V112, P821; HOPKINS N, UNPUB; Luttrell LM, 2002, J CELL SCI, V115, P455; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; NYAKKEN K, 2002, CURR OPIN GENE DEV, V12, P503; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Stickney HL, 2000, DEV DYNAM, V219, P287; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WILBANKS A, UNPUB	27	102	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2264	2267		10.1126/science.1104193	http://dx.doi.org/10.1126/science.1104193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618520				2022-12-24	WOS:000225950000049
J	Wade, JT; Hall, DB; Struhl, K				Wade, JT; Hall, DB; Struhl, K			The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes	NATURE			English	Article							FORK HEAD PROTEIN; SACCHAROMYCES-CEREVISIAE; BINDING-SITES; EXPRESSION; RAP1; PROMOTER; SEQUENCE; ASSOCIATION; RECRUITMENT; ACTIVATOR	Ribosomal protein (RP) genes in eukaryotes are coordinately regulated in response to growth stimuli and environmental stress, thereby permitting cells to adjust ribosome number and overall protein synthetic capacity to physiological conditions(1-5). Approximately 50% of RNA polymerase II transcription is devoted to RP genes(5). The transcriptional regulator Rap1 binds most yeast RP promoters(6), and Rap1 sites are important for coordinate regulation of RP genes(7-10). However, Rap1 is not the specific regulator that controls RP transcription because it also functions as a repressor, and many Rap1-activated promoters are not coordinately regulated with RP promoters(11,12). Here we show that the transcription factors Fhl1 and Ifh1 associate almost exclusively with RP promoters; association depends on Rap1 and ( to a lesser extent) a DNA element at many RP promoters. Ifh1 is recruited to promoters via the forkhead-associated (FHA) domain of Fhl1; the level of Ifh1 associated with RP promoters determines the level of transcription; and environmental stress causes a marked reduction in the association of Ifh1, but not Fhl1 or Rap1. Thus, Ifh1 association with promoters is the key regulatory step for coordinate expression of RP genes.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu		Hall, Daniel B/0000-0002-5085-8334; Wade, Joseph/0000-0002-9779-3160				APARICIO O, 2004, CURRENT PROTOCOLS MO; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brachmann CB, 1998, YEAST, V14, P115; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONCALVES PM, 1995, NUCLEIC ACIDS RES, V23, P1475, DOI 10.1093/nar/23.9.1475; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Kim M, 2002, J BIOL CHEM, V277, P38781, DOI 10.1074/jbc.M201559200; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; PIERANDREIAMALDI P, 1994, GENETICA, V94, P181, DOI 10.1007/BF01443432; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SESHADRI T, 1993, J BIOL CHEM, V268, P18474; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	30	160	164	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1054	1058		10.1038/nature03175	http://dx.doi.org/10.1038/nature03175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616568				2022-12-24	WOS:000225887000048
J	Gaspar, HB; Parsley, KL; Howe, S; King, D; Gilmour, KC; Sinclair, J; Brouns, G; Schmidt, M; Von Kalle, C; Barington, T; Jakobsen, MA; Christensen, HO; Al Ghonaium, A; White, HN; Smith, JL; Levinsky, RJ; Ali, RR; Kinnon, C; Thrasher, AJ				Gaspar, HB; Parsley, KL; Howe, S; King, D; Gilmour, KC; Sinclair, J; Brouns, G; Schmidt, M; Von Kalle, C; Barington, T; Jakobsen, MA; Christensen, HO; Al Ghonaium, A; White, HN; Smith, JL; Levinsky, RJ; Ali, RR; Kinnon, C; Thrasher, AJ			Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector	LANCET			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; LONG-TERM; GAMMA-CHAIN; BONE-MARROW; VIVO	Background X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations in the common cytokine-receptor gamma chain (gammac), resulting in disruption of development of T lymphocytes and natural-killer cells. B-lymphocyte function is also intrinsically compromised. Allogeneic bone-marrow transplantation is successful if HLA-matched family donors are available, but HLA-mismatched procedures are associated with substantial morbidity and mortality. We investigated the application of somatic gene therapy by use of a gibbon-ape-leukaemia-virus pseudotyped gammaretroviral vector. Methods Four children with SCID-X1 were enrolled. Autologouls CD34-positive haemopoietic bone-marrow stem cells were transduced ex vivo and returned to the patients without preceding cytoreductive chemotherapy. The patients were monitored for integration and expression of the gammac vector and for functional immunological recovery. Findings All patients have shown substantial improvements in clinical and immunological features, and prophylactic medication could be withdrawn in two. No serious adverse events have been recorded. T cells responded normally to mitogenic and antigenic stimuli, and the T-cell-receptor (TCR) repertoire was highly diverse. Where assessable, humoral immunity, in terms of antibody production, was also restored and associated with increasing rates of somatic mutation in immunoglobuilin genes. Interpretation Gene therapy for SCID-X1 is a highly effective strategy for restoration of functional cellular and Immoral immunity.	UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, Dept Clin Immunol, London WC1N 3JH, England; Univ Freiburg, Dept Internal Med, D-7800 Freiburg, Germany; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; Cincinnati Childrens Res Fdn, Div Expt Hematol, Cincinnati, OH USA; Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Paediat, DK-5000 Odense, Denmark; King Faisal Specialist Hosp & Res Ctr, Dept Paediat Allergy Immunol, Riyadh 11211, Saudi Arabia; Southampton Gen Hosp, Dept Immunol, Southampton SO9 4XY, Hants, England; UCL, Inst Ophthalmol, Dept Mol Genet, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Freiburg; University of Freiburg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; King Faisal Specialist Hospital & Research Center; University of Southampton; University of London; University College London	Thrasher, AJ (corresponding author), UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England.	a.thrasher@ich.ucl.ac.uk	Barington, Torben/C-3922-2009; Kinnon, Christine/A-1585-2010; Howe, Steven J/C-4801-2008; Barington, Torben/R-6841-2019	Barington, Torben/0000-0001-6968-148X; Howe, Steven J/0000-0003-2940-2874; Thrasher, Adrian/0000-0002-6097-6115; Gilmour, Kimberly/0000-0003-0285-3958; white, harry/0000-0001-8186-7789; Ali, Robin/0000-0003-3126-6517; Jakobsen, Marianne Antonius/0000-0003-2352-9276	Wellcome Trust [062578] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haddad E, 1998, BLOOD, V91, P3646; Hess AD, 1997, IMMUNOL REV, V157, P111, DOI 10.1111/j.1600-065X.1997.tb00977.x; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Schmidt M, 2001, ANN NY ACAD SCI, V938, P146; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Teshima T, 2002, SEMIN HEMATOL, V39, P15, DOI 10.1053/shem.2002.29246; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; White H, 2000, EUR J IMMUNOL, V30, P732; Whitwam T, 1998, BLOOD, V92, P1565, DOI 10.1182/blood.V92.5.1565.417k12_1565_1575	19	495	533	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2181	2187		10.1016/S0140-6736(04)17590-9	http://dx.doi.org/10.1016/S0140-6736(04)17590-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610804				2022-12-24	WOS:000225799700026
J	Meyron-Holtz, EG; Ghosh, MC; Rouault, TA				Meyron-Holtz, EG; Ghosh, MC; Rouault, TA			Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo	SCIENCE			English	Article							SULFUR CLUSTER; DEGRADATION; METABOLISM; CELLS; IRP2; HOMEOSTASIS; ACONITASE; TENSION; MUTANT; HEME	The iron-regulatory proteins (IRPs) posttranscriptionally regulate expression of transferrin receptor, ferritin, and other iron metabolism proteins. Although both IRPs can regulate expression of the same target genes, IRP2(-/-) mice significantly misregulate iron metabolism and develop neurodegeneration, whereas IRP1(-/-) mice are spared. We found that IRP2(-/-) cells misregulated iron metabolism when cultured in 3 to 6% oxygen, which is comparable to physiological tissue concentrations, but not in 21% oxygen, a concentration that activated IRP1 and allowed it to substitute for IRP2. Thus, IRP2 dominates regulation of mammalian iron homeostasis because it alone registers iron concentrations and modulates its RNA-binding activity at physiological oxygen tensions.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.	trou@helix.nih.gov	Meyron-Holtz, Esther/B-5991-2013		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; BOUTON C, 2003, SCI STKE; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; DERUSSO PA, 1995, J BIOL CHEM, V270, P15451, DOI 10.1074/jbc.270.26.15451; DEXTER DT, 1992, ANN NEUROL, V32, P94; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 1999, GENE EXPRESSION, V7, P367; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Schneider B D, 2000, Curr Opin Clin Nutr Metab Care, V3, P267, DOI 10.1097/00075197-200007000-00005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; SMITH SS, UNPUB; Studer L, 2000, J NEUROSCI, V20, P7377; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952	29	185	196	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2087	2090		10.1126/science.1103786	http://dx.doi.org/10.1126/science.1103786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604406				2022-12-24	WOS:000225841000061
J	Bico, J; Roman, B; Moulin, L; Boudaoud, A				Bico, J; Roman, B; Moulin, L; Boudaoud, A			Elastocapillary coalescence in wet hair	NATURE			English	Editorial Material									Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7636, F-75231 Paris 5, France; Ecole Normale Super, Phys Stat Lab, CNRS, UMR 8550, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Bico, J (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7636, 10 Rue Vauquelin, F-75231 Paris 5, France.	jbico@pmmh.espci.fr	Roman, Benoit/C-6273-2014; Bico, José/Q-1614-2015; Boudaoud, Arezki/Q-7436-2016	Roman, Benoit/0000-0002-1473-2734; Bico, José/0000-0002-3872-1239; Boudaoud, Arezki/0000-0002-2780-4717				Chakrapani N, 2004, P NATL ACAD SCI USA, V101, P4009, DOI 10.1073/pnas.0400734101; Cohen AE, 2003, P NATL ACAD SCI USA, V100, P12141, DOI 10.1073/pnas.1534600100; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Hui CY, 2002, LANGMUIR, V18, P1394, DOI 10.1021/la0113567; Lau KKS, 2003, NANO LETT, V3, P1701, DOI 10.1021/nl034704t; Leyvraz F, 2003, PHYS REP, V383, P95, DOI 10.1016/S0370-1573(03)00241-2; Mastrangelo C. H., 1993, Journal of Microelectromechanical Systems, V2, P33, DOI 10.1109/84.232593; Raccurt O, 2004, J MICROMECH MICROENG, V14, P1083, DOI 10.1088/0960-1317/14/7/031; TANAKA T, 1993, JPN J APPL PHYS 1, V32, P6059, DOI 10.1143/JJAP.32.6059	11	341	348	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					690	690		10.1038/432690a	http://dx.doi.org/10.1038/432690a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592402	Bronze			2022-12-24	WOS:000225597200036
J	He, JX; Gendron, JM; Sun, Y; Gampala, SSL; Gendron, N; Sun, CQ; Wang, ZY				He, JX; Gendron, JM; Sun, Y; Gampala, SSL; Gendron, N; Sun, CQ; Wang, ZY			BZR1 is a transcriptional repressor with dual roles in brassinosteroid homeostasis and growth responses	SCIENCE			English	Article							REGULATED GENES; ARABIDOPSIS; CYTOCHROME-P450; RECEPTOR; KINASE; BIOSYNTHESIS; ELONGATION; EXPRESSION; STEROIDS; RESCUE	Brassinosteroid (BR) homeostasis and signaling are crucial for normal growth and development of plants. BR signaling through cell-surface receptor kinases and intracellular components leads to dephosphorylation and accumulation of the nuclear protein BZR1. How BR signaling regulates gene expression, however, remains unknown. Here we show that BZR1 is a transcriptional repressor that has a previously unknown DNA binding domain and binds directly to the promoters of feed back-regulated BR biosynthetic genes. Microarray analyses identified additional potential targets of BZR1 and illustrated, together with physiological studies, that BZR1 coordinates BR homeostasis and signaling by playing dual roles in regulating BR biosynthesis and downstream growth responses.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Wang, ZY (corresponding author), Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390	NIGMS NIH HHS [R01 GM066258, T32 GM007276, R01 GM066258-04, 5T32GM007276, R01 GM66258-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM066258] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann T, 1998, TRENDS GENET, V14, P490, DOI 10.1016/S0168-9525(98)01598-4; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bishop GJ, 1996, PLANT CELL, V8, P959, DOI 10.1105/tpc.8.6.959; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; GODA H, ARABIDOPSIS INFORMAT; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 2003, CURR OPIN PLANT BIOL, V6, P494, DOI 10.1016/S1369-5266(03)00088-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Wang ZY, 2004, TRENDS PLANT SCI, V9, P91, DOI 10.1016/j.tplants.2003.12.009; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	25	542	604	4	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1634	1638		10.1126/science.1107580	http://dx.doi.org/10.1126/science.1107580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15681342	Green Accepted			2022-12-24	WOS:000227622400050
J	Chih, B; Engelman, H; Scheiffele, P				Chih, B; Engelman, H; Scheiffele, P			Control of excitatory and inhibitory synapse formation by neuroligins	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; MENTAL-RETARDATION; ADHESION MOLECULE; AUTISM; CELLS; DISORDERS; MUTATIONS; RECEPTORS; BALANCE; PSD-95	The normal function of neural networks depends on a delicate balance between excitatory and inhibitory synaptic inputs. Synapse formation is thought to be regulated by bidirectional signaling between pre- and postsynaptic cells. We demonstrate that members of the Neuroligin family promote postsynaptic differentiation in cultured rat hippocampal neurons. Down-regulation of neuroligin isoform expression by RNA interference results in a loss of excitatory and inhibitory synapses. Etectrophysiological analysis revealed a predominant reduction of inhibitory synaptic function. Thus, neuroligins control the formation and functional balance of excitatory and inhibitory synapses in hippocampal neurons.	Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Scheiffele, P (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	ps20l8@columbia.edu						Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; CHIH B, UNPUB; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Nusser Z, 1998, J NEUROSCI, V18, P1693; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	27	528	544	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1324	1328		10.1126/science.1107470	http://dx.doi.org/10.1126/science.1107470			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15681343				2022-12-24	WOS:000227313200063
J	Tomoyasu, Y; Wheeler, SR; Denell, RE				Tomoyasu, Y; Wheeler, SR; Denell, RE			Ultrabithorax is required for membranous wing identity in the beetle Tribolium castaneum	NATURE			English	Article							GENE-COMPLEX; DROSOPHILA-MELANOGASTER; HOMEOTIC COMPLEX; EVOLUTION; EXPRESSION; SPECIFICATION; MORPHOGENESIS; ORTHOLOG; SEQUENCE; DPP	The two pairs of wings that are characteristic of ancestral pterygotes ( winged insects) have often undergone evolutionary modification. In the fruitfly, Drosophila melanogaster, differences between the membranous forewings and the modified hindwings ( halteres) depend on the Hox gene Ultrabithorax ( Ubx). The Drosophila forewings develop without Hox input, while Ubx represses genes that are important for wing development, promoting haltere identity(1,2). However, the idea that Hox input is important to the morphologically specialized wing derivatives such as halteres, and not the more ancestral wings, requires examination in other insect orders. In beetles, such as Tribolium castaneum, it is the forewings that are modified ( to form elytra), while the hindwings retain a morphologically more ancestral identity. Here we show that in this beetle Ubx ' despecializes' the hindwings, which are transformed to elytra when the gene is knocked down. We also show evidence that elytra result from a Hox- free state, despite their diverged morphology. Ubx function in the hindwing seems necessary for a change in the expression of spalt, iroquois and achaete- scute homologues from elytron- like to more typical wing- like patterns. This counteracting effect of Ubx in beetle hindwings represents a previously unknown mode of wing diversification in insects.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Kansas State University; Washington University (WUSTL)	Tomoyasu, Y (corresponding author), Kansas State Univ, Div Biol, Chalmers Hall, Manhattan, KS 66506 USA.	tomoyasu@ksu.edu	Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Beeman R.W., 1990, P21; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Beeman RW, 1997, INSECT MOL BIOL, V6, P83, DOI 10.1046/j.1365-2583.1997.00159.x; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; Brown SJ, 2002, GENETICS, V160, P1067; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Curtis CD, 2001, GENESIS, V30, P12, DOI 10.1002/gene.1027; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; El-Kifl A. H., 1953, Bulletin de la Societe Fouad ler d'Entomologie, V37, P173; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; QUENNEDEY A, 1990, TISSUE CELL, V22, P721, DOI 10.1016/0040-8166(90)90067-J; SanchezSalazar J, 1996, DEV GENES EVOL, V206, P237, DOI 10.1007/s004270050049; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STUART JJ, 1991, NATURE, V350, P72, DOI 10.1038/350072a0; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wheeler SR, 2003, DEVELOPMENT, V130, P4373, DOI 10.1242/dev.00646	28	145	149	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2005	433	7026					643	647		10.1038/nature03272	http://dx.doi.org/10.1038/nature03272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703749				2022-12-24	WOS:000226862000047
J	Elion, EA; Qi, MS; Chen, WD				Elion, EA; Qi, MS; Chen, WD			Signaling specificity in yeast	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTOR; INVASIVE GROWTH; TEC1; DIFFERENTIATION		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Elion, EA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	elaine_elion@hms.harvard.edu						Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palecek SP, 2000, GENETICS, V156, P1005; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	12	44	44	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2005	307	5710					687	688		10.1126/science.1109500	http://dx.doi.org/10.1126/science.1109500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692041				2022-12-24	WOS:000226814900031
J	Storch, D; Marquet, PA; Gaston, KJ				Storch, D; Marquet, PA; Gaston, KJ			Untangling an entangled bank	SCIENCE			English	Editorial Material							BIODIVERSITY; PATTERNS		Charles Univ Prague, Ctr Theoret Study, CZ-11000 Prague 1, Czech Republic; Pontificia Univ Catolica Chile, Dept Ecol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	Charles University Prague; Pontificia Universidad Catolica de Chile; University of Sheffield	Storch, D (corresponding author), Charles Univ Prague, Ctr Theoret Study, CZ-11000 Prague 1, Czech Republic.		Marquet, Pablo A/B-7732-2009; Storch, David/C-3339-2017	Marquet, Pablo A/0000-0001-6369-9339; Storch, David/0000-0001-5967-1544				Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; *CZECH REP, 2004, SCAL BIOD; Darwin C., 1959, ORIGIN SPECIES MEANS; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Hubbell Stephen P., 2001, V32, pi; Sizling AL, 2004, ECOL LETT, V7, P60, DOI 10.1046/j.1461-0248.2003.00549.x; Storch D, 2003, SCIENCE, V299	10	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					684	686		10.1126/science.1106935	http://dx.doi.org/10.1126/science.1106935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692039				2022-12-24	WOS:000226814900029
J	Thomas, WG				Thomas, WG			Double trouble for type 1 angiotensin receptors in atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baker Heart Res Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Thomas, WG (corresponding author), Baker Heart Res Inst, Melbourne, Vic, Australia.		Thomas, Walter/I-2208-2015	Thomas, Walter/0000-0003-0685-2952				AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.	5	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					506	508		10.1056/NEJMcibr043928	http://dx.doi.org/10.1056/NEJMcibr043928			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689592				2022-12-24	WOS:000226725400015
J	Semmo, N; Barnes, E; Taylor, C; Kurtz, J; Harcourt, G; Smith, N; Klenerman, P				Semmo, N; Barnes, E; Taylor, C; Kurtz, J; Harcourt, G; Smith, N; Klenerman, P			T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors	LANCET			English	Article							INFECTION	Blood donors are routinely screened for hepatitis C virus infection. Some individuals have weak or restricted virus-specific antibody responses, and are classed as indeterminate. Such donors are almost always negative for viral RNA in blood. We postulated that previous transient virus exposure might account for some of these cases. With sensitive ex-vivo analyses of T-cell responses, we identified virus-specific responses in 15 of 30 indeterminate blood donors tested, compared with none in controls (p=0.0013). Additionally, these responses were typically focused on core. derived peptides. These findings suggest previous exposure to the virus in many indeterminate blood donors.	Univ Oxford, Oxford OX1 3SY, England; Natl Brood Serv, Birmingham, W Midlands, England	University of Oxford	Klenerman, P (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.	paul.klenerman@medawar.ox.ac.uk		Barnes, Eleanor/0000-0002-0860-0831; klenerman, paul/0000-0003-4307-9161				Barnes E, 2002, HEPATOLOGY, V36, P743, DOI 10.1053/jhep.2002.35344; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Dufour DR, 2003, CLIN CHEM, V49, P479, DOI 10.1373/49.3.479; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; *NAT BLOOD SERV IN, 2003, MONTHL DON TEST REP; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001	7	44	48	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2005	365	9456					327	329						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664228				2022-12-24	WOS:000226449600036
J	Maeda, T; Hobbs, RM; Merghoub, T; Guernah, I; Zelent, A; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP				Maeda, T; Hobbs, RM; Merghoub, T; Guernah, I; Zelent, A; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP			Role of the proto-oncogene Pokemon in cellular transformation and ARF repression	NATURE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSOR; TISSUE MICROARRAY; BMI-1 ONCOPROTEIN; GENE-EXPRESSION; CYCLE ARREST; C-MYC; LYMPHOMA; SENESCENCE	Aberrant transcriptional repression through chromatin remodelling and histone deacetylation has been postulated to represent a driving force underlying tumorigenesis because histone deacetylase inhibitors have been found to be effective in cancer treatment. However, the molecular mechanisms by which transcriptional derepression would be linked to tumour suppression are poorly understood. Here we identify the transcriptional repressor Pokemon (encoded by the Zbtb7 gene) as a critical factor in oncogenesis. Mouse embryonic fibroblasts lacking Zbtb7 are completely refractory to oncogene-mediated cellular transformation. Conversely, Pokemon overexpression leads to overt oncogenic transformation both in vitro and in vivo in transgenic mice. Pokemon can specifically repress the transcription of the tumour suppressor gene ARF through direct binding. We find that Pokemon is aberrantly overexpressed in human cancers and that its expression levels predict biological behaviour and clinical outcome. Pokemon's critical role in cellular transformation makes it an attractive target for therapeutic intervention.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Inst Canc Res, Chester Beatty Labs, Leukaemia Res Fund Ctr, London SW3 6JB, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Maeda, Takahiro/AAC-4563-2019; Zelent, Arthur/B-3532-2009; Hobbs, Robin/I-2577-2014	Maeda, Takahiro/0000-0003-4530-6460; Zelent, Arthur/0000-0002-7968-9888; Hobbs, Robin/0000-0002-3853-2614	NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102142] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONLON JA, 1977, NEW ENGL J MED, V297, P461, DOI 10.1056/NEJM197709012970901; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jaffe ES, 2001, PATHOLOGY GENETICS T; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; QUELLE DE, 1995, CELL, V83, P993; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	272	325	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					278	285		10.1038/nature03203	http://dx.doi.org/10.1038/nature03203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662416				2022-12-24	WOS:000226381300046
J	Bertone-Johnson, ER				Bertone-Johnson, ER			Epidemiology of ovarian cancer: a status report	LANCET			English	Editorial Material							FOLLOW-UP; RISK; WOMEN		Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Bertone-Johnson, ER (corresponding author), Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA.	ebertone@schoolph.umass.edu						Anderson JP, 2004, CANCER-AM CANCER SOC, V100, P1515, DOI 10.1002/cncr.20146; Barnett GL, 2004, CURR OPIN OBSTET GYN, V16, P79, DOI 10.1097/00001703-200402000-00014; Bray F, 2005, INT J CANCER, V113, P977, DOI 10.1002/ijc.20649; Engeland A, 2003, JNCI-J NATL CANCER I, V95, P1244, DOI 10.1093/jnci/djg010; Kashyap S, 2004, OBSTET GYNECOL, V103, P785, DOI 10.1097/01.AOG.0000119226.39514.1d; Kjaer SK, 2004, INT J EPIDEMIOL, V33, P596, DOI 10.1093/ije/dyh046; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Larsson SC, 2004, AM J CLIN NUTR, V80, P1353, DOI 10.1093/ajcn/80.5.1353; Purdie DM, 2003, GYNECOL ONCOL, V88, pS145, DOI 10.1006/gyno.2002.6706; Riman T, 2004, ACTA OBSTET GYN SCAN, V83, P783, DOI 10.1111/j.0001-6349.2004.00550.x	10	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					101	102		10.1016/S0140-6736(05)17716-2	http://dx.doi.org/10.1016/S0140-6736(05)17716-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639276				2022-12-24	WOS:000226170700005
J	Croxall, JP; Silk, JRD; Phillips, RA; Afanasyev, V; Briggs, DR				Croxall, JP; Silk, JRD; Phillips, RA; Afanasyev, V; Briggs, DR			Global circumnavigations: Tracking year-round ranges of nonbreeding albatrosses	SCIENCE			English	Article							AUSTRALIA; OCEAN	Although albatrosses are paradigms of oceanic specialization, their foraging areas and migration routes when not breeding remain essentially unknown. Our continuous remote tracking of 22 adult gray-headed albatrosses for over 30 bird-years reveals three distinct strategies: (i) Stay in breeding home range; (ii) make return migrations to a specific area of the southwest Indian Ocean; and (iii) make one or more global circumnavigations (the fastest in just 46 days). The consistencies in patterns, routes, and timings offer the first hope of identifying areas of critical habitat for nonbreeding albatrosses, wherein appropriate management of longline fisheries might alleviate the plight of the world's most threatened family of birds.	British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Croxall, JP (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.							Brothers N, 1998, IBIS, V140, P446, DOI 10.1111/j.1474-919X.1998.tb04606.x; Croxall JP, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P69; Huin N, 2002, AQUAT CONSERV, V12, P89, DOI 10.1002/aqc.479; NICHOLLS D, 1995, EMU, V95, P223, DOI 10.1071/MU9950223; Nicholls DG, 2002, MAR ECOL PROG SER, V231, P269, DOI 10.3354/meps231269; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Prince PA, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P137; Tickell W. L. N., 1968, Antarctic Research Series Washington, V12, P1; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068	11	228	241	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2005	307	5707					249	250		10.1126/science.1106042	http://dx.doi.org/10.1126/science.1106042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653503				2022-12-24	WOS:000226361900041
J	Papania, MJ; Strebel, PM				Papania, MJ; Strebel, PM			Measles surveillance: the importance of finding the tip of the iceberg	LANCET			English	Editorial Material							REPORTING EFFICIENCY; CITY		Ctr Dis Control & Prevent, Measles Rubella Mumps Eliminat Team, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Global Immunizat Div, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Papania, MJ (corresponding author), Ctr Dis Control & Prevent, Measles Rubella Mumps Eliminat Team, Natl Immunizat Program, Atlanta, GA 30333 USA.	mpapania@cdc.gov						CHERRY JD, 1972, J PEDIATR-US, V81, P217, DOI 10.1016/S0022-3476(72)80287-7; DAVIS SF, 1993, AM J PUBLIC HEALTH, V83, P1011, DOI 10.2105/AJPH.83.7.1011; EWERT DP, 1994, AM J PUBLIC HEALTH, V84, P868, DOI 10.2105/AJPH.84.5.868-a; EWERT DP, 1995, PUBLIC HEALTH REP, V110, P161; Harpaz R, 2004, J INFECT DIS, V189, pS185, DOI 10.1086/378501; Hinman A R, 1980, Epidemiol Rev, V2, P153; SYDENSTRICKER E., 1926, Public Health Reports, V41, P2069, DOI 10.2307/4578020; Sydenstricker E, 1926, PUBLIC HLTH REP, V41, P2186; van Isterdael CED, 2004, J CLIN EPIDEMIOL, V57, P633, DOI 10.1016/j.jclinepi.2003.11.012	9	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					100	101		10.1016/S0140-6736(05)17715-0	http://dx.doi.org/10.1016/S0140-6736(05)17715-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639275				2022-12-24	WOS:000226170700004
J	Scholes, D; Hooton, TM; Roberts, PL; Gupta, K; Stapleton, AE; Stamm, WE				Scholes, D; Hooton, TM; Roberts, PL; Gupta, K; Stapleton, AE; Stamm, WE			Risk factors associated with acute pyelonephritis in healthy women	ANNALS OF INTERNAL MEDICINE			English	Article							URINARY-TRACT-INFECTION; SPERMICIDE-COATED CONDOMS; POSTMENOPAUSAL WOMEN; YOUNG-WOMEN; ESCHERICHIA-COLI; ASYMPTOMATIC BACTERIURIA; SEXUAL-ACTIVITY; HOSPITALIZATION; PREVALENCE; CYSTITIS	Background: Although most cases of acute pyelonephritis occur in otherwise healthy women, data on risk factors for this condition are lacking. Objective: To evaluate infection characteristics, incidence, and risk factors associated with acute pyelonephritis in a sample of women. Design: Population-based case-control study. Setting: Group Health Cooperative, a prepaid health plan in Washington. Participants: 788 nonpregnant women, 18 to 49 years of age. Case-patients (n = 242) were women with pyelonephritis who were identified from computerized databases. Controls were 546 similar-age women with no pyelonephritis diagnosis in the previous 5 years who were randomly selected from enrollment databases. Response rates for case-patients and controls were 73% and 64%, respectively. Measurements: Characteristics of infection and potential risk factors for pyelonephritis, ascertained through computer-assisted telephone interview and computerized databases. Results: 7% of case-patients were hospitalized. Escherichia coli was the infecting pathogen in 85% of cases. In multivariable models, factors associated with pyelonephritis risk were frequency of sexual intercourse in the previous 30 days (odds ratio, 5.6 [95% CI, 2.8 to 11.0] for >= 3 times per week), recent urinary tract infection (UTI) (odds ratio, 4.4 [CI, 2.8 to 7.1]), diabetes (odds ratio, 4.1 [CI, 1.6 to 10.9]), recent incontinence (odds ratio, 3.9 [CI. 2.6 to 5.9]), new sexual partner in the previous year (odds ratio, 2.2 [CI, 1.4 to 3.6]), recent spermicide use (odds ratio, 1.7 [CI, 1.1 to 2.8]), and UTI history in the participant's mother (odds ratio, 1.6 [CI, 1.1 to 2.5]). Risk factors for selected subgroups (patients <= 30 years of age, patients > 30 years of age, patients with no UTI history, and inpatients) were also evaluated. Limitations: Potential recall bias, reliance on automated case definition criteria, and limited data on diabetes and incontinence variables. Conclusions: Few nonpregnant, community-dwelling women younger than 50 years of age with pyelonephritis are hospitalized. As with cystitis in reproductive-age women, sexual behaviors and patient and family history of UTI are associated with increased pyelonephritis risk. Diabetes and incontinence also seem to independently increase the risk for pyelonephritis.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle	Scholes, D (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,16th Floor, Seattle, WA 98101 USA.	scholes.d@ghc.org	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002660, R01DK062863, P01DK053369] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK053369-019001, P01 DK053369-020002, 1 PO DK53369, R01 DK062863-02, P01 DK053369, K23 DK002660, P01 DK053369-029001, P01 DK053369-07, K23 DK02660, P01 DK053369-010002, R01 DK062863, P01 DK053369-06A1, R01 DK062863-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; Brown, 2000, Curr Infect Dis Rep, V2, P513, DOI 10.1007/s11908-000-0054-4; Brown JS, 2001, OBSTET GYNECOL, V98, P1045, DOI 10.1016/S0029-7844(01)01630-1; Fihn SD, 1996, AM J EPIDEMIOL, V144, P512, DOI 10.1093/oxfordjournals.aje.a008958; Fihn SD, 1998, ARCH INTERN MED, V158, P281, DOI 10.1001/archinte.158.3.281; Foxman B, 2003, ANN EPIDEMIOL, V13, P144, DOI 10.1016/S1047-2797(02)00272-7; FOXMAN B, 1995, EPIDEMIOLOGY, V6, P162, DOI 10.1097/00001648-199503000-00013; Foxman B, 2001, J CLIN EPIDEMIOL, V54, P710, DOI 10.1016/S0895-4356(00)00352-8; Geerlings SE, 2002, DIABETES CARE, V25, P1405, DOI 10.2337/diacare.25.8.1405; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; Hu KK, 2004, ARCH INTERN MED, V164, P989, DOI 10.1001/archinte.164.9.989; Nicolle LE, 1996, CLIN INFECT DIS, V22, P1051, DOI 10.1093/clinids/22.6.1051; Nicolle LE, 1997, URINARY TRACT INFECT, P8; Pabich WL, 2003, J INFECT DIS, V188, P1054, DOI 10.1086/378203; Raz R, 1999, INFECT DIS CLIN PRAC, V8, P335, DOI 10.1097/00019048-199909000-00011; Raz R, 2000, CLIN INFECT DIS, V30, P152, DOI 10.1086/313596; RUBIN RH, 1992, CLIN INFECT DIS, V15, pS216, DOI 10.1093/clind/15.Supplement_1.S216; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; STROM BL, 1987, ANN INTERN MED, V107, P816, DOI 10.7326/0003-4819-107-6-816; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427	27	129	133	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2005	142	1					20	27		10.7326/0003-4819-142-1-200501040-00008	http://dx.doi.org/10.7326/0003-4819-142-1-200501040-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916DS	15630106	Green Accepted			2022-12-24	WOS:000228366200003
J	Vanhorebeek, I; De Vos, R; Mesotten, D; Wouters, PJ; De Wolf-Peeters, C; Van den Berghe, G				Vanhorebeek, I; De Vos, R; Mesotten, D; Wouters, PJ; De Wolf-Peeters, C; Van den Berghe, G			Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients	LANCET			English	Article							OXIDATIVE STRESS; CRITICAL ILLNESS; ORGAN DYSFUNCTION; MODEL; THERAPY; PHOSPHORYLATION; SEVERITY; MUSCLE; LIPIDS; DAMAGE	Background Maintenance of normoglycaemia by use of insulin reduces morbidity and mortality of patients in surgical intensive care. Studies on mitochondrial function in critical illness or diabetes suggest that effects of intensive insulin therapy on mitochondrial integrity contribute to the clinical benefits. Methods Enzyme activities of the respiratory-chain complexes and oxidative-stress-sensitive glyceraldehyde-3. phosphate dehydrogenase (GAPDH) were measured by spectrophotometry in 36 snap-frozen samples of liver and skeletal muscle obtained after death from patients who had been randomly assigned intensive (normoglycaemia) or conventional (hyperglycaemia) insulin therapy and who were similar in terms of admission diagnoses and causes of death. Mitochondrial ultrastructure was examined by electron microscopy in a random subgroup (n=20). Findings In the liver, hypertrophic mitochondria with an increased number of abnormal and irregular cristae and reduced matrix electron density were observed in seven of nine conventionally treated patients. Only one of 11 patients given intensive insulin treatment had these morphological abnormalities (p=0.005). The effect on ultrastructure was associated with higher activities of respiratory-chain complex I (median 1.53 [IQR 1.14-3.01] vs 0.81 [0.54-1.43] U/g liver; p=0.008) and complex IV (1.69 [1.40-1.97] vs 1.16 [0.97-1.40] U/g; p=0.008) in the intensive group than in the conventional group. There was no detectable difference in GAPDH activity. In skeletal muscle, mitochondrial ultrastructure and function were not affected by intensive insulin therapy. Interpretation Strict glycaemic control with intensive insulin therapy prevented or reversed ultrastructural and functional abnormalities of hepatocyte mitochondria. The lack of effect on skeletal-muscle mitochondria suggests a direct effect of glucose toxicity and glucose control, rather than of insulin, as the likely explanation. Relevance to practice Maintenance or restoration of mitochondrial function and cellular energetics is another therapeutic target, in addition to optimisation of cardiac output, systemic oxygen delivery, and regional blood flow, that might improve outcome for critically ill patients. Our findings could help to explain the mechanism underlying the reduction in mortality found when normoglycaemia was maintained with insulin, and further support use of intensive insulin therapy in this setting.	Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium; Catholic Univ Louvain, Dept Morphol & Mol Pathol, B-3000 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Van den Berghe, G (corresponding author), Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium.	greta.vandenberghe@med.kuleuven.ac.be	Mesotten, Dieter/ABE-4176-2020; Van den Berghe, Greet/J-6788-2018	Mesotten, Dieter/0000-0002-3258-4720; Van den Berghe, Greet/0000-0002-5320-1362; Vanhorebeek, Ilse/0000-0002-5261-5192				Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; BERGMEYER HU, 1985, METHOD ENZYMAT AN, P211; Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427; Bonnefont-Rousselot D, 2002, CURR OPIN CLIN NUTR, V5, P561, DOI 10.1097/00075197-200209000-00016; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BREALEY DA, 2003, 16 ANN C AMST NETH O, pS134; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bulger EM, 2001, ARCH SURG-CHICAGO, V136, P1201, DOI 10.1001/archsurg.136.10.1201; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Fink MP, 2002, INTENS CARE MED, V28, P369, DOI 10.1007/s00134-001-1205-2; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; HALL JC, 1960, J BIOL CHEM, V235, P1536; HALL JC, 1960, J BIOL CHEM, V235, P6; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Mesotten D, 2004, J CLIN ENDOCR METAB, V89, P219, DOI 10.1210/jc.2003-030760; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Munnich A., 2001, METABOLIC MOL BASES, P2261; Oldham KM, 1998, J AM DIET ASSOC, V98, P1001, DOI 10.1016/S0002-8223(98)00230-2; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; RINEHART RW, 1982, ARCH BIOCHEM BIOPHYS, V213, P341, DOI 10.1016/0003-9861(82)90559-8; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Tomita M, 1996, JPN CIRC J, V60, P673, DOI 10.1253/jcj.60.673; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VESTER JW, 1957, J BIOL CHEM, V227, P669; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Wolfe RR, 2000, WORLD J SURG, V24, P639, DOI 10.1007/s002689910105	35	312	336	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					53	59		10.1016/S0140-6736(04)17665-4	http://dx.doi.org/10.1016/S0140-6736(04)17665-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639679				2022-12-24	WOS:000226213100028
J	Tinetti, ME; Bogardus, ST; Agostini, JV				Tinetti, ME; Bogardus, ST; Agostini, JV			Potential pitfalls of disease-specific guidelines for patients with multiple conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; ADVERSE DRUG EVENTS; RANDOMIZED-TRIALS; STATEMENT; THERAPY; DOCTORS; QUALITY; ADULT		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.				NATIONAL INSTITUTE ON AGING [P60AG010469] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; BERENSON RA, 2003, CONFRONTING BARRIERS; Berry DC, 1997, PSYCHOL HEALTH, V12, P467, DOI 10.1080/08870449708406723; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Elwyn G, 2003, BMJ-BRIT MED J, V327, P864, DOI 10.1136/bmj.327.7419.864; Epstein RM, 2004, JAMA-J AM MED ASSOC, V291, P2359, DOI 10.1001/jama.291.19.2359; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gross CP, 2002, ANN INTERN MED, V137, P10, DOI 10.7326/0003-4819-137-1-200207020-00007; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; Haynes RB, 1996, LANCET, V348, P383; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Institute of Medicine, 2001, CROSSING QUALITY CHA; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Lewis DK, 2003, BMJ-BRIT MED J, V327, P841, DOI 10.1136/bmj.327.7419.841; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; *NAT COMM QUAL ASS, 2003, STAT HLTH CAR QUAL 2; National Osteoporosis Foundation, 1999, PHYS GUID PREV TREAT; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Smith SC, 2001, CIRCULATION, V104, P1577, DOI 10.1161/hc3801.097475; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Townsend A, 2003, BRIT MED J, V327, P837, DOI 10.1136/bmj.327.7419.837; Tsevat J, 1998, JAMA-J AM MED ASSOC, V279, P371, DOI 10.1001/jama.279.5.371; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	31	615	618	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2004	351	27					2870	2874		10.1056/NEJMsb042458	http://dx.doi.org/10.1056/NEJMsb042458			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	883IH	15625341				2022-12-24	WOS:000226004300017
J	Chen, CL; Hsu, LI; Chiou, HY; Hsueh, YM; Chen, SY; Wu, MM; Chen, CJ				Chen, CL; Hsu, LI; Chiou, HY; Hsueh, YM; Chen, SY; Wu, MM; Chen, CJ		Blackfoot Dis Study Grp	Ingested arsenic, cigarette smoking, and lung cancer risk - A follow-up study in arseniasis-endemic areas in Taiwan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; DISEASE	Context Arsenic has been documented as a lung carcinogen in humans in only a few follow-up studies, which were limited by a small number of cases or the lack of information on cigarette smoking. Objectives To elucidate the dose-response relationship between ingested arsenic and lung cancer and to assess the effect of cigarette smoking on the arsenic-lung cancer association. Design, Setting, and Participants A total of 2503 residents in southwestern and 8088 in northeastern arseniasis-endemic areas in Taiwan were followed up for an average period of 8 years. Information on arsenic exposure, cigarette smoking, and other risk factors was collected at enrollment through standardized questionnaire interview. Main Outcome Measures The incidence of lung cancer was ascertained through linkage with national cancer registry profiles in Taiwan (January 1985-December 2000). The joint effect of arsenic and cigarette smoking was estimated by both etiologic fraction and synergy index. Results There were 139 newly diagnosed lung cancer cases during a follow-up period of 83 783 person-years. After adjustment for cigarette smoking and other risk factors, there was a monotonic trend of lung cancer risk by arsenic level in drinking water of less than 10 to 700 mug/L or more (P<.001). The relative risk was 3.29 (95% confidence interval, 1.60-6.78) for the highest arsenic level compared with the lowest. The etiologic fraction of lung cancer attributable to the joint exposure of ingested arsenic and cigarette smoking ranged from 32% to 55%. The synergy indices ranged from 1.62 to 2.52, indicating a synergistic effect of ingested arsenic and cigarette smoking on lung cancer. Conclusions There was a significant dose-response trend of ingested arsenic on lung cancer risk, which was more prominent among cigarette smokers. The risk assessment of lung cancer induced by ingested arsenic should take cigarette smoking into consideration.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10018, Taiwan; Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; Natl Hlth Res Inst, Div Biostat & Bioinformat, Taipei, Taiwan	National Taiwan University; Taipei Medical University; National Health Research Institutes - Taiwan	Chen, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, 1 Jen Ai Rd,Sect 1, Taipei 10018, Taiwan.	cjchen@ha.mc.ntu.edu.tw	Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Chiou, Hung Yi/0000-0002-4545-9697				BLACKWELL R. QUENTIN, 1961, JOUR FORMOSAN MED ASSOC, V60, P1143; BOYLE P, 1995, LUNG CANCER, V12, P167, DOI 10.1016/0169-5002(95)00443-5; Chen KP, 1962, MEMOIRS COLLEGE MED, V8, P115; Chiou HY, 1997, STROKE, V28, P1717, DOI 10.1161/01.STR.28.9.1717; HERTZPICCIOTTO I, 1992, EPIDEMIOLOGY, V3, P23, DOI 10.1097/00001648-199201000-00006; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; *INT AG RES CANC, 1980, IARC MON EV CARC RIS, V23, P139; Kuo T.L., 1964, REPORTS I PATHOLOGY, V20, P7; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; LO MC, 1977, 2 TAIW PROV I ENV SA; MACCARTHY P, 1987, ANAL CHEM, V59, pR308, DOI 10.1021/ac00139a017; Natelson S, 1961, MICROTECHNIQUES CLIN, V2nd, P113; Tseng W. P., 1961, MEMOIRS NATIONAL TAI, V7, P1; WALKER AM, 1981, INT J EPIDEMIOL, V10, P81, DOI 10.1093/ije/10.1.81; *WHO INT PROGR SOU, 2001, ARS ARS COMP	15	196	200	2	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2984	2990		10.1001/jama.292.24.2984	http://dx.doi.org/10.1001/jama.292.24.2984			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613666	Bronze			2022-12-24	WOS:000225841900032
J	Young, DC; Hade, EM				Young, DC; Hade, EM			Holidays, birthdays, and postponement of cancer death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; OCCASIONS; SURVIVAL	Context Articles in the medical literature and lay press have supported a belief that individuals, including those dying of cancer, can temporarily postpone their death to survive a major holiday or other significant event, but results and effects have been variable. Objective To determine whether, for the patient dying of cancer, a "death takes a holiday" effect showing a reduction in deaths in the week before a significant event was associated with Christmas, the US holiday of Thanksgiving, or the date of the individual's birthday. Design, Setting, and Subjects Analysis of death certificate data for all 1269474 persons dying in Ohio from 1989-2000, including 309221 persons dying with cancer noted as the leading cause of death. Main Outcome Measure We measured the total number of cancer deaths in the 2 weeks centered on the event of interest and the proportion of these deaths that occurred in the week before the event to determine whether this proportion was significantly different from 0.5 by using an exact binomial test. Results The proportion of persons dying of cancer in the week before Christmas, Thanksgiving, and the individual's birthday was not significantly different from the proportion dying in the week after the event (P=.52, .26, and .06, respectively). However, among black individuals there was an increase in cancer deaths in the week before Thanksgiving (P=.01), whereas women showed an increase in cancer deaths in the week before their birthday (P=.05). There was no statistically significant excess of deaths in the postevent week in any subgroup. Conclusion We found no evidence, in contrast to previous studies, that cancer patients are able to postpone their deaths to survive significant religious, social, or personal events.	Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Young, DC (corresponding author), Ohio State Univ, Ctr Comprehens Canc, M410 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	young-8@medctr.osu.edu		Hade, Erinn/0000-0001-8977-6443	NCI NIH HHS [P30CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anson J, 2001, SOC SCI MED, V52, P83, DOI 10.1016/S0277-9536(00)00125-8; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063; IDLER EL, 1992, AM J SOCIOL, V97, P1052, DOI 10.1086/229861; Keatinge W R, 2002, Int J Circumpolar Health, V61, P292; Kosmin B. A., 2001, AM RELIG IDENTIFICAT; Lee P, 2000, SOC BIOL, V47, P127; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; PHILLIPS DP, 1973, AM SOCIOL REV, V38, P678, DOI 10.2307/2094131; PHILLIPS DP, 1992, PSYCHOSOM MED, V54, P532, DOI 10.1097/00006842-199209000-00001; PYLE E, 2004, COLUMBUS DISPATCH, V133, pA1; Schofield P, 2004, CANCER-AM CANCER SOC, V100, P1276, DOI 10.1002/cncr.20076; Seretakis D, 1997, JAMA-J AM MED ASSOC, V278, P1012, DOI 10.1001/jama.278.12.1012; Skala JA, 2004, PSYCHOSOM MED, V66, P382, DOI 10.1097/01.psy.0000127874.31062.4e; Smith G, 2004, PSYCHOSOM MED, V66, P378, DOI 10.1097/01.psy.0000127875.38685.ba; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124	18	27	27	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3012	3016		10.1001/jama.292.24.3012	http://dx.doi.org/10.1001/jama.292.24.3012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613670				2022-12-24	WOS:000225841900036
J	Liebeschuetz, S; Bamber, S; Ewer, K; Deeks, J; Pathan, AA; Lalvani, A				Liebeschuetz, S; Bamber, S; Ewer, K; Deeks, J; Pathan, AA; Lalvani, A			Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; TYPE-1 INFECTION; ZAMBIAN CHILDREN; RAPID DETECTION; HIV-INFECTION; ENUMERATION; SEROPREVALENCE; POPULATION	Background Childhood tuberculosis often presents non-specifically and is a common differential diagnosis in high prevalence areas. Current diagnostic tools have poor sensitivity and cannot reliably exclude tuberculosis, so overdiagnosis is common. HIV co-infection exacerbates this problem and accounts for an increasing proportion of paediatric tuberculosis worldwide. Methods We assessed the usefulness of a T-cell-based rapid blood test for Mycobacterium tuberculosis infection, the enzyme-linked immunospot assay (ELISPOT), in routine clinical practice. We did a prospective blinded study of 293 African children with suspected tuberculosis in kwaZulu-Natal, a region with high HIV prevalence. Children had full clinical assessment, ELISPOT, and a tuberculin skin test. Test results were compared with final clinical and microbiological diagnoses. Results In children with tuberculosis, sensitivity of ELISPOT was 83% (95% Cl 75-89, n=133), significantly higher (p<0.001) than the 63% (54-72) sensitivity of tuberculin skin test (n=116). Sensitivity of tuberculin skin test fell significantly in children younger than 3 years (to 51%), with HIV co-infection (36%), or with malnutrition (44%). Sensitivity of ELISPOT, which was not significantly adversely affected by these factors, was 85%, 73%, and 78%, respectively in these subgroups. In 116 children with both test results available, sensitivity of the two tests combined was 91% (85-95). Conclusions Diagnostic sensitivity of ELISPOT is higher than that of the skin test and is less affected by factors frequently associated with childhood tuberculosis in developing countries. Used together with the skin test, ELISPOT provides a clinically useful diagnostic sensitivity in African children with suspected tuberculosis.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Ngwelezana Hosp, Empangeni, KwaZulu Natal, South Africa; Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Level 7, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Ewer, Katie J/B-4328-2011; Deeks, Jon/AAV-5745-2020	Ewer, Katie J/0000-0001-9827-9836; Deeks, Jon/0000-0002-8850-1971; Lalvani, Ajit/0000-0002-2396-246X				[Anonymous], 1998, S AFRICA DEMOGRAPHIC; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; CHINTU C, 1993, PEDIATR INFECT DIS J, V12, P499, DOI 10.1097/00006454-199306000-00008; Coovadia HM, 1998, INT J TUBERC LUNG D, V2, P844; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; DONALD PR, 1985, S AFR MED J, V67, P588; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FOURIE PB, 1983, TUBERCLE, V64, P167, DOI 10.1016/0041-3879(83)90012-0; Girardi E, 2000, AIDS, V14, pS47; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Horwood C, 2003, B WORLD HEALTH ORGAN, V81, P858; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Jeena PM, 1996, TUBERCLE LUNG DIS, V77, P437, DOI 10.1016/S0962-8479(96)90117-3; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Lockman S, 1999, INT J TUBERC LUNG D, V3, P23; LUO C, 1994, TUBERCLE LUNG DIS, V75, P110, DOI 10.1016/0962-8479(94)90039-6; Madhi SA, 2000, INT J TUBERC LUNG D, V4, P448; Mukadi YD, 1997, AIDS, V11, P1151, DOI 10.1097/00002030-199709000-00011; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; RAVIGLIONE MC, 1997, AIDS, V11, P115; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305	33	288	315	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2196	2203		10.1016/S0140-6736(04)17592-2	http://dx.doi.org/10.1016/S0140-6736(04)17592-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610806				2022-12-24	WOS:000225799700028
J	Rugg-Gunn, FJ; Simister, RJ; Squirrell, M; Holdright, DR; Duncan, JS				Rugg-Gunn, FJ; Simister, RJ; Squirrell, M; Holdright, DR; Duncan, JS			Cardiac arrhythmias in focal epilepsy: a prospective long-term study	LANCET			English	Article							SUDDEN UNEXPECTED DEATH; HEART-RATE; ECG ABNORMALITIES; ICTAL BRADYCARDIA; RISK-FACTORS; SEIZURES; VARIABILITY; PREVALENCE; MODULATION; DIAGNOSIS	Background Patients with epilepsy are at risk of sudden unexpected death. Neurogenic cardiac arrhythmias have been postulated as a cause. Electrocardiograms (ECG) can be monitored by use of an implantable loop recorder for up to 18 months. We aimed to determine the frequency of cardiac arrhythmias in patients with refractory focal seizures over an extended period. Methods 20 patients received an implantable loop recorder at one hospital in the UK. Devices were programmed to record automatically if bradycardia (<40 beats per min) or tachycardia (>140 beats per min) were detected. Additionally, in the event of a seizure, patients and relatives could initiate ECG recording with an external activator device. Data were analysed at regular intervals and correlated with seizure diaries. Findings More than 220 000 patient-hours were monitored over 24 months, during which ECGs were captured on implantable loop recorders in 377 seizures. One patient withdrew from the study. In 16 patients, median heart rate during habitual seizures exceeded 100 beats per min. Ictal bradycardia (<40 beats per min) was rare, occurring in eight (2.1%) recorded events, in seven patients. Four patients (21%) had bradycardia or periods of asystole with subsequent permanent pacemaker insertion. Three of these four (16% of total) had potentially fatal asystole. Interpretation Clinical characteristics of patients with peri-ictal cardiac abnormalities are closely similar to those at greatest risk of sudden unexpected death in epilepsy. Asystole might underlie many of these deaths, which would have important implications for the investigation of similar patients and affect present cardiac-pacing policies.	UCL, Neurol Inst, Dept Clin & Expt Epilepsy, London, England; UCL, Natl Soc Epilepsy, London, England; UCL Hosp, Heart Hosp, Dept Cardiol, London, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Duncan, JS (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	j.duncan@ion.ucl.ac.uk		Duncan, John S/0000-0002-1373-0681; Simister, Robert/0000-0003-0578-6711	Medical Research Council [G9805989] Funding Source: Medline; MRC [G9805989] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ansakorpi H, 2002, J NEUROL NEUROSUR PS, V72, P26, DOI 10.1136/jnnp.72.1.26; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; Bigger JT, 1996, CIRCULATION, V93, P2142, DOI 10.1161/01.CIR.93.12.2142; BJORNSTAD H, 1994, CARDIOLOGY, V84, P42, DOI 10.1159/000176327; BLUMHARDT LD, 1986, LANCET, V1, P1051; Camm AJ, 1996, CIRCULATION, V93, P1043; Darbin O, 2002, EPILEPSIA, V43, P336, DOI 10.1046/j.1528-1157.2002.34801.x; Hennessy MJ, 2001, NEUROLOGY, V57, P1650, DOI 10.1212/WNL.57.9.1650; Hilz MJ, 2002, BRAIN, V125, P985, DOI 10.1093/brain/awf092; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; JOHNSTON SC, 1995, ANN NEUROL, V37, P531, DOI 10.1002/ana.410370416; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2001, ANN NEUROL, V49, P336; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; MAMELI O, 1993, EPILEPSY RES, V15, P171, DOI 10.1016/0920-1211(93)90053-A; Naritoku DK, 2003, EPILEPSIA, V44, P912, DOI 10.1046/j.1528-1157.2003.48302.x; Nashef L, 1996, J NEUROL NEUROSUR PS, V60, P297, DOI 10.1136/jnnp.60.3.297; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; Nashef L, 1996, LANCET, V348, P1324, DOI 10.1016/S0140-6736(05)65402-5; Nei M, 2000, EPILEPSIA, V41, P542, DOI 10.1111/j.1528-1157.2000.tb00207.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Opherk C, 2002, EPILEPSY RES, V52, P117, DOI 10.1016/S0920-1211(02)00215-2; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pedley TA, 2002, LANCET, V359, P1790, DOI 10.1016/S0140-6736(02)08726-3; Reeves AL, 1996, EPILEPSIA, V37, P983, DOI 10.1111/j.1528-1157.1996.tb00536.x; Rocamora R, 2003, EPILEPSIA, V44, P179, DOI 10.1046/j.1528-1157.2003.15101.x; Rugg-Gunn FJ, 2000, J NEUROL NEUROSUR PS, V68, P108, DOI 10.1136/jnnp.68.1.108; SLEIGHT P, 1995, CLIN SCI, V88, P103, DOI 10.1042/cs0880103; SWARTZ CM, 1994, J NEUROL NEUROSUR PS, V57, P97, DOI 10.1136/jnnp.57.1.97; TERRENCE CF, 1981, ANN NEUROL, V9, P458, DOI 10.1002/ana.410090508; Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4; Tinuper P, 2001, BRAIN, V124, P2361, DOI 10.1093/brain/124.12.2361; Walczak T, 2003, DRUG SAFETY, V26, P673, DOI 10.2165/00002018-200326100-00001; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; WANNAMAKER BB, 1985, EPILEPSIA, V26, pS31, DOI 10.1111/j.1528-1157.1985.tb05722.x; Zaidi A, 1999, SEIZURE-EUR J EPILEP, V8, P184, DOI 10.1053/seiz.1998.0261; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zijlmans M, 2002, EPILEPSIA, V43, P847, DOI 10.1046/j.1528-1157.2002.37801.x	40	256	303	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2212	2219		10.1016/S0140-6736(04)17594-6	http://dx.doi.org/10.1016/S0140-6736(04)17594-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610808				2022-12-24	WOS:000225799700030
J	Fish, J; Raule, N; Attardi, G				Fish, J; Raule, N; Attardi, G			Discovery of a major D-loop replication origin reveals two modes of human mtDNA synthesis	SCIENCE			English	Article							MITOCHONDRIAL-DNA REPLICATION; MOUSE L-CELLS; SEQUENCE; BUBBLE; BURST; REGION	Mammalian mitochondrial DNA mtDNA, replication has long been considered to occur by asymmetric synthesis of the two strands, starting at the multiple origins of the strand-displacement loop (D-loop). We report the discovery of a major replication origin at position 57 in the D-loop of several human cell lines (HeLa, A549, and 143B.TK-) and immortalized lymphocytes. The nascent chains starting at this origin, in contrast to those initiated at the previously described origins, do not terminate prematurely at the 3' end of the D-loop but proceed well beyond this control point, behaving as "true" replicating strands. This origin is mainly responsible for mtDNA maintenance under steady-state conditions, whereas mtDNA synthesis from the formerly identified D-loop origins may be more important for recovery after mtDNA depletion and for accelerating mtDNA replication in response to physiological demands.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Attardi, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	attardi@cattech.edu		Fish, Jennifer/0000-0002-2654-2583	NIGMS NIH HHS [GM11726] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6; Kai Y, 1999, BBA-GENE STRUCT EXPR, V1446, P126, DOI 10.1016/S0167-4781(99)00015-9; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891; Ohsato T, 1999, BIOCHEM BIOPH RES CO, V255, P1, DOI 10.1006/bbrc.1998.0133; ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737; WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	22	92	97	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2098	2101		10.1126/science.1102077	http://dx.doi.org/10.1126/science.1102077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604407				2022-12-24	WOS:000225841000064
J	Kim, MY; Mauro, S; Gevry, N; Lis, JT; Kraus, WL				Kim, MY; Mauro, S; Gevry, N; Lis, JT; Kraus, WL			NAD(+)-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1	CELL			English	Article							POLY(ADP-RIBOSE) POLYMERASE; HISTONE; DNA; CATALYSIS; DOMAINS; H-1; ACF	PARP-1 is the most abundantly expressed member of a family of proteins that catalyze the transfer of ADPribose units from NAD(+) to target proteins. Herein, we describe previously uncharacterized nucleosome binding properties of PARP-1 that promote the formation of compact, transcriptionally repressed chromatin structures. PARP-1 binds in a specific manner to nucleosomes and modulates chromatin structure through NAD(+)-dependent automodification, without modifying core histories or promoting the disassembly of nucleosomes. The automodification activity of PARP-1 is potently stimulated by nucleosomes, causing the release of PARP-1 from chromatin. The NAD+-dependent activities of PARP-1 are reversed by PARG, a poly(ADPribose) glycohydrolase, and are inhibited by ATP. In vivo, PARP-1 incorporation is associated with transcriptionally repressed chromatin domains that are spatially distinct from both histone H1-repressed domains and actively transcribed regions. Thus, PARP-1 functions both as a structural component of chromatin and a modulator of chromatin structure through its intrinsic enzymatic activity.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	wlk5@cornell.edu	Kim, Mi Young/C-1829-2011		NIDDK NIH HHS [DK58110, R01 DK069710, DK069710] Funding Source: Medline; NIGMS NIH HHS [GM25232] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069710, R01DK069710, R01DK058110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Cheung E, 2002, MOL CELL BIOL, V22, P2463, DOI 10.1128/MCB.22.8.2463-2471.2002; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; GRADWOHL G, 1987, BIOCHEM BIOPH RES CO, V148, P913, DOI 10.1016/S0006-291X(87)80219-X; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; HOM PJ, 2002, SCIENCE, V297, P1824; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1996, MOL CELL BIOL, V16, P3112; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P9146, DOI 10.1073/pnas.95.16.9146; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kraus WL, 1999, STEROID NUCL RECEPTO, P167; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Lis JT, 2000, GENE DEV, V14, P792; LOETSCHER P, 1987, P NATL ACAD SCI USA, V84, P1286, DOI 10.1073/pnas.84.5.1286; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; OGATA N, 1981, J BIOL CHEM, V256, P4135; PARANJPE AC, 1995, WORLD PSYCHOL, V1, P9; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; ROLLI V, 2000, DNA DAMAGE STRESS SI, P335; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; WILLIAMS GT, 1985, EXP CELL RES, V160, P419, DOI 10.1016/0014-4827(85)90189-2; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zhang QH, 2002, SCIENCE, V295, P1895	41	434	440	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					803	814		10.1016/j.cell.2004.11.002	http://dx.doi.org/10.1016/j.cell.2004.11.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607977	Bronze			2022-12-24	WOS:000225907200011
J	Whalen, PJ; Kagan, J; Cook, RG; Davis, FC; Kim, H; Polis, S; McLaren, DG; Somerville, LH; McLean, AA; Maxwell, JS; Johnstone, T				Whalen, PJ; Kagan, J; Cook, RG; Davis, FC; Kim, H; Polis, S; McLaren, DG; Somerville, LH; McLean, AA; Maxwell, JS; Johnstone, T			Human amygdala responsivity to masked fearful eye whites	SCIENCE			English	Article							EXPRESSIONS; FACES		Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Wisconsin, Waisman Ctr, WM Keck Lab Brain Imaging & Behav, Madison, WI 53706 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Tufts Univ, Dept Psychol, Medford, MA 02155 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Tufts University; Dartmouth College	Whalen, PJ (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	pwhaten@wisc.edu	McLaren, Donald/G-9906-2011; Maxwell, Jeffrey/D-2482-2009; Johnstone, Tom/C-5909-2011	Johnstone, Tom/0000-0001-8635-8158	PHS HHS [069315, 01866] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADOLPHS R, IN PRESS NATURE; Ekman P., 1976, PICTURES FACIAL AFFE; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; KIM H, IN PRESS J COGN NEUR; LeDoux J. E., 1996, EMOTIONAL BRAIN; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	10	549	563	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2061	2061		10.1126/science.1103617	http://dx.doi.org/10.1126/science.1103617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604401				2022-12-24	WOS:000225841000053
J	Reid, PC; Mukri, F				Reid, PC; Mukri, F			Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIAL; OUTCOMES; AUDIT		Luton & Dunstable Hosp NHS Trust, Directorate Obstet & Gynaecol, Luton LU4 0DZ, Beds, England		Reid, PC (corresponding author), Luton & Dunstable Hosp NHS Trust, Directorate Obstet & Gynaecol, Luton LU4 0DZ, Beds, England.	Peter.Reid@ldh-tr.anglox.nhs.uk						COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Fender GRK, 2001, BRIT MED J, V322, P523, DOI 10.1136/bmj.322.7285.523; Grant A, 1999, BRIT J OBSTET GYNAEC, V106, P360; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Kennedy A D M, 2003, Health Technol Assess, V7, P1	5	67	68	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					938	939		10.1136/bmj.38376.505382.AE	http://dx.doi.org/10.1136/bmj.38376.505382.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15695496	Green Published, Bronze			2022-12-24	WOS:000228715900020
J	Basso, O; Olsen, J				Basso, O; Olsen, J			Subfecundity and neonatal mortality: longitudinal study within the Danish national birth cohort	BRITISH MEDICAL JOURNAL			English	Article							PRETERM DELIVERY		Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus, Denmark	Aarhus University	Basso, O (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus, Denmark.	bassoo2@niehs.nih.gov	Basso, Olga/E-5384-2010	Basso, Olga/0000-0001-9298-4921				Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; OLIVENNES F, 1993, HUM REPROD, V8, P1297, DOI 10.1093/oxfordjournals.humrep.a138245; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201	5	40	42	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2005	330	7488					393	394		10.1136/bmj.38336.616806.8F	http://dx.doi.org/10.1136/bmj.38336.616806.8F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15695499	Green Published, Bronze			2022-12-24	WOS:000227220400018
J	Ruxin, J; Paluzzi, JE; Wilson, PA; Tozan, Y; Kruk, M; Teklehaimanot, A				Ruxin, J; Paluzzi, JE; Wilson, PA; Tozan, Y; Kruk, M; Teklehaimanot, A			Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines	LANCET			English	Article									Columbia Univ, Mailman Sch Publ Hlth, Ctr Global Hlth & Econ Dev, New York, NY 10027 USA; Columbia Univ, Earth Inst, New York, NY 10027 USA; Partners Hlth, Boston, MA USA; UN Millennium Project Secretariat, New York, NY USA	Columbia University; Columbia University; Partners Healthcare System	Ruxin, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Global Hlth & Econ Dev, 215 W 125th St, New York, NY 10027 USA.	jnr4@columbia.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432				[Anonymous], 2004, HUM RES HLTH OV CRIS; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Chen XY, 2004, LANCET, V364, P417; *GFATM, GFATM PROGR REP; *GLOB HIV PREV WOR, HIV PREV ER EXP TREA; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; STOP TB, 2004, PARTNERSHIP PROGR RE; *UN MILL PROJ, 2005, COMB AIDS DEV WORLD; *UN MILL PROJ, 2005, COM GRIPS MAL NEW MI; UN Millennium Project, 2005, PRESCR HLTH DEV INCR; UN Millennium Project 2005, 2005, INV STRAT REV GLOB I; *UNAIDS, 2004, 2004 REP GLOB HIV AI; WHO, WORLD MED SIT; *WHO, 2000, TECHN REP SER WHO, V892; *WHO, 2004, 3 WHO; World Health Organization, 2004, Wkly Epidemiol Rec, V79, P6	17	28	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					618	621						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708108				2022-12-24	WOS:000226984300037
J	Hagel, BE; Pless, IB; Goulet, C; Platt, RW; Robitaille, Y				Hagel, BE; Pless, IB; Goulet, C; Platt, RW; Robitaille, Y			Effectiveness of helmets in skiers and snowboarders: case-control and case crossover study	BRITISH MEDICAL JOURNAL			English	Article							SKIING INJURIES; ADOLESCENTS; CHILDREN	Objective To determine the effect of helmets oil the risk of head and neck injuries in skiers and snowboarders. Design Matched case-control and case crossover Study. Setting 19 sk areas in Quebec, Canada, November 2001 to April 2002. Participants 1082 skiers and snowboarders (cases) with head and neck injuries reported by the ski patrol and 3295 skiers and snowboarders (controls) with non-head or ion-neck injuries matched to cases at each hill. Main outcome measures Estimates of matched odds ratios for the effect of helmet use on the risk of any head or neck injury and for people requiring evacuation by ambulance. Results The adjusted odds ratio for helmet use in participants with any head injury was 0.71 (95% confidence interval 0.55 to 0.92), indicating a 29% reduction in the risk of head injury. For participants who required evacuation by ambulance for head injuries, the adjusted odds ratio for helmet use was 0.44 (0.24 to 0.81). Similar results occurred with the case crossover design (odds ratio 0.43, 0.09 to 1.83). The adjusted odds ratio for helmet use for participants with any neck injury was 0.62 (0.33 to 1.19) and for participants who required evacuation by ambulance for neck injuries it was 1.29 (0.41 to 4.04). Conclusions Helmets protect skiers and snowboarders against head injuries. We cannot rule out the possibility of an increased risk of neck injury with helmet use, but the estimates on which this assumption is based are imprecise.	Univ Alberta, Dept Publ Hlth Sci, Alberta Ctr Injury Control & Res, Edmonton, AB T6G 2E1, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada; Minist Affaires Municipales Sport & Loisir, Direct Promot Secur, Trois Rivieres, PQ G9A 5S9, Canada; Inst Natl Sante Publ Quebec, Montreal, PQ H2J 3G8, Canada	University of Alberta; McGill University; McGill University; Institut national de sante publique du Quebec (INSPQ)	Hagel, BE (corresponding author), Univ Alberta, Dept Publ Hlth Sci, Alberta Ctr Injury Control & Res, Edmonton, AB T6G 2E1, Canada.	brent.hagel@ualberta.ca	Hagel, Brent/AAK-3319-2020	Platt, Robert/0000-0002-5981-8443				Bridges EJ, 2003, BRIT J SPORT MED, V37, P511, DOI 10.1136/bjsm.37.6.511; Cadman R, 1996, AM SOC TEST MATER, V1266, P58, DOI 10.1520/STP37914S; Davidson TM, 1996, WESTERN J MED, V164, P310; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Hagel BE, 2004, INJURY PREV, V10, P275, DOI 10.1136/ip.2004.005546; Hagel BE, 1999, CLIN J SPORT MED, V9, P9, DOI 10.1097/00042752-199901000-00003; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; KATAGI K, 2000, SKI MAGAZINE     OCT, P219; KLEINBAUM DG, 1996, LOGISTIC REGRESSION; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; OH S, 1983, Z KINDERCHIR, V38, P66; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Rothman K., 1998, MODERN EPIDEMIOLOGY; Thompson DC, 2000, COCHRANE DB SYST REV, V2	16	118	119	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 5	2005	330	7486					281	283		10.1136/bmj.38314.480035.7C	http://dx.doi.org/10.1136/bmj.38314.480035.7C			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895EM	15632094	Green Published, Bronze			2022-12-24	WOS:000226843700014
J	Dorgan, KM; Jumars, PA; Johnson, B; Boudreau, BP; Landis, E				Dorgan, KM; Jumars, PA; Johnson, B; Boudreau, BP; Landis, E			Burrow extension by crack propagation	NATURE			English	Editorial Material							GROWTH		Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Univ Maine, Dept Civil & Environm Engn, Orono, ME 04469 USA	University of Maine System; University of Maine Orono; Dalhousie University; University of Maine System; University of Maine Orono	Dorgan, KM (corresponding author), Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA.	kelly.dorgan@umit.maine.edu		Boudreau, Bernard/0000-0002-7748-1151				ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; BOUDREAU BP, IN PRESS GEOLOGY; Broek D., 1978, ELEMENTARY ENG FRACT; ELDER HY, 1980, ASPECTS ANIMAL MOVEM, P71; FULL RJ, 1995, J EXP BIOL, V198, P2441; HAMILTON EL, 1980, J ACOUST SOC AM, V68, P1313, DOI 10.1121/1.385100; HUNTER RD, 1989, J ZOOL, V218, P209, DOI 10.1111/j.1469-7998.1989.tb02533.x; Johnson BD, 2002, MAR GEOL, V187, P347, DOI 10.1016/S0025-3227(02)00383-3; KANAZAWA K, 1992, PALAEONTOLOGY, V35, P733; Menand T, 2001, NATURE, V411, P678, DOI 10.1038/35079552; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241	11	121	122	4	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2005	433	7025					475	475		10.1038/433475a	http://dx.doi.org/10.1038/433475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690029				2022-12-24	WOS:000226727200032
J	Bertaux, JL; Leblanc, F; Perrier, SV; Quemerais, E; Korablev, O; Dimarellis, E; Reberac, A; Forget, F; Simon, PC; Stern, SA; Sandel, B				Bertaux, JL; Leblanc, F; Perrier, SV; Quemerais, E; Korablev, O; Dimarellis, E; Reberac, A; Forget, F; Simon, PC; Stern, SA; Sandel, B		SPICAM Team	Nightglow in the upper atmosphere of Mars and implications for atmospheric transport	SCIENCE			English	Article							MARTIAN ATMOSPHERE; ODD NITROGEN; VENUS; AIRGLOW; MODEL	We detected light emissions in the nightside martian atmosphere with the SPICAM (spectroscopy for the investigation of the characteristics of the atmosphere of Mars) ultraviolet (UV) spectrometer on board the Mars Express. The UV spectrum of this nightglow is composed of hydrogen Lyman a emission (121.6 nanometers) and the gamma and delta bands of nitric oxide (NO) (190 to 270 nanometers) produced when N and O atoms combine to produce the NO molecule. N and O atoms are produced by extreme UV photodissociation of O-2, CO2, and N-2 in the dayside upper atmosphere and transported to the night side. The NO emission is brightest in the winter south polar night because of continuous downward transport of air in this region at night during winter and because of freezing at ground level.	CNRS, Serv Aeron, Inst Pierre Simon Laplace, F-91371 Verrieres Le Buisson, France; Moscow Space Res Inst, Moscow 117810, Russia; Univ Paris 06, Meteorol Dynam Lab, IPSL, F-75252 Paris, France; Inst Aeron Spatiale Belgique, B-1180 Brussels, Belgium; SW Res Inst, Boulder, CO 80302 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Arizona	Bertaux, JL (corresponding author), CNRS, Serv Aeron, Inst Pierre Simon Laplace, BP 3, F-91371 Verrieres Le Buisson, France.	bertaux@aerov.jussieu.fr	Korablev, Oleg I/K-6770-2017; Korablev, Oleg/L-5083-2013	Korablev, Oleg I/0000-0003-1115-0656; Korablev, Oleg/0000-0003-1115-0656				BARTH CA, 1971, J GEOPHYS RES, V76, P2213, DOI 10.1029/JA076i010p02213; BARTH CA, 1967, SCIENCE, V158, P1675, DOI 10.1126/science.158.3809.1675; BARTH CA, 1992, MARS, P1054; Bertaux JL, 2000, PLANET SPACE SCI, V48, P1303, DOI 10.1016/S0032-0633(00)00111-2; BERTAUX JL, 2004, EUROPEAN SPACE AGENC, P95; BERTAUX JL, IN PRESS ADV SPACE R; BOUGHER SW, 1990, J GEOPHYS RES-SPACE, V95, P6271, DOI 10.1029/JA095iA05p06271; Bougher SW, 1997, SPACE SCI S, P259; FELDMAN PD, 1979, NATURE, V279, P221, DOI 10.1038/279221a0; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Fox J. L., 1992, VENUS MARS ATMOSPHER, V66, P191, DOI [10.1029/GM066p0191, DOI 10.1029/GM066P0191]; GERARD JC, 1981, GEOPHYS RES LETT, V8, P633, DOI 10.1029/GL008i006p00633; GERARD JC, 1988, ICARUS, V75, P171, DOI 10.1016/0019-1035(88)90135-2; HEDIN AE, 1983, J GEOPHYS RES-SPACE, V88, P73, DOI 10.1029/JA088iA01p00073; KEATING GM, 2003, P MARS ATM MOD OBS W; MCCOY RP, 1983, J GEOPHYS RES-SPACE, V88, P3197, DOI 10.1029/JA088iA04p03197; QUEMERAIS X, UNPUB; STEWART A. M., 1961, AUSTRALIAN JOUR EXPTL AGRIC AND ANIMAL HUSBANDRY, V1, P85; STEWART AI, 1979, SCIENCE, V203, P777, DOI 10.1126/science.203.4382.777; STEWART AI, 1979, SCIENCE, V205, P59, DOI 10.1126/science.205.4401.59	20	79	80	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					566	569		10.1126/science.1106957	http://dx.doi.org/10.1126/science.1106957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681381				2022-12-24	WOS:000226694000043
J	Green, RE; Cornell, SJ; Scharlemann, JPW; Balmford, A				Green, RE; Cornell, SJ; Scharlemann, JPW; Balmford, A			Farming and the fate of wild nature	SCIENCE			English	Article							10 BILLION PEOPLE; LOS-TUXTLAS; POPULATION; WORLD; LAND; BIODIVERSITY; ENVIRONMENT; COUNTRYSIDE; DIVERSITY; HABITATS	World food demand is expected to more than double by 2050. Decisions about how to meet this challenge will have profound effects on wild species and habitats. We show that farming is already the greatest extinction threat to birds (the best known taxon), and its adverse impacts took set to increase, especially in developing countries. Two competing solutions have been proposed: wildlife-friendly farming (which boosts densities of wild populations on farmland but may decrease agricultural yields) and land sparing (which minimizes demand for farmland by increasing yield). We present a model that identifies how to resolve the trade-off between these approaches. This shows that the best type of farming for species persistence depends on the demand for agricultural products and on how the population densities of different species on farmland change with agricultural yield. Empirical data on such density-yield functions are sparse, but evidence from a range of taxa in developing countries suggests that high-yield farming may allow more species to persist.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7701 Rondebosch, South Africa	University of Cambridge; Royal Society for Protection of Birds; University of Leeds; University of Cape Town	Green, RE (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	reg29@hermes.cam.ac.uk	Cornell, Stephen J/D-3955-2009; Scharlemann, Jorn/A-4737-2008	Scharlemann, Jorn/0000-0002-2834-6367; Balmford, Andrew/0000-0002-0144-3589				Angelsen A., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, P89, DOI 10.1079/9780851994352.0089; [Anonymous], 2003, WORLD POP PROSP 2002; Avery DT, 1997, ISSUES SCI TECHNOL, V14, P59; AVERY M., 2001, ECOS, V22, P3; Barbier EB, 1997, LAND ECON, V73, P174, DOI 10.2307/3147281; Barrett Christopher B., 2001, TRADEOFFS SYNERGIES; Bongaarts J, 1996, POPUL DEV REV, V22, P483, DOI 10.2307/2137717; Borlaug NE, 2002, IN VITRO CELL DEV-PL, V38, P221, DOI 10.1079/IVP2001279; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estrada A, 1998, J TROP ECOL, V14, P577, DOI 10.1017/S0266467498000418; Estrada A, 1997, BIODIVERS CONSERV, V6, P19, DOI 10.1023/A:1018328930981; *EUR ENV AG, 2002, 9 EUR ENV AG; FAO, 2001, GLOBAL FOREST RESOUR; FAOSTAT, 2001, FAO STAT DAT; Freudenberger MS, 2002, NATURAL RESOURCES MANAGEMENT IN AFRICAN AGRICULTURE: UNDERSTANDING AND IMPROVING CURRENT PRACTICES, P181, DOI 10.1079/9780851995847.0181; Goklany I. M., 1992, SUSTAINING DEV BIODI; Groombridge B, 2002, WORLD ATLAS BIODIVER; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; IUCN Species Survival Commission, 2001, IUCN RED LIST CAT CR; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; LOH J, 2002, LIVING PLANET REPORT; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; McNeely J.A., 2002, ECOAGRICULTURE STRAT; Myers N, 2003, P NATL ACAD SCI USA, V100, P4963, DOI 10.1073/pnas.0438061100; Pain D.J, 1997, FARMING BIRDS EUROPE; Pretty J., 2002, AGR RECONNECTING PEO; Richards J.F., 1990, EARTH TRANSFORMED HU, P163; ROBINSON JG, 1994, INT WILDL, V24, P30; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; RSPB, 2001, FUT LARG SCAL HAB RE; Southgate D., 1994, CAUSES TROPICAL DEFO, P134; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Waggoner PE, 1996, POPUL DEV REV, V22, P531, DOI 10.2307/2137720; WAGGONER PE, 1995, TECHNOL SOC, V17, P17, DOI 10.1016/0160-791X(94)00024-8	42	1302	1365	17	844	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					550	555		10.1126/science.1106049	http://dx.doi.org/10.1126/science.1106049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15618485				2022-12-24	WOS:000226694000039
J	Esnault, C; Heidmann, O; Delebecque, F; Dewannieux, M; Ribet, D; Hance, AJ; Heidmann, T; Schwartz, O				Esnault, C; Heidmann, O; Delebecque, F; Dewannieux, M; Ribet, D; Hance, AJ; Heidmann, T; Schwartz, O			APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses	NATURE			English	Article							EDITING ENZYME APOBEC3G; MAMMALIAN-CELLS; VIF PROTEIN; ANTIRETROVIRAL FACTOR; INDICATOR GENE; HIV-1; DNA; RETROELEMENTS; GENOME; MOBILE	Endogenous retroviruses are multicopy retroelements accounting for nearly 10% of murine or human genomes(1,2). These retroelements spread into our ancestral genome millions of years ago and have acted as a driving force for genome evolution(2-4). Endogenous retroviruses may also be deleterious for their host, and have been implicated in cancers and autoimmune diseases(5). Most retroelements have lost replication competence because of the accumulation of inactivating mutations, but several, including some murine intracisternal A-particle (IAP) and MusD sequences, are still mobile(6,7). These elements encode a reverse transcriptase activity and move by retrotransposition, an intracellular copy-and-paste process involving an RNA intermediate. The host has developed mechanisms to silence their expression, mainly cosuppression and gene methylation(4,8). Here we identify another level of antiviral control, mediated by APOBEC3G, a member of the cytidine deaminase family that was previously shown to block HIV replication(9-12). We show that APOBEC3G markedly inhibits retrotransposition of IAP and MusD elements, and induces G-to-A hypermutations in their DNA copies. APOBEC3G, by editing viral genetic material, provides an ancestral wide cellular defence against endogenous and exogenous invaders.	Inst Gustave Roussy, CNRS, UMR8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; Inst Pasteur, Dept Virol, CNRS, URA 1930,Virus & Immun Grp, F-75015 Paris, France; Hop Bichat Claude Bernard, INSERM, U552, F-75018 Paris, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR8122, Unite Retrovirus Endogenes & Elements Retroides E, Rue Camille Desmoulins, F-94805 Villejuif, France.	heidmann@igr.fr; schwartz@pasteur.fr	Ribet, David/AAA-6659-2020; Schwartz, Olivier/AAZ-3765-2021	Ribet, David/0000-0003-1175-6471; Schwartz, Olivier/0000-0002-0729-1475; Dewannieux, Marie/0000-0003-3918-2414				Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Baust C, 2003, J VIROL, V77, P11448, DOI 10.1128/JVI.77.21.11448-11458.2003; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Boeke J. D., 1997, P343; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lower R, 1999, TRENDS MICROBIOL, V7, P350, DOI 10.1016/S0966-842X(99)01565-6; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	30	261	271	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2005	433	7024					430	433		10.1038/nature03238	http://dx.doi.org/10.1038/nature03238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674295				2022-12-24	WOS:000226546200046
J	Gartenberg, MR; Neumann, FR; Laroche, T; Blaszczyk, M; Gasser, SM				Gartenberg, MR; Neumann, FR; Laroche, T; Blaszczyk, M; Gasser, SM			Sir-mediated repression can occur independently of chromosomal and subnuclear contexts	CELL			English	Article							YEAST KU; NUCLEAR ARCHITECTURE; SILENCING PROTEINS; TELOMERES; CHROMATIN; DYNAMICS; ORGANIZATION; MOTION; GENES; LOCI	Epigenetic mechanisms silence the HM mating-type loci in budding yeast. These loci are tightly linked to telomeres, which are also repressed and held together in clusters at the nuclear periphery, much like mammalian heterochromatin. Yeast telomere anchoring can occur in the absence of silent chromatin through the DNA end binding factor Ku. Here we examine whether silent chromatin binds the nuclear periphery independently of telomeres and whether silencing persists in the absence of anchorage. HMR was excised from the chromosome by inducible site-specific recombination and tracked by real-time fluorescence microscopy. Silent rings associate with the nuclear envelope, while nonsilent rings move freely throughout the nucleus. Silent chromatin anchorage requires the action of either Ku or Esc1. In the absence of both proteins, rings move throughout the nucleoplasm yet remain silent. Thus, transcriptional repression can be sustained without perinuclear anchoring.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08901 USA; Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland; Univ Geneva, Frontiers Genet NCCR Program, CH-1211 Geneva, Switzerland; Univ Lausanne, Inst Appl Math, CH-1015 Lausanne, Switzerland	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Geneva; University of Geneva; University of Lausanne	Gartenberg, MR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	gartenbe@umdnj.edu		Gartenberg, Marc/0000-0003-0713-7993; Neumann, Frank/0000-0002-0138-6836; Gasser, Susan/0000-0003-3610-9123	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054102] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051402, GM54102] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Holmes SG, 1997, GENETICS, V145, P605; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Maillet L, 2001, EMBO REP, V2, P203, DOI 10.1093/embo-reports/kve044; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692	49	145	149	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					955	967		10.1016/j.cell.2004.11.008	http://dx.doi.org/10.1016/j.cell.2004.11.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620354	Bronze			2022-12-24	WOS:000226109700008
J	McKinnell, LW; Rudnicki, MA				McKinnell, LW; Rudnicki, MA			Molecular mechanisms of muscle atrophy	CELL			English	Editorial Material							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; UBIQUITIN LIGASES; DISUSE ATROPHY; HYPERTROPHY; ACTIVATION; EXPRESSION; PATHWAY; ATROGIN-1	Skeletal muscle atrophy has extreme adverse consequences. Molecular mechanisms that mediate the process of atrophy are not well defined. Recent studies have focused on diverse molecular cascades that control the activation of ubiquitin ligases, indicating that the involvement of the ubiquitin proteasome may be common to a range of atrophic stimuli.	Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca		Rudnicki, Michael/0000-0002-3866-5249				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4	19	103	117	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					907	910		10.1016/j.cell.2004.12.007	http://dx.doi.org/10.1016/j.cell.2004.12.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620349	Bronze			2022-12-24	WOS:000226109700003
J	Sullenger, BA				Sullenger, BA			Riboswitches - To kill or save the messenger	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE-EXPRESSION		Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University	Sullenger, BA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.							Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844	5	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2759	2760		10.1056/NEJMcibr043522	http://dx.doi.org/10.1056/NEJMcibr043522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616213				2022-12-24	WOS:000225877300015
J	Sharp, D				Sharp, D			Safe bubbly	LANCET			English	Editorial Material							EYE; INJURY		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							*AM AC OPHTH, 2004, POP OP BOTTL BUBBL R; ARCHER D, 1967, LANCET, V2, P487; BRAZIER DJ, 1984, LANCET, V2, P1335; Kuhn F, 1998, OPHTHALMOLOGE, V95, P332, DOI 10.1007/s003470050282	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2165	2165		10.1016/S0140-6736(04)17610-1	http://dx.doi.org/10.1016/S0140-6736(04)17610-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610790				2022-12-24	WOS:000225799700010
J	Diamond, J				Diamond, J			The astonishing micropygmies	SCIENCE			English	Editorial Material							INDONESIA; HOMININ; FLORES		Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Jones R., 1977, SUNDA SAHUL PREHISTO, P317; Jones R., 1977, SUNDA SAHUL PREHISTO, P113; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Sim R, 1994, ARCHAEOLOGY IN THE NORTH, P358	6	14	14	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2047	2048		10.1126/science.1107565	http://dx.doi.org/10.1126/science.1107565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604394				2022-12-24	WOS:000225841000046
